>XP_042375699.1 putative disease resistance RPP13-like protein 3 isoform X2 [Zingiber officinale]
MAETIAPIVQLVASTIAGPIANEGQILLTVEEKVGWLHRELRRMHSFLADAERSATDDPQSSRWISEIRD
LVYDSEDIIDAFDAIGTYPVACFFCHLRSRHQIGSRILELKSRLDEFFRSKSDYGIPTDGGPNSDDRWIH
GLLASSPLIHQGDFVGFESHFNEVIDWAMSDRQELSVLSLVAMGGSGKTTLVKRVFNHNVVKRRFDRLAW
IYVSKSFRMRNLFKEVAKGLMTMPSEEVNALNEKQLQELLLETLKEKRFLLVLDDVWDASVWEAIRLVLP
RNENGSRVIITTRNSAVASSITEVKSCCHELQPLSFEQSWELFCRKVFPESEPCPDELKEDAEGIVKNCH
GLPLAIVTIGGMMSRKGRSQLEWNNVLAKMYSNLIGNEVEVQGPLFLSYKHLPYPLKSCFLLFSIFPHDS
NIRSKKLIRLLMAEGLVKEGEGEGERMEDVAEKYLMELINRSMIQISILGSTGRVKTFRIHHLIHQLSIS
IAKMQSFSIVHEDRRAKHPNNAYRISLQKSSYDALNNTGTNI


>XP_042375707.1 putative disease resistance RPP13-like protein 3 isoform X3 [Zingiber officinale]
MAETIAPIVQLVASTIAGPIANEGQILLTVEEKVGWLHRELRRMHSFLADAERSATDDPQSSRWISEIRD
LVYDSEDIIDAFDAIGTYPVACFFCHLRSRHQIGSRILELKSRLDEFFRSKSDYGIPTDGGPNSDDRWIH
GLLASSPLIHQGDFVGFESHFNEVIDWAMSDRQELSVLSLVAMGGSGKTTLVKRVFNHNVVKRRFDRLAW
IYVSKSFRMRNLFKEVAKGLMTMPSEEVNALNEKQLQELLLETLKEKRFLLVLDDVWDASVWEAIRLVLP
RNENGSRVIITTRNSAVASSITEVKSCCHELQPLSFEQSWELFCRKVFPESEPCPDELKEDAEGIVKNCH
GLPLAIVTIGGMMSRKGRSQLEWNNVLAKMYSNLIGNEVEVQGPLFLSYKHLPYPLKSCFLLFSIFPHDS
NIRSKKLIRLLMAEGLVKEGEGEGERMEDVAEKYLMELINRSMIQISILGSTGRVKTFRIHHLIHQLSIS
IAKMQSFSIVHEDRRAKHPNNAYRISLQKSSYDALNNTDT


>XP_042375889.1 disease resistance protein RGA2-like [Zingiber officinale]
MSTALAIGGWFAQGFIQTLLDKASDSAVQRLAGLRGLDGDLRRLRASLFKIHALLDMAERRRCNSSNLVE
LMKQLKDASFDAENLLDEFEYQNLKHKIEGQASDFFTLAFNAAKNFFSADGDGFGSRLRAIQEKLCEIAA
DMIDIMQLLSMDDAGRQSTGKLVRRETSSFLTEEIVFGRDNEREKVIALLLGSAEGSESSNHVFSVLPLV
GIGGVGKTTLAQLVYNDDRVGNYFQLKIWICVSDDFDVKRLTKELIESTTKEEQSGLTNLDTLQSRLKEK
IELKRFLLVLDDVWSENKDEWDKLCAPLSFGAHGSKIIVTTRHTKVASIVGTVSTIFLHGLEDDALWELF
KKHAFASQIVVEEHPELVIIGREIASKLKGSPLAAKTLGSLLRSDLNEQHWRTIMESEVWQLPQQENEIL
PVLQLSYHYLSGHLKQCFAFCSVFRKDYIFCEHTLVSIWMAEGFIAPQENMRMEDVGSSCFHELVSRSFF
QETQRRGRFVMHDLIHDLAQFVSVGECHRVDGDKFEEIPKTICHLSATLTAQRKLMEFSGYHKLRTLMIN
YQNNQNQFVLRIETPLVPDDLFRRLKDIRVLSLPKCGMKELTETIGEIIHLRYLDISYNSGIVKLPESLC
VLYNLQVLRLCGCQLQGFPQGMSNLINLRQLHAADEIISKVKEVGKLISLQELPIFKVLKYDDGHKLAQL
CDLKQLHGELTISNLENVNSEEEASLAKLKNKKYLDALKLEWKAGQESNLEKEHVSEEVLEGLQPHHSLR
SLTIRRYNGGVLPSWLQASPVLKLETLKLESCKRCRDLSCTGELPLLKVLHIKGMPQVKQISPSLCCHTK
SKFFQQLHELVLEDMLALEELPDLGQLPYLKSIQMKGMNALRCIGNGFHGANGSNWFPRLEKLRLQNMQA
MEELPFLGHLPCLKVIDIRQMPALKHIYHAHYDSIERNWFSTLEVMVLENMLSLEELPCLGQLPCVKYLR
LDIKKIAHGFFRVPSENNWLPKLEKLELKGIPGYEELPSLEQLPHLTVLHLDGMTSVKAIRQGCTFTAEQ
IKCFSRLEELVFRDMPTWEEWSWAEGGEHFACLCRLKIAQCPKLKQLPPLPACLLELELIHVGLTELPGL
WKGTNGNSRSKISSLTRLHISECPSLRNLEEGLLSNHLPHINSILILDCVELMFLPVKKFSELTSLEMFS
VRHCPKLMMTQSQDIDVQLPTSIKILGLCNCASFGKSLPGCLYSLSLLTRLSISNCPHMETLPGEAMLHL
KQLWDVSIKSCDELRSIGGITFLSTLTRLELADCPKLLLNGMVEEGKCLSLLELRVDNTALLKVSPILNS
LPSIHFLYIFSSYQAVMFDGEDQGLLQSLTAIKCLEFGFCKNLKSLPTELHSLPSLKSLALFECPEIQSL
PEKGLPPFLTDLRFQGCHSLLTKKLEEHLQEIKNSGRFDSVFA


>XP_042377360.1 disease resistance protein RGA2-like [Zingiber officinale]
MKDDYEYRLIYLKSLAIAAAMDIVSPILEISGVNHVINKLVDKTTNYLQDQCYWETYLQEELKSLQDLLP
QIEAVVSFAEHRLTSYESSDRALIKWLWKFRDVIDEAEDVLDELEYFELKKKANSDKNRLSRRVDASVKA
AKRLLKFDDVLARLRTCVKNLNTSASDVGKFLALVAPTGGADIGQTQQGILPLSQQSRITSSLPVLSFKG
REKEKQIIIQFLLGEEAEIQISENVHCLPLVGMGGMGKTSLAQQVFDHFKTVKKEHFDIKIWVCDSLPDL
NASNLIKKILEYLTGGSESGPLELIPEKLKEKLHSKRFLLILDDVWDDKNQREWEKLCAPLLYGQKGSWV
LLTTRSKSVANMVAREIRGTMMPMMLQGLSEDECRSLLYEYAFAGQDPNGFPLLKEIGTEILKKLKGVPL
LAKSIGGALNSKLEVDHWTSILRSELWKRPQDSTYNFIPALTLSYVMHPPRLKRCFAYCSIFPQDYKFNK
QKLVCMWVAAGLIYSDGLEEGSNEEDIANCCFDMLCNKSFFDVHHFYQSPFFYNKVPYALEEDYYTMHDM
LNCLACHISQYECCRIVDGTTPSLILDNNTIRHIYITCSNAQLHDLANIVSKLKHLRTLWIEYDGDRQQF
EDFIRDACKSPRRIRVLIMDSNLSDRCLKSISNFVKIRFLQIQNKFLPSISMRKFYFLQVLMGEVNILAK
DVKDVKDANKLTNLRHLYKVHEDALLSVAKVGKLTSLLELCFTVGTKPRYRIDELMNMDNLRQLKIKQLS
NVRSLEEANMVNLVKKRYLIRLELDWNDASNPVDDASNPELDQPVLAALQPYSTIRELTIRGYKGGRAAP
WMDTPSLSLLENLQLNDCTSLEELPSLWKLPCLKFLELNKMNAIRSLGCHFFGQIDIQFPVLEEL


>XP_042377374.1 disease resistance protein RGA2-like [Zingiber officinale]
MDVVSPILQVSGASHVVNKLVDKATTYVRDQYYWKTDLQEELQNLRRLLPQIQVIVGFAEDRLTSYGSSN
RALMEWLGQFRDGIDEAEEVLDELEYLELEKKANSDKNRLSKTVDGSVKAAKRFLKFDDLLIERLRACVK
NLNASASNAHNFLAILGHTGGIGTGQMQQEFLPLTDQSRITSSLPEVLFKGREEQKQEIIRYLSGESVEE
SEIQMSENVHCLPLVAMGGMGKTTLAQQVFDHFENMKKEHFGIRIWVCDSLPDLDATSILKKILDSTRQS
DDSSTNLDASSLMKKMLDLTHQSESSELLPVKLKEKLSSKKFLLVLDDAWDDKNQTAWKRLCDPLLHGQK
GSWILLTTRMESVAKMVSKVIKGTMKSMKLQGLSKDECRSLLYEHAFAGQDPDKFPQLKEIGEEILEKLK
GVPLLAKSIGGALNSKLTEDHWTSISRSELWKTPLESKYEFRPVLILSYLMLPPRLKRCFSYCGIFPQDY
EFNKQKLMYMWVAAGLIYSEESEEGSDEDIANSCFDTLCNKSFFDNRSMPRMKKIFFYDTTEEIYTMHDM
LNSLACHVSRYECCRIVHGTPSRILDSNVIRHISITYSTDAQLLDLAKMVCKLKHLQTLWIQYNGDPKKL
DDFIRDACKSPRRIRVLIVQSNDFKISNQCLKSIRDFVKIRFLEIQTIPPSLSMRKFYFLQYLIGDRYHS
HLGCLAKDSNKLTNLRHLYQVAEDALLSVAEVGKLTSLQELCFTVGTKPRYRIDELMYMNNLRQLKIKQL
SNVQSLEEANMVNLVEKRHLTSLELDWFGKRDASNPDLDQQEVLAALQPSTTIKELMIRWNKGGRPVPWM
DTPSLSRLEHLQLEFCTSWEELPPLWKLPHLKFLRLVYMKAIRSLGCPLSDRMDIQFPVLEELEFHDLPL
LEEWNGADDYVWFPLLKSVQIEKCPRLKKIPDLPLSIENLRFKDLGLEDLPRFYKCSNGSRTFGGFQQLM
FLKSLEIYKCPGIAQIGAIGEEDDHLLPSSLETLELENIEEHKDLANYLRSLTLLTKFHLHCSPGLESFP
LASELEHLTVLQDLCISDGESLTSLGDLYILKSLKSLEIFDCPKFLVAEVESEKFLKDTTRKHAVSSSSI
FDQSAGNKAARILPSSLESLKFKNSDISQERLGRCLQDLTSLRRLEVSNCQHLMSLPNIEYLHNLTALRA
LDISDCKELCELESLTTIASLIYLDIKCCPKLLATTFATLQNPATATEQSATKKKKGTLPFLERIDIDDI
FYLPMLPISEKLKRLYIESSDKEFTCFPSEIEESLLQYRKSLEYLGLDRIPHLQSLPAILESFSSLKDLC
IYSAPALKSLPRMPVSLERLRIFGCSAKLKKRCQENIGRDWPNIKHIPYIDIRAGKENKAEAQVNCNCVS
SRLWSSK


>XP_042377448.1 disease resistance protein RGA2-like isoform X2 [Zingiber officinale]
MDIVSPILEKAGASYVINKLIDAATGYVQDQYYWKTDLQGELQKLGRLLPQIQAVVDFAEPRLTMYESSN
PALIKWLWQFRNGIDEAEDVLDDLEYIELEKKANSDKSRLSRRVDTSVKAAKRLLKFDDVLGRLRACVKN
LNTFASDVQNFLALVTQTAGIGTGQMQYYHSSRITNPLPVLSFKGREDEKGKIIQYLLGESVEKSEIWIN
ESVHCLPLVAIGGMGKTVLAKQVFHHFENVKKKHFDIKIWVCDSLPDLNASSLIKKILEYQTGGSESGPL
ERLPVKLQKILHSKRFLLVLDDVWDDNNQTEWEKLCAPLVYSQKGSWIILTTRLRSVAKMISKVIRSTME
PMILRGLSNDECRSLLYEHAFYGEDPNKFPLLKEIGEEIVEKLKGVPLLAKSIGGALNSKLEADHWTSIS
RSELWKMSIDSKYEFNPVLRLSYVMLPPRLKRCFSYCSIFPQDYQFKKQKLVCMWVAAGLIYKDELEDGL
DEEDIANRCFDILCNKSFFDVHTYSRSLSHSQMLFCQRYSLYDFKEDFYTMHDMLNGLACHVSRYECCRI
VHGTPSHILDNNAIRHIYVTSSHAQLHDLAKIVSKLKHLRTLWINYHGDPQKLDDCIRYACKSSRRIRVL
IMESNYSRSSYQCLKSINDFLKL


>XP_042377449.1 disease resistance protein RGA2-like isoform X2 [Zingiber officinale]
MDIVSPILEKAGASYVINKLIDAATGYVQDQYYWKTDLQGELQKLGRLLPQIQAVVDFAEPRLTMYESSN
PALIKWLWQFRNGIDEAEDVLDDLEYIELEKKANSDKSRLSRRVDTSVKAAKRLLKFDDVLGRLRACVKN
LNTFASDVQNFLALVTQTAGIGTGQMQYYHSSRITNPLPVLSFKGREDEKGKIIQYLLGESVEKSEIWIN
ESVHCLPLVAIGGMGKTVLAKQVFHHFENVKKKHFDIKIWVCDSLPDLNASSLIKKILEYQTGGSESGPL
ERLPVKLQKILHSKRFLLVLDDVWDDNNQTEWEKLCAPLVYSQKGSWIILTTRLRSVAKMISKVIRSTME
PMILRGLSNDECRSLLYEHAFYGEDPNKFPLLKEIGEEIVEKLKGVPLLAKSIGGALNSKLEADHWTSIS
RSELWKMSIDSKYEFNPVLRLSYVMLPPRLKRCFSYCSIFPQDYQFKKQKLVCMWVAAGLIYKDELEDGL
DEEDIANRCFDILCNKSFFDVHTYSRSLSHSQMLFCQRYSLYDFKEDFYTMHDMLNGLACHVSRYECCRI
VHGTPSHILDNNAIRHIYVTSSHAQLHDLAKIVSKLKHLRTLWINYHGDPQKLDDCIRYACKSSRRIRVL
IMESNYSRSSYQCLKSINDFLKL


>XP_042377450.1 putative disease resistance protein RGA3 isoform X3 [Zingiber officinale]
MDIVSPILEKAGASYVINKLIDAATGYVQDQYYWKTDLQGELQKLGRLLPQIQAVVDFAEPRLTMYESSN
PALIKWLWQFRNGIDEAEDVLDDLEYIELEKKANSDKSRLSRRVDTSVKAAKRLLKFDDVLGRLRACVKN
LNTFASDVQNFLALVTQTAGIGTGQMQYYHSSRITNPLPVLSFKGREDEKGKIIQYLLGESVEKSEIWIN
ESVHCLPLVAIGGMGKTVLAKQVFHHFENVKKKHFDIKIWVCDSLPDLNASSLIKKILEYQTGGSESGPL
ERLPVKLQKILHSKRFLLVLDDVWDDNNQTEWEKLCAPLVYSQKGSWIILTTRLRSVAKMISKVIRSTME
PMILRGLSNDECRSLLYEHAFYGEDPNKFPLLKEIGEEIVEKLKGVPLLAKSIGGALNSKLEADHWTSIS
RSELWKMSIDSKYEFNPVLRLSYVMLPPRLKRCFSYCSIFPQDYQFKKQKLVCMWVAAGLIYKDELEDGL
DEEDIANRCFDILCNKSFFDVHTYSRSLSHSQMLFCQRLKSIATVSAADFGVPHDHI


>XP_042377451.1 putative disease resistance protein RGA3 isoform X3 [Zingiber officinale]
MDIVSPILEKAGASYVINKLIDAATGYVQDQYYWKTDLQGELQKLGRLLPQIQAVVDFAEPRLTMYESSN
PALIKWLWQFRNGIDEAEDVLDDLEYIELEKKANSDKSRLSRRVDTSVKAAKRLLKFDDVLGRLRACVKN
LNTFASDVQNFLALVTQTAGIGTGQMQYYHSSRITNPLPVLSFKGREDEKGKIIQYLLGESVEKSEIWIN
ESVHCLPLVAIGGMGKTVLAKQVFHHFENVKKKHFDIKIWVCDSLPDLNASSLIKKILEYQTGGSESGPL
ERLPVKLQKILHSKRFLLVLDDVWDDNNQTEWEKLCAPLVYSQKGSWIILTTRLRSVAKMISKVIRSTME
PMILRGLSNDECRSLLYEHAFYGEDPNKFPLLKEIGEEIVEKLKGVPLLAKSIGGALNSKLEADHWTSIS
RSELWKMSIDSKYEFNPVLRLSYVMLPPRLKRCFSYCSIFPQDYQFKKQKLVCMWVAAGLIYKDELEDGL
DEEDIANRCFDILCNKSFFDVHTYSRSLSHSQMLFCQRLKSIATVSAADFGVPHDHI


>XP_042377487.1 putative disease resistance protein RGA3 [Zingiber officinale]
MDVVSPIMEKAGARCVINKLIDAATTYVRDQYYWKTDLKEELQSLRRLLPQIEAVVDFAEHRLTMYESSN
RALMEWLWQFRNGIEEAEEVLDELEYLELKKKVNRDKNRLSLTVDASVKTAKRLLKFDDVLERLRTCVKN
LNTSASDVQNFLTLVTQKDGNSNGQMQCYLSSRITNPLPVLSFKGREEEKGKIIRYLLGESVEESKIQMS
ENVHCLPLVAMGGMGKTALAKQVFDHFENVKKEHFDIKIWICDSLPNLDASSLMKKILKYLTCQSESDPL
ELVAVKLKEKLHSKRFLLVLDDAWDDKNQTEWDKLCDPLLYGQKGSWILLTTRLRSVAKIVSKVIKRGTM
EPMILQGLSNDACRSLLYEHAFVGRDPNGFPLLREIGEEIIEKLKGVPLLVKSIGGALNSKLEADHWTSI
SRSELWKMPQDSKYEFSPVLTLSYVMLPPRLKRCFSYCGIFPQDYRFNKQKLVCMWVAAGLIYSEESEAG
SDEDIANCCFDMLCNKSFFDVHIYGQIWSSFWERNSLYDLEEDYYTMHDMLSCLACHVSRYECCKIVHDA
PSCILDYNAVRHLSITSNLVQLHDLAKMVCKFQHLRTLWIEDDGNHQQFHEVILDACKSPRRIRVLIMES
NYSRISYPCLERISDFVKLRFLEMSRFSGPPSLSKCKFYFLQVLIGYNVIPTKDANKLTNLRHLYRVHHD
ALFSVAKVGKLTSLQELCFTVGTKPEYRIDELMNMDNLHQLTIQQLSNVRSHKEASMVNLVKKRHLTRLA
LNYWFGVSNPDGVSNSDIDHQEILAALQPPPTIRELIITGYKGGRPAPWMDTSSLSRLEYLQLHTCTSLE
ELPPLWKLPCLKFLKLHDMKAIRSLGCHFSNQMDIQFPVLENLIFYALPLWEEWNGVDSHIWFPHLKRFE
IYHCPKLKKIPDLPLSIENLKMEYLGLEALPHSYKCSNGTRTFGGFQQLMSLESLHIYQCPGIVQIGTIG
EEDDNLLPSSLKQLGLGGIFVEHKYLASYLRGLTSLTHLSLSCSRGMTSLPLANELEHLTTLQHLRIWGG
EAFISPGGLYIIKSLKSLEISNCPKFLSAEAESREFLKDKPTKHAVSSSLVFDHSASNKATSILPSSLVS
LKLENSDILQESLGRCLQGLTSLKELQVSYCHHLVSFPNIEYLHNLAAFETLDISNCKELCELESLTTLA
SLRELYIERCPKLLTTTFSTLQNPAATTEQSATKKKKGTLPSLEHIYMDEIFYLPILPIPERLNSLSIDN
IFMGNSQVFPCFPSEIEEWLLQCRESLEVLELGQMPHLQSLPASLESFSSLRSLRIDFSPELKSLSRMPT
SLKILKIYGCSAKLKKRCQENIGPDWPNISHIPDIHIIVGKDDKDEAQVNCNCVSSRLWSSR


>XP_042378549.1 probable disease resistance protein RF45 [Zingiber officinale]
MYDADDIIDICMIKGGKLLKARALSGDEDEISSFEEIGIKLVNKCDGLPLAIKAIAGVLYHQNKAKWEEV
LESDAWNMDQIEEELRPLYLSYEDLPSRFKQCFLYCSLYPQKDMFSMEIVQFWAAEGLIMSEEDNWRRDL
PTQNQRTLEDLGEEIYRELLGRNLLEAKKDELSKSFFSMHDHFRSLCANLMREEGILYRHGREFKADDNV
KVRRLSISCMGPMLVLPAQILRQACLRTLILTDSPQTKTIEDSVVRALLCLRVLDLSETSIEKIPDCIGE
LLHLRYLDLDGTNIREIPTTIGNLVNLQSLNIIRCKFLERLPVSITKLHNLRWLNMIGCPLLTYVPKGIG
KLENIYSLYGFMIGQNDSTSEEGCDLEELKNLSKLRVLIILRLERAEKGASALANKPFLKDLTLSWMRPD
EEEDDNGGGHDAQANEEEDGDGKDDGSGQRTETKEEEEDENEEVEDEGEEEEDENEEVDGEEEEKGWNEE
QISKAERICNEMSQPSSTLVHLHFYDYPGRQFPSWMTSSSLAESFPNLTYLMLLGLPCCVELLPLGTLPQ
LKYLRIESANAITTIGSQFLGSRSSAFPKLEALRFEDMPRWEEWTFNGAPLSVKLFPSLMECAIIDCPML
RALPDGLHRATNLNQLGLLRTYELGEINNITLAYRLEVAKCRGLKKISNISSLRSLVVIECGNLECVENL
DKLQHLVLICSEEMEQLPQWFMDLIEQHNNMASSHRSLKKFEMACNLQLLMSCLEGNENWDILKHIPVVE
IQTYSSKEYIRYTKDPYNYDTNIPSN


>XP_042378553.1 putative disease resistance protein RGA3 isoform X1 [Zingiber officinale]
MAMILDFFVSKFMTITANMVEVEIFKVLGVDKEIKALQERLGTINGYLHEAKEKRHENDEIDLWVRKLKD
VMYDADDVIDLCMIEGGKLLKARALSGSTTINIPFNYLFSCFQCLKYRHDIANQIIALNNRLEDLKKDIV
IRSNLDRTTKESIEYVNRLVTHETSHLQVEGDIIGTQIKNATEVLVNLILENNPKKYRVLGVVGTGGIGK
STLASKIFEDERIKDNFSNRIWLYVSKNYTESDLLKNLIRSAEGSETKGENLEGKSKVELENKLVSILTQ
NTFIVLDDVWNSSVWVDFLRKPIMKSATSCTVLVTSRIEKIVMLMKPRYIHPVEKMDEESGWTLLKHLVF
DVEGDEDEISSFEEIGIKLVNKCDGLPLAIKAIAGVLYQQNKAKWEDVLESDAWNMDQIEEELRPLYLSY
EDLPSRFKQCFLYCSLYPQKDMYSKEIVQFWVAEGLIMDEQDELRRDIPNKKQRTMEDLGEEIYRELLGR
NLLEAKKNDLSKSFFSMHDHFRSLCANLLREEGVLYRHGREFKVDDNVKIRRLSISCMGPMLVLPAQILR
QACLRTLILTDSPQTKTIEDSVLQALLCLRVLDLTKTSIEKIPDCIGDLLHLRYLDLDETNIREIPTTIG
NLVNLQSLNILRCKFLERLPVSITKLHNLRWLNMIGCPLLTYVPKGIGKLENIYSLYGFMIGQNDSTEEG
CDLEELKNLSKLRVLIILRLERAEKGASALANKPFLKDLTLSWMRPNEEEDDNGGGHDAQANEEEDGDGK
DDGSGQRTETKEEEEDENEEVEDEGEEEEDENEEVDGEEEEKGWNEVQISKAERICNEMSQPSSTLIHLH
FYEYCGRQFPSWMASSSLAESFPNLTYLKLVGLPCCTELPPLGTLPQLKFLSIVSANAITAIGSQFLGSR
SSAFPKLEVLRFEDMPKWEEWTFKGTPLAVKLFPSLRSCAIINFPKLRALPDDLHRAANLNELYLFQTYE
LREINNLPLAYKLKVANGRGLKKISNIPSLRYLEVDDCPNLECVENLDKLQHLVLICSEEMEQLPQWFQD
LIEQHNNMASTHRSLKKFEMHCNLQLLMSCLEGNENWDILKHIPVVKIQTYSSKEYIRYTKDPYNYDANI
PSN


>XP_042378554.1 putative disease resistance protein RGA3 isoform X1 [Zingiber officinale]
MAMILDFFVSKFMTITANMVEVEIFKVLGVDKEIKALQERLGTINGYLHEAKEKRHENDEIDLWVRKLKD
VMYDADDVIDLCMIEGGKLLKARALSGSTTINIPFNYLFSCFQCLKYRHDIANQIIALNNRLEDLKKDIV
IRSNLDRTTKESIEYVNRLVTHETSHLQVEGDIIGTQIKNATEVLVNLILENNPKKYRVLGVVGTGGIGK
STLASKIFEDERIKDNFSNRIWLYVSKNYTESDLLKNLIRSAEGSETKGENLEGKSKVELENKLVSILTQ
NTFIVLDDVWNSSVWVDFLRKPIMKSATSCTVLVTSRIEKIVMLMKPRYIHPVEKMDEESGWTLLKHLVF
DVEGDEDEISSFEEIGIKLVNKCDGLPLAIKAIAGVLYQQNKAKWEDVLESDAWNMDQIEEELRPLYLSY
EDLPSRFKQCFLYCSLYPQKDMYSKEIVQFWVAEGLIMDEQDELRRDIPNKKQRTMEDLGEEIYRELLGR
NLLEAKKNDLSKSFFSMHDHFRSLCANLLREEGVLYRHGREFKVDDNVKIRRLSISCMGPMLVLPAQILR
QACLRTLILTDSPQTKTIEDSVLQALLCLRVLDLTKTSIEKIPDCIGDLLHLRYLDLDETNIREIPTTIG
NLVNLQSLNILRCKFLERLPVSITKLHNLRWLNMIGCPLLTYVPKGIGKLENIYSLYGFMIGQNDSTEEG
CDLEELKNLSKLRVLIILRLERAEKGASALANKPFLKDLTLSWMRPNEEEDDNGGGHDAQANEEEDGDGK
DDGSGQRTETKEEEEDENEEVEDEGEEEEDENEEVDGEEEEKGWNEVQISKAERICNEMSQPSSTLIHLH
FYEYCGRQFPSWMASSSLAESFPNLTYLKLVGLPCCTELPPLGTLPQLKFLSIVSANAITAIGSQFLGSR
SSAFPKLEVLRFEDMPKWEEWTFKGTPLAVKLFPSLRSCAIINFPKLRALPDDLHRAANLNELYLFQTYE
LREINNLPLAYKLKVANGRGLKKISNIPSLRYLEVDDCPNLECVENLDKLQHLVLICSEEMEQLPQWFQD
LIEQHNNMASTHRSLKKFEMHCNLQLLMSCLEGNENWDILKHIPVVKIQTYSSKEYIRYTKDPYNYDANI
PSN


>XP_042378555.1 putative disease resistance protein RGA3 isoform X1 [Zingiber officinale]
MAMILDFFVSKFMTITANMVEVEIFKVLGVDKEIKALQERLGTINGYLHEAKEKRHENDEIDLWVRKLKD
VMYDADDVIDLCMIEGGKLLKARALSGSTTINIPFNYLFSCFQCLKYRHDIANQIIALNNRLEDLKKDIV
IRSNLDRTTKESIEYVNRLVTHETSHLQVEGDIIGTQIKNATEVLVNLILENNPKKYRVLGVVGTGGIGK
STLASKIFEDERIKDNFSNRIWLYVSKNYTESDLLKNLIRSAEGSETKGENLEGKSKVELENKLVSILTQ
NTFIVLDDVWNSSVWVDFLRKPIMKSATSCTVLVTSRIEKIVMLMKPRYIHPVEKMDEESGWTLLKHLVF
DVEGDEDEISSFEEIGIKLVNKCDGLPLAIKAIAGVLYQQNKAKWEDVLESDAWNMDQIEEELRPLYLSY
EDLPSRFKQCFLYCSLYPQKDMYSKEIVQFWVAEGLIMDEQDELRRDIPNKKQRTMEDLGEEIYRELLGR
NLLEAKKNDLSKSFFSMHDHFRSLCANLLREEGVLYRHGREFKVDDNVKIRRLSISCMGPMLVLPAQILR
QACLRTLILTDSPQTKTIEDSVLQALLCLRVLDLTKTSIEKIPDCIGDLLHLRYLDLDETNIREIPTTIG
NLVNLQSLNILRCKFLERLPVSITKLHNLRWLNMIGCPLLTYVPKGIGKLENIYSLYGFMIGQNDSTEEG
CDLEELKNLSKLRVLIILRLERAEKGASALANKPFLKDLTLSWMRPNEEEDDNGGGHDAQANEEEDGDGK
DDGSGQRTETKEEEEDENEEVEDEGEEEEDENEEVDGEEEEKGWNEVQISKAERICNEMSQPSSTLIHLH
FYEYCGRQFPSWMASSSLAESFPNLTYLKLVGLPCCTELPPLGTLPQLKFLSIVSANAITAIGSQFLGSR
SSAFPKLEVLRFEDMPKWEEWTFKGTPLAVKLFPSLRSCAIINFPKLRALPDDLHRAANLNELYLFQTYE
LREINNLPLAYKLKVANGRGLKKISNIPSLRYLEVDDCPNLECVENLDKLQHLVLICSEEMEQLPQWFQD
LIEQHNNMASTHRSLKKFEMHCNLQLLMSCLEGNENWDILKHIPVVKIQTYSSKEYIRYTKDPYNYDANI
PSN


>XP_042378556.1 putative disease resistance RPP13-like protein 1 isoform X2 [Zingiber officinale]
MAMILDFFVSKFMTITANMVEVEIFKVLGVDKEIKALQERLGTINGYLHEAKEKRHENDEIDLWVRKLKD
VMYDADDVIDLCMIEGGKLLKARALSGDEDEISSFEEIGIKLVNKCDGLPLAIKAIAGVLYQQNKAKWED
VLESDAWNMDQIEEELRPLYLSYEDLPSRFKQCFLYCSLYPQKDMYSKEIVQFWVAEGLIMDEQDELRRD
IPNKKQRTMEDLGEEIYRELLGRNLLEAKKNDLSKSFFSMHDHFRSLCANLLREEGVLYRHGREFKVDDN
VKIRRLSISCMGPMLVLPAQILRQACLRTLILTDSPQTKTIEDSVLQALLCLRVLDLTKTSIEKIPDCIG
DLLHLRYLDLDETNIREIPTTIGNLVNLQSLNILRCKFLERLPVSITKLHNLRWLNMIGCPLLTYVPKGI
GKLENIYSLYGFMIGQNDSTEEGCDLEELKNLSKLRVLIILRLERAEKGASALANKPFLKDLTLSWMRPN
EEEDDNGGGHDAQANEEEDGDGKDDGSGQRTETKEEEEDENEEVEDEGEEEEDENEEVDGEEEEKGWNEV
QISKAERICNEMSQPSSTLIHLHFYEYCGRQFPSWMASSSLAESFPNLTYLKLVGLPCCTELPPLGTLPQ
LKFLSIVSANAITAIGSQFLGSRSSAFPKLEVLRFEDMPKWEEWTFKGTPLAVKLFPSLRSCAIINFPKL
RALPDDLHRAANLNELYLFQTYELREINNLPLAYKLKVANGRGLKKISNIPSLRYLEVDDCPNLECVENL
DKLQHLVLICSEEMEQLPQWFQDLIEQHNNMASTHRSLKKFEMHCNLQLLMSCLEGNENWDILKHIPVVK
IQTYSSKEYIRYTKDPYNYDANIPSN


>XP_042378558.1 putative disease resistance RPP13-like protein 1 isoform X1 [Zingiber officinale]
MQNKYHTPKFVSPFLFHIPIMAMVLDFFISKFITATTNMMETEIFKVLGVDKEIKALQERLGTINGYLRQ
AEQKRHGNDEIDIWMQKLKDLMYDADDIIDLCIIEGGMLLKARALSGSSTVSIPFSYLFSCFQCLKYRHD
IANQIIALNSKIEDLKKDTVIKNNLDWATKVPVEYVNRVITHETSHLQVEGDIVGTQIETATETLINWIV
KKNPKCRVFGVVGTGGIGKSTLARKIFEDERIKDYFPNRKWLYVSKNYIEIDLLKKLIRFDEGSETNGEI
LEGKSKAELENKLVSILTRNTFIVLDDVWNSSVWADCLRIPIMKGAASCTVLVTSRKEQVVTLMKATYIY
PVEKMNDESGWNLLKHLAFEGEGDEDQISSFEEIGIKLVNKCDGLPLAIKAIAGVLYQQNKAKWEEVLQS
DAWNMDQIKEELRPLYLSYEDLPSSLKQCFLYCSLYPQKDMYSKEIVQFWVTEGLIMDEQDKLRRDLPTE
KQRTKEDIGEEIYRELLCRNLLEVDVDLDMSKSFFSMHDHFRSLGAHLMREEGILYRHGREFKVDDNIKI
RRLSISCMGPKLVLPAQVLRQGCLRTLILTDSPKTKTIEDSVLRALPCLRVLDLTKTSIEKIPDCIGDLL
HLRYLDLDGTNISEIPTSIGNLVNLQSLNISECEFLERLPVSITKLHNLRWLDMRDSPMLTHVPKGIGKL
ENFYNLEGFMVGQNGSASEEGCDLEELKNLSELRVLSIYRLERAEGGASALANMPFLMELVLGWKRPDEE
EDAKADEEVEGDGKDDGDADKDMGDGDDDGSGAEDENEETEKEDENEEDSEEEDKGWSEEQISKAERICN
EMTQPSSTIFDLLFSQYPGRQFPIWMQSSSLAESFPNLTYLKLIRLPCCTKLPPLGTLPQLKYLRIESAT
AITTIGSQFLGSRSSAFPKLEMLQFQDMPSWEEWTFNGTPLAVKLFPILRTCNIIDCPNLRALPEGLCRA
TNFNQLCLHETYELGEIDNLALAYRLEVTNGIELKKISNIPSLRYLAVDGCPSLECVENLGKLQHLALIC
SEETEQLPQWLLGLIEQHNNTASTQRSLRKFEMQCNLQLLKSCLEGNENWDIIKQIPNVKIQTYSSQEYM
FYTKDPYNYDAKIPSN


>XP_042378560.1 putative disease resistance RPP13-like protein 1 isoform X2 [Zingiber officinale]
MKGAASCTVLVTSRKEQVVTLMKATYIYPVEKMNDESGWNLLKHLAFEGEGDEDQISSFEEIGIKLVNKC
DGLPLAIKAIAGVLYQQNKAKWEEVLQSDAWNMDQIKEELRPLYLSYEDLPSSLKQCFLYCSLYPQKDMY
SKEIVQFWVTEGLIMDEQDKLRRDLPTEKQRTKEDIGEEIYRELLCRNLLEVDVDLDMSKSFFSMHDHFR
SLGAHLMREEGILYRHGREFKVDDNIKIRRLSISCMGPKLVLPAQVLRQGCLRTLILTDSPKTKTIEDSV
LRALPCLRVLDLTKTSIEKIPDCIGDLLHLRYLDLDGTNISEIPTSIGNLVNLQSLNISECEFLERLPVS
ITKLHNLRWLDMRDSPMLTHVPKGIGKLENFYNLEGFMVGQNGSASEEGCDLEELKNLSELRVLSIYRLE
RAEGGASALANMPFLMELVLGWKRPDEEEDAKADEEVEGDGKDDGDADKDMGDGDDDGSGAEDENEETEK
EDENEEDSEEEDKGWSEEQISKAERICNEMTQPSSTIFDLLFSQYPGRQFPIWMQSSSLAESFPNLTYLK
LIRLPCCTKLPPLGTLPQLKYLRIESATAITTIGSQFLGSRSSAFPKLEMLQFQDMPSWEEWTFNGTPLA
VKLFPILRTCNIIDCPNLRALPEGLCRATNFNQLCLHETYELGEIDNLALAYRLEVTNGIELKKISNIPS
LRYLAVDGCPSLECVENLGKLQHLALICSEETEQLPQWLLGLIEQHNNTASTQRSLRKFEMQCNLQLLKS
CLEGNENWDIIKQIPNVKIQTYSSQEYMFYTKDPYNYDAKIPSN


>XP_042378561.1 disease resistance protein RGA2-like isoform X1 [Zingiber officinale]
MTMVLDFFVSKFIAATTNMMETEIFKVLGVNKEIKTLQERLGAINGYLRQAERKRHGNDEIDLWVRKLKD
IMYDIDDVIDLCMIEGGKLLKSQALSSSTTVSIPFNYLFSCFQCLKYRHDIANQIIALNSKLEDLKNDTF
IKNNLDWVTKEQVEYVNRVITYETSHLQIEGDVIGTQIEIAIETLIDWILKNNPNKCRVFGVVGTGGIGK
STLAGKIFEDERIKDYFPNRKWLYVSKNYMESDLLKKLIKFGEGSETKGEYLEGKSKAELENILVSVLTQ
NTFIVLDDVWNSSVWVDFLRKPIMKSASSCTVLVTTRKENIVKLMKPTYIHLVEKMDEESGWNLLKHLVF
EGEGDEDEISSFEEIGIKLVNKCDGLPLAIKAIAGVLYQQNKARWVEVLQSDAWNMNQIEEELRPLYLSY
EDLPSSLRQCFLYCSLYPQKYMFSKEVIQFWIAEGLIMDEQDKLRMDLPTEKLRTMEDIGDEIYRELLGR
NLLEANEYEESKNFFSMHDHFRSLCANLMREEGILYRHGREFKAGDIVKIRRLSVSYMGPNLVLPDQIIR
QACLRTLILTDSPKTKTIEDRVLQALPCLRVLDLTKTSIEKIPDCIGDLLHLRYLDLDGTNIREIPTTIG
NLVNLQSLNISDCEFLERLPVSITKLHNLRSLNMNDCPLLTYVPKGIGKLENFYSLDGFIVGQNDSASEE
GCDLEELKNLSELRILSIYRLDRAAGGASALANKPFLKVLMLSWMQPDEEEEEEDGRWVEVKANEEADGD
GKDDGSGQGTEIKEEEEDVNEEVEREEEEKGWSEEQISKAERICNEMAQPSSTLFQLHLGEYPGRQFPSW
MASSSLAESFPNLAYLNLFGLPCCAELLPLGTLPQLKYLRIKSASAITTIGSQFLGSRSSAFPKLQVLIF
NDMPAWEEWTFNGTPLAVKLFPSLRECVIIDCPELRALPEGLHRATNLYRVCLRQTYELGEIENLTLAYR
LEVTNGIGLKKISNIPSLRYLRVGNCPNLECVENLGKLQHLVVIYSVETEQLPQWLRGLIEQHNNTASTH
RSFRKFEMHCNLSLLKSCLEGNENWDIVKQIPNVKVQTYSGQEYMRYTKDPYNYDANIPSN


>XP_042378586.1 putative disease resistance protein RGA3 [Zingiber officinale]
MAMVLDFFVSKFITATTNMMETEIFKVLGVNKEIKTLQERLGAINGYLHQVERKRHGNDEIDLWVRKLKD
IMYDADDVIDLCMIEGGKLLKSQALSSSSTVSIPFNYLFSCFQCLKYRHDIANQIIALNSKLEDLKNDTF
IKNNLDWVTKEPVEYVNRVITYETSHLQIEGDVIGTQIETAIETLIDWILKNNPNKCHVFGVVGTGGIGK
STLASKIFEDERIKDYFPNRKWLYISKNYMESDLLKKLIKFGEGSETKGENLEGKSKAELENILVSVLTQ
NTFIVLDDVWNSSVWVDFLRKPIMKCASSCTVLVTTRKENIVKLMKPTYIHPVEKMDEESGWNLLKHLVF
ESEGDEDEISSFEEIGIKLVNKCDGLPLAIKAIAGVLYQQNKAKWVEILQSDAWNMNQIKEELRPLYLSY
EDLPSSLKQCFLYCSLYPQKDMYSKEIVQSWVAEGLIMDEQDQLRRDLPIENQRTMEEIGEEMYRELICR
NLLEADASFDLSKSFFSMHDHFRSLSANLMREEGILYRHGREFKVDDTIKIRRLSISCMGPKLVLPAEIL
RQACLRTLILIDSPKTKTIEDSVLQALPCLRVLDLTKTSIEKIPDCIGDLLHLRYLDLDGTNICEIPTSI
GNLVNLQSLDISVCMYLERLPESIAKLHNLRRLDISCCPLLTYVPKGIGILEILYSLHGFMVGQNNSTSE
KGCDLEELKNLSKLRSITIDRLERAEGGASALANKPFLKQLSLSWMQPDEEEEVDNGRGDDAKANEEADG
DGTYDEDGNNDMGDGKDDGYGQGNESEEAGDTSTGSEVENEETENEEKVWSEEQISKAERICNEMTQPSS
TIFNILFRQYPGRQFPSWMTSSSLAESFPNLTYLKLLGLPCCTELPPFGTLPQLKYLNIERASSITAIGS
QFLGSRSSAFPKLEVLQFEDMPGWEEWTFNGAPLAVKLFPSLRACAIINCPKLRALPDGLHRATNLNELG
LLQTYELGEINNITLAYRLEVTNGIGLKKISNIPSLRYLEVNDCPNLECVENLGKLQHLDLVCSEEMEQL
PLWLRGLIEQHNNTASTHRSLKKFEMRCNRQLLKSCLEGNENWDIIEQIPNVKVQTYSGQEYLFYTKDPY
NYDAKIDSTPTMATLRQKINALRQLQLSQIQA


>XP_042378607.1 putative disease resistance protein RGA1 [Zingiber officinale]
MEAALVGAASRFMVDKVAVLLKLDEKLKTITGTKRKMEKLKELAPIIDTVIQHIESRPLMEDAVKELLKK
LKYLAYDLEDVVDYYDTKVFQKKQRSKSLLRPVSVFFSADNQVAFKSRVGGMIKAITDSLDSILLQNSIL
SNLLQEQGSIPMSEPSLNNRETHSRNSFVVIGREPEKNKIVDMLTKDDDDDDDDESHHGTVKVIAIVGMG
GLGKTTLAQHVYNDARVQDHFASPTMWKVVGAEFNPTKIMKSLLELATGGSSVNSFEIDLVKRKLEEELS
GKRFLLVLDDVWNDNELQWGVLKAALTCGARGSKILVTTRSKWVSSIMSSSDTTHQLQQLSGDDCLSLFQ
RFAFGDQAVDQNLMAIGAKVVEKCGGVPLAAISLGSMLRSTREENYWSSVLNSEIWKLGNQEDKVLAVLK
LSYDALPLRSKRCFAFASLFSKDVTMKKDELIKLWIANGFVRSEGNFDAETVGKHVFDDLVLRSFFLLVP
SKYVTECTMHDLMYDLARSVSADAYWNSYQDSVENFGNRTYHLQIDRRKFPNMTQDLGKKPLYLRTFMHI
YTFSHLSINLLELFSELKPLHLRALDLTHGGIREVPTSIGILIHLRYLNLSWNDIEVLPDSITLLPNLQY
FNLSFNHKLRELPKELGNIQNLRDLDLQTYSRFITHMPCGLSRLTNLRSLPLFIAGDKTGACSIIELENL
KLHGKMVIQFSEDFKNYSCDGRKILKNIDLNELCIEFNERYDKDMFVDLCPNTSLKKLDICRYRSPQFPA
WLMESQLPNLVEVSLGNCRGCELIPPFGNLQFLKKLDLDYMDGITHLGAEFHGYRGFPSLRELSLVRMFN
LEEWSESHVVDQLFPLLRKLLISWCPKLKSTPRLPRIQELKISYSESILSCIGRFTSLSLLQLTGMPDIA
SLPSGSIRNLTSLTKFQIRNCRQLQSLPVDEMQFLEMLRSLTIEECDNLVFFPSEVGSLSFLCFRWNGVI
PQPKELVQILNLVDEFQIEICDNKVDLRGQLQYLTHAQKIMSIWFTS


>XP_042378608.1 putative disease resistance protein RGA1 [Zingiber officinale]
MEAALVGAASRFMVDKVAVLLKLDEKLKTITGTKRKMEKLKELAPIIDTVIQHIESRPLMEDAVKELLKK
LKYLAYDLEDVVDYYDTKVFQKKQRSKSLLRPVSVFFSADNQVAFKSRVGGMIKAITDSLDSILLQNSIL
SNLLQEQGSIPMSEPSLNNRETHSRNSFVVIGREPEKNKIVDMLTKDDDDDDDDESHHGTVKVIAIVGMG
GLGKTTLAQHVYNDARVQDHFASPTMWKVVGAEFNPTKIMKSLLELATGGSSVNSFEIDLVKRKLEEELS
GKRFLLVLDDVWNDNELQWGVLKAALTCGARGSKILVTTRSKWVSSIMSSSDTTHQLQQLSGDDCLSLFQ
RFAFGDQAVDQNLMAIGAKVVEKCGGVPLAAISLGSMLRSTREENYWSSVLNSEIWKLGNQEDKVLAVLK
LSYDALPLRSKRCFAFASLFSKDVTMKKDELIKLWIANGFVRSEGNFDAETVGKHVFDDLVLRSFFLLVP
SKYVTECTMHDLMYDLARSVSADAYWNSYQDSVENFGNRTYHLQIDRRKFPNMTQDLGKKPLYLRTFMHI
YTFSHLSINLLELFSELKPLHLRALDLTHGGIREVPTSIGILIHLRYLNLSWNDIEVLPDSITLLPNLQY
FNLSFNHKLRELPKELGNIQNLRDLDLQTYSRFITHMPCGLSRLTNLRSLPLFIAGDKTGACSIIELENL
KLHGKMVIQFSEDFKNYSCDGRKILKNIDLNELCIEFNERYDKDMFVDLCPNTSLKKLDICRYRSPQFPA
WLMESQLPNLVEVSLGNCRGCELIPPFGNLQFLKKLDLDYMDGITHLGAEFHGYRGFPSLRELSLVRMFN
LEEWSESHVVDQLFPLLRKLLISWCPKLKSTPRLPRIQELKISYSESILSCIGRFTSLSLLQLTGMPDIA
SLPSGSIRNLTSLTKFQIRNCRQLQSLPVDEMQFLEMLRSLTIEECDNLVFFPSEVGSLSFLCFRWNGVI
PQPKELVQILNLVDEFQIEICDNKVDLRGQLQYLTHAQKIMSIWFTS


>XP_042378664.1 putative disease resistance protein RGA1 [Zingiber officinale]
MEGALVAAAARLMFDKVTALLQVDEKLKTITGTKRKMEKLKELSTIIDMVIRDIEYRPFIDDAVKDLLKK
LKYLAYDLEDVVDYYDTKVLQKKQRSKTSLGSVRDFFSADNQVVFKSRVGGMIKAITESLDSILLQKSIL
LNLPQSSIRMPEPSLCRETHSCNSFVVIGREPEKNKIVDMLTKDDDDESNHGTVKVIAIVGMGGLGKTSL
AQLVYNDARVQDHFASLTMWKVVGAEFNPTKIMKSILELATGASVNISEIDLVKQNLEKELSGRRFMLVL
DDVWNEDELQWGVLKAALTCGARGSKILVTTRSQQVSSIMGSSNSTHQIHQLSRGDCLSLFQQFAFGDQA
VDQNLMKIGEKIVEKCGGVPLAAISLGSMLRSTREENYWSSVLNSEIWKLRNEEEKVLAVLKLSYDSLPP
RSKKCFAFASLFPKNYWLAKDELIKLWIANGFVCSEGNFDAETNGNHVFNDLQMGSFFLLAPSRDYEYVS
HVTKCTMHDLMHDLARSVFADVYWNFKQDLLKDIGKRTYHLQIYLREKSSMTHVLGKKPLYLRTFMPQVT
FSRVSINLLEVFPKLKYLRALDLTDGEIREVPTSIGNLIHLRYLNLSKNKIKVLPDSITLLPNLQYLNLS
FNNRLRELPKELGKMQNLRDLNFSKSDFRLTYIPCGISRLTNLRSLPLFIASDKTDTCSIIELEDLKLHG
KMEIKFSKDFKNYSCGGRKILKNKDLTELWLEFNNSERCDKDMLDDLCPNTSLKKLTIWDYTSPQFPTWL
IELQVPNLVEVNLSNCFDCEYIPPLGNLQFLKKLELCLMNGITQMGAKFHGYRGFPSLQELILNRMYNLE
EWSESNVVDQLFPLLQKLWISNCPELKCMPRLPRIQELEILYCSKSILSCIRRLASLSVLRVKNMIDMTS
LPSDCIRTLTSLTELQITECRELQSLPGDEMQCLKMLRSLTIERCDNLASFPSEVGRLSSLCFLRLSQCP
SITLQPEELVQILNSVHDFQIQICDNKVNLRGQLQYLPILKKLSLFGSHVTNNYMIGLGLSTLSICCCHE
LESLMTAEPTSSIVLKQLYINGISYLTTLPDWLQHLKSLRFLLIEDCPQLERVPRGLKNLHMLEKLWIVR
CPQLKSRCERETGEDWPVISHVRHVDIS


>XP_042378692.1 putative disease resistance protein RGA4 [Zingiber officinale]
MIQVVTNSLDSILLQKSILLNLPQSNSHMSLNSYRETHSCNSFVVIGRELEKNKIVNMLTKDDNESSHGT
LKVITIVGMGGLGKTTLAQLAFNDEGVKAHFESSRMWTVVGAEFNPVKIMKSVLELATDAPVKISQIDSV
RKNLEKTLSGKKFLLVLDDVWNKDPLKWGVLKAALTCGARGSKILVTTRSQQVSSIMGSSNTTHQLQQLS
GYDCLSLFKQFAFGDEVADRTLMEIGRKIVEKCGGVPLAAISLGSMLRSSREETYWSSVLKSEIWQLGNE
EDKVLAVLKLSYDTLPPRSKKCFAFASLFPKNTRIAKDELIRLWIANGFIRSEGNFDAETNGKHVFNDLV
MGLFFLFEDKCTMHDLMRDLARSVSANIYWNSKEDLVKHSGNRTYHLHLESSDISKITQALGKKSLYLRT
LILIHCYLYVNLPAIVFSELKFLRVLDLSYNGIREVPTSIENLIHLRYLNLSRNHIEVLPDSVTLLPNLQ
YLNLSFNHGLRQLPKELGNMQNLWDFNLSGNNIQVLPDSITLLSNLRYLNLSFNVELRELPKELGNMQNL
RDLDLQRDFRLTHMPCGLSQLTNLRSLPLFIAGDKTSACSIIELEDLKLHGKMEIKFSNDYKNYSCGGRK
ILKNKDLNELCLEFNGSERYDNDMLDDLCPNTSLKKLSIWDYMSPQFPTWLIELQLPKLVEVSLVNCRGC
EPIPPFGNLQFLKKLCLRSMADFTQMGAEFYGYRGFPSLQELFLYEMNNLEEWSESHGVVELFPKLQSLK
ILGCRKLKSMPRLPRIQHLDISCCSGSILSCIGGLTSLSVLQVEKMNDMTSLPSGWIRNLTSLTELQIKG
CRQLQSLPGDEMQYLEMLRSLTIEQCYNLASFPSKVGRLSSLCFLRLRGCPSIILQPEELVEILNSVHEF
KIHICGNKVNLSGQLQYLHKLKKLSLCGAHDESFTYNYKIGNEIQKLTICCCDELESLMTTEPTSSALQK
LKINDISNLTTLPEWLQHLKSLHFLSIQDCPRLERVPRGLKNLYMLKRLWIVGCPQLKSRCQRETGEDWP
IISYVPYVHIP


>XP_042378693.1 putative disease resistance protein RGA4 [Zingiber officinale]
MIQVVTNSLDSILLQKSILLNLPQSNSHMSLNSYRETHSCNSFVVIGRELEKNKIVNMLTKDDNESSHGT
LKVITIVGMGGLGKTTLAQLAFNDEGVKAHFESSRMWTVVGAEFNPVKIMKSVLELATDAPVKISQIDSV
RKNLEKTLSGKKFLLVLDDVWNKDPLKWGVLKAALTCGARGSKILVTTRSQQVSSIMGSSNTTHQLQQLS
GYDCLSLFKQFAFGDEVADRTLMEIGRKIVEKCGGVPLAAISLGSMLRSSREETYWSSVLKSEIWQLGNE
EDKVLAVLKLSYDTLPPRSKKCFAFASLFPKNTRIAKDELIRLWIANGFIRSEGNFDAETNGKHVFNDLV
MGLFFLFEDKCTMHDLMRDLARSVSANIYWNSKEDLVKHSGNRTYHLHLESSDISKITQALGKKSLYLRT
LILIHCYLYVNLPAIVFSELKFLRVLDLSYNGIREVPTSIENLIHLRYLNLSRNHIEVLPDSVTLLPNLQ
YLNLSFNHGLRQLPKELGNMQNLWDFNLSGNNIQVLPDSITLLSNLRYLNLSFNVELRELPKELGNMQNL
RDLDLQRDFRLTHMPCGLSQLTNLRSLPLFIAGDKTSACSIIELEDLKLHGKMEIKFSNDYKNYSCGGRK
ILKNKDLNELCLEFNGSERYDNDMLDDLCPNTSLKKLSIWDYMSPQFPTWLIELQLPKLVEVSLVNCRGC
EPIPPFGNLQFLKKLCLRSMADFTQMGAEFYGYRGFPSLQELFLYEMNNLEEWSESHGVVELFPKLQSLK
ILGCRKLKSMPRLPRIQHLDISCCSGSILSCIGGLTSLSVLQVEKMNDMTSLPSGWIRNLTSLTELQIKG
CRQLQSLPGDEMQYLEMLRSLTIEQCYNLASFPSKVGRLSSLCFLRLRGCPSIILQPEELVEILNSVHEF
KIHICGNKVNLSGQLQYLHKLKKLSLCGAHDESFTYNYKIGNEIQKLTICCCDELESLMTTEPTSSALQK
LKINDISNLTTLPEWLQHLKSLHFLSIQDCPRLERVPRGLKNLYMLKRLWIVGCPQLKSRCQRETGEDWP
IISYVPYVHIP


>XP_042378695.1 putative disease resistance protein RGA4 [Zingiber officinale]
MIQVVTNSLDSILLQKSILLNLPQSNSHMSLNSYRETHSCNSFVVIGRELEKNKIVNMLTKDDNESSHGT
LKVITIVGMGGLGKTTLAQLAFNDEGVKAHFESSRMWTVVGAEFNPVKIMKSVLELATDAPVKISQIDSV
RKNLEKTLSGKKFLLVLDDVWNKDPLKWGVLKAALTCGARGSKILVTTRSQQVSSIMGSSNTTHQLQQLS
GYDCLSLFKQFAFGDEVADRTLMEIGRKIVEKCGGVPLAAISLGSMLRSSREETYWSSVLKSEIWQLGNE
EDKVLAVLKLSYDTLPPRSKKCFAFASLFPKNTRIAKDELIRLWIANGFIRSEGNFDAETNGKHVFNDLV
MGLFFLFEDKCTMHDLMRDLARSVSANIYWNSKEDLVKHSGNRTYHLHLESSDISKITQALGKKSLYLRT
LILIHCYLYVNLPAIVFSELKFLRVLDLSYNGIREVPTSIENLIHLRYLNLSRNHIEVLPDSVTLLPNLQ
YLNLSFNHGLRQLPKELGNMQNLWDFNLSGNNIQVLPDSITLLSNLRYLNLSFNVELRELPKELGNMQNL
RDLDLQRDFRLTHMPCGLSQLTNLRSLPLFIAGDKTSACSIIELEDLKLHGKMEIKFSNDYKNYSCGGRK
ILKNKDLNELCLEFNGSERYDNDMLDDLCPNTSLKKLSIWDYMSPQFPTWLIELQLPKLVEVSLVNCRGC
EPIPPFGNLQFLKKLCLRSMADFTQMGAEFYGYRGFPSLQELFLYEMNNLEEWSESHGVVELFPKLQSLK
ILGCRKLKSMPRLPRIQHLDISCCSGSILSCIGGLTSLSVLQVEKMNDMTSLPSGWIRNLTSLTELQIKG
CRQLQSLPGDEMQYLEMLRSLTIEQCYNLASFPSKVGRLSSLCFLRLRGCPSIILQPEELVEILNSVHEF
KIHICGNKVNLSGQLQYLHKLKKLSLCGAHDESFTYNYKIGNEIQKLTICCCDELESLMTTEPTSSALQK
LKINDISNLTTLPEWLQHLKSLHFLSIQDCPRLERVPRGLKNLYMLKRLWIVGCPQLKSRCQRETGEDWP
IISYVPYVHIP


>XP_042379848.1 putative disease resistance protein RGA3 [Zingiber officinale]
MSHPTGVIPIRGRTAEEETMLQALLETTTAHGESFLNCSKFSVLSIVGPGGIGKTVLAQLAFHNKVVKRH
FDIMAWVCVSTQFDLKKLTIKIIESASMKRPSDLREIISLGELRKILTAGMQGKRFLIVLDDVWEESTTA
WRYLLTPLNCGKEGSKVVVTTRLEEIARMLETKVMIKLDGLEEEEYLELLKDSAFGVERTFLQPDMEQMC
CDIARQLGGLPLAAVRIRDFLKDRFGRGNWPPAETSLVARDGDLMSVLGQSYQQLPEHLKQCYVSCALFP
KNYCFDKNQLLRFWMALGLTPRNGSSSSYNLVDDLSSRSFFVDAWRKKNKFVIHAMMHELADHICDGEFF
RLEEDADEEIEIPTKAHHVYVTADNFVRFSKVLRKRKILRSLVVDGRLSSHISNSEFMDSLREVLKDSSR
LRLLMLSELPGNLPDAIVHLRHLRYLEFPDTGVNKLPKSFCRLYHRWRLNLKAGSKHLLLRNNMDQVIKL
CALDPNLEDVYIPAPCPN


>XP_042380219.1 putative disease resistance protein RGA3 [Zingiber officinale]
MDIVSPILEISGVNHVINKLVDKTTNYLQDQCYWETYLQEELKSLQDLLPQIEAVVYFAEHRLTSYESSD
RALIKWLWKFRDVIDEAEDVLDELEYLELERKANSDKSWLSRRVDASVNAAKRLLKFDDVLGRLRTCVKN
LNTSASDVEKFLALVTPTGGVGTGQMQQGILPLSHQSRITFSLPVSSFKGRVEEKEKIIKYLLGEESEIQ
ISENVHCLPLVALGGMGKTALAQEVFDHFKNVKKEHFDIKIWVCDSLPDLNSSNLTKKILEYSTGRSESG
PLELIPEKLKEKLHSKRFLLVLDDAWDDKNQREWEKLCAPLLYGQKGSWVLLTTRSKSVANMVAREIKGT
MMPMMLQGLSEDECLSLLYEHAFAGQDPNGFPLLKEIGREIVKKLKGVPLLAKSIGGALNSKLEADHWTS
ILRSELWKRSQDSTYNFIPVLTLSYVMLPPRLKRCFAYCSMNSRLQI


>XP_042380220.1 putative disease resistance protein RGA3 [Zingiber officinale]
MGKTALAQEVFDHFKNVKKEHFDIKIWVCDSLPDLNSSNLTKKILEYSTGRSESGPLELIPEKLKEKLHS
KRFLLVLDDAWDDKNQREWEKLCAPLLYGQKGSWVLLTTRSKSVANMVAREIKGTMMPMMLQGLSEDECL
SLLYQHAFAGQDPNGFPLLKEIGREIVKKLKGVPLLAKSIGGALNSKLEADHWTNILRSELWKRSQDSTY
NFIPVLTLSYVMLPPRLKRCFAYCSIFPQDYKFNK


>XP_042380247.1 putative disease resistance protein RGA4 [Zingiber officinale]
MEQLPVKLKEKLHSKRFLLVLDDAWDDNNQIEWEKLCAPLLYGQKGSWIILTTRLISVAKMVSKVMRGVT
MEPMMLQGLSNDECRSLLYEHAFVGQDPNRFPLLKEIGEEIVEKLKGVPLLAKSIGGVLNSRLEVDHWTS
ISRSELWKMPQDSKYDFIPSLTLSYMMLPPRLKRCFSYCGIFPQDYKFNKQKLVCMWVAAGLIYSDGLEE
GSDEDIANCCFDMLCNKSFFDIHTYIWRSI


>XP_042380382.1 putative disease resistance protein RGA1 [Zingiber officinale]
MASHQEDEHEKSLFEMSIESIDEGGVSTKENSSSREATDNEIDKDQSFRLRSKPIAYFNMQQDVVSEGRR
KVIESSSLISTVSIPWSYLFSCFRCLKYRHNIANQIIALNSKLEDLKKDIVITNYLDRAIKEVVENVDIV
IAHETSHLQVEGDIVGAQIENAIEALVNLILENNPKKCRVFGVVGTGGIGKSTLASKIFEDERIKDNFPK
RIWLYVSKIYTESDLLKKLIRSYEGSETKGENFEGKSKAELENTLVSILTRNTFIVLDDVWNSSVWTDFL
RKPIMKSAINCTVLVTTRKEKVVMLMKPRYIHPVEKMDEESGWTLLKHLVFDVEGDEDEISSFEEIGIKL
VNKCDGLPLAIKAIAGVLYQQNKAKWEEVLESDAWNMDQIEEELRPLYLSYKDLPSRFKQCFLYCSLYPQ
KDMFSKEIVQFWAAEGLIMSEEDNWRRDLPTQNQRTMEDLGEEIYRELLGRNLLEAKKNELSKSFFSMHD
HFRSLCANLMREEGILYRHGREFKADDNVKIRRLSISCMGPMLVLPAQILRQACLRTLILTDSPQTKTIE
DSVVQALLCLRVLDLSETSIEKIPDCIGELLHLRYLDLDGTNIREIPTTIGNLVNLQSLNIIRCKFLERL
PVSITKLHNLRWLNMIGCPLLIYVPKGIGKLENIYSLYGFMIGQNDSTSEEGCDLEELKNLSKLRVLIIL
RLERAEKGASALANKPFLKELTLSWMRPNAEEDDNGGGHDAQANEEEDSDGKDDGSGQRTETIEEEEDEN
EEVESEGEEEEDENEEVDGEEEEKGWNEEQISKAERICNEMSQPSSTLVHLHFYVYPGRQFPSWMTSSSL
AESFPNLAYLDLFGLPCCVELLPLGTLPQLKFLCIESANAITAIGSQFLGSRSSAFPKLEVLRFVDMPKW
EEWTFNGAPLAVKLFPSLKECAIIDCPMLRALPDGLHRATNLNQLGLLRTYELGEINNITLAYRLEVAKC
RGLKKISNISSLRSLVVIECGDLECVENLDKLQHLIVECYETEQLPQWLPGLIERHNNTASTHRSLKKFE
MACNLQLLMSCLEGNENWDILKHIPVVEIQTYSSKEYIRYTKDPYNYDTNIPSN


>XP_042380387.1 putative disease resistance protein RGA3 [Zingiber officinale]
MAMVLDFFISKFMTVTANMVEAEIFKVLGVDKEIKALQERLGIINGYLHQAERNRHGNNEIDIWVRKLKD
VMYDADDVIDLCMIEGGKLLKAQVLSGSSTVSIPFNYLFSCFQCLKYRHDIANQIIALNSKLEDLKKDVV
IKNNLDWATKEPDEYVNRATAHETSHLQVEGDIIGTQIETAIETLVSLILENNPKKCRVFGVVGTGGIGK
STLASKIFEDERIKDYFPNRKWLYVSKNYTESDLLKKLIKFEEGSETKGKNLEGNSRAELENRFVSVLTR
NTLIVLDDVWDSSVWIDFLRKPIMNSTISCTVLVTSRKEKVIIPMKPRYIHPVEKMDEGSGWNLLKHLAF
EAEGDEDEISSFEEIGIKLVNKCDGLPLAIKAIGGVLYQQNKAKWEEVLESDAWHMDLIEEELRPLYLSY
EDLPSSLRQCFLYCSLYPQKDMYSKKVIQFWVAEGLIMDEQDKLRRDLPSQKQRTMEDLGEQIYRELICR
NLLEADALLDVSKSFFSMHDHFRSLSANLMREEGILYRHGRELQVDDNIKIRRLSISCMELNLVLPTQII
RQGCLRTLILMDSPETKMIEDSVLQALPCLRVLDLTATSIEKIPDCIGDLLHLRYLDLAGTDIREIPTTI
GNLINLQTLNVYGCQYLERLPASITKLHNLRWLNMIDCLLLTYVPRGIGKLENFYCLEGFMVGQNDSAYE
EGCDLEELKNLSELRFLSIFRLERAGGGASALANKPFLKHLALSYSKGQMQITSWFAMLHGAASLGHTAS
AQVPPY


>XP_042380389.1 putative disease resistance protein RGA4, partial [Zingiber officinale]
MEAALVGAASRFMVDKVAVLLKLDEKLKTITGTKRKMEKLKELAPMIDTVIQHIESRPLMEDTVKELLKK
LKYLAYDLEDVVDYYDTKVFQKKQRSKAFLRPVSDFFSADNQVAFKSRVGGMIKAITESLDSILLQKSIL
SNLLQGSSPMSEPSLNNRETHSRNSFVVIGREPEKNKIVDMLTNDDDDDESHHGTVKVIAIVGMGGLGKT
TLAQHVYNDARVQDHFASPTMWKVVGAEFDPTEIMKAVLQLATGGSSVNISEIDLVKRKLEEELSGKRFL
LVLDDVWNEDALKWGVLKAALTCGARGSKILVTTRSQRVSSLMSSSKTTHQLQQLSRDDCLSLFQRFAFG
DQAVDQNLMAIGAKVVEKCGGVPLAAISLGSMLRSTREENYWSSVLNSEIWKLGNQEDKVLAVLKLSYDA
LPLRSKKCFAFASLFSKDVKMKKNELIKLWIANGFVRSEGNFDAETVGEHVFDDLVLRSFFLLVPSQYVT
ECTMHDLMHDLARSVSADVYWNSYQDSVENFGNRTYHLQIDRRKFPNMTQDLGKKPLYLRTFMHIYTFSH
LSINLLELFSELKPLHLRALDLTHGGIREVPTSIGILIHLRYLNLSWNDIEVLPDSITLCKKKN


>XP_042380391.1 putative disease resistance protein RGA1 [Zingiber officinale]
MEAALVGAASRFMVDKVADLLQLDEKLKTITGTKRKMEKLKELPPIIDMVIQHIESRPLMEDAVKELLKK
LKYLAYDLEDVVDYYDTKVFQKKQRSKSFLRPVSDFFSADNQVAFKSRVGGMIKAITDSLDSILLQKSIL
SNLLQEQGSISMSEPSLNNRETHSRNSFVVIGREPEKNKIVDMLTKDDDDDESHHGTVKVIAIVGMGGLG
KTTLAQHVYNDARVQDHFASLTMWKVVGAEFNPTKIMKSLLELTTGGSSVNIFEIDLLNRKLEEELSGKR
FLLVLDDVWNENELQWDILKAALTCGARGSKILVTTRSKRVSSIMSSSNTTHQLQQLSRDDCLSLFQRFA
FGDQAVDQNLMAIGAKVVEKCGGVPLAAISLGSMLRSTREENYWSSVLNSEIWQLGNEEDKVLAVLKLSY
DALPLRSKKCFAFASLFSKDVPMEKDELIKLWIANGFIRSEGNFDAETVGEHVFDDLVLRSLFVTSQYVT
ECTMHDLMYDLARSVSADVYWNSYQDSVENFGNRTYHLQIDPRKFPNITQDLGKKPLYLRTFMHIDTFSH
LSINLLELLSELKPLYLRALDLSNAGIREVPTSIGILIHLRYLNLSWNHIEVLPDSITLLPNLQYFNLSF
NHELRELPKELGNMQNLRDLDLQTYSRFITHMPCGLSRLTNLRSLPLFIAGDKTGACSIIELENLKLHGK
MVIQFSEDFKNYSCDGRKILKNIDLNELCIEFNERYDKDMFVDLCPNTSLKKLDICRYRSPQFPAWLMES
QLPNLVEVRLRDCSGCEHIPPFGNLQFLKRLDLDYMNGITHLGAEFHGYRGFPSLRELSLNWISNLEEWS
ECHVVDQLFPLLQKLLICWCPKLKSTPRFPRIQELQISCGNGSILSCIGRFTSLSVLQLTAMPDIASLPS
GCIRNLTSLTKLQITNCRQLQSLPGDEMQFLEMLRSLIIERCDNLVFFPSEVGSLSSLCFRRNGTISQPK
ELVQILNSVDEFHIEICDNKVDLRGQLQYLHTLKILSLFGSHAANQLTIQNGIRKLSICCCDELESLMAA
EEVSNTVLEQLYINRFSNLTTLPDWLQHLKSLRILSIRNCPRLERVPRDLKNLHMLKTLNIVGCPQLKSR
CARETGEDWPIISNIPNVDIE


>XP_042380401.1 putative disease resistance protein RGA3 [Zingiber officinale]
MEGALVAAAARLMFDKVTALLQVDEKLKTITGTKRKMEKLKELSTIIDMVIQDIEYRPFIHDAVKDLLKK
LKYLAYDLEDVVDYYDTKVLQKKQRSKTSLRPVRDFFSFDNQVVFKSRVGGMIKAITESLDSILLQKSIL
LNLPQSSIRMSEPSLCRETHSCNSFVVIGREPEKNKIVDMLTKDDDDESNHGIVKVIAIVGMGGLGKTTL
AQLVYNDARVQDHFSSLTMWKVVGAEFNPTKIMKSVLELATGASVNISEIDLVKQKLEKALSRKKFLLVL
DDVWNEDELQWGVLKAALTCGARGSKILVTTRSQQVSLIMGSSNTTHPIQQLSRDDCLSLFQQFAFGDQA
VDQNLMKIGAKIVEKCGGVPLAAISLGSMLRSTREETYWSSVLNSEIWRLGNQEDKVLAVLKLSYDTLHP
WSKKCFSFASLIPKNYRMAKDLLIKLWIANGFVRSEGNFDAETNGNHVFNDLVMRSFLILFTPYYDYYSD
SHVTECTMHDLMHDLARSVSADVYWNSDEDSVEDIGKRIYHLQIYERKFPNMTRVVLDKKPLHLRTFMYF
TPPPIYITFEKDQSA


>XP_042381036.1 putative disease resistance protein RGA1 [Zingiber officinale]
MEAALVATTARFVADKVTILVQLDEKLKTITGTKRKMEKLKELSTIIDMVIRDIECRPFIDDAVKDMLKK
LKYLAYDLEDVVDYYDTKVLQKKQRSKTSLRPVRDFFSFDNQVVFKSRVGGMIKAITESLDSILLQKSIL
LNLPQSSIRMSEPISLYRETHSCNSFVVIGRGPEKNKIVNMLTKDDDDDDDDDDAESNHGTVKVFAIVGM
GGIGKTTLAQLVFNDEKVKAHFASLKMWTVVGAEFDPKRIMKSVLELATDAEVNISQIELVRQNLEKALS
GKKFLLVLDDVWNEDELQWGVLKAALTCGARGSKILVTTRSQQVSLIMGSSNTTHQIQQLSVDDCLSLFK
QFAFGDQAADRTLMKIGGKIVEKCGGVPLAAISLGSMLRSTREETYWSSVLNSEIWQLRNEEDKVLSVLK
LSYDTLPPRSKKCFAFASLFPKKYRMAKDELIKLWIANGFIHSEGNFDAETNGNHVFNDLVMGSFFLLAP
SRDYEYDSHVTKCTMHDLMHDLARSVSVDVYWNSIQDSVEDIGKRTYHLQISKGDLLDMTQVLGKKPLYL
RTFMHLYTLSRSISCLSINLFEIVFSELKFLRVVDLSYNAIREVPTSIGNLKHLKYLNLSKNNIEVLPDS
ITLLPNLQYFNLSFNYELKELPKELGNIQNLRDLDLQYDLTLTHMPCGLSRLTNLRSLPLFIADDKTSTC
SIIELEDLKLHGGMKIKFSKEFKNYSCDGRKILKNKDLNELCIEFNGSKIYDKYMLDDLCPNTSLKKLDI
WYYRSPQFPTWLIELQLPNLVEVSLQNCRDCEHIPPFGNLQFLKKLYLQSMTDVTQMGDEFHGYGGFPSL
QELFLHGMDNLEEWSESHGVDELFPKLQSLNIFNCPKLKSMPRLPRIQHLKISYCSGSILSCIRGLTSLS
VLKVEEMNDMTSLPSGCIRNLTSLTELQITECRQLQSLRGDEMQYLEMLRSFTIESCDNLTSFPSEVEHL
SSLCCLRLSDCPSIILKPEELVQILNSVDKYGIRKLSICYCDELQSLMTTEAASSTVLEELYIDGISNLT
TLPDWLQHLNSFRLLSIENCPQLERVPRCLKNGRLSVAHN


>XP_042383417.1 putative disease resistance protein RGA3 [Zingiber officinale]
MDIVSPILEISGVNHVINKLVDKTTNYLQDQCCWETYLQEELKSLQDLLPQIEAVVSFAEHRLTSYESSD
RALIKWLWKFRDVIDEAEDVLDELEYLELERKANSDKSWLSRRVDASVNAAKRLLKFDDVLGRLRTCVKN
LNTSASDVEKFLALVTPTGGVGTGQMQQGILPLSHQSRITTSLPVSSFKGRVEEKEKIIKYLLGEESEIQ
ISENVHCLPLVALGGMGKTALAQQVFDYFKNVKKEHFDIKIWVCDSLPDLNASNLMKKILEYSTGGSESG
PLELIPEKLKEKLHSKRFLLVLDDAWDDKNQREWEKLCAPLLYGQKGSWILLTTRSKSVANMVSKEIRGT
MVPMMLQGLSEDECRSLLYERAFAGQDPNGFPLLKDIGGEIVKKLNGVPLLAKSIGGALNSKLEANHWMS
ISRSELWEMPQDLTYNFIPALTLSYVMLPSCLKRCFSYCSIFPQDYEFNKQKLVCMWVAAGLIYSDGLEE
GSDEDIANCCFDMLYNKSFFDAHHDNWSPFFYDKTLYVLEEDYYTMHDMLNSLACHVSHYECCRIVDGTT
PSLILDNNTIRHISITCSHAQLHDLANIVSKLKHLRTLWIEYDGDRQQFEDFIRDACKSPRRIRVLIMAS
NLSDRCLKSISNFVKIRFLQIPNHFLPSLSMRKFYFLQVLMGEDSILAKDANKLTNLRHLYEVHEDALLS
VAKVGKLTSLQELCFTVGTKPRYRIDELMNMNNLHKLSIKQLSNVRSLEEANMVNLVKKRYLIRLELDWN
DVSNPDDYASNPDLDQPVLAALQPYPTIRELTIRGYKGGRLAPWMDTSLSLLQNLQLNACTSLEELPSLW
KLPCLKFLKLKEMNAIRSLGCHFSGQIDIQFPVLEKLGFYDLPLWEEWNGADDYIWFPHLKNFQILDCPK
IKKIPELPLSIENLTMKNLGLEALPRSYNYKCSNGSRTFGGFQRLMFLETLQIYECAKIVQIGSIGEEDD
HLLPSSLKELTLSILFKDDDLASYLQGLTSLTDLSLYFSPDVESLPSANELEHLTTLQTLYIRGGETLTS
PGGLYIIKSLKFLKISHCPKFLSAAAEVESEEFLKDKTRKHAVSSSSGFDHSTSDKVTSILPSSLEYLIF
TDSGISQESLGRCLQGLSSLKGLEVSGCHRLVSLPNIEYLHNLTALEELGIFYCKELCELESLTALASLR
KLDIKRCPKLATTTEQSATKIKKGTLPSLENIDIDDIFYLPILPISEKLKTLFIKSNDKEFTCFPSEIEE
SLLQYRKSLENLYLYWMSHLESLPGILESFSSLKKLIIHSAPALKSLPRMPASLEELRISGCSAKLKKRY
QKNIRRDLPNIKYIEITADKEDKAEAQVNCNWVSSRLWCST


>XP_042383418.1 putative disease resistance protein RGA3 [Zingiber officinale]
MDIVSPILEISGVNHVINKLVDKTTNYLQDQCCWETYLQEELKSLQDLLPQIEAVVSFAEHRLTSYESSD
RALIKWLWKFRDVIDEAEDVLDELEYLELERKANSDKSWLSRRVDASVNAAKRLLKFDDVLGRLRTCVKN
LNTSASDVEKFLALVTPTGGVGTGQMQQGILPLSHQSRITTSLPVSSFKGRVEEKEKIIKYLLGEESEIQ
ISENVHCLPLVALGGMGKTALAQQVFDYFKNVKKEHFDIKIWVCDSLPDLNASNLMKKILEYSTGGSESG
PLELIPEKLKEKLHSKRFLLVLDDAWDDKNQREWEKLCAPLLYGQKGSWILLTTRSKSVANMVSKEIRGT
MVPMMLQGLSEDECRSLLYERAFAGQDPNGFPLLKDIGGEIVKKLNGVPLLAKSIGGALNSKLEANHWMS
ISRSELWEMPQDLTYNFIPALTLSYVMLPSCLKRCFSYCSIFPQDYEFNKQKLVCMWVAAGLIYSDGLEE
GSDEDIANCCFDMLYNKSFFDAHHDNWSPFFYDKTLYVLEEDYYTMHDMLNSLACHVSHYECCRIVDGTT
PSLILDNNTIRHISITCSHAQLHDLANIVSKLKHLRTLWIEYDGDRQQFEDFIRDACKSPRRIRVLIMAS
NLSDRCLKSISNFVKIRFLQIPNHFLPSLSMRKFYFLQVLMGEDSILAKDANKLTNLRHLYEVHEDALLS
VAKVGKLTSLQELCFTVGTKPRYRIDELMNMNNLHKLSIKQLSNVRSLEEANMVNLVKKRYLIRLELDWN
DVSNPDDYASNPDLDQPVLAALQPYPTIRELTIRGYKGGRLAPWMDTSLSLLQNLQLNACTSLEELPSLW
KLPCLKFLKLKEMNAIRSLGCHFSGQIDIQFPVLEKLGFYDLPLWEEWNGADDYIWFPHLKNFQILDCPK
IKKIPELPLSIENLTMKNLGLEALPRSYNYKCSNGSRTFGGFQRLMFLETLQIYECAKIVQIGSIGEEDD
HLLPSSLKELTLSILFKDDDLASYLQGLTSLTDLSLYFSPDVESLPSANELEHLTTLQTLYIRGGETLTS
PGGLYIIKSLKFLKISHCPKFLSAAAEVESEEFLKDKTRKHAVSSSSGFDHSTSDKVTSILPSSLEYLIF
TDSGISQESLGRCLQGLSSLKGLEVSGCHRLVSLPNIEYLHNLTALEELGIFYCKELCELESLTALASLR
KLDIKRCPKLATTTEQSATKIKKGTLPSLENIDIDDIFYLPILPISEKLKTLFIKSNDKEFTCFPSEIEE
SLLQYRKSLENLYLYWMSHLESLPGILESFSSLKKLIIHSAPALKSLPRMPASLEELRISGCSAKLKKRY
QKNIRRDLPNIKYIEITADKEDKAEAQVNCNWVSSRLWCST


>XP_042383440.1 disease resistance protein RGA2-like [Zingiber officinale]
MDVVSPILQVSGASHVVNKLVDKATTYVRDQYYWKTDLQEELQNLRRLLPQIQVIVGFAEDRLTSYGSSN
RALMEWLGQFRDGIDEAEEVLDELEYLELEKKANSDKNRLSKTVDGSVKAAKRFLKFDDLLIERLRACVK
NLNASASNAHNFLAILGQTGGIGTGQMQQEFLPLTDQSRITSSLPEVSFKGREEQKQEIIRYLSGESVEE
SEIQISENVHCLPLVAMGGMGKTTLAQQVCDHFENMKKEHFDIRIWVCDSLPDLDATSILKKILDSTRQS
DDSSTNLDASNLMKKMLDLTHQSEPSELIPVKLKEKLSSKKFLLVLDDAWDDKNQTAWKRLCDPLLHGQK
GSWILLTTRMESVAKMISKVIKGTMKSMMLQGLSKDECRPLLYEHAFDGQDPNKFPRLKEIGEEILEKLK
GVPLLAKSIGGALNSKLTEDHWTNISRSELWKTPLESKYEFRPILVLSYLMLPPRLKRCFSYCGIFPQDY
RFKKQQLVCMWVAAGLIYSEGSEEGSDEDIANRCFDTLCNKSFFDNRSMLWMKKILFYDTTEEIYTMHDM
LNSLACHVSRYECCRIVHGTPSRILDSNAIRHISITCSIDAQLLDLAKMVCKLKHLRTLWIQYNGDPQKL
DDFIRDACKSPRRIRVLIVRSNDFKVSNQCLKSISDFVKIRFLEIQTILPSLSMRKFYFLQYLIGDQYGS
HLGRLAKDANKLTNLRHLYQVTEDALLSVAEVGKLTSLQELCFTVGTKPRYRIDELMNMDNLRQLKIKKL
SNVRSLEEANMANLVKKYHLTGLDLHWIGASNPDLDEQEVLAALQPSTTIKELMIRWYKGGRPAPWMDTP
SLSRLEHLQLEFCTSLEELPPLWKLPCLKFLKLKYMEAIRSLGGHFSDWMGIQFPVLEELEFCDLPLLEE
WNGADDYVWFPLLKSFQIEKCPRLKNIPDLPLSIENLRFKDLGLEVLPRFYKCSNGSRTFGGFQQLMFLK
SLEIYKCPGIVQIGSIGEEDDHLLPLSLETLELENIEEHKDLANYLRGLTLLTKFHLHCSPGLESFPLAS
ELEHLTVLQDLGISDGESLTSLGDLYILKSLKSLEIFDCPKFLVAEVESEEFLKDTTRKHAVSSSSIFDQ
SASNKAARILPSSLESLEFKNSGISQEPLGRCLQGLTSLERLIVSGCHHLVSLPNIEYLHNLTALQTLNI
SDCKELCELESLTAIASLRHLCINCCPKLLATTFSALQNPATATEHSATKKKKGTLPSLENIYIDDIFYL
PSLPISEKLKTLSIQSSDKEFTCFPSEIEESLLQYRKSLEYLSLGGMHHLQYLPASLESFSSLKNLGIYS
APALKSLPRMPVSLVRLRIFGCSAKLKKRCQENIGRDWPNIKHIPYIDITAGNEDEAEAQVNCNWLSSRL
WSSK


>XP_042383441.1 disease resistance protein RGA2-like [Zingiber officinale]
MDVVSPILQVSGASHVVNKLVDKATTYVRDQYYWKTDLQEELQNLRRLLPQIQVIVGFAEDRLTSYGSSN
RALMEWLGQFRDGIDEAEEVLDELEYLELEKKANSDKNRLSKTVDGSVKAAKRFLKFDDLLIERLRACVK
NLNASASNAHNFLAILGQTGGIGTGQMQQEFLPLTDQSRITSSLPEVSFKGREEQKQEIIRYLSGESVEE
SEIQISENVHCLPLVAMGGMGKTTLAQQVCDHFENMKKEHFDIRIWVCDSLPDLDATSILKKILDSTRQS
DDSSTNLDASNLMKKMLDLTHQSEPSELIPVKLKEKLSSKKFLLVLDDAWDDKNQTAWKRLCDPLLHGQK
GSWILLTTRMESVAKMISKVIKGTMKSMMLQGLSKDECRPLLYEHAFDGQDPNKFPRLKEIGEEILEKLK
GVPLLAKSIGGALNSKLTEDHWTNISRSELWKTPLESKYEFRPILVLSYLMLPPRLKRCFSYCGIFPQDY
RFKKQQLVCMWVAAGLIYSEGSEEGSDEDIANRCFDTLCNKSFFDNRSMLWMKKILFYDTTEEIYTMHDM
LNSLACHVSRYECCRIVHGTPSRILDSNAIRHISITCSIDAQLLDLAKMVCKLKHLRTLWIQYNGDPQKL
DDFIRDACKSPRRIRVLIVRSNDFKVSNQCLKSISDFVKIRFLEIQTILPSLSMRKFYFLQYLIGDQYGS
HLGRLAKDANKLTNLRHLYQVTEDALLSVAEVGKLTSLQELCFTVGTKPRYRIDELMNMDNLRQLKIKKL
SNVRSLEEANMANLVKKYHLTGLDLHWIGASNPDLDEQEVLAALQPSTTIKELMIRWYKGGRPAPWMDTP
SLSRLEHLQLEFCTSLEELPPLWKLPCLKFLKLKYMEAIRSLGGHFSDWMGIQFPVLEELEFCDLPLLEE
WNGADDYVWFPLLKSFQIEKCPRLKNIPDLPLSIENLRFKDLGLEVLPRFYKCSNGSRTFGGFQQLMFLK
SLEIYKCPGIVQIGSIGEEDDHLLPLSLETLELENIEEHKDLANYLRGLTLLTKFHLHCSPGLESFPLAS
ELEHLTVLQDLGISDGESLTSLGDLYILKSLKSLEIFDCPKFLVAEVESEEFLKDTTRKHAVSSSSIFDQ
SASNKAARILPSSLESLEFKNSGISQEPLGRCLQGLTSLERLIVSGCHHLVSLPNIEYLHNLTALQTLNI
SDCKELCELESLTAIASLRHLCINCCPKLLATTFSALQNPATATEHSATKKKKGTLPSLENIYIDDIFYL
PSLPISEKLKTLSIQSSDKEFTCFPSEIEESLLQYRKSLEYLSLGGMHHLQYLPASLESFSSLKNLGIYS
APALKSLPRMPVSLVRLRIFGCSAKLKKRCQENIGRDWPNIKHIPYIDITAGNEDEAEAQVNCNWLSSRL
WSSK


>XP_042383442.1 disease resistance protein RGA2-like [Zingiber officinale]
MDVVSPILQVSGASHVVNKLVDKATTYVRDQYYWKTDLQEELQNLRRLLPQIQVIVGFAEDRLTSYGSSN
RALMEWLGQFRDGIDEAEEVLDELEYLELEKKANSDKNRLSKTVDGSVKAAKRFLKFDDLLIERLRACVK
NLNASASNAHNFLAILGQTGGIGTGQMQQEFLPLTDQSRITSSLPEVSFKGREEQKQEIIRYLSGESVEE
SEIQISENVHCLPLVAMGGMGKTTLAQQVCDHFENMKKEHFDIRIWVCDSLPDLDATSILKKILDSTRQS
DDSSTNLDASNLMKKMLDLTHQSEPSELIPVKLKEKLSSKKFLLVLDDAWDDKNQTAWKRLCDPLLHGQK
GSWILLTTRMESVAKMISKVIKGTMKSMMLQGLSKDECRPLLYEHAFDGQDPNKFPRLKEIGEEILEKLK
GVPLLAKSIGGALNSKLTEDHWTNISRSELWKTPLESKYEFRPILVLSYLMLPPRLKRCFSYCGIFPQDY
RFKKQQLVCMWVAAGLIYSEGSEEGSDEDIANRCFDTLCNKSFFDNRSMLWMKKILFYDTTEEIYTMHDM
LNSLACHVSRYECCRIVHGTPSRILDSNAIRHISITCSIDAQLLDLAKMVCKLKHLRTLWIQYNGDPQKL
DDFIRDACKSPRRIRVLIVRSNDFKVSNQCLKSISDFVKIRFLEIQTILPSLSMRKFYFLQYLIGDQYGS
HLGRLAKDANKLTNLRHLYQVTEDALLSVAEVGKLTSLQELCFTVGTKPRYRIDELMNMDNLRQLKIKKL
SNVRSLEEANMANLVKKYHLTGLDLHWIGASNPDLDEQEVLAALQPSTTIKELMIRWYKGGRPAPWMDTP
SLSRLEHLQLEFCTSLEELPPLWKLPCLKFLKLKYMEAIRSLGGHFSDWMGIQFPVLEELEFCDLPLLEE
WNGADDYVWFPLLKSFQIEKCPRLKNIPDLPLSIENLRFKDLGLEVLPRFYKCSNGSRTFGGFQQLMFLK
SLEIYKCPGIVQIGSIGEEDDHLLPLSLETLELENIEEHKDLANYLRGLTLLTKFHLHCSPGLESFPLAS
ELEHLTVLQDLGISDGESLTSLGDLYILKSLKSLEIFDCPKFLVAEVESEEFLKDTTRKHAVSSSSIFDQ
SASNKAARILPSSLESLEFKNSGISQEPLGRCLQGLTSLERLIVSGCHHLVSLPNIEYLHNLTALQTLNI
SDCKELCELESLTAIASLRHLCINCCPKLLATTFSALQNPATATEHSATKKKKGTLPSLENIYIDDIFYL
PSLPISEKLKTLSIQSSDKEFTCFPSEIEESLLQYRKSLEYLSLGGMHHLQYLPASLESFSSLKNLGIYS
APALKSLPRMPVSLVRLRIFGCSAKLKKRCQENIGRDWPNIKHIPYIDITAGNEDEAEAQVNCNWLSSRL
WSSK


>XP_042383505.1 disease resistance protein RPM1-like [Zingiber officinale]
MAETALQFVLQKLNYWIVQEQQLLGGLRPAIKDIRDELECIAEFIREADAGEDKDGAKAFMRQLREIAYD
IEDHLEDYTLHFGQPQEDRCFGMLRRSLHDLKHWRSWHRMATEIREIKSRVRSISDRRKMYKFRTTNSTA
SRNILHDRHVAALFMDEAELVGISEPREQIIRWLVEGKSNLQAISVVGMGGLGKTTLVRKVYDDERVKAF
FTSHAWISVTQSYTEEVLLRSIISQLYEEIHETLPARIETMGIIQLIPTLRHFLEHKRYIIVFDDIWHIH
AWNCFKLALPDDHCGSRVLVTTRIGDVGLHCLEACGHVYQLEPLPPAVAWSLFCKKAFRSLPGAACPPEL
HVISQEIVRVCEGLPLAIVTLAGLLSKKNSVLEWTTMRDNLHAELANNPKLETIMRILQLSYNDLPHHLK
PCFLYFSIFPKERSVELPVSRITLIRLWIAEGFIETDESESMERVATEYLNDLIDRNMVEVAVHYDYGRV
KSCRVHDLFHELIVFKSKEENFSTSLIRKGSQIQEKIRRLSTHNISEPLLQGTDLSHLRAIFVFGQNASV
ISSQANLFSRLKLLKILDLSEAPIESCPFEFGNLPHLRYLSFRNTRIKKLSKSLGKLKNLETLDLKGTYV
TELPKTILNLQRLRHLLAYRYYTDDEPPLYHVVGMKLPKGIGAFRELQKLAYLEMDQDGGIIKELGSLTQ
LKRLAIVKLRREDGANVCSSLEKMKQLKSFSASSSHMGEFLHLEALKSPPPFLERLYFRGPLRSLPSWIS
SLNSLISLRLRWSRLPENSLGILEALPNLLELVLVHAYVGARLFFHKGGFQRLKVLDLEQLDSLNYVILD
GAMPNLQIMYIRSCAQLEMVPQGIEELIHLKELHLFDMPEVFLQRLWRLKGIDHPKVNHIPIVRSYDDQN
RVYEI


>XP_042383508.1 disease resistance protein RPM1-like [Zingiber officinale]
MAASGALQFALQKLDSILVQEQQLLRGFNTRIKDIRDELESLKIFLRGADAGDDKDDIKAWMRQLRDIAY
DMEDLLEEYTFHFGQPHRHRLLGFLTTSIQSLRHLFTRRKMSIAIQDIKTQLRNISERRSTYKFNSSFNA
TKKRVHDRHLAALFMEEAELVGIRKPKEEIVGRLVKGGGSSSLTVVSVVGMGGLGKTTLVRKVYDDEQVK
GWFNSHAWITVTPSFTVEELLKSIIIQFYEERHEKLPARIQTMECIQLIDTLRQFLQDKRYIAVLDDLWH
ITPWECLKYALPNSECGSRIVVTTRNKDIGLSCIESCGSLYELQPLPQPEAWFLFCKKAFRSVSAGVCPS
ELQDVAEDIVKVCGGLPLAIVTIAGLLSKKAHVLEWRKLRDNLHAELANNPKLEIIKQILLLSYNDLPHF
LKSCILYFSIFPKEHAVTRITLIRLWIAEGFIESERGETMERIAGDYLNDLIDRSMVQVAERYDYGRVRS
CRVHDLIHEVIVLKSEEENFSTLMITRDTKRHGKIRRSSTHAAGEHLLQSDLSHLRALFMFRENVLPIPS
VVNLLSRLRLLRILDLTGAPIESFPLEFGKLPHLRYLSFRNTRISKLPKSLGQLKNLETLDLKETYVTEL
PKTILNLQNLRHLLAYHYYTSHRPPYYLADGVKLPHGIGKFRELQKLTYLEINQDSRIVRELGNLTQLKR
LGLVKLRRVDGASLCKSIEKMEKLLSLSVTSVGMDEYLNLRSLTSPPPLLQRLYLRGPLQALPNWISSLK
HLVRMRLRWSRLKEDSFGVLEELPSLVELTLIHAYDGANLRCQKGGFQKLKILDLERLNNLNHVVVDGSM
PNLQKMYIRSCVQLQEVPQGIQQLVLLKEIHLFDMPEEFVQRLEGEDYALVSHVPIRRSYDSEKGVYKEL


>XP_042383519.1 disease resistance protein RGA2-like [Zingiber officinale]
MDIVSPILEKAGASYVINKLIDAATGYVQDQYYWKTDLQGELQNLGRLLPQIQAVVDFAEPRLTMYESSN
PALIKWLWQFRNGIDEAEDVLDDLEYIELEKKANSDKSRLSRRVDASVKAAKRLLKFDDVLGRLRACVKN
LNTFASDVQNFLALVTQTVGIGTGQMRYYHSSRITNPLPVLSFKGREDEKGKIIQYLLGESVEKSEMWIN
ESVHCLPLVAIGGMGKTVLAKQVFHHFENVKKKHFDIKIWVCDSLPDLNASSLIKKILEYQTGGSESGPL
ERLPVKLQKILHSKRFLLVLDDVWDDNNQTEWEKLCAPLVYSQKGSWIILTTRLRSVAKMISKVIRSTME
PMILRGLSNDECRSLLYEHAFSGEDPNKFPLLKEIGEEIVEKLKGVPLLAKSIGGALNSKLEADHWTSIS
RSELWQMPIDSKYEFNPVLTLSYVMLPPRLKRCFSYCSIFPQDYQFKKQKLVCMWVAADLIYKDELEDGL
DEEDIANRCFDILCNKSFFDVHTYSRSLSRSQMLFCQRYSLYDFKEDFYTMHDMLNGLACHVSRYECCRI
VHDTPSHILDNNVIRHIYVTGSHAQLHDLAKIVSKLKHLRTLWINYHGDPQKLDDCIRYACKSSRRIRVL
IMESNYSRSSYQCLKSINDFLKLRFLEMTGLLLPP


>XP_042383549.1 putative disease resistance protein RGA3 [Zingiber officinale]
MDVVSPIMEKAGARCVINKLIDAATTYVRDQYYWKTDLKEELQSLRRLLPQIEAVVGFAEHRLTMYESSN
RALMEWLWQFRNGIEEAEEVLDELEYLELKKKVNRDKNRLSLTVDASVKTAKRLLKFDDVLERLRTCVKN
LNTSASDVQNFLTLVTQKDGNSNGQMQCYLSSRITNPLPVLSFKGREEEKGKIIRYLLGESVEESKIQMN
ENVHCLPLVAMGGMGKTALAKQVFDHFENVKKEHFDIKIWICDSLPNLDASSLMKKILKYLACQSESDPL
ELTPVKLKEKLHSKRFLLVLDDAWDDKNQTEWDKLCDPLLYGQKGSWILLTTRLRSVAKIVSKVIKRGTM
EPMILQGLSNDECRSLLYEHAFAGQDPNGFPLLKEIGEEIVEKLKGVPLLAKSIGGALNSKLEANHWTSI
SRSELWKMPQDSKYEFSPVLTLSYVMLPPRLKRCFSYCGIFPQDYRFNKQKLVCMWVAAGLIYSEESEEG
SNEDIANCCFDMLCNKSFFDVHIYGQIWSSFWERNSLYDLEEDYYTMHDMLNCLACHVSRYECCKIVHDA
PSCILDYNAIRHLSITNNLVQLHDLSKMVCKFQHLRTLWIEDDGNHQQFHEVILDACKSPRRIRVLIMKS
NYSRISYQCLERISDFVKLRFLEMSRFSGPPSLSKCKFYFLQVLIGYNVIPAKDANKLANLRHLYRVHDD
ALFSVAKVGKLTSLQELCFTVGTKPEYRIDELMNMDNLHQLTIQQLSNVQSHKEANMANLVKKRHLTRLA
LNYWFGVSNPDGVSNPDIDHQEILAALQPPPTIRELIITGYKGGRPAPWMDTPSISRLEYLQLHTCTSLE
ELPPLWKLPCLKFLKLHDMKTIRSLGCHFSNQMDIQFPVLENLIFYALPLWEEWNGVDSHIWFPHLKRFE
IYHCPKLKKIPDLPLSIENLKMEYLGLEALPHSYKCSNGSRTFGGFQQLMSLESLHIYQCPGIVQIGTIG
EEDDNLLPSSLKQLGLGGIFVEHKYLASYLRGLTSLTHLSLSCSRGMTSLPLANELEHLTTLQHLRIWGG
EAFISPRGLYIIKSLKSLEISNCPKFLSAEVESQEFLKDKPTKHAVSSSLVFDHSASNKATSILPSSLVS
LKLENSDILQESLGRCLQGLTSLKELQVSYCHHLVSFPNIEYLHNLAAFETLDISNCKELCELESLTTLA
SLRELYIERCPKLLTTTFSTLQNPAATTEQSATKKKKGTLPSLEHIYMDEIFYLPSLPIPERLNSLSIDN
IFMGSSQVFHCFPSEIEDWLLQCRESLEVLELGQMPHLQSLPASLESFSSLRSLRIDFSPELKSLSKMPT
SLKILKLYGCSAKLKKRCQENIGPDWPNISHMPDIHIIVGKDDKDEVQINCNCVSSRLWSSR


>XP_042383550.1 putative disease resistance protein RGA3 [Zingiber officinale]
MDVVSPIMEKAGARCVINKLIDAATTYVRDQYYWKTDLKEELQSLRRLLPQIEAVVGFAEHRLTMYESSN
RALMEWLWQFRNGIEEAEEVLDELEYLELKKKVNRDKNRLSLTVDASVKTAKRLLKFDDVLERLRTCVKN
LNTSASDVQNFLTLVTQKDGNSNGQMQCYLSSRITNPLPVLSFKGREEEKGKIIRYLLGESVEESKIQMN
ENVHCLPLVAMGGMGKTALAKQVFDHFENVKKEHFDIKIWICDSLPNLDASSLMKKILKYLACQSESDPL
ELTPVKLKEKLHSKRFLLVLDDAWDDKNQTEWDKLCDPLLYGQKGSWILLTTRLRSVAKIVSKVIKRGTM
EPMILQGLSNDECRSLLYEHAFAGQDPNGFPLLKEIGEEIVEKLKGVPLLAKSIGGALNSKLEANHWTSI
SRSELWKMPQDSKYEFSPVLTLSYVMLPPRLKRCFSYCGIFPQDYRFNKQKLVCMWVAAGLIYSEESEEG
SNEDIANCCFDMLCNKSFFDVHIYGQIWSSFWERNSLYDLEEDYYTMHDMLNCLACHVSRYECCKIVHDA
PSCILDYNAIRHLSITNNLVQLHDLSKMVCKFQHLRTLWIEDDGNHQQFHEVILDACKSPRRIRVLIMKS
NYSRISYQCLERISDFVKLRFLEMSRFSGPPSLSKCKFYFLQVLIGYNVIPAKDANKLANLRHLYRVHDD
ALFSVAKVGKLTSLQELCFTVGTKPEYRIDELMNMDNLHQLTIQQLSNVQSHKEANMANLVKKRHLTRLA
LNYWFGVSNPDGVSNPDIDHQEILAALQPPPTIRELIITGYKGGRPAPWMDTPSISRLEYLQLHTCTSLE
ELPPLWKLPCLKFLKLHDMKTIRSLGCHFSNQMDIQFPVLENLIFYALPLWEEWNGVDSHIWFPHLKRFE
IYHCPKLKKIPDLPLSIENLKMEYLGLEALPHSYKCSNGSRTFGGFQQLMSLESLHIYQCPGIVQIGTIG
EEDDNLLPSSLKQLGLGGIFVEHKYLASYLRGLTSLTHLSLSCSRGMTSLPLANELEHLTTLQHLRIWGG
EAFISPRGLYIIKSLKSLEISNCPKFLSAEVESQEFLKDKPTKHAVSSSLVFDHSASNKATSILPSSLVS
LKLENSDILQESLGRCLQGLTSLKELQVSYCHHLVSFPNIEYLHNLAAFETLDISNCKELCELESLTTLA
SLRELYIERCPKLLTTTFSTLQNPAATTEQSATKKKKGTLPSLEHIYMDEIFYLPSLPIPERLNSLSIDN
IFMGSSQVFHCFPSEIEDWLLQCRESLEVLELGQMPHLQSLPASLESFSSLRSLRIDFSPELKSLSKMPT
SLKILKLYGCSAKLKKRCQENIGPDWPNISHMPDIHIIVGKDDKDEVQINCNCVSSRLWSSR


>XP_042383553.1 disease resistance protein RGA2-like [Zingiber officinale]
MEWLWQFRDGIDEAEEVLDELEYLERKKKANSDKNRLSRMVDATVKAAKRLLKFDDVLGRLRTCVKNLNT
SASDVQNFLTLVMQKDGNSTGQMQQEILPLSSIQSRITSSLPVLSFKGREEEKGTIIQYLLGESVEESEI
QISENVHFLPLVAMGGMGKTALAQQVFDHFENVKKEHFDIKIWVCISTDFDASSLMKKILEYSTSRSEFG
PMEQLPVKLKEKLHSKRFLLVLDDAWDDNNQIEWEKLCAPLLYGQKGSWIILTTRLTSVAKMVSKVMRGV
TMEPMMLQGLSNDECRSLLYEHAFVGQDPNRFPLLKEIGEEIVEKLKGVPLLAKSIGGALNSRLEVDHWT
SISRSELWKMPQDSKYDFIPSLTLSYMMLPPRLKRCFSYCGIFPQDYKFNKQKLVCMWVAAGLIYLDGLE
EGSDEDIANCCFDMLCNKSFFDIHTYIWRSIWIGQTCNAPYGLGQDYYTMHDMLNGLACYVSRYECCRII
HGAPTCILDYNAICHISFTSNHPAQLHELGKMLCKFQHLRTLWIEYDGDHQQFDNFIRDACKSSRRI


>XP_042383554.1 disease resistance protein RGA2-like [Zingiber officinale]
MEWLWQFRDGIDEAEEVLDELEYLERKKKANSDKNRLSRMVDATVKAAKRLLKFDDVLGRLRTCVKNLNT
SASDVQNFLTLVMQKDGNSTGQMQQEILPLSSIQSRITSSLPVLSFKGREEEKGTIIQYLLGESVEESEI
QISENVHFLPLVAMGGMGKTALAQQVFDHFENVKKEHFDIKIWVCISTDFDASSLMKKILEYSTSRSEFG
PMEQLPVKLKEKLHSKRFLLVLDDAWDDNNQIEWEKLCAPLLYGQKGSWIILTTRLTSVAKMVSKVMRGV
TMEPMMLQGLSNDECRSLLYEHAFVGQDPNRFPLLKEIGEEIVEKLKGVPLLAKSIGGALNSRLEVDHWT
SISRSELWKMPQDSKYDFIPSLTLSYMMLPPRLKRCFSYCGIFPQDYKFNKQKLVCMWVAAGLIYLDGLE
EGSDEDIANCCFDMLCNKSFFDIHTYIWRSIWIGQTCNAPYGLGQDYYTMHDMLNGLACYVSRYECCRII
HGAPTCILDYNAICHISFTSNHPAQLHELGKMLCKFQHLRTLWIEYDGDHQQFDNFIRDACKSSRRI


>XP_042383555.1 disease resistance protein RGA2-like [Zingiber officinale]
MEWLWQFRDGIDEAEEVLDELEYLERKKKANSDKNRLSRMVDATVKAAKRLLKFDDVLGRLRTCVKNLNT
SASDVQNFLTLVMQKDGNSTGQMQQEILPLSSIQSRITSSLPVLSFKGREEEKGTIIQYLLGESVEESEI
QISENVHFLPLVAMGGMGKTALAQQVFDHFENVKKEHFDIKIWVCISTDFDASSLMKKILEYSTSRSEFG
PMEQLPVKLKEKLHSKRFLLVLDDAWDDNNQIEWEKLCAPLLYGQKGSWIILTTRLTSVAKMVSKVMRGV
TMEPMMLQGLSNDECRSLLYEHAFVGQDPNRFPLLKEIGEEIVEKLKGVPLLAKSIGGALNSRLEVDHWT
SISRSELWKMPQDSKYDFIPSLTLSYMMLPPRLKRCFSYCGIFPQDYKFNKQKLVCMWVAAGLIYLDGLE
EGSDEDIANCCFDMLCNKSFFDIHTYIWRSIWIGQTCNAPYGLGQDYYTMHDMLNGLACYVSRYECCRII
HGAPTCILDYNAICHISFTSNHPAQLHELGKMLCKFQHLRTLWIEYDGDHQQFDNFIRDACKSSRRI


>XP_042383556.1 disease resistance protein RGA2-like [Zingiber officinale]
MEWLWQFRDGIDEAEEVLDELEYLERKKKANSDKNRLSRMVDATVKAAKRLLKFDDVLGRLRTCVKNLNT
SASDVQNFLTLVMQKDGNSTGQMQQEILPLSSIQSRITSSLPVLSFKGREEEKGTIIQYLLGESVEESEI
QISENVHFLPLVAMGGMGKTALAQQVFDHFENVKKEHFDIKIWVCISTDFDASSLMKKILEYSTSRSEFG
PMEQLPVKLKEKLHSKRFLLVLDDAWDDNNQIEWEKLCAPLLYGQKGSWIILTTRLTSVAKMVSKVMRGV
TMEPMMLQGLSNDECRSLLYEHAFVGQDPNRFPLLKEIGEEIVEKLKGVPLLAKSIGGALNSRLEVDHWT
SISRSELWKMPQDSKYDFIPSLTLSYMMLPPRLKRCFSYCGIFPQDYKFNKQKLVCMWVAAGLIYLDGLE
EGSDEDIANCCFDMLCNKSFFDIHTYIWRSIWIGQTCNAPYGLGQDYYTMHDMLNGLACYVSRYECCRII
HGAPTCILDYNAICHISFTSNHPAQLHELGKMLCKFQHLRTLWIEYDGDHQQFDNFIRDACKSSRRI


>XP_042383557.1 disease resistance protein RGA2-like [Zingiber officinale]
MEWLWQFRDGIDEAEEVLDELEYLERKKKANSDKNRLSRMVDATVKAAKRLLKFDDVLGRLRTCVKNLNT
SASDVQNFLTLVMQKDGNSTGQMQQEILPLSSIQSRITSSLPVLSFKGREEEKGTIIQYLLGESVEESEI
QISENVHFLPLVAMGGMGKTALAQQVFDHFENVKKEHFDIKIWVCISTDFDASSLMKKILEYSTSRSEFG
PMEQLPVKLKEKLHSKRFLLVLDDAWDDNNQIEWEKLCAPLLYGQKGSWIILTTRLTSVAKMVSKVMRGV
TMEPMMLQGLSNDECRSLLYEHAFVGQDPNRFPLLKEIGEEIVEKLKGVPLLAKSIGGALNSRLEVDHWT
SISRSELWKMPQDSKYDFIPSLTLSYMMLPPRLKRCFSYCGIFPQDYKFNKQKLVCMWVAAGLIYLDGLE
EGSDEDIANCCFDMLCNKSFFDIHTYIWRSIWIGQTCNAPYGLGQDYYTMHDMLNGLACYVSRYECCRII
HGAPTCILDYNAICHISFTSNHPAQLHELGKMLCKFQHLRTLWIEYDGDHQQFDNFIRDACKSSRRI


>XP_042383558.1 disease resistance protein RGA2-like [Zingiber officinale]
MEWLWQFRDGIDEAEEVLDELEYLERKKKANSDKNRLSRMVDATVKAAKRLLKFDDVLGRLRTCVKNLNT
SASDVQNFLTLVMQKDGNSTGQMQQEILPLSSIQSRITSSLPVLSFKGREEEKGTIIQYLLGESVEESEI
QISENVHFLPLVAMGGMGKTALAQQVFDHFENVKKEHFDIKIWVCISTDFDASSLMKKILEYSTSRSEFG
PMEQLPVKLKEKLHSKRFLLVLDDAWDDNNQIEWEKLCAPLLYGQKGSWIILTTRLTSVAKMVSKVMRGV
TMEPMMLQGLSNDECRSLLYEHAFVGQDPNRFPLLKEIGEEIVEKLKGVPLLAKSIGGALNSRLEVDHWT
SISRSELWKMPQDSKYDFIPSLTLSYMMLPPRLKRCFSYCGIFPQDYKFNKQKLVCMWVAAGLIYLDGLE
EGSDEDIANCCFDMLCNKSFFDIHTYIWRSIWIGQTCNAPYGLGQDYYTMHDMLNGLACYVSRYECCRII
HGAPTCILDYNAICHISFTSNHPAQLHELGKMLCKFQHLRTLWIEYDGDHQQFDNFIRDACKSSRRI


>XP_042384165.1 disease resistance protein RGA2-like isoform X1 [Zingiber officinale]
MEGALVAAAARLMFDKVTALLQVDEKLKTITGTKRKMEKLKELSTIIDMVIRDIECRPFIDDAVKDMLKK
LKYLAYDLEDVVDYYDTKVLQKKQRSKTSLRPVRDFFSFDNQVVFKSRVGGMIKAITESLDSILLQKSIL
LNLPQSSIRMSEPSLCRETHSCNSFVVIGREPEKNKIVDMLTKDDDDESNHGTVKVIAIVGMGGLGKTSL
AQLVYNDARVQNHFASLTMWKVVGAEFNPTKIMKSVLELATGASVNISEIDLVKQKLEKALSRKKFLLVL
DDVWNEDELQWGVLKAALTCGARGSKILVTTRSQQVSLIMGSSNTTHQIQQLSRDDCLSLFQQFAFGDQA
VDQNLMKIGAKIVEKCGGVPLAAISLGSMLRSTRDETYWSSVLNSEIWRLGNQEDKVLAVLKLSYDTLHP
WSKKCFSFASLIPKNYRMAKDLLIKLWIANGFVRSEGNFDAETNGNHVFNDLVMRSFLILFTPYYDYYSD
SHVTECTMHDLMHDLARSVSADVYWNSDEDSVEDIGKRIYHLQIYERKFPNMTRVVLDKKPLHLRTFMSF
TPPLYILRSRRINQLEVISELKFLRALDLNNGGIKEVPTSIGNLIHLRYLNLSRNYIEVLPDSITLLPNL
QYLNLSFNYTLRELPKELGNIQNLRDLSILESDSELTHMPCGLSRLTNLGSLPLFIAGDKIGACSIIELV
DLKLYGKMKIEFSKNFKNYSCGGRKILKNKVLNELCLEFNGSEIYDKDMLDDLCPNTSLKKLSIFNYRSP
QFPTWLIELQLPNLVEVRLENCRDCEHIPPLGNLQKLQMYNCLELKCMPRLPRIQELSISYCSGSLLSCV
ERLTSLSVLKVDGFNGMTSLPSGCIRNLTSLTELQISNCGQLQSLPGDEMQYLKMLRSLTIQMCDNLTSF
PSEVGRLSSLCFLRISECTNIILQPEELAQILNPVHEFDIEICGNKVNLRGQLQYLHTLQNLSLHGSHVT
NNYTFGCEIRKLSICCCDELESLMTVEPASSTVLEQLYIDGISNLMALPDWLQHLNSLRFLLIEDCPRLE
RVPRGLKNLHMLEYLRIVGCPQLESRCERETGEDWPIISHVPHTCLYLIDISDSGYGWKDQCVREV


>XP_042384166.1 disease resistance protein RGA2-like isoform X1 [Zingiber officinale]
MEGALVAAAARLMFDKVTALLQVDEKLKTITGTKRKMEKLKELSTIIDMVIRDIECRPFIDDAVKDMLKK
LKYLAYDLEDVVDYYDTKVLQKKQRSKTSLRPVRDFFSFDNQVVFKSRVGGMIKAITESLDSILLQKSIL
LNLPQSSIRMSEPSLCRETHSCNSFVVIGREPEKNKIVDMLTKDDDDESNHGTVKVIAIVGMGGLGKTSL
AQLVYNDARVQNHFASLTMWKVVGAEFNPTKIMKSVLELATGASVNISEIDLVKQKLEKALSRKKFLLVL
DDVWNEDELQWGVLKAALTCGARGSKILVTTRSQQVSLIMGSSNTTHQIQQLSRDDCLSLFQQFAFGDQA
VDQNLMKIGAKIVEKCGGVPLAAISLGSMLRSTRDETYWSSVLNSEIWRLGNQEDKVLAVLKLSYDTLHP
WSKKCFSFASLIPKNYRMAKDLLIKLWIANGFVRSEGNFDAETNGNHVFNDLVMRSFLILFTPYYDYYSD
SHVTECTMHDLMHDLARSVSADVYWNSDEDSVEDIGKRIYHLQIYERKFPNMTRVVLDKKPLHLRTFMSF
TPPLYILRSRRINQLEVISELKFLRALDLNNGGIKEVPTSIGNLIHLRYLNLSRNYIEVLPDSITLLPNL
QYLNLSFNYTLRELPKELGNIQNLRDLSILESDSELTHMPCGLSRLTNLGSLPLFIAGDKIGACSIIELV
DLKLYGKMKIEFSKNFKNYSCGGRKILKNKVLNELCLEFNGSEIYDKDMLDDLCPNTSLKKLSIFNYRSP
QFPTWLIELQLPNLVEVRLENCRDCEHIPPLGNLQKLQMYNCLELKCMPRLPRIQELSISYCSGSLLSCV
ERLTSLSVLKVDGFNGMTSLPSGCIRNLTSLTELQISNCGQLQSLPGDEMQYLKMLRSLTIQMCDNLTSF
PSEVGRLSSLCFLRISECTNIILQPEELAQILNPVHEFDIEICGNKVNLRGQLQYLHTLQNLSLHGSHVT
NNYTFGCEIRKLSICCCDELESLMTVEPASSTVLEQLYIDGISNLMALPDWLQHLNSLRFLLIEDCPRLE
RVPRGLKNLHMLEYLRIVGCPQLESRCERETGEDWPIISHVPHTCLYLIDISDSGYGWKDQCVREV


>XP_042384167.1 disease resistance protein RGA2-like isoform X2 [Zingiber officinale]
MEGALVAAAARLMFDKVTALLQVDEKLKTITGTKRKMEKLKELSTIIDMVIRDIECRPFIDDAVKDMLKK
LKYLAYDLEDVVDYYDTKVLQKKQRSKTSLRPVRDFFSFDNQVVFKSRVGGMIKAITESLDSILLQKSIL
LNLPQSSIRMSEPSLCRETHSCNSFVVIGREPEKNKIVDMLTKDDDDESNHGTVKVIAIVGMGGLGKTSL
AQLVYNDARVQNHFASLTMWKVVGAEFNPTKIMKSVLELATGASVNISEIDLVKQKLEKALSRKKFLLVL
DDVWNEDELQWGVLKAALTCGARGSKILVTTRSQQVSLIMGSSNTTHQIQQLSRDDCLSLFQQFAFGDQA
VDQNLMKIGAKIVEKCGGVPLAAISLGSMLRSTRDETYWSSVLNSEIWRLGNQEDKVLAVLKLSYDTLHP
WSKKCFSFASLIPKNYRMAKDLLIKLWIANGFVRSEGNFDAETNGNHVFNDLVMRSFLILFTPYYDYYSD
SHVTECTMHDLMHDLARSVSADVYWNSDEDSVEDIGKRIYHLQIYERKFPNMTRVVLDKKPLHLRTFMSF
TPPLYILRSRRINQLEVISELKFLRALDLNNGGIKEVPTSIGNLIHLRYLNLSRNYIEVLPDSITLLPNL
QYLNLSFNYTLRELPKELGNIQNLRDLSILESDSELTHMPCGLSRLTNLGSLPLFIAGDKIGACSIIELV
DLKLYGKMKIEFSKNFKNYSCGGRKILKNKVLNELCLEFNGSEIYDKDMLDDLCPNTSLKKLSIFNYRSP
QFPTWLIELQLPNLVEVRLENCRDCEHIPPLGNLQKLQMYNCLELKCMPRLPRIQELSISYCSGSLLSCV
ERLTSLSVLKVDGFNGMTSLPSGCIRNLTSLTELQISNCGQLQSLPGDEMQYLKMLRSLTIQMCDNLTSF
PSEVGRLSSLCFLRISECTNIILQPEELAQILNPVHEFDIEICGNKVNLRGQLQYLHTLQNLSLHGSHVT
NNYTFGCEIRKLSICCCDELESLMTVEPASSTVLEQLYIDGISNLMALPDWLQHLNSLRFLLIEDCPRLE
RVPRGLKNLHMLEYLRIVGCPQLESRCERETGEDWPIISHVPHTCLYLIDISDSGYGWKDNKR


>XP_042384168.1 disease resistance protein RGA2-like isoform X3 [Zingiber officinale]
MEGALVAAAARLMFDKVTALLQVDEKLKTITGTKRKMEKLKELSTIIDMVIRDIECRPFIDDAVKDMLKK
LKYLAYDLEDVVDYYDTKVLQKKQRSKTSLRPVRDFFSFDNQVVFKSRVGGMIKAITESLDSILLQKSIL
LNLPQSSIRMSEPSLCRETHSCNSFVVIGREPEKNKIVDMLTKDDDDESNHGTVKVIAIVGMGGLGKTSL
AQLVYNDARVQNHFASLTMWKVVGAEFNPTKIMKSVLELATGASVNISEIDLVKQKLEKALSRKKFLLVL
DDVWNEDELQWGVLKAALTCGARGSKILVTTRSQQVSLIMGSSNTTHQIQQLSRDDCLSLFQQFAFGDQA
VDQNLMKIGAKIVEKCGGVPLAAISLGSMLRSTRDETYWSSVLNSEIWRLGNQEDKVLAVLKLSYDTLHP
WSKKCFSFASLIPKNYRMAKDLLIKLWIANGFVRSEGNFDAETNGNHVFNDLVMRSFLILFTPYYDYYSD
SHVTECTMHDLMHDLARSVSADVYWNSDEDSVEDIGKRIYHLQIYERKFPNMTRVVLDKKPLHLRTFMSF
TPPLYILRSRRINQLEVISELKFLRALDLNNGGIKEVPTSIGNLIHLRYLNLSRNYIEVLPDSITLLPNL
QYLNLSFNYTLRELPKELGNIQNLRDLSILESDSELTHMPCGLSRLTNLGSLPLFIAGDKIGACSIIELV
DLKLYGKMKIEFSKNFKNYSCGGRKILKNKVLNELCLEFNGSEIYDKDMLDDLCPNTSLKKLSIFNYRSP
QFPTWLIELQLPNLVEVRLENCRDCEHIPPLGNLQKLQMYNCLELKCMPRLPRIQELSISYCSGSLLSCV
ERLTSLSVLKVDGFNGMTSLPSGCIRNLTSLTELQISNCGQLQSLPGDEMQYLKMLRSLTIQMCDNLTSF
PSEVGRLSSLCFLRISECTNIILQPEELAQILNPVHEFDIEICGNKVNLRGQLQYLHTLQNLSLHGSHVT
NNYTFGCEIRKLSICCCDELESLMTVEPASSTVLEQLYIDGISNLMALPDWLQHLNSLRFLLIEDCPRLE
RVPRGLKNLHMLEYLRIVGCPQLESRCERETGEDWPIISHVPHTCLYLIDISDSGYGWKG


>XP_042384169.1 putative disease resistance protein RGA4 isoform X4 [Zingiber officinale]
MVGKVGAASRFMVDKVADLLQVDEKLKTITGTKRKMEKLKELSTIIDMVIQDIESRPFIHDAVKDLLKKL
KYLAYDLEDVVDYYDTKVFQKKQRSKAFLRPVSDFFSADNQVAFKSRVGGMIKAITESLDSILLQKSILS
NLLQGTIPASEPSPYRDTFSSNSLVVIGRESEKNEIVDMLTKDDDDDDESNHGTVKVIAIVGMGGMGKTA
LAQLVYNDARVQDHFARSKMYWKVVGTEFDPAKIMKSVLELATGASDNISEIELVKQKLKKELSGKRFLL
VLDDVWNDNQSKWNVLKAALTCGARGSKILVTTRSQQVSSIMGSSNTTHQIQQLSRDDCLSLFQQFAFGD
QVVDQNLMEIGGKIVEKCGGVPLAAISLGSMLRSTREETYWSSVLNSEIWKLRNEEDKVLAVLKLSYDTL
HPWSKKCFAFTSLFPKNERMAKDELIKLWIANGFVRSQGNFDAETNGNYVFDDLVMGSFLILLAPYNDYH
SDSHVTECTMHDLMHDLARSVSADVYWNSDEDSVEDIGKRTYHLQIYEGKLPNMTRVVLDKKPLYLRTFM
PLYVFSSWRRINLFEVFSELKFLRALDLTGGGISEVPTAIGNLIHLRYLNLSKNNIEILPESITLLSNLQ
YLNLSFNSRLRELPKELGNMQNLRDLDILPKYSILTHMPCGSSRLTNLLSLPLFIASDKASTCSITELEN
LKLRGKMIIRFSEDFKKYSCGGRKILKNKNLTELGLMFNG


>XP_042384170.1 putative disease resistance protein RGA4 isoform X5 [Zingiber officinale]
MVDKVADLLQVDEKLKTITGTKRKMEKLKELSTIIDMVIQDIESRPFIHDAVKDLLKKLKYLAYDLEDVV
DYYDTKVFQKKQRSKAFLRPVSDFFSADNQVAFKSRVGGMIKAITESLDSILLQKSILSNLLQGTIPASE
PSPYRDTFSSNSLVVIGRESEKNEIVDMLTKDDDDDDESNHGTVKVIAIVGMGGMGKTALAQLVYNDARV
QDHFARSKMYWKVVGTEFDPAKIMKSVLELATGASDNISEIELVKQKLKKELSGKRFLLVLDDVWNDNQS
KWNVLKAALTCGARGSKILVTTRSQQVSSIMGSSNTTHQIQQLSRDDCLSLFQQFAFGDQVVDQNLMEIG
GKIVEKCGGVPLAAISLGSMLRSTREETYWSSVLNSEIWKLRNEEDKVLAVLKLSYDTLHPWSKKCFAFT
SLFPKNERMAKDELIKLWIANGFVRSQGNFDAETNGNYVFDDLVMGSFLILLAPYNDYHSDSHVTECTMH
DLMHDLARSVSADVYWNSDEDSVEDIGKRTYHLQIYEGKLPNMTRVVLDKKPLYLRTFMPLYVFSSWRRI
NLFEVFSELKFLRALDLTGGGISEVPTAIGNLIHLRYLNLSKNNIEILPESITLLSNLQYLNLSFNSRLR
ELPKELGNMQNLRDLDILPKYSILTHMPCGSSRLTNLLSLPLFIASDKASTCSITELENLKLRGKMIIRF
SEDFKKYSCGGRKILKNKNLTELGLMFNG


>XP_042384171.1 putative disease resistance protein RGA4 isoform X6 [Zingiber officinale]
MVGKVGAASRFMVDKVADLLQVDEKLKTITGTKRKMEKLKELSTIIDMVIQDIESRPFIHDAVKDLLKKL
KYLAYDLEDVVDYYDTKVFQKKQRSKAFLRPVSDFFSADNQVAFKSRVGGMIKAITESLDSILLQKSILS
NLLQGTIPASEPSPYRDTFSSNSLVVIGRESEKNEIVDMLTKDDDDDDESNHGTVKVIAIVGMGGMGKTA
LAQLVYNDARVQDHFARSKMYWKVVGTEFDPAKIMKSVLELATGASDNISEIELVKQKLKKELSGKRFLL
VLDDVWNDNQSKWNVLKAALTCGARGSKILVTTRSQQVSSIMGSSNTTHQIQQLSRDDCLSLFQQFAFGD
QVVDQNLMEIGGKIVEKCGGVPLAAISLGSMLRSTREETYWSSVLNSEIWKLRNEEDKVLAVLKLSYDTL
HPWSKKCFAFTSLFPKNERMAKDELIKLWIANGFVRSQGNFDAETNGNYVFDDLVMGSFLILLAPYNDYH
SDSHVTECTMHDLMHDLARSVSADVYWNSDEDSVEDIGKRTYHLQIYEGKLPNMTRVVLDKKPLYLRTFM
PLYVFSSWRRINLFEVFSELKFLRALDLTGGGISEVPTAIGNLIHLRMKVEGGG


>XP_042384173.1 putative disease resistance protein RGA4 isoform X7 [Zingiber officinale]
MLTKDDDDDDESNHGTVKVIAIVGMGGMGKTALAQLVYNDARVQDHFARSKMYWKVVGTEFDPAKIMKSV
LELATGASDNISEIELVKQKLKKELSGKRFLLVLDDVWNDNQSKWNVLKAALTCGARGSKILVTTRSQQV
SSIMGSSNTTHQIQQLSRDDCLSLFQQFAFGDQVVDQNLMEIGGKIVEKCGGVPLAAISLGSMLRSTREE
TYWSSVLNSEIWKLRNEEDKVLAVLKLSYDTLHPWSKKCFAFTSLFPKNERMAKDELIKLWIANGFVRSQ
GNFDAETNGNYVFDDLVMGSFLILLAPYNDYHSDSHVTECTMHDLMHDLARSVSADVYWNSDEDSVEDIG
KRTYHLQIYEGKLPNMTRVVLDKKPLYLRTFMPLYVFSSWRRINLFEVFSELKFLRALDLTGGGISEVPT
AIGNLIHLRYLNLSKNNIEILPESITLLSNLQYLNLSFNSRLRELPKELGNMQNLRDLDILPKYSILTHM
PCGSSRLTNLLSLPLFIASDKASTCSITELENLKLRGKMIIRFSEDFKKYSCGGRKILKNKNLTELGLMF
NG


>XP_042384266.1 putative disease resistance protein RGA1 [Zingiber officinale]
MEAALVGAASRFMVDKVADLLQLDEKFKTITGTKRKMEKLKELSPIIDMVIQHIESRPLMEDAAKELLKK
LKYLAYDIEDVVDYYDTKVFQKKQRSKNFLRPVRDFISSENQVMFKSRIGGMIKAITESLDSILLQKSIL
SNLIQEQGSIPASEPSLYNRVAHSRNSFVVIGRETEKQMIVNMLIKDDDDDESSHGTLKIISIVGMGGLG
KTTLAQHVFNDEKVKEHFASLKLWTVIGAEFDPVEIMKSVLQLATLKPVNISEIDLVMQELETALSGKRF
LLVLDDVWNEYESKWNVLKAALTCGARGSKILVTTRSQRVSSIMSSSNTTHQIQQLSGDDCLSLFQQSAF
GHQAADQNLMEIGEKIVEKCGGVPLAAISLGSMLRSNREENYWSSVLNSEIWQLRNEEQKVLAVLKLSYV
TLPLRSKKCFVFASLFPKNYRMAKDELIKLWIANGFVRSEGNFDAETNGNRVFNDLVMGSFFLLAPSRDF
EYDSHVTKCMMHDLMHDLARSTSADVYWNSDQESVEDIGNRIYHLQIDQRMFQNMTQVISGKKPLYLRTF
MLLHSFSAFTRLSINLLEVFSELKFLRALDLTYGGIWEVPTSIGNLIHLRYLNLSNNNIGVLPDSVTLLP
NLQYLNLSFNRELRELPKELGNMQNLRDLNLQKDFRLTHMPCGLSRLTNLRSLPLFIASEKTGTCSILEL
EDLKLHGEMKIKFSKDFKNYSCGGRKILKNKDLNELWLEFNGLERYDKDILDDLYPNTSLKKFNIFNYRS
PQFPAWLMELQLPNLVEVRLENCSGCEHIPPFGNLQFLKKLRLRSIADITHIGAEFHGYGGFPSLQELFL
HEMDNLEEWSSESHVVDQLFPVLQKLWISKCPKLESMPRLPRVQELTISYFSGSLLSCLRRLTSLHVLKV
NNKDDMTSLPSGCIRSLTSLRELEIIECRELQSLPGDEILYLEMLRSLTIERCNNLASFLSEVGRRLSSL
RFLRLSQCPSIISQPEELVQILNSVDRLQIQICGMKVNLRGQLQHLHTLKELSLCDSHVTSNYKIVNGIR
KLSICCCHKLELLMTAEPTRSTALEQLYIEGFSYLTMLPKWLQHLKYLRFLSIRNCPELIWLPRDLENLH
MLETLKIVGCPELKSGYEWLNISHIPRVDIS


>XP_042384267.1 putative disease resistance protein RGA1 [Zingiber officinale]
MEAALVGAASRFMVDKVAVLLKLDEKLKTITGTKRKMEKLKELAPIIDTVIQHIESRPLMEDAVKELLKK
LKYLAYDLEDVVDYYDTKVFQKKQRSKSLLRPVSDFFSADNQVAFKSRVGGMIKAITDSLDSILLQNSIL
SNLLQEQGSIPMSEPSLNNRETHSRNGFVVIGREPEKNKIVNMLTKDDDDDDESNHGIVKVIAIVGTGGL
GKTTLAQHVYNDARVQDHFASPTMWKVVGAEFNPTKIMKSLLELATGGSSVNISEIDLVKRKLEEALSGK
RFLLVLDDVWNEDELQWGVLKAALTCGARGSKILVTTRSKRVSSIMSSSNTTHQIQQLSRGDCLFLFQQF
AFGDQTVDQNLMAIGAKIVEKCGGVPLAAISLGSMLRSTREENYWSSVLNSEIWKLGNQEDKVLAVLKLS
YDALPLRSKKCFAFASLFSKDVTMKKYELIKLWIANGFVRSEGNFDAETVGEHVFDDLVLRSFFLLVPSR
YVTECTMHDLMRDLARSVSADVYWNSYQDSVENFGNRTYHLQIDGRKFPNMTQDLGKKPLYLRTFMQIYT
FSHLSINLLELFSELKPLYLRALDLTNGGIREVPTSIGILIHLRYLNLSQNHIEVLPDSITLLPNLQYLN
LRCNYELRELPKELGEMKNLRDLDLLSNSRLTHMPCGLSRLTNLRSLPLFIAGGKTGACSIIELENLKLH
GKMRIEFLKDFKNYSCGGRKILKNKNLNELCIVFNESYDKDMFVDLCPNTSLKRLELWGYSSPQFPVWLM
ESQLPNLVEVSLRNCRDCELIPPFGNLQFLKKLNLYSMNGITHLGDEFHGYRGFPSLRELSLNWMSNLEE
WSESHVVDQLFPLLQKLLIFWCPKLKSTPRLPRIRRLEISSSESILSCIGRFTSLSLLQLTGMPDIASLP
SGCIRNLTSLTNLQIISCRRLQSLPRDEMQYLEMLRSLTIDECDNLVFFPSEVGSLSSLCFRQNGVISQP
KELVQILNSVDEFRIEICGNKVDLRGQLQYLHTLKILSLFGSHLNNQLMFKYEIRALSICCCDELESFMA
AEATNSTKLEQLYINGFSNLTTMPDWLQHLKSLRRLSIRNCPRLERVPRDLKNLHMLKTLKIVGCPRLKS
RCARETGEDWPIISNVPNVDIE


>XP_042384268.1 putative disease resistance protein RGA1 [Zingiber officinale]
MEAALVGAASRFMVDKVAVLLKLDEKLKTITGTKRKMEKLKELAPIIDTVIQHIESRPLMEDAVKELLKK
LKYLAYDLEDVVDYYDTKVFQKKQRSKSLLRPVSDFFSADNQVAFKSRVGGMIKAITDSLDSILLQNSIL
SNLLQEQGSIPMSEPSLNNRETHSRNGFVVIGREPEKNKIVNMLTKDDDDDDESNHGIVKVIAIVGTGGL
GKTTLAQHVYNDARVQDHFASPTMWKVVGAEFNPTKIMKSLLELATGGSSVNISEIDLVKRKLEEALSGK
RFLLVLDDVWNEDELQWGVLKAALTCGARGSKILVTTRSKRVSSIMSSSNTTHQIQQLSRGDCLFLFQQF
AFGDQTVDQNLMAIGAKIVEKCGGVPLAAISLGSMLRSTREENYWSSVLNSEIWKLGNQEDKVLAVLKLS
YDALPLRSKKCFAFASLFSKDVTMKKYELIKLWIANGFVRSEGNFDAETVGEHVFDDLVLRSFFLLVPSR
YVTECTMHDLMRDLARSVSADVYWNSYQDSVENFGNRTYHLQIDGRKFPNMTQDLGKKPLYLRTFMQIYT
FSHLSINLLELFSELKPLYLRALDLTNGGIREVPTSIGILIHLRYLNLSQNHIEVLPDSITLLPNLQYLN
LRCNYELRELPKELGEMKNLRDLDLLSNSRLTHMPCGLSRLTNLRSLPLFIAGGKTGACSIIELENLKLH
GKMRIEFLKDFKNYSCGGRKILKNKNLNELCIVFNESYDKDMFVDLCPNTSLKRLELWGYSSPQFPVWLM
ESQLPNLVEVSLRNCRDCELIPPFGNLQFLKKLNLYSMNGITHLGDEFHGYRGFPSLRELSLNWMSNLEE
WSESHVVDQLFPLLQKLLIFWCPKLKSTPRLPRIRRLEISSSESILSCIGRFTSLSLLQLTGMPDIASLP
SGCIRNLTSLTNLQIISCRRLQSLPRDEMQYLEMLRSLTIDECDNLVFFPSEVGSLSSLCFRQNGVISQP
KELVQILNSVDEFRIEICGNKVDLRGQLQYLHTLKILSLFGSHLNNQLMFKYEIRALSICCCDELESFMA
AEATNSTKLEQLYINGFSNLTTMPDWLQHLKSLRRLSIRNCPRLERVPRDLKNLHMLKTLKIVGCPRLKS
RCARETGEDWPIISNVPNVDIE


>XP_042384269.1 putative disease resistance protein RGA1 [Zingiber officinale]
MEAALVGAASRFMVDKVAVLLKLDEKLKTITGTKRKMEKLKELAPIIDTVIQHIESRPLMEDAVKELLKK
LKYLAYDLEDVVDYYDTKVFQKKQRSKSLLRPVSDFFSADNQVAFKSRVGGMIKAITDSLDSILLQNSIL
SNLLQEQGSIPMSEPSLNNRETHSRNGFVVIGREPEKNKIVNMLTKDDDDDDESNHGIVKVIAIVGTGGL
GKTTLAQHVYNDARVQDHFASPTMWKVVGAEFNPTKIMKSLLELATGGSSVNISEIDLVKRKLEEALSGK
RFLLVLDDVWNEDELQWGVLKAALTCGARGSKILVTTRSKRVSSIMSSSNTTHQIQQLSRGDCLFLFQQF
AFGDQTVDQNLMAIGAKIVEKCGGVPLAAISLGSMLRSTREENYWSSVLNSEIWKLGNQEDKVLAVLKLS
YDALPLRSKKCFAFASLFSKDVTMKKYELIKLWIANGFVRSEGNFDAETVGEHVFDDLVLRSFFLLVPSR
YVTECTMHDLMRDLARSVSADVYWNSYQDSVENFGNRTYHLQIDGRKFPNMTQDLGKKPLYLRTFMQIYT
FSHLSINLLELFSELKPLYLRALDLTNGGIREVPTSIGILIHLRYLNLSQNHIEVLPDSITLLPNLQYLN
LRCNYELRELPKELGEMKNLRDLDLLSNSRLTHMPCGLSRLTNLRSLPLFIAGGKTGACSIIELENLKLH
GKMRIEFLKDFKNYSCGGRKILKNKNLNELCIVFNESYDKDMFVDLCPNTSLKRLELWGYSSPQFPVWLM
ESQLPNLVEVSLRNCRDCELIPPFGNLQFLKKLNLYSMNGITHLGDEFHGYRGFPSLRELSLNWMSNLEE
WSESHVVDQLFPLLQKLLIFWCPKLKSTPRLPRIRRLEISSSESILSCIGRFTSLSLLQLTGMPDIASLP
SGCIRNLTSLTNLQIISCRRLQSLPRDEMQYLEMLRSLTIDECDNLVFFPSEVGSLSSLCFRQNGVISQP
KELVQILNSVDEFRIEICGNKVDLRGQLQYLHTLKILSLFGSHLNNQLMFKYEIRALSICCCDELESFMA
AEATNSTKLEQLYINGFSNLTTMPDWLQHLKSLRRLSIRNCPRLERVPRDLKNLHMLKTLKIVGCPRLKS
RCARETGEDWPIISNVPNVDIE


>XP_042384270.1 putative disease resistance protein RGA1 [Zingiber officinale]
MEAALVATTARFMVDKVVDLLQLDEKLKTITGIKRKMEKLKELSPIIDTVIQHIESRPLMEDTVKELLKK
LKYLAYDLEDVVDYYDTKVFQKKQRSKAFLRPVSDFFSVDNQVAFKSRVGGMIKAITDSLDSILLQKSIL
SNLLQEQGSIPMSEPSLNNRETHSHNSFVVVGREPEKNKIVDMLTKDDDDDDDDDESHHGTVKVIAIVGM
GGLGKTTLAQHVYNDARVQDHFASPTMWKVVGAEFNPAEIMKAVLQLATGGSSVNISEIDLVKRKLEEEL
SGKRFLLVLDDVWNEDALKWGVLKAALTCGARGSKILVTTRSKRVSSIMSSSDTTHQLQQLSRDDCLSLF
QRFAFRDQAVDQNLMAIGAKVVEKCGGVPLAAISLGSMLRSTRDENYWSSVLNSEIWKLGNQEDKVLAVL
KLSYDALPLRSKKCFAFASLFSKDVKMKKDELIKLWIANGFVRSEGNFDAETVGEHVFDDLVLRSFFLLV
PSQYVTECTMHDLMHDLARSVSADVYWNSYQDSVENFGNRTYHLQIDPRKFPNMTQDLSKKPLYLRTFMH
IYTFSHLSINLLELFSELKPLYLRALDLTRGRIREVPTSIGILIHLRYLNLSWNHIEVLLDSITLLPNLQ
YFNLSFNQKLRELPKKLGNMQNLRDLDLLSNYRLTHMPCGLSRLTNLRSLPLFIASGKPGACSIIELENL
KLHGKMTIKFLKDFKNYSCGGRKILNNKNLNELCIVSNERYDKGMFVDLCPNTSLKRLEICGYSSPQFPV
WLMESQLPNLVEVSLGNCRGCELIPPFGNLQFLKKLDLDYMDGITHLGAEFHGYRGFPSLRELSLVRMFN
LEEWSESHVVDQLFPLLRKLLISWCPKLKSTPRLPRIQELKISYSESILSCIGRFTSLSLLQLTGMPDIA
SLPSGSIRNLTSLTKFQIRNCRQLQSLPVDEMQFLEMLRSLTIEECDNLVFFPSEVGSLSFLCFRWNGVI
PQPKELVQILNLVDEFQIEICDNKFDLRGQLQYLTHAQKIMSIWFTS


>XP_042384310.1 putative disease resistance RPP13-like protein 1 isoform X1 [Zingiber officinale]
MKCAASCTVLVTSRKEQVVTLMKATYIYPVEKMNDESGWNLLKHLAFEGEGDEDQISSFEEIGIKLVYKC
DGLPLAIKAIAGVLYQQNKAKWEEVLQSDAWNMDQIKEELRPLYLSYEDLPSSLKQCFLYCSLYPQKDMY
SKEIVQFWVAEGLIMDEQDKLRRDLPTEKQRTKEDIGEEIYRELLCRNLLEVDVDLDMSKSFFSMHDHFR
SLGAHLMREEGILYRHGREFKGDDNIKIRRLSISCMGPKLVLPAQILRQACLRTLILTDSPKTKTIEDSV
LQALPCLRVLDLTKTSIEKIPDCIGDLLHLRYLDLDGTNIREIPTTIGNLVNLLSLNISECEFLERLPVS
ITKLHNLRWLDMRDSPMLTHVPKGIGKLENFYNLEGFMVGQNGSASEEGCDLEELKNLSELRVLSIYRLE
RAEGGASALANMPFLMELVLGWKRPDEEEVDAKADEEVEGDGKDDGDADKDMGDGDYDGSGAEDENEETE
KEDENEEEDSEEEDKGWSEEQISKAERICNEMTQPSSTIFDLLFSQYPGRQFPIWMQSSSLAESFPNLTY
LKLIRLPCCTKLPPLGTLPQLKYLRIESATAITTIGSQFLGSRSSAFPKLEMLQFQDMPSWEEWTFNGTP
LAVKLFPILRTCNIIDCPNLRALPEGLCRATNFNQLCLHETYELGEIDNLALAYRLEVTNGIELKKISNI
PSLRYLAVNGCPSLECVENLGKLQHLALICSEETEQLPQWLLGLIEQHNNTASTQRSLRKFEMQCNLQLL
KSCLEGNENWDIIKQIPNVKIQTFSSQEFMFYTKDPYNYDAKIPSN


>XP_042384311.1 putative disease resistance RPP13-like protein 1 isoform X2 [Zingiber officinale]
MKATYIYPVEKMNDESGWNLLKHLAFEGEGDEDQISSFEEIGIKLVYKCDGLPLAIKAIAGVLYQQNKAK
WEEVLQSDAWNMDQIKEELRPLYLSYEDLPSSLKQCFLYCSLYPQKDMYSKEIVQFWVAEGLIMDEQDKL
RRDLPTEKQRTKEDIGEEIYRELLCRNLLEVDVDLDMSKSFFSMHDHFRSLGAHLMREEGILYRHGREFK
GDDNIKIRRLSISCMGPKLVLPAQILRQACLRTLILTDSPKTKTIEDSVLQALPCLRVLDLTKTSIEKIP
DCIGDLLHLRYLDLDGTNIREIPTTIGNLVNLLSLNISECEFLERLPVSITKLHNLRWLDMRDSPMLTHV
PKGIGKLENFYNLEGFMVGQNGSASEEGCDLEELKNLSELRVLSIYRLERAEGGASALANMPFLMELVLG
WKRPDEEEVDAKADEEVEGDGKDDGDADKDMGDGDYDGSGAEDENEETEKEDENEEEDSEEEDKGWSEEQ
ISKAERICNEMTQPSSTIFDLLFSQYPGRQFPIWMQSSSLAESFPNLTYLKLIRLPCCTKLPPLGTLPQL
KYLRIESATAITTIGSQFLGSRSSAFPKLEMLQFQDMPSWEEWTFNGTPLAVKLFPILRTCNIIDCPNLR
ALPEGLCRATNFNQLCLHETYELGEIDNLALAYRLEVTNGIELKKISNIPSLRYLAVNGCPSLECVENLG
KLQHLALICSEETEQLPQWLLGLIEQHNNTASTQRSLRKFEMQCNLQLLKSCLEGNENWDIIKQIPNVKI
QTFSSQEFMFYTKDPYNYDAKIPSN


>XP_042384317.1 putative disease resistance protein RGA3 isoform X1 [Zingiber officinale]
MAMILDFFVSKFMTITANMVEVEIFKVLGVDKEIKALQERLGTINGYLHRAEEKKHENDEIDLWVRKLKD
VMYDADDVIDLCMIEGGKLLKAQALSGSTTINIPFSYLFSCFQCLKYRHDIANQIIALNNRLEDLKKDIV
IRSNLDRTAKESIEYVNRLVTHETSHLQVEGDIIGTQIKNATEVLVNLILENNPKKYRVLGVVGTGGIGK
STLASKIFEDEKIKDNFSNRIWLYVSKNYTESDLLKKLIRSVEGNETKGENLEGKSKVELENKLVSILTQ
NTFIVLDDVWKSSVWVDFLRKPIMKSATSCTVLVTSRIEKIVMLMKPRYIHPVEKMDEESGWTLLKHLVF
DVEGDEDEISSFEEIGIKLVNKCDGLPLAIKAIAGVLYQQNKAKWEDVLESDAWNMDQIEEELRPLYLSY
EDLPSRLKQCFLYCSLYPQKDMYSKEIVQFWIAEGLIMDEQDELRRDIPNKKQRTMEDLGEEIYRELLGR
NLLEAIRNDLSKSFFSMHDHFRSLCANLLREEGVLYRHGREFKVDDNVKIRRLSISCMGPMLVLPAQILR
QACLRTLILTDSPQTKTIEDSVLQALLCLRVLDLTKTSIEKIPDCIGDLLHLRYLDLDETNIREIPTTIG
NLVNLQSLNILRCKFLERLPVSITKLHNLRWLNMIGCPLLTYVPKGIGKLENIYSLYGFMIGQNDSTSEE
GCDLEELKNLSKLRVLIILRLERAEKGASALANKPFLKELTLSWMRPNEEEDDNGGGHDAQANEEEDGDG
KDDGSGQRTETKEEEEDENEEVEDEGEEEEDENEEVDGEEEEKGWNEEQISKAERICNEMSQPSSTLVHL
HFYEYCGRQFPSWMASSSLAESFPNLTYLKLVGLPCCTELPPLGTLPQLKFLSIVSANAITAIGSQFLGS
RSSAFPKLEVLRFEDMPKWEEWAFKGTPLAVKLFPSLRSCAIINCPKLRALPDGLHRAANLNELYLFQTY
ELREINNLPLAYKLKVSNGRWLKKISNIPLLRYLEVGNCPNLECVENLDKLQHLVLICSEEMEQLPQWFQ
DLIEQHNNMASSHRSLKKFEMHCNLQLLMSCLEGNENWDIIKHIPVVKIQTYSSKEYIRYTKDPYNYDAN
IPSN


>XP_042384318.1 putative disease resistance protein RGA3 isoform X1 [Zingiber officinale]
MAMILDFFVSKFMTITANMVEVEIFKVLGVDKEIKALQERLGTINGYLHRAEEKKHENDEIDLWVRKLKD
VMYDADDVIDLCMIEGGKLLKAQALSGSTTINIPFSYLFSCFQCLKYRHDIANQIIALNNRLEDLKKDIV
IRSNLDRTAKESIEYVNRLVTHETSHLQVEGDIIGTQIKNATEVLVNLILENNPKKYRVLGVVGTGGIGK
STLASKIFEDEKIKDNFSNRIWLYVSKNYTESDLLKKLIRSVEGNETKGENLEGKSKVELENKLVSILTQ
NTFIVLDDVWKSSVWVDFLRKPIMKSATSCTVLVTSRIEKIVMLMKPRYIHPVEKMDEESGWTLLKHLVF
DVEGDEDEISSFEEIGIKLVNKCDGLPLAIKAIAGVLYQQNKAKWEDVLESDAWNMDQIEEELRPLYLSY
EDLPSRLKQCFLYCSLYPQKDMYSKEIVQFWIAEGLIMDEQDELRRDIPNKKQRTMEDLGEEIYRELLGR
NLLEAIRNDLSKSFFSMHDHFRSLCANLLREEGVLYRHGREFKVDDNVKIRRLSISCMGPMLVLPAQILR
QACLRTLILTDSPQTKTIEDSVLQALLCLRVLDLTKTSIEKIPDCIGDLLHLRYLDLDETNIREIPTTIG
NLVNLQSLNILRCKFLERLPVSITKLHNLRWLNMIGCPLLTYVPKGIGKLENIYSLYGFMIGQNDSTSEE
GCDLEELKNLSKLRVLIILRLERAEKGASALANKPFLKELTLSWMRPNEEEDDNGGGHDAQANEEEDGDG
KDDGSGQRTETKEEEEDENEEVEDEGEEEEDENEEVDGEEEEKGWNEEQISKAERICNEMSQPSSTLVHL
HFYEYCGRQFPSWMASSSLAESFPNLTYLKLVGLPCCTELPPLGTLPQLKFLSIVSANAITAIGSQFLGS
RSSAFPKLEVLRFEDMPKWEEWAFKGTPLAVKLFPSLRSCAIINCPKLRALPDGLHRAANLNELYLFQTY
ELREINNLPLAYKLKVSNGRWLKKISNIPLLRYLEVGNCPNLECVENLDKLQHLVLICSEEMEQLPQWFQ
DLIEQHNNMASSHRSLKKFEMHCNLQLLMSCLEGNENWDIIKHIPVVKIQTYSSKEYIRYTKDPYNYDAN
IPSN


>XP_042384319.1 putative disease resistance RPP13-like protein 1 isoform X2 [Zingiber officinale]
MAMILDFFVSKFMTITANMVEVEIFKVLGVDKEIKALQERLGTINGYLHRAEEKKHENDEIDLWVRKLKD
VMYDADDVIDLCMIEGGKLLKAQALSGDEDEISSFEEIGIKLVNKCDGLPLAIKAIAGVLYQQNKAKWED
VLESDAWNMDQIEEELRPLYLSYEDLPSRLKQCFLYCSLYPQKDMYSKEIVQFWIAEGLIMDEQDELRRD
IPNKKQRTMEDLGEEIYRELLGRNLLEAIRNDLSKSFFSMHDHFRSLCANLLREEGVLYRHGREFKVDDN
VKIRRLSISCMGPMLVLPAQILRQACLRTLILTDSPQTKTIEDSVLQALLCLRVLDLTKTSIEKIPDCIG
DLLHLRYLDLDETNIREIPTTIGNLVNLQSLNILRCKFLERLPVSITKLHNLRWLNMIGCPLLTYVPKGI
GKLENIYSLYGFMIGQNDSTSEEGCDLEELKNLSKLRVLIILRLERAEKGASALANKPFLKELTLSWMRP
NEEEDDNGGGHDAQANEEEDGDGKDDGSGQRTETKEEEEDENEEVEDEGEEEEDENEEVDGEEEEKGWNE
EQISKAERICNEMSQPSSTLVHLHFYEYCGRQFPSWMASSSLAESFPNLTYLKLVGLPCCTELPPLGTLP
QLKFLSIVSANAITAIGSQFLGSRSSAFPKLEVLRFEDMPKWEEWAFKGTPLAVKLFPSLRSCAIINCPK
LRALPDGLHRAANLNELYLFQTYELREINNLPLAYKLKVSNGRWLKKISNIPLLRYLEVGNCPNLECVEN
LDKLQHLVLICSEEMEQLPQWFQDLIEQHNNMASSHRSLKKFEMHCNLQLLMSCLEGNENWDIIKHIPVV
KIQTYSSKEYIRYTKDPYNYDANIPSN


>XP_042384321.1 probable disease resistance protein RF45 [Zingiber officinale]
MYDADDIIDICMIEGGKLLKARALSGDEDEISSFEEIGIKLVNKCDGLPLAIKAIAGVLYHQNKAKWEEV
LESDAWNMDQIEEELRPLYLSYEDLPSRFKQCFLYCSLYPQKDMFSMEIVQFWAAEGLIMSEEDNWRRDL
PTQNQRTLEDLGEEIYRELLGRNLLEAKKDELSKSFFSMHDHFRSLCANLMREEGILYRHGREFKADDNV
KVRRLSISCMGPMLVLPAQILRQACLRTLILTDSPQTKTIEDSVVQALLCLRVLDLSETSIEKIPDCIGE
LLHLRYLDLDGTNIREIPTTIGNLVNLQSLNIIRCKFLERLPVSITKLHNLRWLNMIGCPLLTYVPKGIG
KLENIYSLYGFMIGQNDSTSEEGCDLEELKNLSKLRVLIILRLERAEKGASALANKPFLKDLTLSWMRPD
EEEDDNGGGHDAQANEEEDGDGKDDGSGQRTETKEEEEDENEEVEDEGEEEEDENEEVDGEEEEKGWNEE
QISKAERICNEMSQPSSTLVHLHFYDYPGRQFPSWMTSSSLAESFPNLTYLMLLGLPCCVELLPLGTLPQ
LKYLRIESANAITTIGSQFLGSRSSAFPKLEALRFEDMPRWEEWTFNGAPLSVKLFPSLMECAIIDCPML
RALPDGLHRATNLNQLGLLRTYELGEINNITLAYRLEVAKCRGLKKISNISSLRSLVVIECGDLECVENL
NKLQHLIVECFETEQLPQWLPGLIERHNNTASTHRSLKKFEMACNLQLLMSCLEGNENWDILKHIPVVEI
HTYSSKEYIRYTKDPYNYDTNIPSN


>XP_042384322.1 probable disease resistance protein RF45 isoform X1 [Zingiber officinale]
MALVLDFFVSKFLTATANMVETEIFKVLGINKEIKSLQKRLGTINDNLQQVEQKRRINHEIDIWARKLKD
IMYDADDIIDICMIEGGKLLKARALSGDEDEISSFEEIGIKLVNKCDGLPLAIKAIAGVLYHQNKAKWEE
VLESDAWNMDQIEEELRPLYLSYEDLPSRFKQCFLYCSLYPQKDMFSMEIVQFWAAEGLIMSEEDNWRRD
LPTQNQRTLEDLGEEIYRELLGRNLLEAKKDELSKSFFSMHDHFRSLCANLMREEGILYRHGREFKADDN
VKVRRLSISCMGPMLVLPAQILRQACLRTLILTDSPQTKTIEDSVVQALLCLRVLDLSETSIEKIPDCIG
ELLHLRYLDLDGTNIREIPTTIGNLVNLQSLNIIRCKFLERLPVSITKLHNLRWLNMIGCPLLTYVPKGI
GKLENIYSLYGFMIGQNDSTSEEGCDLEELKNLSKLRVLIILRLERAEKGASALANKPFLKDLTLSWMRP
DEEEDDNGGGHDAQANEEEDGDGKDDGSGQRTETKEEEEDENEEVEDEGEEEEDENEEVDGEEEEKGWNE
EQISKAERICNEMSQPSSTLVHLHFYDYPGRQFPSWMTSSSLAESFPNLTYLMLLGLPCCVELLPLGTLP
QLKYLRIESANAITTIGSQFLGSRSSAFPKLEALRFEDMPRWEEWTFNGAPLSVKLFPSLMECAIIDCPM
LRALPDGLHRATNLNQLGLLRTYELGEINNITLAYRLEVAKCRGLKKISNISSLRSLVVIECGNLECVEN
LDKLQHLVLICSEEMEQLPQWFMDLIEQHNNMASSHRSLKKFEMACNLQLLMSCLEGNENWDILKHIPVV
EIQTYSSKEYIRYTKDPYNYDTNIPSN


>XP_042384324.1 putative disease resistance protein RGA3 [Zingiber officinale]
MALVLDFFVSKFLTATANMVEAEISKVLGINKEIKSLQKRLGTINGYLQQVEQKRRINHEIDIWARKLKD
IMYDADDIIDICMIEGGKLLKARALSSSSTVSIPWSYLFSCFRCLKYRHNIANQIIALNSKLEDLKKDIV
ITNYLDRAIKEVVENVDIVIAHETSHLQVEGDIVGAQIENAIEALVNLILENNPKKCRVFGVVGTGGIGK
STLASKIFEDERIKDNFPKRIWLYVSKIYTESDLLKKLIRSYEGSETKGENFEGKSKAELENTLVSILTR
NTFIVLDDVWNSSVWTDFLRKPIMKSAISCTVLVTTRKEKVVMLMKPRYIHPVEKMDEESGWTLLKHLVF
DVEGDEDEISSFEEIGIKLVNKCDGLPLAIKAIAGVLYHQNKAKWEEVLESDAWNMDQIEEELRPLYLSY
EDLPSRFKQCFLYCSLYPQKDMFSMEIVQFWAAEGLIMSEEDNWRRDLPTQNQRTLEDLGEEIYRELLGR
NLLEAKKDELSKSFFSMHDHFRSLCANLMREEGILYRHGREFKADDNVKVRRLSISCMGPMLVLPAQILR
QACLRTLILTDSPQTKTIEDSVVRALLCLRVLDLSETSIEKIPDCIGELLHLRYLDLDGTNIREIPTTIG
NLVNLQSLNILGCKFLERLPVSITKLHNLRWLNMIGCPLLTYVPKGIGKLENIYSLYGFMIGQNDSTSEE
GCDLEELKNLSKLRVLIILRLERAEKGASALANKPFLKDLTLSWMRPDEEEDDNGGGHDAQANEEEDGDG
KDDGSGQRTETKEEEEDENEEVEDEGEEEEDENEEVDGEEEEKGWNEEQISKAERICNEMSQPSSTLVHL
HFYDYPGRQFPSWMTSSSLAESFPNLTYLMLLGLPCCVELLPLGTLPQLKYLRIESANAITTIGSQFLGS
RSSAFPKLEALRFEDMPRWEEWTFNGAPLSVKLFPSLMECAIIDCPMLRALPDGLHRATNLNQLGLLRTY
ELGEINNITLAYRLEVAKCRGLKKISNISSLRSLVVIECGNLECVENLDKLQHLVLICSEEMEQLPQWFM
DLIEQHNNMASSHRSLKKFEMACNLQLLMSCLEGNENWDILKHIPVVEIQTYSSKEYIRYTKDPYNYDTN
IPSN


>XP_042386861.1 putative disease resistance RPP13-like protein 1 [Zingiber officinale]
MDEESGWNLLKHLVFESEGDEDEISSFEEIGIKLVNKCDGLPLAIKAIAGVLYQQDKAKWVEILQNMYSK
EIVQSWVAEGLIMDEQDQLRRDLPIENQRTMEEIGEEMYRELICRNLLEADASFDLSKSFFSMHDHFRSL
SANLMREEGILYRHAEILRQACLRTLILIDSPKTKTIEDSVLQALPCLRVLDLTKTSIEKIPDCIGDLLH
LRYLDLDGTNICEIPTSIGNLVNLQSLDISVCMYLERLPESIAKLHNLRRLDISCCPLLTYVPKGIGKLE
NLYSLHGFMVGQNNSTSEKGCDLEELKNLSKLRSITIDRLERAEGGASALANKPFLKQLSLSWMQPDEEE
EVDNGRGDDAKANEEADGDGTYDEDANNDMGDGKDDGYGQGNESEEAGDTSTGSEVENEETENEEKVWSE
EQISKAERICNEMTQPSSTIFNILFRQYPGRQFPSWMTSSSLAESFPNLTYLKLLGLPCCTELPPFGTLP
QLKYLNIERASSITAIGSQFLGSRSSAFPKLEVLQFEDMPRWEEWTFNGAPLAVKLFPSLRACAIIDCPK
LRALPDGLHRATNLNQLGLLQTYELGEINNITLAYRLEVTNGIGLKKISNIPSLRYLEVNDCPNLECVEN
LGKLQHLDLVCSEEMEQLPLWLRGLIEQHNNTASTHRSLKKFEMRCNRQLLKSCLEGNENWDIIEQIPNV
KVQTYSGQEYLFYTKDPYNYDAKIDSTPTMATLRQKINALRQLQLSQIQA


>XP_042387685.1 disease resistance protein RPM1-like [Zingiber officinale]
MPFADVASRMRRISSEFEHIHTFLSNIDVQKHNTVMESWLRLAREIENNLEDVIDEFLYLTAEKQSQILN
RSEVFTYHVGGHTRKTKILQRISSNLEEIEGDLLHLDAMKERYDIKKFLSEDGGCSPRLNTRRLRIDPSD
LLENFKDDKTIHRQKKEILRGWLVDGESNCYLITVLGRGGVGKTTMVDDIYRSKEIASRFDCKIWITLSK
SCGMKELLTRILKELSAKEEENYDVLDLINLLYKVNNLLQETTYLLILDDVLNLQLILDVQRLLIDNTRG
SRIVITTCLLEVEVAAQVNDVMPIKLDELNMDESFELFKRQADIHDLAASENLREILDYCQGLPLAIVAV
ARLWILTNKETEELERIHCKLKQQPKSSNADDVNQVLSLCYEYLPTNLKNCFLYCSMFQLDAGIKRKKLI
RLWVAENFVQDEDKQTKEEVAENILNELIYRSLLRVVEKNNDGSVRRCGMSNLFRKISLSAARKEKFSMV
WNESEAPKLRDEARRLSVHDFTKNSVLFKMDFSRTRSLLIYKHNFSACYYLLHTISTKAKYMRVIDLENA
NIDRVPDGLTELFNLHYLGLRGTRVTELPETIRKLQNLQTIDARYTRIVKLPKGITLLKNLLHLFASGLE
DPSRREFHSIRHVKVPKGLQNLTRLQQFDLEADDESVRQLQNLTNIRVLIISKVRSVHCSQLRFSISQMP
FLYKLSIAACDENEELNLKEFGLFMKNVRVFYLQGKLVELELIDAPQSLLKDNYVQLSQTFISLSDNLRV
LRLSWSRLQRDPLPALYQLQNLTVLYLQKAYDGVTLIFRNTWFPNLKELHLLHLPNLGKITIYQGSLRNL
QFLIMEGLLQLTTIPTGIEFLKSLQKLHFSECNPSFLNAINRDQRSKVEHIPDICYDDGIHGSRTLDIFP
RTSGVIPDQQNLTKVGAEVSLKSVNDADKIVGAGVVQTLDSNARVGGYEIGPNWAGIRLGTPMDNAEHLI
RPYGGLKTIGHAKGSLIAWPCSLLSIRQKL


>XP_042387789.1 putative disease resistance protein RGA3 [Zingiber officinale]
MSSRQTCLTRGLSNLHDEAVKRSRCNLVASRGHSDLAEALRPTKSLQEVLPSPAMMAQGRLLCIQNHLAM
VCDSLWAINSMMIIPKMRVLYNMYLQSKKLDGVLDVPIEFADWETDVAASVTDAGELLGRILDWEASLHR
YIVGNPQQVHFRHVILVELKEMLCCLNSLVLRGSAMGLRRDPMSSMNPLREDYSIVLNNEVVGRQEDIEK
LIVIFQQYQPVPSNNNGNDSDPFVIVIVGKEGVGKATLARMIYHHTWVCKQFHHRIWVDVPRLSPFKIVN
IIRKEFARSINNEEYCDLHRELPLHAFWEYINEQLDGRRYLLVLHFEYLASLTQQEWNELKNILLPVGGP
GSGVLIINRSSTQSVSDMGFLHTVKNIRTYCLNPLSEDAWLELFKRHAATTIPSKQDKSEIDELIPFTKQ
HFQNLIHQPLLAKIVGWLNHDVQTTFPSPLPAALEEFYMLRNLQLVNIRVLQYRILLSGIQNEYNAILRV
LTTEYLIPTEMAGLGWIESHYTTQEVLEFMIPRMVYYLRTKVPKDSTTIPRCCRYLRLEINPRATLFRLP
IVPIEVSRKLISLILQEDETATQEYDEEEITLQAYKKRRMKAATAILKFLNNMLVRLVHLRILIVETSII
QTLPNEVSMLVNLRYLHLSKLKMELLPKSLFDLHNLRVLSLICCKKLQKIPERIYKLEKLEVLSLAYCTK
LQQLPKSITRLQNLLQLDMEGCCWLRKLPEDLFRFKSLRVLHVTGCASLSQIPLGIEQLFGLRSLVVILA
GVDGCFGLAELQALTNLQQLTLQNLERVKETQTEMLMGQQRLRILSLRWGGEEANDSSESATPLQLRSDS
SISGGVLHYHHLVNFPVS


>XP_042387842.1 probable disease resistance protein At1g52660 [Zingiber officinale]
MACINLNLDINVNHCLSGLWTSLRQGRPKSGIENLKKEMQNLSDKRDDMKSSIDQAELEGRIPTKQVNQW
LLDMETLEGQVADIEKDFQSMSCFSFHCFNQTRTGGMSQAQQAGDQVPIREPSNYYSIIRRVSKMLGEAN
KLMDRAKGLDPIAKVQPQEPIVMLPISDQPPIGIESYVKDISSCINGGEGNVIGIYGMGGVGKTTLLNSI
QQHYYRNQSIFDCFIWVVASKDCKLKKLQMDIAKSQGLKTLEESDEEQTCGNKLFIYLKKRNCLLFLDDI
WEHLDLRLLGMAHSASRQGQQRKVVVFTTRSETVCTQMKAQKKIKVRCLDPNQAWQLFLGNSDVDILRSD
KEINSYAKQLAKECAGLPRALITVAQAMLGNKPLVVWKDALQQITNNHEWTTNGHSEDSLIMHKARKLSC
YILENDFMMMQETLGNFAIYIRIILIFCILGF


>XP_042389068.1 disease resistance protein RPM1-like [Zingiber officinale]
MDPSFLIGRAILALAGEAITVIRTLLEDGQLMPFGDIASRMRRIISEFQHIHTFLSNVDVQKHNTVMEPW
LQRAREIANNLEDAIDEFLYLTAVPKRSQISDLLAYRRVWGFHNRKTMILQRISSNLEQIEGDLAHLDAM
KERYDIKNFLSKNGGCSDEPNTGRVRIDPSDLLEHSEDDKTIHRKEREILRGWLADGEPKRSLITVVGKR
GVGKTTMVGEVYRSKALASRFDCKIWITLSKSCEMEELLTRILKELSAKEEEIYNASDLINLPYKVNNLL
QETRYLLILDDVLNLQLISDVQRLLIDNKQGSRIVITTCLVDVDKKVNDLKPMKLNKLNDQESFELFKRQ
ADIHDLVASENLWEILKYCQGLPVAIVAVARLWMLTNKETAELERIHCKLKQQPKSSNADDVNQVLSLCY
EYLPGNVKNCFLYCSMFQLDNYIKGKKMIRLWVAENFVQDEDKQTKEEVAEEIFNELIYRSLLRVVEKNN
DGSVRRCEMSNLFLKITLSAARKEQFSMVWNESEAPKLRDEARRLSVHDFTKNSVLFKMDFSRTRSLLIY
KHNSSAFDELMRTISKEAKFMRVIDLENANIDRVPDGLTELYNLHYLGLRRTRVTQLPETIKKLQNLQTI
DARYTRIVKLPKAITLLKNLLHLLASRLDDPSRREFHSIRHVKVPKGLQNLTRLQHLDLEADDESVWQLQ
NLTNIRVLIISKVRSVHCSQLRYSISQMPFLYKLSIAAYDENEVLNLREFGLFMKNLRVLYLQGKLVELE
LIDAPQSLLKDNYVQLSQTFISLSDNLRVLRLSWSRLQRDPLPALYQLQNLTVLYLQKAYDGVTLTFRNT
WFPNLKELHLLHLPNLGKITIYQGSLRNLQLLIMEGLLQLMTIPIGIEFLASLQKLHFSECNPFFLNAIT
EQRSKVEHIPDICYDDGIHGSRTLDIFPRTGGVIPDQQNLTKEEERSGLLHDQIEDEKSSLKVGAEVSLK
SLNDADKIVGIGVVQTLDSNARVGGYEIGPNWAGIHLGTPMDNTEHLIRPYGSVKILGDAKGSLIAWPCC
LLSIHQNLRDEDSR


>XP_042389958.1 probable disease resistance protein At1g61300 [Zingiber officinale]
MAFATINLNLDVNSCLNGLWASLRLGRPKSGIQKLEKEMARLRSKRGDIKNKIGEAEREGKIPTDEVSQW
LREVEELEGQVADINQDFQSMSCFSYNCFYQTGGSSSQTQQARDQVPIRESSNYCSISRRMVKLLCEANE
LMSRAGALDPIATVGPPEPAVMLPISHRLPVGIESYVENIVGYIDGGEGNIIGIYGMGGVGKTTMLKSIQ
RHYYNHRIFDHVIWVVASKEYQLKMLQMDIAKSLELKTLQETDDERTCGDKLFSYLKNRNCLLLLDDIWE
HLDLQLLGMAHSATERGQQQQQLPRKVVVFTTRSETVCARMIAEKKIKVKCLDPNQAWQLFKENSDDDVL
SSDKRISSCAQDLAKECAGLPLALVTVARAMSGKKSWELWNDALHQIRDKHEWTTMDLLEEDSVMYKAFK
LSYDSLENDSIRECLLCCALWPEDYDIHKFEELIPCWIGCGIIREFNVINEAFTKGCSHLEALMAASLLE
HSSRRWDYYEARHVKMHDVIRDMALLMVPRLKGNGRKWIVKAGIGLHNLPRQEEWQEAEQASFMQNRILS
LPEYEASTFSKLSKLFLLLNDNPLNIPPSLFASMPRLTYLDLSKCDIKELPMEICNLTELQYLNLSYTFI
RSLPLEFGCLCKLEYLLLRYTKLETIPNGAISNLSMLKWLDIRGYFPVFDLLNELKCFKGCHQLSVGITI
NPADLERLGMVPNVSVWNLTVRGWQSSEFLKYDLDSISDNLERLTISDVPGDKLTMNAGVTCESSSRYFK
TLYFESLRQLETICLNGAGFNNLCDLYIYGCDKLKDVSWILQLPSLNLLDMKYCEEIEELISNVGNYNSS
FGIKMLNLAFMKNLHHIACQPCHFPYLEYVRVYDCPRLKKLPFGVEILKSRLKEIIGDQTWWDNLDWDDE
NNKNSFTFYFRDRFH


>XP_042389988.1 disease resistance protein UNI-like isoform X1 [Zingiber officinale]
MAFIKLNLNVDANSCLSGLWASLQLGRPKSGIKKLEKEMARLKGKRDDIKNQIGEAEREGKISTNEVDQW
LREVEELEGQVADINQDFQSMSCFNCNCFNQTGSTSSQTQLAGDQILIRESSNCCSIIRKVAKKLGEANE
LMSRAGALDPIATVALPEPTVMLSMSHRPPVGIESYVKETVGYIDGGKDIIGIYGMGGVGKTTMLKSIQR
YYSNHRLFDLVIWVVASKDCQLKKLQMDIAKSLELNTLQKSDDEPTCGDKLFKYLKNRNCLLLLDDIWEH
LDLQLLGMAHSATKQGQQQQQQGQQQQQPRKAVVFTTRSETLCGRMKAEKKIKVKCLDPNQAWQLFKENS
DEDVLSSDRGINSCAQDLAKECAGLPLALITVARAMSGKKSWEVWKEALHQIRDEHEWTTVCLPEDSIVM
YKAFKLSYDSLENDSIKECLLCCALWPEDYEIHKFKELIPCWIGCGIICEFNVINEAFAKGCSYLETLMA
ASLLERSSRPHNYYEADHVKMHDIIRDMALLMVSELKGNERKWIVKAGIGLHNLPRQEEWQEAERASFMK
NRILSLPEYKASTFSELSILILQYNHLTTIPPSLSASMPHLTYLDLSNCDIKELPTEIGSLTELQYLNLS
YTDIRSLPLEFGCLGKLKYLLLRDTYFKTVPNGVISNLPMLKWLDITQQFPVCEQWWDELVRFKGRHQLS
LGIAIYAANLESLNVLPNVSVWNLTMSGLSSEFQMLQWSHRLSDNLECLTIANVRGDKLMMNASVDCESS
FRCLKTLIFDRIEELEKSWLNGIGFDNLRDLYINCCYKLKNVSWVLQLPCLNLLDISDCWEMEELISNIE
NSNSNFGIKMLTLCHMKKLHRIAHQPLCFSYLEYMRVHDCPRLQKLPFGVEILKSRLKEIEGDRTWWDNL
DWDDESTKDSLTPYFRD


>XP_042389989.1 probable disease resistance protein At1g61190 isoform X2 [Zingiber officinale]
MSRAGALDPIATVALPEPTVMLSMSHRPPVGIESYVKETVGYIDGGKDIIGIYGMGGVGKTTMLKSIQRY
YSNHRLFDLVIWVVASKDCQLKKLQMDIAKSLELNTLQKSDDEPTCGDKLFKYLKNRNCLLLLDDIWEHL
DLQLLGMAHSATKQGQQQQQQGQQQQQPRKAVVFTTRSETLCGRMKAEKKIKVKCLDPNQAWQLFKENSD
EDVLSSDRGINSCAQDLAKECAGLPLALITVARAMSGKKSWEVWKEALHQIRDEHEWTTVCLPEDSIVMY
KAFKLSYDSLENDSIKECLLCCALWPEDYEIHKFKELIPCWIGCGIICEFNVINEAFAKGCSYLETLMAA
SLLERSSRPHNYYEADHVKMHDIIRDMALLMVSELKGNERKWIVKAGIGLHNLPRQEEWQEAERASFMKN
RILSLPEYKASTFSELSILILQYNHLTTIPPSLSASMPHLTYLDLSNCDIKELPTEIGSLTELQYLNLSY
TDIRSLPLEFGCLGKLKYLLLRDTYFKTVPNGVISNLPMLKWLDITQQFPVCEQWWDELVRFKGRHQLSL
GIAIYAANLESLNVLPNVSVWNLTMSGLSSEFQMLQWSHRLSDNLECLTIANVRGDKLMMNASVDCESSF
RCLKTLIFDRIEELEKSWLNGIGFDNLRDLYINCCYKLKNVSWVLQLPCLNLLDISDCWEMEELISNIEN
SNSNFGIKMLTLCHMKKLHRIAHQPLCFSYLEYMRVHDCPRLQKLPFGVEILKSRLKEIEGDRTWWDNLD
WDDESTKDSLTPYFRD


>XP_042390024.1 probable disease resistance protein At1g61300 [Zingiber officinale]
MAFAIINLNVDVDSCLSGLWASLGLGRPKSGIKKLEKEMARLRGKRDDIKNQIDEAEREGRIPTNEVSQW
LLEVETLEGKVAAIKQDFQSIGCFSCHCFNQTGGMLSQAQQAREQVSIRESLNCCSMNRRVAKKLGEANE
LMSRADALDPIATVGPPEPTVILPISHRPPVGIESYVKDIVGYIDGGDDSVIAIYGMGGVGKTTMLKSIH
QHYLLKHSIFDRVIWLVASKDCQFKRLQMDISKSLGLKTMQENDDERTCGDKLFSYLKNKKCLLLLDDIW
EHVNLQLLGMAHSATERRQQQQPRKVVVFTTRSETICAQMKAGKKIKVKCLDTNQAWQLFEENSYGDVLC
SDGGINFIARELAKECAGLPLALITVAQAMSGKRSWEAWNDALHQIRDKHEWTTIGLPEDSVVMYKAFKL
SYDSLENDSIRECLLCCALWPEDYGIHKYYELIPCWIGCGIIREFNVINEAFAKGRSHLEALMAASLLER
SSEIGNFYSRHCVTMHDVIRDMALLMVSGLDLEGIKRKWIVKAGIGLSHLLRQEEWQEAERASFMSNQIT
SLQEYGASTFSKLSMLFLHANCGLTIPPAFFASMPHLEYLDLSNCRITQLPEDIDSLTELQYLNLSYNPI
IRLPTKFGCLGKLEYLRLRKTKIETMLNGTISNLSMLKWLDIREIHPTPEWWWDELKCFKGHPQLSVAID
IDATTANIERLNILPNVSIWNLTIYGKDASSKLPSLDLSTLLWSYNVSDNLESLTIINVAVDKLMLTVDM
GHESSFGCLKILYLFDLQLLEKISLNGVVLRELYIFGCPMLKDVSWVLQLSCLNHLEINNCPKMKELISQ
VGNSDSNSICSSSIQRLALNDMPNLNCIADQPLLFPYLEYISVLDCPKLKKLPFGVEILKNRLKRIDGED
NWWNNLDWDDQIIKNSLTPYFRFR


>XP_042390027.1 probable disease resistance protein At1g61300 [Zingiber officinale]
MACIKLNLNVDVNSCLKGLQATLRLRRPKSEIKRLEKEMARLRGKRDDIKNQIDEAERKGKILTNEVSQW
LREVEILEGQATDIKQDFQSMSCLSCNCFNRTGDTSRNRTEAFAVNLEDEENSTTGQTQQPEDHVSMRES
SNCCSIIQRAAKKLSEANELMSRAGALVQIATVQPPEPVVMLPISHRLPVGIESYVKAIVGYIDGGKENI
IGIYGMGGVGKTTVLKSIQQYYLNQSKFDHVIWVVASKDCQLKRLQEEIATRLGLMTLQENDDEKACGDK
LFIYLKNKKCLLFLDDIWEQLDLQLLGMAHSATERGQQQPRKVVVFTTRSETVCGQMTTTTKFKVKCLDP
DKAWQLFEQNIDGDILKSDGGIKFVAQELAKECAGLPLALITVARAMLGKRSWEVWNDALHQIRDKHEWS
TIGLSKDSVVMYKAFKLSYDSLENDSIRECLLCCSLWPEDYEIDKFEELIPCWIGCGIINEFNVINEAFT
KGCSHLEALMAASLLEHSSEEYYTEKYVKMHDVIRDMALLMVSELKRSKRKWIVKAGTGLSHLPRQEEWQ
EAERASFMRNKITSLQEYGASTFPKLSMLILRVNDCLTIPRSLFASMPRLTYLDLSKCRISELPMEIGTL
TDLRYLNLSDNLIRTLPVEFGCLSKLEYLLLRDTKLKIVPNGTISNLSMLKWLDIRGVFTIRDWWLNELD
IRGMHPMFEWWWDELKCLKGHHQLSVGIDINATTANIERLNMLSNVSIWDLTMDGENISELPNLDLGTPQ
WCYNISDNLESLTILNVAVDKLMLTARCLKTLHFSELKLLEKVSLNGVGVYNLRALYIYGCWMLKDVSWV
LQLPHLNLLVISECPGMKNLISNFGNSNSSSNIRRLSLFFMLNLNCITDQPLHFPYLEYMQVRACPRFKK
LPFGAEILKSRLREIHGDQIWWNNLEWDEENNKNSLTPYFIPDSRRRLWRQSGGEGGGGGNGDCHGDDNS
LENSEGS


>XP_042390937.1 putative disease resistance RPP13-like protein 1 [Zingiber officinale]
MKDTESDYMISLNTPERKYVPEAKHWQSVASFTMGDAVLSPFVSYVVNKALIEAEQELKLIAGVNKELSK
FSQTYETIRAVLEDAEEKQVKNPTVRDWLRNLKDVFYEADDFLDEFAFQALRRKMEGGEQTSQVCGVLSC
FGLSHLSFSTKAAHKIKDIRERLDGIAKERETLRLRELTDTGRFEILRRPPTSSLVDESTVFGREKDKEN
VIKLLLSEDNNNNTTSTLSVLPILGLGGLGKSTLAQIIYNDTRVTEHFDLRMWVFVSQNFNNIKLTNAMV
EAATKSKFDLTNLNMLQETLAEKLKGKKFFLVLDDVWNENRVVWEQACLPLKTGRSGSKVVVTTRNQRVA
EIMGTQPAYPLKRLSEDDCWTLFCRAAFAEDEFADNEKLKAIGKEIVSKLDGVPLAAKTVGSMLFAKYNE
DDWQKVLNSEFWELPVNENDIMPPLKLSYQTLPSHLKQCFSYCSIFQKGYAFDKEKLIKIWMAQGFLQQQ
GEKQMEDVGSENFDDLLGRSFFHKVKGSYNMHDMMHALAQYVSIDECFIAQDGRLQGIPNKVRHLSLTSE
TLQPISLEALFGFSNLRTLIVLYGFNSNPVQVPTDLFIKLKCLRVLDFSNTFLEELPESISNLLHLRYLD
LSATAIAKLPDSICRLWNLQTLRLRDCFSLKGLPNGITSLINLRYLEEDSRLISNVVGIGNLTSLRELPL
FKVQKEIGHKITELKDMTELRGRLCILNLENVADAYEAKEAKLSSKRHIQALQLEWTDYGVPDWTDENVL
ECLQPHDNLKELYIEGYNGTRFPSWIGDPIFTCLTQVRLDYCKCINLPPLGQLQFLSHLQVQGLDEIKRV
GNEFYGHGSNAGFPSLKALHFEEMQQWSEWSEVKKSHFPCIRELSIVRCPKLKGLPTLSSLSSMNISSCS
SLRQLPVNMTRLERLAIQHCENIVVQPESYGLQSLLSLEQLDIENCPNFMSLAKLDEVHLPTSIRKLRIS
SCIGPENMIFKEIKSLTSLQSLEISDCRNLTSLPEGLHGLPSLESFYVIRCAMVEDFPEESLPKTLQYLS
IEGCPTLSECCRKEIALDKHITDHVPNIIIDGQRVTRRKSSVPDQTIE


>XP_042390938.1 putative disease resistance RPP13-like protein 1 [Zingiber officinale]
MKDTESDYMISLNTPERKYVPEAKHWQSVASFTMGDAVLSPFVSYVVNKALIEAEQELKLIAGVNKELSK
FSQTYETIRAVLEDAEEKQVKNPTVRDWLRNLKDVFYEADDFLDEFAFQALRRKMEGGEQTSQVCGVLSC
FGLSHLSFSTKAAHKIKDIRERLDGIAKERETLRLRELTDTGRFEILRRPPTSSLVDESTVFGREKDKEN
VIKLLLSEDNNNNTTSTLSVLPILGLGGLGKSTLAQIIYNDTRVTEHFDLRMWVFVSQNFNNIKLTNAMV
EAATKSKFDLTNLNMLQETLAEKLKGKKFFLVLDDVWNENRVVWEQACLPLKTGRSGSKVVVTTRNQRVA
EIMGTQPAYPLKRLSEDDCWTLFCRAAFAEDEFADNEKLKAIGKEIVSKLDGVPLAAKTVGSMLFAKYNE
DDWQKVLNSEFWELPVNENDIMPPLKLSYQTLPSHLKQCFSYCSIFQKGYAFDKEKLIKIWMAQGFLQQQ
GEKQMEDVGSENFDDLLGRSFFHKVKGSYNMHDMMHALAQYVSIDECFIAQDGRLQGIPNKVRHLSLTSE
TLQPISLEALFGFSNLRTLIVLYGFNSNPVQVPTDLFIKLKCLRVLDFSNTFLEELPESISNLLHLRYLD
LSATAIAKLPDSICRLWNLQTLRLRDCFSLKGLPNGITSLINLRYLEEDSRLISNVVGIGNLTSLRELPL
FKVQKEIGHKITELKDMTELRGRLCILNLENVADAYEAKEAKLSSKRHIQALQLEWTDYGVPDWTDENVL
ECLQPHDNLKELYIEGYNGTRFPSWIGDPIFTCLTQVRLDYCKCINLPPLGQLQFLSHLQVQGLDEIKRV
GNEFYGHGSNAGFPSLKALHFEEMQQWSEWSEVKKSHFPCIRELSIVRCPKLKGLPTLSSLSSMNISSCS
SLRQLPVNMTRLERLAIQHCENIVVQPESYGLQSLLSLEQLDIENCPNFMSLAKLDEVHLPTSIRKLRIS
SCIGPENMIFKEIKSLTSLQSLEISDCRNLTSLPEGLHGLPSLESFYVIRCAMVEDFPEESLPKTLQYLS
IEGCPTLSECCRKEIALDKHITDHVPNIIIDGQRVTRRKSSVPDQTIE


>XP_042392065.1 putative disease resistance protein At5g05400 isoform X1 [Zingiber officinale]
MAFIKLNLNVDVNSCLNGLWASLRLGRPKSGIKKLEKEMARLKGKRDGIKNQIGEAEREGKVSTNEVNQW
LREVEELEGQVADINQDFQSMSCFSCNCFNQNGGTLSQTQQAGDHVPIRESSSNCCSINRRVVKKLSEAN
ELMSRTGALDPIVTVGPPEPVVMFPISHRPPIGMDSYVQDIVGYIDGGEGNIIGIYGMGGVGKTTILKSI
QRHYC


>XP_042393807.1 disease resistance protein RPM1-like [Zingiber officinale]
MDPSFLIGRAILALAGEAITVIRTLLKDGQLMPFGDIASRMRRISSEFQHIQTFLSNVDVQKHNTVMEPW
LQRAREIANNLEDAIDEFLYLTAVPKRSQISDLLAYRRVWGFHNRKTMILQRISSNLEQIEGDLAHLDAM
KERYDIKNFLSKNGGCSDEPNTGRVRIDPSDLLEHSEDDKTIHRKEREILRGWLADGEPKRSLITVLGKR
GVGKTTMVGEVYRSKALASRFDCKIWITLSKSCEMEELLTRILKKLSAKEEEIYNAFDLINLPYKVNNLL
QETRYLLIIDDVLNLQLISDVQRLLIDNKQGSRIVITTCLVDVDKKVNDVKPMKLNKLNDQESFELFKRQ
TGLADELDFDASENLREILNYCQGLPVAIVAVARLWILTNKETAELKRIHCRLKQKPKSSNADDVNQVLS
LCYEYLPGNLKNCFLYCSMFQLDNYIKGKKMIRLWVAENFVQDEDKQTKEEVAEEIFNELIYRSLLRVVE
KNNDGSVRRCEMSNLFLKISLSAARKEQFSMVWNESEAPKLRDEARRLSVHDFTKNSVLFKMDFSRTRSL
LIYKHNSSAFDELMRTISKEAKFMRVIDLENANIDRVPDGLTELYNLHYLGLRRTRVTQLPETIKKLQNL
QTIDARYTRIVKLPKEITLLKNLLHLLASRLDDRSRREFHSIRHVKVPKGLQNLTRLQHLDLEADDESVW
QLQNLTNIRVLIISKVRSVHCSQLRNSISQMPFLYKLSIAAYDENEVLNLREFGLFMKNLRVLYLQGKLV
ELELIDAPQTLLKDNYVQLSQTFISLGDNLRVLRLSWSRLQRDPLPALYQLQNLTVLYLQKAYDGVTLTF
RNTWFPNLKELHLLHLPNLGKITIYQGSLSNLQLLFMEGLLQLMTIPIGIEFLESLQKLHFSECSPFFLN
AITEQRSKVEHISDICYDDGIHGSRTLDIFPRTGGVIPDQQNLTKEEERSGLLHDQIEDEKSSLKVGAEV
SLKSLNDADKIVGIGVVQTLDSNARVGGYEIGPNWAGIHLGTPMDNTEHLIRPYGSVKTLGDAKGSLIAW
PCCLLSIHRNLREEDSP


>XP_042394702.1 probable disease resistance protein At1g61300 [Zingiber officinale]
MAFATINLNLDVNSCLNGLWASLRLGRPKSGIQKLEKEMARLRSKRGDIKNKIGEAEREGKIPTDEVSQW
LREVEELEGQVADINQDFQSMSCFSCNCFYQTGGTSNQTPQAGDQVPIRESSNYCSISRRMVKLLCEANE
LMSRAGALDPIATVGPPEPAVMLPISHRLPVGIESYVENIVGYIDGGEGNIIGIYGMGGVGKTTMLKSIQ
RHYYNHRIFDHVIWVVASKEYQLKMLQMDIAKSLELKTLQETDDERTCGDKLFSYLKNRNCLLLLDDIWE
HLDLQLLGMAHSATERGQQQQQLPRKVVVFTTRSETVCARMIAEKKIKVKCLDPNQAWQLFKDNSDEDVL
SSDKRINSCAQDLAKECAGLPLALVTVARAMSGKKSWELWNDALHQIRDKHEWTTMDLLEEDSVMYKAFK
LSYDSLENDSIRECLLCCALWPEDYDIHKFEELIPCWIGCGIIREFNVINEAFTKGCSHLEALMAASLLE
HSSRRWDYYEAQHVKMHDVIRDMALLMVPRLKGNGRKWIVKAGIGLHNLPRQEEWQEAERASFMQNRILS
LPEYEASTFSKLSKLFLLLNDNPLNIPPSLFASMPRLTYLDLSKCDIKELPMEICNLTELQYLNLSYTFI
GSLPLKFGCLCKLEYLLLRYTKLETIPNGAISNLSMLKWLDIRGYFPVFDLLNELKCFKGCHQLSLGITI
NPADLERLGMVPNVSVWNLTVRGWQSSEFLKYDLDSVSDNLERLTISDVPGDKLTMNAGVNCESSSRYFK
TLYFESLRQLETICLNGVGFNNLCDLYIYGCDKLKDVSWVLQLPSLNLLDMKYCEEIEELISNVGNYNSS
FGIKMLNLAFMKNLHHIACQPCHFPYLEYIRVYDCPSLKKLPFGVEILKSRLKEIIGDQTWWDNLDWDDE
NNKNSFTFYFRDRFH


>XP_042394727.1 putative disease resistance protein At5g05400 [Zingiber officinale]
MAFATINLNVDVNSCLSGLWASLRLGRPKSGIQKLEKEMARLRSKRGDIKNKIGEAEREGKIPTDEVNQW
LREVEELEGQVADINQDFQSMSCFSCNCFNQTGCTSSQTQLAGDQIPIRESSNCCSIIRKVAKKLGEANE
LMSRAGALDPIATVALPEPTVMLSMSHRPPVGIESYVKETVGYIDGGKDIIGIYGMGGVGKTTKSIQRYY
SNHRLFDLVIWVVASKDCQLKKLQMDIAKSLELNTLQKSDDEPTCGDKLFKYLKNRNCLLLLDDIWEHLD
LQLLGMAHSATKQGQQQQQQQQPRKAVVFTRDIVWANESRKEDQSQMPGSKSSMATL


>XP_042394772.1 probable disease resistance protein At1g61300 isoform X1 [Zingiber officinale]
MRESSNCCSIIQRVAKKLSEANELMSRAGALVQIATVQPPEPVVMLPISHRLPVGIESYVKAIVGYIDVG
KENIIGIYGMGGVGKTTILKSIQQYYLNQSKFDHVIWVVASKDCQLKRLQEEIATRLGLMTLQENDDEKA
CGDKLFIYLKNKKCLLFLDDIWEQLDLQLLGMAHSATERDQQQPRKVVVFTTRSETVCGQMTTTTKFKVK
CLDPDKAWQLFEQNIDGDILKSDGGIKFVAQELAKECAGLPLALITVARAMLGKRSWEVWNDALHQIRDK
HEWSTIGLSKDSVVMYKAFKLSYDSLENDSIRECLLCCSLWPEDYEIDKFEELIPCWIGCGIISEFNVIN
EAFTKGCSHLEALMAASLLEHSSEEYYTEKYVKMHDVIRDMALLMVSELKRSKRKWIVKAGTGMSHLPRQ
EEWQEAERASFMRNKITSLQEYGASTFPKLSMLILRVNNCLTIPPSLFASMPRLTYLDISKCRISELPME
IGSLTELRYLNLSGNLVRTLPVEFGCLSKLEYLLLRDTKLKIVPNGTISNLSMLKWLDIRGVFTIRDWWL
NELDIRGMHPMSEWWWDELKCFKGCHQLSVGINIDATTANIERLNMLSNVSIWDLIMDGENISELPNLDL
GTPQWCYNISDNLESLTILNVAVDKLMLTARCLKTLHFSELKLLEKVSLNGVGVYNLRALYIYGCWMLKD
VSWVLQLPHLNLLVISECPGMKNLISNFGNSNSSSNIRRLSLFFMLNLNCITEQPLHFPYLEYMQVRACP
RFKKLPFGAEILKNRLREIHGDQIWWNNLEWDEENNKNSLTPYFIPDFRRRLWRQSRGGEGGSGSNGDCD
GDDNSLENSEGS


>XP_042394773.1 probable disease resistance protein At1g61300 isoform X2 [Zingiber officinale]
MRESSNCCSIIQRVAKKLSEANELMSRAGALVQIATVQPPEPVVMLPISHRLPVGIESYVKAIVGYIDVG
KENIIGIYGMGGVGKTTILKSIQQYYLNQSKFDHVIWVVASKDCQLKRLQEEIATRLGLMTLQENDDEKA
CGDKLFIYLKNKKCLLFLDDIWEQLDLQLLGMAHSATERDQQQPRKVVVFTTRSETVCGQMTTTTKFKVK
CLDPDKAWQLFEQNIDGDILKSDGGIKFVAQELAKECAGLPLALITVARAMLGKRSWEVWNDALHQIRDK
HEWSTIGLSKDSVVMYKAFKLSYDSLENDSIRECLLCCSLWPEDYEIDKFEELIPCWIGCGIISEFNVIN
EAFTKGCSHLEALMAASLLEHSSEEYYTEKYVKMHDVIRDMALLMVSELKRSKRKWIVKAGTGMSHLPRQ
EEWQEAERASFMRNKITSLQEYGASTFPKLSMLILRVNNCLTIPPSLFASMPRLTYLDISKCRISELPME
IGSLTELRYLNLSGNLVRTLPVEFGCLSKLEYLLLRDTKLKIVPNGTISNLSMLKWLDIRGVFTIRDWWL
NELDIRGMHPMSEWWWDELKCFKGCHQLSVGINIDATTANIERLNMLSNVSIWDLIMDGENISELPNLDL
GTPQWCYNISDNLESLTILNVAVDKLMLTARCLKTLHFSELKLLEKVSLNGVGVYNLRALYIYGCWMLKD
VSWVLQLPHLNLLVISECPGMKNLISNFGNSNSSSNIRRLSLFFMLNLNCITEQPLHFPYLEYMQVRACP
RFKKLPFGAEILKNRLREIHGDQIWWNNLEWDEENNKNSLTPYFIPDFRRLAAAKAAAAAMATATVMTTV
LRTRKVPKI


>XP_042395657.1 putative disease resistance protein RGA3 [Zingiber officinale]
MGDAVLSAFVTYVVNKALIEAEEELKLIAGVNKELSKFSQTYETIRAVLEDAEEKQVKNPTVRDWLRNLK
DVFYEADDFLDEFAFQALRRKMEGGEQTSQVCGVLSCFGLSHLSFSTKAAHKIKDIRERLDGIAKERETL
RLRELTDTGRFEILRRPPTSSLVDESTVFGREKDKENIIKLLLSEDNNNNTTITLSVLPILGLGGLGKST
LAQIIYNDTRVTEHFDLRMWVFVSQNFNNIKLTNAMVEAATKSKFDLTNLNMLQETLAEKLKGKKFFLVL
DDVWNENRVVWEQACLPLKTGRSGSKVVVTTRNQRVAEIMGTQPAYPLKRLSEDDCWTLFCRAAFAEDEF
ADNEKLKAIGKEIVSKLDGVPLAAKTVGSMLFAKYNEDDWQKVLNSEFWELPVNENDIMPPLKLSYQTLP
SHLKQCFSYCSIFQKGYAFDKEKLIKIWMAQGFLQQQGEKQMEDVGSENFDDLLGRSFFHKVKGSYNMHD
MMHALAQYVSIDECFIAQDGRLQGIPNKVRHLSLTSETLQPISLEALFGFSNLRTLIVLNGFNSNPVQVP
TDLFIKLKCLRVLDFSNTFLEELPESISNLLHLRYLDLSATAIAKLPDSICRLWNLQTLRLRDCFSLKGL
PNGITSLINLRYLEEDSRLISNVVGIGNLTSLRELPLFKVQKEIGHRITELKDMTELRGRLCILNLENVA
DAYEAKEAKLSSKRHIQALQLEWTDYGVPDWTDENVLECLQPHDNLKELYIEGYNGARFPSWIGDPIFTC
LTQVRLDYCKCINLPPLGQLQFLSHLQVQGLDEIKRVGNEFYGHGSNAGFPSLKALHFEEMQQWSEWSEV
KKSHFPCIRELSIIRCPKLKGLPTLSSLSSMNISSCSSLRHLPVNMTRLERLAIQHCENIVVRPESYGLQ
SLLSLEQLDIENCPNFMSLAKLDEVHLPTSIRKLRISSCIGPENMIFKEIKSLTSLQSLEISDCRNLTSL
PEGLHGLPSLENFYVIRCAMVEDFPEESLPKTLQYLSIEGCPTLSECCRKEIALDKHITDHVPNIIIDGQ
RVTRRKSSVPDQTIE


>XP_042395658.1 putative disease resistance protein RGA3 [Zingiber officinale]
MGDAVLSAFVTYVVNKALIEAEEELKLIAGVNKELSKFSQTYETIRAVLEDAEEKQVKNPTVRDWLRNLK
DVFYEADDFLDEFAFQALRRKMEGGEQTSQVCGVLSCFGLSHLSFSTKAAHKIKDIRERLDGIAKERETL
RLRELTDTGRFEILRRPPTSSLVDESTVFGREKDKENIIKLLLSEDNNNNTTITLSVLPILGLGGLGKST
LAQIIYNDTRVTEHFDLRMWVFVSQNFNNIKLTNAMVEAATKSKFDLTNLNMLQETLAEKLKGKKFFLVL
DDVWNENRVVWEQACLPLKTGRSGSKVVVTTRNQRVAEIMGTQPAYPLKRLSEDDCWTLFCRAAFAEDEF
ADNEKLKAIGKEIVSKLDGVPLAAKTVGSMLFAKYNEDDWQKVLNSEFWELPVNENDIMPPLKLSYQTLP
SHLKQCFSYCSIFQKGYAFDKEKLIKIWMAQGFLQQQGEKQMEDVGSENFDDLLGRSFFHKVKGSYNMHD
MMHALAQYVSIDECFIAQDGRLQGIPNKVRHLSLTSETLQPISLEALFGFSNLRTLIVLNGFNSNPVQVP
TDLFIKLKCLRVLDFSNTFLEELPESISNLLHLRYLDLSATAIAKLPDSICRLWNLQTLRLRDCFSLKGL
PNGITSLINLRYLEEDSRLISNVVGIGNLTSLRELPLFKVQKEIGHRITELKDMTELRGRLCILNLENVA
DAYEAKEAKLSSKRHIQALQLEWTDYGVPDWTDENVLECLQPHDNLKELYIEGYNGARFPSWIGDPIFTC
LTQVRLDYCKCINLPPLGQLQFLSHLQVQGLDEIKRVGNEFYGHGSNAGFPSLKALHFEEMQQWSEWSEV
KKSHFPCIRELSIIRCPKLKGLPTLSSLSSMNISSCSSLRHLPVNMTRLERLAIQHCENIVVRPESYGLQ
SLLSLEQLDIENCPNFMSLAKLDEVHLPTSIRKLRISSCIGPENMIFKEIKSLTSLQSLEISDCRNLTSL
PEGLHGLPSLENFYVIRCAMVEDFPEESLPKTLQYLSIEGCPTLSECCRKEIALDKHITDHVPNIIIDGQ
RVTRRKSSVPDQTIE


>XP_042396672.1 disease resistance protein RPM1-like [Zingiber officinale]
MPFADVASRMRRISSEFEHIHTFLSNIDVQKHNTVMESWLRRAREIENNLEDVIDEFLYLTAEKQSQILN
RSEVFTYYVGGIHTRKTKILQRISSNLEEIEGDLLHLDAMKERYDIKKFLSEDGGCSPRLNTRRLRIDPS
DLLENFKDDKTIHRQKKEILRGWLVDGESNCYLITVLGRGGVGKTTMVDDIYRSKEIASRFDCKIWITLS
KSCGMKELLTRILKELSAKEEENYDVLDLINLLYKVNNLLQETTYLLILDDVLNLQLIWDVQRLLIDNTR
GSRIVITTCLLEVEVAAQVNDVMPIKLDELNMDESFELFKREADMHDLAASENLREILDYCQGLPLAIVA
VARLWILTNKETEELERIHCKLKQQPKSSNADDVNQVLSLCYEYLPTNLKNCFLYCSMFQLDAGIKRKKL
IRLWVAENFVQDEDKQTKEEVAENILNELIYRSLLRVVEKNNDGSVRRCGMSNLFRKLSLSAARKEKFSM
VWNESEALKLRDEARRLSVHDFTKNSVLFKMDFSRTRSLLIYKHNFSACYYLLHTISTKAKYMRVIDLEN
ANIDRVPDGLTELFNLHYLGLRGTRVTELPETIRKLQNLQTIDARYTRIVKLPKGITLLKNLLHLFASGL
EDPSRREFHSIRHVKVPKGLQNLTRLQQFDLEADDESVRQLQNLTNIRVLIISKVRSVHCSELRFSISQM
PFLYKLSIAACDENEELNLKEFGLFMKNVRVFYLQGKLVELELIDAPQSLLKDNYVQLSQTFISLSDNLR
VLRLSWSRLQRDPLPALYQLQNLTVLYLQKAYDAVTLIFRNTWFPNLKELHLLHLPNLRKITIYQGSLRN
LQLLIMEGLLQLTTIPTGIEFLKSLQKLHFSECNPSFLNAINRDQRSKVEHIPDICYDDGIHGSRTLDIF
PRTSGVIPDQQNLTKVGAEVSLKSVNDADKIVGAGVVQTLDSNARVGGYEIGPNWAGIRLGTPMDNAEHL
IRPYGGLKTIGHAKGSLIAWPCSLLSIRQKL


>XP_042396735.1 disease resistance protein RGA2-like [Zingiber officinale]
MVCDSLWAINSMIIIPKMGVLYNMHLQFKKLDRLLDVPVEFADWEIDVAATLTDVGELLGRILDWEASLH
FRHVILVELKEMLCCLNSLVLRGSAMGLRRDPMSSMNPLREDYSIVLKDEVVGREEDLEKLIEIFQQHQP
VPSNNNDNDNNPFVIVIVGKEGVGKATLARMIYHHTWVCQQFHHRIWVDVPRLSPFKIVNIIRKEFARSI
NNEEYCDLHRELPLQALWESINEQFDGRRYLLVLHFEYLASLTQQEWNELKNILLCVGGPGSGVLIINRS
STQSISDMGFLHTVKNIRTYCLNPLSEDAWLDLFKRHAATTIPSKQDKSEIDELIPFAKQHFQNLIHQPL
LAKIVGWLNHDVQTTFPSPLPAAPEDFYMFSNVRLVNIRVLQYRALLSNIQNKYNVILNVLTTEYLMPAE
MAELGWIERHRTTQELLEFMIPRMVSYLCMKVPKDSTTIPRCCRYLRLEINPRATLFRLPIVPIEVSRKL
ISLILQEDETATQEDEEEITVQVYKKRRMKSATAILKFLNNMLVRLVHLRMLIVETSIIQSLPNEVSMLV
NLRYLHLSKLKMELLPKSLFDLQNLRVLSLICCKKLQKIPERIYKLEKLEVLSLAYCTKLQQLPKSITRL
QNLLQLDMEGCCWLKKLPEDLFRFKSLRILHVTGCASLSQIPLGIEQLFGLISLVVILAGDDGGFGLAQL
QALTNLQRLILQNLERVEETQTEMLMGQQRLRNLSLHWGGEEANDSSE


>XP_042396791.1 putative disease resistance protein RGA4 [Zingiber officinale]
MAVELAIDASLLMGEIVVDFISEKVVDLLQLNFKVKAITDIEGKMDKLKDLSTIIDKVIQDLDSRPFIDD
AVKDLLKKLKYLARDLEDVVDYYDTKVFQKQQRSNTSFGMVRDFFSSNNQLLFKSRVGVMIKAITKSLDY
ILLQKSFLHNLPQGSIRMSEPSLYDSLVTGRETERQMIVNMLTKDDDYDSNNVTLKVISIVGMGGLGKTT
LAQFVYNDERVQDYFASLTMWKVVGAEFNPTKIIKSILELATGASVDISEIYLVKQKLKNELSGKRFLLV
LDDVWNENESKWIALKTALTCGLRGSKILVTTRSQQVSKIMGSSNTTHQIQQLSRDDCLSLFYQFAFGDE
VADQNLMNIGAKIVEKCGGVPLAAISLGSMLRGTREEAYWSSVLKSEISQLGNEEDKVLDVLKFSYDTLP
VRSKKCFAFASLFPKNYWMTKDELIKLWIANGFVCSEGNFDAETNGNHVFNDLVMGSFFILAPSRDFEDD
SYVTKCKMHDLMYDLARSVSANIYWNSKQDSVKDIGKRTYHLQLFPGELPNDIFSQLLNKKPLYLRTFIS
PRTFSCLSINLLEVFSELKFLRVLDLSYNGIKEVPTSIGNLIHLSISISVSIKNFKSYQNN


>XP_042397235.1 disease resistance protein RPS2-like [Zingiber officinale]
MESVSTSSVMDILNLLKACCSQSCNYIMTYGGTFSSLASEVGQLKDKSSDVKRDVEAATRDGQTPRSEVL
GWLSSVQDMEGEAESIERKYNQKIKCLCSFPLNVCSAYRLRNRAEAALATIRELKQSAEFTKLADNLNLT
RSIKMPTTKTIGMDKVFEELQRHAKDDSLSVIGIHGMGGVGKTALLRRFNNDFPSETEADVVIFLELSID
YKLEEVQKSLFDRLSLTWQDEVTHRDRATKLFRVLSTLKFILLLDNLWEPLNYQVVGIPLPAPPSKCKII
FTTRTEDTCSHMGTEKMIKMECLEEEAAWNLFRNSARMDVIDADKNVRIEARDLVKECGGLPAALIVLAQ
AMAPKKTWEEWMHALTIMKDTPHQLPGMTNNVFSILKLSYDRLSSDNMRVCASYGALFIKGSWIGKFNIR
NSWIGEGIIDNVQNVMDADHKTQFLLGILHAASLTVRVHDDYFTMHPMTRAMILWVQRECGKKENKWLVW
DRERVEEAPAAEKWRDAERIALVWNQISDLPEAPQCPNLIFLDLQVNKFLRKIPNGFFLHMPLLRILELQ
ETSIEELPWLIMMDSYSGWKEGQSCEGGVSFEELESLKRLKVIGMTVSTLAALQNLCDSPRLAPLTH


>XP_042397241.1 disease resistance protein RPS2-like [Zingiber officinale]
MGYVSPSSLMDIFNLLKACCSPSCNYIMTYDGTFSSLASEVGQLKDKSSDVKRDVEAATRDGMTPRSEVL
GWLSSVQDMEGEAESIERKYNQKIKCLCSFPLNVCSAYRLRNRAEVALATIRELKRSAEFTKLADNLNLT
RSIKMPTTKTIGMEKVFEELQRHAKDDSLSVIGIHGMGGVGKTALLRRFNNDFPSEIEVDVIIFLELSID
YKLEEVQKSLFDRLSLTWQDEVTQRDRATKLFRVLSKLKFILLLDNLWEPLNYQVVGIPLPAPPSKCKII
FTTRTEDICSHMGTEKMIKMECLEEEAAWNLFRNSARMDVIDTDENILIEARDLVKECGGLPAALIVLAQ
AMAPKKTWEEWIHALSIMKDTPHQLPGMTNNVLSILKLSYDRLSSDNLRVCASYGALFEKGSWIYKYNIR
HYWIGEGIIDNADTILDATRKTQFLLGILHAASLTVRVDDVYFTMHPMTRAMILWVQRECGKKENKWLVL
NREQVKEENWRDAERISLGVNQIRELPETPQCPDLIFLNLEFNELLSKIPNGFFLHMPHLKILNLRNTSI
QELPASIGNLVQLHYLDLSRTRITSLPKEMAALVNLKLLSLAFMTSLRIIPDQLFSSLRELQWLDMCDSY
TGWREGQIWEGGVSFEELESLKRLRVIGITVSTLAALQNLCISPRLAAFTCWLYIEGCRDLTLFDIPSKD
FHLENMLEVFCIRLHAMCELEEVVIGNLKPILQSLQQLRLSSLPKAKLVWRATFPSTLFKLEIDGCGAID
RLIKLEGEANGSGETVITIFPDLHTMVLRRLPELKSLSDGERILNFPSLKTIKVEDCPKLTKLTLVADGL
KEIKCERSWWEQLNWGDERTKSFEHLYNPMNID


>XP_042397250.1 disease resistance protein RPS2-like [Zingiber officinale]
MGYVSPSSLMDIFNLLKACCSPSCNYIMTYDGTFSSLASEVGQLKDKSSDVKRDVEAATRDGMTPRSEVL
GWLSSVQDMEGEAESIERKYNQKIKCLCSFPLNVCSAYRLRNRAEVALATIRELKRSAEFTKLADNLNLT
RSIKMPTTKTIGMEKVFEELQRHAKDDSLSVIGIHGMGGVGKTALLRRFNNDFPSEIEVDVIIFLELSID
YKLEEVQKSLFDRLSLTWQDEVTQRDRATKLFRVLSKLKFILLLDNLWEPLNYQVVGIPLPAPPSKCKII
FTTRTEDICSHMGTEKMIKMECLEEEAAWNLFRNSARMDVIDTDENILIEARDLVKECGGLPAALIVLAQ
AMAPKKTWEEWIHALSIMKDTPHQLPGMTNNVLSILKLSYDRLSSDNLRVCASYGALFEKGSWIYKYNIR
DYWIGEGIIDNADTILDATRKTQFLLGILHAASLTVRVDDVYFTMHPMTRAMILWVQRECGKKENKWLVL
NREQVKEENWRDAERISLGVNQIRELPEAPQCPDLIFLNLEFNELLSKIPNGFFLHMPHLKILNLGNTSI
QELPASIGNLVQLHYLDLSMTRITSLPKEMAALVNLKLLSLAFTTSLRIIPDQLFSSLRELQWLDMCDSY
TGWREGQIWEGGVSFEELESLKRLRVIGITVSTLAALQNLCISPRLAAFTYWLYIEGCRGLTLFDIPSKD
FHVENMLKVFCIRLHAMCELEEVVIGNLKPILQSLQQLRLSSLPKAKLVWRATFPSTLFKLEIDGCGAID
RLIKLEGEANGSGETVITIFPDLHTMVLRRLPELKSLSDGERILNFPSLRTIKVEDCPKLTKLMLVADGL
KEIECERSWWEQLNWGDERTNSFQHLYKPMYID


>XP_042397259.1 disease resistance protein RPS2-like isoform X1 [Zingiber officinale]
MEGQATAGRRILLQDRISNASLGHTARLLLFVTSRSSSTMGSVSTSSVMDIFNLLKACCSQSCNYIMTYG
GTFSSLASEVGQLKDKSSDVKRGVEAATRDGMTPRSEVLGWLSSVQDMEGEAESIERKYNQKIKCLCSFP
LNVCSAYRLRNRAEAALATIRELKQSVEFTKLADNLNLIRSIKMPTNKTIGMDKVFEELLRHAKDDSLSV
IGIHGMGGVGKTALLRRFNNDFPSETEADVVIFLELSIDYKLEEVQKSLFDRLSLTWKDEVTHRDRATKL
FRVLSTLKFILLLDNLWEPLNYQVVGIPLPAPPSKCKIIFTSRTEDTCSHMGTEKMIKMECLEQEAAWNL
FRNSARMDVIDADKNIRIKARDLHKECGGLPAALIVLAQAMAPKKTWEEWIHALTIMKDTPHQLPGMTKT
VFSILKLSYDRLSSDNLRVCASYGALFKKGSWIDKFDIRDLWIGEGIFDNADNICDSTQQTQFLLGILHA
ASLTVRVHDDYFTMHPMTRAMILWVQRECGKKENKWLVRDRERVEEAPAAEKWRDAERIALVWNQIRDLP
EAPECPNLIFLNLHVNKFLRKIPNGFFLHMPHLKILDLRDTSIRELPVSIGNLVQLHYLSLCETRITSLP
KEMAALVNLKYLSLESMKYLRNIPDRLISGLRELQWLDMGDSYSGWREGQTWEGGVSFEEMESLKRLKFI
GITVSTFAALQNLCDSPRLAAFTHWLHIKGCPDLTTFNLPSMNFHAETMPRVIHIELHAMSELEEVVIGN
RKHILPSLQELRLSSLPKAKLVWRARFPNALCELEIEDCRALDRLIKLEEEANGSGERVITIFPHLHTMV
LRRLPELKSLSDGE


>XP_042397267.1 disease resistance protein RPS2-like isoform X2 [Zingiber officinale]
MEGQATAGRRILLQDRISNASLGHTARLLLFVTSRSSTMGSVSTSSVMDIFNLLKACCSQSCNYIMTYGG
TFSSLASEVGQLKDKSSDVKRGVEAATRDGMTPRSEVLGWLSSVQDMEGEAESIERKYNQKIKCLCSFPL
NVCSAYRLRNRAEAALATIRELKQSVEFTKLADNLNLIRSIKMPTNKTIGMDKVFEELLRHAKDDSLSVI
GIHGMGGVGKTALLRRFNNDFPSETEADVVIFLELSIDYKLEEVQKSLFDRLSLTWKDEVTHRDRATKLF
RVLSTLKFILLLDNLWEPLNYQVVGIPLPAPPSKCKIIFTSRTEDTCSHMGTEKMIKMECLEQEAAWNLF
RNSARMDVIDADKNIRIKARDLHKECGGLPAALIVLAQAMAPKKTWEEWIHALTIMKDTPHQLPGMTKTV
FSILKLSYDRLSSDNLRVCASYGALFKKGSWIDKFDIRDLWIGEGIFDNADNICDSTQQTQFLLGILHAA
SLTVRVHDDYFTMHPMTRAMILWVQRECGKKENKWLVRDRERVEEAPAAEKWRDAERIALVWNQIRDLPE
APECPNLIFLNLHVNKFLRKIPNGFFLHMPHLKILDLRDTSIRELPVSIGNLVQLHYLSLCETRITSLPK
EMAALVNLKYLSLESMKYLRNIPDRLISGLRELQWLDMGDSYSGWREGQTWEGGVSFEEMESLKRLKFIG
ITVSTFAALQNLCDSPRLAAFTHWLHIKGCPDLTTFNLPSMNFHAETMPRVIHIELHAMSELEEVVIGNR
KHILPSLQELRLSSLPKAKLVWRARFPNALCELEIEDCRALDRLIKLEEEANGSGERVITIFPHLHTMVL
RRLPELKSLSDGE


>XP_042398134.1 probable disease resistance protein At4g33300 [Zingiber officinale]
MDSSFAGEVATELIKELMKVIRGTYLCRPAAEQLKRSVDSLLPIVQEIRHSGVELPQHRQSQLSELADRL
RFALDLARKAAASPRWNVYRSVQLARKMEGIESWISRWIERHMPVHVLADVHHIRVDCAARLDRIERALD
MAASSPVAATASKVPVAFGSAPFSGFPMSDMMDPMAPVKTPFAMGNTLSSGFPMMEGFFPSPAPTKVPVA
MGKPPSSGYPVANIMDGLMMAGEGVKPVGVGIRIGKEKVKEMLMEGSDRSPVVGIFGIGGSGKTTLAREI
CKDPEIRSYFKDRIYFTTLSQSPNLESLKLKLWEQISGNMVLGAYNQIPKWQMELGQIEKGFSLIVLDDV
WSLSELEELIFSLRGCKILVVSRFNFPSIVKNTYEIELLGEEDALSLFCHAAFEQKSVPFSVDKKLVKQV
VDKCKGLPLALKVIGASLRDQPPKFWLRAKNKLTRGEAICESHENKLIERMASSIEFLSAKVRECFLDLG
SFPEDKRIPLDVLINMWMELHDLDEEDAFAILVELSNKNLLTLCKDAQNRAGDIYSSYTELSVTQHDLLR
DLALYVNNQEPSNTRRRLIMARRENELPKEWERNKDHQFEAQIVSINTGEMKETDWFQMHFPKAEVLILS
FCADVYFLPPFLSTMPKLRALILINYGTSCTSLQNCSVFTPLSNLRSLWLEKISVPPLPKSTVRLNNLRK
VSLVLCELNDSLRGSKVDLSSTLPRLSHLTIDHCIDVTELPSCICDINSLECLSISNCHDLSELPCEFGK
LSSLEILRVYACPSLKNLPLSICRMKGLKYLDISQSFNLRELPEELGYMTSLEKIDMRECSQLKTLPRSS
SFLKSLGHVICDEDIALLWKEAERDIPDLRVQVAEESFNLDWLLE


>XP_042398504.1 probable disease resistance protein At4g33300 [Zingiber officinale]
METFFAGDIAKELIKELLNVVRQTYLCRPAAEQLKRSVDSLLPIIQEIRLSGVELPQHRQKQLSELADNL
RLALDLARKAAASPRWNVYRSMQLARKMERIDHWITRWLERQVPAHLLADVHHIRVDYTARLDRIERTLD
LTAASAVARGPVAFGTAPFSVFPETIEGFVPIRAPIAMWSPPATSCFPMPEMMEGLMMPTEAAAEAPVAM
GKSPSSRFPVAEIMEGLMLAGEGVKPVGVGIRVGKEKVKEMLMEGINRIAVVGISGIGGSGKTTLAREIC
RDPEIRSYFEDRIYFETLSQSQNLESLKLRLWEQISGNIVLGVYNQIPQWQMELVPKDKGPFLLVLDDVW
SVSELEELIFRVPGCKILVVSRFKFPAIVKSTYEMELLGEEDALSLFCHAAFEQTYIPSTVDQKLIKQVV
EECKGLPLALKVIGASLRDQPPKFWLRAKNKLARGETISESHENKVLERMASSIDFLSGKARECFLDLGS
FPEDKRIPLDVLINLWMELHDLDEEDAFAILVELSNKNLLTLLKDAQNRAGDIYSSYTELCVTQHDLLRD
LALHVNNQEPLNTRRRLIMPRREKELPKEWERFKDQQLEAQIVSFNTGEMNESDWFQMHFPKTEVLILNF
AADAYFLPPFLSVMPKLKTLILINYGASCTTLQNLSVFTSLSNLRSLWLEKIAVPPLPRTTVPLQNLRKV
SLVLCELTNSLRCSKVELSLTFPRLSHLAIDHCIDITKLPSAICDINSLECLSISNCHDLSELPCEFGKL
SSLGILRVYACPALKRLPQSICLLKGLKYLDISQSFNLQELPEELGHMTSLEKIDMRECSQLKTLPRSSS
SLKSLGHVICDEDIASLWKEAEKDIPDLRIQVAEESFNLDWLVE


>XP_042398831.1 probable disease resistance protein At4g27220 [Zingiber officinale]
MASVLAACLKSLWDPMTHQLAYIFYLGRKLTELEKNKMALASAKADVLVEVENAKIIGCTPTATVINWLR
EADNAVVEAEDICSNARSIMENSTCFRIKIVMRYKLGKQILRASKFSSDVQGRKPGDLFVPPPPVVVLPF
PTSLIKNNTSSFRTLEKLRNFLQDDSIGKIGVWGMGGVGKTRLLRNLNNELQETKRFDVVIFVTVSKNWN
KDMQKLRNDIGKELYMELEKDNVRASRLLYKRLMQKKFLLILDDVWDKINLENLGIPSPTEHKGCKIAIT
TRQRGICNEMETDVEIMVEALPDEESWDLFHEKAGGNIPTTIENVARSVCRECCGLPLAIITVGSALRKE
VHLDQWKRALRLLQKSNFRFENMEDSVFVPLKFSYDMLRDDQLKKCFLFVALFPEDHEIADQDLIEYWVM
EGYIEGAESLGDAYQDAHRLLILLIDSCLLERSRKKDMVKMHDVIRDMAIKITSDGTEEGTKFWVKAGMR
LEELVETEDLKDKDKISLMENNIQLIGVDLYCPNASTLLVKGNVMLYDIPERFFQYMKLLSVLDLSATSI
EFLPESISVLVNLSALILKECARLKRIDRVQCLKKLRFLDMRESGIIELPEGIVHLTGLVYFKISCTYRL
QKIPAGLIAQFSHLEDLEMNQSFYLEGLKNPQEIIKQFKHLKSLNNLSLDLENDKLSSLLETHCNLNNLA
SFYLRVGSVMATSKTEYVAKKEGPRKPERRGRCLDITGDAACKRLAKFANKLCVYQNRKLRSISQLGLDN
LECVEECWVWDCQEMWSIIISEEQKDNTYPHLQLLHLERLPKLSIIFSYNVAAAPSFFNLRKINLCECNM
IPFVFQEEMIDQLGCLEELDVSSCRILKRIIEGYFKRDGMCLPKLRCISFSQLGKLEQLWFSDLSLPSLV
DIKIHRCPNLRPPRLTNELAPTLLVIEAEEQWWESLPEDEIFKLHFASILKPVTVSFTHIFTSVHASSSH


>XP_042398833.1 probable disease resistance protein At4g27220 [Zingiber officinale]
MASVLAACLKSLWDPMTHQLAYIFYLGRKLTELEKNKMALASAKADVLVEVENAKIIGCTPTATVINWLR
EADNAVVEAEDICSNARSIMENSTCFRIKIVMRYKLGKQILRASKFSSDVQGRKPGDLFVPPPPVVVLPF
PTSLIKNNTSSFRTLEKLRNFLQDDSIGKIGVWGMGGVGKTRLLRNLNNELQETKRFDVVIFVTVSKNWN
KDMQKLRNDIGKELYMELEKDNVRASRLLYKRLMQKKFLLILDDVWDKINLENLGIPSPTEHKGCKIAIT
TRQRGICNEMETDVEIMVEALPDEESWDLFHEKAGGNIPTTIENVARSVCRECCGLPLAIITVGSALRKE
VHLDQWKRALRLLQKSNFRFENMEDSVFVPLKFSYDMLRDDQLKKCFLFVALFPEDHEIADQDLIEYWVM
EGYIEGAESLGDAYQDAHRLLILLIDSCLLERSRKKDMVKMHDVIRDMAIKITSDGTEEGTKFWVKAGMR
LEELVETEDLKDKDKISLMENNIQLIGVDLYCPNASTLLVKGNVMLYDIPERFFQYMKLLSVLDLSATSI
EFLPESISVLVNLSALILKECARLKRIDRVQCLKKLRFLDMRESGIIELPEGIVHLTGLVYFKISCTYRL
QKIPAGLIAQFSHLEDLEMNQSFYLEGLKNPQEIIKQFKHLKSLNNLSLDLENDKLSSLLETHCNLNNLA
SFYLRVGSVMATSKTEYVAKKEGPRKPERRGRCLDITGDAACKRLAKFANKLCVYQNRKLRSISQLGLDN
LECVEECWVWDCQEMWSIIISEEQKDNTYPHLQLLHLERLPKLSIIFSYNVAAAPSFFNLRKINLCECNM
IPFVFQEEMIDQLGCLEELDVSSCRILKRIIEGYFKRDGMCLPKLRCISFSQLGKLEQLWFSDLSLPSLV
DIKIHRCPNLRPPRLTNELAPTLLVIEAEEQWWESLPEDEIFKLHFASILKPVTVSFTHIFTSVHASSSH


>XP_042398834.1 probable disease resistance protein At4g27220 [Zingiber officinale]
MASVLAACLKSLWDPMTHQLAYIFYLGRKLTELEKNKMALASAKADVLVEVENAKIIGCTPTATVINWLR
EADNAVVEAEDICSNARSIMENSTCFRIKIVMRYKLGKQILRASKFSSDVQGRKPGDLFVPPPPVVVLPF
PTSLIKNNTSSFRTLEKLRNFLQDDSIGKIGVWGMGGVGKTRLLRNLNNELQETKRFDVVIFVTVSKNWN
KDMQKLRNDIGKELYMELEKDNVRASRLLYKRLMQKKFLLILDDVWDKINLENLGIPSPTEHKGCKIAIT
TRQRGICNEMETDVEIMVEALPDEESWDLFHEKAGGNIPTTIENVARSVCRECCGLPLAIITVGSALRKE
VHLDQWKRALRLLQKSNFRFENMEDSVFVPLKFSYDMLRDDQLKKCFLFVALFPEDHEIADQDLIEYWVM
EGYIEGAESLGDAYQDAHRLLILLIDSCLLERSRKKDMVKMHDVIRDMAIKITSDGTEEGTKFWVKAGMR
LEELVETEDLKDKDKISLMENNIQLIGVDLYCPNASTLLVKGNVMLYDIPERFFQYMKLLSVLDLSATSI
EFLPESISVLVNLSALILKECARLKRIDRVQCLKKLRFLDMRESGIIELPEGIVHLTGLVYFKISCTYRL
QKIPAGLIAQFSHLEDLEMNQSFYLEGLKNPQEIIKQFKHLKSLNNLSLDLENDKLSSLLETHCNLNNLA
SFYLRVGSVMATSKTEYVAKKEGPRKPERRGRCLDITGDAACKRLAKFANKLCVYQNRKLRSISQLGLDN
LECVEECWVWDCQEMWSIIISEEQKDNTYPHLQLLHLERLPKLSIIFSYNVAAAPSFFNLRKINLCECNM
IPFVFQEEMIDQLGCLEELDVSSCRILKRIIEGYFKRDGMCLPKLRCISFSQLGKLEQLWFSDLSLPSLV
DIKIHRCPNLRPPRLTNELAPTLLVIEAEEQWWESLPEDEIFKLHFASILKPVTVSFTHIFTSVHASSSH


>XP_042398835.1 probable disease resistance protein At4g27220 [Zingiber officinale]
MASVLAACLKSLWDPMTHQLAYIFYLGRKLTELEKNKMALASAKADVLVEVENAKIIGCTPTATVINWLR
EADNAVVEAEDICSNARSIMENSTCFRIKIVMRYKLGKQILRASKFSSDVQGRKPGDLFVPPPPVVVLPF
PTSLIKNNTSSFRTLEKLRNFLQDDSIGKIGVWGMGGVGKTRLLRNLNNELQETKRFDVVIFVTVSKNWN
KDMQKLRNDIGKELYMELEKDNVRASRLLYKRLMQKKFLLILDDVWDKINLENLGIPSPTEHKGCKIAIT
TRQRGICNEMETDVEIMVEALPDEESWDLFHEKAGGNIPTTIENVARSVCRECCGLPLAIITVGSALRKE
VHLDQWKRALRLLQKSNFRFENMEDSVFVPLKFSYDMLRDDQLKKCFLFVALFPEDHEIADQDLIEYWVM
EGYIEGAESLGDAYQDAHRLLILLIDSCLLERSRKKDMVKMHDVIRDMAIKITSDGTEEGTKFWVKAGMR
LEELVETEDLKDKDKISLMENNIQLIGVDLYCPNASTLLVKGNVMLYDIPERFFQYMKLLSVLDLSATSI
EFLPESISVLVNLSALILKECARLKRIDRVQCLKKLRFLDMRESGIIELPEGIVHLTGLVYFKISCTYRL
QKIPAGLIAQFSHLEDLEMNQSFYLEGLKNPQEIIKQFKHLKSLNNLSLDLENDKLSSLLETHCNLNNLA
SFYLRVGSVMATSKTEYVAKKEGPRKPERRGRCLDITGDAACKRLAKFANKLCVYQNRKLRSISQLGLDN
LECVEECWVWDCQEMWSIIISEEQKDNTYPHLQLLHLERLPKLSIIFSYNVAAAPSFFNLRKINLCECNM
IPFVFQEEMIDQLGCLEELDVSSCRILKRIIEGYFKRDGMCLPKLRCISFSQLGKLEQLWFSDLSLPSLV
DIKIHRCPNLRPPRLTNELAPTLLVIEAEEQWWESLPEDEIFKLHFASILKPVTVSFTHIFTSVHASSSH


>XP_042398836.1 probable disease resistance protein At4g27220 [Zingiber officinale]
MASVLAACLKSLWDPMTHQLAYIFYLGRKLTELEKNKMALASAKADVLVEVENAKIIGCTPTATVINWLR
EADNAVVEAEDICSNARSIMENSTCFRIKIVMRYKLGKQILRASKFSSDVQGRKPGDLFVPPPPVVVLPF
PTSLIKNNTSSFRTLEKLRNFLQDDSIGKIGVWGMGGVGKTRLLRNLNNELQETKRFDVVIFVTVSKNWN
KDMQKLRNDIGKELYMELEKDNVRASRLLYKRLMQKKFLLILDDVWDKINLENLGIPSPTEHKGCKIAIT
TRQRGICNEMETDVEIMVEALPDEESWDLFHEKAGGNIPTTIENVARSVCRECCGLPLAIITVGSALRKE
VHLDQWKRALRLLQKSNFRFENMEDSVFVPLKFSYDMLRDDQLKKCFLFVALFPEDHEIADQDLIEYWVM
EGYIEGAESLGDAYQDAHRLLILLIDSCLLERSRKKDMVKMHDVIRDMAIKITSDGTEEGTKFWVKAGMR
LEELVETEDLKDKDKISLMENNIQLIGVDLYCPNASTLLVKGNVMLYDIPERFFQYMKLLSVLDLSATSI
EFLPESISVLVNLSALILKECARLKRIDRVQCLKKLRFLDMRESGIIELPEGIVHLTGLVYFKISCTYRL
QKIPAGLIAQFSHLEDLEMNQSFYLEGLKNPQEIIKQFKHLKSLNNLSLDLENDKLSSLLETHCNLNNLA
SFYLRVGSVMATSKTEYVAKKEGPRKPERRGRCLDITGDAACKRLAKFANKLCVYQNRKLRSISQLGLDN
LECVEECWVWDCQEMWSIIISEEQKDNTYPHLQLLHLERLPKLSIIFSYNVAAAPSFFNLRKINLCECNM
IPFVFQEEMIDQLGCLEELDVSSCRILKRIIEGYFKRDGMCLPKLRCISFSQLGKLEQLWFSDLSLPSLV
DIKIHRCPNLRPPRLTNELAPTLLVIEAEEQWWESLPEDEIFKLHFASILKPVTVSFTHIFTSVHASSSH


>XP_042399255.1 putative disease resistance protein RGA4 [Zingiber officinale]
MIVQTAMESALVTAMTRIMGEKVAILIRRNKNVKEITDIEEKMEKLKELLMIVNMVIQDVESRPFTYDVK
ILSRKLRYLVYDLEDVVDCYDTEVLRKQRSRASFRSVHDFFSSNNQILFRSRLGSMIKAVTDSLDSILLQ
KSKLLNLSQGNFYISPSDYKTTHSSISSDIMGRETEKQRIVDLLTDDDDVENNQDTMKVIAIVGMGGLGK
TRLAQLVFNDEKVKAHFASWRMWTVIGMEFDPTKIMKSILEQATNAPSTVTEINSVRQKLEHTLSGKRFL
LVLDDVWNEDATRWGELRAALTCGARGSKILVTSRSLHVSSIMNSFITHQIQQLPPDDCLPLFQQFAFGD
EEKDQKLMDIGRKIVEKCGGVPLAIISLGSMLHNIQDETHWSSVLNSKIWQLRDEEQKVLAALKWSYDTL
PPQSKKCFAFASLFPKGYTIEKDELVRLWMANGFVQSEGNVDAKTMGNRVFDDLVLRSFFLLTPSKEHDF
GDDSHVTKCMMHDLMHDLARSVSGDVYWNVKEDLVTDIGNRTYHLLLYVKNLSNAYQALLRKPLYLRTLI
LSDCYLYLNANLLEIIFSELKFLRVLDLSSNKIKKVPKSIGNLIQLRYLNLSRNNIEVLPNSITLLHNLQ
YLNLSWNEELQELPKELRSMCNINAFVIQM


>XP_042399479.1 disease resistance protein RPP8-like isoform X1 [Zingiber officinale]
MGMRSTFQTRHTGRETEMESTIVNLVLGKLGELASSEVAGLFNVGAEVESLTKKLLLIQSYLRDADQKPR
SEQSQSLQEWLRQIRNLAFEMEDLVDEYATRLGRASAAGGRESCLRRIAAFPSRILTRHRLASHLQDIRA
RFQDVCNQASQLGIHGSSSLALPSSSSSSSSSFSAADARLARRFELEEDIVGFEEDMKDIKRQLFDVSST
DRVVLSIVGTGGLGKTTLANKIYKSAHVKNFFQCKAWVSVSQKYAVKELLCSIAKQVFDFKDGQEKAMEE
LEMKEKLSEHLSNRRYLVVIDDIWEVAAWNAIKAAFPKESRGSRVLLTTRKMKVANVADVPPHELKFWNV
EESWNLFCRKAFRTACCPPEFERFKEDIFKKTKGLPLAIVVLGGVLRGTSQASNWRKKMEHISREFREGE
DQILRILALSYHDLPNHLKPCFLYFAAFPEDYSIWAERIIHLWIAEGFIQTNDKVDQTMEDLAEAYLKDL
TDRSMLQIERGRMYYSHQVRIHDLLLDLARHEARELNFFRTIDDIGDDPRSLRRLSVTENVSDHISLNCS
TTKLRSLVTCRNEGFKRMLAVSIPGAKFLRVLDLQELPIEHLPKEIGDLILLRYLNLERSKLKDLPSSIG
NLIHLQTFNIFGTKIQHLPEAFWKIRTLRHVFLTEENTSMPKAAYYCSEDIRTLENISIGPWVCDGVLEK
LRNLRALYLKSISSSDEDALANAVQNLFRLEKLGLVGESLPLSVLTSSSYHHIQFLYLWGPLVRPARIHI
EAENSRIFSNLISLFISETRLEKDEDIAMLASLANLEILRLRFHAFVGRVLVFPKGGFPSLQEIELFDLS
TMEQWEVGEGAMPFLRELRLWNCIHMRMLPEGLVRLTELNQIGIRGMKMIERRVNKDTGEDYHKIKHIPC
IEIN


>XP_042399524.1 disease resistance protein RGA2-like [Zingiber officinale]
MEGALVAAARFVADKVAILVQLDSKLKAMTGIEEKMEKLKEMSTIIDLVIEDVESHPLNKDAVKDLLRKL
KYLAYDLEDAVDYYDTKVFQKKQRSNTPFGLVSDFISSDNQVLFNSRVGCMIEAVTDSLDSILLQKSILL
NLPQSSSHLPLYPYSETHSLNGFDVIGREPEKNNIVNILTNDDDEGSSHSTLRVIAIVGMGGLGKTTLAQ
LVFNDEKVQGHFASLTMWKVVGAEFNPTKIMKSILELGTGASVNISEIDLVMQKLKKELSGKRFLLVLDD
VWNEDPVKWRILKAALTFGARGSKILVTTRSQQVSSIMDSSYIHQIKQLSPADCLFLFQNFAFGDKEENR
TLMEIGAKIVEKCGGVPLAVISLGNTLRSTRDETYWSSVLNSEIMQLRDMEEKVLAVLKWSYDTLPPWSK
KCFAFASLYPKNSQMEKDELIKLWIANGFVRSEKSFDAETLGNDVFDDLVRRSFFLLAPSRNFEYDSDET
KCTMHDLMHDLARSVSANVYWHSEQDSVEDIGNRTYHLQIYLRGESCMTQVLDKKPVNLRTFMPFDFPYT
QLYLSINLLQVISDSELKFLRALDLGDSGISEVPTSIGNLIHLRYLNLRMNYIKILPMSIGNLIHLMYLN
LLTNHIEVLPMSIGNLIHLRYLNLYDNKIEVLPDSITLLSNLQYLNLGFNDKLRELPKELGNMQNLRVLD
LPNGHFQIDIHMPCGLSRLTNLRSLPVFFAGNRTGACSILELKNLKLHGEMQIKFSKDFKSYSCGGKKIL
KNKDLNELLIEFNNVERYDKDILDDLCPHTSLKELVIKDYGSSQFPTWLIELQLPNLVEVCLENCRGCEH
IPPFGNLQFLKKLVLVAMDVITHLGAEFHGYRSFPSLQELILNRMNNLEEWPDSHNGDDQLFPKLQSLHI
FSCPKLNSMPRFPTIQELAISNCNGSLLSCVGRLTSLSVLLLRWLDDMTSLPSGCIKNLTSLTKLEIMQC
SQLQCLPGDELQHLEMLRSLTIEQCPNLASFPLEVGRLSSFCSLDLLACPSIILQLEELVQILNSVKKFN
IQICGNKVNLRGQLQYLHTLKILSLCGAHLDRKRARFGDSKFLRICCCDELESLMTAEPASSVLEELSID
GIFNLTNLPDWLQHLKSLRSLSIRNCSRLERLPRNLKNLPMLTTLNIANCPLLKSRCERETGEDCPIISH
LPYIYNRYGYLML


>XP_042399567.1 putative disease resistance protein RGA1 [Zingiber officinale]
MEAALVTAASRFMVQNVSDLLQLDEKLKAITASNKTKMKKLKELSAIIDAVIQDVDSRPFIDAAVKILLT
KLKYLAYDLEDVVDYYDTTVLQKKQRSNSTSLRLVRDFFSPNNQVVFKSRIGGMIKAITESLDSILLQKS
VLLDLPQSTSEPRLYRETHSRNSFVVIGREPERNKIVDLLTKDDDDESNHGTVKVIAIAGMGGLGKTTLA
QHVFDDERVKAQFENSRMWTVVGAEFDPAKVMKSVLEAATDAPVNISQIDSVRQNIEKALSGRKFLLVLD
DVWNEDPLKWGILKAALTCGVRGSKILVTTRNQQVSKIMGSSNTTHQLQQLSQDDCLSLFQQFAFGDEAV
DQKLVKIGEKIVEKCGGVPLAAISLGNMLRGTRDETYWSSVLKSEIWQLRDEEDKVLAILKLSYDALPPR
SKKCFAFASLFSKNYKMAKDELIKLWIANDFVRSDKNFDAETIGNNVFDELVNKSFFLSASIRKRNYRDF
SWEPSNELDCEDACTMHDLMHDLARSVSANAYWNSDQDSVEDVGNRTYHVQIQGGEESSMAQVLGKRPLY
LRTFMAQNPSSGLSINLLEVFSELKFLRVLDLSYNHIKEVPTSIGNLILLRYLNLSNNNIEVLPDSITLL
SNLQYLNLSFNEEFQELPKKLGNIQNLRDLDLTCGFFESDFRLTHMPSGLSRLTNLRSLSLFVAGDRIGA
CSIIELEDLKLQGGMTIKFSKNFTNYSCGGRKILKNQDLNALWIEFNNSDRYDKDMLDDLCPNTSLKQLT
ISNYGSPQFPTWLMESQLPNLVEVNLQKCFSCEHIPPFGNLQFLKKLDLKFISDITHMGAEFHGYGGFPS
LQELCLSSMDNLEEWSESHGVDELFPKLQLLQVFDCFKLKSMPRLPTIQHLDISYCSGSLLSCIGRLTSL
SVLSVDGMNDMTSLPSDCIRNLTSLKELEIINCRQLQSLPGDEMQHLEMLRSLTIDNCDNLASFPSEVGR
LSSLCSLQLSNCPIIILQPQELIQILNSVDEFEIEICNKKVNLLGQLQYLHTLKDLSLCGAHDHRSDNFT
FRIPKLSICCCDELKSLMIAEAASHTVLEGICINGISNLTTLPDWLPHLKSLRSLTIEKCPRLERVPRDL
KDLPKLSELILINCPRLEERCERETGEDWPIISHLLTIFI


>XP_042399568.1 putative disease resistance protein RGA1 [Zingiber officinale]
MEAALVTAASRFMVQNVSDLLQLDEKLKAITASNKTKMKKLKELSAIIDAVIQDVDSRPFIDAAVKILLT
KLKYLAYDLEDVVDYYDTTVLQKKQRSNSTSLRLVRDFFSPNNQVVFKSRIGGMIKAITESLDSILLQKS
VLLDLPQSTSEPRLYRETHSRNSFVVIGREPERNKIVDLLTKDDDDESNHGTVKVIAIAGMGGLGKTTLA
QHVFDDERVKAQFENSRMWTVVGAEFDPAKVMKSVLEAATDAPVNISQIDSVRQNIEKALSGRKFLLVLD
DVWNEDPLKWGILKAALTCGVRGSKILVTTRNQQVSKIMGSSNTTHQLQQLSQDDCLSLFQQFAFGDEAV
DQKLVKIGEKIVEKCGGVPLAAISLGNMLRGTRDETYWSSVLKSEIWQLRDEEDKVLAILKLSYDALPPR
SKKCFAFASLFSKNYKMAKDELIKLWIANDFVRSDKNFDAETIGNNVFDELVNKSFFLSASIRKRNYRDF
SWEPSNELDCEDACTMHDLMHDLARSVSANAYWNSDQDSVEDVGNRTYHVQIQGGEESSMAQVLGKRPLY
LRTFMAQNPSSGLSINLLEVFSELKFLRVLDLSYNHIKEVPTSIGNLILLRYLNLSNNNIEVLPDSITLL
SNLQYLNLSFNEEFQELPKKLGNIQNLRDLDLTCGFFESDFRLTHMPSGLSRLTNLRSLSLFVAGDRIGA
CSIIELEDLKLQGGMTIKFSKNFTNYSCGGRKILKNQDLNALWIEFNNSDRYDKDMLDDLCPNTSLKQLT
ISNYGSPQFPTWLMESQLPNLVEVNLQKCFSCEHIPPFGNLQFLKKLDLKFISDITHMGAEFHGYGGFPS
LQELCLSSMDNLEEWSESHGVDELFPKLQLLQVFDCFKLKSMPRLPTIQHLDISYCSGSLLSCIGRLTSL
SVLSVDGMNDMTSLPSDCIRNLTSLKELEIINCRQLQSLPGDEMQHLEMLRSLTIDNCDNLASFPSEVGR
LSSLCSLQLSNCPIIILQPQELIQILNSVDEFEIEICNKKVNLLGQLQYLHTLKDLSLCGAHDHRSDNFT
FRIPKLSICCCDELKSLMIAEAASHTVLEGICINGISNLTTLPDWLPHLKSLRSLTIEKCPRLERVPRDL
KDLPKLSELILINCPRLEERCERETGEDWPIISHLLTIFI


>XP_042399569.1 putative disease resistance protein RGA1 [Zingiber officinale]
MEAALVTAASRFMVQNVSDLLQLDEKLKAITASNKTKMKKLKELSAIIDAVIQDVDSRPFIDAAVKILLT
KLKYLAYDLEDVVDYYDTTVLQKKQRSNSTSLRLVRDFFSPNNQVVFKSRIGGMIKAITESLDSILLQKS
VLLDLPQSTSEPRLYRETHSRNSFVVIGREPERNKIVDLLTKDDDDESNHGTVKVIAIAGMGGLGKTTLA
QHVFDDERVKAQFENSRMWTVVGAEFDPAKVMKSVLEAATDAPVNISQIDSVRQNIEKALSGRKFLLVLD
DVWNEDPLKWGILKAALTCGVRGSKILVTTRNQQVSKIMGSSNTTHQLQQLSQDDCLSLFQQFAFGDEAV
DQKLVKIGEKIVEKCGGVPLAAISLGNMLRGTRDETYWSSVLKSEIWQLRDEEDKVLAILKLSYDALPPR
SKKCFAFASLFSKNYKMAKDELIKLWIANDFVRSDKNFDAETIGNNVFDELVNKSFFLSASIRKRNYRDF
SWEPSNELDCEDACTMHDLMHDLARSVSANAYWNSDQDSVEDVGNRTYHVQIQGGEESSMAQVLGKRPLY
LRTFMAQNPSSGLSINLLEVFSELKFLRVLDLSYNHIKEVPTSIGNLILLRYLNLSNNNIEVLPDSITLL
SNLQYLNLSFNEEFQELPKKLGNIQNLRDLDLTCGFFESDFRLTHMPSGLSRLTNLRSLSLFVAGDRIGA
CSIIELEDLKLQGGMTIKFSKNFTNYSCGGRKILKNQDLNALWIEFNNSDRYDKDMLDDLCPNTSLKQLT
ISNYGSPQFPTWLMESQLPNLVEVNLQKCFSCEHIPPFGNLQFLKKLDLKFISDITHMGAEFHGYGGFPS
LQELCLSSMDNLEEWSESHGVDELFPKLQLLQVFDCFKLKSMPRLPTIQHLDISYCSGSLLSCIGRLTSL
SVLSVDGMNDMTSLPSDCIRNLTSLKELEIINCRQLQSLPGDEMQHLEMLRSLTIDNCDNLASFPSEVGR
LSSLCSLQLSNCPIIILQPQELIQILNSVDEFEIEICNKKVNLLGQLQYLHTLKDLSLCGAHDHRSDNFT
FRIPKLSICCCDELKSLMIAEAASHTVLEGICINGISNLTTLPDWLPHLKSLRSLTIEKCPRLERVPRDL
KDLPKLSELILINCPRLEERCERETGEDWPIISHLLTIFI


>XP_042399571.1 putative disease resistance protein RGA3 [Zingiber officinale]
MEAALVSAASRFMVQNVSDLLQLEEKLKAITASNKTKMKKLKELSTIIDKVIQDVDSRPLIDAAVKNLLT
KLKYLAYDLEDVVDCYDTKVLQKQRSKTFLRPVRYFFSSHDNQIVFKSRVGGMIKAITESLDSILLQKSI
LEILPQGSIRMSELSLHRETHSRNSLVVIGREPEKNMIVDMLTKDDDVESRHSTLKVITIVGMGGLGKTT
LAQLVFNDEKVKAHFASSKMWTVVGAEFDPAKIMKSVLQLATGAPVNISEIELVRQNLETALSGKRFLLV
LDDVWNEDQEKWEVLKATLICGAKGSKILVTTRSQKVSSIMGSSNTTTHQIQQLSKDDCLSLFQQFAFGD
NEADDHQNLMEIGGKIVEKCGGVPLAAKSLGSMLRGTRDETYWSSVLNSEIWQLQDKEQKVLAVLKLSYD
TLPPQSKKCFAFGSLFPKDYRMQKDELIKLWIANYGFIHSEGNFDAETVANRVFDDLVSRSFFKDDRRVT
KCTMHDLMHDLARSMSENVYWNVEDSVEDIGNRTYHLHLYLADISKITQALDKKPLYLRTLILNCCKLSL
NGNLLKIDFSELKFLRVLDLSNNEIKEVPTSIGNLIYLRYLNLSSNCIEVLPDSITLLPNLKYLNLSWNM
ELQELPKDLGNMQSLRDLNCRRHDFQDFRLTHMPRGLSRLTDLRSLPLFVAGDGTDACPITELEKLKLHG
EMDIIFSENFTNYSCGGLKILKNKDLNKLCIKFNGSEKYDEAMLDDLCPNTSLKKLCLKDYESRQFPAWL
MESQLPNLVEVSLKCCCGCEHIPPFGDLQFLKKLELCKMDGITQMGAEFHGDGGFPSLQELCLTRMDNLE
AWSKSDGDDKLFPSLQLLRLSDCLKLKIMPRLPTIQHLEISCCRGSLLSCIGSLTSLSDLKLDKMHDMTF
FPSGYIRNLTSLEELQITECRQLQSLPGDEMQHLKLLRLLTIKGCPSIILQLEELVQILNSVQEFQIQIC
GNTVDLRGQLQSLHTLKELCLRGAHGYKPKYGIAKLEICCCDDELDPLMTAEPTSSVLEKLYIDDFSNLR
TLPHWLQHLKSLSLLSIENCPRLQSVPDLKNLPMLKSLRVFDCPELERRCEKKTGKD


>XP_042399572.1 putative disease resistance protein RGA3 [Zingiber officinale]
MAADLVTGAARFLVKDLLHLDEELKAIMDTKRKMKKLKELSTIIDVVIQDVDSRPFIDAAVKNLLTKLKY
LAYDLEDVVDCYDTKVLQKQRSKARLRRVRYFFSSRDNQIVFKSRVGGMIKAITESLDSILLQKSILENL
PQGSSIRMSELSLHRETHSRNSLVVIGRDAEKNMIVDMLTKDDEGSHGTVKVIAIVGMGGLGKSTLAQLV
FNDEKVKAHFASSKMWTVVGAEFDPAKIMKSVLQLATGAPVNISEIELVRQNLETALSGKRFLLVLDDVW
NEDQEKWEVLKATLICGAKGSKILVTTRSQKVSSIMGSSNTTTHQIQQLSKDDCLSLFQQFAFGDNEADD
HQNLMEIGGKIVEKCGGVPLAAKSLGSMLRGTRDETYWSSVLNSEIWQLQDKEQKVLAVLKLSYDTLPPQ
SKKCFAFGSLFPKDYRMQKDELIKLWIANYGFIHSEGNFDAETVANRVFDDLVSRSFFKDDRRVTKCTMH
DLMHDLARSMSENVYWNVEDSVEDIGNRTYHLHLYLSDISKITQALDKKPLYLRTLILNCCKLSLNANLL
KIDFSELKFLRVLDLSNNEIKEVPTSIGNLIYLRYLNLSSNCIEVLPDSITLLSNLQYLNLSWNMELQEL
PKDLGNMQSLRDLNCRRHDFQDFRLTHMPRGLSRLTDLRSLPLFVAGDGTDACPITELENLKLHGEMDII
FSENFTNYSCGGLKILKNKDLNKLCIKFNGSERYDEAMLDDLCPNTSLKKLCIKDYESRQFPAWLMKSQL
PNLVEVSLKCCCGCEQIPLFGNLQFLKKLELCKMNGITQMGAEFHGHGGFPSLQELCLTRMDNLEEWSKS
DGDDKLFPSLQLLRVSDCLKLKSMPRLPTIQHLEISCCRVSLLSCIGSLTSLSVLKLDKMRDMTFFPSGC
IRNLTSLEELQITECRQLQSLPGDEMQHLKLLRLLTIKGCPSIILQPEELVQILNSVQEFQIQICGNKVD
LRGQLQSLHTLKELCLRGAHGYKYGIAKLEICCCDDELESLMAAEPTSSVLEKLYIDEFFNLRTLPHWLQ
HLKSLSLLSMENCPRLQNVPDLKNLPMLKSLRVFNCPHLERRCEKKTGKD


>XP_042399575.1 putative disease resistance protein RGA3 [Zingiber officinale]
MEGALAAAASRFMVQKVADLLQLDQKLKAMTGIKRKMEKLKELSTIIDKVIQDIDSRPSIDDAVKDLLEK
LKYLAYDLEDVVDYYDIKVFQKQRSKTFLRPVSDFFSSDNQVVFKSRVGGMIKTITESLDSILLQKSILQ
NLSQSSIRMSEQRETHSRNSFVVIGREPEKNMIVNMLTKDDDDDDESNHGTVKVIAIVGMGGLGKTTLAQ
IVYNDARVQDHFASLRMWKVVGAEFDPAKIMKSVLQLAAHKSVEISEIDLVRQKLEKALSGKRFLLVLDD
VWNEDPFEWGKLKAALTCGASGSKILVTTRSQQVSKIMGSSNTTHQLQQLSEDDCLSLFQQFAFGDQAVD
QKLMEISKQIIEKCGGVPLAAISLGSMLRGTRDKTYWSSVLKSEIWQLRDEQKVLAVLKWSYDTLPLQSK
KCFAFGSLFPKDYTMQKDELIKLWISNGFVRSERNFDAETVGNRIFDDLVLRSFFLLAPFEDDPHVTHCT
MHDLMHDLSRSVSANVYWNVEDSVEDIGNRTYHLHLCSTHVSKITQALGKKPLYLRTLILSSCGLFLNAN
PLEIVFSELKFLRVLDLSDNDIREVPTSIGNLIHLRYLNLSTNKIEVLPDSMTLLPNLQYLNLSFNYKLR
ELPKDLGNMQSLRDLTCRRRGFVGSFFRSGLGLTHMPCGLSRLINLHSLPVFVAGDRTGACSILELEDLK
LHGEIEVIFSKDFKNYSCGGRKIFKNKDLNEVYIEFNRSESNDKDMLDDLGPNTSLNKLTIFHYGSRQFP
TWLMELQLPNLVEVRLVNCRVCEHIPPFGNLQFLKKLDLHSMYGITQMGAEFHGYGGFPSLQELRLTWMD
NLDQWSEAHGVGALFPVLQRVKIIHCPKLKSMPMLPTIQHLEISYCCGSILSCIGRLTSLSFLKAAEIND
MTSFPSGCIRNLISLTELKIIECRQLQSLPGDEMQHLEMLRSLTIEKCDNLASFPSEVGRLSSLCFLRLS
ESTSIIFQPEELVQILNSVPKFQIQICSNKVNLRGQLQYLHTLKELSLRGQHYLFTKYRIGYEIAKLSIC
CCDELESLMTTEPTSSVLEKLYIDGISNLMTLPGWLQYLSSLCFLRLSGCPSIVLQPEELVQILNSVPKF
QIQICGNKVNLHGRLQHLHTLRGLFLMGAHYGSSFYEYRERYENPKLSICCCDELESLMTAEATSSVLEE
LSIHGISNLTTLPDWLRHLKSLRVLSLQNCSELGLLPRGLKNLPMLETFRVSNCPQLKRRCEREIGEDWP
IISHLPSVHIS


>XP_042399619.1 putative disease resistance protein RGA3 isoform X1 [Zingiber officinale]
MAGALVGATAGFLANKVAILVELDEKLKAMAGTKRKMEKFKELLTNIDLVIQNVESRPFIDDAVKDLLKK
LKYLAYDLEDVVDYYDTKVLHKKQRSHTALRPVRDFFSTNNQVLFKSRIGSMIKAITESLESILLQKSIL
LNLPPGMSQPSPYRENHSRNRFVVIGREPEKEMIVNMLIDDDDESSHDTVKVIAIVGMGGLGKTTLAQLV
FHDETVKIHFASLRMWTVVEAEFDPLKIMNSVLELATGAPANYTQIDSARQNLEKVLTGKKFLLVLDDVW
NEDPLKWGVLKAALICGVKGSKILVTTRSLHISSIMGSSKTHQLQQLSKDHCLSLFQQFAFGDQTVDQSL
MEIGGKIVEKCGGVPLAAISLGSMLHSTRDESYWSSLLSSKIWKRDNENNLLAVLKLSYNNLSLQSKKCF
TFGSLYPKNCTMVKDELIKLWIANDFVRSDDNFDAETIGNHVFTELVHKSFFLLASSKERDFRDFLWASS
EGYDLGDVSHVTNCTMHDVMHDLARSVSVNIYWNDKEDLAKDIGDRIYHLHMHKDFENLSNTIQARGKKR
LYLRTLILKDISLNTDQLEFVFSNLKFLRVLDLTGNKIKEVPTSIRNLIHLRYLNLSRNIIEVLSDSITL
LANLQYLNLSFNEGLQELPKELWNMQSLRDLDCRCCNSGFIRIPCGLSRLTNLQSLPVFVADSRSGACSI
TELEDLKLNGEMTIKFSENFTNYSCGGRKILQDKHLKELSLEFNRSETNDKGMLDDLCPNTSLKKLGIWH
YGSSQFPTWFIQLQSQLPNLVEVSLNYCRGCEHIPPFGNLHFLKKLDLISTYGITHLGAEFHGNGGFPSL
QELNLHRMNNLKEWSESHGADQLFPSLQRLRVYRCPELKCMPRLPNIQSLEIFYCDGSLLSYVGSLTSLS
ILRVEKMDNMTSFPSGCIRNLTSLIELQIIGCDQLLSLPRGEMKRLKKIRSLTIDRCDSLAFLPSEVGRL
NSLRFLRLAGCPRIKLQPYEVVQILNSVHEFEITICGKNVNLHEQLQRLYTLRELFITGEHDIYSDTQLC
ICCCEELESLMIADPASSVLQHLYINGISNLTKLPDWLQHLESLRFLSIHNCSQLGMLPRFLGLQTLTIS
DCPQLKRRYERDSGEDWPIISHVPYVDI


>XP_042399620.1 putative disease resistance protein RGA3 isoform X2 [Zingiber officinale]
MAGALVGATAGFLANKVAILVELDEKLKAMAGTKRKMEKFKELLTNIDLVIQNVESRPFIDDAVKDLLKK
LKYLAYDLEDVVDYYDTKVLHKKQRSHTALRPVRDFFSTNNQVLFKSRIGSMIKAITESLESILLQKSIL
LNLPPGMSQPSPYRENHSRNRFVVIGREPEKEMIVNMLIDDDDESSHDTVKVIAIVGMGGLGKTTLAQLV
FHDETVKIHFASLRMWTVVEAEFDPLKIMNSVLELATGAPANYTQIDSARQNLEKVLTGKKFLLVLDDVW
NEDPLKWGVLKAALICGVKGSKILVTTRSLHISSIMGSSKTHQLQQLSKDHCLSLFQQFAFGDQTVDQSL
MEIGGKIVEKCGGVPLAAISLGSMLHSTRDESYWSSLLSSKIWKRDNENNLLAVLKLSYNNLSLQSKKCF
TFGSLYPKNCTMVKDELIKLWIANDFVRSDDNFDAETIGNHVFTELVHKSFFLLASSKERDFRDFLWASS
EGYDLGDVSHVTNCTMHDVMHDLARSVSVNIYWNDKEDLAKDIGDRIYHLHMHKDFENLSNTIQARGKKR
LYLRTLILKDISLNTDQLEFVFSNLKFLRVLDLTGNKIKEVPTSIRNLIHLSFNEGLQELPKELWNMQSL
RDLDCRCCNSGFIRIPCGLSRLTNLQSLPVFVADSRSGACSITELEDLKLNGEMTIKFSENFTNYSCGGR
KILQDKHLKELSLEFNRSETNDKGMLDDLCPNTSLKKLGIWHYGSSQFPTWFIQLQSQLPNLVEVSLNYC
RGCEHIPPFGNLHFLKKLDLISTYGITHLGAEFHGNGGFPSLQELNLHRMNNLKEWSESHGADQLFPSLQ
RLRVYRCPELKCMPRLPNIQSLEIFYCDGSLLSYVGSLTSLSILRVEKMDNMTSFPSGCIRNLTSLIELQ
IIGCDQLLSLPRGEMKRLKKIRSLTIDRCDSLAFLPSEVGRLNSLRFLRLAGCPRIKLQPYEVVQILNSV
HEFEITICGKNVNLHEQLQRLYTLRELFITGEHDIYSDTQLCICCCEELESLMIADPASSVLQHLYINGI
SNLTKLPDWLQHLESLRFLSIHNCSQLGMLPRFLGLQTLTISDCPQLKRRYERDSGEDWPIISHVPYVDI


>XP_042399621.1 putative disease resistance protein RGA3 [Zingiber officinale]
MAAALVSDASRFKGENVADLLQLKDKLKAITGIEGKMEKLKESSAIIDAVIQDVDSRPFIDAAVKELVKK
LKYLAYDLEDVVDYYDTKVLQKKPRSKTSFGPVRDFFSSDNQVVYTSRISGMIQAVTESLESILLQKSIL
LNLPQGNILVSKPSPYRETHSRNSFDVIGRESEKNMIVDMLTKDDDVDESSHGTLKVITIVGMGGLGKTA
LAQLVFNDDSVKEYFYLRMWKVVGTEFDPAKIMKSVLELAFAAPVKISEIDLVRQKLEAALSGKRFLLVL
DDVWNENVLKWGVLKAALTCRAPGSKILMTTRSQKVPLIMGSSKTTYHIQQLSRDDCLSLFYHFAFEDEP
VDQKLMEIGEKIVEKCDGVPLAVISLGSMLRGTRDITDWSTVLNCSEIYMADPR


>XP_042399622.1 putative disease resistance protein RGA1 [Zingiber officinale]
MEAALVTATVRFMGEKVANLLELDKKLKVIIGVKGKMKKLKELSTIIDTVIEDVESHPLIDVAVRNLLRK
IEFLANDIEDVVDCYDTEALRKQRSSDFFRPVRDFFSSNNQVVFNCRIDGMIKAITDSLDSILLQKSFLL
NLPQSSIHISELSFHRETHSRNSLVVLGRETEKQIIVNMLTDDESNHDTLKVIAIVGMGGLGKTTLAQLV
FNDEEVKAYFDSSRMWKVVGDEFNPTTIMKSVLELATGAPVVISEIDLVRRNLEKALSGKKFLLVLDDVW
NEDPFEWGKLKAVLTCGSRGSKILVTTRNQQVSSIMDSSYSHQMMQLSPADCWFLFQKFAFGDKEVDQIL
MEIGGKIVEKCGGVPLAVISLGSMLRITRDETYWSSVLNSEIWQLGNEQVKVLAVLKLSYDTLPPRSKKC
FAFASLFSKNYRMSKDELIKLWISNGFVRSEGNFDAETLGNHVFDDLVMRSFFLLVPSQDVTKCTMHDLM
HDLARSVSADVYCNFYQDSMEDIGKRTYHLKIGKGKLPNMKQVLGKKPLYLRTFIFRNRFSRFSYINLHE
VFSELKFLRALDLTNMGIREVPTSIGNLIHLRYLNLSRNHIEVLPDSIILLSNLQYLNLSFNEELQELPK
ELGNMQNLRSLPFFVAGDRIGACSILELENLKLHGEMKIIFSKNFTNYSCGGRKILKNKDLNELCINFNG
SERYDKDMLDDLCPNTSLKKLGIWYYGSPQFPAWLIELQLPNLVEVHFCCSCEHIPPFGNLQFLKKLELW
FMNDITHLGVEFHGYGGFPSLQELRLSWMDNLEEWSELHGVDELFPKLQSLTIFCCPKLKSMPRLIPRIQ
HLKISYCSDNILSCIGRLTSLSFLEVAEMNDMASIPSGCIRNLTSLTKLIITKCRQLQSFPWDEMQHLKM
IHSLTIENCDNLASFPSEVGCLIGSLYFLRLTRCPCIILQPEELIQILNSVHEFQIEICGNKVNLRGQLQ
YLHTLKELSLWGAHAYIITYGIAKLSICCCDELELLMTAEQANSIVLDKLYIEGISNLTTLPDWLQHLKS
LRLLSIQNCPQLERMPRDLKNLCMLETLKVFNCPQLKRRCERETGEDWPVISHISYIDIL


>XP_042399667.1 putative disease resistance RPP13-like protein 3 [Zingiber officinale]
MASTVVNLVLGKLGELASSEVTGLLNVGAEITSLTETLALIQSRLRDADQNLAFEMEDLVDEYAMQLGRA
SAADGRMSSLRRIGAFPSRILTRHRLASRLQDIHARFQDVCKQTSQLGIQASSSWPTSSSSSYSSSTAAD
ARLARRFELEEDIVGFDEDIKGIKRLLFDISSTDRVVLSVVGPGGLGKTTLANKIYKSADVKKYFQCKAW
VSVSQKYGVKELLCSIVKQVFDFKDEQVKGMEELEMKEKLSEHLRDRRYLVVMDDIWQVAAWNAIKAAFP
KESAGSRVLLTTRRMNVANVADVPPHELKFWNVEESWNLFCRKAFRTACCPPEFERFKEDIFRKSKGLPL
AIVVLGGLLRGTSQASDWRKKLDYISYEFREGEDQIQSILALSYHDLPHHLKPRFLYFAAFPEDYIIAAE
RITHLWIAEGFIQTKDKVDQTMEDLAEAYLKDLTDRSMLQMERGPLMI


>XP_042399759.1 disease resistance protein RPP13-like isoform X2 [Zingiber officinale]
MYRFGPLICRETEMASTVVNLVLGKLGELASSEVAGLLNVGAEITSLTETLALIQSRLRDADQKPRPEQS
HSLQEWMRQIRNLAFEMEDLVDEYATRLGRASAARGRKSCLRRIAAFPSRILTRHRLASRLQDIHAKFQD
LCKQTSQLGIQASSSWPTSSSSSSSSSSAADARLARRFELEEDIVGFDEDMKDIKRQLFDISSTDRVVLS
VVGPGGLGKTTLANKIYRSADVKNYFHCKAWVFVSQKYEVKELLCSIVKQVFDFKDGQEKGMEELEMKEK
LSEHLRDRRYLVVMDDIWQVAAWNAIKAAFPKESAGSRVLLTTRKMNVANVADVPPHKLKFWNAEESWNL
FCRKAFRTACCPPEFERFKEDIFRKSKGLPLAIVVLGGLLRGTSQATDWRKKLDYISYEFREGEDQIQTF
PEDYIIAAERITHLWIAEGFIQTKDKVDQTMEDLAEAYLNDLTDRSMLQMERKGGISIQFVRIHDLLLDL
ARHEARELNFYRSINDRGDDPRALRRLCVTENVNDHVSLNCSTIKLRSLVVCRNEGFQRTLAVTISGAKF
LRVLDLIKLPIEQLPKEIGDLILLRYLDLSGSKLKELPSSIGNLIHLQTFNIQFTEIQHLPDAFWKIRTL
RHVLLNKGNMSMPNSTFCSEDIQTLGNISSGPWVCDGALEKLRNLRRLHLRNMSSSDEDAFANAVQNLSR
LEMLALIGESLPVSLLTSSCYHHIQIMDLAGPLVRPARIHIEAENSRIFSNLISLAIVKTRLEKDEDIAL
LASLANLEHLLVCLDAFVGRVLVFPKGGFPRLQEIILGDLNTLEQWEVGEGAMPLLRELKLWYCINLRML
PEGLVRLTELKQIEIRGMEMIEKRVNKDTGEDYHKIKHVPCIEIN


>XP_042399769.1 disease resistance protein RPP13-like isoform X3 [Zingiber officinale]
MYRFGPLICRETEMASTVVNLVLGKLGELASSEVAGLLNVGAEITSLTETLALIQSRLRDADQKPRPEQS
HSLQEWMRQIRNLAFEMEDLVDEYATRLGRASAARGRKSCLRRIAAFPSRILTRHRLASRLQDIHAKFQD
LCKQTSQLGIQASSSWPTSSSSSSSSSSAADARLARRFELEEDIVGFDEDMKDIKRQLFDISSTDRVVLS
VVGPGGLGKTTLANKIYRSADVKNYFHCKAWVFVSQKYEVKELLCSIVKQVFDFKDGQEKGMEELEMKEK
LSEHLRDRRYLVVMDDIWQVAAWNAIKAAFPKESAGSRVLLTTRKMNVANVADVPPHKLKFWNAEESWNL
FCRKAFRTACCPPEFERFKEDIFRKSKGLPLAIVVLGGLLRAFPEDYIIAAERITHLWIAEGFIQTKDKV
DQTMEDLAEAYLNDLTDRSMLQMERKGGISIQFVRIHDLLLDLARHEARELNFYRSINDRGDDPRALRRL
CVTENVNDHVSLNCSTIKLRSLVVCRNEGFQRTLAVTISGAKFLRVLDLIKLPIEQLPKEIGDLILLRYL
DLSGSKLKELPSSIGNLIHLQTFNIQFTEIQHLPDAFWKIRTLRHVLLNKGNMSMPNSTFCSEDIQTLGN
ISSGPWVCDGALEKLRNLRRLHLRNMSSSDEDAFANAVQNLSRLEMLALIGESLPVSLLTSSCYHHIQIM
DLAGPLVRPARIHIEAENSRIFSNLISLAIVKTRLEKDEDIALLASLANLEHLLVCLDAFVGRVLVFPKG
GFPRLQEIILGDLNTLEQWEVGEGAMPLLRELKLWYCINLRMLPEGLVRLTELKQIEIRGMEMIEKRVNK
DTGEDYHKIKHVPCIEIN


>XP_042399806.1 probable disease resistance protein At1g61300 [Zingiber officinale]
MIPSIGIGQILNKIWDAASIFLARPRSRVEDLGRDAERLKAKLVDVNRAIDEAERDGKTATAEARLWKRE
AEAFVYTEVAAIQQDYGAMRCLGGWSWNCVAINWRVTKKLEEAKELISRVDVSRVAARLPPPPAVELPIS
NNIVGMQSDVIQIVNQIKDENVRVIGIYGMGGIGKTTLLKLINNHEETSKLKFEHVVWIVASKGCKLQKL
QMDLAKKVGLNLEDDESEDDRAYKLHNFLKGKNCLLFLDDIWQSYEIVMLGMQPPKRGMEKKRKVIVFTT
RYEQVCTGMSANVIKKVKGLSSDEAWELFLKYAREDVINSERQINQLAKEITKECAGVPLALITVGRAMS
AKRSREAWHDALVQLKKSQMPEVTGMKERDPMFAAFKLSYDSLEDDNIRARLLCCSLWPEDFEIDKDELI
QCWIGLDLIDEFDSINKAFDRGHSHIETLTFACLLELVNKNGETRIKMHDVIRDMALWMASDCGSNQHRW
IVKARARLNQLELENEQWQVVERASFMHNNLSSLPRQTPTFPKLSMLMLQQNPKLDLIPEPFFKALPILA
FLDLSGTNITDLPREINMLSELQYLNLNFTPIKALPVELSSLAKLKYLLLVGTKHLAKVPKGTMSNIALL
KLLDLYESKYSNLDELEGFKGCRKYIGITLHSMIDLERLGSLPQLFTWKLQLQSMRDLAYPSQLFESIMS
SYNTRQGLERLEIVDVTTGGELTIAQSNNDHEEGLECLRYMTLITVNDLQEITWKVVEHQTVFPNLHELS
IFDCKMLRNITWVLHLPNLNVLKVSNCGEMEELINCVGSSANSSIGLRLLSLARLPSLNCISRQSLTFPY
LEQLYVSSCPELRKLPFGAEICQNKLKGIFCQEDWWENIQWENANDKNSLLPYIKFGFQKIVLKLGVKLP
KDKSRIFKTVIELPGVTSMAGLEYVPFDRGG


>XP_042399807.1 probable disease resistance protein At1g61300 [Zingiber officinale]
MIPSIGIGQILNKIWDAASIFLARPRSRVEDLGRDAERLKAKLVDVNRAIDEAERDGKTATAEARLWKRE
AEAFVYTEVAAIQQDYGAMRCLGGWSWNCVAINWRVTKKLEEAKELISRVDVSRVAARLPPPPAVELPIS
NNIVGMQSDVIQIVNQIKDENVRVIGIYGMGGIGKTTLLKLINNHEETSKLKFEHVVWIVASKGCKLQKL
QMDLAKKVGLNLEDDESEDDRAYKLHNFLKGKNCLLFLDDIWQSYEIVMLGMQPPKRGMEKKRKVIVFTT
RYEQVCTGMSANVIKKVKGLSSDEAWELFLKYAREDVINSERQINQLAKEITKECAGVPLALITVGRAMS
AKRSREAWHDALVQLKKSQMPEVTGMKERDPMFAAFKLSYDSLEDDNIRARLLCCSLWPEDFEIDKDELI
QCWIGLDLIDEFDSINKAFDRGHSHIETLTFACLLELVNKNGETRIKMHDVIRDMALWMASDCGSNQHRW
IVKARARLNQLELENEQWQVVERASFMHNNLSSLPRQTPTFPKLSMLMLQQNPKLDLIPEPFFKALPILA
FLDLSGTNITDLPREINMLSELQYLNLNFTPIKALPVELSSLAKLKYLLLVGTKHLAKVPKGTMSNIALL
KLLDLYESKYSNLDELEGFKGCRKYIGITLHSMIDLERLGSLPQLFTWKLQLQSMRDLAYPSQLFESIMS
SYNTRQGLERLEIVDVTTGGELTIAQSNNDHEEGLECLRYMTLITVNDLQEITWKVVEHQTVFPNLHELS
IFDCKMLRNITWVLHLPNLNVLKVSNCGEMEELINCVGSSANSSIGLRLLSLARLPSLNCISRQSLTFPY
LEQLYVSSCPELRKLPFGAEICQNKLKGIFCQEDWWENIQWENANDKNSLLPYIKFGFQKIVLKLGVKLP
KDKSRIFKTVIELPGVTSMAGLEYVPFDRGG


>XP_042399808.1 probable disease resistance protein At1g62630 isoform X1 [Zingiber officinale]
MLLKLINNHEEISKLKFEHVVWIVASKECKLQKLQMDVAKKYAGKDVINSEQGINQLAREIAKVCSGVPL
ILITVRRVMSAKRSWRSDALMQLRQSRMLEVTDMKERDPMFAAFLLSYDSLEDDNMRAPLLCGSLWPEGF
KIHKVELIQRWIGLGLINEFNSINKEFHRELSHIETLTFTCLLELVDSEHTVGIKMHDLIRDMVLWMVSD
YGSNQYKWIVKAHAGLNQLELENEE


>XP_042399828.1 disease resistance protein RPS2-like [Zingiber officinale]
MGQLSVDYWYETRSMPVPNSLLDCKSFSNHRLPNSFYTDCDPSICCFPSIAMSISFDIGQFLNKICHVAS
IHLARPRSSVEDLHIDAELLGAKLSDVDRAISEAAGNGKIVMEEALVWKRLAEAFVSKEAAIQRDYKEMR
CLGGWSWNCVSINRRATEMKKMQELISRGNDIRVVAAPPPPPQLPVKLPISNNVVGMESNVIQIVNQIMD
ANVRVIGIYGMGGIGKTTLLKLICNHDEISKLKFEYVIWIVASKGCKLQKLQMDLAKKVGLKLEDDESED
DRASRLFDSLKEKNCLLFLDDIWESYDLYKLGMEEVPAEHGKERKRKVIVFTTRYEHICTGMNANVIKKV
EGLSSDQAWELFLKYAREDVINSEPGINQLANEIAKECAGVPLALITVGRAMSSKRSWEVWNDALTQLRQ
SQMPELTGMKESDPMFAAFKLSYDSLEDDNMRARLLCCSLWPEDFEIDKVELIQCWIGLGLIAEFDSINK
TFHRGHTHIETLTSACLLELADKKYATRIKMHDIIRDMTLWMASDCGFNQHKWIVKAQARFSQLELENEK
WQVVERASFMHNDLSSLPRQTPIFPKLSMLMLQGNYKLSLIPGSFLQALPVLTFLDLSNTKITELPREIN
MLSELQHLNLNMTPVEALPAELSSLAKLKYLLLVRTNRLAKVPKGTISNLPLLKLLDLYESKYADLDELE
EFKGCRRCIGITLQSVTTLDQLVSLQQLSTWKLQLKNMSDLAYPSQLFESIMSSHNIRKSLERLEIVSVQ
TGDELIVARNNRDREEGLECLRYMVLKAVDDLQEITWKAVKPQTVFPNLRELKISECKMLRNVTWVLQLP
HLSVLTVSNCDKIEELISCVGDSVNSSSSLRLLSLAQLPKLNCISQQSLTFPYLERICVNSCPNLRKLPF
GVEICQNKLKDIFGQTDWWNNIRWEDANDKISLTPYFKSTYMQKIVLKLNMEDAKSRAKALKTAVRIHGV
VSVTLENDLLIMNGDQVDLVALSKTMRRNFGWVELISISEMVD


>XP_042399830.1 probable disease resistance protein At1g61300 [Zingiber officinale]
MNPSINFGQFLNKIWDAASIYLARTRSRVEDLGRDAELLRAKLEDLNRAIDEAERNGQTATEEAQLWKRR
SETFLSTEVVAAIQRDYGAMRCLGGWSWNCVSINRRATKKLEEVKELISRVDVSRVAAMLPPPSAVELPI
SNDIVGMQSDVIQIVNQIRDENVSVIGIYGMGGIGKTTLLKLINNHHREISKLKFDHVIWIVASQGCKLQ
KLQMDLAKNIGLNLKDDESEEGCACKLFNSLKEKNCLLFLDDIWETYDLYMLGMEKTHVEQGKEQKRKVV
VFTTRSEQVCTGMKANVKKKVTGLASDKAWKLFLKNAGENVINSESRINRLAKEIAKECAGVPLALITVG
RAMSAKRSWEAWNDALTQLKQSQMPDVTGMKKRDPMFAAFKLSYDSLEDDNMRVRLLCCSLWPEDFEIDK
VELIQCWIGLGLIDEFDSINKIFDRGHSHIETLTFACLLELVHKEHAINIKMHDVIRDMALWMASDCGSN
QHRWIVKAGARLYDLELENEQLQVVEQASFMHNYIRSLPSETPTFPKLSMLMLQQNLKLYLIPGSFFQAL
PVLTFLDLSGTNITMLPREINLLFELQHLNLNFTPIEALPANLSNLSKLKYLFLKGTMRLTQVPKGTISN
LPLLKLLDLYESKYDNLAELKGFKGYRRYIGITIRTMMALEQLGSLRQLYTWKLQLENMKDLAYPRQLFK
SITSNHNTRQSLERLEIVNILTGGELIVAQSNKDSEEGFECLRYMALIAVDDLQKITWKAVEPQIIFPNL
HELIIAKCKMLRNITWAVQLPNLSVLKVSYCDEMEELISYVGSNVSSSIDLHLLSLAQLPKLNRISRRQL
TFPYLERIYVSECPKLKKLQFGAEICQNKLKGIFGRKKWWENIKWENAKDKNSLTSYFKSSMQIIMLRLN
IRGASFDMGDTNARAVAIKIALAIPGVMSAELDDECLIVRGEQLDPVEIVARLQNLFQAELLNGDIEN


>XP_042399941.1 disease resistance protein SUMM2-like [Zingiber officinale]
MTLSTVLGQILNKICNAASFYLASPQSSVNYLGRAAERLTAKLEDVNQEIAEAERNGQTTTNETRLLKRK
AEAFVSEVAAIQRDYGAMRCLGGWSWNCVSINQRVSERMEEVSELISGVDVSKVAAKLPPPAAVELPISN
NVVGMRSNLIQIVNQIRDENNSVIGIYGMGGIGKTTLLKHIHNHEDISKLKFEHVVWIVASQGCKLQKLQ
MDLAKKVRLKFEDDESEDDRVSKLYNFLKQKSCLLFLDDIWESYDLVKLGMEQVPAEHGKEQKRKVVIFT
TRSEQVCTEMSADVIKKVEGLPYDQAWELFLKNAGEHVINIEPRITGLAKQIAEECAGVPLALITVGKVM
SAKRSIEAWNEVLRQLKKSHMPKVTGMKERDPMLAAFKLSYDNLEDDNMRARLLCCSLWPEDFEIHKVEL
IQCWIGLGLIDEFDSINEAFDRGHFHIETLASACLLELIDGEIHTTKIKMHDVIRDMALWTASN


>XP_042399942.1 disease resistance protein SUMM2-like [Zingiber officinale]
MTLSTVLGQILNKICNAASFYLASPQSSVNYLGRAAERLTAKLEDVNQEIAEAERNGQTTTNETRLLKRK
AEAFVSEVAAIQRDYGAMRCLGGWSWNCVSINQRVSERMEEVSELISGVDVSKVAAKLPPPAAVELPISN
NVVGMRSNLIQIVNQIRDENNSVIGIYGMGGIGKTTLLKHIHNHEDISKLKFEHVVWIVASQGCKLQKLQ
MDLAKKVRLKFEDDESEDDRVSKLYNFLKQKSCLLFLDDIWESYDLVKLGMEQVPAEHGKEQKRKVVIFT
TRSEQVCTEMSADVIKKVEGLPYDQAWELFLKNAGEHVINIEPRITGLAKQIAEECAGVPLALITVGKVM
SAKRSIEAWNEVLRQLKKSHMPKVTGMKERDPMLAAFKLSYDNLEDDNMRARLLCCSLWPEDFEIHKVEL
IQCWIGLGLIDEFDSINEAFDRGHFHIETLASACLLELIDGEIHTTKIKMHDVIRDMALWTASN


>XP_042399943.1 disease resistance protein SUMM2-like [Zingiber officinale]
MTLSTVLGQILNKICNAASFYLASPQSSVNYLGRAAERLTAKLEDVNQEIAEAERNGQTTTNETRLLKRK
AEAFVSEVAAIQRDYGAMRCLGGWSWNCVSINQRVSERMEEVSELISGVDVSKVAAKLPPPAAVELPISN
NVVGMRSNLIQIVNQIRDENNSVIGIYGMGGIGKTTLLKHIHNHEDISKLKFEHVVWIVASQGCKLQKLQ
MDLAKKVRLKFEDDESEDDRVSKLYNFLKQKSCLLFLDDIWESYDLVKLGMEQVPAEHGKEQKRKVVIFT
TRSEQVCTEMSADVIKKVEGLPYDQAWELFLKNAGEHVINIEPRITGLAKQIAEECAGVPLALITVGKVM
SAKRSIEAWNEVLRQLKKSHMPKVTGMKERDPMLAAFKLSYDNLEDDNMRARLLCCSLWPEDFEIHKVEL
IQCWIGLGLIDEFDSINEAFDRGHFHIETLASACLLELIDGEIHTTKIKMHDVIRDMALWTASN


>XP_042400834.1 putative disease resistance protein RGA1 [Zingiber officinale]
MVCDSLWAINSMIVIPKMGMLYNKCLEWDSVFDPELDVPAEFEDWERDVAAAIIDVGELLSRIMDWEASL
HRSIVGNTKQVHFRHVILVELKEMLCHLNSLVLRGSAMGLRRDPMDSMNPLQEDYSIVLKNEVVGREEDL
EKLIAILERQLVSSNNIGDDNNPFVIVIDGTPGVGKTTLAHMIYHHTWVRQQFHHRIWMDLPLVSPFKMI
NIIGNEFLRSINKEEYCDQKLHLDLSLLAMWEYINEQLCGSRYLLVLHCENLVSLMQSGEWNELKNILLR
VGGPGSGVLIIYKFSTVSFVRDTGFLNRMKDIITYPLKTLSADACVELFKRQAATTIPSSKQDKSERDAW
LLRNCIPTQAFGAKVFGSLSHNIPASFAHNLFYEVYMVRNLPLVIIRLHQYQHLLDVDNDYDVILHMLTA
EYLIPTEGLERDWIQLYARPINKRTSLRLSRMVHLHMKVPEYLTTIPRCCRYLCLKINHRAIPFRLPTMP
VEVSNKLITLILREHEEATQEDVEEITLQAYKKRRMKATTAISKFLNKMSVRLVHLRILVVETGMIQRLP
NEVSKLVNLRYLHLSKLKMELLPKSLFDLPNLRILSLLRCQKLQKIPERIHQLKKLQILKLAYCTKLQRL
PKSITRLKNLEVIDVEGCCWLSKLPDDLISFKSLRILNFTRCASLSQIPRGIEQSIDLRKLSGIFVGVDG
GFVLAQLQTLTNLQEIRLRNLERAEKTQTEVLMGQQSLRNLSLHWGGEEANESSESATPLQVLEALRPNV
HLKMLEIISYKGVEFPTWMSKQELVDFDSLVEVRLINLRRCATLPSLGRLPCLEKLEISGMDLIKHIDDT
FYDDGNTYPKLRELTFSEMLALEKWSMTEEKYFKFFPRLRKLTLVQCPKLKEIDLHYYSGTMRIWLNNET
TCSAKFCCWGNLRYIQTIEIVGCQELRCLPQGMKSMKYLNKMTINSCNNLTTLVALDSLRALNIYACPVL
AFNLESFTELVLLTIKGCPKMQM


>XP_042401039.1 putative disease resistance RPP13-like protein 1 [Zingiber officinale]
MWKDELANKAAEIRKRFDQITEEWKLLTLPKNAGKRKRSPSSIDENRETCSLVVESDVLGRVEEKDMLVE
WLLSKDDTTRNGVSVMVVIGMGGLGKTTLAQHPRVKSYFDLRGWVYVSENFHDGEDPTIIYKSESS


>XP_042401475.1 disease resistance protein RGA2-like [Zingiber officinale]
MEAALVATARFAADKVTILVQLDEKLKAMTGIEEKMKKLKEMSTIIDMVIQDVESHPLNNDVVKDLLRKL
KYLAYDLEDVVDCYDTETSRRQRSSIVSDFFSSNNQVVFTSNISDMIQGVTNSLGSILLQKSILLNLPQS
SSHMSLPYRGTHSRNTIEVVGRELEKNKIVNMLTKEDDDDDESDHGTVKVIAIVGMGGLGKTTLAQLVFN
DARVKDHFASPRMWKLVGAEFDPEKIMKSVLELATGAPVNISEIELVRQNLETALSGKRFLLVLDDVWNE
DPFEWGTLKAALTCGAKGSKILVTTRSLHVCSIMGSSTATHQIQQLSRDDCLSLFQQFAFGDEAPDQKLM
KIGKKIVKKCDGVPLAAISLGNMLRGTRDETYWSSVLKSEIWQLRDEEQKVLAVLKWSYDTLPLRSKKCF
AFGSLFPKDYMMQKDKLIKLWIANGFVSSEGNFEAETEGNRIFDDLVSRSFILLAPVQYDRRITKCTMHD
LMHDLARSVSGNIYWNSIQDLVEVIGERTYHLQINEGKLPNMTQVLAKKPTYLRTFFQDKLSRLSINLHE
VFSVLKFLRALNLTESGIRDIPTSIGNLIHLRHLNLYYNEIEVLPDSITLLSNLQYLNLSFNYGLRELPK
ELGNMQNLRDLDLVMDYKLTQIPCGLSRLTNLRSLPVFIASDKTGACSITELEDLKLYGKMGIKISHDFK
NYSRSGRKILKNSDLDELHIEFGVSEGYHKDMLDDLCPNTSLKMLRISNYRSPQFPTWLIELQMPNLVVV
DLGCCCGHILPFRNLQFLKKLSLGRMNGITQMVTEFHGFPDVLN


>XP_042401480.1 putative disease resistance protein RGA1 [Zingiber officinale]
MEGTLVATARFPANKVAILVQLDEKLKTETGTKRKMEKLKELSTIIGAVMEDVESRSFIDDAVKDLLKML
KYLDYDLEDVVDYYDTKVLQKQQRSNTCLRPVRDFFSSDNQVVFKCRIGGMIKVVIESLDSILLQKSILL
NLPQGSIRMSEPSLYKETYSHNSFDVRGREPEKNMIVDVLTKDDDDDENSRGTLKVIAIVGMGGLGKTTL
AQLVFNDERVKVHFVSSRMWTFVGTEFDPTKIMKSVLEQATFDPVNISETDLVRQNLEKTLSGKRFLLVL
DDVWNEDQLKWDELKAALTCGARGSKILMTTRSQQVSSIMGSFNTHQIQQLSRDDCLSLFQQSAFEDEAV
DQNLMKIGAKIVEKCGGVPLAAISLGSMLHGTRDEMYWSSVLMSEIWQSGNDEYEVLATLKLTYDNISPQ
SKKCFAFASLFSKNYGMAKDELIKLWIANGCVRSEGNFDAETVGNHVFDDLVLRSFFLLAPFEDVTKCTM
HDLMHDLARSVSADVYWNSNQDSVEDIGKRTYHLQIFPRELRNDMFSQVLGKKPLNLRTLILSKCKLDQN
ANLLEIVFSELKFLRVLDLSNNNIKEVPTSIRNLIHLRYLNVSGNDIEILPNSIILLLNLQYLYCNNLRL
TYMPRGLSQLSNLRILSFFAAADRTGACSITELEDLKLHGEMTIKFSTNFTNYPRGGRQILKNKHLNQLL
FELNGSESNDKDMLDDLCPDTSLKRLSICNYGSRQFPAWLMESQLPNLIEVSLEKCHGCEHIPPFGNLQF
LKKLDLCMMNGITQLGAEFHGYRGFPSLQELFLHGMDNLEEWSESDDSNQLLPSLQGLRIFHCPKLKSMP
WLARIQRLYIFDCNEGLLSCVGRLTSLSILRVRWMKYMTSLPNGCIRNLTSLTKLKITECNLLQSIPGDE
MQHLGTIQSLTIYWCNDLASFPSEVESLSSLRSLRLTKCLHITVEPEILVRILNSLHKFRIEICCEKVNL
RGQLQRLHSLGELLISGEHGKFAFQRKATQLGICCCDDLESLMTTEQAASSVLEDLYIDGISELMTLPDW
LQHLRSLRILSIQNCPRLEKVPQGLKDLHMLSDLKLVNCPQLEGRCERETGEDWPIISHVPQITIGLVP


>XP_042401481.1 putative disease resistance protein RGA4 [Zingiber officinale]
MEGALVAATRFVADKAVILFQLDEKLKAMTDIEEKMENIKELSTIIDMVIEDVESHTLNKDAVKDWLRKL
KYLAYDLEDVMDCYNTEALRRQRSSISSFEPVRDFFSSNNQIVFTSRISDMIKAVTNSLDSILRQKSFLP
NLPQSSGHMPLNPYRETHSRNSFDVIGREIEKDMIVGMLTKDDDDDDDDDDDKSSHGTLKVITIVGMGGL
GKTTLAQLVFNDARVKDHFESSRMWTVVGAEFDPAKIMKSVLELATGASVNISQIDLVRQKIEKALSGKK
FLLVLDDVWNEDATKWNVLKPALTCGARGSKILVTTRSQQVSSIMGSSNTTHQIQQLSRDDCLSLFQQFA
FGDEAVDQNLMEIGEKIVKKCGGVPLAAISLGSMLRITRDEPYWSSVLNSEIWQLGNKEDKVLAVLKLSY
DSLPPRSKKCFAFASLFSKNNRMTKDELIKLWIANGFVSSEGNFDAETVGNRVFDDLVSRSFFLLVPSQD
VTKCTMHDLMHDLARSVSADVYCNSKQDSVKHIGNRTYHLHIYLANTSKVTRALSKKPLYLRTLILNYVS
LNADQLELVFSELKYLRVLELTGNKIKEVPTSIGNLIHLRYLNLSKNRIRVLPDSITLLHNLQYLYCHHL
RLTHMPCGLARLINLQSLSFFAAADGAGACSIIELEHLKLHGEMKIQFSENFTNYSCGGRKILKNKHINE
LRLKFNCSESNDKDMLDDLCPNSSLKKLSICNYGSRQFPELLIESQLPNLVEVCLKNCRCCEHIPPFGNL
QFLKKLELHKMNAVTQMGAEFHGFGGFPSLQELYLDRMDDLEEWSESDYADELFPLLKTLFIVKCPKLKS
MPRLPRIQYLDISYCSGSLLSCVGRLTSLSVLRVEAMDDMTSFPNGCIRNLTSLTAFEIKGCKQLQCLPG
DEMQHLEMIRTLTIDRCDNLASLPSEVGCLGSLCFLRLREEKIQNWQKGVRMHDIWRRDSLGARMHDSKS
SDYNRQKAVNMIEENLQEDQQKLELHVFEMEVELTCLNEALLIEALSEKLGTADSEIKSLKEMVAMAERL
VESESVLKEMESSMKYPLEMEAEKSIWSSKEKAFLEASEKLKIQNNLMQKLSENLL


>XP_042401482.1 putative disease resistance protein RGA4 [Zingiber officinale]
MEGALVAATRFVADKAVILFQLDEKLKAMTDIEEKMENIKELSTIIDMVIEDVESHTLNKDAVKDWLRKL
KYLAYDLEDVMDCYNTEALRRQRSSISSFEPVRDFFSSNNQIVFTSRISDMIKAVTNSLDSILRQKSFLP
NLPQSSGHMPLNPYRETHSRNSFDVIGREIEKDMIVGMLTKDDDDDDDDDDDKSSHGTLKVITIVGMGGL
GKTTLAQLVFNDARVKDHFESSRMWTVVGAEFDPAKIMKSVLELATGASVNISQIDLVRQKIEKALSGKK
FLLVLDDVWNEDATKWNVLKPALTCGARGSKILVTTRSQQVSSIMGSSNTTHQIQQLSRDDCLSLFQQFA
FGDEAVDQNLMEIGEKIVKKCGGVPLAAISLGSMLRITRDEPYWSSVLNSEIWQLGNKEDKVLAVLKLSY
DSLPPRSKKCFAFASLFSKNNRMTKDELIKLWIANGFVSSEGNFDAETVGNRVFDDLVSRSFFLLVPSQD
VTKCTMHDLMHDLARSVSADVYCNSKQDSVKHIGNRTYHLHIYLANTSKVTRALSKKPLYLRTLILNYVS
LNADQLELVFSELKYLRVLELTGNKIKEVPTSIGNLIHLRYLNLSKNRIRVLPDSITLLHNLQYLYCHHL
RLTHMPCGLARLINLQSLSFFAAADGAGACSIIELEHLKLHGEMKIQFSENFTNYSCGGRKILKNKHINE
LRLKFNCSESNDKDMLDDLCPNSSLKKLSICNYGSRQFPELLIESQLPNLVEVCLKNCRCCEHIPPFGNL
QFLKKLELHKMNAVTQMGAEFHGFGGFPSLQELYLDRMDDLEEWSESDYADELFPLLKTLFIVKCPKLKS
MPRLPRIQYLDISYCSGSLLSCVGRLTSLSVLRVEAMDDMTSFPNGCIRNLTSLTAFEIKGCKQLQCLPG
DEMQHLEMIRTLTIDRCDNLASLPSEVGCLGSLCFLRLRGCPSIIVQPEVLVQIMNLLHKFQIDICYKNV
DVRGQLQHLHMLKKLSIDLMIPIN


>XP_042401483.1 putative disease resistance protein RGA4 [Zingiber officinale]
MKSVLELATSASVNISQIDLVRQNLEKALSGKKFLLVLDDVWNKDPFEWGKLKAALTCGTRGSKILVTTR
SQQVSSIMGSSNTIHQIQQLSGDDYLYLFQQFAFGDQAVDQNLMEIGEKIAKKCGGVPLAAISLGSMLRI
TRDETYWSSVLNSEIWQLGNEEDQVLAVLKLSYDTLPLRSKKCFAFASLFSKNDIMAKDELIKLWIANGF
VRSEGNFNAETAGNRVFDDLVLRSFFLLVPSQDVIRCTIHDLMHDLARSVSADVYWNSEQDSVENIGKRT
YHLKISLSEESSMTHVLGKKPLYLRTFMSRRVYSPLRTNMFEGFLELKFLRSIDLPCNGIIEVPTSIGNL
IHLRYLNLSRNGIKVLPDSITLLPNLQYLDLSFNEELQELPEELGNMQSLRELDCRHLDFQELLPLFSHI
QNIQDLDLLRALSHFNFGLTHMPCGLSRLTNLQSLGAFYAGDRTGACSIIELEDLKLHGEMNIIFSKDFT
NYSCGGRKILKNKDLNELRLEFNGSERYDKEMLDDLCPNKSLKKLSICNYGSRQFPAWLMESQLSNLVEV
SLKNCRGCEHIPPFGNLQFLKKLDLRSINGITHMGVEFHGHGGFPSLQELILNELYNLEEWLESHGVDEL
FPKLQSLKIFACPRLKSMPRLPTIQYLDIFWCSGSLLSCVGRLTSLSLLRLVEMDDMTSLPNGCIRNLTS
LTTFEIQGCKQLQCLPGDEMQHLEIIRSLTIYRCNNLASFPSEVGCLGSLRSLSLRGCPSIKVQPEVLVQ
ILNSLHKFQIEICHKNVDIRRQLQHLHTLKELFITGVHGRYKNHSYIGRNNATQLGICCCDELESLITAE
PTSNVLEELYIDEIFKLTTLPDWLRHLESLRVLSIHNCSELGLLPRGLKNLPMLETFRVSNCPQLKRRCE
REIGEDWPIISHLPFIDIS


>XP_042401508.1 putative disease resistance RPP13-like protein 1 [Zingiber officinale]
MAMIPDFLVTRYLTKLTDFLEGEICKVLGVKEEIKKFQRRLERLSPYLQDAEQKRHQDNRVNTWLRDLKG
IVYDAEDIIEFCTLPGGSELMSLQPLSSSSTLVSRPFTLLASCFACTKFRHEIAVSLKRLNDRLKEIKDD
KDLIEGLIPSMSHQWSQDHPTSQRLTTSLEVKADIVGAKVEDDAQTLILMILKHDHKHNGVFGIVGMGGI
GKTTMAHKIFHDERIKNSFPTRIWICVSKNYTRIDLLKAMLKQAKGSDDGAQSIEELEFKLVGALVNRFF
LVLDDVWSVNAWTDVLRNPILIAKSNGIILITGRHKTVMEDLRASYIHHVQRMNRDDGLELFHKVVFEEE
KNEDPDLDEMAAKIVSKCDGLPLAIKVIAGMLISKKRTRREWERVLESDLWRMRDKEDELPAALYLSYED
LSSVLKQCFLCCASYIGISYRTDLVRLWIAEGLIHVPNGGLMEEVAEDYYKELVMRNLLQLDPRSANETC
YSMHDLLRALGTNLIGDEALVISDGRVADTNPNPLTQIRRLWMSSKGDTLRLPGAVLEQKSLRVLQLYDC
PETKTIEDEAAALPALKNLRVLDVCDTQIERLPDFIFTNLLLLRYLDLDRTMIHEIPESIGRLANLQTLN
ISRCESLRSIPKAVTSLGMLRCLRVRGTPLTHLPRGMGSLTNLNHMEGFVVGHGDSPSNADVGCDMEELR
SLSNLRFLSACKLERATSMAGPSVLENKPLLRHLSLLWTNRKQGDDGEKEAAEKTCSGLLPPSSLEELTL
HNFPGRRFPNWMMSTSSGTSFPHLEFLILRNFPCCTELPPLGQLPRLKFLKIEEASAVRKVGPEFLGVCF
PQAVAFPRLEVLKFTGLTNWEEWTLYAASEEVGDIQERSMNLFPRLERCTFTGCPKLRGLPESIYCAARL
KTVVVSTSDQLSEVEFRRRETMEMDDCPDLFLARDSTELPHWLLDRIDRERDEKNSELPSRTVIKVKANV
IIIQQNRQVDAV


>XP_042401510.1 putative disease resistance RPP13-like protein 1 [Zingiber officinale]
MLKQAKGSDDGTQSIEELEFKLVGALVNRFFLVLDDVWSVNAWTDVLRNPILNAKSNGIIIITGRHKTVM
EDLIASYIHHVQRMNKDDGLELFHKVVFEDEKNEDPDLDEMAAKIVSKCDGLPLAIKVIAGMLISKKRTR
REWERVLESDLWRMRDKEDELPAALYLSYEDLSSVLKQCFLCCASYIGISYRTDLVRLWIAEGLIHVLNG
GLMEEVAEDYYKELVMRNLLHLDPRYSDEIRYSMHDLLRALGTNLIGDEALVISDGRVADTNPNPLTKIR
RLWMSSKGDTLRLPGAVLEQKSLRVLQLYDCPETKTIEDEAAALPALKNLRVLDVCDTQIERLPDFIFTN
LLLLRYLDLDRTMIHEIPESIGRLANLQILNISGCTSLRNLPKAVTSLGMLRWLRVRGTPLAHLPRGMGS
LTNLNHMEGFVVGHGDSPSNADVGCDMEELRSLPNLRFLSACKLERATSMAGPSVLENKPLLRHLSLLWT
NRKQGDDGEKEAAEKTCSGLLPPSSLEELTLHNFPGRRFPNWMMSTSSGTSFHHLEFLILRNFPCCTELP
PLGQLPRLKFLSIEGASAVRKVGPEFLGVCFPQAVAFPRLEVLKFMGMPNWEEWTLYAASEEVGDIQERS
MNLFPRLERCTFTGCPKLRGLPESIYCAARLKTVVVSTSDQLSEVEFRRRETMEMDDCPDLFLARDSTEL
PHWLLDRIDREKDEKNSVLPSRTVITVKANVIIIQQNRRVDAV


>XP_042401511.1 disease resistance protein RPP8-like [Zingiber officinale]
MAMIPDFLVTRYLTKLTDLLEGEICKVLGVKEEIKKFQRRLERLSPYLQDAEQKRHQDNRVNTWLRDLKG
IVYDAEDIIEFCTIPGGSELMSLQPLSSSSTLVSRPFTLLASCFACTKFRHEIAVSFERLNDRLKEIRDD
SEIITGLVPLMSHQWLQDHPTSQRLTTSLEVKADILGAKIEDDAQTLIRLILKHDHKDNGVFGIVGMGGI
GKTTMAHKIFHDERIKNNFPTRIWICVSKNYTRIELLKIGPTNK


>XP_042401513.1 putative disease resistance RPP13-like protein 1 [Zingiber officinale]
MAMIPDLLVTRYLTKLTDFLEGEICKVIGVKEEIKKFKRRLERLSPYLQDAEQKRHQDNRVNTWLRDLKG
IVYDAEDIIELCTLHGGSELMSLQPSSSTLVSRPFTLLASCFACTKFRHEIAVSFERLNDRLKEIKDDSE
IIAGLVPLISHQWSQDHPTSQRLTTSLEVKADIVGAKIENDAQTLIRMILKHDHKHNGVFGIVGMGGIGK
TTMAHKIFHDERIKNSFPTRVWIHVSKNHKGIELLKQLLKNAKGSDDEAQSIQELESKLVGALVNRFFLV
LDDVWSVNAWRDVLRNPILNAKSSGIILVTSRHENVMNDMRASHIHHVQRMNEDDGLELFHKVVFEDEEN
ENPELDEMATKILRKCDGLPLAIKLIAGVLISKKRTRRDWERVVESDSWRMRNNEDELPRALYLSYEDLS
SVLKQCFLCCASYVDVSFTADLVRLWIAEGLINAPNGELMEEVAEDYYKELVMRNLLQFDPRSADKTHYS
MHDLLRALGTNLIGDEALVISDGRVADTNPNPSTQIRRLWMSSKGDTLRLPGAVLEQKSLRVLQLYDCPE
TKTIEDEAAALPALKNLRVLDVCDTQIERLPDFIFTNLLLLRYLDLDRTMIHEIPESIGRLANLQTLNIT
ECESLRSIPKAVTSLGMLRCLRVEGTPLTHLPRGMGSLTNLNHIEGFVVGHGDLPTNVDDGCDMEELRSL
SNLRYLTACKLERATLMAGPLVLENKPLLRHLSLSWTNREQRDDGEKEAAEKTCSGLLPPSSLEELTLHN
FPGRRFPHWMMSTSSGTSFPHLEYLILHNFPCCTELPPLGQLPRLKFLKIEKASAVRKVGPEFLGVCFPQ
AVAFPRLEFLKFTGMPNWEEWTLYAASEEVGAIQERSLKLFSRLERCTFTGCPKLRGLPESIYCAARLKT
VVVSTRDQLSEVEFRRRETMEMDDCPDLILARDSTELPHWLLDRIDREREEKNSVLPSRTVITVKAHEII
IQQNRRVEAV


>XP_042401514.1 probable disease resistance protein At1g63360 [Zingiber officinale]
MKNMISKLKFEHVVWIVASKECKLQKLQMDLAKNVGLNLKDDESEDDCSYKLCNFLKEKHCLLFLDVIWQ
SYELFMLGMEQVTAEHGKEQKRKVIVFTMLSELASMH


>XP_042401516.1 disease resistance protein RPS2-like [Zingiber officinale]
MNANEKKKLANLASDPAWELFLKYAGKDVINSEPGINQLAREIVKECAGLLALITVGRAMSAKRSWDSWN
DALMQLRPSQMPEVTKLVDSEHTVGIKMHDVIRDMDLWMVSDCGSNQYRLPFPQTFHAHAPTEPYATLNS
WDIFQALLVLAFLELSGTDIAELSREIKMLSELQHLNLNFTPIVTVPTELSSLAKLEYLLLVGTERLIKV
PMGTLSNLPLLKLLDSYESKYANLNELEEFQGRQKYIGITLDSKATLERLGSLPLLSIWKLQLQDMRDLA
CPSQLFERIMRSDNIRQGLERLEIVDAMIDDELIVTGNNKDIEKGFECLRYMALTTVNNLQEITWGAVKP
QTLFPILHELNISGCKMLRNITWALQLPNHSIFSSFMVLSVHYVYNANVICKIRYSNNN


>XP_042401592.1 putative disease resistance RPP13-like protein 1 [Zingiber officinale]
MSHQWSQDHPTSQRLTTSLEVKADIVGAKIENDAQTVINMILKHDHKHNGLFGIVGMGGIGKTTMTHKIF
HDERIKNSFPTRIWICVSKNYTRIELLKEMLKQAKGSDDGAQSIEELELKLVGALVNRFFLVLDDVWSVN
AWTDVLRKPILIAKSNGIILVTGRHKTVMEDLRASYIHHVQRMNKDDGLELFHKVVFEDEKNEDPDLDEM
AAKIVSKCDGLPLAIKVMAGMLISKKRTKREWERVLESDLWRMRDKEDELPAALYLSYEDLSSVLKQCFL
CCASYIGISYRTDLVRLWIAEGLIHVPNGGLMEEVAEDYYKELVMRNLLHLNPRYSDEIRYSMHDLLRAL
ATNLIGDEALVISDGRVADTNNPNPLTQIRRLWMSSKGDTLRLPGAVLEQKSLRVLQLYDCTETKTIEDE
AAALPALKNLRVLDVCETQIECLPDFIFMNLLLLRYLDLDRTMIREIPESIGRLANLQTLNISECESLRS
IPKAVTSLGMLRCLRVRGTPLTHLPIGMGSLTNLNHIEGFVIGHGDPPSNADVGCDMEELRSLSNLRFLS
ACKLERATLMAGPSVLENKPLLRHLSLLWTKRKQRDDGEKEAAEKTCSGLLPPSSLEELTLHNFPGRRFP
NWMMSTSSGTSFPHLEFLILCNFPCCTELPPLGQLPRLKFLKIEEASAVRKVGPEFLGVCFPQAEAFPRL
EVLKFTGMPNWEEWTTLYAASEERSLKLFSRLERCTFTGCPKLRGLPESIYCAARLKTVVVSTSDQLSEV
EFRRRETMEMDDCPDLILARDSTELPHWLSDRIDRERDEKNSELPSRTVITVKANVIIIKQNRQVDAV


>XP_042401709.1 putative disease resistance protein At5g47280 [Zingiber officinale]
MESFFAGEVATELIKELVKVIRGTYLCRPAAEQLKRSVDSLLPIVQEIRHSGVELPQNRQSQLSDLADHL
RLALDLARKAAASPRWNVYRSVQLARKMECIESWISRWIERHMPVHVLADVHHIRVDYVARLDRIERALS
VAASSPVVATDSKVPMELGSAPFSGFPVPKTMEGFAQPSAEPVKAPFGIGNKLSSGFPMMEQFFTSPDAR
KVPVAMGKSPSSGFRVANIMDGLMLAGEEVKPVGAGIRIGKEKVKEMLMEGSDSDAVVGISGIGGSGKTT
LAREICKDPEIRSYFNDRIYSVTLSQSPNLESLKLKLWEQISGNMVLGAYNQIPKWQMELGAIDKGSFLI
ILDDVWSLSELEELIFRVPGCKILVVSRFKFPLVKKTYEIELLGEEDALSLFCHAAFELKSVPFTIDKKL
VKQVVKECKGLPLALKVIGASLRDQPPKFWLRAKNKLSQGEAICESHENKLIERMSSSIEFLSVKVRECF
LDLGCFPEDKRIPIDVLINVWMELHDLDEEDAFAMLVELSNKNLLTLLKDAQSRAGDIYSSYVELSVTQH
DLLRDLALYVNNQESLNTRRRLIMSKRENELPKEWERNKDQQFQAQIISINTGEMKESDWFQMHFPKAEV
LILSFCADVYFLPPFLSTMPKLRALILINYGTSCASLQNRTIFTSLNNLRSLWLEKITVPPLPKTTVPLR
NLRKVSLILCELNDSLRGSKVDLSSTLPRLSHLTIDHCVDVTKLPPYICNINSLECLSISNCHDLSELPC
EFGKLSSLKILRVCACPSLKSLPQSICRLKGLKYLDISQSFNLRELPEELGYMMSLEKIDMRECSQLKTL
PRSSSSLKSLGHVICDEDIAFLWKEAEIEIPDLRVQVAEESFNLDWLVE


>XP_042402968.1 putative disease resistance protein RGA4 isoform X1 [Zingiber officinale]
MAGGRDVLFSTITMVLDKMHSLASSSTSSSSSSPHNAIEQEMSKLTETMRRIQAKLDDSEEENHAKSHSE
KLWLSELKDVAYDAEDVVEEYEYETLRSKQLHENSSGTHEDELANKATEIRKRFDEITKEWKLLKLPKNA
GKRKRSPMLLDMNREEGSSVVESDVFGREEEKDVLVKWLLSEDDTTGNGVSVIAVIGMGGLGKTTLAKLV
YNDERVKSYFDLTGWVCVSENFHVVSLTKKILQSFAKVKVHEELDELQHALREKLQGKKFLLILDDVWNE
EFTRWDELRKPLLSAHVGKVIVTTRNQPAARIMGTRSPLNLNCLPFDVCWQLFKRDTLGGADKSPQPHLE
DLGRKIVDKCKGLPLAVKVLGGALRNNEDIDSWEDMLENEMWELEETNKGVLPALKISYDCMPIQLKRCF
QYLSLFPKDRILDSEEIVRFWMSQGLLPLDGDKRAEDIGRNYIKRLAQRSIIHLEWDDTFLMRWKYFSMH
DLVHDLAQCIAQDECLCVMDKFDAKKLQKVRHLSVCIEYPHLLEHVEMIKDLQQLKLMRTLFTTGPGCRS
FMTRQYNSFKVLDDLFQKLKYIRALYLSEISITGLPDSLGNLKLLRYLSIKDYDVVNIPESICSLYNLQT
LDLEDTQISELPRQIGNLINLRHLLLPNDYADYDDYEGVFLPSGIGNMTNLQTLSCFNVSCEKEHCDIGE
LNSLMKLGGHISISDVASVNIFSNSTPPLKTKKYIDSLELDWYRDTLELSEFKKDEKQAEWQLDYLEPHV
NLKILEIKNYPGVKFVGWVGASSFTKLTTLRVWNCKNCNKLPPLGQLPSLKMLEIRGMDSVQHVGREFCS
MLMPSPSSSQNKIAFPSLKRLIFSNMENWEAWDGVEIGDFPSLDSIRIFRCPLLIKFPQWSYMSSVKKME
LGSSGVPDVSNFHSLTNLTIILISQEYSEWMPKCYFPMLQNLTLLSGFAKSVHLSQKVLPSLKTLEISYF
SELQVVTGLKNLTSLNSLILKNCPNLEFKKLPTTLEQVKLDRCRLFEKGFKEQQHMRNVLGEEEEEEMEI
DM


>XP_042402969.1 putative disease resistance RPP13-like protein 1 isoform X2 [Zingiber officinale]
MLLDMNREEGSSVVESDVFGREEEKDVLVKWLLSEDDTTGNGVSVIAVIGMGGLGKTTLAKLVYNDERVK
SYFDLTGWVCVSENFHVVSLTKKILQSFAKVKVHEELDELQHALREKLQGKKFLLILDDVWNEEFTRWDE
LRKPLLSAHVGKVIVTTRNQPAARIMGTRSPLNLNCLPFDVCWQLFKRDTLGGADKSPQPHLEDLGRKIV
DKCKGLPLAVKVLGGALRNNEDIDSWEDMLENEMWELEETNKGVLPALKISYDCMPIQLKRCFQYLSLFP
KDRILDSEEIVRFWMSQGLLPLDGDKRAEDIGRNYIKRLAQRSIIHLEWDDTFLMRWKYFSMHDLVHDLA
QCIAQDECLCVMDKFDAKKLQKVRHLSVCIEYPHLLEHVEMIKDLQQLKLMRTLFTTGPGCRSFMTRQYN
SFKVLDDLFQKLKYIRALYLSEISITGLPDSLGNLKLLRYLSIKDYDVVNIPESICSLYNLQTLDLEDTQ
ISELPRQIGNLINLRHLLLPNDYADYDDYEGVFLPSGIGNMTNLQTLSCFNVSCEKEHCDIGELNSLMKL
GGHISISDVASVNIFSNSTPPLKTKKYIDSLELDWYRDTLELSEFKKDEKQAEWQLDYLEPHVNLKILEI
KNYPGVKFVGWVGASSFTKLTTLRVWNCKNCNKLPPLGQLPSLKMLEIRGMDSVQHVGREFCSMLMPSPS
SSQNKIAFPSLKRLIFSNMENWEAWDGVEIGDFPSLDSIRIFRCPLLIKFPQWSYMSSVKKMELGSSGVP
DVSNFHSLTNLTIILISQEYSEWMPKCYFPMLQNLTLLSGFAKSVHLSQKVLPSLKTLEISYFSELQVVT
GLKNLTSLNSLILKNCPNLEFKKLPTTLEQVKLDRCRLFEKGFKEQQHMRNVLGEEEEEEMEIDM


>XP_042402974.1 putative disease resistance protein RGA4 [Zingiber officinale]
MAGGRDVLFSTITMVLDKMHSLASSSTSSSSSSPHNAIEQEMSKLTETMRRIQAKLDDSEEENHAKSHSE
KLWLSELKDVAYDAEDVVEEYEYETLRSKQLHENSSGTHEDELANKAAEIRKRFDEITKEWKLLKLPTNA
GKRKKSPMLLDMNRETGSLVVESDVLGRAEEKDMLVKWLLSEDDTTGNGVSVIAVIGMGGLGKTTLAQLV
YNDQRVKSYFDLIGWVCVSETFHVVSLTEKILQSFAKVKVHEELDELQHALREILQGKKFLLILDDVWNE
EFTLWEDLSKPLLSAHVGKVIVTTRNQSVARIMGTRSPLNLNCLPFDVCWPLFKRVTLGGADKSLQPHLE
HLGRKIVDKCKGLPLAVKVLGGALRNNEDIDSWEDFLQNEMWESEETNKEVLPALKISYDCMPIQLKRCF
QYLSLFPKDTSLDSEEIVRLWMSQGLLPLDGDKRAEDIGRSYIKRLAERSIIHLEWDDTFLMGWKYFSMH
DLVHDLAQYIAQDEYLCVMDNKFDTKKLQKFRHLSFNVECHKLNIEALPELKLLRTLFMRELDCWKYRLP
DDLFQKLKYIRTLVLNAYGIQELPYSLGNLKLLRYLSIKVKVVESIPESICSLYNLQTLDLADTHISKVP
RQIGNLINLRHLLLPNVGVFFPSGIGNMTNLQTLRRFNVSCEKEHCDIGELNSLMKLGGHISISDIASVN
IFSNSKPPLKTKKYIDSLKLDWDVVTFDLLEDEKQAEWQLEYLEPHVNLENLEINNYPGIKFVGWVGASS
FTKLTRLHVEYCKNCNKLPPLGQLPSLEELEMSRMGGIRHVGSEFCSMLMASPSSSQNKIAFPSLKDLIF
RDMTNWEEWDGVEIGDFPSLHSFKLFGCRRLIKFPRWPFLSSVEEMTLHSGGVPDVSNFHSLTKLAIMFM
SKKNSKWMSRCYFPTLQHLTLVYSIVQSVHLSQKVLPSLKTLGILYSDQLRVVTGLKDLTSMNSLIIKAC
RNLEFKGLPATLEQVKLDGCRLFEQGFKEQQHMRNVLMIEPHNSDDEEEEKEEMDVDDEEEEEEEE


>XP_042402976.1 putative disease resistance RPP13-like protein 1 isoform X1 [Zingiber officinale]
MAGGGFLSSMFTTMVDKLHSLAAPSATSSSSLSHNNIEREMSKLTETMRRIQAKLDDSEEENHAKSHSEK
LWLSELKDVAYDAEDVVEEYEYETLRSKQLHENSSGTHEDELANKAAEIRKRFDEITKEWKLLKLPTNAG
KRKRSPMLLDMNRETGSLVVESDVLGRAEEKDMLVKWLLSEDDTTGNGVSVIAVIGMGGLGKTTLAQLVY
NDQRVKSYFDLIGWVCVSENFHVVSLTEKILQSFAKVKVHEVLDELQHALREILQGKKFLLILDDVWNEE
FTLWEDLSKPLLSAHVGKVIVTTRNRSVARIMGTRSPLNLNCLPFDVCWPLFKRVTLGGADKSLQPHLEH
LGRKIVDKCKGLPLAVKVLGGALRNKEDIDSWKDILENEMWESEEINKGILPALKISYDCMPIQLKRCFQ
YLPLFPKDTSLDSEEIVRLWMSQGLLPLDGDKRAEDIGRNYIKRLAERSLIHLERVDTLFMTEQSPLFMR
KQSFSLHDLVHDLAQYIAQDEYLCVMDNKFDTKKLQKFRHLSFNVEYHKSNIEALRELKLLRTLFIRELD
SWKYRKYKVLDDLFQELKYIRTLVLDNYGIEELPYSLGNLKLLRYLSIKDDVVESIPESICSLYNLQTLD
LTDTQISELPRQIGNLINLRHLLLPCDYFGFKAIFFPSGIGNMINLQTLRRFNASCEKDHCDMGELNSLM
KLSGHISISELAFVNIFSNSKPPLKTKKYIDSLELCWRKYALYNNAFFDYYRKDEKKAEWQLEYLEPHVN
LENLEINSYPGIKFVGWVSASSFTKLTRLHVEYCKNSNKLPPLGQLPSLEELKICRMDGVQCVGREFCSM
LMASPSSSQNKIAFPSLKDLIFRDMTNWEAWDGVEIGDFPSLHSIRITGCCRLIKFPRWPFLSSVEKMML
ESGGVPDVSNFHSLTNLTIMSMSKKNSKWMSKCYFPTLQHLILLFSSAESVHLSHKVLPSLKTLEIRNSP
TLRVVAGLKNLTSLNSLIIEVCPNLEFKGLPATLEQVKLDGCRLFEQGFKEQQHMRNVLMIEPHNSDDEV
EEKEEMDVDDEEEEEEEEDMDVDDEEEEEEEMDGDDDDNNDDNMD


>XP_042402977.1 putative disease resistance RPP13-like protein 1 isoform X2 [Zingiber officinale]
MAGGGFLSSMFTTMVDKLHSLAAPSATSSSSLSHNNIEREMSKLTETMRRIQAKLDDSEEENHAKSHSEK
LWLSELKDVAYDAEDVVEEYEYETLRSKQLHENSSGTHEDELANKAAEIRKRFDEITKEWKLLKLPTNAG
KRKRSPMLLDMNRETGSLVVESDVLGRAEEKDMLVKWLLSEDDTTGNGVSVIAVIGMGGLGKTTLAQLVY
NDQRVKSYFDLIGWVCVSENFHVVSLTEKILQSFAKVKVHEVLDELQHALREILQGKKFLLILDDVWNEE
FTLNLNCLPFDVCWPLFKRVTLGGADKSLQPHLEHLGRKIVDKCKGLPLAVKVLGGALRNKEDIDSWKDI
LENEMWESEEINKGILPALKISYDCMPIQLKRCFQYLPLFPKDTSLDSEEIVRLWMSQGLLPLDGDKRAE
DIGRNYIKRLAERSLIHLERVDTLFMTEQSPLFMRKQSFSLHDLVHDLAQYIAQDEYLCVMDNKFDTKKL
QKFRHLSFNVEYHKSNIEALRELKLLRTLFIRELDSWKYRKYKVLDDLFQELKYIRTLVLDNYGIEELPY
SLGNLKLLRYLSIKDDVVESIPESICSLYNLQTLDLTDTQISELPRQIGNLINLRHLLLPCDYFGFKAIF
FPSGIGNMINLQTLRRFNASCEKDHCDMGELNSLMKLSGHISISELAFVNIFSNSKPPLKTKKYIDSLEL
CWRKYALYNNAFFDYYRKDEKKAEWQLEYLEPHVNLENLEINSYPGIKFVGWVSASSFTKLTRLHVEYCK
NSNKLPPLGQLPSLEELKICRMDGVQCVGREFCSMLMASPSSSQNKIAFPSLKDLIFRDMTNWEAWDGVE
IGDFPSLHSIRITGCCRLIKFPRWPFLSSVEKMMLESGGVPDVSNFHSLTNLTIMSMSKKNSKWMSKCYF
PTLQHLILLFSSAESVHLSHKVLPSLKTLEIRNSPTLRVVAGLKNLTSLNSLIIEVCPNLEFKGLPATLE
QVKLDGCRLFEQGFKEQQHMRNVLMIEPHNSDDEVEEKEEMDVDDEEEEEEEEDMDVDDEEEEEEEMDGD
DDDNNDDNMD


>XP_042403004.1 putative disease resistance protein RGA3 [Zingiber officinale]
MAGGGGFLSSMFTTMVTKLHSLASPSTTSSSSSSPHNTIEQEMSKLTETMRRIQAKLDDSESEEENHAKS
HSEKLWLSELKDVAYDAEDVVEEYEYEVLRSKQLHENNSGAHEDELANKAAAIRKRFDEITKEWKLLKLP
KKAEKRKRSPMLSDMNRETGSLVVESDVLGREEEKDMLVKWLLSKNDTTGNGVSVIAVIGMGGLGKTTLA
QLVYNDQRVKSYFDLTGWVCVSENFHVVSLTEKILESFTKVEVHKELDGLQHALQEKLQGKRFLLILDDV
WNEEFTLWDELRKPLVSAQVSKVIVTTRNHRVAGIMGTRSPLDLNCLSFDICWQLFKRVTLEGAYKRLQP
HLEELGRKIVDKCKGLPLAVKVLGGALRNNEDIDSWEKILENEMWELEETNNGVLPALKISYDCMPIQLK
RCFQYLSIFPKDTSLDSEEIVRLWMSQGLLPLDGDMRAEDIGRNYIKRLVERSMLNSVEINVDSSFVMHD
LVHDLAQYITQDECLCVMDNKFDAKKLQKIRHLSVSVKYPNLLKPLETIKDLQQLKLMRTLFITGPGWPY
FMIRQYNFFKILDDLFQKLKYIRALHLSKIDITELPDSLGNLKLLRYLSIRSAKIRMLPESICNLYYLQT
LDLIATNVHEFPRKIGNLISLRHLLLPYNYKGVFFPSGIGNMTNLQTLRRFNVSCEKEHCDIGELNSLMK
LGGHISIYNVASVNIFSNSKPPLKTKKYIDSLELDWSGVPFDIFKDEKKAKWQLEYLEPHVNLKILEINN
YPAFKFVGWVGASSFTKLTKLVLKYCKYCSKLPPLGQLPSLEELEIAGMHYVRHVGREFCSMLMASPSSS
QNKIAFPSLKDLIFRDMKNWEEWDGVEIGDFPSIHSIKLYGCPRLIKFPQWPFMSSVKKMTLDSGGVPDV
SCFPSLKHLEITVRTQEYSEVMSKCYFPTLQHLILSYSKVESIHLSQRRLPSLKTLKIHDSNELRVVTGL
KNLTSLNSLIIKECPNLEFKKLPATLAQVQLYRCRLFKKGFKEQHMRNVLGEEEEEIENLLDFLVWIAEE
DDNNDGGEDMRNEGEEEEMEIDLELRLWND


>XP_042403010.1 putative disease resistance protein RGA3 [Zingiber officinale]
MAGGGFLSSIITMVLDKLHSLASLSTSSSSSSPHNNIEQEMSKLTETMRRIQAKLDDTEEENRAKSHSEK
LWLSELKDVAYDAEDVVAKYEYEVLRSKQLHENSSWTQEDELANKAAEIRKKFDEITKEWKLLKLPQNVG
KRKRSSWPLVGNRETGSFVVESEVLGREKEKDMLVEWLLSEDDIIWNEVSVIVVIGMGGLGKTTLAQLVY
NDPRVKSYFDLTGWVCVSENFHVVSLTEKILQSFTTVKVHEELDELQHALQENLQGKKFLLILDDVWNEE
FTLWDELRKPLASAQVVKVLVTTRNQSVARIMGTRSPLNLNCLPFDVCWQLFKRVTLGGADKSLQPHLEH
LGRKIVDKCKGLPLAVKLLGGALRNKEDVDSWEDILENEMWESEETNKGVLPALKISYDCMPIQLKRCFQ
YLSLFPKDTSLDSEEIVRLWMSQGLLPLDGDKRAEDIGRNYIKRLAERSLIHLKRADTLFMREQLRKQSF
SLHDLVHDLAQYIAQDECLCVIDDKFDIEKLQKIRHLSLGRSLVREDPHILKHLETIKDHQQLKLMRTLF
IKVRGLFGLTSIRRQDKIFGPLDDFFQKFENLRALHLSNIIGFIGLLDSLGKLRLLKYLSIIDFDVVGIP
ESICSLYNLQTLDLTGTSIYQLPRQIANLINLRHLLLPHYLNVFLPSGIGNLIDLQTLTHFDFCCEKEHC
DIEELNTLMKLGGHILISISTSVNTFSNSKPPLKTKKYLDSLELRWYGWYDDAFDGSKKDEKNAEWQLEY
LEPHVNLKTLRIFFYPGVSFVGWVGCSSFTKLTSLSLYSCNNCNKLPPLGQLPSLEMLEICGMDGVQQVG
REFCSLLMASPSSSQNKIAFPSLKYLHFSTMLHWEVWDGVEIGDFPRLQFIQISKCYVLIKFPQWPFMSS
MEEMTLDSGGVPDVSNFHSLTNLSIDVITQKNTKWLSNCYFPTLQHLTLLYIGMESIHLSQRRLPSLKTL
EIHDSKKLRVVTGLKNLTSLNSLIIKACPNLEFQELPATLEQVKLNRCRLFKKGFKEQQHMRNVLGDGDK
SGVTTLK


>XP_042403014.1 disease resistance protein RGA2-like isoform X2 [Zingiber officinale]
MAGGGFLSSKFTTMVAKLHSLASSSTPSSSSSPHNNIEQEMRKLRKTMRRIQAKLADSEEENQVKSHSEK
LWLSELKDVACEAEDVVEEYEYEVMRSRQLHESNSGAHEDELANKAAEIRKSFDEITKEWKLLTLPKNSG
KRKRIVGNRETGSLVVESDVLGREEEKDMLVKWLLSEDDTSVNKVSVIAVIGMGGLGKTTLAQLVYNDQR
VKSHFDLTGWICVSENFHVVSLTEKILQSFAKVKVHEELDELQHTLQENFPGKGKVSEKLDVLQHALQDN
LQGKKFLLILDDVWNEEFTLWDELRKPLVSAQVGKVIVTTRNQPVAKIMETRSPLDLNCLPFDVCWQLFK
GVTLGGADKSLQPHLEYLGRKIVDKCKGLPRL


>XP_042403015.1 putative disease resistance protein RGA3 [Zingiber officinale]
MAGGGFLSSIITMAVDKLHSLASPSTPSSSSSPHNNIEQEMSKLTETMRRVQAKLADSEEDNHVKSHSEK
LWLSELKEVAYDAEDLVEEYEYEVLRSKQLHGNNSGTHEGELANKAAEIRKRFDEITKEWKLLTLPKNAG
ERKRSPLTLVDNRETGSLVLESDVLGREEEKDMLVEWLLSEDDMTDNRVSVIAIIGMGGLGKTTLAQLVY
NDPKVKSYFNPRGWVCVSENFNVVNLTEKILQSFTEEKGKGEVKIPETLDGLQRALEENLLGKKFLLILD
DVWNEEFTLWNELRKPLVSAQVGKVIVTTRNQPVARIMGIRSPLDLNCLPFDVCWQLFKRVTLGGADQPH
LEDLGRKIVDKCKGLPLAVKVLGGALRNKEDIDSWEDILENKKWELEETNKGVLPALKISYDCMPIQLKR
CFQYLSLFPKHTRLHSEIIVRLWMSQGLLPLDEEIREQRTKAEIT


>XP_042403221.1 putative disease resistance protein RGA1 [Zingiber officinale]
MDTVGVAMMVGEWFAGYIIDKLVSFVASHVSDHWDLLTDVEEKLKEIQDRLPRIQAVIHAAEGRPIRDPA
LVNWLRQIKEAAYEADDLLDEIEFVKNLFVSDDELKRLKDLLGDVDKIYSEIDRKKVELDEDNAKHAASI
RETSSFTQEVVFGRDKEREKILEMLLSSGNDADFRNKGAGSSSHASLGVLPIVGIGGVGKTTLAQIIYND
PRVADHFELRKWVYVSNDFNVKRIARDLEGEMASDSRPDHISLDTQLSNLSRATTAKRFLFVLDDVWDEA
GRKWMELRSALTYGNRGSTVLITTQSPLVAQVMGTMDQIELKLLEESDYWRLFEHCSFGSRVIDSYLRRK
LQLIG


>XP_042403231.1 disease resistance protein RPS2-like [Zingiber officinale]
MESILSILDSIFRPVVAFFTRTFGYAMSCEQYIESLQKEMGELRSKRDDVKREVDREARQGMEATNEVML
WLQNVERLEEEAARITDDFETHYANPAADDSRSKLVVSYHLSKRAEDACGEATVLKTKSHFNKVADRLMP
IRFEERPSALTVGMDSMIEQLRKACDDDVGVIGIHGMGGVGKTALLNRFNNEVLVQVAHLDVVISVKVTR
NFDVEKIQREIGDRIGLSWDERKSDDERSMVLFKVLSRMRFVLLLDDLWEPLDLSIVGIPTPTGASKIIL
TTRIEDVCDRMDARKMRMECLEWEDAWELFEKKAGRGLGTLLRGDPDIRRHAEDLAQRCGGLPLALITLG
RAMASKRTAKEWHHAVTTLANTPWHLLGMEESVLQPLKLSYDKLNDDRLKTFLLYASLLMNKMPMHNATV
INLCIGEGAINEFDDPEDAYSKGYHLLGVLKAASLLESSGDDYVQMHPFVRAMVSWIICEHGKKDGKWLV
QVGTGLAEVPDYEKWEHAERVSLVSNEICSLPEDPYCPELLTLLLSRNYELSKIPNSFFLSMPRLKVLDL
SRTSIKELPPEIGKVLTLQHLDLYETNIASLPKELGNLVKLKSLLLSSTPLLKEIPHGVIARFTELRVLS
MNDSYGNWRVSSSGPGINFEELEGLKRLRYLDITLQNASTLQRLSRARRLSMSTRYLHIRGCLGLTTIHL
PSTSLGRYMKGLRGLRISQSSILEEIIVGGGSTIGEWSLLPNLHVLILQHLLKAKFVFRDRNFQNLRFLY
VWYCIGLEQLVKFEDELSEGQESEVITAFPHLKELHLASLPELKSLGGERVLAFPCLRVLEVKECPKLKE
LSITGDGLTQICCKQEWRDGLEWKDEKIKEALFPLFTPLQ


>XP_042403232.1 disease resistance protein RPS2-like [Zingiber officinale]
MESILSILDSIFRPVVAFFTRTFGYAMSCEQYIESLQKEMGELRSKRDDVKREVDREARQGMEATNEVML
WLQNVERLEEEAARITDDFETHYANPAADDSRSKLVVSYHLSKRAEDACGEATVLKTKSHFNKVADRLMP
IRFEERPSALTVGMDSMIEQLRKACDDDVGVIGIHGMGGVGKTALLNRFNNEVLVQVAHLDVVISVKVTR
NFDVEKIQREIGDRIGLSWDERKSDDERSMVLFKVLSRMRFVLLLDDLWEPLDLSIVGIPTPTGASKIIL
TTRIEDVCDRMDARKMRMECLEWEDAWELFEKKAGRGLGTLLRGDPDIRRHAEDLAQRCGGLPLALITLG
RAMASKRTAKEWHHAVTTLANTPWHLLGMEESVLQPLKLSYDKLNDDRLKTFLLYASLLMNKMPMHNATV
INLCIGEGAINEFDDPEDAYSKGYHLLGVLKAASLLESSGDDYVQMHPFVRAMVSWIICEHGKKDGKWLV
QVGTGLAEVPDYEKWEHAERVSLVSNEICSLPEDPYCPELLTLLLSRNYELSKIPNSFFLSMPRLKVLDL
SRTSIKELPPEIGKVLTLQHLDLYETNIASLPKELGNLVKLKSLLLSSTPLLKEIPHGVIARFTELRVLS
MNDSYGNWRVSSSGPGINFEELEGLKRLRYLDITLQNASTLQRLSRARRLSMSTRYLHIRGCLGLTTIHL
PSTSLGRYMKGLRGLRISQSSILEEIIVGGGSTIGEWSLLPNLHVLILQHLLKAKFVFRDRNFQNLRFLY
VWYCIGLEQLVKFEDELSEGQESEVITAFPHLKELHLASLPELKSLGGERVLAFPCLRVLEVKECPKLKE
LSITGDGLTQICCKQEWRDGLEWKDEKIKEALFPLFTPLQ


>XP_042403233.1 putative disease resistance protein RGA3 [Zingiber officinale]
MDTAGVAMMVGGWFPGYIMDKLVNFVTSHTSDHWDLLTDVEEKLNEIQARLPRIRAVIHAAEGRPIRDPA
LVDWLRQLKEAAYEADDLLDQMEYRQLEDQVQDRSKVSALAASALRFFKNLFVSDDELKRLKNLLGDVDK
IYSEIDRKNVELNEDNAKHTASIRETSSFTQEVVFGRDKERERILEMLLSSGNDADFLNKGAGSGSHASL
GVLPIVGIGGVGKTTLAQIIYHDPRVADHFELRKWVCVSNDFNVKRIARELEAEEPSDYRWDHISLDSQL
TKLIHATESKRFLFVLDDVWDEAGRKWMELRSALTYGNRGSTILITTQSPIVAEVMGTIDRIELKLLEES
DYWSLFEHCSFGSRVIDPYLRRKLQLIGQQIAKKLHGLPLSGKVVGSLLHARLEEQYWKMIRESEWWEND
FLLENILPSLGLSYQHLSSNVKQCFAFTAMFPKGHIFDKEQLVEMWIAQGFVRPEAQHGRMTLEDIGNQI
FDELTRRYFFLHTVNKRYVIHDLIRELAVYISRDECFVIDDEPSKIPPTARHLTVMRTAELDTLAELSKL
HKVRTLVFYRDYHPENFFSLGENGSRQFYESLERILKTLKNLRILDLSYMLIEIKKLPDATCDLSHLRYL
DISGTKIRHLPGSFSKSYHLQVLKLNRCWIKKLPEGMNRLIKLRHLHADADTISLVDGIGRLTDLQELDE
FRITRKRGHQIGELKELRNIRRRLVIQNLEYVESQEEAMEAKLKDKEYLDHLVLNFKEGKRSQGDIEKDI
IEGLEPHCNLKRLVIQNYGCLNSPCWLEKNYLTNLESIHLNCCARWEDLPPLGHLPFLMDIFIFNLPVRR
IGAKFYGGADQVFPSLQELTFHTLNEWEELSESDSRPIFPCLMKMRIENCLKLRRIPVLPLISIKHLDIR
NSGDIGNALPDYLLTLTSLTYLELHNCAQRASVSLYNLQFLEYLRLVQCPELSLIGGLQSLANLKDLIIH
ACPKLFEPAQMPEQPYVEQEMRSLCTVWIDDDVLKHVWVILGRTPCIQVLRIHHCNDLSHFNPEHEEWFQ
QLTSLHFLEFHNCSKLRKLPSSLGTASIKILCIHHCPNIESLPDNGLPFLLRKLEMHGCTKLRDRCRKDD
GSDWPLISNIPNIDIDGELIQMK


>XP_042403243.1 putative disease resistance protein RGA3 [Zingiber officinale]
MDTTGVAIMVGENFASSIIDKLVDFVTSHVSGHWDLLSDVEEKVKQIQDRLPRIQAVIHAAEGRPIRDPA
LVNWLRQLKEAAYEADDLLDEIEYRQLDDQVQDRGKVSALATLALRFVKNLFVSDDELKRLKNLLGDVDK
VYSEIDRKKVELDEDNAKHTKSIGETSSFTQEVVFGRDKERERILEMLLSSGNDADFLNKGAGSSSHASL
GVLPIVGIGGVGKTTLAQIIYNDPRVADHFELRKWVYVSNDFNVKRIARELEGKVASDSRPEHISLDAQL
TNLSRAIASKRFLFVLDDVWDEDGRKWMELRNAMSHGNRGSTVLITTQSPLVAEVMGTMDQIELKLLEES
DYWRLFEHCSFGSGVIDPYLGRKLQSIGRQIAKKLHGLPLSGKVVGSLLHARLEEQYWKMIRESEWWEND
FLLENILPSLGLSYQHLSSNVKQCFADTAMFPKGHIFDKEQLVQMWIAQGFVRPGTQRGRMTMEDIGNQI
FDELTCRYFFLHTINERYMIHDLIRELAVYISRDECFVIDDEPSKIPPTARHLTVVRTAKLDTLAELSKL
HKVRTLVFYRDYHPEDLFSLGENGSRKFYESLEGILKSLKNLRILDLSYMRVELKKLPHATCDLSHLRYL
DISGTKIRQLPGSFSKICHLQVLNLKRCWIKKLPEGMNRLIRMRHLHADADTISLVDGIGRLTDLQELDE
FRITRKRGHQIGELKELRNIRRRLDIQNLEYVESQEEAMEAKLKDKEYLDYLVLNFKEGKRSQGDIEKDI
IEGLEPHCNLKRLMIQHYGGLNSPCWLEKNYLTNLESIHLNWCARWEDLPPLGHLPFLMDISICKLPVRR
IGAKFYGDADQVFPSLQELTFHTLNEWEELSESDSRPIFPCLMKMRIENCLKLRRIPVLPLISMKQLDIW
NSGDIGNALPDYLLTLTSLTYLELHNCAQRASVSLYNLQFLEYLRLVQCPELNLIGGLQSLANLKDLIIH
ACPKLFEPVQMPEQPYVEQELRSLCTVWIDDDVLKHVWVILGRTPCIQVLRIHHCNDLSHFNPEHEEWFQ
QLTSLHFLEFHYCSKLRKLPSSLGTASIKILCIHHCPNIESLPDNGLPFLLRKLEMHGCTKLRDRCRKDD
GSDWPLISNIPNIDIDGELIQMK


>XP_042403311.1 disease resistance protein RGA2-like [Zingiber officinale]
MIGRFALASSEKVADSLLGALVGKAVEVAVQQFCEQRGVEDDRKQLQDSLDHARLILGTIENVWIKDEIE
QQGYEAGNLADAEDDRGSIQLLSLASPHMGGDVDAIHLEGLDEESLWKFFKECAFGSSNSEVHHPHLEAM
AKKMMCMLKGSPLAAKILGGLLSMKLDEQHWKSILDSELWQLPQEENGIIFSESELIGLWMAEGFIEPQE
SIRMEELASNYFHELVNRIEKDKSCEIPTTIHHLSMHEEG


>XP_042403382.1 disease resistance protein RGA2-like [Zingiber officinale]
MKDESLQQSLKEFLIRLKNAAYDADDLLDEFQYRILKQQIEQQGNEAGNRASSSSNSAPPPSKRTKTSFS
SYNSGLFRKGDDNDDDVQRIRKIKGRLDDNSVALEKIYSSLSAEDDRGKKQLVSWDSRQTSCFSTEPQLF
GRDKDLQELKDLLLKREIASKFGQSGFSVLSIAGIGGIGKTTLAQEVFNDSSVKEYFKLRIWICVSENYS
TDRLTREIIEYATKKKCDLPNFAALQEVLKEKITPERVLLVLDDVWNEDRHKWESFCAPLRSGKPGSKIL
VTTRSRKIANMVGDVDPIYLEGLDEESFWEFFKKCAFGSSNSGIHHPHLEALAKKMTYKLEGLPLAAKTL
GGLLSMKLDEQYWKSILDSEIWQLPQEENGTMPVLQLSYQYLPPHLKQCFAFCSLFPKDYKFSESELISF
WIAEGFIVPQGSTRMEELGSNYFHELVNRSFFQKSKDEKFIMHGLIHDLAELISVGESYRIEKGKSHEIL
STIRHLLVHEEEEGTQTRRLTEFSHCNKLRTLMLSVPYKCKSFILDCCVLQKLKRIRVLVLKNCALEEMP
DSIVKLIHLRSLNLSCNFKIRRLSESLCDLYNLQSLILNHCALEELPNNIGKLIHLYYLDLECNKEIRRL
PESLCDLYNLQTLIISGCGKLESLPHGMIKLINLKILDGADKFIPEITEVGKLTSLQNLSAFKVLKKNEH
KLAELNSLKQLRGALCITNLENVENKDEANIANLKSKEHLNHLELEWTFSQESGSEVNLQISEQVLEGLR
PHHNLQRLTIRGYNGARPPNWLNEQVYSRLEALELVNCRRWNELSVIGQLSQLKSLSLVRIPVQIHNLHK
LFDPKDCKFFSQLEVLELKGITMLKDLPNLGQLPCLESLDIRSLPGVKMIGDRFFATTEEGTCFPRLGFL
HFDEMPAWEELYCSDDRNLFPYLKGLEISNCQRLQMLPPLPPSITWLKLNKVGLVDCPRFWKADENSNIT
NSASVTNLSIQECPNLTSLEEALLAHHLQQIHIQKCEQLLWVSVKRLTELTSLCSLSITECPKLMSMTQD
EYIDFQLPPSITQLCLSDCGNLSKSLPGCLRNLTSLHDLKISNCPNLVSLPVEPLLNLARVTIKNCNELR
SVEGLGVKSLQNLKIKGCPKLLLSQGEAQTKKLLVLRLEIDDTSLIKNLISSVTELRISSSCEAAMFEGQ
GQESLQSLTSLDLLSFSNCKNLQFLPTKLYTLTSLRYLWIHNCPQIQSLPEKGLPSALRDLKFEGCHLAL
QQKLERHLSEIKKFGGVI


>XP_042403950.1 putative disease resistance RPP13-like protein 1 [Zingiber officinale]
MAMIPDFLVTRYLTKLTDFLEGEICKVLGVKEEIKKFKRRLERLSPYLQDAEKKRHQDNRVNTWLRDLKG
IVYDAEDIIELCTLPGGSELMSLQPLSSSSTLVSRPFTLLASCFACTKFRHEIAVSFERLNDRLKEIKDD
SEIIAGLVPLMSHPWSQDHPTSQRLTTSLEVKADIVGAKIENDAQTVINMILKHDHKHNGVFGIVGMGGI
GKTTMAHKIFHDERVKNSFPTRIWICVSKNYTRIELLKEMLKQAKGSDDGAQSIEELELKLVGALVNRFF
LVLDDVWSVNAWTDVLRKPILIAKSNGIILVTGRHKTVMEDLRASYIHHVQRMNKDDGLELFHKVVFEDE
KNEDPDLDEMAAKIVSKCDGLPLAIKVMAGMLISKKRTRREWERVLESDLWRMRDKEDELPAALYLSYED
LSSVLKQCFLCCASYIGISYRTDLVRLWIAEGLIHVPNGGLMEEVAEDYYKELVMRNLLHLDPRYSDEIR
YSMHDLLRALGTNLIGDEALVISDGRVADTNNPNPLTQIRRLWMSSKGDTLRLPGAVLEQKSLRVLQLHD
CTETKTIEDEAAALPALKNLRVLDVCEIQIECLPDFIFMNLLLLRYLDLDRTMIREIPESIGRLANLQTL
NISGCESLRSIPKAVTSLGMLRCLRVRGTPLTHLPIGMGSLTNLNHIEGFVVGHGDSRSNADVGCDMEEL
RSLSNLRFLSACKLERATLMAGPSVLENKPLLRHLSLLWTKRKQRDDGEKEAAEKTCSGLLPPSSLEELT
LHNFPGRRFPNWMMSTSSGTSFPHLEFLILCNFPCCTELPPLGQLPRLKFLKIEEASAVRKVGPEFLGVC
FPQAEAFPRLEVLKFTGMPNWEEWTTLYAASEERSLKLFSRLERCSFTGCPKLRGLPESIYCAARLKTVV
VSTSDQLSEVEFRRRETMEMDDCPDLILARDSTELPHWLLDRIDRERDEKNSELPSRTVITVKANVIVIK
QNRQVDAV


>XP_042404729.1 putative disease resistance protein RGA4 [Zingiber officinale]
MLDKAASYINVEEAQAARRKADKPPLVAYRPERRAPQTPDQPLPRARDARPTFQPRQDARPMPRVAAVQV
PRPGPWGPRYCTYHRSHTHATNDCFQFAHDSRRAAELGLPLPELAPQVQRMMEEQRNAAGQASRPRAEQE
GPSMQPQGHTGEPGEAREAENRGNADIRDIGMISGGPTDGDSGRARKSHEGRLEIHAIGCSQEQAAGLVI
SFRPSVFEEMQIDASELQPVATSLYGFTDELANKAAEIRKRFDEITKEWKLLKLPKKAGKRKRSPMLSDM
NRETGSLVVESDVLGREEEKDVLVKWLLSEDDTTGNGVSVIAVIGMGGLGKTTLAQLVYNDQRVKSYFDL
TGWVCVSENFHVVSLTEKILQSFTKVKVHEELDELQRALQENLQGKRFLLVLDDVWNDNFCLWEQLKKPL
LSAIAGKVIVTTRNHSVARIMQTTRDSLKLNVLPFDVCWSLFKKVTLGGADRSLRPDLEDIGRRIVEKCK
GLPLAAKLIGGALRNEEDKESWTDIIESEIWKLDDRNIEVSPALQISYDCMLIQLKRCFQYLSLFPKDTS
LSSKRIVQLWMPQGIFPLDGDKRAEDIGSDYIKRLVERSMLNPEEGSYFSMHDLVHDLAQYVAQDECLCV
IDNNFDRKKLQEIRHLSVNGENIKLCQDKTNFLESDNLFQKLKYIRALDLNYMNITKLPDSLGNLKLLRY
LSIEYTNVRSLPESICNLYNLQILHAESVYTLPRHIGNLINLRHLWFSHQVVFLPSGIGNLTNLQTLNHF
SVSREEEHCNIGELNSLMKLGGSISIDNIGEVNNFSNSKFPLKTKKYLDSLELYWYDWFDYADEKKAEWQ
LEYLEPHVNLKTLEITKYPGIKFVGWVGASSFTKLIKLILRNCKNCSKLPPLGQLPSLEELEIIGMDGVQ
HVGREFCSMLIPSPSSQGELNIWKMDDVQHVGSGISSTLEPFSSSYKIAFPSLKLLLFSSMKNWKAWDGI
QSGDFPNLHFIEIYECSKLINFPKWPLLPSSGT


>XP_042404736.1 putative disease resistance RPP13-like protein 1 [Zingiber officinale]
MAGGGFLSSIITMVIDKLHSLASSSTSSSSSSPRNNIEQEMSKLTETMRRIQAKLDDTEEENRAKSHSEK
LWLSELKDVAYDAEDVVAKYEYEVLRSKQLHENSSGTQEVPDSSVIRTAVNTAITFMILLLFSDELANKA
AEIRKRFDEITKEWKLLKLPQNVGKRKRSSWPLVGNRETGSFVVESEVLGREKEKDMLVEWLLSEDDIIW
NEVSVIVVIGMGGLGKTTLAQLVYNDPRVKSYFDLTGWVCVSENFHVVSLTEKILQSFAKVKVHEELDEL
QHALREKLQGKKFLLTLDDVWNEEFTLWDELRKPLLSAHVGKVIVTTRNQSVARIMGTRSPLNLNCLPFD
VCWQLFKRVTLGGADKSLQPHLEDLGRKIVDKCKGLPLAVKVLGGALRNKEDIDSWEDILENEMWESEET
NKGVLPALKISYDCMPIQLKRCFQYLSLFPKDTSLDSEEIVRLWMSQGLLPLDGDKRAEDIGRNYIKRLA
ERSLIHLKRADTLFMREQSRKQSFSLHDLVHDLAQYIAQDECLCVIDDKFDIEKLQKIRHLSLGRSLVRE
DPHILKHLETIKDHQQLKLMRTLFIKVRGLFGLTSIRRQDKIFGPLDDFFQKFENLRALHLSNIIGFIGL
LDSLGKLRLLKYLSIIDFDVVGIPESICSLYNLQTLDLTGTSIYQLPRQIANLINLRHLLLPHYLNVFLP
SGIGNLIDLQTLTHFDFCCEKEHCDIGELNSLMKLGGHILISISTSVNTLSNSKPPLKTKKYLDSLELRW
YGWYDDAFDGSKKDEKNAEWQLEYLEPHVNLKTLQIFFYPGVSFVGWVGSSSFTKLTSLSLNSCNNCNKL
PPLGQLPSLEMLEICGMDGVQQVGREFCSLLMASPSSSQNKIAFPSLKYLHFSTMPNWEVWDGVEIVALY
TFGGRNDIGWWWCT


>XP_042405070.1 putative disease resistance protein RGA4 [Zingiber officinale]
MESALVTAMTRIMGEKVAILIRRNKNVKEITDIEEKMEKLKELLLIVNMVIQDVESRPFTYDVKILSRKL
RYLVYDLEDVVDCYDTEVLRKQRSRASFRSVHDFFSSNNQILFKSRLGSMIKAVTESGFNFTAKVEAFEF
VTSISSDIMGRETEKQRIVDLLTDDDDDVENNQDTMKVITIVGMGGLGKTRLAQLVFNDEKVKAHFASWR
MWTVIGMEFDPTKIMKSILEQATNALSTVSETNSVRQKLEHTLSGKRFLLVLDDVWNEDASRWGELRTAL
TCGARGSKILVTSRSLHVSSIMNSFITHQIQQLPPDDCLPLFQQFAFGDEEKDQKLMDIGRKIVEKCGGV
PLAIISLGSMLHNIQDETHWSSVLNSKIWQLRDEEQKVLAALKWSYDTLPPQSKKCFAFASLFPKGYTIE
KDELVRLWMANGFVQSEGNVDAKTMGNRVFDDLVLRSFFLLTPSKEHDFGDDSHVTKCMMHDLMHDLARS
VSGDVYWNVKEDLVTDIGNRTYHLLLYVKNLSNAYQALLRKPLTEILEGVRFKQ


>XP_042405112.1 putative disease resistance protein RGA3 [Zingiber officinale]
MEIQPFLIIHQKKEDFKESSPCIIVPLFSSKLSIVSQAQIHRKQLLHPSSEAMAAALVSDASRFKGENVA
DLLQLKDKLKAITGIEGKMEKLKESSAIIDKVIQDVDSRPFDHAVKELVKKLKYLAYDLEDVVDYYDTKV
LQKKPRSKTSLGPVRDFFSSDNQVVYTSRISGMIQAVTESLESILLQKSILLNLPQGNILVSKPSPYRET
HSRNSFDVIGRETEKKMIVDMLTKDDDDDESSHGTLKVITIVGMGGLGKTALAQLVFNDDSVKEYFYLRM
WKVVGTEFDPAKIMRSVLELAIAAPVKISEIDLVRQNLEEALSGKRFLLVLDDVWNENVLKWGVLKAALT
CRAPGSKILMTTRSQKVPLIMGSSKTTYHIQQLPRDDCLSLFYHFAFEDEPVDQKLMEIGEKIVEKCDGV
PLAVISLGSMLRGTRDKTDWSTVLNCSEIWQIPDKEQNVLDVHK


>XP_042405114.1 putative disease resistance protein RGA4 [Zingiber officinale]
MEGALVAATRFVADKAAILFQLDEKLKAMTDIEEKMENIKELSTIIDMVIEDVESHTLNKDAVKDWLRKL
KYLAYDLEDVMDCYDTEALRRQRSSISSFEPVRDFFSSNNQIVFTSRMSDMIKAVTNSLDSILRQKSFLP
NLPQSSSHMSLKPYRETHSRNSFDVIGREIEKDMIVGMLTKDDDDDDDESSHGTLKVIAIVGMGGLGKTT
LAQLVFNDARVKDHFESSRLWTVVGAEFDLAKIMKSVLELATSASVNISQIDLVRQNLEKALSGKRFLLV
LDDVWNEDPFAWGKLKAALTCGTRGSRILVTTRSQQVSSIMGSSNTIHQIQQLSGDDCLYLFQQFAFGDQ
AVDQNLMEIGEKIAKKCGGVPLAAISLGSMLRITRDETYWSSVLNSEIWQLGNEEDQVLAVLKLSYDTLP
LRSKKCFAFASLFSKNDIMAKDELIKLWIANGFVRSEGNFNAETAGDRVFDDLVLRSFFLLVPSQDVTRC
TMHDLMHDLARSVSADVYWNSEQDSVENIGKRTYHLKISQSEESSMTHVLGKKPLYLRTFMSRRVYSPLR
TNMFEGFLELKFLRSIDLPCNGIIEVPTSIGNLIHLRYLNLSRNGIKVLPDSITLLPNLQYLDLSFNEEL
QELPEELGNMQSLRELDCRHLDFQKLLPLFSHIQNIQDLDLLRALSHFNFGLTHMPCGLSRLTNLQSLGA
FYAGDRTGACSIIELEDLKLHGEMNIIFSKDFTNYSCGGRKILKNKDLSELRLEFNGSERYDKEMLDDLC
PNKSLKKLSICNYGSRQYPAWLMESQLSNFVEVSLKNCRGCEHIPPFGNLQFLKKLDLRSMNGITHMGVE
FHGHGGFPSLQELILNELYNLEEWLESHGVDELFPKLQSLKIFACPRLKSMPRLPTIQYLDIFWCSGNLL
SCVGRLTSLSLLRLVDMDDMTSLPNGCIRNLTSLTTFEIQGCKQLQCLPGDEMQHLEMIRSLTIYRFNNL
ASFPSEVGCLGSLRSLSLRGCPSIKVQPEVLVQILNSLHKFQIEICHKNVDIRRQLQHLHTLKELFITGV
HGRYKNHSYIGRNNATQLGICCCDELESLITAEPTSNVLEELYIDEIFKLTTLPDWLRHLESLRVLSIHN
CSELGLLPRGLKNLPILETLRVSNCLQLKRRCEREIGEDWPIISHLPFIDIS


>XP_042405133.1 putative disease resistance RPP13-like protein 1 [Zingiber officinale]
MAMIPDFLVTRYLTKLTDFLEGEICKVLGVKEEIKKFKRRLERLSPYLQDAEQKRHQDNRVNTWLRDLKG
IVYDAEDIIELCTLHGGSELMSLQPSSSTLVSRPFTLLASCFACTKFRHEIAVSFERLNDRLKEIKDDSE
IIAGLVPLMSHQWSQDHPTSQRLTTSLEVKADIVGAKIENDAQTLIRMILKHDHKHNGVFGIVGMGGIGK
TTMAHKIVHDERIKNNFPTRIWICVSKNYTRIELLKEILKQAKGSDNGTQSIEELEFKLVGALVNRFFLV
LDDVWSVNAWTDVLRNPILIAKSNGIILITGRHKTVMEDLRASYIHHVQRMNKDDGLELFHKVLFEDEKN
EDPDLDEMAAKIVSKCDGLPLAIKVIAGMLISKKRTRREWERVLESDLWRMRDKEDELPAALYLSYEDLS
SVLKQCFLCCASYIGISYRTDLVRLWIAEGLIHVPNGGLMEEVAEDYYKELVMRNLLHLDPRYSDEIRYS
MHDLLRALGTNLIGDEALVIRDGRVAGTNPNPLTKIRRLWMSSKGDTLRLPGAVLEQKSLRVLQLYDCPE
TKTIEDEAAALPALKNLRVLDVCETQIERLPDFIFTNLLLLRYLDLDRTMIHEIPESIGRLANLQILNIS
GCTSLRNLPKAVTSLGMLRCLRVRGTPLTHLPRGMGSLTNLNHIEGFVVGHGDFPTNADVGCDMEELRSL
SNLRFLSACKLERATSMAGPSVLENKPLLRHLSLLWTNRKQGDDGKKEAAEKTCSGLLPPSSLEELTLHN
FPGRRFPNWMMSGTSFPHLEFLILCNFPCCTELPPLGQLPRLKFLKIEEASAVRKVGPEFLGICFPQAVA
FPRLEVLKFTGLPNWEEWTLYAASVEVGDIQERSMNLFPRLERCTFTGCPKLRGLPESIYCAARLKTVVV
STSDQLSEVEFRRREIMEMDDCPDLFLARDSTELPHWLLDRIDKEKDEKNSVLPSRTVITVKANVIIIQQ
NRRVDAV


>XP_042405134.1 putative disease resistance RPP13-like protein 1 [Zingiber officinale]
MAMIPDLLVTRYLTKLTDFLEGEICKVIGVKEEIKKFKRRLERLSPYLQDAEQKRHQDNRVNIWLRDLKG
IVYDAEDIIELCTLHGGSELMSLQPSSSTLVSRPFTLLASCFACTKFRHEIAVSFERLNDRLKEIKDDSE
IIAGLVPLISHQRSQDHPTSQRLTTSLEVKADIVGAKIENDAQTLIRMILGMGGIGKTTMAHKIFHDERI
KNSFPTRVRIHVSKNYKGIELLKQLLKNAKGSDDEAQSIQELESKLVGALVNRFFLVLDDVWSVNAWRDV
VFEDEENENPELDEMATKILRKCDGLPLAIKLIAGVLISKKRTRRDWERVVESDSWRMRNNEDELPRALY
LSYEDLSSVLKQCFLCCASYVDVSFTADLVRLWIAEGLINAPNGELMEEVAEDYYKELVMRNLLQLDPRS
ADETHYSMHDLLRALGTNLIGDEALVISDGRVADTNPNPSTQIRRLWMSSKGDTLRLPGAVLEQKSLRVL
QLYDCPETKTIEDEAAALPALKNLRVLDVCDTQIERLPDFIFTNLLLLRYLDLDRTMIYEIPESIGRLAN
LQTLNIAECESLRSIPKAVTSLGMLRCLRVEGTPLTHLPRGMGSLTNLNHIEGFVVGHGDLPTNVDDGCD
MEELRSLSNLRYLTASKLERATLMAGPLVLENKPLLRHLSLSWTNREQRDDGEKEAAEKTCSGLLPPSSL
EELTLHNFPGRRFPNWMMSTSSGTSFPHLEFLILRNFPCCTELPPLGQLPRLKFLKIEEASAVRKVGPEF
LGVCFPQAVAFPRLEFLKFTGMPNWEEWTLYAASEEVGAIQERSLKLFSRLARCTFTGCPKLRGLPESIY
CAARLKTVVVSTRDQLSEVEFRRRETMEMDDCPDLILARDSTELPHWLLDRIDREREEKNSVLPSRTVIT
VKAHEIIIQQNRPVEAV


>XP_042405156.1 disease resistance protein RPS2-like [Zingiber officinale]
MRADVIKKMEGLPYDQAWELFLKNAGENVINSEPGITRLAKQIAEECAGVPLALITVGKVVSAKRSIEAW
NDVLKQLKKSHLPKVTGMKERDPMLAAFKLSYDNLEDDNMRARLLCCSLWPEDFEIHKDELIQCWIGLGL
IDEFDSINEAFDRGHSHIETLASASLLELIDEETTIMVKMHDVIRDMALWISSDCGSNQHKWIVVAHAGL
RQLEQKNEEWQVVERASFMHNELTCLPGQTATFPKLSVLMLQQNIFLHLIPKSFFRSLPVLTFLDLSYTM
IRELPREIIMLSELQHLNLNFTPIEALRIELSNLAKLKYLLLEGTHSLVQVPMGTIFNLPLLKLLNLYKS
KYSNLDELERCQGCRKNIGITLHSMTDLERLGSLSQLSSWKLQLQNMRGLAYSSQLFENIMSSHNTRQDL
ERLEIANVLTSGELIIARSNKDSTDGLESLRYMALINVYWQKITWKAVKPQTVFPNLHELTIDNCKILRN
ITWVLQLPNLSVLTVSNCGEMEELISCVESFANSSVGLRLLTLVGLPKLNCISRQPLNFPYLEWMHVISC
HKLRKLSFGAEICQNKLKSIVGEVDWWENTQWEDVNDKNSLDVYFKSDWFMEALESTVTITYAEQAMESM
QAMESTSTITDAELALKSTSSITYAEQAMESTSTITDAEQDWFTHVLKSTSSITYAEQAMESMPMMESTS
TITDEDWFMQALKSSSNITYDSK


>XP_042405157.1 disease resistance protein SUMM2-like [Zingiber officinale]
MATFDFGKLLDRIWDAASIYLARPRSRVVDLHRDAELLKAKLVDFNGAIDEAVRNGKTVTKETQLWKRRA
ETFVSEEVDDAIQRDYRAMRCLGGWSWNCVSINRIVTKKLKEVKELISQVDVSRVTVTQLLLPPASVELP
ISKNVVGMQSNLIQIVNQIRDENASVIGIYGMGGIGKTTLLKLIHNHEEISKLKFQHVVWIVASKGCKLQ
KLQTDLAKKVRLNLEDDESEDDRASKLCNFLKEKNCLLFLDDIWESYELYKLGMEQVPAENGKEQKRKVV
VSRRAASKYALK


>XP_042405172.1 disease resistance protein At4g27190-like [Zingiber officinale]
MGGVGKTALLEEIRRKVKEAEMFDLVIDVVVSQNPNIAQIQRDVADALGMSESSNKMLVTRLKQEKKVLI
MLDDVWAQLELVKEVGIPYQEHNGCKVILTSRSAELCNLMETDVSVEVATLSEEDSWQLFRMRAGQVLES
DDIEVVARKVAQECCGLPLAIVVVGRALRSYKDSRYWEEALSQLKQSVPSNIGNVEEKLYKSLELSYQNL
KSSELKQLFLYCCLFHKDYDISEEEVTRYAVGENLLSNISTLEEARGRVHFLLETLKLSCLLLDSKKPRC
VRLHGVVRDVAVYIGSKYDNHFLVKAGLHLRYWRERENFAAWDRISLMNNDLQEIPENPNCSKLVLLLLN
MNPITSLPTNFFENMVTLNVLDLSDTYITCLPLSSACLKKLGTLRLDRCKWLNDINVVGELKTLIILSLR
ECIQISALPENIVALVKLKLLDLSYCTSLPIPRNLIPKLTRLEELYFRGCNVTEALFIENSDVISFCTGV
VPPGSLHKLTTLETLDTIHSRLLPSDTFKKLKQLKIMGCPCLKHVFLPSIANEFQSLEKLEMKNNGSIET
IITDKEVCDLKKGAFPMLQQLLLIKLPRLGCFFIGEPAKTLDWPSLEYIHLSDCSNLARLPIGRESAQKL
KKLHVASLNDVIWFKTLKWKDNTTKSRFDIMNESDVLKAVQNVHAMIDKEVDNGVFYLTVLSVFPAIKLL
KAEYINHRV


>XP_042405322.1 putative disease resistance protein At5g47280 [Zingiber officinale]
MESFFAGEVATELIKELVKVIRGTYLCRPAAEQLKRSVDSLLPIVQEIRHSGVELPQNRQSQLSDLADHL
RLALDLARKAAASPRWNVYRSVQLARKMECIESWISRWIERHMPVHVLADVHHIRVDYAARLDRIERALS
VAASSPVVATASKVPMELGSASFSGFPLPKTMEGFAQPSAEPVKAPFAIGNKLSSGFPMMEQFFTSPDAR
KVPVAMGKSPSSGFRVANIMDGLMLAGEEVKPVGAGIRIGKEKVKEMLMEGSASDAVVGISGIGGSGKTT
LAREICKDPEIRSYFNDRIYSVTLSQSPNLESLKLKLWEQISGNMVLGAYNQIPKWQMELGAIDKGSFLI
ILDDVWSLSELEELIFRVPGCKILVVSRFKFPLVVKKTYEIELLGEEDALSLFCHAAFELKSVPFTIDKK
LVKQVVKECKGLPLALKVIGASLRDQPPKFWLRAKNKLSQGEAICESHENKLIERMSSSIEFLSVKVREC
FLDLGCFPEDKRIPIDVLINVWMELHDLDEEDAFAMLVELSNKNLLTLLKDAQSRAGDIYSSYVELSVTQ
HDLLRDLALYVNNQESLNTRRRLIMSKRENELPKEWERNKDQQFEAQIISINTGEMKESDWFQMHFPKAE
VLILSFCADVYFLPPFLSTMPKLRALILINYGTSCASLQNRTIFTSLINLRSLWLEKITVPPLPKTTVPL
RNLRKVSLILCELNDSLRGSKVDLSSTLPRLSHLSIDHCVDVTKLPPYICNITSLECLSISNCHDLSELP
CEFGKLSSLKILRVCACPSLKSLPQSICRLKGLKYLDISQSFNLRELPEELGYMMSLEKIDMRECSQLKT
LPRSSSSLKSLGHVICDEDIALLWKEAEIEIPDLRVQVAEESFNLDWLVE


>XP_042406451.1 putative disease resistance protein RGA3 [Zingiber officinale]
MAGGGFLSSMFTTMVAKLQSLASLSTISSSSSSPHNTIEQEMSKLTETMRRIQAKLDDSEEENHAKSHSE
KLWLSELKDVAYDAEDVVEEYEYEVLHSKQLHENNSGTHEDELANKAAEIRKRFDQITKEWKLLTLPKNV
GKRKRSPSPLDENRETGSLVVESDVLGREEEKDMLVKWLLSEDDTSVNKVSVIAVIGMGGLGKTTLAQLV
YNDQRVKSYFDLTRWVCVSENFHVVSLTEKILQSFAKVKVHEELDELQHALREKQQGKKFLLILDDVWNE
EFTLWDELRKPLASAQVVKVIVTTRNQSVARIMGTRSPLNLNCLPFDVCWQLFKRVTLGGADKSLQPHLE
DLGRKIVDKCKGLPLAVKVLGGALRNNEDIDSWEDFLQNEMWESEETNKGVLPALKISYDCMPIQLKRCF
QYLSLFPKDTGFDSEEIVRLWMSQGLLPLDGDKRAEDIGRSYIKRLAERSIIHLEWDDTFLMEWKYFLMH
DLVHDLAQYIAQDEYLCVMDNKFDTKKLQKFRHLSFNVECHKLNIEALPEPKLLRTLFMRQLDSWKYRLP
DDLFQKLKYIRTLVLNTYGIEELPYSLGNLKLLRYLSIKAYHVVSIPESICSLYNLQTLDLADTQISELP
RQIGNLINLRHLLLPYNFYDWESIFLSSRIGNMTNLQTLRCFNVSCEREHCNIGELNSLMELGGHISIYN
VASVNIFSNSKPPLKTKKYIDSLELRWMKYGWHDNDAFDYYTKDEKKAEWQLEYLEPHVNLKNLEIISYP
GIKFVGWVGASSFTKLTRLCVEDCKNCNKLPPLGQLPSLEYLFIGAMEGVQHVGREFCSMLMASPSSSQN
KIAFPSLKDLIFKDMTNWEAWDGVEIGDFPSLYSFKLSGCRRLIKFPRWPFLSSVEEMTLDSGGVPDVLN
FHSLTNLTVMSMTKKNSKWMSKCYFPTLQHLRLSFSTAKSVHLSQKVLPSLKTLEISNCPTLRVVAGLKN
LTSLNFLYIEVCPNLEFKGLPATLEQVKLYCCSLFEKGYKEQQHMPNDLMIEAHNSDDEEEEKEEMDVND
EEEEEEEEEEEEEAEEEMDGDDDDNMD


>XP_042406453.1 putative disease resistance RPP13-like protein 1 [Zingiber officinale]
MAGGGGFLSSMFTTMVAKLHSLASPSITSSSSSLPHNNIEREMSKLTETMRRIQAKLDDSEEENHAKSHS
EKLWLSELKDVAYDAEDVVEEYEYKVLRSKQLHEHNSGTYEDELANKAAEIRKRFDEITKEWKLLKLPKK
AGKRKRNPMLSEMNRETGSLVVESDVLGREEEKDVLVKWLLSDDTTGNGVSVIAVIGMGGLGKTTLAQLV
YNDQRVKSYFDLTGWVCVSENFHVVSLTEKILQSFTKVKVHEELDELQRALQEKLQGKRFLLVLDDVWND
NFCLWEQLKKPLLSAIAGKVIVTTRNHSVARIMQTTRDSLKLNVLPFDVCWSLFKKVTLGGADISLRPDL
EDIGRRIVEKCKGLPLAAKLIGGALRNDEDKDSWTDIIESEVWKLDDRNIEVLPALKISYDCMPIQLKRC
FQYLSFFRKDTCLSSKGIVQLWMPQGIFPLDGDKRAEDIGSDYIKRLVERSMLNPEEGSYFSMHDLVHYL
AQYVAQDECLCVIDDNFDRRKLQEIRHLSFDSENIKMIKDINLQQLKHLRTLLIRNGYWGRVFPRQDKFF
GVLDNLFQKLKYIRALGLNHTSVAELPDSLGNLKLLRYLSIENTHVRSLPESICNLYNLQILHAGSVFKL
PRHIGNLINLRHLWLSHQIDFLPSGIGNLTNLQTLSHFNISHEEEHCNIGELNSLMKLGGSISIDIIGYV
NNFSNSKFPLKTKKYLDSLKLCWYDWFDYADEKKAEWQLEYLEPHVNLKTLKITEYPGVKFVGWVGALSF
TKLTKLVLKDCKNCSKLPSLGQLPSLEELEIAGMDGVQHVGREFCSMLIPSPSSQVELNIWQMDGVQHVG
SGISSMLEPFSSSYKIAFPSLKLLLFSRMKNWKAWDGIQSGDFPNLHVIEIFKCSKLINFPKWSLLPSVK
EMVLVSCGALDVRCWFSLTNLTIGISSQEHSEWMSKSYFPILQHLILLNSKVESVRLSQKRIPSLKTLEI
SDCPTLRVVAGLKNLTSLNSLYIEACPNLEFKGLPATLKQVKLRRCSLFKKGLNEQQHMPNDLMIEAHNS
DDEDKEEEEEEEEEEMDVNDEEEEEEQEEMHVNDEEEGDGWRG


>XP_042406479.1 putative disease resistance RPP13-like protein 1 [Zingiber officinale]
MAGGGGVLSSMFTTMVAKLHGLASPSTISSSSSSPHNTIEQEMSKLTETMRRIQAKLDDSEEENCVKSHS
EELWLSELKGIAYDAEDVVEEYEYEVLRSKQLHENNSGAHEDELANKAAEIRKRFDEITKEWKLLKLPKN
AGKRKRSPVLLDMNRETGSLVVESDVLGREEEKDMLVKWLLSEDDDTTGNGVSVIAVIGMGGLGKTTLAQ
LVYNDQRVKSYFDLTGWVCVSENFHVVSLTEKILQSFTKVKVHEELDELQSALQEKLQGKRFLLVLDDVW
NDNFCLWEQLKKPLLSAIAGKVIVTTRNHSVARIMQTTRDSLKLNVLPFDVCWSLFKKVTLGGAERSLRP
DLEDIGRRIVEKCKGLPLAAKLMGGALRNEEDKESWTDIIESEIWKLDDRNIEVLPALQISYDCMPIQLK
RCFQYFSLFPKLKSVSSKRIVQLWMSQGIFPLDGDKTAEDIGSDYIKRLVERSMLNPKAGSYFWMHDLVH
DLAQYVAQDECLCVIDDNFDRKKLQEIRHLSFDSENIKVIKDINLQRLKLLRTVLLLRNPFEEMIFIPRP
AINSGVLEDLFEKLKYIRALSLHSIGIAELPDSLGNLKLLRYLSIENTHVRSLPESICNLYNLQILHAGT
VYILPRHIGNLINLRHLWLSRNVDFLPSGIGNLTNLQTLSHFNISHEEEHCPGGEYPLFCHHEEELCNI


>XP_042406480.1 putative disease resistance protein RGA3 [Zingiber officinale]
MAGGGGVFLSSMFTTMVAKLHGLASPSASSSSSSPHNNIEQEMSKLTETMRRIQAKLADSESEEENHAKS
HSEKLWLSELKDVAYDAEDVVEEYEYEVLRSKQLHENNSGAHEDELANKAAEIRKRFDEITKEWKLLKLP
KNTGKRKRNPMLLDMNRETGSLVVESDVLGREEEKYMLVKWLLSEDDTSVNKVSVIAVIGMGGLGKTTLA
QLVYNDQRVKSYFDLTGWVCVSENFHVVSLTEKILESFTKVEVHKELDGLQHALQEKLQGKRFLLILDDV
WNEEFTLWDELRKPLVSAQVSKVIVTTRNHRVAGIMGTRSPLDLKCLSFDVCWQLFKRVTLEGAYKRLQP
HLEELGRKIVDKCKGLPLAVKVLGGALRNNEDIDSWEKILENEMWELEETNNGVLPALKISYDCMPIQLK
RCFQYLSIFPKDTSLDSEEIVRLWMSQGLLPLDGDMRAEDISRNYIKRLVERSMLNSVEINVDSSFVMHD
LVHDLAQYITQDECLCVMDNKFDAKKLQKIRHLSVSVKYPHLLKPLETIKDLQQLKLMRTLFITGPGWPY
FMIRQYNFFKVLDDLFQKLKYIRALHLSKIDITKLPDSLGNLKLLRYLSIRSAKIRMLPESICNLYYLQT
LDLIATNVHEFPRKIGNLISLRHLLLPYHYKGAFFPSGIGNMTNLQTLRRFNVSCEKEHCDIGELNSLMK
LGGHISIYNVASVNIFSNSKPPLKTKMYIDSLELRWFAFDCSKKDEKNAEWQLQYLEPHVNLKTLQIFFY
PGVSFVGWVGSSSFIKLTSLSLNSCNNCNKLPPLGQLPSLEELEISRMDGIRHVGREFCSILMASPSSSQ
NKIAFPSLKDLIFRDMTNWEEWDGVEIGDFPSIHSIKLYGCPRLIKFPQWPFMSSVKKMTLDSGGVPDVS
CFPSLKHLEIIVRTQEYSEVMSKCYFPTLQHLILSYSKVESIHLSQRRLPSLKTLKIHDSKELRVVTGLK
NLTSLNSLIIEECPNLEFEELPATLAQVQLYRCRLFKKGFKEQKHMRNVLGEEEEEIENLLDFLLWIAEE
DDNNDGGEDMRNEGEEEDMEIDLELRLWND


>XP_042406481.1 putative disease resistance RPP13-like protein 1 isoform X1 [Zingiber officinale]
MAGGGFLSSIITMAVDKLHSLALPSTPSSSSSPHNNIEQEMSKLTETMRRVQAKLADSEEDNHVKSHSEK
LWLSELKEVAYDAEDLVEEYEYEVLRSKQLHGNNSGTHEGELANKAAEIRKRFDEITKEWKLLTLPKNAG
ERKRSPLTLVDNRETGSLVLESDVLGREEEKDMLVEWLLSEDDMTDNRVSVIAIIGMGGLGKTTLAQLVY
NDPKVKSYFNPRGWVCVSENFNVVNLTEKILQSFTEEKGKGEVKIPETLDGLQRALEENLLGKKFLLILD
DVWNEEFTLWYELRKPLVSAQVGKVIVTTRNQPVARIMGIRSPLDLNCLPFDVCWQLFKRVTLGGADQPH
LEDLGRKIVDKCKGLPLAVKVLGGALRNKEDIDSWEDILENKKWELEETNKGVLPALKISYDCMPIQLKR
CFQYLSLFPKHTRLHSEIIVRLWMSQGLLPLDEDDRDKRAEDKGRNYIERLAERSMIQLKWSDSFLMHNL
VHDLAQYIAQDECFCMMDNKFDTKKLQKIRHLSVSIEDPHLLKHLETITDQQLKLMRTLFIRVQDKSRGR
PFITRQDKNFGVLDDLFQNLKYIRALHLSQIGIRELPDTLGNLKLLNYLSIKDIAIKSIPESIHNLYNLQ
TLDLTQTNISELPRQIDNLINLRHLLLSHKVAFLPSGIGNLTNLQTLTHFNVGCGKKHCDIGELNSLMKL
GGHISIYNVALLHRSIATMPVNKFSNTKPTLKTKKYLDSLRLDWLREHDNFDRFKQDEKKAEQQLAYLQP
HVNLKFLEINNYPGVRFVEWVSDSSFTKLTRLILEDCKNCTKLPPLGQLRYLEYLDIRGMDGVQHVGREF
CSMLMASPSSSQNNMAFPSLTHLEFSSMPNWKGWDGVEIGDFPSLHFIEISKCSKLIKFPQWPFMSSVKE
MTLGNCGALDVLNLHLWTNLSIGIKTQEHSKWMSKCYFPTLQHLTLKSRVECVHLSQKRLPSLKTLEIQS
SEELRVIGGLEGLTSLTSLIIRNCFNLEFEKLPATLQQLRLSNCPLFHKGLEKQPHMLNVLREGEKRERE
ELIEFERRYPIIKDWSDAEQDNINRITWMSDHKDDKEYNGSKTARFLPSRRDSYRMKRSRFAAG


>XP_042406482.1 putative disease resistance RPP13-like protein 1 isoform X1 [Zingiber officinale]
MAGGGFLSSIITMAVDKLHSLALPSTPSSSSSPHNNIEQEMSKLTETMRRVQAKLADSEEDNHVKSHSEK
LWLSELKEVAYDAEDLVEEYEYEVLRSKQLHGNNSGTHEGELANKAAEIRKRFDEITKEWKLLTLPKNAG
ERKRSPLTLVDNRETGSLVLESDVLGREEEKDMLVEWLLSEDDMTDNRVSVIAIIGMGGLGKTTLAQLVY
NDPKVKSYFNPRGWVCVSENFNVVNLTEKILQSFTEEKGKGEVKIPETLDGLQRALEENLLGKKFLLILD
DVWNEEFTLWYELRKPLVSAQVGKVIVTTRNQPVARIMGIRSPLDLNCLPFDVCWQLFKRVTLGGADQPH
LEDLGRKIVDKCKGLPLAVKVLGGALRNKEDIDSWEDILENKKWELEETNKGVLPALKISYDCMPIQLKR
CFQYLSLFPKHTRLHSEIIVRLWMSQGLLPLDEDDRDKRAEDKGRNYIERLAERSMIQLKWSDSFLMHNL
VHDLAQYIAQDECFCMMDNKFDTKKLQKIRHLSVSIEDPHLLKHLETITDQQLKLMRTLFIRVQDKSRGR
PFITRQDKNFGVLDDLFQNLKYIRALHLSQIGIRELPDTLGNLKLLNYLSIKDIAIKSIPESIHNLYNLQ
TLDLTQTNISELPRQIDNLINLRHLLLSHKVAFLPSGIGNLTNLQTLTHFNVGCGKKHCDIGELNSLMKL
GGHISIYNVALLHRSIATMPVNKFSNTKPTLKTKKYLDSLRLDWLREHDNFDRFKQDEKKAEQQLAYLQP
HVNLKFLEINNYPGVRFVEWVSDSSFTKLTRLILEDCKNCTKLPPLGQLRYLEYLDIRGMDGVQHVGREF
CSMLMASPSSSQNNMAFPSLTHLEFSSMPNWKGWDGVEIGDFPSLHFIEISKCSKLIKFPQWPFMSSVKE
MTLGNCGALDVLNLHLWTNLSIGIKTQEHSKWMSKCYFPTLQHLTLKSRVECVHLSQKRLPSLKTLEIQS
SEELRVIGGLEGLTSLTSLIIRNCFNLEFEKLPATLQQLRLSNCPLFHKGLEKQPHMLNVLREGEKRERE
ELIEFERRYPIIKDWSDAEQDNINRITWMSDHKDDKEYNGSKTARFLPSRRDSYRMKRSRFAAG


>XP_042406483.1 putative disease resistance RPP13-like protein 1 isoform X1 [Zingiber officinale]
MAGGGFLSSIITMAVDKLHSLALPSTPSSSSSPHNNIEQEMSKLTETMRRVQAKLADSEEDNHVKSHSEK
LWLSELKEVAYDAEDLVEEYEYEVLRSKQLHGNNSGTHEGELANKAAEIRKRFDEITKEWKLLTLPKNAG
ERKRSPLTLVDNRETGSLVLESDVLGREEEKDMLVEWLLSEDDMTDNRVSVIAIIGMGGLGKTTLAQLVY
NDPKVKSYFNPRGWVCVSENFNVVNLTEKILQSFTEEKGKGEVKIPETLDGLQRALEENLLGKKFLLILD
DVWNEEFTLWYELRKPLVSAQVGKVIVTTRNQPVARIMGIRSPLDLNCLPFDVCWQLFKRVTLGGADQPH
LEDLGRKIVDKCKGLPLAVKVLGGALRNKEDIDSWEDILENKKWELEETNKGVLPALKISYDCMPIQLKR
CFQYLSLFPKHTRLHSEIIVRLWMSQGLLPLDEDDRDKRAEDKGRNYIERLAERSMIQLKWSDSFLMHNL
VHDLAQYIAQDECFCMMDNKFDTKKLQKIRHLSVSIEDPHLLKHLETITDQQLKLMRTLFIRVQDKSRGR
PFITRQDKNFGVLDDLFQNLKYIRALHLSQIGIRELPDTLGNLKLLNYLSIKDIAIKSIPESIHNLYNLQ
TLDLTQTNISELPRQIDNLINLRHLLLSHKVAFLPSGIGNLTNLQTLTHFNVGCGKKHCDIGELNSLMKL
GGHISIYNVALLHRSIATMPVNKFSNTKPTLKTKKYLDSLRLDWLREHDNFDRFKQDEKKAEQQLAYLQP
HVNLKFLEINNYPGVRFVEWVSDSSFTKLTRLILEDCKNCTKLPPLGQLRYLEYLDIRGMDGVQHVGREF
CSMLMASPSSSQNNMAFPSLTHLEFSSMPNWKGWDGVEIGDFPSLHFIEISKCSKLIKFPQWPFMSSVKE
MTLGNCGALDVLNLHLWTNLSIGIKTQEHSKWMSKCYFPTLQHLTLKSRVECVHLSQKRLPSLKTLEIQS
SEELRVIGGLEGLTSLTSLIIRNCFNLEFEKLPATLQQLRLSNCPLFHKGLEKQPHMLNVLREGEKRERE
ELIEFERRYPIIKDWSDAEQDNINRITWMSDHKDDKEYNGSKTARFLPSRRDSYRMKRSRFAAG


>XP_042406484.1 putative disease resistance RPP13-like protein 1 isoform X1 [Zingiber officinale]
MAGGGFLSSIITMAVDKLHSLALPSTPSSSSSPHNNIEQEMSKLTETMRRVQAKLADSEEDNHVKSHSEK
LWLSELKEVAYDAEDLVEEYEYEVLRSKQLHGNNSGTHEGELANKAAEIRKRFDEITKEWKLLTLPKNAG
ERKRSPLTLVDNRETGSLVLESDVLGREEEKDMLVEWLLSEDDMTDNRVSVIAIIGMGGLGKTTLAQLVY
NDPKVKSYFNPRGWVCVSENFNVVNLTEKILQSFTEEKGKGEVKIPETLDGLQRALEENLLGKKFLLILD
DVWNEEFTLWYELRKPLVSAQVGKVIVTTRNQPVARIMGIRSPLDLNCLPFDVCWQLFKRVTLGGADQPH
LEDLGRKIVDKCKGLPLAVKVLGGALRNKEDIDSWEDILENKKWELEETNKGVLPALKISYDCMPIQLKR
CFQYLSLFPKHTRLHSEIIVRLWMSQGLLPLDEDDRDKRAEDKGRNYIERLAERSMIQLKWSDSFLMHNL
VHDLAQYIAQDECFCMMDNKFDTKKLQKIRHLSVSIEDPHLLKHLETITDQQLKLMRTLFIRVQDKSRGR
PFITRQDKNFGVLDDLFQNLKYIRALHLSQIGIRELPDTLGNLKLLNYLSIKDIAIKSIPESIHNLYNLQ
TLDLTQTNISELPRQIDNLINLRHLLLSHKVAFLPSGIGNLTNLQTLTHFNVGCGKKHCDIGELNSLMKL
GGHISIYNVALLHRSIATMPVNKFSNTKPTLKTKKYLDSLRLDWLREHDNFDRFKQDEKKAEQQLAYLQP
HVNLKFLEINNYPGVRFVEWVSDSSFTKLTRLILEDCKNCTKLPPLGQLRYLEYLDIRGMDGVQHVGREF
CSMLMASPSSSQNNMAFPSLTHLEFSSMPNWKGWDGVEIGDFPSLHFIEISKCSKLIKFPQWPFMSSVKE
MTLGNCGALDVLNLHLWTNLSIGIKTQEHSKWMSKCYFPTLQHLTLKSRVECVHLSQKRLPSLKTLEIQS
SEELRVIGGLEGLTSLTSLIIRNCFNLEFEKLPATLQQLRLSNCPLFHKGLEKQPHMLNVLREGEKRERE
ELIEFERRYPIIKDWSDAEQDNINRITWMSDHKDDKEYNGSKTARFLPSRRDSYRMKRSRFAAG


>XP_042406485.1 putative disease resistance RPP13-like protein 1 isoform X1 [Zingiber officinale]
MAGGGFLSSIITMAVDKLHSLALPSTPSSSSSPHNNIEQEMSKLTETMRRVQAKLADSEEDNHVKSHSEK
LWLSELKEVAYDAEDLVEEYEYEVLRSKQLHGNNSGTHEGELANKAAEIRKRFDEITKEWKLLTLPKNAG
ERKRSPLTLVDNRETGSLVLESDVLGREEEKDMLVEWLLSEDDMTDNRVSVIAIIGMGGLGKTTLAQLVY
NDPKVKSYFNPRGWVCVSENFNVVNLTEKILQSFTEEKGKGEVKIPETLDGLQRALEENLLGKKFLLILD
DVWNEEFTLWYELRKPLVSAQVGKVIVTTRNQPVARIMGIRSPLDLNCLPFDVCWQLFKRVTLGGADQPH
LEDLGRKIVDKCKGLPLAVKVLGGALRNKEDIDSWEDILENKKWELEETNKGVLPALKISYDCMPIQLKR
CFQYLSLFPKHTRLHSEIIVRLWMSQGLLPLDEDDRDKRAEDKGRNYIERLAERSMIQLKWSDSFLMHNL
VHDLAQYIAQDECFCMMDNKFDTKKLQKIRHLSVSIEDPHLLKHLETITDQQLKLMRTLFIRVQDKSRGR
PFITRQDKNFGVLDDLFQNLKYIRALHLSQIGIRELPDTLGNLKLLNYLSIKDIAIKSIPESIHNLYNLQ
TLDLTQTNISELPRQIDNLINLRHLLLSHKVAFLPSGIGNLTNLQTLTHFNVGCGKKHCDIGELNSLMKL
GGHISIYNVALLHRSIATMPVNKFSNTKPTLKTKKYLDSLRLDWLREHDNFDRFKQDEKKAEQQLAYLQP
HVNLKFLEINNYPGVRFVEWVSDSSFTKLTRLILEDCKNCTKLPPLGQLRYLEYLDIRGMDGVQHVGREF
CSMLMASPSSSQNNMAFPSLTHLEFSSMPNWKGWDGVEIGDFPSLHFIEISKCSKLIKFPQWPFMSSVKE
MTLGNCGALDVLNLHLWTNLSIGIKTQEHSKWMSKCYFPTLQHLTLKSRVECVHLSQKRLPSLKTLEIQS
SEELRVIGGLEGLTSLTSLIIRNCFNLEFEKLPATLQQLRLSNCPLFHKGLEKQPHMLNVLREGEKRERE
ELIEFERRYPIIKDWSDAEQDNINRITWMSDHKDDKEYNGSKTARFLPSRRDSYRMKRSRFAAG


>XP_042406486.1 putative disease resistance RPP13-like protein 1 isoform X1 [Zingiber officinale]
MAGGGFLSSIITMAVDKLHSLALPSTPSSSSSPHNNIEQEMSKLTETMRRVQAKLADSEEDNHVKSHSEK
LWLSELKEVAYDAEDLVEEYEYEVLRSKQLHGNNSGTHEGELANKAAEIRKRFDEITKEWKLLTLPKNAG
ERKRSPLTLVDNRETGSLVLESDVLGREEEKDMLVEWLLSEDDMTDNRVSVIAIIGMGGLGKTTLAQLVY
NDPKVKSYFNPRGWVCVSENFNVVNLTEKILQSFTEEKGKGEVKIPETLDGLQRALEENLLGKKFLLILD
DVWNEEFTLWYELRKPLVSAQVGKVIVTTRNQPVARIMGIRSPLDLNCLPFDVCWQLFKRVTLGGADQPH
LEDLGRKIVDKCKGLPLAVKVLGGALRNKEDIDSWEDILENKKWELEETNKGVLPALKISYDCMPIQLKR
CFQYLSLFPKHTRLHSEIIVRLWMSQGLLPLDEDDRDKRAEDKGRNYIERLAERSMIQLKWSDSFLMHNL
VHDLAQYIAQDECFCMMDNKFDTKKLQKIRHLSVSIEDPHLLKHLETITDQQLKLMRTLFIRVQDKSRGR
PFITRQDKNFGVLDDLFQNLKYIRALHLSQIGIRELPDTLGNLKLLNYLSIKDIAIKSIPESIHNLYNLQ
TLDLTQTNISELPRQIDNLINLRHLLLSHKVAFLPSGIGNLTNLQTLTHFNVGCGKKHCDIGELNSLMKL
GGHISIYNVALLHRSIATMPVNKFSNTKPTLKTKKYLDSLRLDWLREHDNFDRFKQDEKKAEQQLAYLQP
HVNLKFLEINNYPGVRFVEWVSDSSFTKLTRLILEDCKNCTKLPPLGQLRYLEYLDIRGMDGVQHVGREF
CSMLMASPSSSQNNMAFPSLTHLEFSSMPNWKGWDGVEIGDFPSLHFIEISKCSKLIKFPQWPFMSSVKE
MTLGNCGALDVLNLHLWTNLSIGIKTQEHSKWMSKCYFPTLQHLTLKSRVECVHLSQKRLPSLKTLEIQS
SEELRVIGGLEGLTSLTSLIIRNCFNLEFEKLPATLQQLRLSNCPLFHKGLEKQPHMLNVLREGEKRERE
ELIEFERRYPIIKDWSDAEQDNINRITWMSDHKDDKEYNGSKTARFLPSRRDSYRMKRSRFAAG


>XP_042406487.1 putative disease resistance RPP13-like protein 1 isoform X2 [Zingiber officinale]
MAGGGFLSSIITMAVDKLHSLALPSTPSSSSSPHNNIEQEMSKLTETMRRVQAKLADSEEDNHVKSHSEK
LWLSELKEVAYDAEDLVEEYEYEVLRSKQLHGNNSGTHEGELANKAAEIRKRFDEITKEWKLLTLPKNAG
ERKRSPLTLVDNRETGSLVLESDVLGREEEKDMLVEWLLSEDDMTDNRVSVIAIIGMGGLGKTTLAQLVY
NDPKVKSYFNPRGWVCVSENFNVVNLTEKILQSFTEEKGKGEVKIPETLDGLQRALEENLLGKKFLLILD
DVWNEEFTLWYELRKPLVSAQVGKVIVTTRNQPVARIMGIRSPLDLNCLPFDVCWQLFKRVTLGGADQPH
LEDLGRKIVDKCKGLPLAVKVLGGALRNKEDIDSWEDILENKKWELEETNKGVLPALKISYDCMPIQLKR
CFQYLSLFPKHTRLHSEIIVRLWMSQGLLPLDEDDRDKRAEDKGRNYIERLAERSMIQLKWSDSFLMHNL
VHDLAQYIAQDECFCMMDNKFDTKKLQKIRHLSVSIEDPHLLKHLETITDQQLKLMRTLFIRVQDKSRGR
PFITRQDKNFGVLDDLFQNLKYIRALHLSQIGIRELPDTLGNLKLLNYLSIKDIAIKSIPESIHNLYNLQ
TLDLTQTNISELPRQIDNLINLRHLLLSHKVAFLPSGIGNLTNLQTLTHFNVGCGKKHCDIGELNSLMKL
GGHISIYNVALLHRSIATMPVNKFSNTKPTLKTKKYLDSLRLDWLREHDNFDRFKQDEKKAEQQLAYLQP
HVNLKFLEINNYPGVRFVEWVSDSSFTKLTRLILEDCKNCTKLPPLGQLRYLEYLDIRGMDGVQHVGREF
CSMLMASPSSSQNNMAFPSLTHLEFSSMPNWKGWDGVEIGDFPSLHFIEISKCSKLIKFPQWPFMSSVKE
MTLGNCGALDVLNLHLWTNLSIGIKTQEHSKWMSKCYFPTLQHLTLKSRVECVHLSQKRLPSLKTLEIQS
SEELRVIGGLEGLTSLTSLIIRNCFNLEFEKLPATLQQLRLSNCPLFHKGLEKQPHMLNVLRGREEGERR
AYRV


>XP_042406494.1 disease resistance protein RGA2-like [Zingiber officinale]
MAGGGGFLSSMFTTMVAKLHSLASPSITSSSLLHNNIEREMSRLTETMRRIQAKLADSEEENHAKSHWEK
LWLSELKDVAYDAEDVVEEYEYEVLRSKQLHENNSGAHEDELANKAAEIRKRFDEITKEWKLLKLPKKAG
KRKRSPMLSDMNRETGSLVVESDVLGRVDEKDMLVEWLLSEDDSTEDRVSVIAIIGMGGLGKTTLAQIVY
NDPRVENYFYPRGWVCVSENFDVVGLTEKILQSLVDEKVHKELDGLQHALGENLQGKGKVKVPEDLVVLQ
RALQENLQGKKFLLILDDVWNENFTLWDELRKPLLSAQVGKVIVTTRNRPVARIMETIFPLDLIAYHLMY
AGNCSRESLWEEQIRAYNHILKTSAER


>XP_042406707.1 disease resistance protein RPS2-like [Zingiber officinale]
MESIISILDSIFRPVVAFFTRTFGYAMSCEQYIESLQKEMGELRSKRDDVKREVDREARQGMEATNEVML
WLQNVERLEEEAARITDDFETHYANPAADDSRSKLVVSYHLSKRAEDACGEATVLKTKSHFNKVADRLMP
IRFEERPSALTVGMDSMIEQLRKACDDDVGVIGIHGMGGVGKTALLNRFNNEVLVQVAHLDVVISVKVTR
NFDVEKIQREIGDRIGLSWDERKSDDERSMVLFKVLSRMRFVLLLDDLWEPLDLSIVGIPTPTGASKIIL
TTRIEDVCDRMDARKMRMECLEWEDAWELFEKKAGRGLGTLLRGDPDIRRHAEDLAQRCGGLPLALITLG
RAMASKRTAKEWHHAVTTLANTPWHLLGMEESVLQPLKLSYDKLNDDRLKTFLLYASLLMNKMPMHNATV
INLCIGEGAINEFDDPEDAYSKGYHLLGVLKAASLLESSGDDYVQMHPFVHAMVSWIVCEHGKKDGKWLV
QVGTGLAEVPDYEKWEHAERVSLVSNEICSLPEDPYCPELLTLLLSRNYELSKIPNSFFLSMPRLKVLDL
SRTSIKELPPEIGKVLTLQHLDLYETNIASLPKELGNLVKLKSLLLSSTPLLKEIPHGVIARFTELRVLS
MNDSYGNWRVSSSGPGINFEELEGLKRLRYLDITLQNASTLQRLSRARRLSMSTRYLHIRGCLGLTTIHL
PSTSLGRYMKGLRGLRISQSSILEEIIVGGGSTIGEWSLLPNLHVLILQHLLKAKFVFRDRNFQNLRFLY
VWYCIGLEQLVKFEDELSEGQESEVITAFPHLKELHLASLPELKSLGGERVLAFPCLRVLEVKECPKLKE
LSITGEGLTQICCKQEWWDGLEWKDEKIKEALFPLFTPLQ


>XP_042408399.1 putative disease resistance protein At5g47280 [Zingiber officinale]
METFFVGDIAKELIKELLNVVRQTYLCRPAAEQLKCSVDSLLPIIQEIRLSGVELPQHRQKQLSELTDNL
RLALDLARKAAASPRWNVYRSMQLARKMERIDHWITRWLERQVPAHLLADVHHIRVDYAARLDRIERTLD
LTAASEVARGPVAFGTAPFSVFPETIEGFVPIRAPIAMWSPPATSCFPMPEMMEGLMMPTEAAAEAPVAM
GKSPSSRFPVAEIMEGLMLAGEGVKPVGVGIRVGKEKVKEMLMEGINRVAVVGISGIGGSGKTTLAREIC
RDPEIRSYFEDRIYFETLSQSQNLESLKLRLWEQISGNIVLGVYNQIPQWQMELVPKDKGPFLLVLDDVW
SVSELEELIFRVPGCKILVVSRFKFPAIVKSTYEMELLGEEDALSLFCHAAFEQKYIPSTVDQKLIKQVV
EECKGLPLALKVIGASLRDQPPKFWLRAKNKLARGETISESHENKVLERMASSIDFLSGKARECFLDLGS
FPEDKRIPLDVLINLWMELHDLDEEDAFAILVELSNKNLLTLLKDAQNRAGDIYSSYTELCVTQHDLLRD
LALHVNNQEPLNTRRRLIMPRREKELPKEWERFKDQQLEAQIVSFNTGEMNESDWFQMHFPKTEVLILNF
AADAYFLPPFLSVMPKLKTLILINYGASCTTLQNLSVFTSLSNLRSLWLEKIAVPPLPRTTVPLQNLRKV
TLVLCELTNSLRCSKVELSLTFPRLSHLAIDHCIDITKLPSAICDINSLECLSISNCHDLSELPCEFGKL
SSLGILRVYACPALKRLPQSICLLKGLKYLDISQSFNLQELPEELGHMTSLEKIDMRECSQLKTLPRSSS
SLKSLGHVICDEDIAFLWKEAEKDIPDLRIQVAEESFNLDWLVE


>XP_042408683.1 probable disease resistance protein At4g27220 isoform X1 [Zingiber officinale]
MTSVLAASYVVPIECLKLLWDPMTRHLVYIFHFRRKLRELERNKRIHASVMAHVSTEVGNAEIRGCICTD
EVIDWLRDADTAVAEAEDICSNAGSMMQNSSCFRFKIMMRYKLGKQILRASKFSFDVRLRKPENLFVPPP
PVAVLPYPTSLIKNNTSSSRALAKLWDFLQDDSIGKIGVWSMGGVGKTRLMRNLNNEFQGTKRFDVVIFI
TVSKNWNKDMQKLRTDIGKELYMELEKENEARALRLLCERLMKKKFLLILDDVWDKIDLENLGIPSPTEH
KGCKIAITTRQRGICNEMETDVEIMVEILPDKESWDLFYEKAGKNIPTTIENVARSVCRECSGLPLAIIT
VGSALRNEVHLDQWKRALRLLQKSNFRFENMKDRVFVPLKFSYDMLRDGQLKKCFLFVALFPEDHDIADQ
DLIEYWVMEGYIEGAESLGDAYQDAHRLLILLIDSCLLERSRKKDMVKMHDVIRDMAIKITSDSTEEGKR
FWVKAGMRLEELVETEDLKDKDKISLMENNIQLIGVDLYCPNASTLLVKGNVMLYDIPERFFQYMKLLSV
LDLSATSIEFLPESISVLVNLSALILKECARLKRIDRVQCLKKLRFLDMRESGIIELPEGMVHLTGLVYF
KISYTYRLQKIPAGLIAQFSHLEDLEMNQSFYLEGLQNPQEIIKQFKHLKCLNNLSLDLENDKLSSLLET
HCNLNNLASFYLRVGSVMATSKTEYVAKKEGPRKPERRGRCLDITGDAACKRLAKFANKLCVYQNRELRS
ISQLGLDNLECVEECWVWDCQEMWSIIISEEQKDNTYPHLQLLHLERLPKLSIIFSYNVAAAPSFFNLQK
IILCECNMIPFVFQEEMIDQLGCLEELDVSSCRILKRIIEGYFKRDGMCLPKLRCISFSQLGKLEQLWFS
DLSLPSLVDIKIRRCPNLRPPRLTNELAPTLLVIEAEEQWWESLPEDEIFKVRFASIFKPATMPHTIMKP
ATMPHRIMKPVTGSFTDIFQSVHASSSH


>XP_042408684.1 probable disease resistance protein At4g27220 isoform X1 [Zingiber officinale]
MTSVLAASYVVPIECLKLLWDPMTRHLVYIFHFRRKLRELERNKRIHASVMAHVSTEVGNAEIRGCICTD
EVIDWLRDADTAVAEAEDICSNAGSMMQNSSCFRFKIMMRYKLGKQILRASKFSFDVRLRKPENLFVPPP
PVAVLPYPTSLIKNNTSSSRALAKLWDFLQDDSIGKIGVWSMGGVGKTRLMRNLNNEFQGTKRFDVVIFI
TVSKNWNKDMQKLRTDIGKELYMELEKENEARALRLLCERLMKKKFLLILDDVWDKIDLENLGIPSPTEH
KGCKIAITTRQRGICNEMETDVEIMVEILPDKESWDLFYEKAGKNIPTTIENVARSVCRECSGLPLAIIT
VGSALRNEVHLDQWKRALRLLQKSNFRFENMKDRVFVPLKFSYDMLRDGQLKKCFLFVALFPEDHDIADQ
DLIEYWVMEGYIEGAESLGDAYQDAHRLLILLIDSCLLERSRKKDMVKMHDVIRDMAIKITSDSTEEGKR
FWVKAGMRLEELVETEDLKDKDKISLMENNIQLIGVDLYCPNASTLLVKGNVMLYDIPERFFQYMKLLSV
LDLSATSIEFLPESISVLVNLSALILKECARLKRIDRVQCLKKLRFLDMRESGIIELPEGMVHLTGLVYF
KISYTYRLQKIPAGLIAQFSHLEDLEMNQSFYLEGLQNPQEIIKQFKHLKCLNNLSLDLENDKLSSLLET
HCNLNNLASFYLRVGSVMATSKTEYVAKKEGPRKPERRGRCLDITGDAACKRLAKFANKLCVYQNRELRS
ISQLGLDNLECVEECWVWDCQEMWSIIISEEQKDNTYPHLQLLHLERLPKLSIIFSYNVAAAPSFFNLQK
IILCECNMIPFVFQEEMIDQLGCLEELDVSSCRILKRIIEGYFKRDGMCLPKLRCISFSQLGKLEQLWFS
DLSLPSLVDIKIRRCPNLRPPRLTNELAPTLLVIEAEEQWWESLPEDEIFKVRFASIFKPATMPHTIMKP
ATMPHRIMKPVTGSFTDIFQSVHASSSH


>XP_042408685.1 probable disease resistance protein At4g27220 isoform X1 [Zingiber officinale]
MTSVLAASYVVPIECLKLLWDPMTRHLVYIFHFRRKLRELERNKRIHASVMAHVSTEVGNAEIRGCICTD
EVIDWLRDADTAVAEAEDICSNAGSMMQNSSCFRFKIMMRYKLGKQILRASKFSFDVRLRKPENLFVPPP
PVAVLPYPTSLIKNNTSSSRALAKLWDFLQDDSIGKIGVWSMGGVGKTRLMRNLNNEFQGTKRFDVVIFI
TVSKNWNKDMQKLRTDIGKELYMELEKENEARALRLLCERLMKKKFLLILDDVWDKIDLENLGIPSPTEH
KGCKIAITTRQRGICNEMETDVEIMVEILPDKESWDLFYEKAGKNIPTTIENVARSVCRECSGLPLAIIT
VGSALRNEVHLDQWKRALRLLQKSNFRFENMKDRVFVPLKFSYDMLRDGQLKKCFLFVALFPEDHDIADQ
DLIEYWVMEGYIEGAESLGDAYQDAHRLLILLIDSCLLERSRKKDMVKMHDVIRDMAIKITSDSTEEGKR
FWVKAGMRLEELVETEDLKDKDKISLMENNIQLIGVDLYCPNASTLLVKGNVMLYDIPERFFQYMKLLSV
LDLSATSIEFLPESISVLVNLSALILKECARLKRIDRVQCLKKLRFLDMRESGIIELPEGMVHLTGLVYF
KISYTYRLQKIPAGLIAQFSHLEDLEMNQSFYLEGLQNPQEIIKQFKHLKCLNNLSLDLENDKLSSLLET
HCNLNNLASFYLRVGSVMATSKTEYVAKKEGPRKPERRGRCLDITGDAACKRLAKFANKLCVYQNRELRS
ISQLGLDNLECVEECWVWDCQEMWSIIISEEQKDNTYPHLQLLHLERLPKLSIIFSYNVAAAPSFFNLQK
IILCECNMIPFVFQEEMIDQLGCLEELDVSSCRILKRIIEGYFKRDGMCLPKLRCISFSQLGKLEQLWFS
DLSLPSLVDIKIRRCPNLRPPRLTNELAPTLLVIEAEEQWWESLPEDEIFKVRFASIFKPATMPHTIMKP
ATMPHRIMKPVTGSFTDIFQSVHASSSH


>XP_042408686.1 probable disease resistance protein At4g27220 isoform X1 [Zingiber officinale]
MTSVLAASYVVPIECLKLLWDPMTRHLVYIFHFRRKLRELERNKRIHASVMAHVSTEVGNAEIRGCICTD
EVIDWLRDADTAVAEAEDICSNAGSMMQNSSCFRFKIMMRYKLGKQILRASKFSFDVRLRKPENLFVPPP
PVAVLPYPTSLIKNNTSSSRALAKLWDFLQDDSIGKIGVWSMGGVGKTRLMRNLNNEFQGTKRFDVVIFI
TVSKNWNKDMQKLRTDIGKELYMELEKENEARALRLLCERLMKKKFLLILDDVWDKIDLENLGIPSPTEH
KGCKIAITTRQRGICNEMETDVEIMVEILPDKESWDLFYEKAGKNIPTTIENVARSVCRECSGLPLAIIT
VGSALRNEVHLDQWKRALRLLQKSNFRFENMKDRVFVPLKFSYDMLRDGQLKKCFLFVALFPEDHDIADQ
DLIEYWVMEGYIEGAESLGDAYQDAHRLLILLIDSCLLERSRKKDMVKMHDVIRDMAIKITSDSTEEGKR
FWVKAGMRLEELVETEDLKDKDKISLMENNIQLIGVDLYCPNASTLLVKGNVMLYDIPERFFQYMKLLSV
LDLSATSIEFLPESISVLVNLSALILKECARLKRIDRVQCLKKLRFLDMRESGIIELPEGMVHLTGLVYF
KISYTYRLQKIPAGLIAQFSHLEDLEMNQSFYLEGLQNPQEIIKQFKHLKCLNNLSLDLENDKLSSLLET
HCNLNNLASFYLRVGSVMATSKTEYVAKKEGPRKPERRGRCLDITGDAACKRLAKFANKLCVYQNRELRS
ISQLGLDNLECVEECWVWDCQEMWSIIISEEQKDNTYPHLQLLHLERLPKLSIIFSYNVAAAPSFFNLQK
IILCECNMIPFVFQEEMIDQLGCLEELDVSSCRILKRIIEGYFKRDGMCLPKLRCISFSQLGKLEQLWFS
DLSLPSLVDIKIRRCPNLRPPRLTNELAPTLLVIEAEEQWWESLPEDEIFKVRFASIFKPATMPHTIMKP
ATMPHRIMKPVTGSFTDIFQSVHASSSH


>XP_042408687.1 probable disease resistance protein At4g27220 isoform X1 [Zingiber officinale]
MTSVLAASYVVPIECLKLLWDPMTRHLVYIFHFRRKLRELERNKRIHASVMAHVSTEVGNAEIRGCICTD
EVIDWLRDADTAVAEAEDICSNAGSMMQNSSCFRFKIMMRYKLGKQILRASKFSFDVRLRKPENLFVPPP
PVAVLPYPTSLIKNNTSSSRALAKLWDFLQDDSIGKIGVWSMGGVGKTRLMRNLNNEFQGTKRFDVVIFI
TVSKNWNKDMQKLRTDIGKELYMELEKENEARALRLLCERLMKKKFLLILDDVWDKIDLENLGIPSPTEH
KGCKIAITTRQRGICNEMETDVEIMVEILPDKESWDLFYEKAGKNIPTTIENVARSVCRECSGLPLAIIT
VGSALRNEVHLDQWKRALRLLQKSNFRFENMKDRVFVPLKFSYDMLRDGQLKKCFLFVALFPEDHDIADQ
DLIEYWVMEGYIEGAESLGDAYQDAHRLLILLIDSCLLERSRKKDMVKMHDVIRDMAIKITSDSTEEGKR
FWVKAGMRLEELVETEDLKDKDKISLMENNIQLIGVDLYCPNASTLLVKGNVMLYDIPERFFQYMKLLSV
LDLSATSIEFLPESISVLVNLSALILKECARLKRIDRVQCLKKLRFLDMRESGIIELPEGMVHLTGLVYF
KISYTYRLQKIPAGLIAQFSHLEDLEMNQSFYLEGLQNPQEIIKQFKHLKCLNNLSLDLENDKLSSLLET
HCNLNNLASFYLRVGSVMATSKTEYVAKKEGPRKPERRGRCLDITGDAACKRLAKFANKLCVYQNRELRS
ISQLGLDNLECVEECWVWDCQEMWSIIISEEQKDNTYPHLQLLHLERLPKLSIIFSYNVAAAPSFFNLQK
IILCECNMIPFVFQEEMIDQLGCLEELDVSSCRILKRIIEGYFKRDGMCLPKLRCISFSQLGKLEQLWFS
DLSLPSLVDIKIRRCPNLRPPRLTNELAPTLLVIEAEEQWWESLPEDEIFKVRFASIFKPATMPHTIMKP
ATMPHRIMKPVTGSFTDIFQSVHASSSH


>XP_042408688.1 probable disease resistance protein At4g27220 isoform X1 [Zingiber officinale]
MTSVLAASYVVPIECLKLLWDPMTRHLVYIFHFRRKLRELERNKRIHASVMAHVSTEVGNAEIRGCICTD
EVIDWLRDADTAVAEAEDICSNAGSMMQNSSCFRFKIMMRYKLGKQILRASKFSFDVRLRKPENLFVPPP
PVAVLPYPTSLIKNNTSSSRALAKLWDFLQDDSIGKIGVWSMGGVGKTRLMRNLNNEFQGTKRFDVVIFI
TVSKNWNKDMQKLRTDIGKELYMELEKENEARALRLLCERLMKKKFLLILDDVWDKIDLENLGIPSPTEH
KGCKIAITTRQRGICNEMETDVEIMVEILPDKESWDLFYEKAGKNIPTTIENVARSVCRECSGLPLAIIT
VGSALRNEVHLDQWKRALRLLQKSNFRFENMKDRVFVPLKFSYDMLRDGQLKKCFLFVALFPEDHDIADQ
DLIEYWVMEGYIEGAESLGDAYQDAHRLLILLIDSCLLERSRKKDMVKMHDVIRDMAIKITSDSTEEGKR
FWVKAGMRLEELVETEDLKDKDKISLMENNIQLIGVDLYCPNASTLLVKGNVMLYDIPERFFQYMKLLSV
LDLSATSIEFLPESISVLVNLSALILKECARLKRIDRVQCLKKLRFLDMRESGIIELPEGMVHLTGLVYF
KISYTYRLQKIPAGLIAQFSHLEDLEMNQSFYLEGLQNPQEIIKQFKHLKCLNNLSLDLENDKLSSLLET
HCNLNNLASFYLRVGSVMATSKTEYVAKKEGPRKPERRGRCLDITGDAACKRLAKFANKLCVYQNRELRS
ISQLGLDNLECVEECWVWDCQEMWSIIISEEQKDNTYPHLQLLHLERLPKLSIIFSYNVAAAPSFFNLQK
IILCECNMIPFVFQEEMIDQLGCLEELDVSSCRILKRIIEGYFKRDGMCLPKLRCISFSQLGKLEQLWFS
DLSLPSLVDIKIRRCPNLRPPRLTNELAPTLLVIEAEEQWWESLPEDEIFKVRFASIFKPATMPHTIMKP
ATMPHRIMKPVTGSFTDIFQSVHASSSH


>XP_042408689.1 probable disease resistance protein At4g27220 isoform X1 [Zingiber officinale]
MTSVLAASYVVPIECLKLLWDPMTRHLVYIFHFRRKLRELERNKRIHASVMAHVSTEVGNAEIRGCICTD
EVIDWLRDADTAVAEAEDICSNAGSMMQNSSCFRFKIMMRYKLGKQILRASKFSFDVRLRKPENLFVPPP
PVAVLPYPTSLIKNNTSSSRALAKLWDFLQDDSIGKIGVWSMGGVGKTRLMRNLNNEFQGTKRFDVVIFI
TVSKNWNKDMQKLRTDIGKELYMELEKENEARALRLLCERLMKKKFLLILDDVWDKIDLENLGIPSPTEH
KGCKIAITTRQRGICNEMETDVEIMVEILPDKESWDLFYEKAGKNIPTTIENVARSVCRECSGLPLAIIT
VGSALRNEVHLDQWKRALRLLQKSNFRFENMKDRVFVPLKFSYDMLRDGQLKKCFLFVALFPEDHDIADQ
DLIEYWVMEGYIEGAESLGDAYQDAHRLLILLIDSCLLERSRKKDMVKMHDVIRDMAIKITSDSTEEGKR
FWVKAGMRLEELVETEDLKDKDKISLMENNIQLIGVDLYCPNASTLLVKGNVMLYDIPERFFQYMKLLSV
LDLSATSIEFLPESISVLVNLSALILKECARLKRIDRVQCLKKLRFLDMRESGIIELPEGMVHLTGLVYF
KISYTYRLQKIPAGLIAQFSHLEDLEMNQSFYLEGLQNPQEIIKQFKHLKCLNNLSLDLENDKLSSLLET
HCNLNNLASFYLRVGSVMATSKTEYVAKKEGPRKPERRGRCLDITGDAACKRLAKFANKLCVYQNRELRS
ISQLGLDNLECVEECWVWDCQEMWSIIISEEQKDNTYPHLQLLHLERLPKLSIIFSYNVAAAPSFFNLQK
IILCECNMIPFVFQEEMIDQLGCLEELDVSSCRILKRIIEGYFKRDGMCLPKLRCISFSQLGKLEQLWFS
DLSLPSLVDIKIRRCPNLRPPRLTNELAPTLLVIEAEEQWWESLPEDEIFKVRFASIFKPATMPHTIMKP
ATMPHRIMKPVTGSFTDIFQSVHASSSH


>XP_042408691.1 probable disease resistance protein At4g27220 isoform X2 [Zingiber officinale]
MTSVLAASYVVPIECLKLLWDPMTRHLVYIFHFRRKLRELERNKRIHASVMAHVSTEVGNAEIRGCICTD
EVIDWLRDADTAVAEAEDICSNAGSMMQNSSCFRFKIMMRYKLGKQILRASKFSFDVRLRKPENLFVPPP
PVAVLPYPTSLIKNNTSSSRALAKLWDFLQDDSIGKIGVWSMGGVGKTRLMRNLNNEFQGTKRFDVVIFI
TVSKNWNKDMQKLRTDIGKELYMELEKENEARALRLLCERLMKKKFLLILDDVWDKIDLENLGIPSPTEH
KGCKIAITTRQRGICNEMETDVEIMVEILPDKESWDLFYEKAGKNIPTTIENVARSVCRECSGLPLAIIT
VGSALRNEVHLDQWKRALRLLQKSNFRFENMKDRVFVPLKFSYDMLRDGQLKKCFLFVALFPEDHDIADQ
DLIEYWVMEGYIEGAESLGDAYQDAHRLLILLIDSCLLERSRKKDMVKMHDVIRDMAIKITSDSTEEGKR
FWVKAGMRLEELVETEDLKDKDKISLMENNIQLIGVDLYCPNASTLLVKGNVMLYDIPERFFQYMKLLSV
LDLSATSIEFLPESISVLVNLSALILKECARLKRIDRVQCLKKLRFLDMRESGIIELPEGMVHLTGLVYF
KISYTYRLQKIPAGLIAQFSHLEDLEMNQSFYLEGLQNPQEIIKQFKHLKCLNNLSLDLENDKLSSLLET
HCNLNNLASFYLRVGSVMATSKTEYVAKKEGPRKPERRGRCLDITGDAACKRLAKFANKLCVYQNRELRS
ISQLGLDNLECVEECWVWDCQEMWSIIISEEQKDNTYPHLQLLHLERLPKLSIIFSYNVAAAPSFFNLQK
IILCECNMIPFVFQEEMIDQLGCLEELDVSSCRILKRIIEGYFKRDGMCLPKLRCISFSQLGKLEQLWFS
DLSLPSLVDIKIRRCPNLRPPRLTNELAPTLLVIEAEEQWWESLPEDEIFKNHEASNW


>XP_042408692.1 probable disease resistance protein At4g27220 isoform X2 [Zingiber officinale]
MTSVLAASYVVPIECLKLLWDPMTRHLVYIFHFRRKLRELERNKRIHASVMAHVSTEVGNAEIRGCICTD
EVIDWLRDADTAVAEAEDICSNAGSMMQNSSCFRFKIMMRYKLGKQILRASKFSFDVRLRKPENLFVPPP
PVAVLPYPTSLIKNNTSSSRALAKLWDFLQDDSIGKIGVWSMGGVGKTRLMRNLNNEFQGTKRFDVVIFI
TVSKNWNKDMQKLRTDIGKELYMELEKENEARALRLLCERLMKKKFLLILDDVWDKIDLENLGIPSPTEH
KGCKIAITTRQRGICNEMETDVEIMVEILPDKESWDLFYEKAGKNIPTTIENVARSVCRECSGLPLAIIT
VGSALRNEVHLDQWKRALRLLQKSNFRFENMKDRVFVPLKFSYDMLRDGQLKKCFLFVALFPEDHDIADQ
DLIEYWVMEGYIEGAESLGDAYQDAHRLLILLIDSCLLERSRKKDMVKMHDVIRDMAIKITSDSTEEGKR
FWVKAGMRLEELVETEDLKDKDKISLMENNIQLIGVDLYCPNASTLLVKGNVMLYDIPERFFQYMKLLSV
LDLSATSIEFLPESISVLVNLSALILKECARLKRIDRVQCLKKLRFLDMRESGIIELPEGMVHLTGLVYF
KISYTYRLQKIPAGLIAQFSHLEDLEMNQSFYLEGLQNPQEIIKQFKHLKCLNNLSLDLENDKLSSLLET
HCNLNNLASFYLRVGSVMATSKTEYVAKKEGPRKPERRGRCLDITGDAACKRLAKFANKLCVYQNRELRS
ISQLGLDNLECVEECWVWDCQEMWSIIISEEQKDNTYPHLQLLHLERLPKLSIIFSYNVAAAPSFFNLQK
IILCECNMIPFVFQEEMIDQLGCLEELDVSSCRILKRIIEGYFKRDGMCLPKLRCISFSQLGKLEQLWFS
DLSLPSLVDIKIRRCPNLRPPRLTNELAPTLLVIEAEEQWWESLPEDEIFKNHEASNW


>XP_042408694.1 probable disease resistance protein At4g27220 [Zingiber officinale]
MDSVPVACLKLLWDPMSHQLAYIFGFSQKLRQLEMNKGILTSAKADVLREIENAEIRGYIRTDGVICWLH
DADMAVAEAEEICSKARRMKNSACFGIKIVTRYKLGKQIVRASSFSSDVQGRTSMNFFVPPPPVVPPPVA
ELHYPTSQIKNNTSSSRTLKKLRNFLQDDAIGKIGVWGMGGVGKTRLMINLNNEHQGTKCFDVVIFETIS
KNWNKDVKKLRNNIGKWVYLELEKENERKASGVLYTRLKQKKFLLILDDVWDNIDLENLGISSPTEHNGS
KIVIATRQKWICNEMETDVEIMVKILPDEESWNLFYEKAGGNIHSRIGNVARSVCRECRGLPLAIITVGS
ALRKEVHLDQWERALRLLRESNFGVENMEDSVFVPLKFSYDMLRDDQLKKCFLFAALFPEDHDIAVQELI
QYWVMEGYIDGAKSLRDAYQDAHRLLILLIDSCLIERSRKKDMVKMHDLIRDMAIKITTDSTEEGKRFWV
KAGMGLEKLVDTEDLKDKDKISLMENDIQLIEVDLNCPNASTLLVKGNASLYEIPEGFFQHMKLLSVLDL
SATSIEFLPESISVLVNLSALILKECPHLRSIDRVQLLKKLRFLDMRESGIIELPEGMVCLTQLVYFNIS
CTYRLKKIPAGLIAKFSRLEDLEMNRSFYLRGLQNAKEIIEELEHLKRLNNLSLDLENQRLSFLLEKHCN
WNNLTSFYLRVGSVMAPIEYVEKKEEGPREPERRRGRCLDITSNAFACRRLLKYANKLCVYQNTKLCSIS
ELGLDNLECVEECWVWECEEMEFIIISEVGKENTYPHLQLLHLEHLPRLVSIFSYHNVVAAPSFFNLRKI
NLCKCNMIQFVFEEEMISQLGCLEELEVYGCPYLNMIIEDYSERDGMCLPKLRCISLSELKMLEELWLIN
LSLPSLVEIKIHQCPKLKPPRLTNELAPTLQVIEAEERWWESLPENEIFKLHFASIFKPSTKLYRESDQS
GKGVQSTNTQASSSH


>XP_042409298.1 disease resistance protein RGA2-like [Zingiber officinale]
MEGALVAAARFVADKVAILVQLDAKLKAMTGIEEKMEKLKEMSTIIDLVIEDVESHPLNKDAVKDLLRKL
KYLAYDLEDAVDYYDTKVFQKKQRSNTSFGLVSDFISSDNQVLFNSRVGCMIEAVTDSLDSILLQKSILL
NLPQSSSHLSLYPYSETHSLNGFDVIGREPEKNNIVNILTNDDDEGSSHSTLRVIAIVGMGGLGKTTLAQ
LVFNDEMVQDHFASLTMWKVVGAEFNPTKIMKSILELATGEPGNISEIDLVKQKLKKELSGKRFLLVLDD
VWNEDPVKWRILKAALTFGARGSKILVTTRSQQVSSIMDSSYIHQIKQLSQTDCLILFQNFAFGDKEENR
TLMEIGAKIVEKCGGVPLAVISLGNTLRNTGDETYWSSVLNSEIMQLRYMEEKVLAVLKWSYDTLPPRSK
KCFAFASLYPKNSRMKKDELIKLWIANGFVRSEKSFDAETLANDVFDDLVRRSFFLLAPSRNFKYFSYGT
EYTMHDLMHDLARSVSANVYWHSEQDSVEDIGNRTYHLQIYIRGESCMTQVLDKKPLNLRTFMPFRFYRQ
SYLSINLLQVISDSELKFLRALDLSSSGISEVPTSIGNLIHLRYLNLYNNGIEVLPDSITLLSNLQYLNL
ILNFNFRELPKELGNMQNLRVLDLQRHHSQIDIHMPCGLSRLTNLRSLPVFFAGNRTGACSILELENLKL
HGEMQIKFSKDFKNYSCGGKKILKNKDLNDLLIEFNNLERYDKDMLDDLCPDTSLKELIIKNYGSPQFPT
WLMELQLPNLVEVCLENCGGCEHIPPFGNLQFLEKLVLTAMDVITDLGAEFHGYRSFPSRQELILNRMNN
LEEWPDSHDGDNQLFPKLHSLHIFDCPKLNAEISYNPRAYYNQL


>XP_042409335.1 putative disease resistance protein RGA3 isoform X1 [Zingiber officinale]
MAGALVGATAGFFANKVAILVELDEKLKAMAGTKRKIEKFKELLTNTDSVIQNVESRPSINPDVKELLKK
LKYLAYDLEDVVDYYDTKVLQKKQRSNTALRPVRDFFSPNNQVVFKSRIGSMIKAITESLESILLQKSIL
LNLPPGMSQPSPYRENHSRNRFVVKGREPEKQMIVNMLIDDDESSHDTVKVIAIVGMGGLGKTTLAQLVY
NDQRVQDHFASPTMWTVVGAEFDPANIMKSVLELTTEATVNISEIDLVRQKLEKALSGKRFLLVLDDVWN
EDQEKWDVLKATLICGAKGSKILVTTRSQNVSSIMGSSNTTTHQIQQLSKDDCLSLFQQFAFGDNEADDH
QNLMEIGGKIVEKCGGVPLAAKSLGSMLRGTRDETYWSSVLKSEIWQLRDEEQKVLAVLKLSYDVLSPQS
KKCFTFGSLFPKDYPMRKDELIKLWIANDFVRSEGNFDAETNGNHIFDDLVRRSFFLLDLFEDDPNVANI
TMHDLMHDLARSESAYAYWNSYQDSVEVIQKRAYHLQVVEGKLPDMTQVFGKKPLYLRTFMSLMPRYSSS
LSINLLEVFSKLKYLRALDLTGCGIRKISASIENLIHLRYLNLYYNTIEVLPDSITYLSNLQYLNLGFNH
ELRELPKELGNMQNLRELDLVMDNRLIHIPCGLSRLTNLRSLPVFIASDKTGACSIRELEDLKLQGEMII
KFSDDFKNYSCSGRKILKNKVLNKLLIEFNGSGSYHKDMLDDLSPNTTLKKLHISNYTSPQFPTWMKELQ
LPNLVEVHLHCSCGHIPPPFRNLQSLKRLTFSMHGITHLGAEFHGSGGFPSLQELKLSRMDDLQEWSESH
VDDQLFPSLRWLHIFRCPNLKSTPRLPTLRHLEILCCSQSILSCIGRLTSLSFLRVHSIYGVTSLPSGCI
RNLTSLTELQIISCRQLQSLPGDEMQYLQMLRSLTIEGCINLASFPSEVGSLTSLCRLQLSQCPSIILQP
EEFVRILNSVDEFQIQICGDNVNLCGRLQYLRMLEKLSLYGARYRAPLTWYTNQYKKSQLRICCCNELES
LMTAEPANNIVLEELYICGIYNLKTLPDWLQHLKFLRLLSVENCPLLETVPRGLKNLHMLETLKIANCPL
LESRCERETGVDWPIISHVRNVYVRSSAGHGEEVEDEDWADMKTEQMKTRHEIIVASYEIL


>XP_042409337.1 putative disease resistance protein RGA3 isoform X2 [Zingiber officinale]
MSQPSPYRENHSRNRFVVKGREPEKQMIVNMLIDDDESSHDTVKVIAIVGMGGLGKTTLAQLVYNDQRVQ
DHFASPTMWTVVGAEFDPANIMKSVLELTTEATVNISEIDLVRQKLEKALSGKRFLLVLDDVWNEDQEKW
DVLKATLICGAKGSKILVTTRSQNVSSIMGSSNTTTHQIQQLSKDDCLSLFQQFAFGDNEADDHQNLMEI
GGKIVEKCGGVPLAAKSLGSMLRGTRDETYWSSVLKSEIWQLRDEEQKVLAVLKLSYDVLSPQSKKCFTF
GSLFPKDYPMRKDELIKLWIANDFVRSEGNFDAETNGNHIFDDLVRRSFFLLDLFEDDPNVANITMHDLM
HDLARSESAYAYWNSYQDSVEVIQKRAYHLQVVEGKLPDMTQVFGKKPLYLRTFMSLMPRYSSSLSINLL
EVFSKLKYLRALDLTGCGIRKISASIENLIHLRYLNLYYNTIEVLPDSITYLSNLQYLNLGFNHELRELP
KELGNMQNLRELDLVMDNRLIHIPCGLSRLTNLRSLPVFIASDKTGACSIRELEDLKLQGEMIIKFSDDF
KNYSCSGRKILKNKVLNKLLIEFNGSGSYHKDMLDDLSPNTTLKKLHISNYTSPQFPTWMKELQLPNLVE
VHLHCSCGHIPPPFRNLQSLKRLTFSMHGITHLGAEFHGSGGFPSLQELKLSRMDDLQEWSESHVDDQLF
PSLRWLHIFRCPNLKSTPRLPTLRHLEILCCSQSILSCIGRLTSLSFLRVHSIYGVTSLPSGCIRNLTSL
TELQIISCRQLQSLPGDEMQYLQMLRSLTIEGCINLASFPSEVGSLTSLCRLQLSQCPSIILQPEEFVRI
LNSVDEFQIQICGDNVNLCGRLQYLRMLEKLSLYGARYRAPLTWYTNQYKKSQLRICCCNELESLMTAEP
ANNIVLEELYICGIYNLKTLPDWLQHLKFLRLLSVENCPLLETVPRGLKNLHMLETLKIANCPLLESRCE
RETGVDWPIISHVRNVYVRSSAGHGEEVEDEDWADMKTEQMKTRHEIIVASYEIL


>XP_042409338.1 putative disease resistance protein RGA3 isoform X3 [Zingiber officinale]
MAGALVGATAGFFANKVAILVELDEKLKAMAGTKRKIEKFKELLTNTDSVIQNVESRPSINPDVKELLKK
LKYLAYDLEDVVDYYDTKVLQKKQRSNTALRPVRDFFSPNNQVVFKSRIGSMIKAITESLESILLQKSIL
LNLPPGMSQPSPYRENHSRNRFVVKGREPEKQMIVNMLIDDDESSHDTVKVIAIVGMGGLGKTTLAQLVY
NDQRVQDHFASPTMWTVVGAEFDPANIMKSVLELTTEATVNISEIDLVRQKLEKALSGKRFLLVLDDVWN
EDQEKWDVLKATLICGAKGSKILVTTRSQNVSSIMGSSNTTTHQIQQLSKDDCLSLFQQFAFGDNEADDH
QNLMEIGGKIVEKCGGVPLAAKSLGSMLRGTRDETYWSSVLKSEIWQLRDEEQKVLAVLKLSYDVLSPQS
KKCFTFGSLFPKDYPMRKDELIKLWIANDFVRSEGNFDAETNGNHIFDDLVRRSFFLLDLFEDDPNVANI
TMHDLMHDLARSESAYAYWNSYQDSVEVIQKRAYHLQVVEGKLPDMTQVFGKKPLYLRTFMSLMPRYSSS
LSINLLEVFSKLKYLRALDLTGCGIRKISASIENLIHLRYLNLYYNTIEVLPDSITYLSNLQYLNLGFNH
ELRELPKELGNMQNLRELDLVMDNRLIHIPCGLSRLTNLRSLPVFIASDKTGACSIRELEDLKLQGEMII
KFSDDFKNYSCSGRKILKNKVLNKLLIEFNGSGSYHKDMLDDLSPNTTLKKLHISNYTSPQFPTWMKELQ
LPNLVEVHLHCSCGHIPPPFRNLQSLKRLTFSMHGITHLGAEFHGSGGFPSLQELKLSRMDDLQEWSESH
VDDQLFPSLRWLHIFRCPNLKSTPRLPTLRHLEILCCSQSILSCIDNSNLFLGMKCSTFKCFVH


>XP_042409339.1 putative disease resistance protein RGA3 isoform X4 [Zingiber officinale]
MAGALVGATAGFFANKVAILVELDEKLKAMAGTKRKIEKFKELLTNTDSVIQNVESRPSINPDVKELLKK
LKYLAYDLEDVVDYYDTKVLQKKQRSNTALRPVRDFFSPNNQVVFKSRIGSMIKAITESLESILLQKSIL
LNLPPGMSQPSPYRENHSRNRFVVKGREPEKQMIVNMLIDDDESSHDTVKVIAIVGMGGLGKTTLAQLVY
NDQRVQDHFASPTMWTVVGAEFDPANIMKSVLELTTEATVNISEIDLVRQKLEKALSGKRFLLVLDDVWN
EDQEKWDVLKATLICGAKGSKILVTTRSQNVSSIMGSSNTTTHQIQQLSKDDCLSLFQQFAFGDNEADDH
QNLMEIGGKIVEKCGGVPLAAKSLGSMLRGTRDETYWSSVLKSEIWQLRDEEQKVLAVLKLSYDVLSPQS
KKCFTFGSLFPKDYPMRKDELIKLWIANDFVRSEGNFDAETNGNHIFDDLVRRSFFLLDLFEDDPNVANI
TMHDLMHDLARSESAYAYWNSYQDSVEVIQKRAYHLQVVEGKLPDMTQVFGKKPLYLRTFMSLMPRYSSS
LSINLLEVFSKLKYLRALDLTGCGIRKISASIENLIHLSISISVSITNFESYQKS


>XP_042409344.1 putative disease resistance protein RGA3 [Zingiber officinale]
MEAALVTAASRFMVQNVSDLLQLDEKLKAITASNKTKMKKLKELSAIIDAVIQDVDSRPFIDAAVKNLLT
KLKYLAYDLEDVVDYYDTTVSQKKQRSNTSLRPVRDFFSPNNQVVFKSRIGGMIKAITESLDSILLQKSV
LLDLPQSKSEPRLYRETHSRNSFVVIGREPERNKIVDLLTKDDDDESNHGTVKVIAIAGMGGLGKTTLAQ
HVFDDERVKAQFENSRMWTVVGAEFDPAKVMKSVLEAATDAPVNISQIDSVRQNIEKALSGRKFLLVLDD
VWNEDPLKWGILKAALTCGVRGSKILLTTRNQQVSKIMGSSNTTHQLQQLSQDDCLSLFQQFAFGDEAVD
QKLVKIGEKIVEKCGGVPLAAISLGNMLRGTRDETYWSSVLKSEIWQLRDEEDKVLAILKLSYDTLLPRS
KKCFAFASLFSKNYKMAKDELIKLWIANDFVRSDKNFMLRQLATTSLMNL


>XP_042409346.1 putative disease resistance protein RGA3 [Zingiber officinale]
MEATLVTAASRFMVQNVSDLLQLEEKLKAITASNKTKMKKLKELSKIIDAVIQDVDSRPFIDAAVKILLT
KLKYLAYDLEDVVDYYDTTVSQKKQRSNTSLRSVRDFFSPNNQIVLKSRVGGMIKAITESLDDILLQKSI
LLNLPQGSIRMSELSLHRDTHSRNSLVVIGREPEKNMIVDMLTKDDDDDESDHGTVKVIAIVGMGGLGKT
TLAQLVFNDARVKDHFASPRMWKLVGAEFDHAKIMKSVLELATGAPVNISEIELVRQNLETALSGKRFLL
VLDDVWNEDQEKWEVLKATLICGAKGSKILVTTRSQKVSSIMGSSNTTTHQVQQLSKDDCLSLFQQFAFG
DQAVDQSLMEIGGKIVEKCGGVPLAAISLGSMLYGTRDETYWDSVLKSEIWQLQDKEQKVLAVLKLSYDT
LPPQSKKCFAFGSLFPKDYRMQKDELIKLWIANYGFIHSEGNFDAETEANRVFDGLVLRSFFLSDPLEVH
PHVTKCTMHDLMHYLARSMSENVYWNVEDSVEDIGNRTYHLHLYLADISKITQALDKKPLYLRTLILNCC
KLSLNGNLLKIDFSELKFLRVLDLSNNEIKEVPTSIGNLIYLRYLNLSSNCIEVLPDSITLLSNLQYLNL
SWNMELQELPKDLGNMQSLRDLNCRRHEFRDFRLTHMPRGLSRLTNLRSLPVFVAGDGPDACPITELENL
KLHGEMDIIFSENFTNYSCGGLKILKNKDLNKLCIKFNGSERYDEAMLDDLCPNTSLKKLCIKDYVSRQF
PAWLMKSQLPNLVEVSLKSCCGCEHIPQFRNLQFLKKLELCKMDGITQMGAEFHGDGGFPSLQELCLTRM
DNLEEWSKSDGDGKLFPSLQLLRLSDCLKLKSMPRLPTIQHLEISCCRGSLLSCIGSLTSLSDLKLDKMR
DMTVFPSGYIRNLTSLEELQITECRQLQSLPGDEMQHLKLLRLLTIKGCPSIILQPEELVQILNSVQEFQ
IQICGNTVDLRGQLQSLHTLKELCLRGAHGYKPKYGIAKLEICCCDDELDPLMTAEPTSSVLEKLYIDDF
SNLRTLPHWLQHLKSLSLLSIENCPRLQSVPDLKNLPMLKSLRVFDCPELERRCEKKTGKD


>XP_042409347.1 putative disease resistance protein RGA3 [Zingiber officinale]
MEATLVTAASRFMVQNVSDLLQLEEKLKAITASNKTKMKKLKELSKIIDAVIQDVDSRPFIDAAVKILLT
KLKYLAYDLEDVVDYYDTTVSQKKQRSNTSLRSVRDFFSPNNQIVFKSRVGGMIKAITESLDDILLQKSI
LLNLPQGSIRMSELSLHRDTHSRNSLVVIGREPEKNMIVDMLTKDDDDDESDHGTVKVIAIVGMGGLGKT
TLAQLVFNDARVKDHFASPRMWKLVGAEFDHAKIMKSVLELATGAPVNISEIELVRQNLETALSGKRFLL
VLDDVWNEDQEKWEVLKATLICGAKGSKILVTTRSQKVSSIMGSSNTTTHQIQQLSKDDCLSLFQQFAFG
DQAVDQSLMEIGGKIVEKCGGVPLAAISLGSMLYGTRDETYWDSVLKSEIWQLQDKEQKVLAVLKLSYDT
LPPQSKKCFAFGSLFPKDYRMQKDELIKLWIANYGFIHSEGNFDAETEANRVFDGLVLRSFFLSDPLEVH
PHVTKCTMHDLMHYLARSMSENVYWNVEDSVEDIGNRTYHLHLYLADISKITQALDKKPLYLRTLILNCC
KLSLNGNLLKIDFSELKFLRVLDLSNNEIKEVPTSIGNLIYLRYLNLSSNCIEVLPDSITLLSNLQYLNL
SWNMELQELPKDLGNMQSLRDLNCRRHEFRDFRLTHMPRGLSRLTNLRSLPVFVAGDGPDACPITELENL
KLHGEMDIIFSENFTNYSCGGLKILKNKDLNKLCIKFNGSERYDEAMLDDLCPNTSLKKLCIKDYVSRQF
PAWLMKSQLPNLVEVSLKSCCGCEHIPQFRNLQFLKKLELCKMDGITQMGAEFHGDGGFPSLQELCLTRM
DNLEEWSKSDGDGKLFPSLQLLRLSDCLKLKSMPRLPTIQHLEISCCRGSLLSCIGSLTSLSDLKLDKMR
DMTVFPSGYIRNLTSLEELQITECRQLQSLPGDEMQHLKLLRLLTIKGCPSIILQPEELVQILNSVQEFQ
IQICGNTVDLRGQLQSLHTLKELCLRGAHGYKPKYGIAKLEICCCDDELDPLMTAEPTSSVLEKLYIDDF
SNLRTLPHWLQHLKSLSLLSIENCPRLQSVPDLKNLPMLKSLRVFDCPELERRCEKKTGKD


>XP_042409349.1 putative disease resistance protein RGA3 [Zingiber officinale]
MEGALAAAASRFMVQKVADLLQLDQKLKAMTGIKRKMEKLKELSTIIDKVIQDIDSRPSIDDAVKDLLEK
LKYLAYDLEDVVDYYDIKVFQKQRSKTFLRPVSDFFSSDNQVVFKSRVGGMIKAITESLDSILLQKSILQ
NLSQSSIRMSEQRETHSRNSFVVIGREPEKNMIVNMLTKDDDDDESNHGTVKVIAIVGMGGLGKTTLAQI
VYNDARVQDHFASLRMWKVVGAEFDPAKIMKSVLQLTAHKSVEISEIDLVMQDLETALSGKRFLLVLDDV
WNEDPFEWGKLKAALTCGARGSKILVTTRSQQVSKIMGSSNTTHQLQQLSQDDCLSLFQQFAFGDQAVDQ
KLMEISKQIVEKCGGVPLAAISLGSMLRGTRDKTYWSSVLKSEIWQLRDEQKVLAVLKWSYDTLPLQSKK
CFAFGSLFPKDYTMQKDELIKLWISNGFVHSERNFDAETVGNRIFDNLVLRSFFLLALLKMILM


>XP_042409387.1 putative disease resistance protein RGA1 [Zingiber officinale]
MVRLLVFSSSLTRLNPKSPPLRRARPVRCRHAGAPPTSLSDSSRGIISHILRKQLLHNPSSGAMAEALVS
DAYRLMSERLADLLQLNDKLKATTGIEGKMEKLKFLSTIIDKVIQEVDSRPFIDDAVKDLLKKLKYLACD
LEDVVDHYDTKVLQMQISNASFESVRDFISSDNLFKSRVNCMIKAITQSLDFILLQKSILLNLPQSSSHM
SLNPYRETHSRNSFVVIGRETEKNMIVNMLTNDDDDDEEESNHATVKVIAIVGMGGLGKTTLAQLVYNDA
RVQEHFASLTMWKIVGPEFNPTKILKSILELATRKSVGISEIDLVRQELETTLSGKRFLLVLDDVWNEDA
LKWGVLKAALTCGSRGSKILMTTRNQCISSIMDSSYIHQMKQLSPADCSFLFQKFAFGDRKVDRTLMEIG
GKIAKKCGGVPLAAISLGSMLRITRDETYWSSVLNSEIWQLGNEEDKVLAVLKLSYDTLPPRSKKCFTFG
SLFPKNYRMAKDELIKLWIANDFVRSEGNFDAETNGNHVFNDLLMGSFILWAPSNVYDDSHVNMCTMHDL
MHDLARSVSANAYWNSDQDSVEDVGNRTYHLQIQRGEESSMTQVLGKKPLYLRTFMYNSSRLSINLLEVF
SELKFLRALDLRYGGIREVPTSIGNLIHLRYINLSNNMIEVLPDSITLLSNLQYLNLSFNKELRELPKDL
GNMQSLRDLDLSSYLFDSGFKLTHMPCGLSRLTNLRSLSVFVAGDGTDACSIIELEDLKLHGEMEIKFSD
DFKNYSCGGRKILKNKDLNELCIKFNGSERYDKDMLDDLCPNTSLKKLTISNYGSPQFPTWSIDLQLPNL
VEVCITSRFCQHLPPFGNLQFLKKLDLQCMHGIRQMGVEFHGWGGFPSLQELILDGMHILEEWSESHGVN
QLFPLLQRVKIINCPELKCMPRLPRIQELEVLWCRRRLLSCVGRLTSLSVLEVVDVRDMVSLPSGCIRNL
TSLTKLEIICCLQLQSLPGNEMKHLKMLRSLTIEGCYNLTSFPLEVGHLSSLCFLRLSGCPSIILHPEEL
VQILNSIPEFEIQICGNQVNLREQLQHLHTLGGLLLIGDHNAPDLFENHAYEHPELCICCCDELELLMTA
EAASSIVLEELHIIGISNLTTLPDWLLHLKSLSLLSIENCPLLERLPKNLKNIHMLEGLTIANCPQLESR
CKRETGEDWPIISYL


>XP_042409388.1 putative disease resistance protein RGA4 isoform X1 [Zingiber officinale]
MAGALVGATAGFLANKVAILVELDEKLKAMAGTKRKMEKFKELLTNIDSVIQNVESRPFIDDAVKDLLKK
LKYLAYDLEDVVDYYDTKVLHKKQRSHSTVLRPVRDFFSTNNQVLFKSRIGSMIKAITESLESILLQKSI
LLNLPPGMSQPSPYRENHSRNRFVVIGREPEKEMIVNMLIDDDDESSHETVKVIAIVGMGGLGKTTLAQL
VFHDETVKIHFASLRMWTVVEAEFDPLKIMNSVLELATGAPANYTQIDSARQNLEKVLTGKKFLLVLDDV
WNEDPLKWGVLKAALICGVKGSKILVTTRSLHISSIMGSSKTHQLQQLSKDHCLSLFQQFAFGDQTVDQS
LMEIGGKIVEKCGGVPLAAISLGSMLHSTRDESYWSSLLSSKIWKRDNENNLLAVLKLSYNNLSLQSKKC
FTFGSLYPKNCTMVKDELIKLWIANDFVRSDANFDAETIGNHVFTELVHKSFFLLASSKERDFRDFLWAS
SEGYDLGDVSHVTNCTMHDVMHDLARSVSVNIYWNDKEDLAKDIGDRIYHLHMHKDFENLSNTIQARGKK
RLYLRTLILKDISLNTDQLEFVFSNLKFLRVLDLTGNKIKEVPTSIRNLIHLRYLNLSRNIIEVLSDSIT
LLANLQYLNLSFNEGLQELPKELWNMQSLRDLDCRCCNSGFIRIPCGLSRLTNLQSLPVFVADSRSGACS
ITELEDLKLNGEMTIKFSENFTNYSCGGRKILQDKHLKELSLEFNRSETNDKGMLDDLCPNTSLKKLGIW
HYGSSQFPTWFIQLQSQLPNLVEVSLNYCRGCEHIPPFGNLHFLKKLDLISTYGITHLGAEFHGNGGFPS
LQELNLHRMNNLKEWSESHGADQLFPSLQRLRVYRCPELKCMPRLPNIQSLEIFYCDGSLLSYVGSLTSL
SILRVEKMDNMTSFPSGCIRNLTSLIELRIIGCDQLLSLPRGEMKRLKKIRSLTIDRCDSLAFLPSEVGR
LNSLRFLRLAGCPRIKLQPYEVVQILNSVHEFEITICGKNVNLHEQLQRLYTLRELFITGEHDIYSDTQL
CICCCEELESLMIPDPASSVLQHLYIDGISNLTKLPDWLQHLESLRFLSIHNCSRLETLPRLLWLQTLTI
IDCPQLKRRYERDSGEDWPIIAHVPYVDI


>XP_042409389.1 putative disease resistance protein RGA1 isoform X2 [Zingiber officinale]
MAGALVGATAGFLANKVAILVELDEKLKAMAGTKRKMEKFKELLTNIDSVIQNVESRPFIDDAVKDLLKK
LKYLAYDLEDVVDYYDTKVLHKKQRSHSTVLRPVRDFFSTNNQVLFKSRIGSMIKAITESLESILLQKSI
LLNLPPGMSQPSPYRENHSRNRFVVIGREPEKEMIVNMLIDDDDESSHETVKVIAIVGMGGLGKTTLAQL
VFHDETVKIHFASLRMWTVVEAEFDPLKIMNSVLELATGAPANYTQIDSARQNLEKVLTGKKFLLVLDDV
WNEDPLKWGVLKAALICGVKGSKILVTTRSLHISSIMGSSKTHQLQQLSKDHCLSLFQQFAFGDQTVDQS
LMEIGGKIVEKCGGVPLAAISLGSMLHSTRDESYWSSLLSSKIWKRDNENNLLAVLKLSYNNLSLQSKKC
FTFGSLYPKNCTMVKDELIKLWIANDFVRSDANFDAETIGNHVFTELVHKSFFLLASSKERDFRDFLWAS
SEGYDLGDVSHVTNCTMHDVMHDLARSVSVNIYWNDKEDLAKDIGDRIYHLHMHKDFENLSNTIQARGKK
RLYLRTLILKDISLNTDQLEFVFSNLKFLRVLDLTGNKIKEVPTSIRNLIHLSFNEGLQELPKELWNMQS
LRDLDCRCCNSGFIRIPCGLSRLTNLQSLPVFVADSRSGACSITELEDLKLNGEMTIKFSENFTNYSCGG
RKILQDKHLKELSLEFNRSETNDKGMLDDLCPNTSLKKLGIWHYGSSQFPTWFIQLQSQLPNLVEVSLNY
CRGCEHIPPFGNLHFLKKLDLISTYGITHLGAEFHGNGGFPSLQELNLHRMNNLKEWSESHGADQLFPSL
QRLRVYRCPELKCMPRLPNIQSLEIFYCDGSLLSYVGSLTSLSILRVEKMDNMTSFPSGCIRNLTSLIEL
RIIGCDQLLSLPRGEMKRLKKIRSLTIDRCDSLAFLPSEVGRLNSLRFLRLAGCPRIKLQPYEVVQILNS
VHEFEITICGKNVNLHEQLQRLYTLRELFITGEHDIYSDTQLCICCCEELESLMIPDPASSVLQHLYIDG
ISNLTKLPDWLQHLESLRFLSIHNCSRLETLPRLLWLQTLTIIDCPQLKRRYERDSGEDWPIIAHVPYVD
I


>XP_042409573.1 disease resistance protein RPS2-like [Zingiber officinale]
MDLAKKVGLNLEDDESEDDRAYKLHNFLKEKNCLLFLDDIWQSYEVVMLGMQPPKRGMEKKRKVIVFTTR
YEQVCTGMSANVIKKVKGLSSDEAWELFLKYAREDVINSERQINQLAKEITKECAGVPLALITVGRAMSA
KRSREAWNDALVQLKKSQMPEVTGMKERDPMFGAFKLSYDSLEDDNIRARLLCCSLWPEDFEIDKDELIQ
CWIGLGLIDEFDSINKAFDRGHSHIETLTFACLLELVNKNGATRIKMHDVIRDMALWMASDCGSNQHRWI
VKARARLNQLELENEQWQVVERASFMHNNLSSLPRQTLTFPKLSMLMLQQNPKLDLIPEPFFKALPVLAF
LDLSGTNITDLPREINMLSELQYLNLNFTPIKALPVELSSLAKLKYLLLVGTKRLAKVPKGTMSNIALLK
LLDLYESKYANLDELEGFKGCRKYIGITLHSMIDLERLGSLPQLSRWKLQLQSMRDLAYPSQLFESIMSS
HNTRQGLERLEIVDVTTGGELTVAQSNKDHEEGLECLRYMTLITIDDLQEITWKVVEHQTIFPNLHELNI
FDCKMLRNINWVLHLPNLNVLKVSNCGEMEELINCVGSSANSSIGLRLLSLTRLPSLNCIARQPLTFPYL
EQLYVSSCPELRKLPFGAEICQNKLKGIFCQKDWWENIQWEDVNDKNSLFPYIKFGFDVIVLKLGVKLPK
AKSRIFKTVIEVPGVIQVRLDSSTCHLTVVGDGVDGATLMNRLQRNIGQVELISVGTTGG


>XP_042409574.1 probable disease resistance protein At1g62630 isoform X1 [Zingiber officinale]
MLLKLINNHEEISKLKFEHVVWIVASKECKLQKLQMDVAKKYAGKDVINSEQGINQLAREIAKVCSGVPL
ILITVRRVMSAKRSWRSDALMQLRQSRMLEVTDMKERDPMFAAFLLSYDSLEDDNMRAPLLCGSLWPEGF
KIHKVELIQCWIGLGLINEFNSINKEFHRELSHIETLTFACLLELVDSEHTVGIKMHDLIRDMVLWMVSD
YGSNQYKWIVKAHAGLNQLELENEE


>XP_042409576.1 probable disease resistance protein At1g61300 [Zingiber officinale]
MPVPNSLLDCKSFSNHPLPNSFSTDCYPSIRCFPSIAMSISFDIGQFLNKICHVASIHLARPRSGVEDLH
IDAELLGAKLSDVDRAINEAAGNGQIVMEEALVWKRLAEAFVSKEAAIQRDYNEMRCLGGWSWNCVFINR
RVTEMKKMQELISRGNDIRVVAAPPPSSSPSPPPLQLPVKLPISNNVVGMESNVIQIVNQIMDANARVIG
IYGMGGIGKTTLLKLICNHDEISKLKFEYVIWIVASKGCKLQKLQMDLAKKVGLKLEDDESEDDRASRLF
DSLKEKNCLLFLDDIWESYDLYKLGMEEVPAEHDKERKRKVIIFTTRYEHICTGMNANVIKKVEGLSSDQ
AWELFLKYAREDVINSEPGINQLAIEIAKECAGVPLALITVGRAMSAKRSWEVWNDALTQLRQSQMPELT
GMKESDPMFAAFKLSYDSLEDDNMRARLLCCSLWPEDFEIDKVELIQCWIGLGLIAELDSINKTFQRGHT
HIETLTSACLLELADKKYATRIKMHDIIRDMTLWISSDCGFNQHKWIVKAQARFSQLELENEKWQVVERA
SFMHNDLSSLPRHTPTFPKLSMLMLQGNYKLSLIPGPFLQALPVLTFLDLSNTKITELPREINMLSELQH
LNLNMTPVEALPAELSSLAKLKYLLLVRTNRLAKVPKGTISNLPLLKLLDLYESKYADLDELEEFKGCRR
CIGITLQSVTTLDQLVSLQQLSTWKLQLKNISDLAYPSQLFESIMSSHNIRKSLERLEIVNVQTGDELIV
ARNNRDREEGLECLRYMVLKAVDDLQEITWKAVKPQTVFPNLRELKISECKMLRNVTWVLQLPHLSVLTV
SNCDKIEELISCVGDSVNSSSSLRLLSLAQLPKLNCISQQPLTFPYLEQICVNSCPNLRKLPFGVEICQN
KLKDIFGQTDWWNNIRWEDANDKISLTPYFKSTYMQKIVLKLNMEDAKSRAKALKTAVRIHGVVSVTLEN
DLLIMNGDQVDLVALSKTMRRNFGWVELISISEMVD


>XP_042409577.1 probable disease resistance protein At1g61300 [Zingiber officinale]
MNPSINFGQFLNKIWDAASIYLARPRSRVEDLGRDAELLRAKLEDLNRAIDEAERNGQTATEEAQLWKRR
SETFLSTEVVAAIQRDYGAMRCLGGWSWNCVSINRRATKKLEEVKELISRVDVSRVAAMLPPPSAVELPI
SNDIVGMQSDVIQIVNQIRDENVSVIGIYGMGGIGKTTLLKLINNHHREISKLKFDHVIWIVASQGCKLQ
KLQMDLAKNIGLNLKDDESEEGCACKLFNSLKEKNCLLFLDDIWETYDLYMLGMEKTHVEQGKEQKRKVV
VFTTRSEQVCTGMKANVKKKVTGLASDKAWKLFLKNAGENVINSESRINRLAKEIAKECAGVPLALITVG
RAMSAKRSWEAWNDALTQLKQSQMPDVTGMKKRDPMFAAFKLSYDSLEDDNMRVRLLCCSLWPEDFEIDK
VELIQCWIGLGLIDEFDSINKIFDRGHSHIETLTFACLLELVHKEHAINIKMHDVIRDMALWMASYCGSN
QHRWIVKAGARLYDLELENEQLQVVEQASFMHNHIRSLPSETPTFPKLSMLMLQQNLKLYLIPGSFFQAL
PVLTFLDLSGTNITMLPGEINLLFELQHLNLNFTPIEALPTNLSNLSKLKYLFLKGTMRLTQVPKGTISN
LPLLKLLDLYESKYDNLAELKGFKGYRRYIGITIRTMMALEQLGSLRQLYTWKLQLENMKDLAYPRQLFK
SITSNHNTRQSLERLDIVNILTGGELIVAQSNKDSEEGFECLRYMVLIAVDDLQKITWKAVEPQIIFPNL
HELIIAKCKMLRNITWALQLPNLSVLKVSYCDEMEELISYVGSNVNSSIDLHLLSLAQLPKLNRISRRQL
TFPYLERIYVSECPKLKKLPFGAEICQNKLKGIFGRKKWWENIKWENAKDKNSLTSYFKSSMQIIMLRLD
IRSASFDMGDTNARAVAIKIALAIPGVMSAELDDECLIVRGEQLDPVEIVARLQNLFQAELLNGDIEN


>XP_042409694.1 disease resistance protein RPS2-like [Zingiber officinale]
MRLRATGKPSWKKLLVWKRQAEAFVSKEAAIQRDYKAMRCLGGWSWNCVSINRRVTKKVKKMQELISRGN
DISIVVPPPQQQQQPPPQQQPPPQQPPQQPQQQQSPPPPPPPPAMELPISNNVVGMQLNVIQIVNRIKDE
NAKVIGIYGMGGIGKTTLLKLIHNHEEISKLKFEHVVWIVASQGCKLQKLQMDLAKKVRLKFEDDESEDD
RLSKLYNFLKQKNCLLFLDDIWESYDLIKLGMEQVPGKEQKRKVIVFTTRSEQVCTEISADVIKKVEGLP
YDQAWELFLKNAGEHVINLEPRITRLAKQIAEECAGVPLALITVGKAMSSKKSWEAWNDALTQLRQSQMP
KVTRMKERDPMFAAFKLSFDSLEDDNMRARLLCCSLWPEDFEIEKVELIQCWIGLGLIDEFDSINKAFHR
GHSHIETLTSACLLELIDGEVHTTTIKMHDVIRDMALWMASDCGSNQYRWIVIARTGLRQLELKNEECQV
VERASFMHNKLDYLPEQTATFPKLSVLMLQHNESLDLIPKSFFSSLPVLTFLDLSGTNITKLPKEINILS
ELQHLNLSFTNVEALPVELSSLVKLKYLLLERTESLAQVPKGTISNLPLLKLLDLYESSYADLDELEGFQ
GCWKNIGITLDSMTNLKRLSSLSQLSTWKLKLQNMIDLAYPSQLFKNIMSSYNTRQGLERLEIINVRTDD
GLIVVRSNKDHEEGLECLRYMALKHVDYLQEITWKAVEPQTIFPNLHELTIDKCNKLINITWVLHLPNLS
VLKVSDCDEMEELISCVESSVNSSIGLRLLSLNRLPKLNCISRQPLTFPYLVRIDVISCYKIRKLPFGAE
ICQHKLKRIICDEIWWELIEWENFKDKNSLTPYFKLINSFNCLGDYEYAEPRRKKRRDDLDSFDPAWDSF
DPEDSSDPEDPLDLAWIR


>XP_042409695.1 probable disease resistance protein At1g61300 [Zingiber officinale]
MTSIAIGISEILKGIWGAASTYLARPRSRVENLHRDAELLNAKLVDFNGAIERNGQTVTEETRLWKLRAE
TFLSTEVDAIQRDYRAMRCLGGWSWNCVSINRRVTKKLEEVKELISQVDVSKVATTPPPPAMKLSISNNV
VGMQSNLIQIVKQIRDENASVIGIYGMGGIGKTTLLKLINNHEEISKLMFEHVVWIVASKGCKLQKLQMD
LAKKVGLNLKDEESEDDRASKLCDFLKEKNCLLFLDDIWELYDLNMLGMEQVQVEHGKEQKRKVVVFTTR
SEQVCTEMRVNMKKKVKGLTFDQAWELFLKYAGEDVINSELAINRLAKEVAKECTGVPLALITVGRAMSA
KRSWEVWNDALTQLKLSQMPKVTGMRERDPMFAAFKLSYDSLEDDNMRARLLCCSLWPEDFEIDKVELIQ
CWIGLGLIDEFDSINRAFHRGHSHIETLTNACLLELVEEVRNKLIEEVHPTKIKMHDVIRDMALWIASDC
ESNQRKWIVISQAGLRQLELKNEEWQVVERASFMHNKLTYLPRQTATFPKLSVLMLQQNKFLDFIPKSFF
LSLPVLTFLDLSYTMIRELPREINMLSELQHLNLSFTKVEALPIELSSLAKLKYLLLERTWSLAQVPKGT
ISNLPLLKLLDLYKSKYTDLGELEGFQGCRKNIGITLHSMIDLERLGSLSQLSIWKLQLRDMRDLAYPSQ
LFENIMRSHNTRLGLERLDIVNVTTGGKLAVAQSNKDHQEGLECLRYMTLITIDDLLEITWKEVQPQMVF
PNLHELTINNCKMLRNITGVFQLPNLSILRVSNCGEMEELISCVGSSVNSGIGLRSLFLYGLPKLNCISR
QLLTFPYLERINVFFCPELRKLPFGAEICQNKLKGIVGEVDWWENIQWKDINDKNSLAPYFKFVY


>XP_042409944.1 putative disease resistance RPP13-like protein 1 [Zingiber officinale]
MALLFTLSDLGRLVVSLIDSLVEKLRRDEVHRLQMLPEVGVVLRDLETRVIQIRHIISPAENSFAIATDQ
QIKLELKGLLMQLKNTVYDGEDLVEEIEHDVLHHEVDQHQYEASSQSSSSFNSSIAKRTSAPSPVKLPAL
IKAADSSVYKLRKINLRLGRIATAIAKIIQVTNSVGADDGQKIHNADSVSSNTTSFSVDGKMYGRDGEFN
TLRQLLLKPSVGSGSSNGSLSVVAIFGVGGVGKTTLAQQLYRDTSITEYFQLKIWVYLSENFTVKRLIKK
ILQSANIDFPDHINLDMLQVVVKKKIASKRFLLVIDDLWNAEWDMHKWGMLFAMLRPGVPSSKVLLTTRF
PRLPTVASNECAFHLDRMDEEEFWEFFKLCAFGSQSSQEKPPLIDIAKKMVSRLNGLPLAARMVGEWVSI
RDTYRVHVQVPYLQDLHKTLRPLSVFAEFVKPERLMDIFVNERLRTLIFSSMKEPWCETKISANHLFNRL
KCIRVLILHDCGMIELPWTINRLIHLRYLDISDNFGIQQLPDSLSYLHNLQYFDLNNCQVQTFPAGITNL
INLRQLISVDEIISKINNIGKLINLQTLPTFKVLKGDGHKLTELSSLTQLHGRLRILNLGNVEDKMEASA
AKLHDKVHLDELVLAWTSDQNSSFDDNALHASEEILEELQPHSKLKSLTIRGYKGARAPSWVHTETLASL
ETLRLENCGRWEDVSFIRQLLHLRSLYLKGIPAMKQTTQELFGPIENKFFQGLKELVLEGMDLLDELSSD
EVMFCGVLDPILIRSREAPHPVGVLVLASTAFEIKGNHFPCLEELKFSNMSEWEEWTWTGDSELFPCLLV
LKIEDCPKLKMLPPLPPSLMTLELWQNGLVELPGLWNKINGSSSNMIASLSKLYVSECPNLRMLDQGLLF
HDLPNIESIEIHECQELLWLPVKRFKEFTSLKNLSVKNCPMLMSSTEYKSDELLLPPSIQKLTLLDCGNL
SEPLPRCLLNLPSISQLEIGHPPSQG


>XP_042409945.1 putative disease resistance protein RGA3 [Zingiber officinale]
MTMLFTLSDLGRLGVTLIGSFVEKLRRVEVHRLQMLPEVGVVLRDLETCVIQIRHIISAAENSFTIATDE
LMKLELEGLLMHLKDTVYDGEDLVEKIEHDVLHHGVDQHQYEARSQSSSSFNSSATKSKNASSPVKVHTV
VEIEDSRVYKLRKIYQSLDKIATALVKIIKVVNSVDADDRQNIHTADSISSNATSFLVNGKVYGRDKEFN
TLRQLLLKPSLGSGFSNGSLSFIRILGDEGVGKTTLAQRLYSDTSITEYFQLKIWVYPSENFNGKRLTKE
ILQSANIDTPDCMNLDMLPVMVKKKIASKRFLIVLDDLWNTDMHGWDMLCASLSSGVPGSKVLLTTRFPR
LPTVASNECAFHLNRMDEEELWEFFKFCAFGSQSSQEKPPLTDIAKKMVSRLNGLPLAARMVRGLLNTNM
DVSHWNNILNNEIWQIPEYGLLPVSQISYHCLPVPLKRCIAFCSLFPRGYWFAEEKLIRIWNAEGFIVAQ
ANRRMEDVGKSYFQELVNRSFFQRLPHKSLQEEQTIFYVNHDLIHDLVE


>XP_042411847.1 putative disease resistance protein RGA3 [Zingiber officinale]
MTPFMLKALAWFADNFLGSLVGKAADYAVQQFGVQHGLRDDIDKLQSSSEKSRLIIHQVEKLRIQDEGVK
ARLKGLLMQLKDAAYDADDLLDEFQYQVLMKQVEQEENESTNFSLPSSSTALPATKKPRISVSTIADLIS
SSRDKDRVQKIKERIENITGDISQLIPLFPLSDLENQQQLISSTSRTTSSVLVETEVFGRDKYLKELKDL
LLNASDGAGSSNISIPVLAIVGIGGIGKTTLAQQVYNDEAIQEHFQLKIWVCVSGNFSVERLTKEIIESA
TRKKCMVGAVDPIHLYGLEAESFWAFFKKCVFGSQNNGDHPPDLETIAKTIAERLNGLPLAAKTVGGLLK
VNMEKSHWETIMKSEIWQLPQNESDVLPVLQLSYQCLPAHLKRCFAFCSLFLKDYVFSKKELVRIWIAEG
FVIPQGKERMEDVGSSYFEDLVSRSFFQKSRIFSSKYVMHDLIHDLAQLVSDGECYQLENGNTQEVSSLV
RHLSVWPPASKPAYQLERQVLVLSRNNKWRSLIWNDNFNFTIWRSLIWNDNYYNINNPTLKDLWRSLKYI
RVFILQRSGIVELPEDVAELRQLRYLDLSSNYQMKRLPDSLCRLHNLQALKLDRCPIQSFPQGMSKLINL
RHCDSKLISKIYRIGRLTSLQQLDRFNVQKHPGHKLEELSGLTQLHGKLRISNLENVGSKEEANAGKLHN
KVFIDSLTLEWMPNQDGSSEGNQLLILEELLKDLKWHPTLKELEISGYSWAAWDENYSWAKDIKLFPSVL
HVLHVFCCPKLKRLPPLPPSLVDLQLSESGLVKLPNIWEEIDGSGHCKVATLKHLYLHCPYLMSLEDGLL
SQNLPCLQTIILEDCQELMWLPMEKLKVFASLKEMQILNCPKLLTMTHDLNDFLILPQSLKKLSLSNCGD
LDKLLPRCLHNLTSLAHLEIAECPHLHSLPKEPLLHLKQLEYVKICGCDELRSMEGLGVLKSLKDLIILK
CPNLLINGRDEHGEEEEQGLLSLREICIDNTALLKIPPLRNALPSIHRLQIQSSVEEVMFEGEEQELLRR
LTVLRILMFSYCEELQSLPKELYTLPSLELLSIAYCPEIESLPETGLPTSLTDLRCQCENPMLKQQIQEK
MKELTSSGRYRPVHDRIIF


>XP_042411931.1 probable disease resistance protein At5g04720 [Zingiber officinale]
MSTSFAGEIATELIKELLNVVRMTYLCRPTAEQLKRSVDSLLPIVQEISLSGVELPQHRQNQLSELADNL
RLALELARKAAASPRWNVYRSMQLARKMERIDNWITRWIERQIPAHVLADVHHIRADYAARFDRIERTLD
ITAASVMARGPVALGTAPFSMFPEMMKGFVPLAAPAKAPIAMGSPPPSSGFPMPEMMEGLMPSEEAAKVP
VAMEKSQSSGFPVSEMMEGLILAGEGMKPVGVGIRFGKEKVKEMLMDGFDRVAVVGISGIGGSGKTTLAR
EICKDPEIRSYFKDRIYFETLSQSQNLESLKLKLWEQISGNMVLGAYNQIPQWQVELGTRDKGPFLLVLD
DVWSASELEELVFRVPGCKILVVSRFKFPSIVKNTYEIESLGEEDALSLFCHAAFEQKYIPSTFDKKLVK
QVVDECKGLPLALKVIGASLRDQPPKLWLRAKNKLARGESICESHENKLLERMASSIEFLSGKVRECFLD
LGSFPEDKRIPLDVLINMWMELHDLDEEDAFAILVELSNKNLLTLLKDAQNRAGDIYSSYTELSVTQHDL
LRDLALHVNSQETLTSRRRLIMPRKENELPKEWDRVKDQQLEAQIVSINTGEMKESDWFQMHFPKAEVLI
LNFSADAYFLPPFLSIMPNLKTLILINYGASCTTLQNLSVFTSLSNLRSLWLEKIAVPPLPKTTVPLQNL
RKVSLVLCELTNSLRGSKVDLSLTLPRLSHLTIDHCIDVTKLPSAICDINSLECLSISNCHDLSELPCEF
GKLNSLKILRVYACPALKRLPHSICLLKGLKYLDISQSFNLRELPEELGYMTSLEKFDMRECSQLKTLPR
SSSSLKSLGHVICDEDIALLWKEAERDIPDLHIQVAEESFNLDWLVE


>XP_042412499.1 probable disease resistance protein At1g58602 [Zingiber officinale]
MDASAVVRVVDKLSKLMYQEANYLGGFRDAVEWLNIELHRIQCFLKDAEPKGSKGDERVKNWVREIRDVA
YEIEDLIDIIGAASKRKNHRRRKRTFVGLASRYATAPFDYYSRHHLLCGIDRIKEKIVDISRSREIFGVS
NFGGSRDPDRVDVNLPTPLLASPDFEDEVHLVGFEEDKELLVRHLIDQQNQWRSFVSVVGMGGLGKTTLA
KKVYRDPRVRRQFDVLCWVSVSKNYRGAEFLNCIIEKVMGLTGEELLRMRREELERKLDQRFQERRCLIV
LDDVWLSSTCEDLKRLFPDHKNGSRVLLTTRSLDVARSADPSFAPHMPRFLDDDESWELLQKKAFPSRRG
HERRCPGDLEEVGRKLAKNCHGLPLALVVLGSLLFKKGPFPATWNRVFESLDWEFMEDGNKCFDILALSY
DDLPDDSFRSCFLYISSFPEGSEIFVSRLIELWNAEGFIRPRPKEAVEKTAKDYIDELSQRCMVQVVKRI
AGHGPAKSIRIHDLLREWCISKARMEGFLHVVGGKEKNAAALDATTACRRTALPDGLNGGGGPYVPSPKL
RALLAFNCKNLGNSKQLSFTSLRTLRVLYLEGSSGIMKLPEDIKSMVHLRYLGLKTRLVELPPSIGDLPY
LEVLDARLSRIIQLPSRLWRIATLKKVYVGSVEQPVKISKLGNSQSLRVVEWVDIAGGWIERTENEISSF
RKLGITGIQQAHRKALTRFLRKLRHLASLNLCFSDHDGEILTHVLRSLSDHHELRSLKLHGRYFLAIARR
AWGAFPPNLTKLVLNRFEFLQDPMEELEKLRHLVDLQILAPEVGHRLVAPDYKVMTCSAGGFPRLQHLQM
YGLKVEEWRIEASAMRSLTSLTVISMVKVRKVPEGLQHIATLQELAFNDMSRDFYGRIKASEGEDWQFIS
HVPCVSIREGFMKIWLSDSFPSQQLKAFIFSRKAAKEFIMGGRSSNVPEKLQLELLASEDSPGVLDETDT
VIEGR


>XP_042413068.1 putative disease resistance protein RGA3 [Zingiber officinale]
MEMQSPQASAASIALFYSKSMVRGRLKFLHLKDVHASTSSFRSLPPFSLKAGTLSACNTRAFVNATDSSS
GLGILFGARFGESLEDQIMAMILTAFIPQVIQVLDGITKREEILLLGVADEVKGLVRRLEELRNILQDAE
RRSYNEKEIQWWLTKLRDIIYDIDDMIDQCKIEGESHKRLLEQQAQSFRLRISTKCSVSLFSFFNRSFHH
EITERIKRLSSRLDQVIKEAAKFQLISSIHGYEVSLTNKCIVRAMDPESVEFKFKKDAESMFKLLTMEER
MNLLVITGVGGIGKTRLAQKIYYDERTKAHFQVRIWICVTQQTTFIDMLKQIITGAGQTYGEAQTSEQLE
IELKRVLEHKKFLLVLDDVWSIQICNDLLQRSSQNIVSGSRVLITTRNETLARELPGAHLHRMKPLSTKE
GWSMLRKELYQEDHVQEMQELNNIGIKIVRKCKGFPLAIRVIAGVLRTRGWSSEEWEKVFLDPAWSSFDL
PNDVTRALYLAYKDLPANLRQCLVYCSLFPEDHLFDQQSITKYWIAERLVEEKERSTIEDTAEGYYKELI
WRNLLERDFGQQDAHKMHGLLRFLAHFLAGEENLFGNLDLMDATSTKPRRLSIVAKGLMAIPTELKEQNS
LRTLLLFRNPLSGKILDDFLQGLNHLRVLDIHGTDVDSLPDCIGDLIHLRHLNVSSTRLKQLPDSIERLI
NLQFLSVRGCESMTALPQHLVKLQSIRSLDLVGTQVNWLPVGVGKLENLNSLLGFLVDSGSEGILMSTLD
DLGPLTMLKYLLLQKLERVSNGAESARANLRRKKYLKNLSMHWSLNIADAQLLEVDKFKEVLEALCPSSS
LEELEIMGYPGLDLPSWISTVKKLTKLVLHRCSSIQQLPQLGHLPHLSFLYISGATAVTKIGTEFFGLDA
WPPFPKLNTLVMEDMINWEDWQWQLEDGEALPCLRELQLVNCYKLPSLPDGLRHATALTVLAMDGANRLM
KIENLSTIRKLSVSSSFNLVEISNLSSLENLKVSNCSSLKKFEHLVHLQQLNVIDESMNNLPEGLGEYAT
KDLRWLELECNEDMFKSCHHGGSEWHKFQHIQDVHIHSKDRYMYFSYGKSLQYCEEATGSESNLAIVPVV
SNTPLTNTSPVAIPNTDMVTNQGHFCFSPQKLLLILYIYLTIYILFESFFLSPTHLSYLGSSLISFLIDV
IFFLISLPLCIMRDTFGSLSSVVSAAYKLFDMLVNVANYMDASIGAVVEPGVDFLFSSFSFSSIVVLSWL
IASYGGWFHQ


>XP_042413281.1 putative disease resistance protein RGA3 [Zingiber officinale]
MAAADLKRILSQVLPSPSLKAQAGLLRVQNHLEMIEGSLWKINSMYMHGLMTAITKPDVEQWTNDVKEAV
LDVDQLLGRILRCQLPKEAAAKSPSVCGDILLWLTETAEKSPSVRGDILLGLTETASKLNHLAFGGASSL
GLRAEMMDSIDADHEDFSTVLNNEVQGLEDTTNKIVKELQSQQQYEEIPTIFYIVGHEGMGKTTLARKVF
HHNWVRNYFQHHVWVDSPDSFSFDPMTVARSFVEAVTKKPCGHRGYLQQLWLDVSKKLNVGRYFLVLDDV
PVLMKDRDKWEQLRHVFLRLGSPGSRVVAVTSVHHSDFPEGNPTFKQLPPVLGLSRDSWTTLLRRRASAL
IRDDDEGKQIRKSSSAILDRFAGRLHEKSRGSPSLAKVWGSALQCTEVGRWEDQIEKYLLPKPLQDEQHF
GSWSSQYLIPKDAHLYLFSSLFQQDHEHDYEDLFHVMAAQGFIQDSSNKALIISNLKRSLRHFATKDSRQ
QKSLTNDLIRSLPILEATQPSSESEKKVLSYWKTKGFPKSTHQPQCQHLSVLIHPSTDLTLPMTLPSKLR
TLKLTMLVAENEEQKKKMEGQKIETVLKDEFSNLRHLRVLDLRATKMAEMPDTVDGLVNLRYLNLSWSDI
ATLPDSFCNLGSLQILKLAHCHKLSELPHRIGKLQNLQVMKLPFCENLTKLPKSVTNLIDLQELDLECCR
QLVEFPDEFGNLKSLRSLSLVGCLSLTKMPSGMRQLTELRQLSGFVVLQECGSCTVTELGPLKYLEDLQL
RGLEGVRSTNDAEAMKLKNKRFTRNLVLHWNGDDGASSDSLLEILECLQPSTALRTLEINSYSGKDFPMW
MKDGQPYHYTLTEIKLVNLRDCASLPPLGQLARLEVVEISGMVKVRKVDDEFYGLNGTFASLRKLTFSEM
PELQKWVKVTRKSQLFPKLTELMIIQCPKLEQLEVEVTAVKKLRLWLSNGTLLTSKSWDWSKFSGLTELE
IVGCPGVKHLPKSMKILKQMVDHLTLIGLGTLESLPNWLKKDCCLDISRCGKVKEQECQNASEAFSSATS
IESREWDKK


>XP_042413872.1 probable disease resistance protein At1g61300 [Zingiber officinale]
MAFIKLNLNVDVNSCLSGLWASLQLAIGRPKTAIKKLEKEMARLRGKRNDIKNQIGEAEREGKIPTNEVN
QWLQEVEELEGQVADINQDFQSMISCFSCNCFSLTQEAGDQVPIREPSNCCSIIRRVVKKLGEANELMSR
ASIVLDPIATVGPPEPTVMLPIVHRPPVGIESYVEDIVGYIDGGEGNITGIYGMGGVGKTTVLKSIQRHY
YNHRIIFDHVIWVVASKDCQLKRLQMEIARTLGLNTLQESDDEATCGDKLFSYLKNKNCLLLLDDSCEYL
NLQLLGMAHSATEQGQQQHELRRKVVVFTTRSEIVCARLEAEKKIKVKCLDQDQAWQLFKENVDGDVLSS
DRGINSCAQEIAKECAGLPLALITVARAMLGKKSWELWKDALHQIRDKHEWTSTIDLSEEDSVVMYKAFK
LSYDSLENDSIRECLLCCALWPEDYEIHKFKELIPCWIGCGIIREFNVINEAFTKGCSHLEALMAASLLE
HSSRRPNYYEAEHVKMHDVIRDMALLMFSELKGNRRKSIVKAGFGLHNLPRQEEWQEAERALFIENQIIS
LPEYEASSFPKLSMLILFFNYPPLNIPRSLFTSMPRLTYLDLSKCFIIELPMEIGSLTELQYLNLSYNTI
TNLPLELGCLDKLEYLLLRDNCLKTVPNGIISNLLMLKWLDISQQIPVCKQWWDELVHFRGCHQLSLEIS
IYATDLKRLNMLPNVSVRNLAMSGLSSKFQMLQWSLRVTDNLECLTISNVWKGDQLMVNAGVDCESSFKC
LKTLNLKFLYQLKINWMDGVGFNNLRDLYISNCYKLKDVSWVLQLPCLNLLSILNCQEMEEIISNVGSSN
SSFGIKMLALSKMDNLQRIAHQPLHFPYLEYISVSYCPRLKKLPFGAETVKNRLKEIQGGPNWWDDLDWD
DYSIKDSLAPYFRDGSNLLRQEKWQPTLIVEDHIIWLPAGLDDPEDDGSDDEEDGENEPEANGEGGSEQE
DDEDDDNDDDEEEEDDEYEEEENVEKDDELQHHQQRRGSEVYCCILLGYLVLVEFFIFFLFIFTSA


>XP_042415102.1 putative disease resistance protein RGA3 [Zingiber officinale]
MTMLFTLSDLGQLGVTLIDSFVEKLRRVEVHRLQMLPEVGVVLRDLETCVIQIRHIISAAENSFTIATDE
LMKLELEGLLMHLKDTVYDGEDLVEKIEHDVLHHGVDQHQYEALHTVVEIEDSHVYKLRKIYLSIYKIAT
ALVKIIQVVNSVDADDRQNIHTADSISSNATSFLVNGKVYGRDKEFNTLRQLLLKPSLGSGFSNGSLSFI
RILGDEGVGKTTLAQRLYSDTSITEYFQLKIWVYPSENFNGKRITKEILQSANIDTPDCMNLDMLQVMVK
KKIASKRFLIVLDDLWNKDRHGWDMLCASLSSGVPGSKVLLTTRFPRLPTVASNECAFHLNRMDEEEFWK
IFKLCAFGFQSSQEKPPLTDIAKKMVSRLNGLPLAARMVGGLLNTNMDVNH


>XP_042415103.1 putative disease resistance protein RGA3 [Zingiber officinale]
MIYLPRDDLGSDTAGTLGANDFTFCHIKVVNSVDADDRQNIHTADSISSNATSFLVNGKVYGRDIEFNTL
RQLLLKPSLGSGFSNGSLSFIKILGDEGVGKTTLAQRLYSDTSITEYFQLKIWVYPSENFNGKRITKEIL
QSANIDTPDCMNLDMLQVMVKKKIASKRFLIVLDDLWNKDRHGWDMLCASLSSGVPGSKVLLTTRFPRLP
TVASNECAFHLNRMDEEEFQ


>XP_042415354.1 putative disease resistance protein RGA3 [Zingiber officinale]
MEMQSPQESAASIALFYSKSMVRGRLKFLHLKDVHASTSSFRSLPPFSLKAGTLSACNTRAFVNATDSSS
GLRILFGARTLGAKFGESLEDQIMAMILTAFIPQVIQVLDGITKQEEILLLGVADEVKGLVRRLEELRNI
LQDAERRSYNEKEIQWWLTKLRDIIYDIDDMIDQCKIEGESHKRLLEQQAQSFRLRISTKCSVSLFSFFN
RSFHHELAERIKKLSSRLDQVTKEASKFQLISSIHGYEVSLTNKCIVRAMDPESVEFKFKKNAESMFKLL
TMEERMNLLVITGVGGIGKTRLAQKIYYDERTKAHFQVRIWICVTQQTTFIDMLKQIITGAGQTYGEAQT
SEQLEIELKRVLEHKKFLLVLDDVWSIQICNDLLQRSSQNIVSGSRVLITTRNETLARELPGAHLHRMKP
LSTKEGWSMLRKELYQEDHVQELNIIGIKIVRKCKGFPLAIRVIAGVLRTRGWSSEEWEKVFLDPAWSSF
DLPNDVTRALYLAYKDLPANLRQCLVYCSLFPEDHLFDQQSITKYWIAERLVEEKERSTIEDTAEGYYKE
LIWRNLLERDFGQQDAHKMHGLLRFLAHFLAGEENLFGNLDLMDATSTKPRRLSIVAKGLMAIPTELKEQ
NSLRTLLLFRNPLSGKILDDFLQGLNHLRVLDIHGTDVDSLPDCIGDLIHLRHLNVSSTRLKQLPDSIER
LINLQFLSVRGCESMTALPQYLVKLQSLRSLDLVGTQVNWLPVGVGKLENLSSLLGFLVDSGSEGILMST
LDDLGPLTMLKYLLLQKLERVCNGAESARANLRRKKYLKNLSMHWSLNIADAQLLEVDKFEEVLEALCPS
SSLEELEIMGYPGLNLPSWISTVKKLTKLVLHRCSSIQQLPQLGHLPHLSSLYISAATAVTKIGTEFFGL
DAWPPFPKLNTLVMEDMINWEDWQWQFEDGEALPCLRELQLVNCYKLPSLPDGLQHATALTVLAMDGANR
LMKIENLSTIRKLSVSSSFNLVEISNLSSLENLKVSNCPSLKKFEHLVLLQQLNVIDESMNNLPEGLGEY
ATKDLRWLELECNEGMFKSCHHGGSEWHKLQHIPDVHIHSKDRYMYFSYGKSLQYCEEATGSESNLAIVP
VVSNTPLTNTSPVTIPNTDMVTNQEHFCFSPQNLLLILLPLCIMRDTFGSLSSVVSAAYKLFDMLVNVAN
YMDASIGAVVEPGVDFLFSSFSFSSIVVLSWLIASYGDDKIQRQSRDREKKASKDDAMPLASIEVKAMAV
APCHCHTCRHRLTARSLKAFGADCQVSLLHAAGP


>XP_042416559.1 putative disease resistance protein RGA3 [Zingiber officinale]
MTPFMLKALVWFADNFLGSLVGKVADYAVQQFGVQHGLQDDIDKLQSSSEKSRLIIHQVEKLRIQDEGVK
ARLKELLMQLKDAAYDADDLLDEFQYQVLMKQVEQEENESTSFSLPSSSTALPATKKPRISVPTIADLIS
SSRDKDRVQKIKERIENITGDINQLIPLFPLSDLENQQQLISSTSRTTSSVLVETEVFGRDKYLNELKDL
LLNASDGAGSSNISIPVLAIAGIGGIGKTTLAQQVYNDEAIQEHFQLKIWVCVSGNFSVERLTKEIIESA
TRKKCELTNLDALHVILNENITSKKFLLVLDDVWNEDSSKWEKFYAPLKNGAKGSKILVTTRSTTIAGMV
GAVDPIHLYGLEAESFWAFFKKCVFGSQNNGDHPPDLETIAKTIAERLNGLPLAAKTVGGLLKVNMEKSH
WETIMKSEIWQLPQNESDVLPVLQLSYQCLPAHLKRCFAFCSLFHKDYVFDKEELVRIWIAEGFVIPQGK
ERMEDVGSSYFEDLVSRSFFQKSTTRSYVMHDLIHDLAQLVSDGECYLLENGNTQEVSSLVRHLSVWPPA
SKPAYQLERKLLVLSGNNKWRSLIWKGNYYYNNWRSLIWNDNYYNNNNPTLKDLWRSLKYIRVLILQRSG
IVELPEDVGELRHLRYLDLSFNYEMIRLPDSLCRLHNLQVLQLYECPIQSFPQGMSKLINLRYIDFRDMT
LISKIYRIGRLTSLQQLNTFKVQNHPGHKLEELSGLTQLHGSLRISNLENVGSKEEANAGKLHNKVFIDS
LTLEWMPNQDDSSEGNQLLILEELLKDLKWHPTLKELEISGYSWAAWDENYSWAKDIKLFPSVLQELHVF
YCPKLKRLPPLPPSLVDLQLLQSGLTKLPNIWEEIDGSGHCKVATLKHLYIRCPYLTSLEDGLLSQNLPC
LEYLILEDCKELMWLPMEKLKVFASLKEMRIWNCPKLLTMTHDLNDFLILPQSLKKLTLSNCGDLDKLLP
RCLHNLTSLAHLEIGECPHLRSLPKEPLLHLKQLEYVKIHGCDELRSMEGLGVLKSLKNLIILECPNLLI
NGRDEHGKEEEEEEQGLLSLREICVDNTALLKIPPLRNALPSIHRLQIESSVEEVMFEGEEQELLRRLTV
LRILMFSYCKELQYLPKELCTLPSLELLSISSCPEIESLPETGLPTSLTDLRCQCVNPMLKQQIQEKIKE
LTSSGRYRSVNERL


>XP_042416561.1 putative disease resistance protein RGA3 [Zingiber officinale]
MAFKVKVLGWFADHFLGRLVGKAADFADQQFGEQHGVQDDINKLQSSSEKSRLIIHQVEKLRIQDEGVKT
RLKGLLMQLKDAAYDADDLLDEFQYQVLKKQVEQQENESINFSLPSSSTAVPATKKPRISVSTIVDQISS
SRDKDRVRKIKERIESITGDISQLIPLFPLSDLDNCRNQQQLISSTSRTTSSVLVVTEVFGRDKDLKELK
DLLLNASDGAGSSNSSIPVLAIVGIGGIGKTTLAQQVYNDEAVQEHFQLKIWVCVSENFSVERLTKEIIE
STTRNKCELTNLDALHVILKEEVTSKKFFIVLDDVWNEDSGKWEKFYAPLKNGVQGSKILVTTRSTTIAG
MVGALDPIHLDGLEDESFWTFFKKCVFGSQNNCDHPPDLKAIAKTIAKRLNGLPLAAKTVGGLLKVNMEK
SHWETIMNSEIWQLPQNESDVLPVLQLSYQCLPAHLKRCFAFCSLFRKDYRFLKKELVRIWIAEGFVIPR
GKERMEDVGSNYFEDLVSRSFFQKSGRFLIEYVMHDLIHDLSQLVSDGECYRLENGNTQEVSSLVRHLSV
WPPASMTAGELCRNNKWRSLIWYDNYYNANTPTTKDLWRCLKYIRVLILQRSGIVELPEDVGELRHLRYL
DISFNYEMKRLPDSLCRLHNLQVLKLYECPIQSFPQGMSKLINLRHIDFEDTILISKIYRIGRLASLQQL
DKFEVQNHPGHKLEELSGLTQLHGKLRISNLENVGSKEEANAGKLHNKVFIEKLTLEQDGSSETNQLLIL
EELLKDLQPHPTLKKMNICGYSWTAAWDETYSWAKDIKLFPSVLQELWVSDCPKLKRLPPLPPSLVNLEL
HRSGLIKLPNIWEEIDGSGNCKVATLSRLYINCPNLTSLEEGLLSQNLPYLKTIILEDCEELMWLPMEKF
KLFASLKELKIMNCPKLLTMTRDINYWPILPQSVEKLSLSNYGDLDKLLPSCLHNLTSLAHLEIAECPHV
RSFPKEPLLHLKQLDFVKISGCDELRLMEGLGVLQSLKDLIICKCPNLVINGRNEHGEEDGVLLSLRELC
IDNTALLKIFPLRNALQSIHRLQIQSSVEEVMFEGEEQELLRRLTVLRILMFGCCKKLQSLPKELYTLPS
LELLSIWDCPEIQSLPETGLPTSLTDLKCDRVNPMLSRQIWEKWEELRSSGRYRLVIERPKVL


>XP_042416647.1 probable disease resistance protein At4g33300 [Zingiber officinale]
MSTSLAGEIATELIKELLNVVRMTYLCRPTAEQLKRSVDSLLPIVQETSLSGVELPQHRQNQLSELADNL
RLALELARKAAASPRWNVYRSMQLARKMERIDNWITRWIERQIPAHVLADVHHIRADYAARFDRIERTLD
ITAASVMARGPVALGTAPFSMFPEMMKGFVPVAAPAKAPIAMGSPPPSSGFPMPEMMEGLMPSEEAAKVP
VAMGKSQSSGFPVAEMMEGLILAGEGMKPVGVGIRFGKEKVKEMLMDGFDRVTVVGISGIGGSGKTTLAR
EICKDPEIRSYFKDRIYFETLSQSQNLESLKLKLWEQISGNMVLGAYNQIPQWQVELGTRDKGPFLLVLD
DVWSASELEELVFRVPGCKILVVSRFKFPSIVKNTYEIESLGEEDALSLFCHAAFEQKYIPSTFDKKLVK
QVVEECKGLPLALKVIGASLRDQPPKLWLRAKNKLARGESICESHENKLLERMASSIEFLSGKVRECFLD
LGSFPEDKRIPLDVLINMWMELHDLDEEDAFAILVELSNKNLLNLLKDAQNRAGDIYSSYTELSVTQHDL
LRDLALHVNSQETLTSRRRLIMPRKENELPKEWDRVKDQQLEAQIVSINTGEMKESDWFQMHFPKAEVLI
LNFAADAYFLPPFLSIMPNLKTLILINYGASCTTLQNLSVFTSLSNLRSLWLEKIAVPPLPKTTVPLQNL
RKVSLVLCELTNSLRGSKVDLSLTLPRLSHLTIDHCIDVTKLPSAICDINSLECLSISNCHDLSELPCEF
GKLNSLKILRVYACPALKRLPHSICLLKGLKYLDISQSFNLRELPEELGYMTSLEKFDMRECSQLKTLPR
SSSSLKSLGHVICDEDIALLWKEAERDIPDLHIQVAEESFNLDWLVE


>XP_042417193.1 probable disease resistance protein At1g58602 [Zingiber officinale]
MDASAVVRVVDKLSKLIYQEANYLGSFRDAVEWLNIELHRIQCFLKDAEPKGSKGDERVKNWVREIRDVA
YEIEDLIDIIGAASKRKNHRRRKRTFVGLASRYATAPFDYYSRHHLLCGIDRIKEKIVDISRSREIFGVS
NFGGSRDPDRVDVNLPTPLLASPDFEDDVHLVGFEEDKELLVRHLIDQQNQWRSFVSVVGMGGLGKTTLA
KKVYRDPRVRKQFDVLCWVSVSKNYRGAEFLNCIIEKVMGLTGEELLRMRREELERKLDQQFQERRCLIV
LDDVWLSSTCEDLKRLFPDHKNGSRVLLTTRSLDVARSADPSFAPHMPRFLDDDESWELLQKKAFPSRRG
HERRCPGDLEEVGRKLAKNCHGLPLALVVLGSLLFKKGPFPATWNRVFESLDWEFMEDGNKCFDILALSY
DDLPDDSFRSCFLYISSFPEGSEIFVSRLIELWNAEGFIRPRPKEAVEKTAKDYIDELSQRCMVQVVKRI
AGHGPAKSIRIHDLLREWCISKARMEGFLHVVGGKEKNAAAIDATTACRRTALPDGLNGGGGPYVPSPKL
RALLAFNCKNLGNSKQLSFTSLRTLRVLYLEGSSGIMKLPEDIKSMVHLRYLGLKTRLVELPPSIADLPY
LEVLDARLSRIIQLPSRLWRIATLKKVYVGSVEQPVKISKLGNSQSLRVVEWVDIAGGWIERTENEISSF
RKLGITGIQQAHRKALTRFLRKLRHLASLNLCFSDHDGEILTHVLRSLSDHHELRSLKLHGRYFLAISRR
AWGAFPPNLTKLVLNRFEFLQDPMEELEKLRHLVDLQILAPEVGHHLVAPDYKVMTCSAGGFPRLQHLQM
YGLKVEEWRIEASAMRSLTSLTVISMVKLRRVPEGLQHIATLQELAFNDMSRDFYRRIKASEGEDWQFIS
HVPCVSIREGFMKIWLSDSFPSQQLKAFIFSRKAAKEFIMGGRSSNVPEKLQLELLTSEDSPGVLDETDT
VIEGR


>XP_042417194.1 probable disease resistance protein At1g58602 [Zingiber officinale]
MDASAVVRVVDKLSKLIYQEANYLGSFRDAVEWLNIELHRIQCFLKDAEPKGSKGDERVKNWVREIRDVA
YEIEDLIDIIGAASKRKNHRRRKRTFVGLASRYATAPFDYYSRHHLLCGIDRIKEKIVDISRSREIFGVS
NFGGSRDPDRVDVNLPTPLLASPDFEDDVHLVGFEEDKELLVRHLIDQQNQWRSFVSVVGMGGLGKTTLA
KKVYRDPRVRKQFDVLCWVSVSKNYRGAEFLNCIIEKVMGLTGEELLRMRREELERKLDQQFQERRCLIV
LDDVWLSSTCEDLKRLFPDHKNGSRVLLTTRSLDVARSADPSFAPHMPRFLDDDESWELLQKKAFPSRRG
HERRCPGDLEEVGRKLAKNCHGLPLALVVLGSLLFKKGPFPATWNRVFESLDWEFMEDGNKCFDILALSY
DDLPDDSFRSCFLYISSFPEGSEIFVSRLIELWNAEGFIRPRPKEAVEKTAKDYIDELSQRCMVQVVKRI
AGHGPAKSIRIHDLLREWCISKARMEGFLHVVGGKEKNAAAIDATTACRRTALPDGLNGGGGPYVPSPKL
RALLAFNCKNLGNSKQLSFTSLRTLRVLYLEGSSGIMKLPEDIKSMVHLRYLGLKTRLVELPPSIADLPY
LEVLDARLSRIIQLPSRLWRIATLKKVYVGSVEQPVKISKLGNSQSLRVVEWVDIAGGWIERTENEISSF
RKLGITGIQQAHRKALTRFLRKLRHLASLNLCFSDHDGEILTHVLRSLSDHHELRSLKLHGRYFLAISRR
AWGAFPPNLTKLVLNRFEFLQDPMEELEKLRHLVDLQILAPEVGHHLVAPDYKVMTCSAGGFPRLQHLQM
YGLKVEEWRIEASAMRSLTSLTVISMVKLRRVPEGLQHIATLQELAFNDMSRDFYRRIKASEGEDWQFIS
HVPCVSIREGFMKIWLSDSFPSQQLKAFIFSRKAAKEFIMGGRSSNVPEKLQLELLTSEDSPGVLDETDT
VIEGR


>XP_042417195.1 putative disease resistance RPP13-like protein 3 [Zingiber officinale]
MDASAVVRVVDKLSKLIYQEANYLGGFRDAVEWLNTELHRIQCFLKDAEPKGSKGDERVKNWVREIRGVA
YEIEDLIDIIGAASKRKNHRRRKRTFVGLASRYATAPFDYYSRHHLLCGIDRIKEKIVDISRSREIFGVS
NFGGSRDPDRVDVNLPTPLLASPDFEDDVHLVGLEEDKELLVRHLIDQQNQWRSFVSVVGMGGLGKTTLA
KKVYRDPRVRRQFDVLCWVSVSKNYRGAEFLNCIIEKVMGLTGEELLRMRREELERKLDQQFKCWV


>XP_042418551.1 probable disease resistance protein At1g61300 [Zingiber officinale]
MAFIKLNLNVDVNSCLSGLWASLQLAIGRPKTAIKKLEKEMARLRGKRNDIKNQISEAEREGKIPTNEVN
QWLQEVEELEGQVADINQDFQSMISCFSCNCFSFSLTQEAGDQVPIREPSNGCSIIRRVVKKLGEANELM
SRASIVLDPIATVGPPEPTVMLPIVHRPPVGIESYVEDIVGYIDGGEGSIIGIYGMGGVGKTTVLKSVQR
HYYNHRIIFDHVIWVVASKDCQLKRLQMEIARTLGLNTLQESDDEATCGDKLFSYLKNKNCLLLLDDSCE
YLNLQLLGMAHSATEQGQQQHELRRKVVVFTTRSEIVCARMEAEKKIKVKCLDQDQAWQLFKENVDGDVL
SSDRGINSCAQEIAKECAGLPLALITVARAMLGKKSWELWKDALHQIRDKHEWTSTIDLSEEDSVVMYKA
FKLSYDSLENDSIRECLLCCALWPEDYEIHKFKELIPCWIGCGIIREFNVINEAFTKGCSHLEALMAASL
LEHSSRRPNYYEAEHVKMHDVIRDMALLMFSELKGNRRKSIVKAGFGLHNLPRQEEWQEAERALFIENQI
VSLPEYEASSFPKLSMLILFFNYPPLNIPRSLFTSMPRLTYLDLSKCFIIELPMEIGSLTELQYLNLSYN
TITSLPLELGCLGKLEYLLLRDNCLKTVPNGIISNLLMLKWLDISQQIPVCEQWWDELVHFRGCHQLSLE
ISIYATDLKRLNMLPNVSVRNLAMSGLSSNFQMLQWSLRVTDNLECLTISNVWKGDQLMVNAGVDCESNF
KCLKTLNFKFLYQLKINWVDGVGFNNLRDLYISNCYKLKDVSWVLQLSCLNLLSILNCQEMEEIISNVGS
SNSSFGIKMLGLSKMDNLQRIAYQPLHFPYLEYITVSYCPRLKKLPFGAETVKNRLKEIQGGPNWWDDLD
WDDHRIKDSLTPYFRDGSNLLRQEKWQPTLIVEDHIIWLPAGLDDPEDNGSDDEEDGENEPEANGEGGSE
QEDDEDDDDEEEEDDEYEEEENVEKDDGLQHHQQRRGSEVYCCILLGYLVLVEFFIFFLVIFTSA


>XP_042419425.1 probable disease resistance protein At1g61310 [Zingiber officinale]
MTYEGTFSSLANEVGQLKGKSVDVKREVEAAERDGLTPRREVLGWLNSVQNMEDEAKSIEGIYDQKIKCL
CSFPFNVCSAYRLRNRAEAALATIRELKQSAEFTKLADNLNLTRSIKMPNTKTIGMDKVFEELQRHGKDD
SLSVIGIHGMGGVGKTALLRRFNNDFPSETEADVVIFHELSIDYKLEEVQKSLFDRLSLTWQDEVTHRDR
ATKLFRVLSTLNFVLLLDNLWEPLNYQVIGIPLPAAPSKCKIIFTTRTEDTCSHMGTDKMIKVECLEEEA
AWNLFRNSARMDAIDADKNILFEARDLVKECGVLPAALIVLAQAMAHKKTWEEWIHALRIMKDVHQLPGM
TNNVFSILRN


>XP_042419437.1 disease resistance protein RPS2-like [Zingiber officinale]
MEDEAKSIEGIYDQKIKCLCSFPFNVCSAYRLRNRAEAALATIRELKQSVEFTKLADNLNLTRSIKMPTT
KTIGMDKVFEELLRHAKDDSLSVIGIHGMGGVGKTALLRRFNNDFPSETEADVEPLNYQVVGIPLPAPPS
KCKIIFTTRTEDTCSHMGTEKMIKMECLEQEEAWNLFRNSARMDVIDADKNIRIKARDLVKECGGLPAAL
IVLAQAMAPKKTWEEWMHALTIMKDAPHQLPGMTNNVFSILKLSYDRLSSDNLRVCASYGALFKKGSWMG
KYNIRNLWIGEGIIDNAENIWDCTRKTQFLLGILHATSLTERVHDDYFTIHPMTRAMILWVQRECGKKEN
KWLVRDRERIEEAPTAEKWQDAERIALDWNQISDLPEAPQCPNLIFLNLHVNKFLRKIPNGFFLHMPHLK
ILDLQNTSIRELPVSIGNLVQLHFLDLSETRITSLPKEMAALVNLKYLSLESMKYLRTIPDRLISGLREL
QWLDMADSYSGWREGQTWEGGVSFEELESLKRLKVIGITVSTLAALQNLCDSLRLAAFTHWLHIEGCQDL
TMFNIPSTDFHAETMLRLIRIQLHAMSELEEVVIGNRQPILLPLHELRLSSLPKAKLVWRPTFPNTLRQL
KIEGCGAIDRLIKLEGEANGSGETVITIFPDLHTMVLRRLPELKSLSDGERILNFPSLKTIKVEDCPKLT
KLMLVADGLKEIECERSWWEQLNWGDERTKSFQHLYKPMYID


>XP_042419482.1 disease resistance protein RPS2-like [Zingiber officinale]
MGSVSPSSLMDIFNLLKACCSPSCNYIMTYEGTFSSLASEVGQLKDKSSDVKRDIEAATRDGQTPRSEVL
GWLSSVQDMEGEAESIERKYNQKIKCLCSFPLNVCSAYRLRNRAEAALATIRELKQSVEFTKLADNLNLT
RSIKMPTTKTIGMDKVFEELQRHAKDDSLSVIGIHGMGGVGKTALLRRFNNDFPSETEADVVIFLELSID
YKLEEVQKSLFDRLSLTWQDEVTHRDRATKLFRVLSTLKFILLLDNLWEPLNYQVVGIPLPAPPSKCKII
FTTRTEDTCSHMGTEKMIKMECLEEEAAWNLFRNSARMDVIDADKNVRIEARDLVKECSGLPAALIVLAQ
AMAPKKTWEEWMHALTIMKDTPHQLPGMTNNVFSILKLSYDRLSSDNMRVCASYGVLFIKGSWIGKYNIR
NSWIGEGIIDNVQNVMDADHKTQLLHDASHDPGHDIVERECGKKENKWLVRDRERVEEAPAAEKWRDAER
IALVWNQISDLPEAPQCPNLVFLNLQVNKFLRKIPNGFFLHMPLLRILDLQNTSIEELPVSIGNLVQLHF
LELSRTRITSLPKEMAALVNLKYLSLAFMKYLRIIPDQLISSLRELQWLIMMDSYSGWKEGQSCEGGVSF
EELESLKRLKVIGMTVSTLAALQNLCDSPRLAPLTHWLHIEGCPDLTMFNIPSMDFHAETMSSLGQIQLH
AMSELEEVVIGNRQPILLPLQDLQLSSLPKAKLVWRAMFPNTLRELKIEGCGAIDRLIKLEGEANGSGET
VITIFPDLHTMVLRRLPELKSLSDGERILIFPSLKTIKVEDCPKLTKLMLVADGLKEIECERSWWEQLNW
GDERTKSFQHLYKPMYID


>XP_042419507.1 disease resistance protein RPS2-like [Zingiber officinale]
MECLEEEAAWNLFRNSARMDVIDADKNIRIQARDLVKECGGLPAALIVLAQAMAPKKTLEEWIHALTIMK
DTPHQLPVTTCEFAPLMVHYSKKDLGLANIILGIWIGEGIIDNADNIWDSTRKTQFLLGILHAASLTERV
NDDYCLSRAPISNNYFTIHPMTRAMILWVQRECGKKENKWLVRDRERVEEASAVEKWRDAERIALVWNQI
RDLPEAPQCPNLIFLNLDVNKYLRKFPNGFFLHMPHLKILDLQQTSIEELPVSIGNLMQLHFLQLSGTRI
TSLPKEMAALVNLKYLSLESMKYLRTIPDRLISGLRELQWLDMVDSYSGWREGQTWEGGVSFEELESLKR
LKVIGITVSTLAALQNLCDSPRLAAFTHWLHIEGCQDLMMFNIPSMDFHAETMLRLIRIQLHAMSELEEV
VIGNRQPILLPLQELRLSSLPKAKLVWRAWFPNTLVALKIEDCRAIDRLIKLEGEANGSGETIITIFPYL
QIMVLRQLPELKSLSDGQRILNFPSLKTIKVEDCPKLTKLTLVADGLKEIECERLWWEQLNWGDERTKSF
EHLYNPMI


>XP_042419532.1 disease resistance protein RPS2-like [Zingiber officinale]
MGSVSPSSVMDIFNLLKACCSQSCNYIMTYGGTFSSLASEVGQLKDKSSDVKRDVEAATRDGQTPRSEVL
GWLSSVQDMEGEAESIERKYNQKIKCLCSFPLNVCSAYRLRNRAEAALATIRELKQSAEFTKLADNLNLT
RSIKMPTTKTIGMEKVFEELLCHAKDDSLSVIGIHGMGGVGKTALLRRFNNDFPSETEADVVIFLELSID
YKLEEVQKSLFERLSLTWQDEVTHRDRATKLFRVLSTLKFILLFDNLWEPLNYQVVGIPLPAPPSKCKII
FTTRTEDTCSHMGTEKMIKMECLEEEAAWNLFRNSARMDVIDADKNVRIEARDLVKECGGLPAALIVLAQ
AMAPKKTWDEWIHALTIMKDTPHQLPGMTNNVFSILKLSYDRLSSDDLRVCASYGALFKKGSRIGKYNIR
NLLIGEGIIDNVQNPIDADNKTQFLLGILHAASLTVRVHDDYFTMHPMTRAMILWVQRECGKKENKWLVR
DRDRVEEAPAAEKWRDAERIALVWNQIRDLPEAPQCPNMIFLNLHVNKFLRKIPNGFFLHMPHLKILDLQ
ETSIEELPVSIGNLMQLHFLELSRTRITSLPKEMAALVNLKYLSLESMKYLRTIPDRLISGLRELQWLDM
VDSYSGWREGQTWEGGVSFEELESLKRLKVIGITVSTLAALQNLCDSPRLAAVTHWLHIEGCQDLTVFNI
PSTDFHAETMLRLIRIQLHAMSELEEVVIGNRQSILLPLVELRLSSLPKAKLVWRPTFPNTLVALKIERC
GAIDRLIKLEGEANGSGETVITIFPYLRTMVLRRLPELKSLSDGERILNFPWLKTIKVEDCPKLTKLTLV
ADGLKEIECERSWWEQLNWGDEQTKSFQHLYNSM


>XP_042420179.1 probable disease resistance protein At4g27220 [Zingiber officinale]
MPSHRYCSGFIILLSPLVASGSILLAIIDIAEIMVPPCFNTCCGGIGSGTGNEIVKYSWKKLKTHACYFI
YCKKKFEKLKEQFDLLKAIRDDTQQKVEAAKRNNKVISDEVNLWLNKVLELEGKFNNIEKNFNRIVEDEK
FCIPSLVSRYKVGREATRKKDKALKLLDRSNFQAFSHPLDPSTVNHPSNADFVSFGATKEAMQKVIDALN
DDKVNLIGIYGMGGVGKTTLMEEIGRMVKGAKTFDVVIDVVVSQNPNIAQIQRDIADALDMRESSNKMLA
TRLKQEKKVLIMLDDVWARLELVKAVGIPYREHKGCKVILTSRKAETCNVMETDVSVEVATLSEEDSWHL
FRMRAGQVAASDGIEPIARKVAQECCGLPLAIVVVGRALRSYKDSSAWEDALSQLKQAVPLNMEEVEEKL
YKPLELSYQNLKTAELKQLFLYCCLFREDYDISEDEVTRYAVGENLLSNLSTLEDVRGRVHFLLQKLKLS
CLLLDSKKAGCVKLHDVVRDVAVYIGSKDNNHFLVKAGHGLTDWPECGNLSDCKRISLSNNFLQEIPEKP
NCSKLILLLLNMNPITWVPINFFENMATLTVLDFSNTGITSLPSSLTCLNGLGTLRLDRCKQLKDINVVG
ELKTLIILTLQECRGISALPETIDGLLKLKLLDLSNCTSLQILRNFIPKLTQLEELYLRGYNVTEELLVE
VASLKRLVRVELYVKCARDFSEQVFPNNAYKVLRHFIIYNEPDWFSLASKYQRNFFIKQASQSMISWGKP
FLRSAEELRLDSCQWNFTDLMSCFATLKSLLIVNCHQIQCLLWSTDDTPSNAFGELMKLTLSDMEKLEQV
CHGQLPAHSLGKLRTLELRWCRNIVDILPQDLLQRVHPSLVELLLEGCPGPHVLLNFEGLGHDSIIFPKL
QMIRVSQMSDVISFCNGVVPPGSLHNLTTFEVVNCKKLLNLFSQTLDTTHSRLLPSETFKKLKQLQIMGC
PCLKHVFLPSIANELQSLERLEIKNNSSIETIIANEEGCNLKKGAFPILKRLLFIKLPRLICFFEGEPAK
TLDWPSLEYIHFGDCSNLARLPIGHESAQKLKKVHVARLDDVNWFESLKWEVDTIKSRFDIIQSINEVK


>XP_042420180.1 probable disease resistance protein At4g27220 [Zingiber officinale]
MVDPCLSNFCGGLESAIVKYFWKKLKTHTSYFIYCKKKFEKFKQQFDHLKAIRDGTQQKVEAAKRNNEVI
SDEVNLWLNDVLELEEKFNNIENNFNRIVRDEKCCIPNLAPRYKVGRDATKKKAEASELLDRKNFQVFSH
TIDPSNLGHSSNKDFVSFGATNEAMQKVIDALNDDKVNLIGIYGMGGVGKTTLMEEVGRKMKEAEIFHVV
IDVVVSHNPNIAQIQRDIADQLGMRESSNKMLTTRLKQEKKVLIMLDDVWARLELVKEVGIPYREHKGCK
VMLTSRKAETCNVMEADVSVEVANLSEEDSWQLFRMRAGQVAESDGIELVARKVARECCGLPLAIAVVGR
ALRSYKDASAWEDALSQLKQSVPLHMEELEEKLFKPLELSYQNLKTAELKQLFLYCCLFREDYDISEDEV
TQYVVGENLLSNLSTLEDVRGRVHFLLQKLKLSCLVLDSKKAGCVKLHDVVRDVAIYIGSKDNNHFLVKA
GLGLRGWPECKNLADCKRISLSNNFLQKFPEKPNCSKLILLLLNMNPITSVPDNFFENMATLNVLDFSNT
DITSLPSSLTCLKCLGTLRLDRCKWLIDINVVGELKTLIILTLQECRGISALPESLYCLVKLKLLDLSNC
TMLQIPRNSIHKLTQLEELYLRGYNVTEALLVEVASLKSLVRVELYVKYAKDFSEQIIPADSYKVLRHFI
IYNESDRFSLASKYQRNIFIKQANHSMISWGKPFLRRAEELRLDSCQWNFTDLIPLENLSCFATLKSLLI
VNCRQIQCLLRSTDDTPSNAFGELMKLTLLDMEKLEQVCHGQLPAHSLGKLRTLELRRCRNIIDILPQDL
LVRVHQSLVELLLEGCPGPHVLLNFEGLGHDSVIFPKLQMIRLSQMSNLISFCNGVVPLGSLHNLTTFEV
VNCKKLLNLFSQTLDATHSRLLPSETFKKLKQLQIMGCPCLKHVFLPSIANELHSLERLEINNNGSIETI
IADEDGCDLKKGAFPMLKKVVFIKLPRLRYFFEGEPTKILDWPSLEYIHVVECWNLARLPIERGSFQKLE
NVHFVRFDNVNWFKTLKWEDHTTKSRFDIIQSINEVK


>XP_042420181.1 probable disease resistance protein At4g27220 [Zingiber officinale]
MRAGQVAESDGIEPIARKVAQECCGLPLAIVVVGRALRSYEDASAWEDALSQLKQSVPLNMEEVEEKLFK
PLELSYQNLKTAELKQLFLYCCLFREDYNISEDEVTRYAVGENLLSNLSTLEDVRGRVHFLLQKLKLSCL
VLDSKKAGCVKLHDVVRDVAVYIGFKDNNHFLVKAGLGLIDWPKYENLADCKRISLSNNFLQEIPEKPNC
SKLVLLLLNMNPITSVPINFFENMVTLNVLDFSSTEITSLPSSLTCLKRLGTLRLDRCKRLNDINVVGEL
KTLIILSLQQCKGISALPETVDGLVKLKLLDLSNCTLLQIPRNLIPKLTQLEELYLRGYNVTEALFVEIA
SLKRLVRVELYVKDAQDFSLKVIPSNAFKNLCHFIIYNELDWFTMASAYQRKLFIKQASQSVIIWGMPFL
RGTEDLMLDSCQCNLTDLTPLENMSCFANLKSLTLTNNHQIQCLLRSTNGTPSNAFGELVKVNILNMEKL
DQICHGHLPDLSLRKLRTLVLKRCRNLVDIFPRDLLQRVHSSLVELLLEGCPGSGILLNFEGLGHDSVFF
PKLQTIRLSQISDVISFCTGVVPPGSLHNLTTFEVVNCEKLSYLFSPTLDATHSRLLPSDTFKKLKHLKI
MGCPCLKHVFLPSTANELQSLERLEIKNNDSMETIIAEEEGCDLEKGAFPMLNRLLFIKLPVLCCFFKGE
PAKTLDWPSLEYIHLGDCSKLAGLPIGRESAQKLKKVHVVRPDDVDWFTTLKWEDDTIKSRFDIIQSIDE
VE


>XP_042420182.1 probable disease resistance protein At4g27220 isoform X1 [Zingiber officinale]
MPSHRSFSEFIILFIAVFFFFPDFILLTIIGIAEIMVVPCFSNFCGGMESEIGNVIVKYFWNKLKTHACY
FIYSKEKFEELKEHFDILKAIRDDTQQKMEAAERNNEVISDEVNLWLNNVLELEGKFNNIENNFNRIVRD
EKCCIPSLVPRYKVGREATKKRAKALELLDRKNFQAFSHTLDPSTLTHPSNKDFVSFGATKEAMRKVIDA
LNDDKVNLIGIYGMGGVGKTVLMEEIGRKMKEAETFDVVIDVVVSQNPNIAQIQRHIADALGMRESSNKM
LATRLEKEKKVLIMLDDVWARLELVTEVGIPYQEHKGCKVMLTSRKAETCNVMETDVSVEVATLSEEDSW
QLFRMRAGQVAESDGIEPVARKVAQECCGLPLAIAVVGRALRSYKDARAWEDALSQLKQSVPGNMEEVEE
KLFKPLELSYQNLKTAELKQLFLYCCLFREDYDISEDEITRYAVGENLLSNLSTLENVRGRVHFLLQKLK
LSCLVLDSKKAGCVKLHDVVRDVAVYIGFKDNNHFLVKAGLGLIDWPKYENLADCKRISLSNNFLQEIPE
KPNCPKLILLLLNINPITSVPDNFFENMVSLNVLDLSNTDITSLPSSLICLKGLGTLRLDRCKQLNDINV
VGELKTLVILTLQECRGITALPETVYGLVKLKLLDLSNCTLLQIPRNLVPKLTQLEELYLRGYNVTEALL
VEVASLKKLVRVELYVKYARDFSEQIIPDNAYKALRHFIIYNEPDWFSLASKNQRDFFVKQASQSMISWG
KPFLKRAEALRLDSCQWNFTDLIPLESMSCFANLQSLLIVNCHQIQCLLRSTDDTPSNAFGELMKLTLLD
MENLEQICPGQLPAYSLKKLRTLELRRCRNIVDILPQDLLQRVHPSLVELLLEGCPGPHVLLNFEGLGHD
SVIFPKLQMIRLSQMSNLISFCNGVVPPGSLHNLTTFEVVNCKKLLNLFTQTLEATHSRLLPSETFKKLK
QLQIMRCPCLKHVFLPSIANELQSLERLEIKNNDFLETIITDEEGCDLKKGAFPMLKQLLLIKLPSLRYF
FEGEPAKTLDWPSLEYIHLSDCLNLARLPIGHESAQKLKKVHVVRLDDVNWFKTLIWEDNITKSRFDIIQ
SINEVK


>XP_042420183.1 probable disease resistance protein At4g27220 isoform X2 [Zingiber officinale]
MVVPCFSNFCGGMESEIGNVIVKYFWNKLKTHACYFIYSKEKFEELKEHFDILKAIRDDTQQKMEAAERN
NEVISDEVNLWLNNVLELEGKFNNIENNFNRIVRDEKCCIPSLVPRYKVGREATKKRAKALELLDRKNFQ
AFSHTLDPSTLTHPSNKDFVSFGATKEAMRKVIDALNDDKVNLIGIYGMGGVGKTVLMEEIGRKMKEAET
FDVVIDVVVSQNPNIAQIQRHIADALGMRESSNKMLATRLEKEKKVLIMLDDVWARLELVTEVGIPYQEH
KGCKVMLTSRKAETCNVMETDVSVEVATLSEEDSWQLFRMRAGQVAESDGIEPVARKVAQECCGLPLAIA
VVGRALRSYKDARAWEDALSQLKQSVPGNMEEVEEKLFKPLELSYQNLKTAELKQLFLYCCLFREDYDIS
EDEITRYAVGENLLSNLSTLENVRGRVHFLLQKLKLSCLVLDSKKAGCVKLHDVVRDVAVYIGFKDNNHF
LVKAGLGLIDWPKYENLADCKRISLSNNFLQEIPEKPNCPKLILLLLNINPITSVPDNFFENMVSLNVLD
LSNTDITSLPSSLICLKGLGTLRLDRCKQLNDINVVGELKTLVILTLQECRGITALPETVYGLVKLKLLD
LSNCTLLQIPRNLVPKLTQLEELYLRGYNVTEALLVEVASLKKLVRVELYVKYARDFSEQIIPDNAYKAL
RHFIIYNEPDWFSLASKNQRDFFVKQASQSMISWGKPFLKRAEALRLDSCQWNFTDLIPLESMSCFANLQ
SLLIVNCHQIQCLLRSTDDTPSNAFGELMKLTLLDMENLEQICPGQLPAYSLKKLRTLELRRCRNIVDIL
PQDLLQRVHPSLVELLLEGCPGPHVLLNFEGLGHDSVIFPKLQMIRLSQMSNLISFCNGVVPPGSLHNLT
TFEVVNCKKLLNLFTQTLEATHSRLLPSETFKKLKQLQIMRCPCLKHVFLPSIANELQSLERLEIKNNDF
LETIITDEEGCDLKKGAFPMLKQLLLIKLPSLRYFFEGEPAKTLDWPSLEYIHLSDCLNLARLPIGHESA
QKLKKVHVVRLDDVNWFKTLIWEDNITKSRFDIIQSINEVK


>XP_042420184.1 putative disease resistance protein RGA4 [Zingiber officinale]
MAASRPAVSLHHSLFPPPALLSTIHRLASYLSSCRTPPPSSDLHRNLSALHASLLRTATLVDYVTRLPPS
LTGKLVDAIFAADDLVDQLEYESLQKQVEEMEKAEAEKDGVGGKIVDLSVFRGFQTGEDDDTANLKLAAP
SSSISGSLRRPALNPSVETEAKGAELTLESNTDRGLDVESRVPDPSICGCFCSSKTKKQRETRSSRFLSC
CFGFNKDSRSAVNGNHAAKKEDSITVAARTEIGGEIGSGTQKNDLSSSQVSNSEGQKNSLEEINVDRIMK
IVESLDIVSAYLRESTGISFSTCDLESPHEILHKEKAASSLSLGDLFFYNDEKEQLVKELLKFNEDNVCI
FPILGPRGVGKTTLAHFVYQDERIEEYFHSRVWICASDDLNSMRITGVTADPPSISTPLAARELEKLKFM
VRNLQDQLKEKRFLLVLDDVESIEWVMQFASLKDCGKGSKIIITAREEGVIDERGKGNKILLKGVIDEGN
HFLSFFNWCAFNCEDPQNYSELQVISKRISTLLNGNPLAAKAVGGVLQTEFTDAHWTRILNELLELKDDL
TDIMPVLMLCYNHLPPHLKWCFAYCSVFSKGYPFDAQNLINMWISLGFVEPTDSNKTVEDVGREYLDGLL
SRSFLELPIYNRSYWRSRYYAMHNLMYDLSKSVGVKECLVYENETIYQLYLDRWKYFRSFICNSKHVINF
GVLSRIRVLDLSYSGMKQLSNSIGNCIHLRYLNLDGNNLYKLPESLCKLYHLKFLAVPENCHRLPERFNN
LINLRHLNASEEAIAWIANKGRLARLQELKKFHVRLKKGYDIGQLKDLIELKGELCIQDLNDVGRKEEVI
EADLNGKTRIEKLQLKWRTWRKEGLRVDAQEVLESLKPPPCLKHLEIHSFGGSQSPGWLEDQSLIFLQSI
HLKNCNKWNQLPPFGHLPHLKVLKIEGMNVIVDGGTWMIDPYPSLRELYLDNTSIMFEDISWQEQRCKCF
LKLKKLVAVKCKRVGGLPPLALLSSLEELEIKKSPDLESQLSGCLKHLKSLTTLKMSAPNLTHFPCQVLQ
HLKYLEIDGCQSLVSWLIDNEEDVHHSSLVSLSIVNSPLPAGPVLVKFLTSIRELRIDQCIKISSFSKEQ
KEWFASLISLEKLSISNCAQLRELPPNLHQLLSLKQMIIQGCPNLDSLPSNLPESLKVFEILKCNSVLVS
QLLGEEAPDWIKRIPFRYIA


>XP_042421678.1 disease resistance protein RPS2-like [Zingiber officinale]
MADIISGIISFFTCLKDCCFQSSNYIVSYERIISSLATELAQLKSKREDIKRQIEAAERDGLNPKREVLG
WLQSVEALTSEAENINGTYHQMFKCLCNFPVNVCSGYPLRSKAEAALMTAADLKEKAGEFTDVADDLDVD
RFLEMPNPKTVGMDTALAALQGNARDDDVSIIGIHGMGGVGKTALLRRFNNHFAEMEVDNMDVVIYLELS
TGYKVEEIQKSLFDRLKLTWKDEESQRNKAGRLFRVLSKMTFSLLLDNVWEPLNCQIVGIPLPQPPSKSK
IVFATRMEEVCSRMGAEKTIKLECLSEEASWDLFRFNAKLELVNTNTLILNLARALVQQCAGLPAALITV
AQAMASKRTIAEWRHVLAIMKEAPFQLPGMEEHVYHPLKLSYDRLSDTLRTCASYFALVQEGCWLSKFYV
RELWIGEGFINDFERLSDTADKASYLLGMLLAASLIQRIDSEYFKMHPMVRSMILWMECDCGKKESKWLI
GDRHSLAEAPGAEKWRAAERISLGWNNIALLPDEPQCPDLIYLHLRNNHPLKNIPNEFFSHMPCLRILDL
QQTSIEELPPGIGNLSQLQLLDLSSTRIASLPREIQSLVNLRYLAMSSATHLRSIPSAVIPCLHHLQWLN
MYNSYSGWRVMGALQLDGEGVLLNEVESLKKLKVLGVTMNSVTTLRRFCESQRLTAAVHWLQIEGCGGLT
SLDIPSTYCLGENMQNMVQIRLHAMTDLEEVFIGGDLHACNALSCLEYLRLLALPKAKIIWKNRCLENLL
ELEIEDCNAIDRLMKVVTNATNSTETITIFPRLRKIVLRKLPELESLSDGDQVIAFPSLKTMEVRNCPKL
KKLALAAENLTEIKCDREWQDELDWSDERTLSFQKLFERPDRR


>XP_042421684.1 disease resistance protein RPS2-like [Zingiber officinale]
MADIISGISSIFTCLKGCCFQSCNYIVSFEGAISSLIAELDQLKSKSMDIKRQVEAAQRDELNVKQEVLG
WVKSLEDLSSEAENINAAYRRKFKCLCNFPINVCSSYPLRTRAEAALTAAADLKKKAGEFADVADDLDVD
RVLEVPNPKVIGMDTALEELQGHVRDDDVIIIGIHGMGGVGKTALLRRFNNDFAGKELDNLDVVIYLDLP
TEYQVEELQKPLFSQLKLTWKDEATQRDRAGRLFRVLSKMRFLLLLDNVWEPLNCQVVGIPLPQPPSKSK
IVFATRMEDVCSRMGAEKTIKLECLSSEEAWDLFRFNAKLNLASTDASILDLARALARQCAGLPAALISV
AHAMASKRTFAEWRHVLAIMKEAPFQLPGMEEHVYHPLKLSYDRLSDTLRTCASNFALVQEGRLLSKQYV
TDLWIGQGFINDFEKSSDTSDKASYLLGMLLAASLIQRFDDKYFKMHPMVRSMILWMECDCGKKESKWLK
RDGHGLAEAPGAEKWRVAERISLGWNNIALLPDEPQCPDLIYLNLRKNPPLRNIPNKFFSHMPCLRILDL
QQTSIEELPSGIGNLSQLQLLDLSFTKIASLPREIQALVNLRYLAMPSATHLRSISSAVIPCLHRLQWLD
IYNSYSGWRVAGALQSDGEGILLDELESLKKLKVLGITISSETALRRLSELQRLAAAVHWLQIEGCGTLA
RLDIPSTYCFGENMKNLKQIRLQAMPDLEEVIIGGDLHARNALSCLNFLYLSALPKAKIIWKNRCLANLC
GLDIQDCNVIDRLLKLEDNAANSTETITIFPRLTKIVLRKLPELESLSDGDRVIAFPSLKTMEVRNCPKL
KKLTLVAENLREIQCDKEWWDKLDWSDERTLSFQKLFKQAD


>XP_042421685.1 disease resistance protein RPS2-like [Zingiber officinale]
MADIISGISSIFTCLKGCCFQSCNYIVSFEGAISSLIAELDQLKSKSMDIKRQVEAAQRDELNVKQEVLG
WVKSLEDLSSEAENINAAYRRKFKCLCNFPINVCSSYPLRTRAEAALTAAADLKKKAGEFADVADDLDVD
RVLEVPNPKVIGMDTALEELQGHVRDDDVIIIGIHGMGGVGKTALLRRFNNDFAGKELDNLDVVIYLDLP
TEYQVEELQKPLFSQLKLTWKDEATQRDRAGRLFRVLSKMRFLLLLDNVWEPLNCQVVGIPLPQPPSKSK
IVFATRMEDVCSRMGAEKTIKLECLSSEEAWDLFRFNAKLNLASTDASILDLARALARQCAGLPAALISV
AHAMASKRTFAEWRHVLAIMKEAPFQLPGMEEHVYHPLKLSYDRLSDTLRTCASNFALVQEGRLLSKQYV
TDLWIGQGFINDFEKSSDTSDKASYLLGMLLAASLIQRFDDKYFKMHPMVRSMILWMECDCGKKESKWLK
RDGHGLAEAPGAEKWRVAERISLGWNNIALLPDEPQCPDLIYLNLRKNPPLRNIPNKFFSHMPCLRILDL
QQTSIEELPSGIGNLSQLQLLDLSFTKIASLPREIQALVNLRYLAMPSATHLRSISSAVIPCLHRLQWLD
IYNSYSGWRVAGALQSDGEGILLDELESLKKLKVLGITISSETALRRLSELQRLAAAVHWLQIEGCGTLA
RLDIPSTYCFGENMKNLKQIRLQAMPDLEEVIIGGDLHARNALSCLNFLYLSALPKAKIIWKNRCLANLC
GLDIQDCNVIDRLLKLEDNAANSTETITIFPRLTKIVLRKLPELESLSDGDRVIAFPSLKTMEVRNCPKL
KKLTLVAENLREIQCDKEWWDKLDWSDERTLSFQKLFKQAD


>XP_042422892.1 disease resistance protein RGA2-like isoform X1 [Zingiber officinale]
MLVFLELKHLLLEVLPSPTMVAQGRLLCIQNHLAMVCDSLWAINSMIEIPEMGVLFNYIWHHRFNSPLHV
PVEFADWVTDVATAVIDMGELLSRIMDWEASLHFRHVILVELKEMLCDLNSLALRGSAMGLPRDPMGSMN
PLREDYSIVLKNEVVGRHEDLEKLIEIFQQQQLVPSNNNGDDYNPFVIVIDGEERVGKTTLAYMIYHHTW
VRQQFHHRIWVDLSPSVSTLEMIKIIGKEFAESINNEEYCDQKLHLELPLQAMWEYINEQLDGSRYLLVL
HCLDLNSLISQPEWSELKNILLRVGGPGSAVLVILKSSTQSVSDMSFQNRVKDITTYYLKPLSDDAWLEL
FKRHAAMTIPPSKRDIVFKGSTFAMPLFQLVGQTFGAKFWGSLGHSIQVEDLFPCEIKDIHMVRNFPFAI
VRLLQYHYLLDKDYNVILHMLTAESLIPVEGLSPGWTEIYERFRYGRESTFCFPRKVYLHRKVPGDSTTI
PRCCRYLRLEINARAIPFRLPTMPVEVNKKMIALILREDEATTQEDDKRMTFQVYKKRLMKPATTISLQV
YKKRRTKAATTISKFLDKMSVRLVHLHILVVETSMIQSLPNEISKLVSLRYLHLSKLEIELLPKSLFDLL
NLQILSLLHCKNLQKMPGRIHKLKKLQILKLAYCTKLQQLPRSITRLKNLEELNVEGCCFLRKLPEDLVS
FKSLKILNVAGCASLSQIPHGIEQSIGLRKLSGIFVGVNEGFVLTQLQVLTNLQEIRLQNLERAEEIQTE
VLMGQQSLWDLSLHWGGEEKKESSESTTSLQVLEALRPSLQLKRLEIISYKGVEFPTWMSKQQLAGFNSL
VEVRLINLKRCATLPSLGQLANLGKLEISGMDLITHLDDTFYGDGDIFPMLTELTFSEMLALEKWYMTKR
KYIRYFSKLRQLSLIQCPKLKEINLFVYGTIRIWLNNETIWSVKFCSWDNLQNIEIIEIVGCQELRCLPQ
SMQRLKHLYKMTINSCNNLTTLVALDSLKELNIYACPVLAFDLEAFTKLRGLTSKGCPKMQIYHDAWKKK
DEERWWKNRRR


>XP_042422893.1 putative disease resistance protein RGA3 isoform X2 [Zingiber officinale]
MLVFLELKHLLLEVLPSPTMVAQGRLLCIQNHLAMVCDSLWAINSMIEIPEMGVLFNYIWHHRFNSPLHV
PVEFADWVTDVATAVIDMGELLSRIMDWEASLHFRHVILVELKEMLCDLNSLALRGSAMGLPRDPMGSMN
PLREDYSIVLKNEVVGRHEDLEKLIEIFQQQQLVPSNNNGDDYNPFVIVIDGEERVGKTTLAYMIYHHTW
VRQQFHHRIWVDLSPSVSTLEMIKIIGKEFAESINNEEYCDQKLHLELPLQAMWEYINEQLDGSRYLLVL
HCLDLNSLISQPEWSELKNILLRVGGPGSAVLVILKSSTQSVSDMSFQNRVKDITTYYLKPLSDDAWLEL
FKRHAAMTIPPSKRDIVFKGSTFAMPLFQLVGQTFGAKFWGSLGHSIQVEDLFPCEIKDIHMVRNFPFAI
VRLLQYHYLLDKDYNVILHMLTAESLIPVEGLSPGWTEIYERFRYGRESTFCFPRKVYLHRKVPGDSTTI
PRCCRYLRLEINARAIPFRLPTMPVEVNKKMIALILREDEATTQEDDKRMTFQVYKKRLMKPATTISLQV
YKKRRTKAATTISKFLDKMSVRLVHLHILVVETSMIQSLPNEISKLVSLRYLHLSKLEIELLPKSLFDLL
NLQILSLLHCKNLQKMPGRIHKLKKLQILKLAYCTKLQQLPRSITRLKNLEELNVEGCCFLRKLPEDLVS
FKSLKILNVAGCASLSQIPHGIEQSIGLRKLSGIFVGVNEGFVLTQLQVLTNLQEIRLQNLERAEEIQTE
VLMGQQSLWDLSLHWGGEEKKESSESTTSLQVLEALRPSLQLKRLEIISYKGVEFPTWMSKQQLAGFNSL
VEVRLINLKSWDNLQNIEIIEIVGCQELRCLPQSMQRLKHLYKMTINSCNNLTTLVALDSLKELNIYACP
VLAFDLEAFTKLRGLTSKGCPKMQIYHDAWKKKDEERWWKNRRR


>XP_042422965.1 disease resistance protein RGA2-like [Zingiber officinale]
MVEWLASSFIGRLADKICSYAGNQYEHQSYDTEEKIKQLGSKAKMIKDLIHAAEASQTSNLIFADYILRL
KNEFYVLDDIFDKFDYRKIEEKVRNRNKSQAAHGFFQWRLLNHAAKHAQVVINRLCFSDQDLNDLLEATR
MLDNVHSEMSNLTKLVQSDLAPKSDDSLEWRITTSISGTKLFGRDNEKVSLVKLLLQPFDATSSSSRNFS
VISIVGVGGVGKTSLAQAAFNDPAVMARFTTKVWACAHRFDLKSLSIEILAEASSRRQENFHNLRSLEKI
QLSLMKHLRGKRFLIVLDDVWNEASGKWEMLSRSFQSAKEGSIVLITTRNQRISDMMEAKESMKLEGLGN
KDFLPFFMNCAFGCHNPGHYPKLLQLGQQIARKMGGSPLAAKTVGGALKSNLEEDHWRRILASKLWQLHQ
NEYDIVPALRLSYEQLPKHLKQCFAYCSIFPKNHCFEKDSLVQMWMALGFVQPDGQRRLEDIAGEYIDDL
YSRFFFQNAAGRSNRFAIHDLLHDVGESVSTKDHFRLENETSEIPRSVNHLSSNATHLKKVYEFAHEMKN
LRSLVVFGEKPLARPAFVELFEEVLKQLKGLRIVVLHDLPVTKLPEAIGNLVHLRYLEIQSSHAVEFPNS
LYKLYHLQGLKIKIKMLSSVNSYGWSPKPHPAAIGDLINLRYLRISPESLYAIPGIGSLTLLQDLEQFHA
RKSSGFQIKELGNLRQLHGEICIKNLDNVRSKKHAQEARLCNKEHLRKLSLYWNYHRQGCPSTWEYEEVL
EGLQPHQNLIELKIRRYMGIRSPSWMQTSNLEYIELSHCNRWKLLPSLGQLPFLRFLHMRSMAELEELGT
QFYGDNGTAFESLEELKIEDMPELKEWSYSSIEPSCNLFPRLTKLHIRNCPKLRGPIPTPTLPKEIALFL
SDKITPIANDKNKLCKRQDSRLVLTTDRIWRVAQCIPEASLGFIHWLEMSSSFLVTFTAEQEEWLQQLSY
LRHLSFSECNNMTCLPAVLKSITSLETLHIKKCPEVKSLPQNGLPGALKEIHINGCHRELKQRCSWSGAD
GHKISHVSTILIDGEERRRIKKMRA


>XP_042423127.1 putative disease resistance protein RGA3 [Zingiber officinale]
MDVPSYITIGGWFIQVIFDKYLSSRLLAWATNSGIGDDLEKLRIAMLRIQSLLSCTEKTSSNGFVRWMKE
LRNVVYDAEDLLDELEYRRLRQQLEGETSSPVSAFLASNLEAARDAANRAGGFLSSNLFNSSEGDNAMKT
KHGNSRPLNTPELTWDRATKASIQTITERLNQASSGVSETLTLFKLEHCNGLTQRTEKGTTSSVSSTKVF
GRQNNAKNLVELLLRLDDVQVSILPIVGMGGIGKTTLAQLVYSNPKIVEHFELRMWVHVSSSFSDMEFTR
EILECASDDKHEFDGVKNFDRLQSAIKEKLMRKRYLLVLDDVWNQENSSKLSVMERWAKLLAPLKAGKNG
SKILMTTRSRVVSEMLTARNSINLKGLSDQDCWSLIKEITFSGANPVEELKLEEIGQKIAQRAKGSPLAA
KAAAIILKNKQNAEEWKMMLEGKNLYSDIIPIMKPSYDNLPAHLQRCFAYCSIFPKCWKFSDDLIHLWMA
QGYIQPKSKDARMQEIGQDYMDELVCRSFFEVEKKEFVTHYVIPDLLHEMACAICKDECIRVEDNEPTNI
PPSIRHLFIKSEQFAAVTDVYQFHNLRTLICCSEIQSNVRNVLEDVLKNLKSIRVLDLSNCKMDDLPEAI
CHCIHLRYLNLSATSIRQLPESLCRLYHLQVLNLLGCSLLSLPSCMNRLVNLRHLAAAHQLVSDIAEIGR
LICLQRLEVFRVRYEIGYKIEELKDLNELQKSLHIRNLENVQGKNEASEAMLHMKGHLSGLQLHWLPSQR
NHMVDAEVLEGLRPHQNLKRLEIIGCRGNMYPTWLETEWLTNLEIIYLSGNENWGCLPPLAQLPSLKVLW
IQGLHSVKRIGTELFGTDEKALKWLEELVLDDMPQLECLEGRQMFPHLKSVVIKDCNKLKTLPPLPSSLT
ELTVLNQGFWLPYYDDMRMGKSPSVVSSLCIYNCSLLIAEFSVLLLQETLSSLRTLCIGDLSLLTGLIIR
KNLARLQNLDIQNCLEITLLTIEQEKAFENLTALKSLCFSGCANLQYLPELRGLHSLEKLIILNCPLIQS
LPKKGLPSLLKVLEIDSCHPLLKEGFRNNCADYWLSIKHVPRVEIDGEMIQENASGN


>XP_042423128.1 disease resistance protein RPS5-like [Zingiber officinale]
MGSGTGNAIVKYSWKKLKKHACYFIYYKKKFEKLKEQFDLLKAITDDTQQKVEISKRNNEIISDEVNLWL
KKVIELEEKFNNIKNNFDRIVENEKYCIPSLIFRYKVGREATRKKDKTLKLLDQSKFQSFSHTLDPSAVN
HPSNIDFVSFGATKEAMQKVIDALNDDKVNLIGIYGMGGVGKTTLMEEISRKMKETETFDMVIDVVVSQN
PNIAQIQRDIADVLGMRESSNKMLATRLKQVKKVLIMLDDVWARLELVKEVGIPYQEHKGCKVILTSRKA
ETCNVMEADVSVEVATLSKEDSWQLF


>XP_042423201.1 putative disease resistance protein RGA3 [Zingiber officinale]
MATASKLRHVLMKILPAPEMVAQGKTFHISNHLDMIRNSLWTINSFLLDATLSVVEQPDVAEWMKDVGVA
VEDVDSLLKRILDYWEPNEEDEVEKKRMMISNFLSMSSRQAILVELKDMACMLNYLVNRGAALGLWVETM
DSMDPTHDDYSAILNEEVIGREEDIDQIIELLQQQQCDEDGNAPFIITLEGTMNGKTTLARTIYHHPWVH
RHFQHRIWLDAPLSIRSIRDFKSNVIAKEIAKYTGKSCTNTDYWPLINEHFGGDRYLLILDGVQVSHLFA
YKWKEFMLKLLHCGAPGSKVILTGDCFYVFGMEFYIKNYKLNMLSEDTGARILLRYSTFVHPIEANSNHK
EKASPAAVTDMQIPLKYPLLVKGLGLIYRRINTRLDKEILRRYDLDTLLKYYSWPIERERYFQYQELFGR
YSNQCSDEDLFEILVAEGTLRYNWMKNTEYDVPFNFKTDPCFFRMKAWEGSRIPLQCRHLYLPIHSKNIS
KIKKVIEKAGVANRLRTLILHMKEKKEQIYQYQTVSKILESMFVNLKHLCTLHMGGIMIQDLPSSVGTLH
CLRYLNLAENKIETLPESLCYLGNLCVLNLSSCNKLKELPRQIHKLRKLQILKLSGFLRIQKLPESITWL
VNLKELDVGDCCYLSKLPDDLCSMKNLMQLKMHGCASLTRMPIGIGQLTNLEVLQGYDAIDGLGNVMLSE
LQTLTNLESLHIRHLERLELAEEKNISPPTNLLENQCLNELMLHWEWWNDMVAEGTLEPTMQLTQSFQHN
LRDLIVLKMVSYMSDKFPSWLMIADRDSLLNNLTTVHLINLRRCERLPPLGHLRNLKEVAISGFDSVKVV
DETFYGKDHNCVFLHLRRLTFSEMPRLEKWVGLKHTQSRLLFRSLKELTLIQCPKLKEFHMRFPESLSLK
LFLSNEMLMPISKFVGWQNLRQVNMLQIFGCQELRNLPDGLRMIPNLETLEIINCNKLEALPIWLKKSRL
KSLCLSGCPALSFIPEELKFMERLTNLYVEACPKLQSQLSEVCWCSGDF


>XP_042423367.1 probable disease resistance protein At1g61300 [Zingiber officinale]
MATIIAGITALFNTLKDCCFQSSNYIVSFEGIISSLAVELVQLKNKSEDINRQIEAAKRDELNPKQEVLG
WLKSVEDFTSEAENINTAYRRMFKCLCNFPVNLCSSYPLRNRAEAALTVAADLKRKAGEFADVADDLEVD
RLFKMPNPQTVGMDTAVEALLGHARDDDVSIIGIHGMGAVGKTTLLIRFNNDFAEKELNNLDVVIYVDLP
TEYNAEELQKSLFDRLKLTWKDEEPQRNRAGRLFRVLSKMRFLLLLDNVWEPLNCQILGIPLPQPPCKSK
IVFATRMEEVCSRMGAEKTIKLECLPEEAAWDLFRFNAKLDLAGTDRRILDLARILVRQCAGLPAALITM
AQTMATKRKIEEWRHVLITMEEAPFQLPRMEENVYHPLKLSYDHLNDTLLTCASYFALVPEGYRLSKYQV
NWLWIGEGFINDSETWLESVDKASYLLGMLLAASLIQRIDDEFFKMHPMVRSMILGMQCDCGKKESKWLI
RAGHGLEEAPGAEKWRISERISLGWNNIALLPDEPQCPDLIYLLLQNNHPLKNIPDEFFSHMPRLKVLDL
QNSSIKELPPGIGNLSQLRLLDLSSTRIASLPREIQALVNLRVLRMTSTTHLRSIPGDAIPCLHQLQWLD
MFNSYSGWRVVGDQQLDGEGILLDEVESLKKLKKLKVLNITMSSVAALRRLCESQRLAAAVYCLQIEGCG
GLASLDIPSTFCLGENIHNVALIRLHDLEEVIIGGDLQVLNALSCLEYLRLLALPKAKIIWKNRCLENLL
ELEIEDCNAIDRLMKVVNNATNSTETITIFPRLRKIVLRKLPELENLSDGDQVIAFPSLKTMEVRNCPKL
KKLTLAAENLTEIKCDREWQDELDWSDERTLSFQELFKQAD


>XP_042423635.1 putative disease resistance protein RGA4 [Zingiber officinale]
MLASYELKYLLLKMRPSPTMMAIQPLGIQHHLEMIRDNLWAVNSMTARTRFKLLYEVGWLKNEEMEWLRD
VDVATADMKNLLNQILDSKKTIVESSGRHLHCSCLSDIRPTHHRHLILVELKEMLLNLNYLMHRGSRLGL
QRESMDSMDPLEEEYMTILKSEVVGRDEDVDKIIAILQQPSFNNHNDDDDDNDDDDNNINHDDNDGGGGG
AAVIDDENDDPLVIVINGSKMVGKTTFARMINHHTWVCQYFHHRIWVDVDLNSSLNLTNMIVREFQRSII
KMGETSESVCKLKLGLPLQVMWEFVNEQLGGSRYFLVLDCKDFPNRLQEEWDGLKRTLLRVGGQGSAILI
THRTRTEFDTDMLHGVRFVETYNLDGLSEDAWLKLFLRHHDASANPSEQPKLSLGHAKQLFKDCNGLPIW
AKYTASFRYDVDWINFEFENDNDPTETFSLIRIRTFQYLSLFLSKPNPEVILHILIADGTILDFIGVIDE
ISYDFWQRKWLFKGDEFDLIEIIDEISEEFWVRKLKLEEGKFDPNEMEAIVGIQYLQIRVGKDSRVKIPR
QCRHLCLVFDSKAGAFRLPTLPVEVSSKLRTLIVQDDETATPISKVQTRRRAEEAAAAMRTIKMLAKLVD
LHTFYLETTLIRQLPREVSKWVNLRYLHISKNDMEFLPESLCSLSNLLILSLLRCHKLQMLPERIHELQK
LQILELVHCTKLGKLPKLVTRLKNLEELNVEGCCWLMELPEDLSSMQTLRVLNIVGCASMSLLPHGIQKM
INLRKLSGIFITAGLSDGSFGLRELQALTNLEELRLRNLERVSKTEDETHIEPLWMIQKLQYASLHWDND
MSACEPATLLQLLEAFKFNTHLKSIEVISYMGMEFPSWMGKEISNANSLVEVKLINLKKCSTLRPLGELE
NLRKLEISGMDSIKEVDDACIGVSLKELTFSEMPALQQLSIVSYYRFRALHELKLIQCTKLNSINMESWV
LYDNKVNLWLNMEPWWSREFSGWKNMKFVRSIEIVGCQELRYLPGGMQNLRNLQELKIMSCNNLVALPNW
LNKLKSLCSLHIYACPKLSYIPEIIKTHLRVLKIEECPKLQM


>XP_042423636.1 disease resistance protein RGA2-like [Zingiber officinale]
MPVFRELQHLLLQVLPSSSLMAQGRLLCIQNHLAMVCDSLWTINSMIVISEMGMMHNNYFKNWPGFNLLD
VPVEFADWERDVAVAVIDAGELLSRIMDWEASLHRSIVGNTQQVNFRHVILVELKEMLCSLNSLVLRGSS
MGLRRDPMGSMNPLREDYSIVLKNEVVGRDEDLEKIIAILERQLVSSNNNGDDNNPFVIVIVGKGGVGKT
TLAHMIYHHTWVCQQFHHRIWVDLPLFSTFKMINIIGDEFVRSINKEEYCDQKLHLDLPLPAMWEYINEQ
FCGSRYLLVLHCENLVSLMQPAEWNELKNILLRVGGPGSGVLIIDKSSTQSALRDMSFLNGMKDIITYRL
NPLSVDALVELFKRQAATTIPSSKQHKSKKDARIFRNYFPSQTFGVKVFRSLSQNIPTTFVTEFLNDIYM
VRNFPLVIVRLHQYHQLLNVDNDYDVILHMLTAEYLIPTEGLERGWIQLYARSLSDINRIVLALRLSRMV
YLHMKVPEDSTTISRYCRYLCLKINHRAIPFRLPTMPIEVSNKLIILILREHEEATQEDVEEITLQVYKK
RSMKATTAISKFLNKMSVRLVHLHMLVVETGMIQRLPDEVSKLVNLRYLHLSKLKMELLPKSLFDLPNLR
ILSLLRCQKLQKIPEQIHQLKKLQILKLAYCTKLQRLPKSITRLKNLEVIDVEGCCWLNKLLDDLVSFKS
LRIRNVTRCASLSQIPHGIEQSIDLRKLSGIFVGVDGGFVLAQLQTLTNLQEIRLRNLERAEKTQAEVLM
GQQSLRDLSLHWGGEEANESSESATPLQVLKALRPSVHLKSLEIMSYKGVEFPGWMSEQQLARFDSLVEV
RLINLRRCATLPSLGQLPCLEKLEISGMDLIAHIEDTFYGDGGTFSMLRELTFSEMLALEKLSVPERKDA
DFFPNFSQLTLVQCPKLQEIDLHNCSTMRIWLNNETIWSAKYYNWDNLQDLRIIEIVGCQELWCLPQGIR
SLKYLYGMTINSCNNLTTLVALDSLIELNIYACPLLAFNLEAFTRLGRLTIKGCPKMQIYHDVWKKKEEK
R


>XP_042423639.1 disease resistance protein RGA2-like [Zingiber officinale]
MSVFHELKHLLLQVLPSSSLMAQGRLLCIQNHLAMVCDNLWAINSMIAFPEMRMLSKNFSERWANFGKVL
DVPPEFEDWERDVAAAVIDVGELLSRIMDWEASFHRSIVGNTQQVNFRHVILVELKEMLCSLNSLVLRGS
SMGLRRDPMGSMNPLREDYSIVLKNEVVGREEDLEKFIAILEQQLVSSNNNGDDDDPFVIVIDGEQGVGK
TTLAHMIYHHTWVCQQFHHRIWVDLPLVSTFKTINIIGNEFVRSMNKEEYCDQKLHLDLPLPAMWEYINE
QLCNSRYLLVLHCENLVSLMQPTEWNELKNILLRVGGPGSGVLIIDKSSTQSALRDMNFLNGMKDIITYC
LNPLSMDAWVELFKRQAATTIPSLKQDKSKKDAWRIRNYFPSHTSGVKAFGLLSQNATAATHLLNDIYMV
RNFPLVIIRLHQYHHLLDAYNDYDVILHMLTAEYLIPTEGLERGWIQLYARSLRYINKRELALRLSRMVY
LHMKVPENSTIISRCCRYLCLKISHRAIPFRLPTMPVEVSNKLITLILREQEEATQEDVEEITLQLYKKR
RMKATTAISKFLNKMSVRLVHLRILVVESGMIQRLPNEVSKLVNLRYLHLSKLKMELLPKSLFDLPNLRI
LSLLRCQKLQKIPERIHQLKKLQILKLAYCTKLQQLPKSITRLKNLEALDVEGCCWLSKLPEDLVNFKSL
RILNITRCASLSQIPHGIGQSIDLRKLSGIFISVDGGFVLTQLQALTNLQEIRLRNLERAEKTQTELLMG
QQSLHDLSLHWGGEEVDESSELALSQQVLEALRPNVHLKSLEIMSYKGVEFPTWMSKRQLVRFDSLVEVR
LINLRRCATLPSLGQLPCLEKLEISGMDLIKHIDNTFYGDGDTFCVLRELTFSEMLALEKWSMPERNVFV
ELEQLTLIQCPKLKEIDLHSRPSLFYDVTIRVWLNNETIWSVEFYSWDKLHYIEFYSWDKLHYIEFYSWG


>XP_042423640.1 putative disease resistance protein RGA1 [Zingiber officinale]
MSVLLELKHLLLQVLPSPGMIAQGHLLCIQNHLAMVCDSLWAINSMIVIPNMGMLYNNCLEWDSIFDPEL
DVPGEFEDWERDVAAAVIDVGELLSRIMDWEASLHRSIVGNTKQVHFRHVILVELKEMLCHLNSLVLRGS
AMGLRRDPMDSMNPLQEDDSIVLKNEVVGREEDLEKLVAIFEQQLVSSNNNGDDNNPFVIVIDGTPGVGK
TTLAHMIYHHTWVRQQFHHRIWVDLPFISTFKMINLIENEFVRSINKKEYCDQKLHLHLPLPSMWECINE
QLCGSRYLLVLHCENLVSLMQPGEWNELKNTLLCVGGPGSGVLIIYKLSTKAAVRDTGFLNGMKDIITYR
LKPLSIDALMELFKRQAATTIPLSKQDKSEKDAWQFRNYVPSQTFGAKVFGSLSHNISASFACNLFYDVY
MVRNLPLVIIRLHQYHHLLDVDNDYDVILHMLTAEYLIPTEGLERGWIQLYARYINKRVLALVFSRMVYL
HMKVPEDSTIIPRYCRYLCLKINHRAIPFRLPTMPVEVSNKLITLILREHEEVAQEDVEEITLQVYKKRR
MKATTAISKFLDKMSVRLIHLRILVVETSMIQRLPNEVSKLVNLRYLHLSKLKMELLPKSLFDLPNLRIL
SLCRCQKLQKIPERIHQLKKLQILKLAYCTKLQRLPKSITRLKNLEVIDVEGCCWLSKLPDDLVSFKSLR
ILNVTRCASLSQIPRGIEQSIDLRKLSGIFVGVDGGFVLAQLQTLTNLQEIRLRNLERAEKTQTEVLMGQ
QSLRDLSLHWGGEEANESSESATPLQVLETLRPNVCLKSLEIMSYQGAEFPSWMSKRQLARLDSLVEVKL
INLTRCATLPSLGQLPCLEKLEISGMDLIKHIDDTFYGDGDTIPKLRELTFSEMLALEKWSVPKGKYFIF
FPRLTQLTLVQCPKLKEIDLHYYCGTMRVWLNNETIWSAEFCCWDNLRYTQEIEIVGCPQGLDQLVSGWE
VVP


>XP_042423652.1 putative disease resistance RPP13-like protein 1 [Zingiber officinale]
MSGSHELKRLLLQVLPSSTMMAQGRLLCIQNHLAMVCDSLWAINSMIVIPEMRVVYNEYFPSLEMLDVPV
EFEDWETDVAAAVIDVGELLSRIMDWEASLHRSIVGNTQQVNFRHVILVELKEMLCNLNSLVLRGSSMGL
PRDPMGSMNPLREDYSIVLKNEVVGREEDLEKIIAILEQQLVSSNNNGDDNNPFVIVIVGKGVGKTTLAH
MIYHHTWVRQQFHHRIWVDLPLFSTFKMINIIGDEFVRSINKEKCCDQKLHLDLPLPAIWEFINEQLCGS
RYLLVLHCENLTTLMQPEWNELKNILLLVGSPGSGVLIIYKTSTQLESDMGFLNGTKDIITYCLNPLSLD
ARVELFKRHAKQDKSEKDAWIFRNYFPSQTFGAKIFGSLIHNIPTSFVTDVLNDIYMIMNFPFVIIRLHQ
YHHLLDVENDNDVILHMLTAEYLIPTEGLERDWTQLYARYLRYINKTVLALVFSRMVYLHMKVPEDSTII
PWYCRYLCLKINHRVIPFRLPTMPVEVSNKLITLILREHEEATQEDVEEITLEVYKKRRMKATTAISKFL
NKMSVRLVHLRILVVETGMIQRLPNEVSKLINLRYLHLSKLKMELLPKSLFDLPNLRILSLLHCQKLQKI
PERIHQLKKLQILKLAYCTKLQQLPKSITRLKNLEVIDVEGCCWLSKLPDDLLSFKSLRILNVTRCASLS
QIPRGIEQSIDLRKLSGIFVDVDGGFVLAQLQTLTNLQEIRLRNLERAEKTQTEVLMGQQSLRDLSLHWG
GEEANESSESATPLQLRSDSSISGGVLHYHHSLNFLVSRSLR


>XP_042423656.1 putative disease resistance protein RGA4 [Zingiber officinale]
MSVFRELQHLLLQVLPSSSLIAQGRLLCIQNHLAMVCDSLWTIDSMIVIPEMGMMYNNYCKNWPGFNLLD
MPVEFADWERDVAAVVIDAGELLSRIMDWEASLHRSIAGNTQQVHFRHVILVELKEMLCNLNSLVLRGSA
MGLRRDPMGSMNPLREDYSIVLKNEVVGREEDLEKLVAIFEQQLVSSNNNGDDNNPFVIVIDGKVGVGKT
TLAHMIYHHTWVRQQFHHRIWVDLPLVSTFKMINIIGNEFVRSINKEEYCDQKLHLDLPLPAMWEYINEQ
LCGEWNELKNILLCVGGRGSGVLIIYKSSTKSAVRDMGFLNGMKDIITYRLNPLSVDAWVELFKRQAVMR
IPSSKQDKSEKDAWLFQNYFPSKTFGAKVFGSLSHNILAPFANKLFNDIYMVRNFPLVIIRLHQYHHLLD
VDNDYDVILHMLTAEYLIPTEGLEQGWIQLYARSLRYINMRVQALLFSRMVYLHMKVPEDSTIIPRYCRY
LCLKINHRAIPFRLLTIPVEVSNKLITLILREHEEATQEDVEEITLQVYKKRRMKATTAISKFLDKMSVR
LIHLRILVVETGMIQRLPNEISKLVNLRYLHLSKLKIELLPKSLFDLPNLRILSLLRCQNLQKIPEQIHR
LKKLQILKLAYCTKLQRLPKSITRLKNLEVIDVEGCCWLSKLLDYLVSFKSLRILNITRCASLSQIPHGI
EQSIDLRKLSGIFVGVDGGFVLAQLQTLTNLQEIRLRNLERAEKTQTEVLMGQQSLCDLSLHWGGEEADE
SSESATSLQVLEALRPNVHLKRLEIISYKGVEFPTWMSKQELVRFDSLVEVRLINLRRCATLPSLGQLPC
LEKLEISGMDLIKHIDNIFYGDGDTFSVLRELTFSEMLALEKWSVPKGKCILFFPRLTQLTLVQCPKLKE
IDLHYYCGTMRVWLNNETIWSAKFYCWDNFRYIRIIEIVGCQELRCLPQGMRRFERLSKMTINSCNNLTT
LVALDSLIELNIYACPLLAFNLEAFTELRRLTIKGCPKMQM


>XP_042423666.1 putative disease resistance RPP13-like protein 1 [Zingiber officinale]
MVVFLELKHLLLEVLPSPTMVAQGRLLCIQNHLAMVCDGLWAINSMIEIPEMGTLNNQLFKMFYRFDAVT
SFVPAEFADWETDVATAVIDVGELLSRIMDWEASSHRSIVGNTQQVHFRHVILIELKEILCDLNSLVLRG
SAMGLRRDPMGSMNPLREDYSIVLKNEVVGREEDMEKLIAIFEQQLVSSNNNGFDNNPFAIVIVGKQGVG
KRTLAHMIYHHTWIGQQFHHRIWVDLPLVSTFKMIDIIGNEFVRSIDKEEYCDQKLHLDLPLPDMWEYIN
EQLCGNRYLLVLHCENLVSLMQPEWNELKNIMLRVGGPGNGVLIIYKSSTESAVRDMRFLNRLKDITTFC
LNPLSDYAWVEFVSRHAATTIPSKQDKSKKDELIQLAKLYCTNFPGQTFGAKVFGSLFHYIPTTFAILQS
RLLDDICKVRNFPLVIIRLLQYHYLLNADTDNYYDNDYDVISHMLTAECLIPTEGLEPGWIECYERHFTQ
IHRKRDLKELLFGRMVYWHMKIPKDSTTISRCCRCLCLEINPRVKPFRLPIMPIKVSSKLITLILQEDKK
TTREDVEEITLRVYKKRCMKAATAISKFLNKMSVRFIHLHMLVVETSMIQSLPNEISKLVSLRYLHLSKL
KMELLPKSLFDLLNLRILSLLHCKKLQKIPERIHKLKKLQILKLAYCTKLQWLPKSITRLTNLEELNMEG
CCFLSKLPEDLVSFKSLRILNVAGCASLSQLPRGIEQLIGLRKLSGIIVGVQGGFVLTQLQALTNLQEIR
LQNLERAEEIQTEVLMGQQSLRHLSLHWGGEEANRGSETAPSQHVLEALRPNLHLKCLDIISYKGVEFPT
WMSKQQLARFDSLVEVRFINLRRCAILPSLGQLPFLEKLEISGMDLIKHIDYTFYGDGNTFAMLRELTFS
EMLGLKKWSVPSERKNKIFFPELRQLTLIQCPKLMEICPRLFLMLQ


>XP_042425344.1 putative disease resistance protein RGA3 [Zingiber officinale]
MAMVLDFFVSKFIKDTSDMVEKEIFKVLGVDKEIKTLQVWLGTINGYLRQAKQKRQGTDEIDIWVRKLKD
IMYDADDIIDLCMIEGGKLLTAQVSSSSSTVSIPFNYLISCFKCLKYRHDIANQIISLNSRLEGLKNDAV
IKNNLDQTIKEPVENANKVVFARETSHLQVEGDIVGMQIENATEKLISLILENNPKKTRVFGVVGTGGIG
KSTLASKIFKDERIKENFPKRKWLYVSKNYIETDLLKKLIRFEEGSETKGEIFEGKSKAELENKLVTVLT
RNTFIVLDDVWNSIVWTDFLRKPIVKCASSCTILITSRKEKVVTNMRPKYIHPVEKMNEESGWNLLKHLA
FEGEEEDEISSLKEIGSKLVKKCDGLPLAIKAIGGVLYQQNKAKWEEVLESDVWKMDQIEEELRPLYLSY
EDLTSRLKQCFLYCSLYSQKGMYYKEIVQFWIAEGLIMDDVPTEKQKTMEDIGEEIYRELIWRNVLEADA
IVDVSKDYFSMHDHFRSLGAHLMREEGILYRHGREFKTDDNIKIRRLSVSNMGSKLVLPSQILKQGCLRT
LILMDSRKTKTIEDSVLQELSCLRVLDLTSTSIEKIPDCIGDLLHLRYLDLDGTNIHEIPKTIGNLVNLQ
TLNISECQYLERLTESITMLHNLRCLEMRDTPLLTYVPKGIGKLGNFYNLQGFMVGQDDSTSEEGCDLEE
LKNLSKLRGISIYRLERAERGASALADKPFLKQLTLGWMQPDEDDTDEEDESEGSEEEEANEGGADDTVA
SESEADANDDEDAGNEKGDGNDDSSKQENENEEAEEAGNETEDETEEDEAEEEEKGWSDEQISKAERICN
EMSQPSSSIEDLLFVEYPGRQLPSWMICSSLAESFPNLAYLKLLGLPCCTELPPLGTLPQLKYLSIERAS
AITTIGSRFLGSRSSAFPKLEVLQFEDMPRWEEWTFDGVEELTGHGTPLSVKLFPSLRDCVLIDCPKLRA
LPADLYRATDLNELCLRQTYQLGEIINLPMAYKFEVTNGSGLKKISNISSVRYLEVDNCPNLECVENLGK
LQHLVLICSEETEQLPQWLSSLIEQHNNTSSTHRSFRKFEMQCSLQLLKTCLEGSENWDIIKQIPIVKVT
TYSEKEYIRYTKDPYMYDPHVPAN


>XP_042425346.1 putative disease resistance protein RGA3 [Zingiber officinale]
MAMVLDFFVSKFIKDTSDMVEKEIFKMLGVDKEIKTLQVKLGTINGYLQQAERKRHGNDEIDIWVRKLKD
VMYDADDVIDLCMIEGGKLLMAHASSSSSTVSIPFSYLFSCFKCLKYRHDIANQIISLNSRLEGLKNDAV
IKNNLDQAMKEPIENANKVVFGRETSHLQVEGDIIGTQIENATEKLISLILENNPKKTRVFGVVGTGGIG
KSTLASKIFEDERIKENFSNRKWLYVSKNYIETDLLKKLIRFEEGSETKGENFEGKSKADLENKLVSVLT
RNTFIVLDDVWNSTVWIDLLRKPIVKSASTCTILVTSRKEKVVMQMKPAYIHSVEKMNEESGWILLKHLV
FEGGEEEDEISSLEEIGIKLVKKCDGLPLAIKAIGGVLYQQNKAKWEEVLESDAWKMDQIEEELRPLYLS
YEDLPSTLKQCFLYCSLYPQKNMYYKEVVQFWVAEGLIVDDQDKSRKDLPTGKQKTLEDLGEEIYRELIL
RNLLEADAIVDVSKNYFSMHDHFRSLGAHLMREEGILYRHGREFKTDENIKIRRLSISNMAPKLVLPSQI
LNQACLRTLILMESPKTKAIEDSVLQSLPCLRVLDLTSTSIEKIPDCIGDLLHLRYLDLDGTNIREIPTT
IGNLVYLQNLNISECQYLERLPKSITMLHNLRCLDMRDTPLLTYVPKGIGKLENFYNLQGFLVGQNDSTS
EEGCDLEELKNLSKLRGISIFRLERAERGASALADKPFLKQLTLGWMQPDEDDADEEEESEGANEVGSDE
EADNDGNDDKDAGNEKGDDNDDCSKQENENEEAEEAGNETEDETEEDEAEEDKKGWNEKQIRKAERICNE
MSQPSSNIEDLFFYEYPGRQLPSWMISSSLAESFPNLAYLKLLGLPCCTELPPFGTLPQLKYLSIERASA
ITTIGSRFLGSRSSAFPKLEVLQFDDMPKWEEWTFDGVEELTGHGTPLAVKLFPSLRDCVIFDCPKLRAL
PAGLYRATNFNELCLRQTYVLGEIINLPMAYKLEVTNGSGLKKISNISSVRYLEVDNCPNLECVENLTKL
QHLVLICSEETEQLPQWLSGLIEQHNNTSSTHRSFRKFEMQCSLQLLQTCLEGNENWDIIKQIPNVKVKT
PSGKAYIRYTKDPYMYDPHVPAN


>XP_042425349.1 putative disease resistance protein RGA3 [Zingiber officinale]
MAMILDFYVSRVIKVTADMVEAEIFKVLGVDKEIKTLQGRLRTINGYLHQAERKRQGNDEIDIWVRKLKD
IMYDADDIIDLCMIEGGKVLRAQASSGSSTVSIPSSYLFSCFRCLRYRHEVANQIIALNGRLEALKNDSF
IKNNLDQTVKEPVENTHRVFGRETSHLQVEGDIIGSQIENATDKLINLILENNPKKTRVFGVVGTGGIGK
STLASKIFEDERIKENFPNRKWLYVSKNYIETDLLKKLIRFEEGSETKGETFEGKSKAELEDKLVTVLTK
NTFIVLDDVWNATVWIDILRKPIVKGASSCTILVTSRKEKVVTLMKPTHIHPVEKMNEESGWNLLKHLVF
EGGEEEDEISNLEEIGIKLVKKCDGLPLAIKAIGGVLYQQNKAKWEEVLESDAWKMDQIEEELRPLYLSY
EDLPSTLKQCFLYCSLYHQKDMYYKEIVQFWVAEGLIMDEQEKSRNDLPTEKQKTMEDIGEEIYRELIWR
NLLEADALVDASKDYFSMHDHFRSLGAHLMREEGILYRHGREFKTDDNIKIRRLSISNMGPKLVLPSQIL
KQGCLRTLILMDSSKTKTIEDSLLQALSCLRVLDLTSTSIEKIPDCIGDLLHLRYLDLDGTNIREIPATI
GNLVNLQTLNISECQYLERLPKSITMLHNLRCLEMRNTPLLTYVPKGIGKLGNFYNLQGFLVGQNDSISE
EGCDLEELKNLSKLRGISIFRLERAERGASALADKPFLKQLTLGWMQPDEDDADEEEESEGANEVGADEE
ADNDGNDDKDAGNEKGDDNDDGSKQENENEEAEEAGNETEDETEEDEAEEEEKGWSDEQISKAERICNEM
SQPSSSIEDLFFYEYPGRQLPSWMISSSLAESFPNLAYLQLLGLPCCTELPPFGTLPQLKYLRIEQASAI
TAIGSQFLGSRSSVFPKLELLRFVGMPKWEEWTLDGVEELTGHGTPLAVKLFPSLRDCILIDCPKLRALP
ADLYRATNFSELCLRQTYELGEIINLPMANKLEVTNASGLKKISNISSVRYLEVDNCPNLECVENIGKLQ
HLVLICSEEMEQLPQWLSVLIEQHNNTSSTHRSLRKFEMQCSLQLLKTCLEGNENWDIIKQIPIVKVTTY
SEKEYIRYTKDPYMYDPHVPAN


>XP_042425823.1 putative disease resistance protein RGA3 [Zingiber officinale]
MGGIGKTTLAQLVYSNPKIVEHFELRMWVHVSSSFSDMEFTREILECASDDKHEFDGVKNFDRLQSAIKE
KLMRKRYLLVLDDVWNQENSSKLSVMERWAKLLAPLKAGKNGSKILMTTRSRVVSEMLTARNSINLKGLS
DQDCWSLIKEITFSGANPVEELKLEEIGQKIAQRAKGSPLAAKAAAIILKNKQNAEEWKMMLEGKNLYSD
IIPIMKPSYDNLPAHLQRCFAYCSIFPKCWKFSDDLIHLWMAQGYIQPKSKDARMQEIGQDYMDELVCRS
FFEVEKKEFVTHYVIPDLLHEMACAICKDECIRVEDNEPTNIPPSIRHLFIKSEQFAAVTDVYQFHNLRT
LICCSEIQSNVHNVLEDVLKNLKSIRVLDLSNCKMDDLPEAICHCIHLRYLNLSATSIRQLPESLCRLYH
LQVLNLLGCSLLSLPSCMNRLVNLRHLAAAHQLVSDIAEIGRLICLQRLEVFRVRYEIGYKIEELKDLNE
LQKSLHIRNLENVQSKNEASEAMLHMKGHLSGLQLHWLPSQRNHMVDAEVLEGLRPHQNLKRLEIIGCRG
NMYPTWLETEWLTNLEIIYLSGNENWGCLPPLAQLPSLKVLWIQGLHSVKRIGTELVGTDEKALKWLEEL
VLDDMPQLECLEGRQMFPHLKSVVIKDCNKLKTLPPLPSSLTELTVLNQGFWLPYYDDMRMGKSPSVVSS
LCIYNCSLLIAEFSVLLLQETLSSLRTLCIGDLSLLTGLIIRKNLARLQNLDIQNCLEITLLTIEQEKAF
ENLTALKSLCFSGCANLQYLPELRGLHSLEKLIILNCPLIQSLPKKGLPSLLKVLEIDSCHPLLKEGFRN
NCADYWLSIKHVPRVEIDGEMIQENASGN


>XP_042425825.1 putative disease resistance protein RGA4 [Zingiber officinale]
MAASRPAASLHHSLFPPPALLSTIHRLASYLSSCRTPPPSSDLHRNLSALHASLLRTATLVDYVTRLPSS
LTGKLVDAIFAADDLVDQLEYESLQKQVEEMEKAEAEKDGVGGKIVDLSVFRGFQTGEDDDTANLKLAAP
SSSISGSLRRPALNTSVETEAKGAELTLESNTDRGQDVESRVPDPSICGCFCSSKTKKQRETRSSRFLSC
CFGFNKDSRSAVNGNHAAKKEDSSTVAARTEIGGEIGSGTQKNDLSSSQVSNSEGQKNSLEEINVDRIMK
IVESLDIVSAYLRESTGIAFSTCHLESPHEILHKEKAASSLSLGDLFFYNDEKEQLVKELLKFNEDDVCI
FPILGPRGVGKTTLAHFVYQDERIEEYFHSRVWICASDDLNSMRITGVTADPPSISTPLAFRELEKLKFM
VRNLQDQLKEKRFLLVLDDVESIEWVMQFASLKDCGKGSKIIITAREEGVIDERGKGNKILLKGVIDEGN
HFLSFFNWCAFNCEDPQGYSELQVISKRISTLLNGNPLAAKAVGGVLQTKFSDAHWTRILNELLELKDDL
TLKDDLTDIMPVLMLCYNHLPPHLKWCFAYCSVFSKGYPFDAQNLINMWISLGFVEPTDSNKTVEDVGRE
YLDGLLSRSFLELPIYNRSYWRSRYYAMHNLMYDLSKSVGVKECLVYENETIYQLYLDRWKYFRSFICNS
KHVINFGVLSRIRVLDLSYSGMKQLSNSISNCIHLRYLNLDGNNLYKLPESLCKLYHLRFLAVPENCRRL
PERFNNLINLRHLNASEEAIAWIANKGRLARLQELKKFHVRLKKGYDIGQLKDLIELKGELCIQDLDDVG
RKEEVIEADLNGKTRIEKLQLKWRTWRKKSLRVDAQEVLESLKPPPCLKHLEIHSFGGSQSPGWLEDQSL
IFLQSIHLKNCNKWNQLPPFGHLPHLKVLKIEGMNVIVDGGTWMIDPYPSLRELYLDNTSIMFEDISWQE
QCCKCFLKLKKLVAVKCKRVGGLPPLALLSSLEELEIKKSPDLESQLSGCLKHLKSLTTLKMSAPNLTHF
PCQVLQHLKYLEIDGCQSLVSWLIDNEEDVHHSSLVSLSIVNSPLPAGPVLVKFLTSIRELRIDQCIKIS
SFSKEQKEWFASLISLEKLSISNCAQLRELPPNLHQLLSLKQMIIQGCPNLDSLPSNLPESLKVFEILKC
NSVLVSQLLGEEAPDWIKRIPFRYIA


>XP_042426036.1 probable disease resistance protein At4g14610 [Zingiber officinale]
MRLDVAVKQLAGLVSFFEKYRENDFALAMVDAKKIAFDMEIESVFPTKRKISRKRHFDEIANTERENQSL
EESFRTNYFILVVDIALGQLKISTKLPLEFPDGTTPVTCQLGEELWFTVGGQHIPFGASPQQKWPISFPA
SLHSSLVSRIAAFNLATTSCRTREPSPPLLRSWPNSKSKREDIKRQIDAAERDGLNPKREVIDWLQSVEA
LASEAENINAAYRQMFKCFCNFPVNVCSSYSLRNRAEAALMELVELKGHARDDDISIIGIHGMGCVGKTA
ILRRFNNDFEEKELDNLDVVIYLELSTGYKVEELQRSLFDRLKLKWQDEEPQRNRAYRLFRVLSKMRFLL
LLDSVWEPLNSQVVGIPLPQPPSKSKIVFATRMEEVCSRMGAEKIIKLECLSEEEAWDLFRFNAKLDLAG
TNQLIQNLARTLARQCAGLPEALITVARAMANKRTIAEWRHVLAIMKEAPFYDTLRTCVSYFAQAPGAEK
ESKWMIGDRRGLTEAPGAEKWRVVERISLGCNNITVLPDEPQCPDLIYLSLRYNHPLKNIPNEFFSHIPC
LRSLDLRNTSIEELPDGIATHLRSIPCAVIPCLHQLQWLNMNNIYSGWRVMGALQLDGEGILLDEVESLK
KLKVLGITMSSETALRRFCQSQRLAAAGHWLQIEGCRGLASLNIPFTCCLGKNMQNMIMILLHAMHDLEE
VMIGGDLHVLNALSCLEYLRLLALPKAKIIWKNRCLVNLCVLEIKDCSVIDRLLKLEDHETNSTETIATF
PRLTKIVLRKLPELESLSDRDRVRAFPSLKTMEARNCPKLKKLTLVAENLTEIKYDKEWRDELDWSDERT
LSFQKLLK


>XP_042426042.1 disease resistance protein RPS2-like [Zingiber officinale]
MGTIIAGIAALFNTLKDCCFQSSNYIVSFEGAISSLALEVAQLKNKSEDINRQIEAAKRDELNPKQEVLG
WLKSVEDLALEAENINASYRRMFKCLCNFPINLCSSYPLRSRAEAALTAAADLKKAGEFVNVADNLDVDR
VREMPNPKTVGMDTTLEALLGHARDDDVSIIGIHGMGGIGKTALLRRFNNNLAEKELDNLDVVIYVDLPI
EYKVEELQRSLFDPLKLTWKDEEPQRNRAGRLFRVLSKMRFLLLLDNVWEPLNCQVVGIPLPQPPSKSKI
VFATRIEEVCSRMGAEKIIKLECLSEEEAWDLFRFNAKLDLAGTNPWILDLARALVQQCDGLPAALITMA
QAMASKRTIEEWRHVLAIMEEAPFRLPGMEENVYHPLKLSYDRLSGTLRTCASYFALVQEGRWLSKYYVR
HLWIGEGCIGDFERLVDATDKSSYLFGMLLGASLIQRIDGEYLKMHPMVRSMILWMECDCGKKESKWLTG
EGHCLAEAPGTEKWRIAERISLGWNNIALLPDEPRCPDLIYLNLRNNHPLKNIPDAFFSHMPCLRVLDLQ
QTFIEELPSGIGNLSQLRLLDLTGTRIASLPREIQALVNLRFLGMPSTTHLRNIPGDVIHCLHQLQLLDM
YDSYSGWRVVGALQLDGEGILLDEVESLKKLKFLGITMSSLTTLRRFCESQRLAEAVYRLQIEGCGGLAS
LHIPSTYCLGESMKQTIRIRLHAMPDLEEVIIGGDLHVLNALSCLGNLELSALPKAKIIWKNRCLENLVE
LEIEDCNAIDRLMKLENNATHSTETIIVFPILTKIVLRKLPELESLSDGDQVIAFPSLQTMEVMNCPKLK
KLTLVAENLTEIRCDREWWDELDWSDERTLSFQELFKQAD


>XP_042426299.1 disease resistance protein RGA2-like [Zingiber officinale]
MLASYELKYLLLKMRPSPTMMAIQPLGIQHHLEMIRDNLWAVNSMTAKIRFELLFAVGWLKNEEMDWLRD
VDVAIADMKNLLNQILDSKKTIVESSGRHLHCSCLSGIRPTHHRHLILVELKEMLLNLNYLMHRGSRLGL
QRESMYSMDPLEEEYMTILKSEVVGRDEDVDKIIAILQQPSFNNHNDDDDNDDDDDNDVNHDDDDGGAAA
AVIDDENDDPLVIVINGPKMVGKTTFARMIYHHTWVCQYFHHRIWVDVDLNSSLNLTNMIVREFQRSIIK
MGEASEHVCKLKLGLPLQVMWEFVNEQLGGSRYFLVLDCKYFPNRLQEEWDGLKRTLLRVGGQGSAILIT
HRTRTEFDTDMLPGMRFVETYNLDGLSEDAWLKLFLRHHDASANPSEQPKLSLGHAKQLFKDCNGLPIWA
KYTGSFRYDVDWINFEFENDNDPTETFSLIRIRTFQYLSLFLSKPNPEVILHVLIADGTILDFIGVIDEI
SYDFWQRKWLFKGDDFDLIEIIDEISEEFWLGKLKLEEGKFDPNEMEAIVGIQYLQIRVGKDSRVKIPRQ
CRHLCLVFDSKASAFRLPTLPVEVSSKLRTLIVQDDETATPISKVQTRRRPEEAAAAMRTIKMLAKLVDL
HTFYLETTLIRQLPREVSKWVNLRYLHISKNDMESLPESLCSLTNLLILSLVRCHKLQMLPERIHELQKL
QILELVHCTKLGKLPKLVTRLKNLEELNVEGCCWLMELPEDLSSMQTLRVLNIVGCASMSLLPNGIQKMI
NLRKLSGIFITAGLSDGSFGLRELQALTNLEELRLRNLERVSKTEDETHIEPLWMIQKLQYASLHWDNDM
SVCEPATLLQLLEAFKFNTHLKSIEVISYMGMEFPSWMGKEISNANSLVEVKLINLKKCSTLRPLGQLEN
LKKLEISGMDSIKEVDDACIGVSLEELTFSEMPALQQLSIVSYYCDRALRELKLIQCTKLNSFNMDSWVL
YDKKVDLWLNMEPWWSREFSGWKNMKFVRSIEIVGCQELRYLPGDMQNLRKLQELKIMSCNNLVALPNWL
NKLKSLCSLHIYACPKLSYIPEIIKTHLRVLKIEECPMLQM


>XP_042426308.1 disease resistance protein RGA2-like [Zingiber officinale]
MSVLLELKHLLLQVLPSPGMIAQGHLLCIQNHLAMVCDSLWAINSMIVIPKMGMLYNNCLKFYSIFDPEL
DVPAEFEDWERDVAAAVIDVGELLSRIMDWEASLHRSIVGNTQQVNFRHVILVELKEMLCHLNSLVLRGS
SMGLRRDPMGSMNPLREDYSIVLKNEVVGREEDLEKLVAIFEQQLVSSNNTGDDNNPFVIVIDGTPGVGK
TTLAHMIFHHTWVRQQFHHRIWMDLPLVSPFKMINIIGNEFARSINKEEYCDQKLLLDLPLLAMWEYINK
QLCGSRYLLVLHCENLVSLMQSGEWNELKNILLRVGGPGSGVLIIYKFSTVSFVRDTGFLNRMKDIITYP
LKTLSADACVELFKRQAATTIPSSKQDKSERDAWLLRNCIPEQAFGAKVFGSLSHNIPAYFANSLFYEVY
IVRNLPLVIIRLHQYQRLLDVYNDYDVILHMLTAEYLIPTEGLERDWIRLYARPINERTSLRLSRMVHLH
MKVPEYLTSIPRCCRYLCLKINHRAIPFRLPTMPVEVSNKLITLILREHEEATQEDVEEITLQVYKKRCM
KATTAISKFLNKMSVRLVHLRILVVETGMIQRLPNEVSKLVNLRYLHLSKLKMELLPKSLFDLPNLRILS
LLRCQKLQKIPERIHQLKKLQILKLAYCTKLQRLPKSITRLQNLEVIDVEGCCWLSKLPDDLVSFKSLRI
LNFTRCASLSQIPRGIEQSIDLRKLSGIFVGVDGGFMLAQLQTLTNLQEIRLRNLERAEKTQTEVLMGQQ
SLRDLSLHWGGEEANESSESATPLQVLEALRPNVHLKSLEIMSYQGVEFPTWMSKRQLARLDSLVEVKLI
NLRRCATLPSLCQLPCLEKLEINGMDLIKHIDDTFYGDGDTIPKLRELTFSEMLALEKWSMTEEKYFKFF
PRLRKLTLVQCPKLKEIDLHYYSGTMRVWLNNETICSAKFCCWGNLRYIQTIEIVGCQELRCLPQGMKSM
KYLNKMTINSCNNLTTLVALDSLRALNIYACPLLAFNLESFTELVLLTIKGCPKMQIFHDVWKKKEGEEI
KRRRAEEEKRRQAQVEAYDNAIATRSVIDWLELW


>XP_042426309.1 disease resistance protein RGA2-like [Zingiber officinale]
MSAPLYRSHPSPKLKHLLLQVLPSSSMMAQGRLLCIQNHLAMVCDSLWAINSMIVIPEMRMLYNNMSERW
TYFGKVLDVPPEFADWERDVAAAVIDAGELLSRVMDWEASLHRSIVGNTQQVNFRHVILVELKEMLCNLN
SLVLRGSSMGLPRDLMGSMNPLREDYSIVLKNEVVAREEDLEKLIAILERQLVSSNNNGDDNNPFVIVID
GEQEVGKTTLAHMIYHHTWVRQQFHHRVWMYLPIVSTFKMINIIGNEFVRSINKEEYCDQKLHLDLPLLA
MWEYVNEQLCGSRYLLVLHCENLASLMQPEWNELKNILLRVGGPGSGVLIIYKTSTESAVRDMSFLNGMK
DIITYCLNPLSVDTWVALFKRHTATTIPSKQDKLEKDTWLIPFARQHSLDLPSQTFGAKVFGSLIHINLA
AFDRSFVAQEIFMVRNFPLVIV


>XP_042426310.1 putative disease resistance protein RGA4 [Zingiber officinale]
MSVFHELKHLLLQVLPSSSLMAQGRLLCIQNHLAMVCDNLWAINSMIAFPEMRMLSKNFSERWANFGKVL
DVPPEFEDWERDVAVAVIDVGELLSRIMDWEVSLHRSIVGNTQQVNFRHVILVELKEMLCSLNSLVLRGS
SMGLRRDPMGSMNPLREDYSIVLKNEVVDREEDLEKFIAILEQQLVSSNNNDDDDDPFVIVIDGEQGVGK
TTLAHMIYHHTWVCQQFHHRIWVDLPLVSTFKTINIIGNEFVRSINKEEYCDQKLHLDLPLPAMWEYINE
QLCGSRYLLVLHCENLVSLMQPAEWNELKNILLRVGGPRSGVLIIDKSSTQSAFRDMVFLNGMKDIITYC
LNPLSKDAWVELFKRQAATTIPSLKQDKSKKDAWRFRNYFPSHTSGVKVFGLLSQNATAATHLLNDIYMV
RNFPLVIIRLHQYHHLLDVYNDYDVILHMLTAEYLIPTEGLERGWIQLYARSLRYINRRELALRLSRMVY
LHMKVPEDSTIISRCCRYLCLKISHRAIPFRLPTMPVEVSNKLITLILREQEEATQEDVEEITLQLYKKR
RMKATTAISKFLNKMSVRLVHLRILVVETGMIQRLPNEVSKLVNLRYLHLSKLKMELLPKSLFDLPNLRI
LSLLRCQKLQKIPERIHQLKKLQILKLAYCTKLQQLPKSITRLKNLEALDVEGCCWLSKLPEDLVNFKSL
RILNITRCASLSQIPHGIGQSISLRKLSGIFIGVNGGFVLTQLQTLTNLLEIRLRNLERVEKTQTELLMG
QQSLRDLSLHWDGEEADESSELAPSQQVLEALQPNVHLKMLEIISYKGVEFPTWMSKQQLALFDSLVEVR
LINLKRCATLPSLGQLPCLEKLEISGMDLIKHIDNTFYGDGDTFSVLRELTFLEMLALEKWSMPERKNVH
VFNKLERLTLIQCPKLKEIDLHSRPCLFFGVTIRVWLNNETIWSVEFYSWENLQYIEIIEIVGCQELRCL
PQGMQSLKHLSEMTINSCSNLTTLVALHSLEELNIYACPLLPFNLEAFRELRRLTIKGCPKMQM


>XP_042426311.1 putative disease resistance protein RGA4 [Zingiber officinale]
MVCDSLWAINSMIEIPEMGVRYNEYPPSWGKLDVPVEFVDWEIDVAAAVIDVGELLSRIMDWEASLHRFI
VGNTQQVNFRHVILVELKEMLCHLNSLVLRGSSMGLRRDPMGSMNPLREDYSIVLKNEVVGREEDLEKLV
AIFEQQLVSSNNNGDDNNPFVIVIDGKPGVGKTTLAHMIYHHTWVRQQFHHRIWVDLPLVSTFKMITIIG
NEFVRSINKEEYCDQKLHLDLPLPAMWEYINEQLCGSRYLLVLHCENLVSLMQPGEWNELKNILLRVGGC
GSGVLIIYKSSTKSVVRDTGFLNGMKDIITYCLNPLSVDAWVELFKRQATTTIPSSKQDKSAKDAWLFRT
YFPSQTFGPKVFGSLSQNIQAPFKTDFLYNIYKVRNFPLVIIRLHQYHHLLDVDNDYDVISHMLTAEYLI
PTEGLERGWIQLYAGSLRYISRQLPALVFSRIIYLHMKVPEDSTIIPRYCRYLCLKINHRAIPFRLPTMP
VEVSNKLITLILREHEEATQEDVEEITLEVYKKRRMKTTTAISKFLDKMSVRLIHLRILVVETGMIQRLP
NEVSKLVNLRYLHLSKLKMELLPKSLFDLHNLRILSLLRCQKLQKIPERIHQLKKLQILKLAYCTKVQQL
PKSVTRLKYLQVLDVEGCCWLSKLPEDLVSFKSLRILNVTRCASLSQIPHGIGQSIDLRKLSGIFIDVNG
GFVLTQLQALTNLQEIRLRNLERAEKTQTEVLMGQQSLCDLSLHWGGEEADESSESATPLQVLEALRPNM
HLKMLEIISFKGVEFPTWMSKQQLVRFDSLVEVRLINLRRCATLPSLGQLPCLKKLEISGMDLIKHIDNT
FYGDGGTFSVLRELTFSEMLALEKWSEPERKNAYVFDKLQQLTLIQCPKLKEIDLHSRPYLFFGGTMRVW
LNNEIIWSAEFCNWNNLRYIEIIEIVGCQELKCLPQGMRSFECLSKMTINSCNNLTTLVALDSLIELNIY
ACPLLAFNPEAFTSLRRLTIKGCPKMQM


>XP_042426317.1 disease resistance protein RGA2-like [Zingiber officinale]
MELKHLLLEVLPSSTMVAQGRLLCIQNHLAMVCDSLWAINSMIEIPEMGLLYNNAWHHRFNSPLDVPVEF
ADWVTDVATAVIDVGELLSRIMDWEASLYFRHVILVELKEMLCDLNSLVLRGSAMGLPRDPMGSMNPLRE
DYSIVLKNEVVGRHEDLEKLIEIFQQQQLVPSNNNGDDYNPFVIVIDGQKGVGKTTLAYMIYHHTWVRQL
FHHRIWVDLPPGVSTPKMINFIGKEFAKSIKNEEYCDKKLHLELPLQAMWEFINEQLDGSRYLLVLHCPD
LASLILQPEWNELKKILLRVGGPGSAVLVILKSSTQSVSDMSFQNRVKDITTYCLKPLSDDAWLELFKRH
AAMTIPPSNRDIVFKCSPYAMPHFQFVGETFGAKFWGSLGHNIQLGNLYPCEIKDIHMVRNFPFAIVRLL
QYHYLLDKDYNFILHMLTAEGLIPVEGLSPSWTEIYDRFRYNRILTFCLPRKVYLHRKVPGVSTTIPRCC
RYLHLEINPRAIPFRLPTMPVEVSKKMIALVLREDEATTQEDDEVMTLQVYKKRRTKAATAISKFLDKTS
VRLVHLHILVVETRMIQRLPNEVSKLVSLRYLHLSKLEIELLPKSLFDLPNLRILSLLHCKNLQKIRERI
HKLKKLQILKLAYCTKLQQLPRSITRLKNLEELNVEGCCFLRKLPEDLVSFKSLRILNVAGCASLSQIPH
GIEQSIGLRKLSGIFVGVNEGFGLTQLQALTNLHELKLRNIERTEETQTEVLMGQQSLWDLSLHWGGEEK
KESSESTTSLQLLEALRPSLQLRRLEIISYKGVEFPTWMSKQQLAGFNSLVEVRLINLKRCATLPSLGQL
ANLEKLEISGMDLITHLDDTFYGDGDIFPKLTELTFSEMLALEKWYMPKRKYIPLGQLSLIQCPKLKEIN
LFVYNTIRIWLNNETIWSVRFCSWDNLQSIQIIEIVGCQELRCLPQSMQRLKHLYKMIINSCNNLTTLVA
LDSLEALNIYACPVLAFDLAAFTNLWTLTIKGCPKMQIYHDAWKKKDEERW


>XP_042426321.1 putative disease resistance protein RGA3 [Zingiber officinale]
MVAQGRLLCIQNHLAMVCDGLWAINSMIEIPEMGVLYNYIWHHRFNSPLDVPVEFADWVTDVATAVIDVG
ELLSRIMDWEASLHFRHVILVELKEMLRDLNSLVLRGSAMGLPRDPMGSMNPLREDYSIVLKNEVVGRHE
DLEKLIEIFQQQQLVPSNNNGDDYNPFVIVIDGEERVGKTTLAYMIYHHTWVRQQFHHRIWVDLPLSVST
LKMINIIGKEFAKSINNEEYCDQKLHLELLLQAMWEYINEQLDGSRYLLVLHCLDLNRLISQPKWSELKN
ILLRVGGPGSAVLVILKSSTQSVSDMSFQNEVKDITTYCLKPLSDDAWLELFKRHAAMIIPPSKRDIVFK
GGTFAMPLFQLVGQTFGAKFWGSLGHSIQVEDLFPCEIKDIHMVRNFPFAIVRLLQYHYLLDKDYNVILH
MLTAEGLIPVEGLSPGWTEIYERFHYGRVSTFCFPRKVYLHRKVPGDSTSIPRCCRYLHLEINPRAIPFR
LPTMPVEVSKKMIALILREDEATTQEDIAEMTFQVYKKRRTKAATAISKFLDKMSVRLVHLHILVVETSM
IQCLPNEISKLVSLRYLHLSKLEIELLPKSLFDLPNLQILSLLHCKNLQKMPGRIHKLKKLKILKLAYCT
KLQQLPRSITRIKNLEELNVEGCCFLRKLPEDLVSFKSLRILNVAGCASLSQIPHGIEQSIGLRKLSRIF
VGVNEGFVLTQLQVLTNLQEIRLQNLERAEEIQIEVLMGQQSLWDLSLHWGGEKKEESSESTTSLQVLEA
LRPSLQLKRLEIISYKGVEFPTWMSKQQLAGFNSLVEVRLINLKRCATLP


>XP_042426322.1 disease resistance protein RPS4-like [Zingiber officinale]
MVVFLELKRLLLEVLPSPTMMAQGRLQCIQNHLALVCDSLWAINSMIEIPEMGMLNNHFSKKFYGFDVVT
SFVPAEFADWETDVATAVHFRHVILVELKEILCHLNSLVLRGSAMGLRRDLMASMNPLREDYSIVLKNEV
VGREEELEKLIAIFEQQLVSSNNNGFDNNPFAIVIVGKQGVGKRTLAHMIYHHTWIGQQFHHRIWVDLPL
VSTFKMINIIGNEFVRSIDKKEYCDQKLHLDLPLPDMWEYINEQLCGSRYLLVLHCENLVSLMQPEWNEL
KNIMLRVGRSGSGVLIIYKSSTESAVRYMSFLNRLKDITTFCLNPLSADAWVELVSRHAATTIPLKRDKS
EKDELIPFAEQHSSNFLGQTFGAKVFGSLFHDIPTTFATLESCSLDDIYMVRNFPLVIVRLLQYRHLLDA
DTDKYYDNDYDVISHMLTAECLIPTEGLEPGWIERYERFFTEIDIKWELFELLFRRMVYLHMKIPKDSTT
IYRCCRCLCLEINPRVIPFRLPIMPIKVSSKLITLILHEDKKTTREDVEEITLRVYKKRRMKAATAISKF
LNKMSVRFVHLHMLVVETSMIQSLPNEISKLVSLRYLHLSKLKMELLPKSLFDLLNLRILSLLHCKKLQK
IPERIHKLKKLQILKLAYCTKLQWLPKSITRLTNLEELNTQGCCFLSKLPEDLVSFKSLRILNVAGCASL
SQLPRGIEQSIGLRKLSGIFIGVQGGFVLTQLQALTNLQTIRLKNLERVEEIQTVKC


>XP_042426395.1 probable disease resistance protein At4g27220 [Zingiber officinale]
MVVPCFSNSCGGMESEIGNVIVKYFWNKLKTHVCYFIYSKEKFEKLKEHFDILKAIRDDTQQKMEAAERN
NEVISDEVNLWLNNVLELEGKFNNIENNFNRMVRDEKCYMPSLVPRYKVGREATKKRAEALELLDRKNFQ
AFSHTLDPSTLNYPSNKDFVSFGATKEAMRKVIDALNDDKVNLIGIYGMGGVGKTVLMEEIGRKMKEAET
FDVVIDVVVSQNPNIAQIQRCIADALGMRESSNKMLATRLEKEKKVLIMLDDVWARLELVTEVGIPYQEH
KGCKVMLTSRKAETCNVMETDVSVEVATLSEEDSWQLFRMRAGQVAESDGIEPVARKVAQECCGLPLAIA
VVGRALRSYKDASAWEDALSQLKQSVPGNMEEVEEKLFKPLELSYQNLKTAELKQLFLYCCLFREDYDIS
EDEITRYAVGENLLSNLSTLENVRGRVHFLLQKLKLSCLVLDSKKAGCVKLHDVVRDVAVYIGFKDNNHF
LVKAGLGLIDWPKYENLADCKRISLSNNFLQEIPEKPNCPKLILLLLNINPITSVPDNFFENMVSLNVLD
LSNTDITSLPSSLICLKGLGTLRLDRCKQLNDINVVGELKTLVILTLQECRGISALPETVYGLVKLKLLD
LSNCTLLQIPRNLVPKLTQLEELYLRGYNVTEALLVEVASLKKLVRVELYVKYARDFSEQIIPDNAYKAL
RHFIIYNEPDWFSLASKNQRDFFVKQASQSMISWGKPFLKRAEALRLDSCQWNFTDLIPLESMSCFANLQ
SLLIVNCHQIQCLLRSTDDTPSNAFGELMKLTLLDMENLEQICPGQLPAHSLKKLRTLELRRCRNIVDIL
PQDLLQRVHPSLVELLLEGCPGPDVLLNFEGLGHDSVIFPKLQMIRLSQISDVISFCTGVVPPGSLHNLT
TFEVVNCKKLLNLFSQILEATHSRLLPSETFKKLKQLQIMGCPCLKHVFLPSIANELQSLERLEIKNNDF
LETIITDEEGCDLKKGAFPMLKQLLFIKLPSLRYFFEGEPAKTLDWPSLEYIHLSDCLNLARLPIGHESA
QKLKKVHVVRLDDVNWFKTLIWEDNITKSRFDIIQSINEVK


>XP_042426591.1 disease resistance protein RGA2-like isoform X1 [Zingiber officinale]
MVVFMELKHLLLEVLPSPTMVAQGRLLCIQNHLAMVCDSLWAINSMIEIPEMGVLFNYIWHRRFNSPLHV
PVEFADWVTDVATAVIDVGELLSRIMDWEASLHFRHVILVELKEMLCDLNSLVLRGSAMGLPRDPMGSMN
PLREDYSIVLKNEVVGRHEDLEKLIEIFQQQLVPSNNNGDDYNPFVIVIDGEERVGKTTLAHMIYHHTWV
RQQFHHRIWVDLPPSVSTLEMIKIIGKEFAESINNEEYCDQKLHLELPLQAMWEYINEQLDGSRYLLVLH
CLDLNSLISLPEWSELKNILLRVGGPGSAVLVILKSSTQSMSDMSFQNRVKDITTYCLKPLSDDAWLELF
KRHAAMTIPPSKRDIVFKRISYAMPRFQLAGQTFGAKFWGSLGHNFQVENLFPYKIEDIPMVRDFPFAII
QLLQYHYLLDKDYNVILHMLTAEGLIPVEGLSPGWTEIYERFPYGRVSIFCFPRKVYLHRKVPGDSTSIP
RCCRYLCLEINPRAIPFRRPIMLVEVSKKMIALILREDEATTQEDNAEMTFQVYKKRLMKPATTISLQVY
KKRQTKAATAISKFLDKMSVRLVHLHILVVETSMIQSLSNEISKLVSLRYLHLSKLEIELLPKSLFDLPN
LRILSLLHCKKLQKIRERIHKLKKLQILKLAYCTKLQQLPRSITRLKNLEELNMEGCCFLRKLPEDLVSF
KSLRILNVAGCASLSQIPHGIEQSIGLRKLSGIFVGVNEGFVLTQFQVLTNLQEIRLQNLERAEEIQIEV
LMGQQSLWDLSLHWGGEKKKESSESTTSVLKALRPSLQLKRLEIISYKGVEFPTWMSKQQLAGFNSLVEV
RLINLKRCATLPSLGQLANLGKLEISGMDLITHLDDTFYGDGDIFPMLTELTFSEMLALEKWYMPKRKYI
RYFSKLRQLSLIQCPKLKEINLFVYGTIRIWLNNETIWSVKFCSWDNLQNIEIIEIVGCQELRCLPQGMQ
SLNFLSKMTINSCNNLTTLVALDSLEELNIYACPVLAFNLAAFTKLRTLTIKGCPKMQIHNVIISVITMP
GRKKMRNDGEKTEEDRR


>XP_042426592.1 disease resistance protein RGA2-like isoform X2 [Zingiber officinale]
MVVFMELKHLLLEVLPSPTMVAQGRLLCIQNHLAMVCDSLWAINSMIEIPEMGVLFNYIWHRRFNSPLHV
PVEFADWVTDVATAVIDVGELLSRIMDWEASLHFRHVILVELKEMLCDLNSLVLRGSAMGLPRDPMGSMN
PLREDYSIVLKNEVVGRHEDLEKLIEIFQQQLVPSNNNGDDYNPFVIVIDGEERVGKTTLAHMIYHHTWV
RQQFHHRIWVDLPPSVSTLEMIKIIGKEFAESINNEEYCDQKLHLELPLQAMWEYINEQLDGSRYLLVLH
CLDLNSLISLPEWSELKNILLRVGGPGSAVLVILKSSTQSMSDMSFQNRVKDITTYCLKPLSDDAWLELF
KRHAAMTIPPSKRDIVFKRISYAMPRFQLAGQTFGAKFWGSLGHNFQVENLFPYKIEDIPMVRDFPFAII
QLLQYHYLLDKDYNVILHMLTAEGLIPVEGLSPGWTEIYERFPYGRVSIFCFPRKVYLHRKVPGDSTSIP
RCCRYLCLEINPRAIPFRRPIMLVEVSKKMIALILREDEATTQEDNAEMTFQVYKKRLMKPATTISLQVY
KKRQTKAATAISKFLDKMSVRLVHLHILVVETSMIQSLSNEISKLVSLRYLHLSKLEIELLPKSLFDLPN
LRILSLLHCKKLQKIRERIHKLKKLQILKLAYCTKLQQLPRSITRLKNLEELNMEGCCFLRKLPEDLVSF
KSLRILNVAGCASLSQIPHGIEQSIGLRKLSGIFVGVNEGFVLTQFQVLTNLQEIRLQNLERAEEIQIEV
LMGQQSLWDLSLHWGGEKKKESSESTTSVLKALRPSLQLKRLEIISYKGVEFPTWMSKQQLAGFNSLVEV
RLINLKRCATLPSLGQLANLGKLEISGMDLITHLDDTFYGDGDIFPMLTELTFSEMLALEKWYMPKRKYI
RYFSKLRQLSLIQCPKLKEINLFVYGTIRIWLNNETIWSVKFCSWDNLQNIEIIEIVGCQELRCLPQGMQ
SLNFLSKMTINSCNNLTTLVALDSLEELNIYACPVLAFNLAAFTKLRTLTIKGCPKMQIYHDAWKKKDEE
RW


>XP_042426593.1 putative disease resistance protein RGA4 isoform X3 [Zingiber officinale]
MVVFMELKHLLLEVLPSPTMVAQGRLLCIQNHLAMVCDSLWAINSMIEIPEMGVLFNYIWHRRFNSPLHV
PVEFADWVTDVATAVIDVGELLSRIMDWEASLHFRHVILVELKEMLCDLNSLVLRGSAMGLPRDPMGSMN
PLREDYSIVLKNEVVGRHEDLEKLIEIFQQQLVPSNNNGDDYNPFVIVIDGEERVGKTTLAHMIYHHTWV
RQQFHHRIWVDLPPSVSTLEMIKIIGKEFAESINNEEYCDQKLHLELPLQAMWEYINEQLDGSRYLLVLH
CLDLNSLISLPEWSELKNILLRVGGPGSAVLVILKSSTQSMSDMSFQNRVKDITTYCLKPLSDDAWLELF
KRHAAMTIPPSKRDIVFKRISYAMPRFQLAGQTFGAKFWGSLGHNFQVENLFPYKIEDIPMVRDFPFAII
QLLQYHYLLDKDYNVILHMLTAEGLIPVEGLSPGWTEIYERFPYGRVSIFCFPRKVYLHRKVPGDSTSIP
RCCRYLCLEINPRAIPFRRPIMLVEVSKKMIALILREDEATTQEDNAEMTFQVYKKRLMKPATTISLQVY
KKRQTKAATAISKFLDKMSVRLVHLHILVVETSMIQSLSNEISKLVSLRYLHLSKLEIELLPKSLFDLPN
LRILSLLHCKKLQKIRERIHKLKKLQILKLAYCTKLQQLPRSITRLKNLEELNMEGCCFLRKLPEDLVSF
KSLRILNVAGCASLSQIPHGIEQSIGLRKLSGIFVGVNEGFVLTQFQVLTNLQEIRLQNLERAEEIQIEV
LMGQQSLWDLSLHWGGEKKKESSESTTSVLKALRPSLQLKRLEIISYKGVEFPTWMSKQQLAGFNSLVEV
RLINLKRCATLPSLGQLANLGKLEISGMDLITHLDDTFYGDGDIFPMLTELTFSEMLALEKWYMPKRKYI
RYFSKLRQLSLIQCPKLKEINLFVYGTIRIWLNNETIWSVKFCSWDNLQNIEIIEIVGCQELRCLPQALD
SLEELNIYACPVLAFNLAAFTKLRTLTIKGCPKMQIHNVIISVITMPGRKKMRNDGEKTEEDRR


>XP_042426594.1 putative disease resistance protein RGA4 isoform X4 [Zingiber officinale]
MVVFMELKHLLLEVLPSPTMVAQGRLLCIQNHLAMVCDSLWAINSMIEIPEMGVLFNYIWHRRFNSPLHV
PVEFADWVTDVATAVIDVGELLSRIMDWEASLHFRHVILVELKEMLCDLNSLVLRGSAMGLPRDPMGSMN
PLREDYSIVLKNEVVGRHEDLEKLIEIFQQQLVPSNNNGDDYNPFVIVIDGEERVGKTTLAHMIYHHTWV
RQQFHHRIWVDLPPSVSTLEMIKIIGKEFAESINNEEYCDQKLHLELPLQAMWEYINEQLDGSRYLLVLH
CLDLNSLISLPEWSELKNILLRVGGPGSAVLVILKSSTQSMSDMSFQNRVKDITTYCLKPLSDDAWLELF
KRHAAMTIPPSKRDIVFKRISYAMPRFQLAGQTFGAKFWGSLGHNFQVENLFPYKIEDIPMVRDFPFAII
QLLQYHYLLDKDYNVILHMLTAEGLIPVEGLSPGWTEIYERFPYGRVSIFCFPRKVYLHRKVPGDSTSIP
RCCRYLCLEINPRAIPFRRPIMLVEVSKKMIALILREDEATTQEDNAEMTFQVYKKRLMKPATTISLQVY
KKRQTKAATAISKFLDKMSVRLVHLHILVVETSMIQSLSNEISKLVSLRYLHLSKLEIELLPKSLFDLPN
LRILSLLHCKKLQKIRERIHKLKKLQILKLAYCTKLQQLPRSITRLKNLEELNMEGCCFLRKLPEDLVSF
KSLRILNVAGCASLSQIPHGIEQSIGLRKLSGIFVGVNEGFVLTQFQVLTNLQEIRLQNLERAEEIQIEV
LMGQQSLWDLSLHWGGEKKKESSESTTSVLKALRPSLQLKRLEIISYKGVEFPTWMSKQQLAGFNSLVEV
RLINLKRCATLPSLGQLANLGKLEISGMDLITHLDDTFYGDGDIFPMLTELTFSEMLALEKWYMPKRKYI
RYFSKLRQLSLIQCPKLKEINLFVYGTIRIWLNNETIWSVKFCSWDNLQNIEIIEIVGCQELRCLPQALD
SLEELNIYACPVLAFNLAAFTKLRTLTIKGCPKMQIYHDAWKKKDEERW


>XP_042426595.1 putative disease resistance protein RGA3 isoform X5 [Zingiber officinale]
MVVFMELKHLLLEVLPSPTMVAQGRLLCIQNHLAMVCDSLWAINSMIEIPEMGVLFNYIWHRRFNSPLHV
PVEFADWVTDVATAVIDVGELLSRIMDWEASLHFRHVILVELKEMLCDLNSLVLRGSAMGLPRDPMGSMN
PLREDYSIVLKNEVVGRHEDLEKLIEIFQQQLVPSNNNGDDYNPFVIVIDGEERVGKTTLAHMIYHHTWV
RQQFHHRIWVDLPPSVSTLEMIKIIGKEFAESINNEEYCDQKLHLELPLQAMWEYINEQLDGSRYLLVLH
CLDLNSLISLPEWSELKNILLRVGGPGSAVLVILKSSTQSMSDMSFQNRVKDITTYCLKPLSDDAWLELF
KRHAAMTIPPSKRDIVFKRISYAMPRFQLAGQTFGAKFWGSLGHNFQVENLFPYKIEDIPMVRDFPFAII
QLLQYHYLLDKDYNVILHMLTAEGLIPVEGLSPGWTEIYERFPYGRVSIFCFPRKVYLHRKVPGDSTSIP
RCCRYLCLEINPRAIPFRRPIMLVEVSKKMIALILREDEATTQEDNAEMTFQVYKKRLMKPATTISLQVY
KKRQTKAATAISKFLDKMSVRLVHLHILVVETSMIQSLSNEISKLVSLRYLHLSKLEIELLPKSLFDLPN
LRILSLLHCKKLQKIRERIHKLKKLQILKLAYCTKLQQLPRSITRLKNLEELNMEGCCFLRKLPEDLVSF
KSLRILNVAGCASLSQIPHGIEQSIGLRKLSGIFVGVNEGFVLTQFQVLTNLQEIRLQNLERAEEIQIEV
LMGQQSLWDLSLHWGGEKKKESSESTTSVLKALRPSLQLKRLEIISYKGVEFPTWMSKQQLAGFNSLVEV
RLINLKSWDNLQNIEIIEIVGCQELRCLPQGMQSLNFLSKMTINSCNNLTTLVALDSLEELNIYACPVLA
FNLAAFTKLRTLTIKGCPKMQIHNVIISVITMPGRKKMRNDGEKTEEDRR


>XP_042426596.1 putative disease resistance protein RGA3 isoform X6 [Zingiber officinale]
MVVFMELKHLLLEVLPSPTMVAQGRLLCIQNHLAMVCDSLWAINSMIEIPEMGVLFNYIWHRRFNSPLHV
PVEFADWVTDVATAVIDVGELLSRIMDWEASLHFRHVILVELKEMLCDLNSLVLRGSAMGLPRDPMGSMN
PLREDYSIVLKNEVVGRHEDLEKLIEIFQQQLVPSNNNGDDYNPFVIVIDGEERVGKTTLAHMIYHHTWV
RQQFHHRIWVDLPPSVSTLEMIKIIGKEFAESINNEEYCDQKLHLELPLQAMWEYINEQLDGSRYLLVLH
CLDLNSLISLPEWSELKNILLRVGGPGSAVLVILKSSTQSMSDMSFQNRVKDITTYCLKPLSDDAWLELF
KRHAAMTIPPSKRDIVFKRISYAMPRFQLAGQTFGAKFWGSLGHNFQVENLFPYKIEDIPMVRDFPFAII
QLLQYHYLLDKDYNVILHMLTAEGLIPVEGLSPGWTEIYERFPYGRVSIFCFPRKVYLHRKVPGDSTSIP
RCCRYLCLEINPRAIPFRRPIMLVEVSKKMIALILREDEATTQEDNAEMTFQVYKKRLMKPATTISLQVY
KKRQTKAATAISKFLDKMSVRLVHLHILVVETSMIQSLSNEISKLVSLRYLHLSKLEIELLPKSLFDLPN
LRILSLLHCKKLQKIRERIHKLKKLQILKLAYCTKLQQLPRSITRLKNLEELNMEGCCFLRKLPEDLVSF
KSLRILNVAGCASLSQIPHGIEQSIGLRKLSGIFVGVNEGFVLTQFQVLTNLQEIRLQNLERAEEIQIEV
LMGQQSLWDLSLHWGGEKKKESSESTTSVLKALRPSLQLKRLEIISYKGVEFPTWMSKQQLAGFNSLVEV
RLINLKSWDNLQNIEIIEIVGCQELRCLPQALDSLEELNIYACPVLAFNLAAFTKLRTLTIKGCPKMQIH
NVIISVITMPGRKKMRNDGEKTEEDRR


>XP_042426626.1 putative disease resistance protein RGA4 [Zingiber officinale]
MDTAGVAMMVGGWFPGYIMDKLVNFVTSHTSDHWDLLTDVEEKLNEIQARLPRIRAVIHAAEGRPIRDPA
LVDWLRQLKEAAYEADDLLDQMEYRQLEDQVQDRSKVSALAASALRFFKNLFVSDDELKRLKNLLGDVDK
IYSEIDRKNVELNEDNAKHTASIRETSSFTQEVVFGRDKERERILEMLLSSGNDADFLNKGAGSGSHASL
GVLPIVGIGGVGKTTLAQIIYHDPRVADHFELRKWVCVSNDFNVKRIARELEAEESSDYRWDHISLDSQL
TKLIHATESKRFLFVLDDVWDEAGRKWMELRSALTYGNRGSTILITTQSPIVAEVMGTMDQIELKLLEES
DYWSLFEHCSFGSRVIDPYLRRKLQSIGRQIAKKLHGLPLSGKVVGSLLHARLEEQYWKMIRESEWWEND
FLLENILPSLGLSYQHLSSNVKQCFAFTAMFPKGHVFDKEQLVEMWIAQGFVRPEAQHGRMTLEDIGNQI
FDELTCRYFFLHSINKRYVIHDLIRELAVYISRDECFVIDDEPSKIPPTARHLTVMRTAELDTLAELSKL
HKVRTLVFYRDYHPENFFSLGENGSRQFYESLERILKTLKNLRILDLSYMLIEIKKLPDATCDLSHLRYL
DISGTKIRHLPGSFSKSYHLQVLKLNRCWIKKLPEGMNRLIKLRHLHADADTISLVDGIGRLTDLQELDE
FRITRKRGHQIGELKELRNIRRRLVIQNLECVESQEEAMEAKLKDKEYLDHLVLNFKEGKRSQGDIQKDI
LEGLEPHCNLKRLVIQNYGCLNSPCWLEKNYLTNLESIHLNCCARWEDLPPLGHLPFLMDIFIFNLPVRR
ISAKFYGDADQVFPSLQELAFHTLNEWEELSESDSRPIFPCLMKMRIENCLKLRRIPVLPLISIKHLDIR
NSGDIGNALPDYLLTLTSLTYLELHNCAQRASVSLYNLQFLEYLRLVQCPELSLIGGLQSLANLKDLIIH
ACPKLFEPAQMPEQPYVEQEMRSLCTVWIDDDVLKHVWVILGRTPCIQVLRIHHCNDLSHFNPEHEEWFQ
QLTSLHFLEFHNCSRLRKLPSSLGTASIKILCIHHCPNIESLPDNGLPFLLRKLEMHGCTKLRDRCRKDD
GSDWPLISNIPNIDIDGELIQMK


>XP_042426638.1 putative disease resistance RPP13-like protein 1 [Zingiber officinale]
MALATFARVLRLIDSSEASIPPSRTRPAFLSDLSKHMAALKQNLTRIQVAIRGAEERQAIDPSAKLWLYE
ITSLAYDAEDVLLDFDDLLLRPQIRSALNHSDSGLLPNSFSSLASISQRIKELGERLVELHGKSEALQLG
EEGGVEGSADVRRLRPTGSLMDGESPIFGREKDKEKILELLRPSGDEGPIPNKLLVLPIVGMGGLGKTTL
AQQVYADDQIKYFFDLKIWIHVSQDFNLINLTKAMVESVTGNPCFLSELHSLQSELGKILEGKRFFLVLD
DVWDESSSHWESLQMPLLSANLDSKVLLTTRSHGVARSIGTMPSFNLDPLKDDDAWLLFSENAFHGREPG
ERLVTIGKKIVKECNGLPLTLIALGLHLCNEEREDKWSAILESNIWHLSGSQETILPILMLSYLQLPAPV
KQCFAYCSLFGKGHLFLRHKIVRHWIAQGFVETDGERKAEDVGSEYFYILLSRSFFQQCARNQYFITHDL
IHDLAEDVSGAERFKIDLLQDEDGSRMKVERAYNFPEGVRHTSLTFHSTSTETDLQPLLEANSLRTLMVN
CTSWPPMPHPHANVLNDLFVKLRYLRVLLLDYTFAPAPRLPDSISNLKYLHYLRIGRLSFQGQGFPESVC
SLRNLQTLEWYSDESIELPRGISNLINLRHLHSETYYASFPEGIGRLTKLQELPDFHTSKEHRCARIAEL
KDLVNLQGELKLLNLENVIDVEDARAADLKGKPGLTALELQWGKHNRSPQNAPLVLQYLQPHTNIQELRI
GNYKHGQLSEWICHPSYSKLVTIKIQYCFLSTVPAFGQLLSLEHLSLVSIKGLEYIGPVFFHGGFPSLKK
LRLSAIYKMVEWSGADHGHFPHLNELTVTSCPSLRCLPIDNFTSLKGLHISHCSNLQTLYSENSPLVGIQ
QHCSLKNLEVVQCPKLKFLPEYQVPESLQLLDITKSTLLINWYRRIAGKLTHVKNLLGVDLKEVKLDDIF
SVEEARNACLTKQRIYMLHLEWETSSLRSVDDTNCEVDEVLEYLQPNVSLNKLVIRGYRGLKLAEWLCSP
LYSNLISIKLDLCPNCKFLPALGQLPYLMELHLERLNGITSIDLSFYGNGSQKGFQSLRRLQLMSMAGLE
EWKGASDGGFPILRQLIVQDCMKLGGLPCLSPSVQEIKVEDCPALTLELPSSLAALLSLHVSNVAEMNEL
HNLSYLSVLAVENCSGCRLIELPSLRSLMINGWSERMLLDSLPGLTALTTLKISCLENLEALPLHNFRIL
EELLVSDCPKLVSIECFSTSTYEPYYVEGLQSLSALKCMVLSGCPELHFSASEQLPASLQSLTISRCPTL
RIWYERYSSKFRTSVVQFAD


>XP_042426666.1 disease resistance protein RPS2-like [Zingiber officinale]
MADIISGISGRASPGDLPGLIPGCEQWPPTPTPSSQTNSSFRVFHLFSPVNSRFGIVGLRATARINHNLI
PPLSGIISFFTCLKDCCFQSCNYIVSYERIISSLATELAQLKSKREDIKRQIEAAERDGLNPKKEVLGWL
QSVEALTSETENINAAYHQMFKCLCNFPVNVRSGYPLRSKAKAALITAADLKEKAREFTDVADNLDVEKA
REFTDVADNLDVDRFLEMPNPKTVGMKTALAALQGNARDDDVSIIGIHGMGGVGKTALLRRFNNHFAEKE
VDNLDVVIYLELSTGYKVEEIQKSLFDRLKLTWKDEESQRNRAGRLFRVLSKMTFSLLLDNVWEPLNCQI
VGIPLLQKPSKSKIVFATRMEEVCSSMGAEKTIKLECLSEEASWDLFRFNAKLELVNTSTLILNLARALV
QQCAGLPAALITVAQAMASKRTIAEWRHVLAIMKEAPFQLPGMEEHVYHPLKLSYDRLSDTLRTCASYFA
LVQEGCWLSKFYVRELWIGEGFINDFERLSDTADKASYLLGMLLAASLIQRIDSEYFKMHPMVRSMILWM
ECDCGKKESKWLIGDRHSLAEAPGAEKWRVAERISLGWNNITLLPDEPQCPDLIYLHLRNNHPLKNIPNE
FFSHMPCLRILDLQQTSIDELPPGIGNLSQLQLLDLSSTRIASLPREIQALVNLRYLAMSSATHLRSIPS
AVIPCLHHLQWLNMYNSYSGWRVMGALQLDGEGVLLNEVESLKKLKVLGITMSSVTTLRRFCESQRLTAA
VHWLQIEGCGGLTSLDIPSTYCLGENMQNMVQIRLHAMTDLEEVFIGGDLHACNALSGLEYLRLLALPKA
KIIWKNRCLENLLELEIEDCNAIDRLMKVVTNATNSTETITIFPRLRKIVLRKLPELESLSDGDQVIAFP
SLETMEVRNCPKLKKLTLAAENLTEIKCDREWQDELDWSDERTLSFQKLFERPDRR


>XP_042426758.1 putative disease resistance protein RGA1 isoform X1 [Zingiber officinale]
MLVFLELKHLLLEVLPSPTMVAQGRLLCIQNHLAMVCDSLWAINSMIEIPEMGVLFNYIWHHRFNSPLDV
PVEFADWVTDVATAVIDVGELLSRIMDWEASLHFRHVILVELKEMLCDLNSLVLRGSAMGLPRDPMGSMN
PLREDYSIVLQNEVVGRHEDLEKLIEIFQQQQQQLVPSNNNGDDYNPFVIVIDGEERVGKTTLAHMIYHH
TWVRQQFHHRIWVDLPPSVSTLEMIKIIGKEFAESINNEEHCDQKLHLELPLQAMWKYISEQLDGSRYLL
VLHCLDLNSLILQPEWSELKNILLRVGGPGSAILVILKSSTQSVSDMSFQNRVKDITTYCLKPLSDDAWL
ELFKRHAAMTIPLSKRDIVFKGSTFAMPLFQLVGQTFGAKFWGSLGHSIQVEDLFPCEIKDIHMVRNFPF
AIVRFLQYHYLLDKDYNVILHMLTAEGLIPVEGLSPGWTEIYERFRYGRESTFCFPRKLYLHRKVPGDST
TIPRCCRYLRLEINPRVIPFRLPTMPVEVSKKMIALILREDEATTRAFQVYKKRLMKPATTISLQVYKKR
RTKAATAISKFLDKMSVRLVHLHILVVETSMIQSLPNEISKLVSLRYLHLSKLEIELLPKSLFDLPNLRI
LSLLHCKNLQKIPERIHKLKKLQILKLAYCTKLQQLPRSITRLKNLEELNVEGCCFLRKLPEDLVSFKLL
RILNVAGCASLSHIPHGIEQSIGLRKLSGIFVGVNEGFELTQLQALTNLHELRLRNIERTEETQTEVLMG
QQSLWDLSLHWGGEEKKESSESTTSLQVLEALRPSLQLKRLEIISYKGVEFPTWMSKQQLAGFNSLVEVR
LINLKRCATLPSLGQLANLEKLEISGMDLITHLDDTFYGDDGIFPMLTELTFSEMLALEKWYVPKKKIFY
IFHALCNCH


>XP_042426759.1 uncharacterized protein LOC122014564 isoform X2 [Zingiber officinale]
MLVFLELKHLLLEVLPSPTMVAQGRLLCIQNHLAMVCDSLWAINSMIEIPEMGVLFNYIWHHRFNSPLDV
PVEFADWVTDVATAVIDVGELLSRIMDWEASLHFRHVILVELKEMLCDLNSLVLRGSAMGLPRDPMGSMN
PLREDYSIVLQNEVVGRHEDLEKLIEIFQQQQQQLVPSNNNGDDYNPFVIVIDGEERVGKTTLAHMIYHH
TWVRQQFHHRIWVDLPPSVSTLEMIKIIGKEFAESINNEEHCDQKLHLELPLQAMWKYISEQLDGSRYLL
VLHCLDLNSLILQPEWSELKNILLRVGGPGSAILVILKSSTQSVSDMSFQNRVKDITTYCLKPLSDDAWL
ELFKRHAAMTIPLSKRDIVFKGSTFAMPLFQLVGQTFGAKFWGSLGHSIQVEDLFPCEIKDIHMVRNFPF
AIVRFLQYHYLLDKDYNVILHMLTAEGLIPVEGLSPGWTEIYERFRYGRESTFCFPRKLYLHRKVPGDST
TIPRCCRYLRLEINPRVIPFRLPTMPVEVSKKMIALILREDEATTRAFQVYKKRLMKPATTISLQVYKKR
RTKAATAISKFLDKMSLSRCLEEKR


>XP_042426774.1 putative disease resistance protein RGA4 [Zingiber officinale]
MLVFLELKHLLLEVLPSPTMVAQGRLLCIQNHLAMVCDSLWAINSMIEIPEMGVLFNYIWHHRFNSPLDV
PVEFADWVTDVATAVIDVGELLSRIMDWEASLHFRHVILVELKEMLCDLNSLVLRGSAMGLPRDPMGSMN
PLREDYSIVLKNEVVGRHEDLEKLIEIFQQQQLVPSNNNGDDYNPFVIVIDGEERVGKTTLAHMIYHHTW
VRQQFHHRIWVDLPPSVSTLEMIKIIGKEFAESINNEEYCDQKLHLELPLQAMWEYISEQLDGSRYLLVL
HCLDLNSLILQPKWNELKNILLRVGGTGSAVLVILKSSTQSVSDMSFQNGVKDITTYCLKPLSDDAWLEL
FKRHAAMTIPPSKRDIVFKGSTFAMPLFQLVGQTFGAKFWGSLGHSIQVEDLFPCEIKDIHMVRNFPFAI
VRLLQYHYLLDKDYNVILHMLTAEGLIPVEGLSPSWTEIYDRFRYGRESTFCFPRKVYLHRKVPGDSTTI
PRCCRYLRLEINPRAIPFRLPTMPIEVSKKMIALILREDEATTQEDDKRMTFQVYKKRLMKPATTISLQV
YKKRRTKAATAISKFLDKMSVRLVHLHILVVETSMIQSLPNEISKLVSLRYLHLSKLEIELLPKSLFDLP
NLQILSLLHCKNLQKMPGRIHKLKKLQILKLAYCTKLQQLPRSITRLKNLEELNVEGCCFLRKLPEDLVS
FKSLRILNVAGCASLSQIPHGIEQSIGLRKLSGIFVGVNEGFGLTQLQALTNLHELKLRNIERTEETQTE
VLMGQQSLWDLSLHWGGEEKKESSESTTSLQVLEALRPSLQLKRLEIISYKGVEFPTWMSKQQLAGFNSL
VEVRLINLKRCATLPSLGQLANLGKLEISGMDLITHLDDTFYGDGDIFPKLTELTFSEMLALEKWYVPKK
KYILYFSRLMQLSLIQCPKLKEINLFAYGTIRIWLNNETIWSVRFCSWDNLRNIYIIEIVGCQELRCLPQ
GMQRLKRLYKMIFNSCNNMTTLVALDSLEELNIYACPVLAFNLAAFTKLRTLTIKGCPKMQIYLDAWKKK
YEERWW


>XP_042426804.1 putative disease resistance protein RGA4 [Zingiber officinale]
MIRNSLWTINSFLLDATLSVVEQPDVAEWMKDVGVAVEDVDSLLKRILDYWEPSEEDKVENRRLMISNFL
SMSSRQAILVELKDMACMLNYLVNRGAALGLWVEMMDSMDPTHDDYSAILSKEVIGREEDIDQIIELLQQ
QQCDEDGNAPFIITLEGTMNGKTTLARTIYHHPWVHRHFQHRIWLDAPLSIRSIRDFKSNVIAKEIAKYT
GKSCTNTDYWPLINEHFGGDRYLLILDGVQVSHLFAYKWKEFMLKLLHCGAPGSKVILTGDCFYVFGMEF
YIKNYKLNMLSEDTGARILLRYSTFVHPIEANSNHKEKASPAVTDMQIPLKYPLLVKGLGLIYRRINTRL
DKEILSRYDLDTLLKYYSWPIERERYFQYQELFGRYSNQCSDEDLFEILVAEGTLRYNWMKNTEYDVPFN
FKTDPCFFRMKAWEGSRIPLQCRHLYLPIHSKNISKIKKVIEKAGVADRLRTLILHMKEKKEQIYQYQTV
SKILESMFVNLKHLCTLHMGGIMIQYLPSSVGTLHCLRYLNLAENKIETLPESLCNLGNLCVLNLSSCKK
LKELPRQIHKLRKLQILKLSSCLRIQKLPESITWLVNLKELDVGDCCYLSKLPDDLCSMKNLMQLEMHGC
ASLTRMPIGIRQLTNLEVLRGYDAIDGLGNVMLSELQTLTNLESLHIRHLERLELAEEKNITPPTNLLEN
QCLNELTLHWEWWNDMVAEGTLEPTMQLTQGFQHNLRDLIVLKMVSYMSDKFPSWLMIADRDSLLNNLTT
VHLINLRRCERLPPLGHLRNLKEVAISGFDSVKVVDETFYGEDHNSVFLHLRRLTFSEMPRLEKWVGLKH
THSRLLFRSLKELTLIQCPKLKEFHMRFPESLSLKLLLSNEMLMPISKFVGWQNLRQVNMLQIFGCQELR
NLPDGLRMIPNLETLEIINCNKLEALPIWLKKSRLKSLFLSGCPALSFIPEELKFMERLTNLYVEACPKL
QRQSQLSELCRCSGDF


>XP_042426873.1 uncharacterized protein LOC122014612 [Zingiber officinale]
MLVFLELKHLLLEVLPSPTMVAQGRLLCIQNHLAMVCDSLWAINSMIEIPEMGLLFNYIWHHRFNSPLDV
PVEFADWVTDVATAVIDVGELLSRIMYWEASLHFRHVILVELKEMLCDLNSLVLRGSAMGLPRDPMGSMN
PLREDYSIVLQNEVVGRHEDLEKLIEIFQQQQLVPSNNNGDDYNPFVIVIDGEERVGKTTLAHMIYHHTW
VRQQFHHRIWVDLPPSVSTLEMIKIIGKEFAESINNEEYCDQKLHLELPLQAMWEYINEQLDGSRYLLVL
YCLDLNSLISQPEWSELKNILLRVGGPGSAVLVILKSSTQSVSDMSFQNRVKDITTYCLKPLSDDAWLEL
FKRHAAMTIPPSKRDIVFKGSTFAMPLFQLVGQTYGAKFWGSLGHSIQVEDLFPCEIKDIHMVRNFPFAI
VRLLQYHYLLDKDYNVILHILTVEGLIPVEGLSPGWTEIYERFRYGEESTFCFPRKVYLHRKVPGDSTTI
PRCCRYLRLEINPRAIPFRLPTMPVEVSKKMIALILREDEATTQEDDKRMTFQVYKKKANETSNYNITSS
IQKKANQSSNCNIEVPRQDVGKTRTFAYISCRN


>XP_042427091.1 putative disease resistance protein RGA4 [Zingiber officinale]
MIGWFALTSLGWLAESFMAALVGKAVDRIVQQFGEQHGVEDDLEKLQDSLDHARLTISTIESLRIKDKGL
QKKLKEFLTSLKDAAYDADDLLDEFQYRILKQQIEQQGNEAGNRASFSSYSTPPPSKKLKTSFSSYTSGL
FGKGDDNNDDVRRIRKIKRRLDDNSVALEKIYSSLGVQDDRGKKQLVSSASRQMSSFWTKPRLFGRDKEL
QELKDLLLEPEAVSGQSGFSVLSIVGIGGIGKTTLAQEVFNDSSVKEYFELRIWVRVSENFSTEKLTREI
IEYATKKNCNLPNFAALQDFLKEKITPERFLLVLDDVWNEDRHQWESLCAPLRSGKPGSKILVTTRSRKI
AGMVGDLDAIHLEGLDEKCFWEFFKKCAFSSSNSGVHHYHLEAMAKKMIYKLKGLPLAAKTLGGLLSMKL
DEQHWKSILDSEIWQLPQEEENGIIPALQLSYQYLPPHLKQCFAFCSLFPKNYSFSESKLISIWIAEGFI
VPQGSIRMEELGNNYFHELVNRSFFQKIKSKGFIKQFGMHDLIHDLTELISVGESSRIEKSNFHEIPNTI
RHLSVHQEEEGMQTRCLTEFSHYNKLRTLMLPRRYSNNSLLVDSSVLEKLKKIRVLILSKCALKELPDNI
GKLIHIRYLDLSDNYDIRSLPESLCDLYNLQTLILYRCYKLESLPHDMVKLINLRKLDGVAPMFFLKITE
VGKLTSLQNLPVFKVLKDNGYKLAELKGLKQLRGELRITNLENVENKGEANIANLKSKEHLDKLVLEWTS
DSDVNLHISEQVLEGLQPHNNLQSLTIREYNGARPPNWLDEQVYSRLEKLELQNCKRWNDLSVIGQLSQL
KRLYLGRTSVHTQNLHKLFDPIHCKFFFQLESLSLEGITMLEDLPNLGQLPCLEFLDIRSLPGVKMIGDR
FFSTSEEGSCFPSLHTLHFNEMPAWEEFYCSEDRDLFPCLIELQISDCQNLRMLPPLSPSIELLQLSNVG
LVDCPRFWKVIDESSNVTNSASITELFIQECPNLTILEQGLLAHHLQQIDIQKCEQLLWAPVKRLKELTS
LESLSIKECPKLMSMTQDEYINFELPPSITQLCLSDCGNLSKSLPGCLHNLTSLRDLEISNCPNLVSLPV
EQLLNLESVTIKNCNELRSVERLQIKSLHNLKIAGCPKLLLSQGEAQTEKSALQMLEIDDTAFMKQSVIK
NLLSSVNYLRISSSCEAVMFEGDDQESLQSLTSLDSLSFSDCKNLQSLPTKLYTLTSLQILGIHYCPQIQ
SLPEKGLPPSLTNLYFHGCHLALEQQLERHLAGIKKFG


>XP_042427126.1 putative disease resistance protein RGA1 [Zingiber officinale]
MIGFALTALGWLAESFMVALAGKAVDRAVQQFGEQHGVEEDLKKLKDSLANAMLQISTIENLWLKDESLQ
KRLKELLIGLKDAAYDADDLLDEFQYRILKQQIEQQADEAGNRASSSSYSTPPPGKKIKTSLSSYASGLF
GKGDDDDNNNDVQRMREIKRRLDDNSAALEKIYSSLGAEDDRGKKQLVSSESRQTSSFSIEPQLFGRDKE
LQELKDLLLKSEVASKFDQGGVSVLSITGIGGIGKTTLAQEVFNDNTVEEYFKLRIWVCVSENFSTERLT
REIIEYTTKKKCNVPNFAALQVVLKEKITQERFLLVLDDVWNEERHKWESLCAPLRFGKPGSKILVTTRS
RSIAGMVGDVDPIHLDGMDEKSFWNFFKKCAFGSSNSGIHHPHLEAMAKKMTYKLKGLPLAAKTLGGLMS
MKLDEQHWKSILDSEIWQLPQEENGIMPALQLSYQYLPPHLKQCFAFCSLFPKDYEFSESKLIGIWIAEG
FIVHQGSIRMEELGSNYFHELVNRSFFEKSTTRMVERGSNYFHELVYRRSFFQKLGTTTDRRGRVFIQSS
TDEKFVMHDLIHDLAELISMGESYRVEKGKFHAIPSTIRHLSMYKEEEGMLTRGLIDYLITINYER


>XP_042427161.1 putative disease resistance protein RGA1 [Zingiber officinale]
MIEFALAALGWLAQSIIGALVGKAADRAVQQFGEQHGVEEDLEKLKDSLASAMLKINDIENLWLKDDESR
QQRVKELLIRLKDAAYDADDLLDEFQYRILKQQIEQRGDEAGNRASSSSYSTPPPSKKIKTSLSSYTSGL
FGKGDDDDNNNDVQRMREIKGRLDDNSVALEKIYSSPGAEDDRGKKQLVSSSSRQTSSLSTERQLFGRRN
DLQELKAKLLESEVASEFGQSGCSVLSIVGIGGIGKTALAQEVFNDSEVKEYFKLRIWVCVSENFCTDRL
TREILEYVTMVKCDLTNFAVLQEVLKEKITPERFLLVLDDVWNEDRHKWESFCAPLRSGKPGSKILVTTR
SRKIANMVGDVDPICLEGLDEESFWEFFKKCAFGSSNSGAHHPHLEALAKKMTCKLKGLPLAAKTLGGLL
SMKLDEQYWKSILDSEMWQLPQQENDIMPVLQLSYQYLPPHLKQCFVFCSLFPKDYRFSESELIVIWIAE
GIIVPKGSIRMEELGSYYFHELVNRSFFQKSQDIEFIMHDLIHDLAKLISKDEFYRTEKDILSEIPSTIR
HLSMHGMEEGMQIRRLTEFSHYNKLRTLRLSGPYICKSFILDCGVLQKIKKIRVLVLNNCALEELPDSIG
KLIYLRSLNLSYNYMIRKLPESLCDLYNLQSLILNHCGLEELPNNIGNLIQLRYLDLSCNSNIRRLPKSL
YDLYNLQTLIFSRTA


>XP_042427758.1 putative disease resistance protein RGA3 [Zingiber officinale]
MAMVLDFFVSKFIKDTSDMVEKEIFKMLGVDKEIKTLQVKLGTINGYLQQAERKRHGNDEIDIWVRKLKD
IMYDADDVIDLCMIEGGKLLMAHASSSSSTVSIPFSYLFSCFKCLKYRHDIANQIISLNSRLEGLKNDAV
IKNNLDQAMKEPIENANKVVFGRETSHLQVEGDIIGTQIENATEKLISLILENNPKKTRVFGVVGTGGIG
KSTLASKIFEDERIKENFSNRKWLYVSKNYIETDLLKKLIRFEEGSETKGENFEGKSKADLENKLVSVLT
RNTFIVLDDVWNSTVWIDLLRKPIVKSASTCTILVTSRKEKVVMQMKPAYIHSVEKMNEESGWNLLKHLV
FEGGEEEDEISSLEEIGIKLVKKCDGLPLAIKAIGGVLYQQNKAKWEEVLESDAWKMDQIEEELRPLYLS
YEDLPSTLKQCFLYCSLYPQKNMYYKEVVQFWVAEGLIVDDQDKSRKDLPTGKQKTLEDLGEEIYRELIL
RNLLEADAIVDVSKNYFSMHDHFRSLGAHLMSEEGILYRHGREFKTDENIKIRRLSISNMAPKLVLPSQI
LNQACLRTLILMESPKTKAIEDSVLQSLPCLRVLDLTSTSIEKIPDCIGDLLHLRYLDLDGTNIREIPTT
IGNLVYLQNLNISECQYLERLPKSITMLHNLRCLDMRDSPLLTYVPKGIGKLENFYNLQGFLVGQNDSTS
DEGCDLEELKNLSKLRDISIYRLERAERGASALADKPFLKQLTLGWMQPDEDDADEEEESEGANEVGSDE
EADNDGNDDKDAGNEKGDDNDDGSKQENENEEAEEAGNETEDETEEDEAEEDKKGWSEKQIRKAERICNE
MSQPSSNIEDLFFYEYPGRQLPSWMISSSLAESFPNLAYLKLLGLPCCTELPPFGTLPQLKYLSIERASA
ITTIGSRFLGSRSSAFPKLEVLQFDDMPKWEEWTFDGVEELTGHGTPLAVKLFPSLRDCVIFDCPKLRAL
PAGLYRATNFNELCLRQTYVLGEIINLPMAYKLEVTNGSGLKKISNISSVRYLEVDNCPNLECVENLTKL
QHLVLICSEETEQLPQWLSGLIEQHNNTSSTHRSFRKFEMQCSLQLLQTCLEGNENWDIIKQIPNVKVKT
PSGKAYIRYTKDPYMYDPHVPAN


>XP_042427808.1 probable disease resistance protein At4g27220 isoform X1 [Zingiber officinale]
MPSHRYCSGFIILLSPLVASGSILLAIIDIAEIMVPPCFNTCCGGIGSGTGNEIVKYSWNKLKTHACYFI
YCKKKFEKLKEQFDLLKAIRDDTQQKVEAAKRNNKVISDEVNLWLNKVLELEGKFNNIEKNFNRIVEDEK
YYIPSLVSRYKVGREATRKKDKALKLLDRSNFQAFSHPLDPSTVNHPSNADFVSFGATKEAMQKVIDALN
DDKVNLIGIYGMGGVGKTTLMEEIGRMVKEAKTFDVVIDVVVSQNPNIAQIQRDIADALDMRDSSNKMLV
TRLKQEKKVLIMLDDVWARLELVKAVGIPYREHKGCKVILTSRKAETCNVMETDVSVEVATLSEEDSWYL
FRMRAGQVAASDGIEPVARKVAQECCGLPLAIVVVGRALRSYKDSSAWEDALSQLKQAVPLNMEEVEEKL
YKPLELSYQNLKTAELKQLFLYCCLFREDYDISEDEVTRYAVGENLLSNLSTLEDVRGRVHFLLQKLKLS
GLLLDSKKAGCVKLHDVVRDVAVYIGSKDNNHFLVKAGHGLADWPECGNLADCKRISLSNNFLQEIPEKP
NCCKLILLLLNMNPITRVPINFFENMATLNVLDFSNTGITSLPSSLTCLNGLGTLRLDRCKELKDINVVG
ELKTLIILTLQECRGITALPETIDGLVKLKLLDLSNCTSLQILRNLIPKLTQLEELYLRGYNVTEELLVE
VASLKRLVRVELYVKCARDFSEQVFPNNAYKVLRHFIIYNEPDWFSLASKYQRNFFIKQASQSMISWGKP
FLRSAEELRLDSCQWNFTDLMSCFATLKSLLIVNCHQIQCLLWSTDDTPSNAFGELMKLTLSDMEKLEQV
CHGQLPAHSLGKLRTLELRWCRNIVDILPQDLLQRVHPSLVELLLEGCPRPHVLLNFEGLGHDSVIFPKL
QMIRVSQMSDVISFCNGVVPPGSLHNLTTFEVVNCKKLLNLFSQTLDTTHSRLLPSETFKKLKQLQIMGC
PCLKHVFLPSIANELQSLERLEIKNNSSIETIIANEEGCDLKKGAFPILKRLLFIKLPRLICFFEGEPAK
TLDWPSLEYIHFGDCSNLARLPIGHESAQKLKKVHVARLDDVNWFESLKWEVDTIKSRFDIIQSINEVK


>XP_042427809.1 probable disease resistance protein At4g27220 isoform X2 [Zingiber officinale]
MPSHRYCSGFIILLSPLVASGSILLAIIDIAEAIRDDTQQKVEAAKRNNKVISDEVNLWLNKVLELEGKF
NNIEKNFNRIVEDEKYYIPSLVSRYKVGREATRKKDKALKLLDRSNFQAFSHPLDPSTVNHPSNADFVSF
GATKEAMQKVIDALNDDKVNLIGIYGMGGVGKTTLMEEIGRMVKEAKTFDVVIDVVVSQNPNIAQIQRDI
ADALDMRDSSNKMLVTRLKQEKKVLIMLDDVWARLELVKAVGIPYREHKGCKVILTSRKAETCNVMETDV
SVEVATLSEEDSWYLFRMRAGQVAASDGIEPVARKVAQECCGLPLAIVVVGRALRSYKDSSAWEDALSQL
KQAVPLNMEEVEEKLYKPLELSYQNLKTAELKQLFLYCCLFREDYDISEDEVTRYAVGENLLSNLSTLED
VRGRVHFLLQKLKLSGLLLDSKKAGCVKLHDVVRDVAVYIGSKDNNHFLVKAGHGLADWPECGNLADCKR
ISLSNNFLQEIPEKPNCCKLILLLLNMNPITRVPINFFENMATLNVLDFSNTGITSLPSSLTCLNGLGTL
RLDRCKELKDINVVGELKTLIILTLQECRGITALPETIDGLVKLKLLDLSNCTSLQILRNLIPKLTQLEE
LYLRGYNVTEELLVEVASLKRLVRVELYVKCARDFSEQVFPNNAYKVLRHFIIYNEPDWFSLASKYQRNF
FIKQASQSMISWGKPFLRSAEELRLDSCQWNFTDLMSCFATLKSLLIVNCHQIQCLLWSTDDTPSNAFGE
LMKLTLSDMEKLEQVCHGQLPAHSLGKLRTLELRWCRNIVDILPQDLLQRVHPSLVELLLEGCPRPHVLL
NFEGLGHDSVIFPKLQMIRVSQMSDVISFCNGVVPPGSLHNLTTFEVVNCKKLLNLFSQTLDTTHSRLLP
SETFKKLKQLQIMGCPCLKHVFLPSIANELQSLERLEIKNNSSIETIIANEEGCDLKKGAFPILKRLLFI
KLPRLICFFEGEPAKTLDWPSLEYIHFGDCSNLARLPIGHESAQKLKKVHVARLDDVNWFESLKWEVDTI
KSRFDIIQSINEVK


>XP_042428062.1 putative disease resistance protein RGA3 [Zingiber officinale]
MAMILDFYVSRVIKVTADMVEAEIFKVLGVDKEIKTLQGRLRTINGYLHQAERKRQGNDEIDIWVRKLKD
IMYDADDIIDLCMIEGGKVLRAQASSGSSTVSIPSSYLFSCFRCLRYRHEVANQIIALNGRLEALKNDSF
IKNNLDQTVKEPVENTHRVFGRETSHLQVEGDIIGSQIENATDKLINLILENNPKKTRVFGVVGTGGIGK
STLASKIFEDERIKENFPNRKWLYVSKNYIETDLLKKLIRFEEGSETKGETFEGKSKAELEDKLVTVLTK
NTFIVLDDVWNATVWIDILRKPIVKGASSCTILVTSRKEKIVTLMKPTHIHPVEKMNEESGWNLLKHLVF
EGGEEEDEISNLEEIGIKLVKKCDGLPLAIKAIGGVLYQQNKAKWEEVLESDAWKMDQIEEELRPLYLSY
EDLPSTLKQCFLYCSLYHQKDMYYKEIVQFWVAEGLIMDEQEKSRNDLPTEKQKTMEDIGEEIYRELIWR
NLLEADALVDASKDYFSMHDHFRSLGAHLMREEGILYRHGREFKTDDNIKIRRLSISNMGPKLVLPSQIL
KQGCLRTLILMDSSKTKTIEDSLLQALSCLRVLDLTSTSIEKIPDCIGDLLHLRYLDLDGTNIREIPATI
GNLVNLQTLNISECQYLERLPKSITMLHNLRCLEMRNTPLLTYVPKGIGKLGNFYNLQGFLVGQNDSISE
EGCDLEELKNLSKLRGISIFRLERAERGASALADKPFLKQLTLGWMQPDEDDADEEEESEGANEVGADEE
ADNDGNDDKDAGNEKGDDNDDGSKQENENEEAEEAGNETEDETEEDEAEEEEKGWSDEQISKAERICNEM
SQPSSSIEDLFFYEYPGRQLPSWMISSSLAESFPNLAYLQLLGLPCCTELPPFGTLPQLKYLRIEQASAI
TAIGSQFLGSRSSVFPKLELLRFVGMPKWEEWTLDGVEELTGHGTPLAVKLFPSLRDCILIDCPKLRALP
ADLYRATNFSELCLRQTYELGEIINLPMANKLEVTNASGLKKISNISSVRYLEVDNCPNLECVENIGKLQ
HLVLICSEEMEQLPQWLSVLIEQHNNTSSTHRSLRKFEMQCSLQLLKTCLEGNENWDIIKQIPIVKVTTY
SEKEYIRYTKDPYMYDPHVPAN


>XP_042428556.1 putative disease resistance protein RGA1 isoform X1 [Zingiber officinale]
MAVSLTVVGGWVAQAFIQTLIDKASDTAIQLFAERRGFAADMKKLRTSLLETRIILDKVQSSGSNSTKWK
TLMRDLKDAAYDAEDLIDEFQYHLLRQKIKGEEEDKASGSSGLSNIFSAAKKRLFASSYSLGEDDIRARV
REIQERLEGIAISVKDIMKVLPPNDQPEVKFQARESCSSPVTDILFGRDKELNQVVDWLLGSASQVKPAS
GFVNDTFSVLPIVGIGGVGKTTLAQYVHKDNRVQDHFHLKIWVCVSDNFSVQRLTKSIIESVTLKKEYDN
IELEPLQKIFHQHIAKKKFLLFLDDVWSDDKSIWEKFCALLKVGEHGSKIIVTTRDMKVSKMVSPAEPIL
LHDLDEDAFWKLFKKCSFGTLNPEDYPELEDIGRKIARKLKGSPLAAKTLGSVLQLDLRKQHWATIMKSD
IWKVKQDEDSIMPALHLSYQYLNENLKQCFAFCSVFTKDTSYHKAHLVPMWMAEGFIEDNNTKRMEDVGN
DYFLEFVNRSFFQEFKHGFYPYMMHDLIHDLAEMIAEEETCKIQSNEQTKKLPSTVRHLLVEKRKLPLEL
SGYDKLCTLLLKNSPPDSLFEKLRSIRVLDLSFCGLLELSGHIGKLIHLRFLDLSYNPEIKFLPDSLCDL
YNLQTLRARNCFSMESIPQELHKLVNLRHIDADKKIWLMIKDVWRLTNLQELLTFSVREGDALKLGRLQD
MTQFHGTLHIQNLENVVDSKEAQHAELKNKVHLKELVLEWNDEKDAKLEEEVIEGLQPHDSLEILKIEGY
NGGRSPSWLMPKVLSNLKKLELVNCKGWDDDLPFIGQRLHLIELRMDNMPALKRLSHEFEGKCFPKLEML
MLFNLPAFEEWFWTDGKDLFPCMRELVVINCPKLKRLPPFPPSLETLIIRGCPELILNNETADDEECDRL
LLPSLKVLELSDSGEYAKLLPDCLHNLCLVTRLTISHCPHITSIPLVQLVELRSLAISYCDELTRMECLR
LLKSLDLLEIIGCPKLVQLDVEDEQAGSLSSLRKLCVDNTAVLKMFPLRNSLSFIKELEIASCSEEVIFE
EAMQSLTAVTSLIFYNCKKLQSLPTELLHSLPYLEELTVANCPQIHSLPDKGLLPSLWMLTIDNCPQIHS
LPEKGLPTLLECLHIFDCPQIHVMPDQEGLPKSLYVFDCIGDVHPTLKEQSQKFYTDRNRRVSTPDAHHR
LPNVIAFFSDL


>XP_042428565.1 putative disease resistance protein RGA1 isoform X2 [Zingiber officinale]
MAVSLTVVGGWVAQAFIQTLIDKASDTAIQLFAERRGFAADMKKLRTSLLETRIILDKVQSSGSNSTKWK
TLMRDLKDAAYDAEDLIDEFQYHLLRQKIKGEEEDKASGSSGLSNIFSAAKKRLFASSYSLGEDDIRARV
REIQERLEGIAISVKDIMKVLPPNDQPEVKFQARESCSSPVTDILFGRDKELNQVVDWLLGSASQVKPAS
GFVNDTFSVLPIVGIGGVGKTTLAQYVHKDNRVQDHFHLKIWVCVSDNFSVQRLTKSIIESVTLKKEYDN
IELEPLQKIFHQHIAKKKFLLFLDDVWSDDKSIWEKFCALLKVGEHGSKIIVTTRDMKVSKMVSPAEPIL
LHDLDEDAFWKLFKKCSFGTLNPEDYPELEDIGRKIARKLKGSPLAAKTLGSVLQLDLRKQHWATIMKSD
IWKVKQDEDSIMPALHLSYQYLNENLKQCFAFCSVFTKDTSYHKAHLVPMWMAEGFIEDNNTKRMEDVGN
DYFLEFVNRSFFQEFKHGFYPYMMHDLIHDLAEMIAEEETCKIQSNEQTKKLPSTVRHLLVEKRKLPLEL
SGYDKLCTLLLKNSPPDSLFEKLRSIRVLDLSFCGLLELSGHIGKLIHLRFLDLSYNPEIKFLPDSLCDL
YNLQTLRARNCFSMESIPQELHKLVNLRHIDADKKIWLMIKDVWRLTNLQELLTFSVREGDALKLGRLQD
MTQFHGTLHIQNLENVVDSKEAQHAELKNKVHLKELVLEWNDEKDAKLEEEVIEGLQPHDSLEILKIEGY
NGGRSPSWLMPKVLSNLKKLELVNCKGWDDDLPFIGQRLHLIELRMDNMPALKRLSHEFEGKCFPKLEML
MLFNLPAFEEWFWTDGKDLFPCMRELVVINCPKLKRLPPFPPSLETLIIRGCPELILNNETADDEECDRL
LLPSLKVLELSDSGEYAKLLPDCLHNLCLVTRLTISHCPHITSIPLVQLVELRSLAISYCDELTRMECLR
LLKSLDLLEIIGCPKLVQLDVEDEQAGSLSSLRKLCVDNTAVLKMFPLRNSLSFIKELEIASCSEEVIFE
EAMQSLTAVTSLIFYNCKKLQSLPTELLHSLPYLEELTVANCPQIHSLPDKGLLPSLWMLTIDNCPQIHS
LPEKGLPTLLECLHIFDCPQIHVMPDQEGLPKSLYVFDCIGDVHPTLKEQSQKFYTDRNRRERALK


>XP_042428581.1 putative disease resistance protein RGA1 isoform X1 [Zingiber officinale]
MAFLLTAGGWFAPFFIQNLVDKASNKAIQLFAEGQGFEEDMDKLCTSLLKTQIILDEVQSSGSNNTKWKT
LMQELKDAAYDAEDLIDEFQYHVFKKKIKDEEKYEASGSIGLPNILSRAKKKLFGSSYYMRERVRRIQGK
LERIANSMESIKNVLPRNDKGMQPEVKFQARESCSSPVTDILFGRDKELNQVVDWLLGSASQVELESGFA
NDTFSVLPIVGIGGAGKTTLAQYVHRDDRVQDHFHLKIWICVSDNFTVQGLTKSIIESVTLQKQYDSMRL
EPLQKILQQHIAKKKFLLFLDDVWSDDKSIWENFCALLKVGAHGSKIIVTTRDMKVSKMVSLVEPILLHG
LDEDAFWQLFNKCSFGTLNPKDYPELENIGRKIAHRLKGSPLAAKTLGRVLQSNLCQQHWATVMESDIWK
VKQDEDSIMPALHLSYQYLNENLKQCFAFCSLFPKDYEFNKDKLIQMWMAEGFIEDKNTNRMEDVGSDYF
LEFVNRSFFEEFGNYGLYHFVMHDLIHDLAEMIAAEETCRIKSNERRKMLATVRHLRVEERILPLEFSGF
DKLRTLVLRNSPPNSLFGKLRSIRVLDVSRCHFRELSKHIDKLIHLRYLDLSYNSEIKFLPNSLGDLYNL
QTLKVKGCSKLESIPQELGKLVNLRHIDANCKFWVIMKDVRRLTNLQELPTFRIQEDDAHKLGQLKDMTQ
LHGTLSIQNLENVVDSKEAHHAELKNKVHLKELELEWNDEKDAKLEEEVIEGLQPHESLKKLRIRGYNGA
KSPSWLMPKVLSNLEKLDLEDCKGWDDVLPFIGQRLHLIKLYMINMPALKQLSHEFEGKCFPKLEVLYLF
DLPALEEWSWTEGRDLFPCMRKLCVQICPKLKRLPPFPPSLEKLTIVRCPKLILNSKTEDDEEGGRHFPP
SLKVLELINCGEYAKLLPDCLHNLCLVTRLEIGHCPHITSIPLVQLVELQYLNISNCDELRRMECLGLLI
SLKKLKIVGCPKLVQLDVEDERAQSLSSLLKLCVDNTALLKMFPLRNSLSFITKLQIESCSEEVIFIEPI
LVRSLTAVTSLRFIDCDKLQSLPTELLHCLPFLEKLVMYHCPQLQSLPEKGILPSLRRLKIDDCPRIQSL
SEKGLPPLLEELNIFDCPQIRAMPEDGLPMSLIFFHCFGDVHPTLKEQSEKFYADRKRRVSTLDASYFHV


>XP_042428588.1 putative disease resistance protein RGA1 isoform X2 [Zingiber officinale]
MAFLLTAGGWFAPFFIQNLVDKASNKAIQLFAEGQGFEEDMDKLCTSLLKTQIILDEVQSSGSNNTKWKT
LMQELKDAAYDAEDLIDEFQYHVFKKKIKDEEKYEASGSIGLPNILSRAKKKLFGSSYYMRERVRRIQGK
LERIANSMESIKNVLPRNDKGMQPEVKFQARESCSSPVTDILFGRDKELNQVVDWLLGSASQVELESGFA
NDTFSVLPIVGIGGAGKTTLAQYVHRDDRVQDHFHLKIWICVSDNFTVQGLTKSIIESVTLQKQYDSMRL
EPLQKILQQHIAKKKFLLFLDDVWSDDKSIWENFCALLKVGAHGSKIIVTTRDMKVSKMVSLVEPILLHG
LDEDAFWQLFNKCSFGTLNPKDYPELENIGRKIAHRLKGSPLAAKTLGRVLQSNLCQQHWATVMESDIWK
VKQDEDSIMPALHLSYQYLNENLKQCFAFCSLFPKDYEFNKDKLIQMWMAEGFIEDKNTNRMEDVGSDYF
LEFVNRSFFEEFGNYGLYHFVMHDLIHDLAEMIAAEETCRIKSNERRKMLATVRHLRVEERILPLEFSGF
DKLRTLVLRNSPPNSLFGKLRSIRVLDVSRCHFRELSKHIDKLIHLRYLDLSYNSEIKFLPNSLGDLYNL
QTLKVKGCSKLESIPQELGKLVNLRHIDANCKFWVIMKDVRRLTNLQELPTFRIQEDDAHKLGQLKDMTQ
LHGTLSIQNLENVVDSKEAHHAELKNKVHLKELELEWNDEKDAKLEEEVIEGLQPHESLKKLRIRGYNGA
KSPSWLMPKVLSNLEKLDLEDCKGWDDVLPFIGQRLHLIKLYMINMPALKQLSHEFEGKCFPKLEVLYLF
DLPALEEWSWTEGRDLFPCMRKLCVQICPKLKRLPPFPPSLEKLTIVRCPKLILNSKTEDDEEGGRHFPP
SLKVLELINCGEYAKLLPDCLHNLCLVTRLEIGHCPHITSIPLVQLVELQYLNISNCDELRRMECLGLLI
SLKKLKIVGCPKLVQLDVEDERAQSLSSLLKLCVDNTALLKMFPLRNSLSFITKLQIESCSEEVIFIEPI
LVRSLTAVTSLRFIDCDKLQSLPTELLHCLPFLEKLVMYHCPQLQSLPEKGILPSLRRLKIDDCPRIQSL
SEKGLPPLLEELNIFDCPQIRAMPEDGLPMSLIFFHCFGDVHPTLKEQSEKFYADRKRRLTTARLELE


>XP_042428600.1 putative disease resistance protein RGA4 isoform X1 [Zingiber officinale]
MAVELIVGGWFAQPFIKYLVDKAIDKAIQPFAESWGFTEDMENLRISLLKTQTILDEVQISRSNKTKWEP
LMKELKDAAYDAEDLIDEFQYHVLRQKIKGEEEDKASGSTTGLPNIFAAAKKKLFGSSYDMGSRVKEIQG
RLEKFANTAKDIMQVLPPNDRGKQLEVKFQVRESCSSPVTDILFGRDRELNQVVDWLLGSANQVEPASGT
FSVLAIEGIGGVGKTTLTQYVYKDDKVQDHFDLKIWVCVSDNFTVQRLTKSTIESITLKKKYDNMELEAL
QKILHQHITKKKFLLVLDDVWSDNKSIWETFCSLLKVGAHGSKIIVTTRDMKVSKMVSRVEPILLDGLEG
YFFWELFKKCSFGTLNPEEYPELQDIGRKIASKLEGSPLAAKTLGSVLQSDLSQQHWTTVMKSDIWKVKQ
DECGIMPALELSYQYLNENLKQCFAFCSLFPKDYEFNKTELVQMWMAEGFIEDKNTKRMEDVGSDYFLEF
VNRSFFQKSRYNEFRYNEVEDESEIGFLMHDLIHDLAEMISAEETCRIENNRQIKTLSTVRHLRVVEVKL
PLEFFGYNKLRTLVVLKNSPPDSLFEKLRSIRVLDVRLGGFQKLSEHIGKLIHLRYLDLSYNYEIEILPD
SLCDLYNLQTLKVEVCSKLKTIPRELDKLANLRHIVADDRFWVTIKNVRRLTNLQEWPRPFRIQKDDGLK
LGQLKDLTQLHGTLRIENLENVVDSKEAQLAELKNKVHLKELELVWYFNWNIDENDAKLEEEVIEGLQPH
DSLKILKIEGYNGGRSPSWLMPKVLSNLKKLELVNCKGWDDVLPFIGQRLHLIELRMVNMPALKQLSHEF
EGKCFPKLKVLKLYNLPALEEWSWTEGEDLFPCMRELRVSYCPKLKRLPPFPPSLKILRIINCPSLILNS
KTEDDEEGSRHLPPSLKELELTTCGEYAKLLADCLHNLHSVTRLEISDCPCITSIPQAQLVKLKYLYISS
CDELIRMECLGLFKSLKELKIVGCPKLVQLDVEDEKAGSLSSLRKLCVDNTALLKMFPLRNSLSYIRELT
IESSSEEVIFEEAILVRRLTAVTSLRFSYCEKLQSLPTELLHCLPLLKYLMMYDCPQLRSLPSFSSSLRK
LKIINCPQIQSLPEKGLPPLLQLLDISDCPQIQAMPEAGLPMSLDIFYCTGKVHPTLKEQSEKFYADRET
RREASGSAASLFPEFLEPLDGSYVPCDSIPTGWTIYGPPTFPRQF


>XP_042428613.1 putative disease resistance protein RGA4 isoform X1 [Zingiber officinale]
MAVELIVGGWFAQPFIKYLVDKAIDKAIQPFAESWGFTEDMENLRISLLKTQTILDEVQISRSNKTKWEP
LMKELKDAAYDAEDLIDEFQYHVLRQKIKGEEEDKASGSTTGLPNIFAAAKKKLFGSSYDMGSRVKEIQG
RLEKFANTAKDIMQVLPPNDRGKQLEVKFQVRESCSSPVTDILFGRDRELNQVVDWLLGSANQVEPASGT
FSVLAIEGIGGVGKTTLTQYVYKDDKVQDHFDLKIWVCVSDNFTVQRLTKSTIESITLKKKYDNMELEAL
QKILHQHITKKKFLLVLDDVWSDNKSIWETFCSLLKVGAHGSKIIVTTRDMKVSKMVSRVEPILLDGLEG
YFFWELFKKCSFGTLNPEEYPELQDIGRKIASKLEGSPLAAKTLGSVLQSDLSQQHWTTVMKSDIWKVKQ
DECGIMPALELSYQYLNENLKQCFAFCSLFPKDYEFNKTELVQMWMAEGFIEDKNTKRMEDVGSDYFLEF
VNRSFFQKSRYNEFRYNEVEDESEIGFLMHDLIHDLAEMISAEETCRIENNRQIKTLSTVRHLRVVEVKL
PLEFFGYNKLRTLVVLKNSPPDSLFEKLRSIRVLDVRLGGFQKLSEHIGKLIHLRYLDLSYNYEIEILPD
SLCDLYNLQTLKVEVCSKLKTIPRELDKLANLRHIVADDRFWVTIKNVRRLTNLQEWPRPFRIQKDDGLK
LGQLKDLTQLHGTLRIENLENVVDSKEAQLAELKNKVHLKELELVWYFNWNIDENDAKLEEEVIEGLQPH
DSLKILKIEGYNGGRSPSWLMPKVLSNLKKLELVNCKGWDDVLPFIGQRLHLIELRMVNMPALKQLSHEF
EGKCFPKLKVLKLYNLPALEEWSWTEGEDLFPCMRELRVSYCPKLKRLPPFPPSLKILRIINCPSLILNS
KTEDDEEGSRHLPPSLKELELTTCGEYAKLLADCLHNLHSVTRLEISDCPCITSIPQAQLVKLKYLYISS
CDELIRMECLGLFKSLKELKIVGCPKLVQLDVEDEKAGSLSSLRKLCVDNTALLKMFPLRNSLSYIRELT
IESSSEEVIFEEAILVRRLTAVTSLRFSYCEKLQSLPTELLHCLPLLKYLMMYDCPQLRSLPSFSSSLRK
LKIINCPQIQSLPEKGLPPLLQLLDISDCPQIQAMPEAGLPMSLDIFYCTGKVHPTLKEQSEKFYADRET
RREASGSAASLFPEFLEPLDGSYVPCDSIPTGWTIYGPPTFPRQF


>XP_042428623.1 putative disease resistance protein RGA1 isoform X2 [Zingiber officinale]
MAVELIVGGWFAQPFIKYLVDKAIDKAIQPFAESWGFTEDMENLRISLLKTQTILDEVQISRSNKTKWEP
LMKELKDAAYDAEDLIDEFQYHVLRQKIKGEEEDKASGSTTGLPNIFAAAKKKLFGSSYDMGSRVKEIQG
RLEKFANTAKDIMQVLPPNDRGKQLEVKFQVRESCSSPVTDILFGRDRELNQVVDWLLGSANQVEPASGT
FSVLAIEGIGGVGKTTLTQYVYKDDKVQDHFDLKIWVCVSDNFTVQRLTKSTIESITLKKKYDNMELEAL
QKILHQHITKKKFLLVLDDVWSDNKSIWETFCSLLKVGAHGSKIIVTTRDMKVSKMVSRVEPILLDGLEG
YFFWELFKKCSFGTLNPEEYPELQDIGRKIASKLEGSPLAAKTLGSVLQSDLSQQHWTTVMKSDIWKVKQ
DECGIMPALELSYQYLNENLKQCFAFCSLFPKDYEFNKTELVQMWMAEGFIEDKNTKRMEDVGSDYFLEF
VNRSFFQKSRYNEFRYNEVEDESEIGFLMHDLIHDLAEMISAEETCRIENNRQIKTLSTVRHLRVVEVKL
PLEFFGYNKLRTLVVLKNSPPDSLFEKLRSIRVLDVRLGGFQKLSEHIGKLIHLRYLDLSYNYEIEILPD
SLCDLYNLQTLKVEVCSKLKTIPRELDKLANLRHIVADDRFWVTIKNVRRLTNLQEWPRPFRIQKDDGLK
LGQLKDLTQLHGTLRIENLENVVDSKEAQLAELKNKVHLKELELVWYFNWNIDENDAKLEEEVIEGLQPH
DSLKILKIEGYNGGRSPSWLMPKVLSNLKKLELVNCKGWDDVLPFIGQRLHLIELRMVNMPALKQLSHEF
EGKCFPKLKVLKLYNLPALEEWSWTEGEDLFPCMRELRVSYCPKLKRLPPFPPSLKILRIINCPSLILNS
KTEDDEEGSRHLPPSLKELELTTCGEYAKLLADCLHNLHSVTRLEISDCPCITSIPQAQLVKLKYLYISS
CDELIRMECLGLFKSLKELKIVGCPKLVQLDVEDEKAGSLSSLRKLCVDNTALLKMFPLRNSLSYIRELT
IESSSEEVIFEEAILVRRLTAVTSLRFSYCEKLQSLPTELLHCLPLLKYLMISNHCQRKDFLLFSNY


>XP_042428874.1 putative disease resistance protein RGA1 [Zingiber officinale]
MAVSLTMVGGWFAQAFIQTLIDKASDKAIQLFAERRGFAADMETLCTSLLETQIILDKVQSSQSNDTKWK
TLMQKLKDAAYDAEDLIDEFQYHVLMQKIKGEEEDKAASCSGGLPNIFSAAKEKLFGSSHSLEEDAMRAS
VVEIQGRLERIANSMKSIMNVLPPNDRGKQPDQMKFQSRESCSSPVTDILFGRDKELNQVVEWLLGSANQ
VEPTSGFLNDALSVLPIVGIGGAGKTTLAQYAHKDIRVQDHFHLKIWVCVSNNFTVQGLVKSIIESITLQ
KQYDNMGLESLQKILHQHIAQKKFLLVLDDVWSDNKRIWEKFCALLKVGAYGSKIIVTTRDMKISKMVSL
VEPILLHGLDEDTFWQLFKKSSFGTLNPEEYPELEDIGRKIVRKLKGSPLAAKTLGSVLQSNLCQQHWAT
VMESDIWKVKQDEDDIMPALHLSYRYLNENLKQCFAFCSVFPKDNVFKEAELVRMWIAEGFIQNKNTKRM
EDVGSDYFLEFVNRSFFQEVKYSRFVMHDLIHDLAEMISTEETCRIENSSQRKMFSTIRHLRVEGKLPLE
VSGYDKLRTLMLRKNSPPDSLFEKLRSIHVLDLSDCGLQELSEHVGKLIHLRYLDISWNSEIKILPDSLC
HLHNLQTLEILGCHKLESIPQELGKKMVNLRHINAVNKFWVMIKDVRRLTNLQELPTFSVQVDDGLKLVQ
LKDLTQLHGTLHIQNLENVVDSKEAQHAELKNKVHLKELVLEWNYWQRDRRNDVKLEEEVIEGLQPHESL
KKLKIKWYNGGRSPSWLMPKVLSNLEKLELSNCKGWDDVLPFIGQRLHLIELCMNRMPALKQLSHEFEGK
CFPKLKVLNLWNLPALEESGRGLRAKIYFPACVNFASAVAPN


>XP_042428887.1 disease resistance protein RGA2-like [Zingiber officinale]
MAVSLTVVGGWFAQAFIQTLIDKASDKSIQLFAERRGFAADMDKLRISLLETQIILDEVQISRSNNTKWK
RLMQELKNAAYDAEDLIDEFQYHFLRQKVKGEEDDKESGSSGLPDIFSAAKEKLFGSSHSLEEDAMRASV
VEIQGRLDRIANSMKSIMNVLPLNDRGKQPDQMKFQTRESCSSPVTDILFGRDKELNQVVDWLLGSAKQV
EPASGFLNDALSVLPIVGIGGAGKTTLAQYAHKDNRVQDHFHLKIWVYVSNNFTVQGLAKSIIESVTLQK
QYDNMGLESLQKILHQHIAQKKFLLVLDDVWSDNKRIWEKFCALLKVGAYGSKIIVTTRDMKISKMVSLV
EPILLDGLDKDVFWQLFKKCSFGTLNPEDYPELEDIGRKISRKLKGSPLAAKTLGSVLQSDLCQQHWAII
MESDIWKVKQDEDDIMPALHLSYQYLNENLKQCFAFCSLFPKDYRFYKAELIQMWMAEGFIEDKNTKRME
DVGSDYFLEFVNRSFFQEFRYDYEFEDEFVMHDLIHDLAEMISTEEICRIENNRQTKPPSTTRHLQVEEE
KLPLEFLGYNKLRTLVLRKNLPPDSLFEKLRSIRVLDVSSCDLQELPEHIGKLIHLRYIDISYNFKIKIL
PGSLCDLYNLQTLKVICCPELQFIPQELGKLVNLRHIVADDEFWVMIKDVRKLTNLQELQRFSVEEDDRL
KLGQLKDLTQLHGTLCIQNLENVVDSKEAQDAELKNKVHLKQLELDWNDEKDAKLEEEVIEGLQPHESLK
ILKIEGYNGGRSPSWLMPKVLSNLEKLELVNCNGWDDVLPFIGQRLHLIELIMYSMPALKQLSHEFEGKC
FPKLKVLNLWNLPALEEWSWTEGKDLFPCMRKLLVSNCPKLKRLPPFPPSLEILEIKKCPNLILNSKTED
EEEEEVGRHALSSLKVLELANSGEYAKLLTDFLHNLRLVTRLNIRDCPYITSIPQAQLLELQYLSISNCV
ELGRMECLGLLKSLKELRIVGCPKLVQLDVGDEQAGRLSSLRKLYVDNTALLKMFPLRNSLSFITELKIE
SCSEEVIFEESILARSLTAVTSLSFSYCKKLQTLPTKLLHSFPLLENLMVYCCPQLQSLPEIGLSPLLKK
LEICHCPQIQAMPEDGLPMSLDVFKCSGYVHPTLMEQSEKFNAKREMRRDIEVV


>XP_042428936.1 disease resistance protein RGA2-like [Zingiber officinale]
MAVSLTVVGGWFAQAFIQTLIDKASDKAIQLFAERRGFAADMETLCTSLLETQIILDKVQSSQSNDTKWK
TLMQKLKDAAYDAEDLIDEFQYHVLRLKIKGEEEDKAVSGSGGLPNIFSAAKEKLFGSSHSLEEDAMRAS
VVEIQGRLERIANSMKSIMNVLPPNDRGKQPDQMKFQTRESCSSPVTDILFGRDKELNQVVEWLLGSANQ
VEPASGFLNDTFSVLSIVGIGGAGKTTLAQYAHKDNRVQDYFHLKIWICVSNNFTVQELAKSIIESVTLQ
KQYDNMGLESLQKILHQHIAQKKFLLVLDDVWSDNKRIWEKFCALLKVGAYGSKIIVTTRDMKISKMVSL
VEPILLHGLDEDTFWQLFKKCSFGTLNPEEYPELEDIGRKIVRKLKGSPLAAKTLGGVLQSNLCQQHWAT
VMESDIWKVKQDEDDIMPALHLSYQYLNENLKQCFAFCSVFPKDYRFGKAELVRMWMAEGFIKDKNTRGW
KMLEATIFLSLLTSLSFKNTNLVHL


>XP_042428946.1 putative disease resistance protein RGA1 [Zingiber officinale]
MAVSLTVVGGWFAQAFIQTLIDKASDKSIQLFAERRGFAADMDKLRISLLETQIILDEVQISRSNNTKWK
RLMQELKDAAYDAEDLIDEFQYHFLRQKVKGEEDDKESGSSGLPDIFSAAKEKLFGSSHSLEEDAMRASV
VEIQGRLDRIANSIKSIMNVLPPNDRGKQPDQMKFQTRESCSSPVTDILFGRDKELNQVVDWLLGSAKQV
EPASGFLNDALSVLPIVGIGGAGKTTLAQYAHKDNRVQDHFHLKIWVCVSNNFTVQGLAKSIIESVTLQK
QYDNMGLESLQKILHQHIAQKTFLLVLDDVWSDNKRIWEKFCALLKVGAYGSKIIVTTRDMKISKMVSLV
EPILLHGLDKDTFWQLFKKSSFGTLNPEEYPELEDIGRKIVRKLKGSPLAAKTLGSVLQSNLCQQHWATV
MESDIWKVKQDEDDIMPALHLSYQYLNENLKQCFVFCSLFPKDYKFYKAELIQMWMAEGFIEDKNTKRME
DVGSDYFLEFVNRSFFQEFRYDYEFEDEFVMHDLIHDLAEMISTEEICRIENNRQTKPPSTTRHLRVEEE
KLPLEFSGYNKLRTLVLRKNLPPDSLFEKLRSIRVLDVSWCDLQELSEHIGKLTHLRYIDISYNFKIKIL
PGSLCDLYNLQTLKVICCPELQFIPQELGKLVNLRHIVADDEFWVMIKDVRKLTNLQELQRFSVEEDDRL
KLGQLKDLTQLHGTLCIQNLENVVDSKEAQHAELKNKVHLKQLELDWNDEKDAKLEEEVIEGLQPHESLK
ILKIEGYNGGRSPSWLMPKVLSNLEKLELVNCNGWDDVLPFIGQRLHLIELIMYSMPALKQLSHEFEGKC
FPKLKVLNLWNLPALEEWSWTEGKDLFPCMRKLLVSNCPKLKRLPPFPPSLEILEIKKCPNLILNSKTED
EEEVGRHALPSLKVLELANSGEYAKLLTDFLHNLRLVIRLNIRDCPYITSIPQAQLLELQYLSISNCVEL
RTMECLGFLKSLKELRIVGCPKLVQLDVGDEQAGRLSSLRKLYVDNTALLKMFPLRNSLSFITELKIESC
SEEVIFEESILARSLTAVTSLSFSYCKKLQSLPTKLLHSFPLLENLMVYCCPQLQSLPEIGLSPLLKKLE
ICHCPQIQAMPEDGLPMSLDVFKCSGYVHPTLMEQSEKFNAKREMRRDIEVV


>XP_042428969.1 putative disease resistance protein RGA1 [Zingiber officinale]
MAVSLTVVGGWFAQAFIQTLIDKASDKAIQLFAERRGFAADMETLCTSLLETQIILDKVQSSQSNDTKWK
TLMQKLKDAAYDAEDLIDEFQYHVLRQKIKGEEEDKAASGSGGLPNIFSAAKEKLFGSSHSLEEEAMRAS
VVEIQGRLERIANSMKSIMNVLPPNDRGKQPDQMKFQTRESCSSPVTDILFGRDKELNQVVDWLLGSANQ
VEPASGFLNDSSSVLPIVGIGGAGKTTLAQYAHKDNRVQDHFHLKIWVCVANNFTVQGLAKSIIESVTLQ
KQDDNMGLEPLQKILHQHITKKKFLLVLDDVWSNNKSIWEKFCALLKFGAHGSKIIVTTRDLKVSKMVSL
AEPISLHGLDEDVFWQLFKKCSFGTLNPEDYPELEDIGRKIALKLKGSPLAAKTLGSVLQTDLCQQHWAT
VMESDIWKVKQDEDGIMPALHLSYQYLNENMKQCFAVCSVFPKDYVFEEAELVQMWMAKGFTQNKNAKRM
EDIGSNYFLEFINRTFFQEFKFGGFVMHDLIHDLAEMISTEETCRIENNRQTKMFSTIRHLRVEGKLPLE
VSGYDKLRTLMLKKNSPPDSLFEKLRSIRVLNVSQCGLQELSEHIGKLIHLRYLDLSFNYEVKVLPDSLC
DLYNLQTLKTRKCNAIESVPQELCKLVNLRHIDADDEFWVMIKDVRRLTNLQELPTFSVQEDDGLKLAQL
KDLAQLHGTLHIQNLENVVDSKEAQHAELKNKVHLKELVLEWNDEKDAKLEEEVIEGLQPHESLKILKIE
GYNGGRSPSWLMPKVLPNLEKLELAICKGWDDVLPFIGQRLHLIELRMHRMSALKQLSHEFEGKCFPKLK
VLNLWNLPALEEWSWTEGKHLFPCMRELRVCSCPKLKRLPPFPPSLEILTIEDCPELKLNSKTENDEEGG
CHLLPSLKELDLSYCGEYAKLLPDCLHSLCLITRLEINHCPHITSISLVQLVELQSLYISNCDELRRMEC
LGVLKSLEKLTIIGCPKLVQLDVEDEQAASLLSSLRKLCVDNIALLKMFPLRNSLSFITKLKIESCSEEM
IFEETIWMQNLTAVTSLCFRFCEKLQSLPIELLHSFPFLEELMMYGCPQLQSLPEIGLSPFLKTLVISNC
PRIQPMPEEGLPKSLDVFHCSGNVHPTLMKQSKKFFADRYR


>XP_042428988.1 putative disease resistance protein RGA1 [Zingiber officinale]
MAVALTVGGWFAQAFIQTLIDKASDKSIQLFAQRRGFAEDMENLHPSLLEIQIILDEVQISRSNNTKWKT
LMQELKDAAYDAEDLIDEFQYHVLRQKVKGKEEDKAASGSSGLSNMFYAAKIKLLGSSHSLEEDDMRARV
RKMQGRLEKIANRMKSIMNVLPPHDRRKQPEVKFQARESCSSPATDIMFGRDKELNQVVDWLLESANQVE
PASAFVNDTFSVLPIVGIGGAGKTTLAQYAHKHNRVQVHFHLKIWVCVSDNFTVQGLVKSIIQSVAPQKR
YDNMGLEPLQKLLHEHIADKKFLLVLDDVWSDNKSIWHKLCALLKVGAHGSKIIVTTRDVKVSKMVSLVE
PILLHGLDEDAFWQLFKKCSFGTLNPGDYPELEDIGRKIARKLKGSPLAAKTLGSVLQSDLRQQHWNTIM
KSDIWKVKQDEEDIMPVLHLSYEYLNENMKQCFAFCSVFPKDYKFDKAVLVQMWIAEGFIEDKNTKRMED
VGSDYFLEFVNRSFFQEFVYGLFVMHDLIHDLAEMIYAEETCRIENNRQTKMLSTIRHLRVEEGKLPLEF
SGYDKLHTLMLRKNSPPNSLFEKLRSIRVLDVSRCGLQELSEHIGKLIHLRYLDISWNSEIKILPDSLFD
LYNLQTLKVEGCSKLEYIPQELSKLVNLRCIDADDMFLVMVKDVRRLTNLQELPTFSVQEDDGLKLEQLK
DMTQLHGTLHIQNLENVVDSTEAQQAELKNKVRLNKLVLEWNDEKDAKLEEEVIEGLQPHKSLKILKIEG
YNGSRSPSWLMPKVLSNLEKLYLVNCKGWDDVLPFIGQRLHLIELHMDGMPALKQLSHEFEGKCFPKLEV
LYLYELPALEEWSWTEGKDLFPCMRELRVSYCHKLKRLPPFPPSLEMLTIECCPRLKLNSRTEDDEEGGC
HLPPSLKGLKISQWPHITSISLVQSVELQYLYISKCDELRWMECLGVLKSLKQLNIVGCPKLVQLDVEDE
QSASLLPSLRYLCVDNTALLKMFPLRNSLPFITELVFVSCSEEVIFEEPILVRSLTAVTSLSFIGCEKLQ
SLPAKLLHCLPFLKTLMVYNCPQLQSLPEIGLSPFLKTLDICDCPQIQAMPEDGLPMSLDDFQCSGDVHP
KLKEQSDKFFVDTYNKRKARLELE


>XP_042428995.1 putative disease resistance protein RGA1 [Zingiber officinale]
MAVALTVGGWFAQAFIQTLIDKASDKSIQLFAQRRGFAEDMENLHPSLLEIQIILDEVQISRSNNTKWKT
LMQELKDAAYDAEDLIDEFQYHVLRQKVKGKEEDKAASGSSGLSNMFYAAKIKLLGSSHSLEEDDMRARV
RKMQGRLEKIANRMKSIMNVLPPHDRRKQPEVKFQARESCSSPATDIMFGRDKELNQVVDWLLESANQVE
PASAFVNDTFSVLPIVGIGGAGKTTLAQYAHKHNRVQVHFHLKIWVCVSDNFTVQGLVKSIIQSVAPQKR
YDNMGLEPLQKLLHEHIADKKFLLVLDDVWSDNKSIWHKLCALLKVGAHGSKIIVTTRDVKVSKMVSLVE
PILLHGLDEDAFWQLFKKCSFGTLNPGDYPELEDIGRKIARKLKGSPLAAKTLGSVLQSDLRQQHWNTIM
KSDIWKVKQDEEDIMPVLHLSYEYLNENMKQCFAFCSVFPKDYKFDKAVLVQMWIAEGFIEDKNTKRMED
VGSDYFLEFVNRSFFQEFVYGLFVMHDLIHDLAEMIYAEETCRIENNRQTKMLSTIRHLRVEEGKLPLEF
SGYDKLHTLMLRKNSPPNSLFEKLRSIRVLDVSRCGLQELSEHIGKLIHLRYLDISWNSEIKILPDSLFD
LYNLQTLKVEGCSKLEYIPQELSKLVNLRCIDADDMFLVMVKDVRRLTNLQELPTFSVQEDDGLKLEQLK
DMTQLHGTLHIQNLENVVDSTEAQQAELKNKVRLNKLVLEWNDEKDAKLEEEVIEGLQPHKSLKILKIEG
YNGSRSPSWLMPKVLSNLEKLYLVNCKGWDDVLPFIGQRLHLIELHMDGMPALKQLSHEFEGKCFPKLEV
LYLYELPALEEWSWTEGKDLFPCMRELRVSYCHKLKRLPPFPPSLEMLTIECCPRLKLNSRTEDDEEGGC
HLPPSLKGLKISQWPHITSISLVQSVELQYLYISKCDELRWMECLGVLKSLKQLNIVGCPKLVQLDVEDE
QSASLLPSLRYLCVDNTALLKMFPLRNSLPFITELVFVSCSEEVIFEEPILVRSLTAVTSLSFIGCEKLQ
SLPAKLLHCLPFLKTLMVYNCPQLQSLPEIGLSPFLKTLDICDCPQIQAMPEDGLPMSLDDFQCSGDVHP
KLKEQSDKFFVDTYNKRKARLELE


>XP_042429001.1 putative disease resistance protein RGA1 [Zingiber officinale]
MAVALTVGGWFAQAFIQTLIDKASDKSIQLFAQRRGFAEDMENLHPSLLEIQIILDEVQISRSNNTKWKT
LMQELKDAAYDAEDLIDEFQYHVLRQKVKGKEEDKAASGSSGLSNMFYAAKIKLLGSSHSLEEDDMRARV
RKMQGRLEKIANRMKSIMNVLPPHDRRKQPEVKFQARESCSSPATDIMFGRDKELNQVVDWLLESANQVE
PASAFVNDTFSVLPIVGIGGAGKTTLAQYAHKHNRVQVHFHLKIWVCVSDNFTVQGLVKSIIQSVAPQKR
YDNMGLEPLQKLLHEHIADKKFLLVLDDVWSDNKSIWHKLCALLKVGAHGSKIIVTTRDVKVSKMVSLVE
PILLHGLDEDAFWQLFKKCSFGTLNPGDYPELEDIGRKIARKLKGSPLAAKTLGSVLQSDLRQQHWNTIM
KSDIWKVKQDEEDIMPVLHLSYEYLNENMKQCFAFCSVFPKDYKFDKAVLVQMWIAEGFIEDKNTKRMED
VGSDYFLEFVNRSFFQEFVYGLFVMHDLIHDLAEMIYAEETCRIENNRQTKMLSTIRHLRVEEGKLPLEF
SGYDKLHTLMLRKNSPPNSLFEKLRSIRVLDVSRCGLQELSEHIGKLIHLRYLDISWNSEIKILPDSLFD
LYNLQTLKVEGCSKLEYIPQELSKLVNLRCIDADDMFLVMVKDVRRLTNLQELPTFSVQEDDGLKLEQLK
DMTQLHGTLHIQNLENVVDSTEAQQAELKNKVRLNKLVLEWNDEKDAKLEEEVIEGLQPHKSLKILKIEG
YNGSRSPSWLMPKVLSNLEKLYLVNCKGWDDVLPFIGQRLHLIELHMDGMPALKQLSHEFEGKCFPKLEV
LYLYELPALEEWSWTEGKDLFPCMRELRVSYCHKLKRLPPFPPSLEMLTIECCPRLKLNSRTEDDEEGGC
HLPPSLKGLKISQWPHITSISLVQSVELQYLYISKCDELRWMECLGVLKSLKQLNIVGCPKLVQLDVEDE
QSASLLPSLRYLCVDNTALLKMFPLRNSLPFITELVFVSCSEEVIFEEPILVRSLTAVTSLSFIGCEKLQ
SLPAKLLHCLPFLKTLMVYNCPQLQSLPEIGLSPFLKTLDICDCPQIQAMPEDGLPMSLDDFQCSGDVHP
KLKEQSDKFFVDTYNKRKARLELE


>XP_042429011.1 putative disease resistance protein RGA1 [Zingiber officinale]
MAVALTVGGWFAQAFIQTLIDKASDKSIQLFAERRGFAADMDKLRISLLETQIILNEVQISRSNDTKWKT
LMQELKDAAYDAEDLIDEFQYHVLRKKIKGEEDDKASGSGVLSNIFSATKNKLLGSSHSLEEDAMRASVV
EIQGRLERIANSMKSIMNVLPPNDRGKQPDQMKSQTRESCSSPVTDILLGRDEELNQVVDWLLGSANQAE
PASGFLNNTLSVLPIVGIGGAGKTTLAQYALKDKRVQDHFDLNIWVCVSDNFTVQGLTKSIIESVTLKKQ
DDNMGLEPLRKLLHEHIANKKFLLVLDDVWSDNKSIWHKFCALLIIGAHGSKIIITTRDKKVSKMVSLAE
PILIDGLKEGFFWQLFKKCSFGTLNPEDYPELEDIGRKIALKLKGSPLAAKTLGSVLQSDLCQQHWDTIL
KSDIWKVKQDEDDIMPALHLSYQYLNENLKQCFAFCSLFPKDYEFNKAELVRMWMAEGFIEDTNTKRMED
VGSDYFLEFVYRSFFQELQFGGFVMHDLIHDLAEMISAEDTCIIEKKRQTKTPSTVRHLRVEGKLPLEFF
GYDKLRTWMLRKNSPPDSLFEKLRSIRVLNISQCGLQELSEHIGKLIHLRYLDLSFNYEIKILPDSLCDL
YNLQTLKAQQCIAIESVPQELCKLVNLRCIDADDMFLVMMKDVRRLTNLQELPTFSVQEDEGLKLVQLKD
LTQLHGSLHIQNLENVVDSKEAQDAELKNKVHLKELVLEWNDEKDAKMEEEVIEGLQPHESLKILKIEGY
NGGRSPSWLMPKVLPNLEKLELVNCMGWDDVLPFIGQRLHLIELSMEDMPALKQLSHQFEGKCFPKLEVL
YLFDLPALEEWSWTEGKDLFPCMRVLRVIDCPKLKRLPPFPPSLEILTIQHCPSLMLNSKTEDDEEGDGH
LPPSLKELELRDCGKYEKLLLDCLHNLRLVTRLEINDFPHITSISLVHLVELQYLCITNCEELRWMECLG
LLKSLKKLKIVGCPKLVQLDVEDEQSASLLSSLHTLCVDNIALFKMFPLRNSLSFITELLFVSCSEEVIF
EEAILVRSLTAVTSLSFLRCDKLRSLPAELLHCLPFLKTLMVSNCPQLQSLPEMRLSPFLERLEIYNCPQ
IQAMPEDGLPMSLDVFICSGDVHPKLREQSEKFFVDRYNRRVKLELE


>XP_042429017.1 putative disease resistance protein RGA1 [Zingiber officinale]
MAVALTVGGWFAQAFIQTLIDKASDKSIQLFAERRGFAADMDKLRISLLETQIILNEVQISRSNDTKWKT
LMQELKDAAYDAEDLIDEFQYHVLRKKIKGEEDDKASGSGVLSNIFSATKNKLLGSSHSLEEDAMRASVV
EIQGRLERIANSMKSIMNVLPPNDRGKQPDQMKSQTRESCSSPVTDILLGRDEELNQVVDWLLGSANQAE
PASGFLNNTLSVLPIVGIGGAGKTTLAQYALKDKRVQDHFDLNIWVCVSDNFTVQGLTKSIIESVTLKKQ
DDNMGLEPLRKLLHEHIANKKFLLVLDDVWSDNKSIWHKFCALLIIGAHGSKIIITTRDKKVSKMVSLAE
PILIDGLKEGFFWQLFKKCSFGTLNPEDYPELEDIGRKIALKLKGSPLAAKTLGSVLQSDLCQQHWDTIL
KSDIWKVKQDEDDIMPALHLSYQYLNENLKQCFAFCSLFPKDYEFNKAELVRMWMAEGFIEDTNTKRMED
VGSDYFLEFVYRSFFQELQFGGFVMHDLIHDLAEMISAEDTCIIEKKRQTKTPSTVRHLRVEGKLPLEFF
GYDKLRTWMLRKNSPPDSLFEKLRSIRVLNISQCGLQELSEHIGKLIHLRYLDLSFNYEIKILPDSLCDL
YNLQTLKAQQCIAIESVPQELCKLVNLRCIDADDMFLVMMKDVRRLTNLQELPTFSVQEDEGLKLVQLKD
LTQLHGSLHIQNLENVVDSKEAQDAELKNKVHLKELVLEWNDEKDAKMEEEVIEGLQPHESLKILKIEGY
NGGRSPSWLMPKVLPNLEKLELVNCMGWDDVLPFIGQRLHLIELSMEDMPALKQLSHQFEGKCFPKLEVL
YLFDLPALEEWSWTEGKDLFPCMRVLRVIDCPKLKRLPPFPPSLEILTIQHCPSLMLNSKTEDDEEGDGH
LPPSLKELELRDCGKYEKLLLDCLHNLRLVTRLEINDFPHITSISLVHLVELQYLCITNCEELRWMECLG
LLKSLKKLKIVGCPKLVQLDVEDEQSASLLSSLHTLCVDNIALFKMFPLRNSLSFITELLFVSCSEEVIF
EEAILVRSLTAVTSLSFLRCDKLRSLPAELLHCLPFLKTLMVSNCPQLQSLPEMRLSPFLERLEIYNCPQ
IQAMPEDGLPMSLDVFICSGDVHPKLREQSEKFFVDRYNRRVKLELE


>XP_042429023.1 putative disease resistance protein RGA1 [Zingiber officinale]
MAVALTVGGWFAQAFIQTLIDKASDKSIQLFAERRGFAADMDKLRISLLETQIILNEVQISRSNDTKWKT
LMQELKDAAYDAEDLIDEFQYHVLRKKIKGEEDDKASGSGVLSNIFSATKNKLLGSSHSLEEDAMRASVV
EIQGRLERIANSMKSIMNVLPPNDRGKQPDQMKSQTRESCSSPVTDILLGRDEELNQVVDWLLGSANQAE
PASGFLNNTLSVLPIVGIGGAGKTTLAQYALKDKRVQDHFDLNIWVCVSDNFTVQGLTKSIIESVTLKKQ
DDNMGLEPLRKLLHEHIANKKFLLVLDDVWSDNKSIWHKFCALLIIGAHGSKIIITTRDKKVSKMVSLAE
PILIDGLKEGFFWQLFKKCSFGTLNPEDYPELEDIGRKIALKLKGSPLAAKTLGSVLQSDLCQQHWDTIL
KSDIWKVKQDEDDIMPALHLSYQYLNENLKQCFAFCSLFPKDYEFNKAELVRMWMAEGFIEDTNTKRMED
VGSDYFLEFVYRSFFQELQFGGFVMHDLIHDLAEMISAEDTCIIEKKRQTKTPSTVRHLRVEGKLPLEFF
GYDKLRTWMLRKNSPPDSLFEKLRSIRVLNISQCGLQELSEHIGKLIHLRYLDLSFNYEIKILPDSLCDL
YNLQTLKAQQCIAIESVPQELCKLVNLRCIDADDMFLVMMKDVRRLTNLQELPTFSVQEDEGLKLVQLKD
LTQLHGSLHIQNLENVVDSKEAQDAELKNKVHLKELVLEWNDEKDAKMEEEVIEGLQPHESLKILKIEGY
NGGRSPSWLMPKVLPNLEKLELVNCMGWDDVLPFIGQRLHLIELSMEDMPALKQLSHQFEGKCFPKLEVL
YLFDLPALEEWSWTEGKDLFPCMRVLRVIDCPKLKRLPPFPPSLEILTIQHCPSLMLNSKTEDDEEGDGH
LPPSLKELELRDCGKYEKLLLDCLHNLRLVTRLEINDFPHITSISLVHLVELQYLCITNCEELRWMECLG
LLKSLKKLKIVGCPKLVQLDVEDEQSASLLSSLHTLCVDNIALFKMFPLRNSLSFITELLFVSCSEEVIF
EEAILVRSLTAVTSLSFLRCDKLRSLPAELLHCLPFLKTLMVSNCPQLQSLPEMRLSPFLERLEIYNCPQ
IQAMPEDGLPMSLDVFICSGDVHPKLREQSEKFFVDRYNRRVKLELE


>XP_042429036.1 disease resistance protein RGA2-like [Zingiber officinale]
MAVALTVGGWFAQAFIQTLLDKASDKSIQLFAERRGFAEDMENLRASLLEIQIILDEVQSRGCNDTKWKT
LIQELKDAAYDAEDLIDEFQYHVLRQKIKGEEEGKAATGSSGLSNMFYAAKKRLLGSSHSLEEDDTRARV
RKMQGRLEKIANRMKSIMNVLPPNDRRKQPEVKFQARESCSSPATDKMFGRDKELNQVVDWLLGSANQVE
LASGFVNNTFSVLPIVGIGGVGKTTLAQYAHKDNRVQDHFHLKIWVCVSDNFTVQGLAKSIIESVTLQKQ
DDNMGLEPLQKILHQHIAKKKFLLVLEDAWSDNKNIWEKFYALLKVGAHGSKIIVTTRDMKVSKMVSLVE
PILLDGLDEDAFWQLFKKCSFVTLNPEDYPELEDIGRKIARKLKGLPLAAKTLGSVLQSDLSQQHWATIM
KSDNWKVKQDEDDIMPALHLSYQYLNENMKQCFAFCSVFPKDYVFEEAKLVRMWMAEGFIQNKNTKRMED
VGSDHFLEFVNRSFFQKFKFGGFVMHDLIHDLAEMISAEDTCSIEKKRQTKMLSTIRHLRVKEGKLPLEF
SGYDKLRTLMLRKNSPPNSLFEKLRSIRVLDVSRCDLQELSEHIGKLIHLRYLDLSSNYEIKILPDSFCH
LHNLQTLEILGCHKLESIPQELGKKMVNLRHINADNKFWVMIKDVRRLTNLQELPTFSVQEDDGLKLVQL
KDLTQLHGTLHIQNLENVVDSKEAQDAELKNKVHLKGLGLEWNDEKDAKLEEEVIEALLPHESLKRLKIE
GYNGGRSPSWLMPKVLSNLEKLYLANCKGWDDVLPFIGQRLHLIELCMERMPSLKQLSHEFEGKCFPKLK
VLNLWSLPALEEWSWTEGKDLFPCLRILCVSGCPKLKRLPPFPPSLEKLIIRDCPRLILNTKTEDDEEGG
CYLPPSLKVLELDNCGEYSKLLPDCLHNLRLVTRLVINDCPHITSIPLVQLVELQYLYICNCDELRWMEC
LGVLKSLEELKIVGCPKLVQLDVENEQAASLLSSLRYLCVDNTALLKMFPLRNSLSFITEFEIESCSEEL
IFEETIFRRSLTAVTSLSFIYCDKLQSLPTELLHCLPFLKTLMVSNCPQLQSLPEMGLSPFLERLEICNC
PQIQAMPEDGLPMSLDVFDCSGSIHPTLKEQSEKFNADRVMRRVRLELE


>XP_042430259.1 putative disease resistance RPP13-like protein 1 [Zingiber officinale]
MLVFLELKHLLLEVLPSPTMVAQGRLLCIQNHLAMVCDGLWAVNSMIEIPEMGMLNNHFSKKFYGVDAVT
SFVPAETADWVTDVATAVIDVGELLSRIMDWEASSHRSIVGNTQQVHFRHVILVELKEILCNLNSLVLRG
SAMGLWRDPMGSMNPLREDYSIVLKNEVVGREEDLEELIAIFEQQLVSSNNNGFDNNPFAIVIVGKQGVG
KRTLAHMIYHHTWIRQQFLHRIWVDLPLVSTFKMIDIIGNEFVRSIDKEEYCDQKLHLDLPLPDMWEYIN
EQLCGSRYLLVLHCENLVSLMQPEWNELKNIMLRVGGPGSGVLIIYKSSTESAVRNMRFLNRLKDITTFY
LNPLSDYAWVELVSRHAATTIPLKQDKSNKDELIQLAKLYCTNFPGQTFGAKVFGSLFHYIPTTFAILQS
RLLDDICKVRNFPLVIVRLLQYHYLLDADTDNYYDNDYDVILHMLTAECLIPTEGLEPGWIECYERHFTQ
IHRKRDLPELLFGRMVYWHMKIPKDSTTISRCCRCLCLEINPRVKPFRLPIMPIKVSSKLITLILQEDKK
TTREDVEEITLRVYKKRCMKAATAISKFLNKMSVRFIHLHMLVVETSMIQSLPNEISKLVSLRYLHLSKL
KMELLPKSLFDLLNLRILSLLHCKKLQKIPERIHKLKKLQILKLAYCTKLQWLPKSITRLTNLEELNMEG
CCFLSKLPEDLVSFKSLRILNVAGCASLSQLPRGIEQLIGLRKLSGIIVGVQGGFVLTQLQALTNLQEIR
LQNLEREEEIQTEVLMGQQSLRHLSLHWGGEEATKSSETAPSQHVLEALRPNLHLKCLDIISYKGVEFPT
WMSKQQLARFDSLVEVRFINLRRCAILPSLGQLPFLEKLEISGMDLIKHIDYTFYGDGNTFAMLRELTFS
EMLGLKKWSVPSERKNKIFFPELRQLTLIQCPKLKEISPWLFLHDYDTMRIWLNNETIWSTVFCSWDNLR
YLEIIEIVGCQELRCLPQRMQSLQISKMTINSCNNLTTLVALDSLIELNIYACPLLAFNLEAFAELRILT
IKGCPKMQIYHDAWKKKDEERREKEERRRYNYESSSSSSSSPN


>XP_042430601.1 putative disease resistance protein RGA3 [Zingiber officinale]
MAMVLDFYVSRVMKVTADMVEAEIFKVLGVDKEIKTLQGRLRTINGYLHQAERKIQGNNEIDIWVRKLKD
IMYDADDIIDLCMIEGGKVLRAQASSGSSTVSIPSSYLFSCFRCLRYRHEVANQIIALNGRLEALKNDSF
IKNNLDQAVKEPVENAHREFGRETSHLQIEGDIIGSQIENATDKLINLILENNPKKTRVFGVVGTGGIGK
STLASKIFEDERIKENFPNRKWLYVSKNYIETDLLKKLIRFEEGNETKGETFEGKSKAELEDKLVTILTK
NTFIVLDDVWNATVWIDILRKPIVKSASSCTILVTSRKEKVVAQMKPSYIHPVEKMDEESGWNLLKHLVF
EGGEEEDEISSLAEIGIKLVKKCDGLPLAIKAIGGVLYQQNKAKWEEVLESDAWKMDQIEEELRPLYLSY
EDLPSTLKQCFLYCSLYHQKDMYYKEIVQFWVAEGLIMDEQEKSRNDLPTEKQKTMEDIGEEIYRELIWR
NLLEADANFDVSKDYFSMHDHFRSLGAHLMREEGILYRHGREFKTDDNIKIRRLSISNMGPKLVLPSQIL
KQGCLRTLILMDSPKTKTIEDSVLQELSCLRVLDLTSTSIEKIPDCIGDLLHLRYLDLDGTNIREIPKTI
GKLVNLQTLNISKCQYLERLPESITMLHNLRCLDMSDTPLLTYVPKGIGKLGNFYNLKGFLVGQNDSTSE
EGCDLEELKNLSKLRGISILRLERAERGASALADKPFLKQLTLGWMQPDEDDADEEEESEGANEVGADEE
ADNDGNDDKDAGNEKGDDNDDGSKQENENEEAEEAGNETEDETEEDEAEEEEKGWSDEQISKAERICNEM
SQPSSSIEDLFFYEYPGRQLPSWMISSSLAESFPNLAYLQLLGLPCCTELPPFGTLPQLKYLRIEQASAI
TAIGSQFLGSRSSVFPKLELLRFVGMPKWEEWTLDGVEELTGHGTPLAVKLFPSLRDCILIDCPKLRALP
ADLYRATNFSELCLRQTYELGEIINLPMANKLEVTNASGLKKISNISSVRYLEVDNCPNLECVENIGKLQ
HLVLICSEEMEQLPQWLSVLIEQHNNTSSTHRSLRKFEMQCSLQLLKTCLEGNENWDIIKQIPIVKVTTY
SGKEYVRYTKDPYMYDPHVPSN


>XP_042430704.1 disease resistance protein RPS2-like [Zingiber officinale]
MADIISGISSIFTCLKDCCFQSCNYIVSFEGAISSLIAELDQLKSKSMDIKRQVEAAQRDELNVKQEVLG
WLKSVEDLSSEAENINAAYRRKFKCLCNFPINVCSSYPLRTRAEAALTAAADLKKKAGEFADVADDLDID
RVLEVPNPKVIGMDTALEELQGHARDDDVIIIGIHGMGGVGKTALLRRFNNDFAEKALDNLDVVIYLDLP
TEYQVEELQKPLFCQLKLTWQDEATQRDRAGRLFRVLSKMRFLLLLDNVWEPLNCQVVGIPLPQPPSKSK
IVFATRMEDVCSRMGAEKTIKLECLSSEEAWDLFRFNAKLNLATTDASILDLARALARQCAGLPAALISV
AHAMASKRTFAEWRHVLAIMKEAPFQLPGMEEHVYHPLKLSYDRLSDTLRTCASNFALVQEGRLLSKQYV
TDLWIGQGFINDFEKSSDTSDKASYLLGMLLAASLIQRFDDKYFKMHPMVRSMILWMECDCGKKESKWLK
RDGHGLAEAPGAEKWRVAERISLGWNNIALLPDKPLCLDLIYLNLRKNPPLRNIPNKFFSHMPCLRILDL
QQTSIEELPSGIGNLSQLQLLDLSFTRIASLPREIQDLVNLRYLAMLSATQLRSIPGAVIPCLQQLQWLD
IYSSYSGWRVAGALQSDGEGILLDELESLKKLKVLGITISSETALRRLSELQRLAATVHWLQIEGCGTLA
RLDIPSTYCFGENMKNLKQIRLQAMPDLEEVIIGGDLHARNALSCLNFLYLSALPKAKIIWKNRCLANLC
GLDIQDCNVIDRLLKLEDNAANSAETITIFPRLTKIVLRKLPELESLSDGDRVIAFPSLKTMEVRNCPKL
KKLTLVAENLREIQCDKEWWDKLDWSDERTLSFQELFKQAD


>XP_042430705.1 disease resistance protein RPS2-like [Zingiber officinale]
MADIISGISSIFTCLKDCCFQSCNYIVSFEGAISSLIAELDQLKSKSMDIKRQVEAAQRDELNVKQEVLG
WLKSVEDLSSEAENINAAYRRKFKCLCNFPINVCSSYPLRTRAEAALTAAADLKKKAGEFADVADDLDID
RVLEVPNPKVIGMDTALEELQGHARDDDVIIIGIHGMGGVGKTALLRRFNNDFAEKALDNLDVVIYLDLP
TEYQVEELQKPLFCQLKLTWQDEATQRDRAGRLFRVLSKMRFLLLLDNVWEPLNCQVVGIPLPQPPSKSK
IVFATRMEDVCSRMGAEKTIKLECLSSEEAWDLFRFNAKLNLATTDASILDLARALARQCAGLPAALISV
AHAMASKRTFAEWRHVLAIMKEAPFQLPGMEEHVYHPLKLSYDRLSDTLRTCASNFALVQEGRLLSKQYV
TDLWIGQGFINDFEKSSDTSDKASYLLGMLLAASLIQRFDDKYFKMHPMVRSMILWMECDCGKKESKWLK
RDGHGLAEAPGAEKWRVAERISLGWNNIALLPDKPLCLDLIYLNLRKNPPLRNIPNKFFSHMPCLRILDL
QQTSIEELPSGIGNLSQLQLLDLSFTRIASLPREIQDLVNLRYLAMLSATQLRSIPGAVIPCLQQLQWLD
IYSSYSGWRVAGALQSDGEGILLDELESLKKLKVLGITISSETALRRLSELQRLAATVHWLQIEGCGTLA
RLDIPSTYCFGENMKNLKQIRLQAMPDLEEVIIGGDLHARNALSCLNFLYLSALPKAKIIWKNRCLANLC
GLDIQDCNVIDRLLKLEDNAANSAETITIFPRLTKIVLRKLPELESLSDGDRVIAFPSLKTMEVRNCPKL
KKLTLVAENLREIQCDKEWWDKLDWSDERTLSFQELFKQAD


>XP_042430735.1 putative disease resistance protein RGA3 [Zingiber officinale]
MAMTLNFYVSRVMKVTADLVEAEIFKVLGVDKEIKTLQGRLRAINGYLHQAERKRQGNDEIDIWVRKLKN
IMYDADDIIDLCMIEGGKVLRAQASSGSSTVSIPSSYLFSCFRCLRYRHEVANQIIALNGRLEALKNDSF
IKNNLDQTVKEPVENAHRVFGRETSHLQVEGDIIGSQIENATDKLINLILENNPKKTRVFGVVGTGGIGK
STLASKIFEDERIKENFPNRKWLYVSKNYIETDLLKKLIRFEEGSETKGEIFEGKSKAELEDKLVTVLTK
NTFIVLDDVWNATVWIDILRKPIVKSASSCTILVTSRKEKVVAQMKPSYIHQVEKMDEESGWNLLKHLVF
EGGEEEDEISSLEEIGIKLVKKCDGLPLAIKAIGGVLYQQNKAKWEEVLESDAWKMDQIEEELRPLYLSY
EDLPSTLKQCFLYCSLYRQKDMYYKEIVQFWVAEGLIMDEHEKSRNDLPTEKQKTMEDIGEEIYRELIWR
NLLEADANFDVSKDYFSMHDHFRSLGAHLMREEGILYRHGKEFKTDDNVKIRRLSISNMGPKLVLPSQIL
KQGCLRTLILMDSPKTKTIEDSVLQALSCLRVLDLTSTSIEKIPDCIGDLLHLRYLDLDGTNIREIPKTI
GNLVNLQSLNISECQYLERLPKSITMLQNLRCLDIRDSPLLTYVPKGIGRLENFYNLQGFLVGQNDSTSD
EGCDLEELKNLSKLRGISIYRLERAERGASALADKPFLKQLTLGWMQPDEDDTDEEDESEGSEEEEANEG
GADDTVASESEADGNDDEDARNDDSSKQENENEEAEEAGNETEDETEEDEAEEEEKGWSDEQISKAERIC
NEMSQPSSSIEDLLFDEYPGRQLPSWMICSSLAESFPNLAYLKLLGLPCCTELPPLGTLPQLKYLSIERA
SAITTIGSQFLGSRSSVFPKLEVLRFVDMPKWEEWTLEELTRHGTPLAVKLFPSLTECKLIHCPKLRALP
ADLYRATNFNELYLVKTYDLGEIINLPVAYKLEVRNGRGLKKISNISSVRYLEVNNCPNLECVENLSKLQ
HLVLICSKEMEQLPLWLSALIEQHNNTSSTHRSFRKFEMQCSLQLLQTCLEGNENWDIIKQIPIVKVTTY
SEKEYIRYTKDPYMYDPHVPSN


>XP_042430877.1 probable disease resistance protein At4g27220 [Zingiber officinale]
MVSPCLNTFCGGMGSGTGNAIVKYLWKKSKKHACYFIYYKKKFEKFKEQFDLLKAITDDTQRKVEISKRN
NEVISDEVNLWLNKVIELEEKFNNIENNFDRIVENEKYCIPSLIFRYKVGREATRKKDKTLKLLDQSKFQ
SFSHILDPSAVNHPSNIDFVSFGATKEAMQKVIDALNDDKVNLIGIYGMGGVGKTTLIEEISRKMKEAET
FDMVMDVVVSQNPNIAQIQRDIADALGMRESSNKMLATRLKQVKKVLIMLDDVWARLELVKEVGIPYREH
KGCKVILTSRKAETCNVMEADVSVEVATLSKEDSWQLFRMRAGQVAESDGIEPIARKVAQECCGLPLAIV
VVGRALRSYEDASAWEDALSQLKQSVPLNMEEVEEKLFKPLELSYQNLKTAELKQLFLYCCLFREDYNIS
EDEVTRYAVGENLLSNLSTLEDVRGRVHFLLQKLKLSCLVLDSKKAGCVKLHDVVRDVAVYIGFKDNNHF
LVKAGLGLIDWPKYENLAECKRISLSNNFLQEIPEKPNCSKLVLLLLNMNPITSVPINFFENMVTLNVLD
FSSTEITSLPSSLTCLKCLGTLRLDRCKRLNDINVVGELKTLIILSLQQCKGISALPETVDGLVKLKLLD
LSNCTLLQIPRNLIPKLTQLEELYLRGYNVTEALFVEIASLKRLVRVELYVKDAQDFSLKVIPSNAFKNL
CHFIIYNELDWFTMASAYQRKLFIKQASQSVIIWGMPFLRGTEDLMLDSCQCNLTDLTPLENMSCFANLK
SLTLTNNHQIQCLLRSTNGTPSNAFGELVKVNILNMEKLEQICHGHLPDLSLRKLRTLVLKRCRNLVDIL
PRDLLQRVHSSLVELLLEGCPGPGILLNFEELGHDSVFFPKLQTIRLSQISDVISFCTGVVPPGSLHNLT
TFEVVNCEKLSYLFSPTLDATHSRLLPSDTFKKLKHLKIMGCPCLKHVFLPSIANELQSLERLEIKNNDS
METIIAEEEGCDLEKGAFPMLNRLLFIKLPVLCCFFKGEPAKTLDWPSLEYIHLGDCSKLAGLPIGRESA
QKLKKVHVVRLNDVDWFTTLKWEDDTIKSRFDIIQSIDEVE


>XP_042430878.1 probable disease resistance protein At4g27220 [Zingiber officinale]
MVNPCLSNFCGGLESAIVKYFWKKLKTHTSYFIYYKKKFEKFKQQFDHLKAIRDGTQQKVEAAKRNNEVI
SDEVNLWLNDVLELEEKFNNIENNFNRIVRDEKCCIPNLAPRYKVGRDATKKKAEASELLDRKNFQVFSH
TIDPSNLGHSSNKDFVSFGATNEAMQKVIDALNDDKVNLIGIYGMGGVGKTTLMEEVGRKMKEAEIFHVV
IDVVVSHNPNIAQIRRDIADQLGMRESSNKMLTTRLKQEKKVLIMLDDVWARLELVKEVGIPYREHKGCK
VMLTSRKAETCNVMEADVSVEVANLSEEDSWQLFRMRAGQVAESDGIELVARKVARECCGLPLAIAVVGR
ALRSYKDASAWEDALSQLKQSVPLHMEELEEKLFKPLELSYQNLKTAELKQLFLYCCLFREDYDISEDEV
TQYVVGENLLSNLSTLEDVRGRVHFLLQKLKLSCLVLDSKKDGCVKLHDVVRDVAIYIGSKDNNHFLVKA
GLGLRGWPECKNLADCKRISLSNNLLQKFPEKPNCSKLILLLLNMNPITSVPDNFFENMATLNVLDFSNT
DITSLPSSLTCLKCLGTLRLDRCKWLIDINVVGELKTLIILTLQECRGISALPESLYCLVKLKLLDLSNC
TMLQIPRNSIHKLTQLEELYLRGYNVTEALLVEVASLKSLVRVELYVKYAKDFSEQIIPADSYQVLHHFI
IYNESDRFSLASKYQRNIFIKQANQSMISWGKPFLRIAEELRLDSCQWNFTDLIPLENLSCFATLKSLLI
VNCRQIQCLLRSTDDTPSNAFGELMKLTLLDMEKLEQVCHGQLPAHSLGKLRTLELRRCRNIIDILPQDL
LVRVHQNLVELLLEGCPGPHVLLNFEGLGHDSVIFPKLQMIRLSQMSNLISFCNGVVPPGSLHNLTTFEV
VNCKKLLNLFSQTLDATRSRLLPSETFKKLKQLQIMGCPCLKHVFLPSIANELHSLERLEINNNGSIETI
IADEDGCDLKKGAFPMLKKVVFIKLPRLRYFFEGEPTKILDWPSLEYIHVVECWNLARLPIERGSLQKQE
NVHFVRLDDVNWFKTLKWEDHTTKSRFDIIQSINEVK


>XP_042431506.1 putative disease resistance protein RGA3 [Zingiber officinale]
MAMVLDFFVSKFIKDTSDMVEKEIFKVLGVDKEIKTLQVWLRTINGYLRQAEQKRQGNDEIDIWVRKLKD
IMYDVDDVIDLCMIEGGKLLTAQVSSSSSTVSIPYNYLISCFKCLKYRHDIANQIISLNSRLEGLKNDAV
IKNNLDQAIKEPVENANKVVFAHETSHLQVEGDIVGMQIENATEKLISLILENNPKKTRVFGVVGTGGIG
KSTLASKIFEDERIKENFPKRKWLYVSKNYIETDLLKKLIRFEEGSETKGETFEGKSKAELENKLVTVLT
RNTFIVLDDVWNSIVWTDFLRKPIVKCASSCTILITSRKEKVVTNMRPKYIHPVEKMNEESGWNLLKHLA
FEGEEEDEISSLEEIGSKLVKKCDGLPLAIKAIGGVLYQQNKAKWEEVLESDVWKMDQIEEELRPLYLSY
EDLTSRLKQCFLYCSLYSQKGMYYKEIVQFWIAEGLIMDDVPTEKKKTMEDIGEEIYRELIWRNVLEADA
IVDVSKDYFSMHDHFRSLGAHLMREEGILYRHGREFKTDDNIKIRRLSVSNMGSKLVLPSQILKQGCLRT
LILMDSRKTKTIEDSVLQELSCLRVLDLTSTSIEKIPDCIGDLLHLRYLDLDGTNIHEIPKTIGNLVNLQ
TLNISECQYLERLTESITMLHNLRCLEMRDTPLLTYVPKGIGKLGNFYNLQGFLVGQNDSTTDKGCDLEE
LKNLSKLRGISIYRLERAERGASALADKPFLKQLTLGWMQPDKDDTDEEDESEGSEEEEANEGGADDTVA
SESEADANDDEDAGNEKGDGNDDSSKQENENEEAEEVGNETEDETEEDEAEEEEKGWSDEQISKAERICN
EMSQPSSSIEDLLFVEYPGRQLPSWMICSSLAEFFPNLAYLKLLGLPCCTELPPLGTLPQLKYLSIERAS
AITTIGSRFLGSRSSAFPKLEVLQLEDMPRWEEWTFDGVEELTGHGTPLSVKLFPSLRDCVLIDCPKLRA
LPADLYRATDLNELCLRQTYQLGEIINLPMAYKLEVTNGSGLKKISNISSVRYLEVDNCPNLECVENIGK
LQHLVLICSEEMEQLPQWLSVLIEQHNNTSSTHRSLRKFEMQCSLKLLKTCLEGNENWDIIKQIPIVKVT
TYSEKEYIRYTKDPYMYDPHVPAN


>XP_042432455.1 disease resistance protein RPS2-like [Zingiber officinale]
MVKCSPAVSVWMHYRYSRFVGYSRLSRLQIEKVLCRSEVLAVNPTRVQIFVRVIWVIFRCLDEGAHPVED
SCHGGSKSQGGQRSDIIDQLGDKWSFGRSDETGVAKFQLNGRDTGEAKFGPSSQPAQAATYSLYYPSTSF
WELVPLTPGMDNQKIIRENFGKHADLGEHARALQELYIKGDPSIGGVSSETMMNTFTQELIEGEFFRLLI
RKLPRDFDHLLRKANEYINMEEAQTARKKETSAEPASTLERRPSNNLLALSCLKDCTSDSCNYVVSYEDN
LSSLAGEVSQLKSKSEDVKREVEATMRQGLRPRNEVLGWLSAVEEVAGEADQIRAKYERMVKCFCRFPAN
ICTSVKLRRRAEAALASARELKQRDLPEVVHRHNLVRFIRMQNQQTAGAEKAFEELQRHARDDGVTCFGI
HGMGGVGKSALLREFNNYLENELEYLDIIIFLESSTEHKVEELHKFLFARLNLTWQNGVSQMDRAANIFR
VLSQLKFVLIVDNLWEPLDYRAVGIPFPEPESRCKIIVASRIEDVCSHMRMERMIRMERIEEEAAWELFR
FNARLEPNEADERIIRIAKVMARKCGGLPAALVVVAQTMANKKTVQEWMHAVNLMRDAPFQLPGMEERVL
YPLKLSYDRLLTDRDRLCASYFSLVPEGCLVDNYFIRKLWIGEGIIDDFNNVWESANEAHYLLGMLSSSS
LIQRIDGKSYASEKPIESDRFKMHPMTRAMILWVGRECGKKGSKWLAHYGDGLAEAPTAEKWRVAERVAL
GQNKIKALPEAPQAPDLIYLDLGYNDLLVKIPNGFFSRMPKLKILDLQDNPIEDFPVGICNLALLQFLTL
SGTKITSLPRELGGLVNLRYLACSSTTRLKRIPDQLMSRLQELRWLKMCDGYNQWRAAPSEEEEAYLEEL
EVLTKLKVLGIAISTVTSLRRLFESQRLTTSVHWLQVEDCRGLTRLDIPSTEFPQESMPNIMELRVHAMN
ELEEFAIQGTALANLMELHLSHLPKASLVCRAVGCLGSLRTLRIENCKEIARLIQLDAGTNDGEEIAIFP
ALKRMVLKRLPKFESFSDESRTVTFSSLESIEIEECPKLTRLNLCCGKLKSVRSERAWWDELEWEDDLTK
LSFENLFKPL


>XP_042432494.1 disease resistance protein RGA2-like [Zingiber officinale]
MTMMDQPMATISQLRHIVMKILSEPEMVAQGKAFRISNHLEMIRDSLWAINSFLMDGALCVLEEPDVAEW
MKDVGVAVEDVNSLLKRILDYWDPNEEDETEKKRKMNNFFHPLVDNSIQSMSSRRSILLELKETACLLNY
LVNRGAALGLWVEMMDSMDPTHDDYSTILSDEVMGRDEDEDHIIELLQQQQCDKYGNIPFFIAIKGDKYY
GKTTLARKIYHHTWVRQHFQHRIWLDASSFSDFNSNMIAKEIARLLTGKPCANINCWPLINEHLHGDRYL
LILDDVDVSGVLKYKWEQLKMNLIHYGTPGSKVILAGYTFHGIERDFNVTEYKINQLPNDAWVRILLRYA
TFVYPIESNNNIHKEKVAPVAIDFLIPLVEKYSQNCLGAKCMGLMFSWRDMTQGQELANQLYNFDDFPYK
FNLLSIEEIRSSLCMLLSEGFSCESYHEEDVLHMLVAEGTLTNTRLKSNLRHISTKFNLDLCFFKMKVSE
DSSIPPQCRHLHLLMDSKNILKSKKAIEKAGIANKLRSLALHREEKKEPISQIETKRLEGMFLNLRHLGT
LHMRAIMIEDLPSSICTLHCLRYLNFAENKIETLPESLCNLSNLCVLILSLCKKLKELPRRIHKLRKLQI
LKLTCCLRIHKLPESITQLLNLKELDVGGCCWLSKMPDDLSNMKNLAQLKMHGCASLTRMPSGIRQLTNL
EVLWGYDAIDGLGNVMLSELQALTNLESLHIQHLERLVSAEVEEKDITPPTILQENQHVNELMLHWQWWN
DMVAEGTFKLTLQLTQGFYRNLEELKVLRIVSYMSKKLPSWLIKDGDSALNRLTTVHLVNLRRCERLPPL
GQLHQLEEVAISGFDSVRVIDDDFYGRMPKAQGIPCPRYNHVSLKLWLSNELLMPTSKFNDWESLWGIRT
LQIFGSQELRSLSDSLRKIPNLEKLAIINCNKLEALPIWLVWKLSLKSLCVYGCPMLAIIPEGLRVKGRL
TNLIVEACPKLQSQKYLPDKWDYFR


>XP_042432499.1 putative disease resistance protein RGA3 [Zingiber officinale]
MATISQLRHIVMKILPAPEMVAQGKAFRISNHLEMIQDCLWAINSFLMDAALRVLTEHNVEEWMEDVGVV
DWMKDVGVAVEDVDSLLKRILDYWEPNEQDEAKKKKKMSNFFHPLVNINNNIQSTSSRQAILVELKEMAC
LLNYLVKRGTVLGLWAEMMDSMDPCHDDYAAILSKEMMGRQEDEDQIIELLQQQQCDEDGNVPFIIDIRG
DEFSGRTTLARKIYHHPWVRQHFQHRIWLDASSFREFNSKMIAKEIARLLTGKPCANINCWPLISEHLRG
DRYLLILDDADVPNVFRYKWEEFKLNLLHCGAPGSRVILARHTFAGNPYGEYGIEFNVKKYKLKELPEDA
WVRILLRYATFAHSTEGNNNIHKEKASPIATTNMLIPLAKKCRLDHWHRDRNLLIAKGVGLMFRWRDMNE
WKELPNQLYRFEILHCYFLLVHQQYGSFENIRPSLYNLLLGGSEAESFGEGESYGEDVLYMLIAEGILTN
TRLTRNIQYIGSEFNLDPCFFRMKVSEDSSIPPQCRHLYLPIHSKNVSKSKKAIERAGVANKLRTLVLHR
EEKKGHIYHIETKKFEGMFLNLTCLCTLHMRAIMIHDLPITICTLHCLRYLNLAENKIETLPESLYNLSN
LCVLILSLCKKLKELPRQIYKLRKLQILKLSYCQRIQKLPESITRLMNLKELDVGGCCWLSKLPDDLSDM
KNLVQLNMLGCASLTRMPGGIRQLTNLEVLCGYDAIDGLGNVMLSELRDLTNLESLHLQHLERLVSAKAK
EPNDITAPPTILQENQHVNELMLHWEWWNDMVAEETFEPTLQLTQGFHRNIEELKILRIVSYMSIKLPSW
LIREESISVMNKLTTVHLVNLRRCERLPPLGKLPNLKELAISGFDSIRLIDDDFYGEGGSALFPLLKRLT
FSQMPRLEKWDPPSYFKENPYKFRDRTFYCLKELTLIQCPKLREFHMPICVSHTSRFSLKVWLSNEMLMP
TSKFNDWGNLSGIQSLQIFGCQELRSLPDGLKTLLYLDTLVIINCNKLESLPIWLERSRLESLCVYGCPA
LSIIPEGLKATGRLRNLIVEACACPKLHSQV


>XP_042432500.1 disease resistance protein RGA2-like [Zingiber officinale]
MSMLTAVQLRHIVMKILPAPEMVAQGKAFRISNHLEMIRDSLWAINSFLMDSTCWVGEFEPPDVTEWMKD
VGVAVEDVDNLLKRILDYWDPNEENEAKKKMKMNNFLHPLVNNNIRSTSNRRSILLEFKQTVCLLNYLVK
GGIALGLRMEMMDSMDPNHDDYAAILNEEVIGRDEDEDQIIDLLQQQQCDKDGNVPFIVAIRGSESSGKT
TLARKIYHHTWVRQHFQHRIWLDASSFEDFNSSMIAKEIARLLTRKPCMNVDCWPLINEHLYGERYLLVL
DDVYVSDDLEYKWEELKMNLLHCGAPGSKVIVTEYPYLVYERGFNVKEYELNQLPEDAWVRLLLRYATFV
HPIEDNNSIHKEKYPPIECRQHSFLRNCLGAKYIGLMFRWRDTNQWQELADQFDASPYNSIVWMHSKYWS
IEVTQTFLYELLFEGSSDESYREEDVLHMLVAEGTLTNTRRKRNLEYMTPYTRPPADLEYKSDFNLDLCF
FRMKVGEVSSIPPQCRHLSLLMDSKNILRSKTAIEKAGVANKLRSLALHREEKKEPICQIETKILEGMFL
NLTCLGMLHMRAIMIEDLPSSVATLHCLRYLNIAENKIETLPESLCNLSNLCVLILSLCKRLKELPRRIH
KLRKLQILKLSCCLRIQKLPESITRLVNLKILDVGGCCWLSKLFDDLSNMKNLVQLKINGCASLTRMPGG
IKQLTNLEVLWGYDAVDGLGNVMLPELQALTNLESLHIQHLERLISVETEAEEKDITPPTSLLKNQLLNE
LILHWEWWNDMTTEGTSKSTEQLIEGLKRNLRELKVFRIISYMSNKLPSWLMREGSVLVLNKLTTVHLVN
LRRCKRLPPLGLLPHLLMVAISGFDSVIVIDDDFYGEGSPSPFDNLLRLTFSEMPRLEKWDPPSYFQNNP
KKSCESYFNKLEELTLIQCPKLRELHVPIFVSDYSQLLLKLWLSNEMLMPTSKFNDWGSLQGIRKLQIFG
CQELRSLPDDIREIHYLRALAIINCNKLEALPIWLEQKLSLESLWISGCPALSSIPEGLKVEGRLRNLIV
EACPKLSQVLF


>XP_042432979.1 putative disease resistance protein At3g14460 [Zingiber officinale]
MDFLKASGEALLESFVNPYIIRHPKGHTVPRLDEKSMETMLEFLEKIEADLPRDETNTQLNPPPSFPSPI
RRPSPIACVSRLAFATSSSLRLFSAKHSSVQKLHLHPLSSHLLQMAIGEATQFGIIVVLACNREQFRTRD
EGAGKNHEEMSESVAKIMETPRDSLKLNVSPFDVCWSLFKGIAFEGRDPSMHDTFVEIGLKIVEKCRGLP
LAVKVLGYALRNKDDEYMWMDVLESEMWEFDEGKDEILPARQISYDYMNITGLRRCFPYLSLFPKDIVLR
PGRIVLLWMSQGFLQPASRIGLLHPRDDDCPIYAETDETYTMHDVFQSLAQFVVRDECLGIEDNVGQGPL
CRASICGSLADLLRNSGTDVKSLPDSICNLYNLETLNLNKTYVSELPRQIVNLTSLRHLLLYVSCVYLPQ
GIGELTNLQTLSNFRIVTLLSRPIAEEDHDDCEDEEYYGNSKEGKGDEHAIKEKRLLEYLRPHANLKMLQ
IYDYPGVSFAKWVGTSSFSKPVQLWLCRCRKCNFLPPLGQLHSLKILCIQEMDGMHIVGREFCSSPMVKA
FPSLESLAFVRMPNWEVWDEVEVGDFPHLQHIKLYECPKLTKFPHHLMSSVKELSIKGCDGVSGLLKFH


>XP_042432980.1 putative disease resistance RPP13-like protein 1 [Zingiber officinale]
MRAEAQHEKIAEEWIALKLIKKSSKRKRTPPISNQQMGVAESGVLEREQEKKILVDWILSEDDASMNRVS
VIALTGMGGLGNTTVAHLMYKDLRVKSYFDLRGWISVSEHFDVAALS


>XP_042432981.1 disease resistance protein RGA2-like [Zingiber officinale]
MAAKAARRRRRSCGRSALRRRREVEKGRGPSATVAAGVSPSRRRRAPVRRRQPPLLLLVLDDVWNEELKL
WNPLKRPLMSAKVGKVIVTTRLDSVARIMQTTDPLILESLPFDMCWLLFKQIAFTR


>XP_042433025.1 putative disease resistance protein RGA3 [Zingiber officinale]
MSMAIASQLRHIAMKILSTPEMVEQGKAFRISNHLEMIRDNLWAINSFLMDGALRIQKEPDVAKWMQDVG
VTLEDVDSLLKRILDCWEPNDENEGKKKRKMSNFLHVSINNNIQSTNNCRSILLELKETACLLNYLVKRG
TTLGLWVEMMDSMDPSHDDYATILSEEVIGREDEDQIIDLLQQQQCDEDGNAPFIIAIDGSKYSGKTTLA
RKIYHHPWVRQHFQHRIWLDASSFRDFNSSMIAKEIARLLSQKPCTNVDCWPFINEHLGGDRYLLIFDDV
YVSDVLKYKWEELMLNLLHCGAPGSKVILAGYTFYEYIREFNIKEYKLKQLPKDAWVRILLRYAISVRPI
KGNNNIHKEKASPAVTDILIPLAKKFIQDYDSGYCLGAKCMGLMFRWRDKSQWGELANQWFNIEHLRKYF
LWVHRQYWSIEDTRSSLYKLLFEGSEDDSYDEDVLYMLIAEGTLTNTRLKRNLQIMSFEFDLDQCFFRMK
VGEDSSIPPQCRHLHLLINSKNILKSKKAIEVAGVANKLRTLILHRKEKKGHIYQIETKKLEGLFLNLTC
LCTLHMRAIMIQDLPSTVSTLHCLRYLNLAENKIETLPESLCNLSNLCALILSLCKELKELPRQIHKLRK
LQILKLSCCLRIQKLPESITRLVNLKELDVGGCCWLSKLPDDLSNLKNLMQLNMHGCASLTRMPSGIRQL
TNLEVLLGYDAMDGLGNVMLSELQALTNLESLHIQHLERLISATEEEKDITELTILQENQHLNELMLHWE
WWNDMVAEETFEPTLQLTQGFHRNLEELKVLRIISYMSIKLPSWLIRDRDSVLNKLTIVHLVNLRRCERL
PALGLLPKLEEIVISGFDLVRVIDDDFYGKDREVPFYGLKRLTFSEMPMLEKWDLPIYFKRRLRWIKANA
KIEALAKADDKGLLNAMVRVKAEAWAEAWAEAKARAWAEAKARAWVEARIETEAKAWDRAWDRAWDWAQT
HAWQQAWGRARAWDRAQALARARASARARAKDRGETWAQIRDWAEAKAPSKAWNQAYVPPHLRAEFRARA
ESKAEAWARAEAEAKVRAEVKAQVRAKEWAWTRVLAYSASTRAKAKVGDDYFVRPAKVETNYFTSLIEAE
AKANYFARWIEADYFVKLVELTLIQCPKLREFHLSFPTSSKLKLKLWLSNEMLMPTFKFNDWSEFWRICR
LQLFGCQELRSLPDGLKKITDLEELAIINCNKLEALPIWLEQSSLNSLCVSGCSALSFIPEGLKVKGRLR
NLIVEACSKLQNLKHLTDEWNPF


>XP_042433065.1 disease resistance protein RPS2-like [Zingiber officinale]
MDDVSRASNDTIFHRARQLKAERSKRGGRKAKKWFCKIVPSIEGCAKPPDADPPMSFLDGPSRQQQQQQQ
QKKRSSRGGCSCCCLSSCLCGGKADERTPRTSKKQIPAAEIRLREAGAVFDELPTRNTRDAVNVVVNEVV
TARRSEPADHVFDALSPKKPVEENTNLAERLPPPSKGHVSAASMVLPERLPPGPARDLPVPNPIVGQEVY
LKTALSYLTDDAIGIMGIYGTGGVGKTTLLRSINNKFCGNAARTEFDHVILVAVGKDPDVKKLQRDIAYE
VGLLLMDDESEVTRAAAIFDFLKTKNFLLLLDDLWGPLQLAKVGIPHPLSDGYKQKVIISSRLMDVSGKM
QAHKFLILECLKWEEAWNLFSSKVGEENLADQRIRSIAVALAKECGGLPLALVAMGSAMSAKKTLEEWQK
AVSLLKTAPPLHEISGYQMLKENLISTWMGLGSITDFDDINEAYNIGNSIIESLKAVSLMENSEKSYRRM
EMHDVIREMALWTASGKESSKNKWLVGAKPSETRSDEWSKAERISLMFNEIEALPDSCYCPNLQSLILRG
NKRLMKIPNGLFPCMVLLRFLDLSHTGIVELPNEVGTLINLQFLNLSYTKIACLPKEMKELTTLKYLELE
GTRELRKIPDGVISSLEMLQELNLYMSGFANWSWLSVCSRDNIMFEELVSLQRLRSVGFTVRNIQCLLRL
FSILRVLTHSLTIRELRGLISLHLLPGLLSKNKMGRLKNLTIEFSQGLKELVMGEEAKPLNWRLYQLEVF
NLVCLPELERVIWRGVAAHVCLPNLRFLSLFYCNSLRNIAWVAHLPLLQELYIQNCNEMEQVIADEPPTA
SSEKEEKPATSFPNLKYIFLRDLKSLVKIDDQVLEFPCLERILVHNCIELKQLPLGATSAQKLRIIFGER
NWWESLEWGDHCIKSIFTTCFREIPAGYEPSMKILEGL


>XP_042433067.1 probable disease resistance protein At5g63020 isoform X1 [Zingiber officinale]
MGFLCKFWCSWTPMILFSAAPWDCAILRHQDIVGLPLCFIYGWSLQFLWLLPHPSGFLDSLAVEIHELKS
KRDDIERDVSRARRVGKEPRSQVLWWLDRVELLETKFAKTRREFERRFMLPGGFAVNILSSYRLSVRANE
MIAEACYLKSKGSFNQVANRAAPNHFEEVPSAPTVGMDAVLAQLKQAVEDDAVGLIGIYGMGGVGKTALL
SRFHNEFLADATDLDMVIFIDSCRDLDVESIQNKIRHRLGLSWKKSKSQKEKASMLYKVLFKMKFVLILD
DLWEPLSLQMVGIPIPKQGSSCKIMLATRIEELCDQMDVKNKIKVDLLPWDTAWRLFADKVGEETINSDP
GIRHQAEILVKKCGGLPVALITVARALASKRSVDEWKHAVTIMGNSPVQLPGMVEQVFCSLKLSYDHLPS
DTLRSCAMHFALYWEGCRLHKNLIQEYWIGEGILDDFKDVEQANNKACYFLGILSSASLIERVDADGYTR
MHPMVRAMALWIACEFGKKENQWFVREREGLMEAPEAETWRGAARMALGYNSITVLPEAPESLNLVSLKL
KSNFGLERIPDGFFRFMPCLVALDLHSTPIKEIPSGISNLQRLQFLELGGTKLKSLPKELASLKNLKYLG
LNWTAELASIPERLIQSLSELRVLRMIVSYSSWKAIPAGGGNGVSLRELEALKRLRVLDITVGNAPAFNM
LTQSQRLAPATAALLLKGCPGLTAVELPSGLGRSLKSLKWLRVSHSTELEEVLIAGDGRESDDAVLPELE
NLVLECLLKAKIVWRSSCIQHLRGLYIYGCSGMEQLIWYKDDDDSDAENRGRRGVSPFPNLKQIAFRGLP
KLKRVSDERQLVFPLLESIEVAECPQLKKLNLVAEKLREIRCHRSWWDQLEWEDDAARFSPQMILKPLN


>XP_042433069.1 probable disease resistance protein At5g63020 isoform X2 [Zingiber officinale]
MDINGFLVQVLVFLDTNDTVFCCSVGLCNPSPPGFLDSLAVEIHELKSKRDDIERDVSRARRVGKEPRSQ
VLWWLDRVELLETKFAKTRREFERRFMLPGGFAVNILSSYRLSVRANEMIAEACYLKSKGSFNQVANRAA
PNHFEEVPSAPTVGMDAVLAQLKQAVEDDAVGLIGIYGMGGVGKTALLSRFHNEFLADATDLDMVIFIDS
CRDLDVESIQNKIRHRLGLSWKKSKSQKEKASMLYKVLFKMKFVLILDDLWEPLSLQMVGIPIPKQGSSC
KIMLATRIEELCDQMDVKNKIKVDLLPWDTAWRLFADKVGEETINSDPGIRHQAEILVKKCGGLPVALIT
VARALASKRSVDEWKHAVTIMGNSPVQLPGMVEQVFCSLKLSYDHLPSDTLRSCAMHFALYWEGCRLHKN
LIQEYWIGEGILDDFKDVEQANNKACYFLGILSSASLIERVDADGYTRMHPMVRAMALWIACEFGKKENQ
WFVREREGLMEAPEAETWRGAARMALGYNSITVLPEAPESLNLVSLKLKSNFGLERIPDGFFRFMPCLVA
LDLHSTPIKEIPSGISNLQRLQFLELGGTKLKSLPKELASLKNLKYLGLNWTAELASIPERLIQSLSELR
VLRMIVSYSSWKAIPAGGGNGVSLRELEALKRLRVLDITVGNAPAFNMLTQSQRLAPATAALLLKGCPGL
TAVELPSGLGRSLKSLKWLRVSHSTELEEVLIAGDGRESDDAVLPELENLVLECLLKAKIVWRSSCIQHL
RGLYIYGCSGMEQLIWYKDDDDSDAENRGRRGVSPFPNLKQIAFRGLPKLKRVSDERQLVFPLLESIEVA
ECPQLKKLNLVAEKLREIRCHRSWWDQLEWEDDAARFSPQMILKPLN


>XP_042433072.1 putative disease resistance protein RGA1 [Zingiber officinale]
MIGRFALTAFGWLAESIVSALVGKAVNHAVQQFGEQHGVEDDLKKLKDSLANARLKISTIENLWLKDEFL
QQRVKDLLIDLKNAAYDADDLLDEFQYRILKQQIEQQGDEAGKRASSSSYSAPPPSKRTKTSIASYTSDL
FRKGDDDDDDNVQKIRKIKGSLDDYSAALEEIYSSLGAEDDRGNKQLVSPASRQTSSFSTEPQLFGRDKE
LQELKDLLFKPAVASEFGQSGVSVLSIYGMGGIGKTTLAQEVFNHSSVKKYFKLRIWVCVSENFCTDRLT
REIIECATTEKCDLTNLDTLQKIVNEKITPERFLLVLDDVWNEDRHKWESLCAPLRSGKPGSKILVTTRS
RKIAKMVGDVDVIHLQGLDEESFWEFFKKCAFGCSNSGFHHPHMEAMAKKMTCKLKGLPLAAKTLGGLLS
MKLDEQYWESILDSEIWQLPQEENGIMPVLQLSYQHLPPHLKQCFAFCSLFPKDYRFYESDLIGIWIAEG
FIVTQGSTRMEELGSNYFHELVNRSFIQESKSGGFIMHDLIHDLAELISVGESYRIEKGKFHDIPSTIRH
LSIYTNEEGIETRLLTEFSHCDKLRTMMLIVEKFSWKNFNFDCGVLEKLKNIHVLVLKNCSLKELPDSID
KLIHLRYLDLSQNDFRRLPESLCDLYNLQTLKLDCCSNLEGLPHGMTKLINLRNIYAVVNFIHKIAEIGK
LTSLQNLYAFKVTKDNGHKLVELKGLNQLRGFLCITNLENVENKDEANIASLKSKEHLDELVLEWTSLQE
SDSDVNLHMSEHVLEGLQPHHNLQSLIIRGYNGARPPNWLHEQVYSRLKALKLENCKRWNDLSAIGQLSQ
LKHLFLVRISVQTKNIHKLFDPKVCQFFSQLEKLVLEGITMLEDLPNLGQLPCLTSICIENLPGVKMIGE
KFFATTEEGSCFPRLCTLRFIEMPAWEVFYGSDDRNLFPCLEDLYISNCQKLKMLPPLPPSIQCVKLNNV
GLVDCPRYWKAIDECSSTTNSVSLKDLAIWNCPNLTSLERGLLPHHLLQIHIKKCEQLLWVPVKRLKELA
SLRSLSIKKCPKLMSMTPDKYIDFQLPPSITYLRLSDCGNLSKSLPDLLHNLLTPLLISKCPNPVSLPLE
PWLRVIDLEIEKTTNNLQFLRIKGCPNLLLELTDNLAGLELEINDTALMKQPLIKKLLSSVGKLIISSSC
EAVMFEGEDQESLQSLTSLQTLCFSDCENLQSLPTKLYTLTSLENLWISNCPQIQSLPEWLPPSLEDLEF
EDCDLALEQRHLAEIKKFRLIPLSLREEEEDDDEDKEEEEEEEEEVEDEEEEAGVDAI


>XP_042433073.1 putative disease resistance protein RGA1 [Zingiber officinale]
MIGRFALTAFGWLAESIVSALVGKAVNHAVQQFGEQHGVEDDLKKLKDSLANARLKISTIENLWLKDEFL
QQRVKDLLIDLKNAAYDADDLLDEFQYRILKQQIEQQGDEAGKRASSSSYSAPPPSKRTKTSIASYTSDL
FRKGDDDDDDNVQKIRKIKGSLDDYSAALEEIYSSLGAEDDRGNKQLVSPASRQTSSFSTEPQLFGRDKE
LQELKDLLFKPAVASEFGQSGVSVLSIYGMGGIGKTTLAQEVFNHSSVKKYFKLRIWVCVSENFCTDRLT
REIIECATTEKCDLTNLDTLQKIVNEKITPERFLLVLDDVWNEDRHKWESLCAPLRSGKPGSKILVTTRS
RKIAKMVGDVDVIHLQGLDEESFWEFFKKCAFGCSNSGFHHPHMEAMAKKMTCKLKGLPLAAKTLGGLLS
MKLDEQYWESILDSEIWQLPQEENGIMPVLQLSYQHLPPHLKQCFAFCSLFPKDYRFYESDLIGIWIAEG
FIVTQGSTRMEELGSNYFHELVNRSFIQESKSGGFIMHDLIHDLAELISVGESYRIEKGKFHDIPSTIRH
LSIYTNEEGIETRLLTEFSHCDKLRTMMLIVEKFSWKNFNFDCGVLEKLKNIHVLVLKNCSLKELPDSID
KLIHLRYLDLSQNDFRRLPESLCDLYNLQTLKLDCCSNLEGLPHGMTKLINLRNIYAVVNFIHKIAEIGK
LTSLQNLYAFKVTKDNGHKLVELKGLNQLRGFLCITNLENVENKDEANIASLKSKEHLDELVLEWTSLQE
SDSDVNLHMSEHVLEGLQPHHNLQSLIIRGYNGARPPNWLHEQVYSRLKALKLENCKRWNDLSAIGQLSQ
LKHLFLVRISVQTKNIHKLFDPKVCQFFSQLEKLVLEGITMLEDLPNLGQLPCLTSICIENLPGVKMIGE
KFFATTEEGSCFPRLCTLRFIEMPAWEVFYGSDDRNLFPCLEDLYISNCQKLKMLPPLPPSIQCVKLNNV
GLVDCPRYWKAIDECSSTTNSVSLKDLAIWNCPNLTSLERGLLPHHLLQIHIKKCEQLLWVPVKRLKELA
SLRSLSIKKCPKLMSMTPDKYIDFQLPPSITYLRLSDCGNLSKSLPDLLHNLLTPLLISKCPNPVSLPLE
PWLRVIDLEIEKTTNNLQFLRIKGCPNLLLELTDNLAGLELEINDTALMKQPLIKKLLSSVGKLIISSSC
EAVMFEGEDQESLQSLTSLQTLCFSDCENLQSLPTKLYTLTSLENLWISNCPQIQSLPEWLPPSLEDLEF
EDCDLALEQRHLAEIKKFRLIPLSLREEEEDDDEDKEEEEEEEEEVEDEEEEAGVDAI


>XP_042434297.1 putative disease resistance protein RGA1 isoform X1 [Zingiber officinale]
MIGRFALTAFGWLAESIVGALVGKAVNHAVQQFGEQHGVEDDLKKLKDSLANARLKISTIENLWLKDEFL
QQRVKDLLIDLKNAAYDADDLLDEFQYRILKQQIEQQGDEAGKRASSSSYSAPPPSKRTKTSIASCTSGL
FRKGDDDDDNNNVQKIRKIKGSLDDYSAALEEIYSSLAAEDDRGNKQLVSPASRQTSSFSTEPQLFGRDK
ELQELKDLLFKPAVASEFGQSGVSVLSIYGMGGIGKTTLAQEVFNDSSVKEYFKLRIWVCVSENFCTDRL
TREIIECATTEKCDLTNLDTLQKIVNEKITPERFLLVLDDVWNEDRHKWESLCAPLRSGKPGSKILVTTR
SRKIADMVSDADAIHLQGLDVESFWDFFKKCAFGCSHSGAHHPHMEAMAKKMTCKLKGLPLAAKTLGGLL
SVKLDEQYWESILDSEIWQLPQEENGIMPVLQLSYQHLPPHLKQCFAFCSLFPKDYKFSESELIGIWMAE
GFIVPQGSTRMEELGSNYFHELVNRSFIQGSKRIGFIMHDLIHDLAEFISVGESYRIEKGKFHDIPSTIR
HLSIYKDEEGIGTRLLTEFSHCNKLRTLLLRGFTSMSFNFDCSVLERFKNIHVLVLQNCSLKELPDSIGK
LIHLRYLDLSKNNFQRLPESLCDLYNLQTLKLYYCSNLEGLPHGMTKLINLRKLDGAGRFIPKITEVGKL
TSLQNLYDFKVTKYNGHKLPELNGLKQLRGKLRITNLENVENKDEANIASLKSKEHLDELVLEWTSMQES
DSDINLHISEQVLEGLQPHHNLQRLTIRGYNGARPPNWLHKQVYSRLESLHLENCKRWNDLSAIGQLSQL
KSLSLVRTPVQTKNTHKLFDPKVCKFFSQLENLVLEGITMLEDLPNLGQLPCLTYICIQSLLGVKKIGDK
FFAMTEEGRCFPRLRTLRFTEMPAWEEFYGSDDRNLFPCLEDFDISNCQKLQMLPPLPPSLQQLKLNNVG
LVYCPRFWKAFDECSSTTTSVSLTYLSIQNCPNLTSLDQVLLPHHLFPCLKDLYISNCQKLQMLPPLPPS
IQVLQLNNVGLVDCPRFWKAFDEGSSTTNSASLTYLSIQNCPNLTSLDQVLLPHHLFPCLVDLDISNCQK
LQMLPPLPPSIQVLQLNNVGLVDCPRFWKAFDEGSSTTNSASLTYLSIQNCPNLTSLEPGLLSHHLKAID
LKKCERLSWVSVKRLKELASLCSLSIKECPKLMGMTPDEYIDFQLPPSIEKLCLSDCGNLSKSLPGCLHN
LTSLTFLSISKCPTLVALPVEPSLRLTCLEIQNCNELRSVEELPIKNVDVLQMRGCPKLLLPQTKKLPLW
KLEIDDTAFMKQPIIKNSLSSVSELTISSSREAAMFEGEDQKSLQSLTSLHFFCFSDCKNLQSLPAKLYT
LKSLRFLGIYNCPQIQSLPEKGLPPSLTDLEFKGCDPALEQQLVRHLTEIKKSWLIPHH


>XP_042434298.1 putative disease resistance protein RGA1 isoform X1 [Zingiber officinale]
MIGRFALTAFGWLAESIVGALVGKAVNHAVQQFGEQHGVEDDLKKLKDSLANARLKISTIENLWLKDEFL
QQRVKDLLIDLKNAAYDADDLLDEFQYRILKQQIEQQGDEAGKRASSSSYSAPPPSKRTKTSIASCTSGL
FRKGDDDDDNNNVQKIRKIKGSLDDYSAALEEIYSSLAAEDDRGNKQLVSPASRQTSSFSTEPQLFGRDK
ELQELKDLLFKPAVASEFGQSGVSVLSIYGMGGIGKTTLAQEVFNDSSVKEYFKLRIWVCVSENFCTDRL
TREIIECATTEKCDLTNLDTLQKIVNEKITPERFLLVLDDVWNEDRHKWESLCAPLRSGKPGSKILVTTR
SRKIADMVSDADAIHLQGLDVESFWDFFKKCAFGCSHSGAHHPHMEAMAKKMTCKLKGLPLAAKTLGGLL
SVKLDEQYWESILDSEIWQLPQEENGIMPVLQLSYQHLPPHLKQCFAFCSLFPKDYKFSESELIGIWMAE
GFIVPQGSTRMEELGSNYFHELVNRSFIQGSKRIGFIMHDLIHDLAEFISVGESYRIEKGKFHDIPSTIR
HLSIYKDEEGIGTRLLTEFSHCNKLRTLLLRGFTSMSFNFDCSVLERFKNIHVLVLQNCSLKELPDSIGK
LIHLRYLDLSKNNFQRLPESLCDLYNLQTLKLYYCSNLEGLPHGMTKLINLRKLDGAGRFIPKITEVGKL
TSLQNLYDFKVTKYNGHKLPELNGLKQLRGKLRITNLENVENKDEANIASLKSKEHLDELVLEWTSMQES
DSDINLHISEQVLEGLQPHHNLQRLTIRGYNGARPPNWLHKQVYSRLESLHLENCKRWNDLSAIGQLSQL
KSLSLVRTPVQTKNTHKLFDPKVCKFFSQLENLVLEGITMLEDLPNLGQLPCLTYICIQSLLGVKKIGDK
FFAMTEEGRCFPRLRTLRFTEMPAWEEFYGSDDRNLFPCLEDFDISNCQKLQMLPPLPPSLQQLKLNNVG
LVYCPRFWKAFDECSSTTTSVSLTYLSIQNCPNLTSLDQVLLPHHLFPCLKDLYISNCQKLQMLPPLPPS
IQVLQLNNVGLVDCPRFWKAFDEGSSTTNSASLTYLSIQNCPNLTSLDQVLLPHHLFPCLVDLDISNCQK
LQMLPPLPPSIQVLQLNNVGLVDCPRFWKAFDEGSSTTNSASLTYLSIQNCPNLTSLEPGLLSHHLKAID
LKKCERLSWVSVKRLKELASLCSLSIKECPKLMGMTPDEYIDFQLPPSIEKLCLSDCGNLSKSLPGCLHN
LTSLTFLSISKCPTLVALPVEPSLRLTCLEIQNCNELRSVEELPIKNVDVLQMRGCPKLLLPQTKKLPLW
KLEIDDTAFMKQPIIKNSLSSVSELTISSSREAAMFEGEDQKSLQSLTSLHFFCFSDCKNLQSLPAKLYT
LKSLRFLGIYNCPQIQSLPEKGLPPSLTDLEFKGCDPALEQQLVRHLTEIKKSWLIPHH


>XP_042434299.1 putative disease resistance protein RGA1 isoform X1 [Zingiber officinale]
MIGRFALTAFGWLAESIVGALVGKAVNHAVQQFGEQHGVEDDLKKLKDSLANARLKISTIENLWLKDEFL
QQRVKDLLIDLKNAAYDADDLLDEFQYRILKQQIEQQGDEAGKRASSSSYSAPPPSKRTKTSIASCTSGL
FRKGDDDDDNNNVQKIRKIKGSLDDYSAALEEIYSSLAAEDDRGNKQLVSPASRQTSSFSTEPQLFGRDK
ELQELKDLLFKPAVASEFGQSGVSVLSIYGMGGIGKTTLAQEVFNDSSVKEYFKLRIWVCVSENFCTDRL
TREIIECATTEKCDLTNLDTLQKIVNEKITPERFLLVLDDVWNEDRHKWESLCAPLRSGKPGSKILVTTR
SRKIADMVSDADAIHLQGLDVESFWDFFKKCAFGCSHSGAHHPHMEAMAKKMTCKLKGLPLAAKTLGGLL
SVKLDEQYWESILDSEIWQLPQEENGIMPVLQLSYQHLPPHLKQCFAFCSLFPKDYKFSESELIGIWMAE
GFIVPQGSTRMEELGSNYFHELVNRSFIQGSKRIGFIMHDLIHDLAEFISVGESYRIEKGKFHDIPSTIR
HLSIYKDEEGIGTRLLTEFSHCNKLRTLLLRGFTSMSFNFDCSVLERFKNIHVLVLQNCSLKELPDSIGK
LIHLRYLDLSKNNFQRLPESLCDLYNLQTLKLYYCSNLEGLPHGMTKLINLRKLDGAGRFIPKITEVGKL
TSLQNLYDFKVTKYNGHKLPELNGLKQLRGKLRITNLENVENKDEANIASLKSKEHLDELVLEWTSMQES
DSDINLHISEQVLEGLQPHHNLQRLTIRGYNGARPPNWLHKQVYSRLESLHLENCKRWNDLSAIGQLSQL
KSLSLVRTPVQTKNTHKLFDPKVCKFFSQLENLVLEGITMLEDLPNLGQLPCLTYICIQSLLGVKKIGDK
FFAMTEEGRCFPRLRTLRFTEMPAWEEFYGSDDRNLFPCLEDFDISNCQKLQMLPPLPPSLQQLKLNNVG
LVYCPRFWKAFDECSSTTTSVSLTYLSIQNCPNLTSLDQVLLPHHLFPCLKDLYISNCQKLQMLPPLPPS
IQVLQLNNVGLVDCPRFWKAFDEGSSTTNSASLTYLSIQNCPNLTSLDQVLLPHHLFPCLVDLDISNCQK
LQMLPPLPPSIQVLQLNNVGLVDCPRFWKAFDEGSSTTNSASLTYLSIQNCPNLTSLEPGLLSHHLKAID
LKKCERLSWVSVKRLKELASLCSLSIKECPKLMGMTPDEYIDFQLPPSIEKLCLSDCGNLSKSLPGCLHN
LTSLTFLSISKCPTLVALPVEPSLRLTCLEIQNCNELRSVEELPIKNVDVLQMRGCPKLLLPQTKKLPLW
KLEIDDTAFMKQPIIKNSLSSVSELTISSSREAAMFEGEDQKSLQSLTSLHFFCFSDCKNLQSLPAKLYT
LKSLRFLGIYNCPQIQSLPEKGLPPSLTDLEFKGCDPALEQQLVRHLTEIKKSWLIPHH


>XP_042434300.1 putative disease resistance protein RGA3 isoform X2 [Zingiber officinale]
MIGRFALTAFGWLAESIVGALVGKAVNHAVQQFGEQHGVEDDLKKLKDSLANARLKISTIENLWLKDEFL
QQRVKDLLIDLKNAAYDADDLLDEFQYRILKQQIEQQGDEAGKRASSSSYSAPPPSKRTKTSIASCTSGL
FRKGDDDDDNNNVQKIRKIKGSLDDYSAALEEIYSSLAAEDDRGNKQLVSPASRQTSSFSTEPQLFGRDK
ELQELKDLLFKPAVASEFGQSGVSVLSIYGMGGIGKTTLAQEVFNDSSVKEYFKLRIWVCVSENFCTDRL
TREIIECATTEKCDLTNLDTLQKIVNEKITPERFLLVLDDVWNEDRHKWESLCAPLRSGKPGSKILVTTR
SRKIADMVSDADAIHLQGLDVESFWDFFKKCAFGCSHSGAHHPHMEAMAKKMTCKLKGLPLAAKTLGGLL
SVKLDEQYWESILDSEIWQLPQEENGIMPVLQLSYQHLPPHLKQCFAFCSLFPKDYKFSESELIGIWMAE
GFIVPQGSTRMEELGSNYFHELVNRSFIQGSKRIGFIMHDLIHDLAEFISVGESYRIEKGKFHDIPSTIR
HLSIYKDEEELFFERTT


>XP_042434515.1 disease resistance protein RPS2-like [Zingiber officinale]
MDPIAPAATLITKLWDPIALKLAFIVEAGDNVRSLLLSMNRLKDKSIDVANRVSAAKAQLLTPIQEVLGW
LRRVEELEAEVSAIEQDFLNQPTCFCSCHYDLSSSYRIGREAKRKASEAAEMQARSFDVVATDDSAPAVA
LDLPTPPDVGVESPLENAFQYLFDDQRCVIGVHGMGGVGKTTLLRRINNSFVGRSDFDLVIMVEASLDFK
IEQLQQAIADRVGLPLSQNGTSKSWAIEIKRSLNRKKFLLLLDNIWDPINLTDAGIPTGPSKCKIVISSR
FESTCAQMGAEKKIKMECLTPDKAWELFRQNLSGDLLNDPEIEDLAKQVAEDCNGLPLALVVVAATMSTR
TTREEWQYAVRQMRKMHLESLVPLEANLIPTLKLSYDNLPNDQLKLCFLSCSFYPRGHSILKEELIESWM
GLGFLEEHNDINEIYQKGHFLIGKLREASLVVPGDDERRVKVHDIICALALHISSVGLTPRTEKASSSSS
RSDPEKIWAVDAGTGLTDIRADYLEGSSIERLSLMHNNIDTLPEKTDFPELLSLMLQCNDSLPRVFPRGF
FKGMGRLQYLDLSNTTVEDIHGIGQLLCLEHLNLSGTPISKLPQEIRFLTRLKYLYLINTYSLEIIFAKS
FSGLHNLRVFNAYGSSFRFWATDGAADVDRASLSELNELINLKALGISVGTQSTFQKLFDMSIPIRYLYI
SDPDTAPIDISFNQLRLPSNTLRSRSKIDTSLLEMTIKNCQDLEVVTIGEDRKGAPENVDGGFCRLCTFK
GLEKLHLLHLGKLSNITWNGVKPCEYFPRLRLLRIVGCDKLRSITWTKQLPDLVNLYISGCAEVQQIIAE
EDEDVEQEGREVFPRLKEFVLRDLPKLTSIYQRTLPFPNLVSLQVFRCPKLASLPFGEGSACRLQEIHGG
KEWWGNLKWANRASFDRHFKQAAS


>XP_042434517.1 putative disease resistance protein RGA1 isoform X1 [Zingiber officinale]
MIGRFALTAFGWLAESIMGALVGKAVDRAVQQFGEQHGFEDDLEKLQDSLDHARLTISTIERLRIKDEGQ
QKTLRKLLIRLKNSAYDADDLLDEFQYRILKQQIEQQGDEAGNRASSSSYSTPPPSKRTKTSFSSISTSG
IFRKGDDDDDVQRIRKIKGRLDDNSAALEKIYNSLGAEDDRGEKQLVSSASRQTSSFSTEPRLVGRDKEL
QELKDLLLKPEVASEFGQSGVSVLSICGLGGIGKTTLAQEVFNDSSVKEYFKLRIWVCVSENFCTDRLIR
EIIECATTEKCDLTNLDTLQRIVNEKITPERFLLVLDDVWNEDRHKWEILCAPLRSGKPGSKILVTTRSR
KIADMVSDVDAIHLQGLDEESFWDFFKKCAFGCSHSGAHHPHMEAMAKKMTCKLKGLPLAAKTLGGLLSM
KLDEQYWESILDSEIWQLPQEENGIMPVLQLSYQHLPPHLKQCFAFCSLFPKDYKFSESELIGIWMAEGF
IVPQGSTRMEELGSNYFHELVNRSFIQESKSGRFIMHDLIHDLAELISAGESYRIEKGKSHDIPSTIRHL
SIYTDKEGMQTILTEFSHWNKLRTMMLTVERFPREDFNFVCGVLEKLKNIHVLVLKNCSLRELPDGIDKL
IHLRYLDLSNNKGIQRLPELLCDLYNLQTLILRFCDNLKSLPHGMMKLINLRKLYGVDRLISGITEIGKL
TSLQNLYSFKVTKDNGHKLPELNGLKQLRGKLRITNLENVENKDEANIASLKSKEHLNELVLEWTSIQES
DSDINLHISEQVLEGLQPHHNLQRLTIRGYNGARPPNWLHKQVYSRLESLHLENCKRWNDLSAIGQLSQL
KSLSLVRTPVQTKNIHKLFDPKVCKFFSQLENLVLEGITMLEDLPNLGQLPCLTYIRIQSLLGVKKIDDK
FFAMTEEGSCFPRLCTLQFTEMPAWEELYGSDDRNLFPCLEGLYISNCQKLQMLPPLPPSIQQLKLNNVG
LVDCPRFWKAFDECSSTTTSVSLTYLSIQNCPNLTSLDQGLLPHHLFPCLVDLDISNCQKLQMLPPLPPS
IQQLKLNNVGLVDCPRFWKAFDEGSSTTNSASLTYLSIQNCPNLTSLDQGLLPHHLFPCLEHLDISNCQK
LQMLPPLPPSIQSLDLNDVGLVDCPRFWKAIDECSSTTNYASLRYLFIQNCPNLTSLEPGLLPHHLQHIY
IAKCEQLSWVSVKRLKELASLCSLSIKECPKLMSMTRDEYIDFQLPPSIKELCLSDCENLFKSLPGCLHN
LTSLTSLSISKCPNLVSLPVEPSLRLIHPEIQDCNELRSVEGLPIKNLKVLKIKGCPKLLLPQTEKLPLW
KLEIDDTAFLKQPLIKNSLSSVCELTISSSREAVMFEGEDQESLQSLTSLHLFCFSDCKNLQSLPAKLYT
LKSLRFLWIYNCPQIQSLPEKGLPPSLTDLEFKGCDPALEQQLVRHLAEINKSWLIPSSLRHLWWSDN


>XP_042434518.1 putative disease resistance protein RGA1 isoform X1 [Zingiber officinale]
MIGRFALTAFGWLAESIMGALVGKAVDRAVQQFGEQHGFEDDLEKLQDSLDHARLTISTIERLRIKDEGQ
QKTLRKLLIRLKNSAYDADDLLDEFQYRILKQQIEQQGDEAGNRASSSSYSTPPPSKRTKTSFSSISTSG
IFRKGDDDDDVQRIRKIKGRLDDNSAALEKIYNSLGAEDDRGEKQLVSSASRQTSSFSTEPRLVGRDKEL
QELKDLLLKPEVASEFGQSGVSVLSICGLGGIGKTTLAQEVFNDSSVKEYFKLRIWVCVSENFCTDRLIR
EIIECATTEKCDLTNLDTLQRIVNEKITPERFLLVLDDVWNEDRHKWEILCAPLRSGKPGSKILVTTRSR
KIADMVSDVDAIHLQGLDEESFWDFFKKCAFGCSHSGAHHPHMEAMAKKMTCKLKGLPLAAKTLGGLLSM
KLDEQYWESILDSEIWQLPQEENGIMPVLQLSYQHLPPHLKQCFAFCSLFPKDYKFSESELIGIWMAEGF
IVPQGSTRMEELGSNYFHELVNRSFIQESKSGRFIMHDLIHDLAELISAGESYRIEKGKSHDIPSTIRHL
SIYTDKEGMQTILTEFSHWNKLRTMMLTVERFPREDFNFVCGVLEKLKNIHVLVLKNCSLRELPDGIDKL
IHLRYLDLSNNKGIQRLPELLCDLYNLQTLILRFCDNLKSLPHGMMKLINLRKLYGVDRLISGITEIGKL
TSLQNLYSFKVTKDNGHKLPELNGLKQLRGKLRITNLENVENKDEANIASLKSKEHLNELVLEWTSIQES
DSDINLHISEQVLEGLQPHHNLQRLTIRGYNGARPPNWLHKQVYSRLESLHLENCKRWNDLSAIGQLSQL
KSLSLVRTPVQTKNIHKLFDPKVCKFFSQLENLVLEGITMLEDLPNLGQLPCLTYIRIQSLLGVKKIDDK
FFAMTEEGSCFPRLCTLQFTEMPAWEELYGSDDRNLFPCLEGLYISNCQKLQMLPPLPPSIQQLKLNNVG
LVDCPRFWKAFDECSSTTTSVSLTYLSIQNCPNLTSLDQGLLPHHLFPCLVDLDISNCQKLQMLPPLPPS
IQQLKLNNVGLVDCPRFWKAFDEGSSTTNSASLTYLSIQNCPNLTSLDQGLLPHHLFPCLEHLDISNCQK
LQMLPPLPPSIQSLDLNDVGLVDCPRFWKAIDECSSTTNYASLRYLFIQNCPNLTSLEPGLLPHHLQHIY
IAKCEQLSWVSVKRLKELASLCSLSIKECPKLMSMTRDEYIDFQLPPSIKELCLSDCENLFKSLPGCLHN
LTSLTSLSISKCPNLVSLPVEPSLRLIHPEIQDCNELRSVEGLPIKNLKVLKIKGCPKLLLPQTEKLPLW
KLEIDDTAFLKQPLIKNSLSSVCELTISSSREAVMFEGEDQESLQSLTSLHLFCFSDCKNLQSLPAKLYT
LKSLRFLWIYNCPQIQSLPEKGLPPSLTDLEFKGCDPALEQQLVRHLAEINKSWLIPSSLRHLWWSDN


>XP_042434519.1 putative disease resistance protein RGA1 isoform X1 [Zingiber officinale]
MIGRFALTAFGWLAESIMGALVGKAVDRAVQQFGEQHGFEDDLEKLQDSLDHARLTISTIERLRIKDEGQ
QKTLRKLLIRLKNSAYDADDLLDEFQYRILKQQIEQQGDEAGNRASSSSYSTPPPSKRTKTSFSSISTSG
IFRKGDDDDDVQRIRKIKGRLDDNSAALEKIYNSLGAEDDRGEKQLVSSASRQTSSFSTEPRLVGRDKEL
QELKDLLLKPEVASEFGQSGVSVLSICGLGGIGKTTLAQEVFNDSSVKEYFKLRIWVCVSENFCTDRLIR
EIIECATTEKCDLTNLDTLQRIVNEKITPERFLLVLDDVWNEDRHKWEILCAPLRSGKPGSKILVTTRSR
KIADMVSDVDAIHLQGLDEESFWDFFKKCAFGCSHSGAHHPHMEAMAKKMTCKLKGLPLAAKTLGGLLSM
KLDEQYWESILDSEIWQLPQEENGIMPVLQLSYQHLPPHLKQCFAFCSLFPKDYKFSESELIGIWMAEGF
IVPQGSTRMEELGSNYFHELVNRSFIQESKSGRFIMHDLIHDLAELISAGESYRIEKGKSHDIPSTIRHL
SIYTDKEGMQTILTEFSHWNKLRTMMLTVERFPREDFNFVCGVLEKLKNIHVLVLKNCSLRELPDGIDKL
IHLRYLDLSNNKGIQRLPELLCDLYNLQTLILRFCDNLKSLPHGMMKLINLRKLYGVDRLISGITEIGKL
TSLQNLYSFKVTKDNGHKLPELNGLKQLRGKLRITNLENVENKDEANIASLKSKEHLNELVLEWTSIQES
DSDINLHISEQVLEGLQPHHNLQRLTIRGYNGARPPNWLHKQVYSRLESLHLENCKRWNDLSAIGQLSQL
KSLSLVRTPVQTKNIHKLFDPKVCKFFSQLENLVLEGITMLEDLPNLGQLPCLTYIRIQSLLGVKKIDDK
FFAMTEEGSCFPRLCTLQFTEMPAWEELYGSDDRNLFPCLEGLYISNCQKLQMLPPLPPSIQQLKLNNVG
LVDCPRFWKAFDECSSTTTSVSLTYLSIQNCPNLTSLDQGLLPHHLFPCLVDLDISNCQKLQMLPPLPPS
IQQLKLNNVGLVDCPRFWKAFDEGSSTTNSASLTYLSIQNCPNLTSLDQGLLPHHLFPCLEHLDISNCQK
LQMLPPLPPSIQSLDLNDVGLVDCPRFWKAIDECSSTTNYASLRYLFIQNCPNLTSLEPGLLPHHLQHIY
IAKCEQLSWVSVKRLKELASLCSLSIKECPKLMSMTRDEYIDFQLPPSIKELCLSDCENLFKSLPGCLHN
LTSLTSLSISKCPNLVSLPVEPSLRLIHPEIQDCNELRSVEGLPIKNLKVLKIKGCPKLLLPQTEKLPLW
KLEIDDTAFLKQPLIKNSLSSVCELTISSSREAVMFEGEDQESLQSLTSLHLFCFSDCKNLQSLPAKLYT
LKSLRFLWIYNCPQIQSLPEKGLPPSLTDLEFKGCDPALEQQLVRHLAEINKSWLIPSSLRHLWWSDN


>XP_042434520.1 putative disease resistance protein RGA1 isoform X1 [Zingiber officinale]
MIGRFALTAFGWLAESIMGALVGKAVDRAVQQFGEQHGFEDDLEKLQDSLDHARLTISTIERLRIKDEGQ
QKTLRKLLIRLKNSAYDADDLLDEFQYRILKQQIEQQGDEAGNRASSSSYSTPPPSKRTKTSFSSISTSG
IFRKGDDDDDVQRIRKIKGRLDDNSAALEKIYNSLGAEDDRGEKQLVSSASRQTSSFSTEPRLVGRDKEL
QELKDLLLKPEVASEFGQSGVSVLSICGLGGIGKTTLAQEVFNDSSVKEYFKLRIWVCVSENFCTDRLIR
EIIECATTEKCDLTNLDTLQRIVNEKITPERFLLVLDDVWNEDRHKWEILCAPLRSGKPGSKILVTTRSR
KIADMVSDVDAIHLQGLDEESFWDFFKKCAFGCSHSGAHHPHMEAMAKKMTCKLKGLPLAAKTLGGLLSM
KLDEQYWESILDSEIWQLPQEENGIMPVLQLSYQHLPPHLKQCFAFCSLFPKDYKFSESELIGIWMAEGF
IVPQGSTRMEELGSNYFHELVNRSFIQESKSGRFIMHDLIHDLAELISAGESYRIEKGKSHDIPSTIRHL
SIYTDKEGMQTILTEFSHWNKLRTMMLTVERFPREDFNFVCGVLEKLKNIHVLVLKNCSLRELPDGIDKL
IHLRYLDLSNNKGIQRLPELLCDLYNLQTLILRFCDNLKSLPHGMMKLINLRKLYGVDRLISGITEIGKL
TSLQNLYSFKVTKDNGHKLPELNGLKQLRGKLRITNLENVENKDEANIASLKSKEHLNELVLEWTSIQES
DSDINLHISEQVLEGLQPHHNLQRLTIRGYNGARPPNWLHKQVYSRLESLHLENCKRWNDLSAIGQLSQL
KSLSLVRTPVQTKNIHKLFDPKVCKFFSQLENLVLEGITMLEDLPNLGQLPCLTYIRIQSLLGVKKIDDK
FFAMTEEGSCFPRLCTLQFTEMPAWEELYGSDDRNLFPCLEGLYISNCQKLQMLPPLPPSIQQLKLNNVG
LVDCPRFWKAFDECSSTTTSVSLTYLSIQNCPNLTSLDQGLLPHHLFPCLVDLDISNCQKLQMLPPLPPS
IQQLKLNNVGLVDCPRFWKAFDEGSSTTNSASLTYLSIQNCPNLTSLDQGLLPHHLFPCLEHLDISNCQK
LQMLPPLPPSIQSLDLNDVGLVDCPRFWKAIDECSSTTNYASLRYLFIQNCPNLTSLEPGLLPHHLQHIY
IAKCEQLSWVSVKRLKELASLCSLSIKECPKLMSMTRDEYIDFQLPPSIKELCLSDCENLFKSLPGCLHN
LTSLTSLSISKCPNLVSLPVEPSLRLIHPEIQDCNELRSVEGLPIKNLKVLKIKGCPKLLLPQTEKLPLW
KLEIDDTAFLKQPLIKNSLSSVCELTISSSREAVMFEGEDQESLQSLTSLHLFCFSDCKNLQSLPAKLYT
LKSLRFLWIYNCPQIQSLPEKGLPPSLTDLEFKGCDPALEQQLVRHLAEINKSWLIPSSLRHLWWSDN


>XP_042434521.1 putative disease resistance protein RGA1 isoform X1 [Zingiber officinale]
MIGRFALTAFGWLAESIMGALVGKAVDRAVQQFGEQHGFEDDLEKLQDSLDHARLTISTIERLRIKDEGQ
QKTLRKLLIRLKNSAYDADDLLDEFQYRILKQQIEQQGDEAGNRASSSSYSTPPPSKRTKTSFSSISTSG
IFRKGDDDDDVQRIRKIKGRLDDNSAALEKIYNSLGAEDDRGEKQLVSSASRQTSSFSTEPRLVGRDKEL
QELKDLLLKPEVASEFGQSGVSVLSICGLGGIGKTTLAQEVFNDSSVKEYFKLRIWVCVSENFCTDRLIR
EIIECATTEKCDLTNLDTLQRIVNEKITPERFLLVLDDVWNEDRHKWEILCAPLRSGKPGSKILVTTRSR
KIADMVSDVDAIHLQGLDEESFWDFFKKCAFGCSHSGAHHPHMEAMAKKMTCKLKGLPLAAKTLGGLLSM
KLDEQYWESILDSEIWQLPQEENGIMPVLQLSYQHLPPHLKQCFAFCSLFPKDYKFSESELIGIWMAEGF
IVPQGSTRMEELGSNYFHELVNRSFIQESKSGRFIMHDLIHDLAELISAGESYRIEKGKSHDIPSTIRHL
SIYTDKEGMQTILTEFSHWNKLRTMMLTVERFPREDFNFVCGVLEKLKNIHVLVLKNCSLRELPDGIDKL
IHLRYLDLSNNKGIQRLPELLCDLYNLQTLILRFCDNLKSLPHGMMKLINLRKLYGVDRLISGITEIGKL
TSLQNLYSFKVTKDNGHKLPELNGLKQLRGKLRITNLENVENKDEANIASLKSKEHLNELVLEWTSIQES
DSDINLHISEQVLEGLQPHHNLQRLTIRGYNGARPPNWLHKQVYSRLESLHLENCKRWNDLSAIGQLSQL
KSLSLVRTPVQTKNIHKLFDPKVCKFFSQLENLVLEGITMLEDLPNLGQLPCLTYIRIQSLLGVKKIDDK
FFAMTEEGSCFPRLCTLQFTEMPAWEELYGSDDRNLFPCLEGLYISNCQKLQMLPPLPPSIQQLKLNNVG
LVDCPRFWKAFDECSSTTTSVSLTYLSIQNCPNLTSLDQGLLPHHLFPCLVDLDISNCQKLQMLPPLPPS
IQQLKLNNVGLVDCPRFWKAFDEGSSTTNSASLTYLSIQNCPNLTSLDQGLLPHHLFPCLEHLDISNCQK
LQMLPPLPPSIQSLDLNDVGLVDCPRFWKAIDECSSTTNYASLRYLFIQNCPNLTSLEPGLLPHHLQHIY
IAKCEQLSWVSVKRLKELASLCSLSIKECPKLMSMTRDEYIDFQLPPSIKELCLSDCENLFKSLPGCLHN
LTSLTSLSISKCPNLVSLPVEPSLRLIHPEIQDCNELRSVEGLPIKNLKVLKIKGCPKLLLPQTEKLPLW
KLEIDDTAFLKQPLIKNSLSSVCELTISSSREAVMFEGEDQESLQSLTSLHLFCFSDCKNLQSLPAKLYT
LKSLRFLWIYNCPQIQSLPEKGLPPSLTDLEFKGCDPALEQQLVRHLAEINKSWLIPSSLRHLWWSDN


>XP_042434522.1 putative disease resistance protein RGA3 isoform X2 [Zingiber officinale]
MIGRFALTAFGWLAESIMGALVGKAVDRAVQQFGEQHGFEDDLEKLQDSLDHARLTISTIERLRIKDEGQ
QKTLRKLLIRLKNSAYDADDLLDEFQYRILKQQIEQQGDEAGNRASSSSYSTPPPSKRTKTSFSSISTSG
IFRKGDDDDDVQRIRKIKGRLDDNSAALEKIYNSLGAEDDRGEKQLVSSASRQTSSFSTEPRLVGRDKEL
QELKDLLLKPEVASEFGQSGVSVLSICGLGGIGKTTLAQEVFNDSSVKEYFKLRIWVCVSENFCTDRLIR
EIIECATTEKCDLTNLDTLQRIVNEKITPERFLLVLDDVWNEDRHKWEILCAPLRSGKPGSKILVTTRSR
KIADMVSDVDAIHLQGLDEESFWDFFKKCAFGCSHSGAHHPHMEAMAKKMTCKLKGLPLAAKTLGGLLSM
KLDEQYWESILDSEIWQLPQEENGIMPVLQLSYQHLPPHLKQCFAFCSLFPKDYKFSESELIGIWMAEGF
IVPQGSTRMEELGSNYFHELVNRSFIQESKSGRFIMHDLIHDLAELISAGESYRIEKGKSHDIPSTIRHL
SIYTDKEGMQTILTEFSHWNKLRTMMLTVERFPREDFNFVCGVLEKLKNIHVLVLKNCSLRELPDGIDKL
IHLRYLDLSNNKGIQRLPELLCDLYNLQTLILRFCDNLKSLPHGMMKLINLRKLYGVDRLISGITEIGKL
TSLQNLYSFKVTKDNGHKLPELNGLKQLRGKLRITNLENVENKDEANIASLKSKEHLNELVLEWTSIQES
DSDINLHISEQVLEGLQPHHNLQRLTIRGYNGARPPNWLHKQVYSRLESLHLENCKRWNDLSAIGQLSQL
KSLSLVRTPVQTKNIHKLFDPKVCKFFSQLENLVLEGITMLEDLPNLGQLPCLTYIRIQSLLGVKKIDDK
FFAMTEEGSCFPRLCTLQFTEMPAWEELYGSDDRNLFPCLEGLYISNCQKLQMLPPLPPSIQQLKLNNVG
LVDCPRFWKAIDECSSTTNYASLRYLFIQNCPNLTSLEPGLLPHHLQHIYIAKCEQLSWVSVKRLKELAS
LCSLSIKECPKLMSMTRDEYIDFQLPPSIKELCLSDCENLFKSLPGCLHNLTSLTSLSISKCPNLVSLPV
EPSLRLIHPEIQDCNELRSVEGLPIKNLKVLKIKGCPKLLLPQTEKLPLWKLEIDDTAFLKQPLIKNSLS
SVCELTISSSREAVMFEGEDQESLQSLTSLHLFCFSDCKNLQSLPAKLYTLKSLRFLWIYNCPQIQSLPE
KGLPPSLTDLEFKGCDPALEQQLVRHLAEINKSWLIPSSLRHLWWSDN


>XP_042436844.1 disease resistance protein RPS2-like [Zingiber officinale]
MYFSGISQALGCLKDCTSDSCNYVVSYEDNLSSLAGEVSQLKSKSEDVKREVEATMRQGLTTRNEVLGWL
RAVEGVAGEADQIRAKYERMIKCFCRFPANICTSVKLRRRAEAALASARELKQRDLPEVVHRHNLVRFIR
MQNQQTAGVEKAFEELRRHARDDGVTCIGIHGMGGVGKSALLREFNNYLENELEYLDIIIFLESSTEHKV
EELHKFLFARLNLTWQNGVSQMDRAANIFRVLSHLKFVLIVDNLWEPLDYRAVGIPFPEPESRCKIIVAS
RIEDVCSHMRMERMIRMERIEEEAAWELFRFNARLEPNDADERIIRIAKVMARKCGGLPAALVVVAQTMA
NKKTVQEWMHAVNLMRDAPFQLPGMEERVLYPLKLSYDRLLTDRDRLCASYFSLVPEGCLVDNYFIRKLW
IGEGIIDDFNNVWESANETHYLLGMLSSSSLIQRIDGKSYASEKPIESDRFKMHPMTRAMILWVGRACGK
KGSKWLAHYGDGLAEAPTAEKWRVAERVALGQNKIRALPEAPQAPDLIYLDLGYNDLLVKIPNGFFSRMP
KLKILDLQDNPIEDFPVGICNLALLQFLTLSGTKITSLPRELGALVNLRYLACSSTTRLKRIPDQLMSRL
QELRWLKMCDGYNQWRAAPSEEEEAYLEELEVLTKLKVLGIAISTETSLRRLFESQRLTTSVHWLQVEDC
RGLTRLDIPSTEFPQESMPNIMELRVHAMNELEEFAIQGTALANLMELHLSHLPKASLVCRAVGCLGSLR
TLRIENCKEIARLIQLDAGTNDGEEIAIFPALKRIVLKRLPKFESFSDESRTLTFSSLESIEIEECPKLT
RINLCCGKLKSVRSERAWWDELEWEDDLTKLSFENLFKPL


>XP_042436888.1 putative disease resistance protein RGA3 [Zingiber officinale]
MATISQLRHILMKILPAPEMVAQGKAFRISNHLEMIQDCLWAINSFLMDAALRVLTEHNVEEWMEDVGVV
DWMKDVGVAVEDVDSLLKRILDYWEPNEQDEAKKKKKMSNFFHPLVNINNNIQSTSSRQAILVELKETAC
LLNYLVKRGTALGLWAEMMDSMDPCHDDYAAILSKETMGRQEDEDQIIELLRQQHCDEDGNVPFIIDIRG
EEFSGRTTLARKIYHHPWVRQHFQHRIWLDASSFREFNSKMIAKEIARLLTGKACANINCWPLIIEHLRG
DRYLLILDDADVPNVFRYKWEEFKLNLLHCGAPGSRVILARHTFAGNPYGGYGIEFNVKKYKLKELPEDA
WVRILLRYATFAHSTEGNNNIHKEKASPSATTNMLIPLAKKCRLDHWHRDRNLLIAKGVGLMFRWKDRNE
WQELPDQLYRFEILHCYFLLVHQQYGSFENIRPSLYNLLLGESEAESFGEAESYGEDVLYMLIAEGILTN
TRLTRNIQYIGSEFNLDPCFFRMKVSEDSSIPPQCRHLYLPIHSKNVSKSKKAIEKAGVANKLRTLVLHR
EEEKGHTYHIETKKFEGMFLNLTCLCTLHMRAIMIQDLPITICTLHCLRYLNLAENKIETLPESLCNLSN
LCVLILSLCKKLKELPRQIYKLRKLQILKLSYCQRIQKLPESITRLMNLKELDVGGCCWLSKLPDDLSDM
KNLVQLNMLGCASLTRMPGGIRQLTNLEVLCGYDAIDGLGNAMLSELRDLTNLESLHIQHLERLVSAEAK
EPNDITAPPTILQENQHVNELMLHWEWWNDMVAEETFEPTLQLTQGFHRNIEELKILRIVSYMSIKLPGW
LIREESTSVLNKLTTVHLVNLRRCERLPSLGNLPNLKELAISGFDSIRLIDDDFYGEGSSALFPGLRRLT
FSQMPRLEKWDPPSYFKEKSYQFRDRTFHFLEELTLIQCPKFREFHMPICVSHTSRSSLKVWLSNEMLMP
TSKFNDWGNLCGIQSLQIFGCQELRSLPDGLKTLLYLDTLVIINCNKLEALPIWLEQSRLESLCVYGCPA
LSIIPEGLKVTGRLRNLIVEACACPKLHSQVGSAQQTLLLSILYLLTLLFQFRGHKVKMREHHQSSTPTF
EELYDFLSYYSVASK


>XP_042436889.1 putative disease resistance protein RGA1 [Zingiber officinale]
MSMLTAVQLRHILMKILPAPEMVAQGKAFRISNHLEMVRDSLWAINSFLMDSTCWVGEFEPPDVTDWMKD
VGVAVEDVDNLLKRILDYWEPNEENEAEKKMKTNNFLHPLVNNNIRSTSNRRSILLELKQTACLLNYLVK
GGIALGLRMEMMDSMDPNHDDYAAILNEEVIGRDEDEDQIIDLLQQQQCDKDGNVPFIVAIRGSDRCGKT
TLARKIYHHTWVRQHFQHRIWLDASSFEDFNSSMIAKEIARLLTRKPCMNVDCWPLINEHLYGERYLLVL
DDVYVSDDLEYKWEELKMNLLHCGAPGSKVIVTEYPYLVYERGFNVKEYELNQLPEDAWIRLLLRYATFV
HPIEDNNSIHKEKYPPIEWRQHSFLRNCLGAKYIGLMFRWRDTNQWQELADQFDASPYNSIVWMHSKYWS
IEVTQTFLYELLFEGSSDESYREEDVLHMLVAEGTLTNTRRKRSLEYMTPYTRPPADLEYKSDFNLDLCF
FRMKVGEVSSIPPQCRHLSLLMDSKNILRSKTAIEKAGVANKLRSLALHREENKEPICQIETKILEEVAG
VNHSPREFENFRCWRLLLAFEIV


>XP_042437454.1 probable disease resistance protein At5g63020 isoform X1 [Zingiber officinale]
MGFLCKFWCSWTPMILFSAAPWDCAILRHQDIVGLPLCFIYGWSLQFLWPLPHPSGFLDSLAVEIHELKS
KRDDIERDVSRARRVGKEPRSQVLWWLDRVELLETKFAKTRREFERRFMLPGGFAVNILSSYRLSVRANE
MIAEACYLKSKGSFNQVANRAAPNHFEEVPSAPTVGMDAVLAQLKQAVEDDAVGLIGIYGMGGVGKTALL
SRFHNEFLADATDLDMVIFIDSCRDLDVESIQNKIRHRLGLSWKKSKSQKEKASMLYKVLFKMKFVLILD
DLWEPLSLQMVGIPIPKQGSSCKIMLATRIEELCDQMDVKNKIKVDLLPWDTAWRLFADKVGEETINSDP
GIRHQAEILVKKCGGLPVALITVARALASKRSVDEWKHAVTIMGNSPVQLPGMAEQVFCSLKLSYDHLPS
DTLRSCAMHFALYWEGCRLHKNLIQEYWIGEGILDDFKDVEQANNKACYFLGILSSASLIERVDADGYTR
MHPMVRAMALWIACEFGKKENQWFVREREGLMEAPEAETWRSAARMALGYNSITVLPEAPESLNLVSLKL
KSNFGLERIPDGFFRFMPCLVALDLHSTSIKEIPSGISNLQRLQFLELGGTKLKSLPKELASLKNLKYLG
LNWTAELASIPERLIQSLSELRVLRMIVSYSSWKAIPAGGGNGVSLRELEALKRLRVLDITVGNASAFNM
LTQSQRLAPATAALLLKGCPGLTAVELPSGLGRSMKSLKWLRLSHSTELEGVLIAGDGRENDGAALPELE
NLVLECLLKAKIVWRSSCIQHLRGLYIYGCSGMEQLIWYKDDDESDAENRGRRGVSPFPNLKQIAFRGLP
KLKRVSDERQLVFPLLESIEVAECPQLKKLNLVAEKLREIRCHRSWWDQLEWEDDAARFSPQMILKPLN


>XP_042437455.1 probable disease resistance protein At5g63020 isoform X2 [Zingiber officinale]
MDINGFLVQVLVFLDTNDTVFCCSMGLCNPSPPGFLDSLAVEIHELKSKRDDIERDVSRARRVGKEPRSQ
VLWWLDRVELLETKFAKTRREFERRFMLPGGFAVNILSSYRLSVRANEMIAEACYLKSKGSFNQVANRAA
PNHFEEVPSAPTVGMDAVLAQLKQAVEDDAVGLIGIYGMGGVGKTALLSRFHNEFLADATDLDMVIFIDS
CRDLDVESIQNKIRHRLGLSWKKSKSQKEKASMLYKVLFKMKFVLILDDLWEPLSLQMVGIPIPKQGSSC
KIMLATRIEELCDQMDVKNKIKVDLLPWDTAWRLFADKVGEETINSDPGIRHQAEILVKKCGGLPVALIT
VARALASKRSVDEWKHAVTIMGNSPVQLPGMAEQVFCSLKLSYDHLPSDTLRSCAMHFALYWEGCRLHKN
LIQEYWIGEGILDDFKDVEQANNKACYFLGILSSASLIERVDADGYTRMHPMVRAMALWIACEFGKKENQ
WFVREREGLMEAPEAETWRSAARMALGYNSITVLPEAPESLNLVSLKLKSNFGLERIPDGFFRFMPCLVA
LDLHSTSIKEIPSGISNLQRLQFLELGGTKLKSLPKELASLKNLKYLGLNWTAELASIPERLIQSLSELR
VLRMIVSYSSWKAIPAGGGNGVSLRELEALKRLRVLDITVGNASAFNMLTQSQRLAPATAALLLKGCPGL
TAVELPSGLGRSMKSLKWLRLSHSTELEGVLIAGDGRENDGAALPELENLVLECLLKAKIVWRSSCIQHL
RGLYIYGCSGMEQLIWYKDDDESDAENRGRRGVSPFPNLKQIAFRGLPKLKRVSDERQLVFPLLESIEVA
ECPQLKKLNLVAEKLREIRCHRSWWDQLEWEDDAARFSPQMILKPLN


>XP_042437544.1 disease resistance protein RPS2-like [Zingiber officinale]
MDDVSRASNDTIFHRARQLKAERSKRGGRKAKKWFCKIVPSIEGCAKPPDADPPMSFLDGPSRQQQQQQQ
KKKRSSRGGCSCCCLSSCLCGGKADERTPRTSKKQIPAAEIRLREAGAVFDELPTRNTRDAVNVVVNEVV
TARRSKPADHVFDALSPKKPVEENTNLAERLPPPSKGHVSAASMVLPERLPPGPARDLPVPNPIMGQEVC
LKTALSYLTDDAIGIMGIYGTGGVGKTTLLRSINNKFCGNAARTEFDHVILVAVGKDPDVKKLQRDIAYE
VGLLLMDDESEVTRAAAIFDFLKTKNFLLLLDDLWGPLQLAKVGIPHPLSDGYKQKVIISSRLMDVSGKM
QAHKFLILECLKWEEAWNLFSSKVGEENLADQRIRSIAVALAKECGGLPLALVAMGSAMSTKKTPEEWQK
AVSLLKTAPPLHEISGYQMLKENLIRSWMGLGSITDFDDINEAYNIGYSIIESLKAVSLMENSEKSYRRM
EMHDVIREMALWTASGKESNKNKWLVGAKPSETRSDEWSKAERISLMFNEIEALPDSCYCPNLQSLILRG
NKRLMKIPNGLFPCMVLLRFLDLSHTGIVELPNEVGTLINLQFLNLSYTKIACLPKEMKELTTLKYLELE
GTRELRKIPDGVISSLEMLKELNLYMSGFANWSWLSVCSRDSIRFEELVSLQRLRSVGFTVRSIQCLLRL
FSILRVLTHSLTIRELRGLISLRLLPGLLSKNKMGRLKNLTIEFSQGLKELVMGEEAKTLNWRLYQLEVF
NLVCLPELERVIWRGVAAHVCLPNLRFLSLFYCNSLRNIAWVAHLPLLQELYIQNCNEMEQVIADEPPTA
SSEKEEKPATSFPNLKYIFLRDLKSLVKIDDQVLEFPCLERILVHNCIELKQLPLGATSAQKLRIIFGER
NWWESLEWGDHSIKPIFTTCFREIPAGYEPSMKILEGL


>XP_042438090.1 putative disease resistance protein RGA1 [Zingiber officinale]
MIGRFALTAFGWLAESIVGVLVGKAVDRAVQQFGEQHGVEDDLKKLKDSLANAKLKISTIENLWLKDEFL
QQRVKDLLIDLKNAAYDADDLLDEFQYRILKQQIEQQGDEAGKRASSSSYSAPPPSKRTKTSIASCTSGL
FRKGDDDDDNNNVQKIRKIKGSLDDYSAALEEIYSSLGAEDDRGKQQLVSSASRQTSSFSTEPQLFGRDK
ELQELKDLLFKPAVASEFGQSGVSVLSIYGMGGIGKTTLAQEVFNDSSVKEYFKLRIWVCVSENFCTDRL
TREIIECATTEKCDLTNLDTLQKIVNEKITPERFLLVLDDVWNEDRHKWESLCAPLRSGKPGSKILVTTR
SRKIADMVSDADAIHLQGLDVESFWDFFKKCAFGCSHSGAHHPHMEAMAKKMTCKLKGLPLAAKTLGGLL
SVKLDEQYWESILDSEIWQLPQEENGIMPVLQLSYQHLPPHLKQCFAFCSLFPKGYKFSESDLIGIWIAE
GFIVPRGSTRMEELGSNYFHELVNRSFIQESKYGEWIMHDLIHDLAELISAGESYRIEKGKSHDIPSTIR
HLSIYTDKEGMQTILTEFSHWNKLRTMMLTVERFPREDFNFDCGVLEKLKNIHVLVLNNCSLRELPDGID
KLIHLRYLDLSYNEGIQRLPELLCDLYNLQTLILGFCDNLKSLPHGMMKLINLRKLYGVDRLISGITEIG
KLTSLQNLYSFKVTKDNGHKLVELNGLKQLRGFLCITNLENVKNKDEANIASLKSKEYLDVLELEWTSLQ
ESDSDVNLHISEQVLEGLQPHHNLQRLIIKGYNGARPPNWLHKQVYSRLGSLHLENCKRWNDLSAIGQLS
QLKFLYLVRTPIQTKNIHKLFNPKVCKFFSQLEELVLEGITMLEDLPNLGQLPCLTFIRIQSLPGVKKIG
DKFFAMTEEGSCFPRLRTLRFIEMPAWEELYGSDDRNLFPCLEDLYISNCQKLQMLPPLPPSIQQLKLNN
VGLVDCPRFWKAFDEGSSTTNSASLTYLSIQNCPNLTSLDQGLLPHHLFPCLVNLDISNCQKLQMLPPLP
PSIQQLKLNNVGLVDCPRFWKAFDEGSSTTNSASLTYLSIQNCPNLTSLDQGLLPHHLFPCLVNLDISNC
QKLQMLPPLPPSIQQLKLNNVGLVDCPRFWKAFDEGSSTTNSASLTYLSIQNCPNLTSLEPVLLPHHHHL
QKIHLKKCEQLSWVPVKRLKELTSLWSLSLKDCPKLMGMSTPDEYIDFQLPPSITELCLSDCENLFKSLP
GCLHNLTSLTSLSVSKCPNLVSLPVEPSLRLTRLEIQNCNELRSVEGLPIKNLEVLKIKGCPKLLLPQTE
KLPLLKLEIDDTAFMKQPLIKNSLSSVRGLTISSSREAVMFEGEDQESLQSLTSLYSFCFSDCKNLQTLP
AKLYTLKSLRFLQIHNCPQIQSLPEKGLPPSLAHINFEGCDQALEQQLVRHLAEINKS


>XP_042438091.1 putative disease resistance protein RGA1 [Zingiber officinale]
MIGRFALTAFGWLAESIVGVLVGKAVDRAVQQFGEQHGVEDDLKKLKDSLANAKLKISTIENLWLKDEFL
QQRVKDLLIDLKNAAYDADDLLDEFQYRILKQQIEQQGDEAGKRASSSSYSAPPPSKRTKTSIASCTSGL
FRKGDDDDDNNNVQKIRKIKGSLDDYSAALEEIYSSLGAEDDRGKQQLVSSASRQTSSFSTEPQLFGRDK
ELQELKDLLFKPAVASEFGQSGVSVLSIYGMGGIGKTTLAQEVFNDSSVKEYFKLRIWVCVSENFCTDRL
TREIIECATTEKCDLTNLDTLQKIVNEKITPERFLLVLDDVWNEDRHKWESLCAPLRSGKPGSKILVTTR
SRKIADMVSDADAIHLQGLDVESFWDFFKKCAFGCSHSGAHHPHMEAMAKKMTCKLKGLPLAAKTLGGLL
SVKLDEQYWESILDSEIWQLPQEENGIMPVLQLSYQHLPPHLKQCFAFCSLFPKGYKFSESDLIGIWIAE
GFIVPRGSTRMEELGSNYFHELVNRSFIQESKYGEWIMHDLIHDLAELISAGESYRIEKGKSHDIPSTIR
HLSIYTDKEGMQTILTEFSHWNKLRTMMLTVERFPREDFNFDCGVLEKLKNIHVLVLNNCSLRELPDGID
KLIHLRYLDLSYNEGIQRLPELLCDLYNLQTLILGFCDNLKSLPHGMMKLINLRKLYGVDRLISGITEIG
KLTSLQNLYSFKVTKDNGHKLVELNGLKQLRGFLCITNLENVKNKDEANIASLKSKEYLDVLELEWTSLQ
ESDSDVNLHISEQVLEGLQPHHNLQRLIIKGYNGARPPNWLHKQVYSRLGSLHLENCKRWNDLSAIGQLS
QLKFLYLVRTPIQTKNIHKLFNPKVCKFFSQLEELVLEGITMLEDLPNLGQLPCLTFIRIQSLPGVKKIG
DKFFAMTEEGSCFPRLRTLRFIEMPAWEELYGSDDRNLFPCLEDLYISNCQKLQMLPPLPPSIQQLKLNN
VGLVDCPRFWKAFDEGSSTTNSASLTYLSIQNCPNLTSLDQGLLPHHLFPCLVNLDISNCQKLQMLPPLP
PSIQQLKLNNVGLVDCPRFWKAFDEGSSTTNSASLTYLSIQNCPNLTSLDQGLLPHHLFPCLVNLDISNC
QKLQMLPPLPPSIQQLKLNNVGLVDCPRFWKAFDEGSSTTNSASLTYLSIQNCPNLTSLEPVLLPHHHHL
QKIHLKKCEQLSWVPVKRLKELTSLWSLSLKDCPKLMGMSTPDEYIDFQLPPSITELCLSDCENLFKSLP
GCLHNLTSLTSLSVSKCPNLVSLPVEPSLRLTRLEIQNCNELRSVEGLPIKNLEVLKIKGCPKLLLPQTE
KLPLLKLEIDDTAFMKQPLIKNSLSSVRGLTISSSREAVMFEGEDQESLQSLTSLYSFCFSDCKNLQTLP
AKLYTLKSLRFLQIHNCPQIQSLPEKGLPPSLAHINFEGCDQALEQQLVRHLAEINKS


>XP_042438092.1 putative disease resistance protein RGA1 [Zingiber officinale]
MIGRFALTAFGWLAESIVGVLVGKAVDRAVQQFGEQHGVEDDLKKLKDSLANAKLKISTIENLWLKDEFL
QQRVKDLLIDLKNAAYDADDLLDEFQYRILKQQIEQQGDEAGKRASSSSYSAPPPSKRTKTSIASCTSGL
FRKGDDDDDNNNVQKIRKIKGSLDDYSAALEEIYSSLGAEDDRGKQQLVSSASRQTSSFSTEPQLFGRDK
ELQELKDLLFKPAVASEFGQSGVSVLSIYGMGGIGKTTLAQEVFNDSSVKEYFKLRIWVCVSENFCTDRL
TREIIECATTEKCDLTNLDTLQKIVNEKITPERFLLVLDDVWNEDRHKWESLCAPLRSGKPGSKILVTTR
SRKIADMVSDADAIHLQGLDVESFWDFFKKCAFGCSHSGAHHPHMEAMAKKMTCKLKGLPLAAKTLGGLL
SVKLDEQYWESILDSEIWQLPQEENGIMPVLQLSYQHLPPHLKQCFAFCSLFPKGYKFSESDLIGIWIAE
GFIVPRGSTRMEELGSNYFHELVNRSFIQESKYGEWIMHDLIHDLAELISAGESYRIEKGKSHDIPSTIR
HLSIYTDKEGMQTILTEFSHWNKLRTMMLTVERFPREDFNFDCGVLEKLKNIHVLVLNNCSLRELPDGID
KLIHLRYLDLSYNEGIQRLPELLCDLYNLQTLILGFCDNLKSLPHGMMKLINLRKLYGVDRLISGITEIG
KLTSLQNLYSFKVTKDNGHKLVELNGLKQLRGFLCITNLENVKNKDEANIASLKSKEYLDVLELEWTSLQ
ESDSDVNLHISEQVLEGLQPHHNLQRLIIKGYNGARPPNWLHKQVYSRLGSLHLENCKRWNDLSAIGQLS
QLKFLYLVRTPIQTKNIHKLFNPKVCKFFSQLEELVLEGITMLEDLPNLGQLPCLTFIRIQSLPGVKKIG
DKFFAMTEEGSCFPRLRTLRFIEMPAWEELYGSDDRNLFPCLEDLYISNCQKLQMLPPLPPSIQQLKLNN
VGLVDCPRFWKAFDEGSSTTNSASLTYLSIQNCPNLTSLDQGLLPHHLFPCLVNLDISNCQKLQMLPPLP
PSIQQLKLNNVGLVDCPRFWKAFDEGSSTTNSASLTYLSIQNCPNLTSLDQGLLPHHLFPCLVNLDISNC
QKLQMLPPLPPSIQQLKLNNVGLVDCPRFWKAFDEGSSTTNSASLTYLSIQNCPNLTSLEPVLLPHHHHL
QKIHLKKCEQLSWVPVKRLKELTSLWSLSLKDCPKLMGMSTPDEYIDFQLPPSITELCLSDCENLFKSLP
GCLHNLTSLTSLSVSKCPNLVSLPVEPSLRLTRLEIQNCNELRSVEGLPIKNLEVLKIKGCPKLLLPQTE
KLPLLKLEIDDTAFMKQPLIKNSLSSVRGLTISSSREAVMFEGEDQESLQSLTSLYSFCFSDCKNLQTLP
AKLYTLKSLRFLQIHNCPQIQSLPEKGLPPSLAHINFEGCDQALEQQLVRHLAEINKS


>XP_042438093.1 putative disease resistance protein RGA1 [Zingiber officinale]
MIGRFALTAFGWLAESIVGVLVGKAVDRAVQQFGEQHGVEDDLKKLKDSLANAKLKISTIENLWLKDEFL
QQRVKDLLIDLKNAAYDADDLLDEFQYRILKQQIEQQGDEAGKRASSSSYSAPPPSKRTKTSIASCTSGL
FRKGDDDDDNNNVQKIRKIKGSLDDYSAALEEIYSSLGAEDDRGKQQLVSSASRQTSSFSTEPQLFGRDK
ELQELKDLLFKPAVASEFGQSGVSVLSIYGMGGIGKTTLAQEVFNDSSVKEYFKLRIWVCVSENFCTDRL
TREIIECATTEKCDLTNLDTLQKIVNEKITPERFLLVLDDVWNEDRHKWESLCAPLRSGKPGSKILVTTR
SRKIADMVSDADAIHLQGLDVESFWDFFKKCAFGCSHSGAHHPHMEAMAKKMTCKLKGLPLAAKTLGGLL
SVKLDEQYWESILDSEIWQLPQEENGIMPVLQLSYQHLPPHLKQCFAFCSLFPKGYKFSESDLIGIWIAE
GFIVPRGSTRMEELGSNYFHELVNRSFIQESKYGEWIMHDLIHDLAELISAGESYRIEKGKSHDIPSTIR
HLSIYTDKEGMQTILTEFSHWNKLRTMMLTVERFPREDFNFDCGVLEKLKNIHVLVLNNCSLRELPDGID
KLIHLRYLDLSYNEGIQRLPELLCDLYNLQTLILGFCDNLKSLPHGMMKLINLRKLYGVDRLISGITEIG
KLTSLQNLYSFKVTKDNGHKLVELNGLKQLRGFLCITNLENVKNKDEANIASLKSKEYLDVLELEWTSLQ
ESDSDVNLHISEQVLEGLQPHHNLQRLIIKGYNGARPPNWLHKQVYSRLGSLHLENCKRWNDLSAIGQLS
QLKFLYLVRTPIQTKNIHKLFNPKVCKFFSQLEELVLEGITMLEDLPNLGQLPCLTFIRIQSLPGVKKIG
DKFFAMTEEGSCFPRLRTLRFIEMPAWEELYGSDDRNLFPCLEDLYISNCQKLQMLPPLPPSIQQLKLNN
VGLVDCPRFWKAFDEGSSTTNSASLTYLSIQNCPNLTSLDQGLLPHHLFPCLVNLDISNCQKLQMLPPLP
PSIQQLKLNNVGLVDCPRFWKAFDEGSSTTNSASLTYLSIQNCPNLTSLDQGLLPHHLFPCLVNLDISNC
QKLQMLPPLPPSIQQLKLNNVGLVDCPRFWKAFDEGSSTTNSASLTYLSIQNCPNLTSLEPVLLPHHHHL
QKIHLKKCEQLSWVPVKRLKELTSLWSLSLKDCPKLMGMSTPDEYIDFQLPPSITELCLSDCENLFKSLP
GCLHNLTSLTSLSVSKCPNLVSLPVEPSLRLTRLEIQNCNELRSVEGLPIKNLEVLKIKGCPKLLLPQTE
KLPLLKLEIDDTAFMKQPLIKNSLSSVRGLTISSSREAVMFEGEDQESLQSLTSLYSFCFSDCKNLQTLP
AKLYTLKSLRFLQIHNCPQIQSLPEKGLPPSLAHINFEGCDQALEQQLVRHLAEINKS


>XP_042438094.1 putative disease resistance protein RGA1 [Zingiber officinale]
MIGRFALTAFGWLAESIVGVLVGKAVDRAVQQFGEQHGVEDDLKKLKDSLANAKLKISTIENLWLKDEFL
QQRVKDLLIDLKNAAYDADDLLDEFQYRILKQQIEQQGDEAGKRASSSSYSAPPPSKRTKTSIASCTSGL
FRKGDDDDDNNNVQKIRKIKGSLDDYSAALEEIYSSLGAEDDRGKQQLVSSASRQTSSFSTEPQLFGRDK
ELQELKDLLFKPAVASEFGQSGVSVLSIYGMGGIGKTTLAQEVFNDSSVKEYFKLRIWVCVSENFCTDRL
TREIIECATTEKCDLTNLDTLQKIVNEKITPERFLLVLDDVWNEDRHKWESLCAPLRSGKPGSKILVTTR
SRKIADMVSDADAIHLQGLDVESFWDFFKKCAFGCSHSGAHHPHMEAMAKKMTCKLKGLPLAAKTLGGLL
SVKLDEQYWESILDSEIWQLPQEENGIMPVLQLSYQHLPPHLKQCFAFCSLFPKGYKFSESDLIGIWIAE
GFIVPRGSTRMEELGSNYFHELVNRSFIQESKYGEWIMHDLIHDLAELISAGESYRIEKGKSHDIPSTIR
HLSIYTDKEGMQTILTEFSHWNKLRTMMLTVERFPREDFNFDCGVLEKLKNIHVLVLNNCSLRELPDGID
KLIHLRYLDLSYNEGIQRLPELLCDLYNLQTLILGFCDNLKSLPHGMMKLINLRKLYGVDRLISGITEIG
KLTSLQNLYSFKVTKDNGHKLVELNGLKQLRGFLCITNLENVKNKDEANIASLKSKEYLDVLELEWTSLQ
ESDSDVNLHISEQVLEGLQPHHNLQRLIIKGYNGARPPNWLHKQVYSRLGSLHLENCKRWNDLSAIGQLS
QLKFLYLVRTPIQTKNIHKLFNPKVCKFFSQLEELVLEGITMLEDLPNLGQLPCLTFIRIQSLPGVKKIG
DKFFAMTEEGSCFPRLRTLRFIEMPAWEELYGSDDRNLFPCLEDLYISNCQKLQMLPPLPPSIQQLKLNN
VGLVDCPRFWKAFDEGSSTTNSASLTYLSIQNCPNLTSLDQGLLPHHLFPCLVNLDISNCQKLQMLPPLP
PSIQQLKLNNVGLVDCPRFWKAFDEGSSTTNSASLTYLSIQNCPNLTSLDQGLLPHHLFPCLVNLDISNC
QKLQMLPPLPPSIQQLKLNNVGLVDCPRFWKAFDEGSSTTNSASLTYLSIQNCPNLTSLEPVLLPHHHHL
QKIHLKKCEQLSWVPVKRLKELTSLWSLSLKDCPKLMGMSTPDEYIDFQLPPSITELCLSDCENLFKSLP
GCLHNLTSLTSLSVSKCPNLVSLPVEPSLRLTRLEIQNCNELRSVEGLPIKNLEVLKIKGCPKLLLPQTE
KLPLLKLEIDDTAFMKQPLIKNSLSSVRGLTISSSREAVMFEGEDQESLQSLTSLYSFCFSDCKNLQTLP
AKLYTLKSLRFLQIHNCPQIQSLPEKGLPPSLAHINFEGCDQALEQQLVRHLAEINKS


>XP_042438096.1 putative disease resistance protein RGA1 [Zingiber officinale]
MIGRFALTAFGWLAESIVGVLVGKAVDRAVQQFGEQHGVEDDLKKLKDSLANAKLKISTIENLWLKDEFL
QQRVKDLLIDLKNAAYDADDLLDEFQYRILKQQIEQQGDEAGKRASSSSYSAPPPSKRTKTSIASCTSGL
FRKGDDDDDNNNVQKIRKIKGSLDDYSAALEEIYSSLGAEDDRGKQQLVSSASRQTSSFSTEPQLFGRDK
ELQELKDLLFKPAVASEFGQSGVSVLSIYGMGGIGKTTLAQEVFNDSSVKEYFKLRIWVCVSENFCTDRL
TREIIECATTEKCDLTNLDTLQKIVNEKITPERFLLVLDDVWNEDRHKWESLCAPLRSGKPGSKILVTTR
SRKIADMVSDADAIHLQGLDVESFWDFFKKCAFGCSHSGAHHPHMEAMAKKMTCKLKGLPLAAKTLGGLL
SVKLDEQYWESILDSEIWQLPQEENGIMPVLQLSYQHLPPHLKQCFAFCSLFPKGYKFSESDLIGIWIAE
GFIVPRGSTRMEELGSNYFHELVNRSFIQESKYGEWIMHDLIHDLAELISAGESYRIEKGKSHDIPSTIR
HLSIYTDKEGMQTILTEFSHWNKLRTMMLTVERFPREDFNFDCGVLEKLKNIHVLVLNNCSLRELPDGID
KLIHLRYLDLSYNEGIQRLPELLCDLYNLQTLILGFCDNLKSLPHGMMKLINLRKLYGVDRLISGITEIG
KLTSLQNLYSFKVTKDNGHKLVELNGLKQLRGFLCITNLENVKNKDEANIASLKSKEYLDVLELEWTSLQ
ESDSDVNLHISEQVLEGLQPHHNLQRLIIKGYNGARPPNWLHKQVYSRLGSLHLENCKRWNDLSAIGQLS
QLKFLYLVRTPIQTKNIHKLFNPKVCKFFSQLEELVLEGITMLEDLPNLGQLPCLTFIRIQSLPGVKKIG
DKFFAMTEEGSCFPRLRTLRFIEMPAWEELYGSDDRNLFPCLEDLYISNCQKLQMLPPLPPSIQQLKLNN
VGLVDCPRFWKAFDEGSSTTNSASLTYLSIQNCPNLTSLDQGLLPHHLFPCLVNLDISNCQKLQMLPPLP
PSIQQLKLNNVGLVDCPRFWKAFDEGSSTTNSASLTYLSIQNCPNLTSLDQGLLPHHLFPCLVNLDISNC
QKLQMLPPLPPSIQQLKLNNVGLVDCPRFWKAFDEGSSTTNSASLTYLSIQNCPNLTSLEPVLLPHHHHL
QKIHLKKCEQLSWVPVKRLKELTSLWSLSLKDCPKLMGMSTPDEYIDFQLPPSITELCLSDCENLFKSLP
GCLHNLTSLTSLSVSKCPNLVSLPVEPSLRLTRLEIQNCNELRSVEGLPIKNLEVLKIKGCPKLLLPQTE
KLPLLKLEIDDTAFMKQPLIKNSLSSVRGLTISSSREAVMFEGEDQESLQSLTSLYSFCFSDCKNLQTLP
AKLYTLKSLRFLQIHNCPQIQSLPEKGLPPSLAHINFEGCDQALEQQLVRHLAEINKS


>XP_042438097.1 putative disease resistance protein RGA1 [Zingiber officinale]
MIGRFALTAFGWLAESIVGVLVGKAVDRAVQQFGEQHGVEDDLKKLKDSLANAKLKISTIENLWLKDEFL
QQRVKDLLIDLKNAAYDADDLLDEFQYRILKQQIEQQGDEAGKRASSSSYSAPPPSKRTKTSIASCTSGL
FRKGDDDDDNNNVQKIRKIKGSLDDYSAALEEIYSSLGAEDDRGKQQLVSSASRQTSSFSTEPQLFGRDK
ELQELKDLLFKPAVASEFGQSGVSVLSIYGMGGIGKTTLAQEVFNDSSVKEYFKLRIWVCVSENFCTDRL
TREIIECATTEKCDLTNLDTLQKIVNEKITPERFLLVLDDVWNEDRHKWESLCAPLRSGKPGSKILVTTR
SRKIADMVSDADAIHLQGLDVESFWDFFKKCAFGCSHSGAHHPHMEAMAKKMTCKLKGLPLAAKTLGGLL
SVKLDEQYWESILDSEIWQLPQEENGIMPVLQLSYQHLPPHLKQCFAFCSLFPKGYKFSESDLIGIWIAE
GFIVPRGSTRMEELGSNYFHELVNRSFIQESKYGEWIMHDLIHDLAELISAGESYRIEKGKSHDIPSTIR
HLSIYTDKEGMQTILTEFSHWNKLRTMMLTVERFPREDFNFDCGVLEKLKNIHVLVLNNCSLRELPDGID
KLIHLRYLDLSYNEGIQRLPELLCDLYNLQTLILGFCDNLKSLPHGMMKLINLRKLYGVDRLISGITEIG
KLTSLQNLYSFKVTKDNGHKLVELNGLKQLRGFLCITNLENVKNKDEANIASLKSKEYLDVLELEWTSLQ
ESDSDVNLHISEQVLEGLQPHHNLQRLIIKGYNGARPPNWLHKQVYSRLGSLHLENCKRWNDLSAIGQLS
QLKFLYLVRTPIQTKNIHKLFNPKVCKFFSQLEELVLEGITMLEDLPNLGQLPCLTFIRIQSLPGVKKIG
DKFFAMTEEGSCFPRLRTLRFIEMPAWEELYGSDDRNLFPCLEDLYISNCQKLQMLPPLPPSIQQLKLNN
VGLVDCPRFWKAFDEGSSTTNSASLTYLSIQNCPNLTSLDQGLLPHHLFPCLVNLDISNCQKLQMLPPLP
PSIQQLKLNNVGLVDCPRFWKAFDEGSSTTNSASLTYLSIQNCPNLTSLDQGLLPHHLFPCLVNLDISNC
QKLQMLPPLPPSIQQLKLNNVGLVDCPRFWKAFDEGSSTTNSASLTYLSIQNCPNLTSLEPVLLPHHHHL
QKIHLKKCEQLSWVPVKRLKELTSLWSLSLKDCPKLMGMSTPDEYIDFQLPPSITELCLSDCENLFKSLP
GCLHNLTSLTSLSVSKCPNLVSLPVEPSLRLTRLEIQNCNELRSVEGLPIKNLEVLKIKGCPKLLLPQTE
KLPLLKLEIDDTAFMKQPLIKNSLSSVRGLTISSSREAVMFEGEDQESLQSLTSLYSFCFSDCKNLQTLP
AKLYTLKSLRFLQIHNCPQIQSLPEKGLPPSLAHINFEGCDQALEQQLVRHLAEINKS


>XP_042438098.1 putative disease resistance protein RGA1 [Zingiber officinale]
MIGRFALTAFGWLAESIVGVLVGKAVDRAVQQFGEQHGVEDDLKKLKDSLANAKLKISTIENLWLKDEFL
QQRVKDLLIDLKNAAYDADDLLDEFQYRILKQQIEQQGDEAGKRASSSSYSAPPPSKRTKTSIASCTSGL
FRKGDDDDDNNNVQKIRKIKGSLDDYSAALEEIYSSLGAEDDRGKQQLVSSASRQTSSFSTEPQLFGRDK
ELQELKDLLFKPAVASEFGQSGVSVLSIYGMGGIGKTTLAQEVFNDSSVKEYFKLRIWVCVSENFCTDRL
TREIIECATTEKCDLTNLDTLQKIVNEKITPERFLLVLDDVWNEDRHKWESLCAPLRSGKPGSKILVTTR
SRKIADMVSDADAIHLQGLDVESFWDFFKKCAFGCSHSGAHHPHMEAMAKKMTCKLKGLPLAAKTLGGLL
SVKLDEQYWESILDSEIWQLPQEENGIMPVLQLSYQHLPPHLKQCFAFCSLFPKGYKFSESDLIGIWIAE
GFIVPRGSTRMEELGSNYFHELVNRSFIQESKYGEWIMHDLIHDLAELISAGESYRIEKGKSHDIPSTIR
HLSIYTDKEGMQTILTEFSHWNKLRTMMLTVERFPREDFNFDCGVLEKLKNIHVLVLNNCSLRELPDGID
KLIHLRYLDLSYNEGIQRLPELLCDLYNLQTLILGFCDNLKSLPHGMMKLINLRKLYGVDRLISGITEIG
KLTSLQNLYSFKVTKDNGHKLVELNGLKQLRGFLCITNLENVKNKDEANIASLKSKEYLDVLELEWTSLQ
ESDSDVNLHISEQVLEGLQPHHNLQRLIIKGYNGARPPNWLHKQVYSRLGSLHLENCKRWNDLSAIGQLS
QLKFLYLVRTPIQTKNIHKLFNPKVCKFFSQLEELVLEGITMLEDLPNLGQLPCLTFIRIQSLPGVKKIG
DKFFAMTEEGSCFPRLRTLRFIEMPAWEELYGSDDRNLFPCLEDLYISNCQKLQMLPPLPPSIQQLKLNN
VGLVDCPRFWKAFDEGSSTTNSASLTYLSIQNCPNLTSLDQGLLPHHLFPCLVNLDISNCQKLQMLPPLP
PSIQQLKLNNVGLVDCPRFWKAFDEGSSTTNSASLTYLSIQNCPNLTSLDQGLLPHHLFPCLVNLDISNC
QKLQMLPPLPPSIQQLKLNNVGLVDCPRFWKAFDEGSSTTNSASLTYLSIQNCPNLTSLEPVLLPHHHHL
QKIHLKKCEQLSWVPVKRLKELTSLWSLSLKDCPKLMGMSTPDEYIDFQLPPSITELCLSDCENLFKSLP
GCLHNLTSLTSLSVSKCPNLVSLPVEPSLRLTRLEIQNCNELRSVEGLPIKNLEVLKIKGCPKLLLPQTE
KLPLLKLEIDDTAFMKQPLIKNSLSSVRGLTISSSREAVMFEGEDQESLQSLTSLYSFCFSDCKNLQTLP
AKLYTLKSLRFLQIHNCPQIQSLPEKGLPPSLAHINFEGCDQALEQQLVRHLAEINKS


>XP_042438099.1 putative disease resistance protein RGA1 [Zingiber officinale]
MIGRFALTAFGWLAESIVGVLVGKAVDRAVQQFGEQHGVEDDLKKLKDSLANAKLKISTIENLWLKDEFL
QQRVKDLLIDLKNAAYDADDLLDEFQYRILKQQIEQQGDEAGKRASSSSYSAPPPSKRTKTSIASCTSGL
FRKGDDDDDNNNVQKIRKIKGSLDDYSAALEEIYSSLGAEDDRGKQQLVSSASRQTSSFSTEPQLFGRDK
ELQELKDLLFKPAVASEFGQSGVSVLSIYGMGGIGKTTLAQEVFNDSSVKEYFKLRIWVCVSENFCTDRL
TREIIECATTEKCDLTNLDTLQKIVNEKITPERFLLVLDDVWNEDRHKWESLCAPLRSGKPGSKILVTTR
SRKIADMVSDADAIHLQGLDVESFWDFFKKCAFGCSHSGAHHPHMEAMAKKMTCKLKGLPLAAKTLGGLL
SVKLDEQYWESILDSEIWQLPQEENGIMPVLQLSYQHLPPHLKQCFAFCSLFPKGYKFSESDLIGIWIAE
GFIVPRGSTRMEELGSNYFHELVNRSFIQESKYGEWIMHDLIHDLAELISAGESYRIEKGKSHDIPSTIR
HLSIYTDKEGMQTILTEFSHWNKLRTMMLTVERFPREDFNFDCGVLEKLKNIHVLVLNNCSLRELPDGID
KLIHLRYLDLSYNEGIQRLPELLCDLYNLQTLILGFCDNLKSLPHGMMKLINLRKLYGVDRLISGITEIG
KLTSLQNLYSFKVTKDNGHKLVELNGLKQLRGFLCITNLENVKNKDEANIASLKSKEYLDVLELEWTSLQ
ESDSDVNLHISEQVLEGLQPHHNLQRLIIKGYNGARPPNWLHKQVYSRLGSLHLENCKRWNDLSAIGQLS
QLKFLYLVRTPIQTKNIHKLFNPKVCKFFSQLEELVLEGITMLEDLPNLGQLPCLTFIRIQSLPGVKKIG
DKFFAMTEEGSCFPRLRTLRFIEMPAWEELYGSDDRNLFPCLEDLYISNCQKLQMLPPLPPSIQQLKLNN
VGLVDCPRFWKAFDEGSSTTNSASLTYLSIQNCPNLTSLDQGLLPHHLFPCLVNLDISNCQKLQMLPPLP
PSIQQLKLNNVGLVDCPRFWKAFDEGSSTTNSASLTYLSIQNCPNLTSLDQGLLPHHLFPCLVNLDISNC
QKLQMLPPLPPSIQQLKLNNVGLVDCPRFWKAFDEGSSTTNSASLTYLSIQNCPNLTSLEPVLLPHHHHL
QKIHLKKCEQLSWVPVKRLKELTSLWSLSLKDCPKLMGMSTPDEYIDFQLPPSITELCLSDCENLFKSLP
GCLHNLTSLTSLSVSKCPNLVSLPVEPSLRLTRLEIQNCNELRSVEGLPIKNLEVLKIKGCPKLLLPQTE
KLPLLKLEIDDTAFMKQPLIKNSLSSVRGLTISSSREAVMFEGEDQESLQSLTSLYSFCFSDCKNLQTLP
AKLYTLKSLRFLQIHNCPQIQSLPEKGLPPSLAHINFEGCDQALEQQLVRHLAEINKS


>XP_042438100.1 putative disease resistance protein RGA1 [Zingiber officinale]
MIGRFALTAFGWLAESIVGVLVGKAVDRAVQQFGEQHGVEDDLKKLKDSLANAKLKISTIENLWLKDEFL
QQRVKDLLIDLKNAAYDADDLLDEFQYRILKQQIEQQGDEAGKRASSSSYSAPPPSKRTKTSIASCTSGL
FRKGDDDDDNNNVQKIRKIKGSLDDYSAALEEIYSSLGAEDDRGKQQLVSSASRQTSSFSTEPQLFGRDK
ELQELKDLLFKPAVASEFGQSGVSVLSIYGMGGIGKTTLAQEVFNDSSVKEYFKLRIWVCVSENFCTDRL
TREIIECATTEKCDLTNLDTLQKIVNEKITPERFLLVLDDVWNEDRHKWESLCAPLRSGKPGSKILVTTR
SRKIADMVSDADAIHLQGLDVESFWDFFKKCAFGCSHSGAHHPHMEAMAKKMTCKLKGLPLAAKTLGGLL
SVKLDEQYWESILDSEIWQLPQEENGIMPVLQLSYQHLPPHLKQCFAFCSLFPKGYKFSESDLIGIWIAE
GFIVPRGSTRMEELGSNYFHELVNRSFIQESKYGEWIMHDLIHDLAELISAGESYRIEKGKSHDIPSTIR
HLSIYTDKEGMQTILTEFSHWNKLRTMMLTVERFPREDFNFDCGVLEKLKNIHVLVLNNCSLRELPDGID
KLIHLRYLDLSYNEGIQRLPELLCDLYNLQTLILGFCDNLKSLPHGMMKLINLRKLYGVDRLISGITEIG
KLTSLQNLYSFKVTKDNGHKLVELNGLKQLRGFLCITNLENVKNKDEANIASLKSKEYLDVLELEWTSLQ
ESDSDVNLHISEQVLEGLQPHHNLQRLIIKGYNGARPPNWLHKQVYSRLGSLHLENCKRWNDLSAIGQLS
QLKFLYLVRTPIQTKNIHKLFNPKVCKFFSQLEELVLEGITMLEDLPNLGQLPCLTFIRIQSLPGVKKIG
DKFFAMTEEGSCFPRLRTLRFIEMPAWEELYGSDDRNLFPCLEDLYISNCQKLQMLPPLPPSIQQLKLNN
VGLVDCPRFWKAFDEGSSTTNSASLTYLSIQNCPNLTSLDQGLLPHHLFPCLVNLDISNCQKLQMLPPLP
PSIQQLKLNNVGLVDCPRFWKAFDEGSSTTNSASLTYLSIQNCPNLTSLDQGLLPHHLFPCLVNLDISNC
QKLQMLPPLPPSIQQLKLNNVGLVDCPRFWKAFDEGSSTTNSASLTYLSIQNCPNLTSLEPVLLPHHHHL
QKIHLKKCEQLSWVPVKRLKELTSLWSLSLKDCPKLMGMSTPDEYIDFQLPPSITELCLSDCENLFKSLP
GCLHNLTSLTSLSVSKCPNLVSLPVEPSLRLTRLEIQNCNELRSVEGLPIKNLEVLKIKGCPKLLLPQTE
KLPLLKLEIDDTAFMKQPLIKNSLSSVRGLTISSSREAVMFEGEDQESLQSLTSLYSFCFSDCKNLQTLP
AKLYTLKSLRFLQIHNCPQIQSLPEKGLPPSLAHINFEGCDQALEQQLVRHLAEINKS


>XP_042438776.1 disease resistance protein RPS2-like [Zingiber officinale]
MDLINPGATLITKLWDLIALKLAFIVNAGDNVRRLRLPMNRLKDKSIDVANRVSAAKAQLLTPTQEVLGW
LRRVEELEAEVSAIEQDFLNQPTCFCSCHYDLCSSYRIGRKVKRKASEATAMEAKSFDVVATDDSAPAVA
LDLPTRPDVGVESPLENAFQYLFDDQRCVIGVHGMGGVGKTTLLRRINNSFVGRSDFDLVIMVEASLDFK
IEHLQQAIADRVGLPLSQNGTSKSWAIEIKRSLNRKKFLLLLDNIWDPINLTDAGIPTGPSKCKIVISSR
FESTCAQMGAEKKIKMECLTPDKAWELFRQNLSGDLLNDPEIEDLAKQVAEDCNGLPLALVVVAATMSTR
TTREEWQYAVRQMRKMHLESLVPLEANLIPTLKLSYDNLPNDQLKLCFLSCSFYPRGHSILKEELIESWM
GLGFLEEHNDINEIYQKGHFLIGKLREASLVVPGDDERRVKVHDIICALALHISSVGLTPRTEKASSSSS
RSDPEKIWAVDAGTGLTDIRADYLEGSSIERLSLMHNNIDTLPEKTDFPELLSLMLQCNDSLPRVFPRGF
FKGMGCLQYLDLSNTTVEDIHGIGQLLCLEHLNLSGTPISKLPQEIRFLTRLKYLYLINTYSLEIIFAKS
FSGLHNLRVFNAYGSSFRFWATDGAADVDRASLSELNELINLKALGISVGTHSTFQKLFDMSIPIRYLYI
SDPDTAPIDISFNQLRLPSNTLRSRSKIDASLLEMTIKNCQDLEVVTIGEDRKGEPENADGGFCRLCTFK
GLEKLHLLHLGKLSNITWNGVKPCEYFPRLRLLRIVGCDKLRSITWTKQLPGLVKLYISGCSEVQQIIAE
EDEDVEQEGREVFPRLKEFILRDLPKLTSIYQRTLPFPNLVSLQVFRCPKLASLPFGEGSACRLQEIHGG
KEWWGNLKWANRASFDRHFKQAAS


>XP_042438777.1 disease resistance protein RPS2-like [Zingiber officinale]
MDLINPGATLITKLWDLIALKLAFIVNAGDNVRRLRLPMNRLKDKSIDVANRVSAAKAQLLTPTQEVLGW
LRRVEELEAEVSAIEQDFLNQPTCFCSCHYDLCSSYRIGRKVKRKASEATAMEAKSFDVVATDDSAPAVA
LDLPTRPDVGVESPLENAFQYLFDDQRCVIGVHGMGGVGKTTLLRRINNSFVGRSDFDLVIMVEASLDFK
IEHLQQAIADRVGLPLSQNGTSKSWAIEIKRSLNRKKFLLLLDNIWDPINLTDAGIPTGPSKCKIVISSR
FESTCAQMGAEKKIKMECLTPDKAWELFRQNLSGDLLNDPEIEDLAKQVAEDCNGLPLALVVVAATMSTR
TTREEWQYAVRQMRKMHLESLVPLEANLIPTLKLSYDNLPNDQLKLCFLSCSFYPRGHSILKEELIESWM
GLGFLEEHNDINEIYQKGHFLIGKLREASLVVPGDDERRVKVHDIICALALHISSVGLTPRTEKASSSSS
RSDPEKIWAVDAGTGLTDIRADYLEGSSIERLSLMHNNIDTLPEKTDFPELLSLMLQCNDSLPRVFPRGF
FKGMGCLQYLDLSNTTVEDIHGIGQLLCLEHLNLSGTPISKLPQEIRFLTRLKYLYLINTYSLEIIFAKS
FSGLHNLRVFNAYGSSFRFWATDGAADVDRASLSELNELINLKALGISVGTHSTFQKLFDMSIPIRYLYI
SDPDTAPIDISFNQLRLPSNTLRSRSKIDASLLEMTIKNCQDLEVVTIGEDRKGEPENADGGFCRLCTFK
GLEKLHLLHLGKLSNITWNGVKPCEYFPRLRLLRIVGCDKLRSITWTKQLPGLVKLYISGCSEVQQIIAE
EDEDVEQEGREVFPRLKEFILRDLPKLTSIYQRTLPFPNLVSLQVFRCPKLASLPFGEGSACRLQEIHGG
KEWWGNLKWANRASFDRHFKQAAS


>XP_042441287.1 putative disease resistance RPP13-like protein 1 [Zingiber officinale]
MGSEITIAGWLAALLKASTAKLAADQHLQDKAVEQNLKKLQFNLDKIITASQLDRKQIGSHSIKDWFSSF
KDAIYAADDVIEEFVQQLEKHKKQSSTSSTLRKSANFVSKMIQGGLFNGDDMKQLDEVTKTFDDVVSDIF
GLLKVVQQLEGSGGTKQQEIIPSWRLTTSPYKGRTTTIGRTSEGKKMLEALLEEGGGSTSNFCNFSVVCV
VGTGGIGKTDLARFAYNNEKVRRHFDLKAWVAVCNNFDEKRLTIEIIESASVERPSDLHSITSLEPIQNT
LAKGMKDKRFLIVLDDVWEDSNASWEHLTTPFTHGKEGSRIIVTTQLESVAKSTKAKETIHLDGLEEQEY
LALFKKCAFGDKDKVHQPTLESICTEIAKKYDGSPLAAVSIGLELRSDPTEEHWRRVARNKLGVIERREG
DIVSVLGFSYEQLPARLKQCYLACALFPKKHLFYKNQLIRIWTALRFVSADGNGGNPVDELASKSFFVNS
ISKREDGQFMLHAVLHELADLLCDGEFFRVEDEAGGQEIKIPQKARHVYVSKADNFVRVSEALAEKEQLR
SLVIDGSVPSDATLRANFMVSLETVLKKCKFLRLLMLPEKFPLESLVAIGRLSRLRCLDFHGIQRKALPQ
YLESLNLLQWPDLKQRPVASNLTKGGSRIWKQHSAGSEKDATSSASGPVRSTSNSSPNLPSP


>XP_042441290.1 disease resistance protein RGA2-like [Zingiber officinale]
MDPQVIVLTVIGWIVPHLVTLASLAIKKTLNNPPKDDQDKNLEEKAFKMIKVFDQIYPEITSSKIVKNSL
CDFKTFLIEEMEAIKENQKHDERRRNWKPDGTTMSDMLEEALDMRIMEVAEARQEDEEYKFRCTTGARKH
SVKLRGRDEETRGLLSWLLENSQRSSCSDSKKLSILSIVGLGGIGKTELARQAYNNDRADFGIKAWVSVC
KNCDVKKLTIEIMESADFKLLPSLHSMYSSEKIQSIFTEIIKDQRVLVVFDDVWEEFSTPWEELYASLSH
GRQGSRVIVTTQLERVAKLIGSDETINLDPLEHQEYWKLFEECAFGNQNPNNYPELQQLGQAIASKFEGS
PLAAVEIGRTLASNLTKRHWEKIAGSQFGVLQRSRGDILSALEFCYEQLPTRLKQCYLSCALFPKNYCFD
KDQLLRMWVALGFSPSLADEEIRSLAEDLASRSFFVNAERRNNKFMIHPVYHELADMICDGEFFRLEEET
EETKIPEKARHVYVKADILVKVCKGLGEKENLYSLVIDGSLSSGIPNSKSDFHNSLNKVLNDLKGLRVLI
LSELPGNRLLKSVRKLGHLGYLEIPSNKNRTVPESFLASYHRVQVNLNQVPRDLFIKCEGMDELAKLCGV
AADTQKKAISTTSLSRRKKRSRRRAARRDQLLREQ


>XP_042441291.1 putative disease resistance RPP13-like protein 1 [Zingiber officinale]
MGSEITIAGWLAALLKASTAKLAANQHLQEKAVEQNLKKLQFNLDKIITAAQLDRKQIGSHSIKDWFSSF
KDAIYSADDVIEEFVQQLEKDKKQSSTLSTLRKSANFVSKIIQGGQFNGDDMKQLDEVTKTFDNLVSDIF
ELLKVVQQLEGSGGTKQQEIIPSWRLTTSPYKGRTTTSGRGSEGKKMLEALLEEGGGSTSDCCNFSVVCV
VGTGGIGKTDLARFAYNNEKVRRHFDLKAWVAVCNNFDEKRLTIEIIESASVERPSDLHSITSLEPIQNT
LAKGMKDKRFLIVLDDVWEDSNASWEHLTTPFTHGKEGSRIIVTTQLESVAKSTKAKETIHLDGLEEQEY
LALFKKCAFGDKDKVHQPTLESICTEIAKKYDGSPLAAVSIGLELRSDPTEEHWRRVARNKLGVIERREG
DIVSVLGFSYEQLPARLKQCYLACALFPKKHLFYKNQLIRIWTALRFVSADGNGGNPVDELASKSFFVNS
ISKREDGQFMLHAVLHELADLLCDGEFFRVEDEAGGQEIKIPQKARHVYVSKADNFVRVSEALAEKEQLR
SLVIDGSVPSDATLRANFMVSLETVLKKCKFLRLLMLPEKFPLESLVAIGRLSRLRCLDFHGIQRKALPQ
YLESLNLLQWPDLKQRPVASNLTKGGSRIWKQHSAGSEKDATSSASGPVRSTSNSSPNLPSP


>XP_042441885.1 putative disease resistance RPP13-like protein 1 [Zingiber officinale]
MATDLGTWIRSLLNRSLTSPLPCDPPSSVEADLEKLKTILHRIHAVLYDAERRDIQYKSDQLRQKELKEL
AYDAEDVLDYYHYHILQSRAKAKASHKRKRDEEVLVDLTISSPQLSTCFTCINGKIGELDEIYEAGNVEK
LDEISRQIKKIYDRFTEIVESSIQFSFTQLDGEHIIEGSRHPPVASSMVNESCIFGREREKKELINLLLS
ENREENVSVICISGMAGKGKTTLAQIAYNNDRVRKHFDRKGWVGVPLDFDITKLTKSVLEAVTENACGLT
ELSTLQHALKNELWKKKVLLVLDNVWNVSSSNWESFLMPFVDAENVRIVITTRYEVVTEITQSQPYPLGE
LADVECWSLFTYYAFGGRNSRQAELCEIGEKIVQKCGRLPLAIKALACLLRNDTEVKCWDEVLKSEIWEL
EKENEILPALMLSYKYLPIHLKPLFLFCSMFPKGYLFEKDELVRFWMAHNYIQPRRCKRVEDVGQECFNE
LKERSFFDVVAETTKYKMHDMIRSLGQSIANKEFQAALSKDHADISDDVRHLFVKGKGEVVESLCFKKPN
VLRTLLYERLDVGVPRIPRALPKLRCLQHVFTDSTHESNSSYFPDLIHLRYLRVYNKEFGRFPESICQLY
NLQSLILDYCGDLEELPDGVGNLVNLRYIGLSSLNIARLPDSICQLSNLQKLKLNDCRKIKELPNGINNL
FHLRELTLCEMEISELPDSVCLLTNLQVLNLSGCGNFSGLPKDIGNLSNLYTLEVTKTEIQELPESFCRL
AKLQKLSLSGNWKLKDLPSNFGKLASLNYLELNDVGITLLPKCIVDLSLRYLRFSAVY


>XP_042442508.1 disease resistance protein RPM1-like [Zingiber officinale]
MAEAVIACLIEKIITAVASVSHSFLDRPVQNIHMKMNNIRRVLELTKAFLKHTRTYTGENELVDAWAKLI
QDVAYDIKDIVDEYIFLMTSGRWAGLITRINNDVKAKSLHELGKKLEEREASLWKLVRMKDSYGIRVPER
FSSSPEENDLICHLAESALSVEEDDLVGIEEIKYKLIRLLIDEEPQRTIISVLGMGGVGKTTLVARVYMN
QMVISHFSCCAWISVSKSNTVDDLLKKILKELHRERKEVITLDFDSMDYKTLVENLRLHLAHRRYLIILD
DVWQADVWTDISYALFANNCRSRVVITTRVQDVSSLAGEERIVRVNPLPDAMAWDLFCKKAFPTEVGNTC
PQNLIQWARKMVDECDGLPLAIAAIANLLSHKEREELTWKKIHDSLALSTNQDNQELQKVPRILSLSITN
LPHHLKNCLMHCSLFPEDYPIARNRLIRLWVAEGFVKERGGMSMEDVAEDYLNQLVGRSLLQVTDRNELG
RVRFCRVHDLVRELIIEKSREEHFVDVLEGEFKDVSDRVRRLSIIKDYQGATVNQSMEISSLRSFHTFTP
VPISVLLKCRLLRVLDLHAAPVEALPNAIGHLANLQYLSIRKTNVKRLPNSLGDLQKLETLDAIYTNIEE
LPSGIKKLGNLRHLLVKKFHRQTSKYTILGGGVEVPGGVGNLKGLQTLKAVVANGKMVLQLAKLTQIRSL
DVRGVTTQHSFVLSSSLSKMDRLARLVVMAKHKDDTLLLSDMKPPPQLRKLSLYGNLDKRMLPSWFSTLE
NLTHLVLKMSRLKEDPLPQLTALPNLVTLFLMQAYNGSKLQFHAQCFCRLRSLGLCDMSHLNCIEIEENA
LECLHEMTLVRCSQLKTIPVGLEHLTRLQKLEVEGMPIELVTKLQNGGETEEDSNRLKHIPIIKNWLGRD
GIWVEDRLK


>XP_042442820.1 putative disease resistance protein RGA1 [Zingiber officinale]
MSTALAIGGWFAQGFIQTLLDKASDSAVQRLAGLRGLDGDLRRLRASLFKIHALLDMAERRRCYSSNLVE
LMKQLKDASFDAENLLDEFEYQTLKHKIEGQASDFFTLAFNAAKNLFSADGDDFGSRLRAIQEKLCEIAA
DMIDIMQLLSMDDEGRQSTGKLVRRETSSFLTEEIVFGRDNEREKVIALLLGSAEGSESSNHVFSVLPLV
SIGGVGKTTLAQLVYNDDRVGNYFQLKIWICVSDDFDVKRLTKELIESTTKEEQSGLTNLDTLQSRLKEK
IELKRFLLVLDDVWSENKDEWDKLCAPLSFGAHGSKIIVTTRHTKVASIVGTVSTIFLHGLEDDALWELF
KKHAFASQIVVEEHPELVIIGRDIAGKLKGSPLAAKTLGSLLRSDLNEQHWRTIMESEVWQLPQQENEIL
PVLQLSYHYLSGHLKQCFAFCSVFRKDYIFCEHTLVSIWMAEGFIAPQENMRMEDVGSSCFHELVSRSFF
QETQRRGRFVMHDLIHDLAQFVSVGECHRVDGDKSEEIPKTICHLSATLTAQRKLMEFSGYHKLRTLMIN
YQNNQNQFVLRIETPLVPDDLFRRLKDIRVLSLQKCGMKELTETIGEIIHLRYLDISYNSGIVKLPESLC
VLYNLQVLRLCGCQLQGFPQGMSNLINLRQLHAADEIVSKVKEVGKLISLQELPIFKVLKYDDGHKLAQL
CDLKQLHGELTISNLENVNSEEEASLAKLKNKKYLDALKLEWKSGQESNLEKEHVSEEVLEGLQPHHSLR
SLTIRKFNGGVLPSWLQASPVLKLETLKLENCKRCRDLSCTGELPLLKVLHIKGMPQVKQISPSLCCHTK
SKFFQQLHELVLEDMLALEELPDLGQLPYLKSLQMKGMNALRCIGNGFHGANGSNWFLRLEKLRLQNMQA
MEELPFLGHLPCLKVIDVRQMPALKHIYHAHYDSIERNWFSTLEVMVLENMLSLEELPCLGRLPHVKYLR
LDVKKIAHGFFRVPSENNWLPKLEKLELKGIPGYQELPSLEQLPHLTVLHLDGMTSVKAIRQGCTFTAEQ
IKCFSRLEELVFRDMPAWEEWSWAEGGEHFSCLRRLKIAQCPKLKQLPSLPACLLELELIHVGLTELPGL
WKGTNGNSSSKISSVTRLHISECPSLRNLEEGLLSNHLPHINSILILDCVELMFLPVKKFAELTSLEMFS
VRHCPKLMMTQSQDIDLQLPTSIKILGLCNCASFGKSLPGCLYSLSLLTRLSISNCPHMETLPGEAMLHL
KQLWDVSIKSCVELRSIGGITFLSTLTRFELADCPKLLLNGMVEEGKCSSLLELRVDNTALLKVSPILHS
LPSIHFLYIFSSYQAVMFDGEDQGLLQSLTAIKCLEFGLCKNLKSLPTELHSLPSLKSLALFECPEIQSL
PEKRLPPFLTDLRFQGCHSLLTKKLEEHLQEIKNSGRFDSVFA


>XP_042443029.1 disease resistance protein RGA2-like [Zingiber officinale]
MDPHIIVLTVIGWIVPAVVTMAINKTLNNPPKDDKAKKLEEEIEKKSRIIAQLDEEITSNQIVKHGLWGV
KNVVGGAKEAIENYRKHDGRCRKVLFWKPDARTNWLEEAHGMLDQTDVDFGAVAVARQHDEEYKFRRTTG
ERKHFTKLRGRDAETRALLNWLENSQRSFSSSRKKLSILSVVGPGGIGKTELAREAYNARASFGIKAWVS
VCKNCDVKKMTIEIMDSADIKLPPGLHSINSPEQIRSIFTKRIKGQRVLVVFDDVWEGFSTAWEELYASL
SHGKQGSRVIVTTQLERVAKLIGSDETINLDPLEHQEYWKLFEECAFGNQNPNNYPELQQLGQAIAAKFE
GSPLAAVEIGRRLASNLTKRHWEKIAGSQFGELQRSRGDILSALEFCYEQLPTRLKQCYLSCALFPKNYC
FDKDQLLRLWVALGFAPSLADEEVRSLAEDLASRSFFVNAERRNNKFMIHPVYHELADMICDGEFFRLEE
ETEETKIPEKARHVYVKADILVKVCKGLGEKENLYSLVIDGSLSSGIPNSMSDFHNSLNKVLDDLKGLRV
LILPELPGNGSLRSIQKLSHLEYLEIPSNENRTLSKSFLARYRRGQVKLNQVSMDLFIKREGMDELAKLY
GVTADRQPEAISTASLGRRRRKRSLPRAARKDQLLKEQ


>XP_042443121.1 putative disease resistance protein RGA3 [Zingiber officinale]
MAYLDVRCILFDMLPSPAIVEQGRALGVARQLESIRLHLWAINAVTMDAELRGQEDWMATVGTTMVDLEV
LLTRIADRHETASDRWTSGPFLGLCASFRLACKLTKMVRRLRALVAEASALNLHEDTMRLMDPLREDYSD
ILKEEVLGRDGDRDEIVKSIQQQQPKEEDKFGDAPPCVIVIYGPSGMGKTTLARMVYHHDWVRRCFRHRI
WVNVSDLFSFDMVGVSTEIARSLAGGGPCMKLRSHLQSISEFVLGALAGDRYLLVLDGIDVKGEAADFET
SQSKLIQKWDQMTHQIFSVGAPGSTIIVAVADEYQAKIFKSATTHNLTALSENDWLDLFKKHAIKNRPDK
DEETAAAACTEDALLPFFKGCYEDFSGSPLEAKLLGSAFRHTEVKRWRREIVDLGLLKRSMRENQRYSTA
SFHHLPTRSARLHLYCSLFPELKRATPLEDFIHMMLVEGLVPDSGDRDEAIRYLKDNVVAGFHQQLTRSQ
HYFTWEVGREHSSRIPKQCRHLCLLLDSNAPISATALQGATKLRTLILRTTKNMQQKHQKYQFADLPDAI
FLQLFDYLRILHLADSKIQTLPRAIEKLSDLRYLNLSNSEIVELPGSLCSLQNLQVLKLNHCKMLLGLPG
EIHKLEKLRILKLAHCEKLQKLPDSVTSLVNLQELNVKGCCFLVELPEDFSGMQNLTELNMQECASLIRV
PCGIEQLSELRTLLGYSLVHPIGTWINFTSLTQLGLEKLEHDMAMQNIVRTKLLEQITNLENLALHWQWS
ERNDAANNDIQLDSLILLDHLEPRECLKKLEIFSYFGVAYPKWMESINNLIEIRLVNLKACKSLPPLGHL
PRLQIAVISGMEMVVMVADSFYAGGKFLRLRELTFSEMPNLRTWNTPGSENCGTEENEEYFPLLKELTLF
QCPKLKELNVFLGAWRLKMSLSNGLLLTSQIQKSWDNLKHLEELEIVGCQELERLPAAMANLKYLRKLTI
IWCNNLVALPNWLLGLRYLSRLQVSDCPNLSWMPQGLRQQQPGIAISVHDCPNLQLC


>XP_042443742.1 putative disease resistance RPP13-like protein 1 [Zingiber officinale]
MASEIFSLIASATSKLHALVSSSIISSEDVIQNLKDIKELVYEAKEQQRKMGDQSINQWLKQLKAVAVDA
EDLVEERLYDMTRIQVEDHQRNPRSIHHTKGKNEAKKDGERVISESSAFSRIIRFDIPINLLERIENIRY
LFGEISKGWKPQQVGQAGKKSLDLTNLNVCLHKFLTRGEQLLPRTSSRSRAFTVTETENFRELVILFTGI
DSDSSVEPTNRDLRSARSQVISPASSDPISSVTDDLIMKNMECVPEDCIQGDKQFDTPSSSSMAHGTAVS
QDTEALCLLDDDDKNCFFGYSKDSSLTNKIFGRDQDKENIIQWLLFDASSYSFAFTDGRRRSKFSVISIV
GTAAVGKTTLAKLVYDDPVVCEHFSARGWIHVGNDSSVARLSKAILSSITGKSCDEKEPNDLQTIVQREL
AGKRLLLVLDDIEDLNPSLWNTLQATLCGVRIVKFIITSPNEGDGNMWKLTKIYHLDVLPLDLSWDLFHE
CAFLSARAFYRGYTPPKTEIVDIGKKIVQKCKGLPLALKTLGSILSYQTNKQTWVGALESTLWDSTKNVI
LPALELSYYLLPKYLKPCFLFCSMFPRGYKFEKYELVRLWMALQYIASEGSKRVEDIACRYFYELQRMSF
FEKFWDGTFIMHDLIYNLSELMSEGECISIQGDLDTISDHVCHLHVLSCKRTHKSSFLEVKKNLRTFFCQ
SLDGTLPKFLSIPSDMTMQYLRALVLKVHGDSGDFTTNQEATLKQSKASSIMYSRFIHLRHLQICDKSII
ILPTSVCQLYNLQTLILNKCFMLRELPKELGNLLNLQCLAISESSIKRLPESVSQLFNLESLILDYCRNF
TDLPFRIQNLTNLHYVGLSGTSVGGLHESISDLQKLSILKLNDCKMFMELPNSIRYLTNLQSIQITHAKL
QRLPESVCHLPKLRLLDLSHSMVVELPSGIGELVELGYLGVSHTNICDLPESLCQLSSLHTLKLNGCRNL
SNLPSGIGALKNLHNLILSGTDIEELPVSLCQLWNLQTLELDGCTRFFRIPSHIGDLTNLCRIKLSDTAV
TELPSSLCQLPNLQMLDLNGCHKLSQLPSGIGNLSNLYQLEITETSIRELPKSLCQLSQLRKLNLNGNSN
LQELPSNIENLVNLRQLELSEVGIEVLPKSIAHLSKLYKLSFEYQQTPIASYL


>XP_042443935.1 putative disease resistance RPP13-like protein 1 [Zingiber officinale]
MANDFRTRIWSLCERFLTSPQSSEPPPSFQEDLEKLKTILDRIHAVLYDGERRDIEYRSDQVRLKELKNL
AHDAEDVLDDYYYYILRSRAEAKASHKRKRDEEVLVDLSNSSPQLSICFGNRINGNIGELDEISLQISEI
CHDGNVKKLDNISFQIRKIDDKFTEIVESSVQFSFTQHDGKHISEGSRDQPVTSSMVNESGIFGRVKEKK
EVINFLLSENREENVSVICISGMAGQGKTTLAQIAYNNERVCRHFDRKGWVYVPRDFDITKLTKSVLEAV
TVNAFDLTELNTLQHVLKNELWQKKVLLVLDNVWDVSSSNWESFLMPFVDAEKVRIVITTRNKVTEIMQR
QLYPLGELPDAECWSLFKHYAFGGLNSRQAELCEIGEKIVQKCGRLPLAIKALACLLRNGTEVKCWDEVL
KSEIWELEKENEILPALMLSYKYLPTHLKPLFLFCSMFPKGYLFEKDELVRFWMAHNYIQPRRCKRVEDV
GQECFNELKERSFFDVVAETTKYKMHDMIRSLGQSIANKEFQAALSKDHADISDDVRHLFVKGKGEIVES
LCFKKPNVLRTFLYERLDVGVPRIPRALPKLRCLQHVFTDSTHESNSSYFADLIHLRYLRVYNKEFGRFP
ESICQLYNLQSLILDYCGDLEELPDGIGNLVNLRYIGLSSLNIARLPDSICQLSNLQKLRLNDCRKIKEL
PNGINNLFHLRELTLCEMEISELPDSVCLLTNLQVLNLSGCGNFSGLPKDIGNLSNLYTLEVTKTEIQEL
PESFCRLAKLQKLSLSGNWKLKDLPSNFGKLASLNYLELNDVGIPMLPKCIFDLSLRSLRFSAVY


>XP_042443959.1 putative disease resistance protein RGA1 [Zingiber officinale]
MAYLDVRCILFDMLPSPAIVEQGRALGVARQLESIRLHLWAINAVTMDAELRGQEDWMATVGTTMVDLEV
LLTRIADRHETASDRWASGPFLGLCASFRLACKLTKMVRRLRVLVAEASALNLHEDTMRLMDPLREDYSD
ILKEEVLGRDGDRDEIVKSIQQQQPKEEDKFGDAPPCVIVIYGPSGMGKTTLARMVYHHDWVRRCFRHRI
WVNVSDLFSFDMVGVSTEIARSLAGGGPCMKLRSHLQSISEFVLGALAGDRYLLVLDGIDVKGEAADFET
SQSKLIQKWDQMTHQIFSVGAPGSTIIVTVADKYQAEIFKSATTHNLTALSENDWLDLFKKHAIKNRPDK
DEETAAAAFTEDALLPFLKGCYEDFSGSPLEAKLLGSAFRHTEVKRWRREIVDLGLLKRSMRENQRYSTA
SFHHLPTRFARLQLYCSLFPELKRATPLEDFIHMMLVEGLVPDSGDRDEAIRYLKDNVVAGFHQQLTRSQ
HYFTWEVGREHSSRIPKQCRHLCLLLDSNAPISATALQGATKLRTLILRTTKNMQQKHQKYQFADLPEAI
FLQLFDYLRILHLADSKIQTLPRAIEKLSDLRYLNLSNSEIVELPGSLCSLRNLQVLKLNHCKMLLGLPG
EIHKLEKLRILKLAHCEKLQKLPDSVTSLVNLQELNVKGCCFLVELPEDFSGMQNLTELNMQECASLIHV
PRGIEQLSELRRLLGYSLVHPIGTWINFTSLKQLGLEKLEHDMAMQNIVRTKLLEQITNLENLALHWQWS
ERNDAANNDIQLDSLILLDHLEPRECLKKLEIFSYFGVAYPKWMESINNLVEIRLVNLKACKSLPPLGHL
PRLQIAVISGMEMVVMVADSFYAGGKFLRLRELTFSEMPNLRTWNTPGSENCGTEENEEYFPLLKELTLF
QCPKLKELNVFLGAWRLKMSLSNGLLLTSQIQKSWDNLKHLEELEIVGCQEVLERLPAAMANLKYLRKLT
IIWCNNLVALPNWLLGLRHLSRLQVCDCPNLSWMPQGLKQQQPGIAISVHGCPNLQRC


>XP_042443968.1 putative disease resistance RPP13-like protein 1 [Zingiber officinale]
MGSEITIAGWLAALLKASTAKLAANQHLQEKAVEQNLKKLQFNLDKIITAAQLDRKQIGSHSIKDWFSSF
KDAIYSADDVIEEFVQQLAKDKKQSSTLSTLRKSANFVSKMIQGGQFNGDDMKQLDEVTKTFDDLVSDIF
ELLKVVQQLEGSGGTKQQEIIPSWRLTTSPYKGRTTTSGRGSEGKKMLEALLEEGGGSTSDCCNFSVVCV
VGTGGIGKTDLARFAYNNEKVRRHFDLKAWVAVCNNFDEKRLTIEIIESASVERPSDLHSITSLEPIQNT
LAKGMKDKRFLIVLDDVWEDSNASWEHLTTPFTHGKEGSRIIVTTQLESVAKSTKAKETIHLDGLEEQDY
LALFKKCAFGDKDKDHQPTLESICTEIAKKYDGSPLAAVSIGLELRSDPTEEHWKRVARNKLGVIERREG
DIVSVLGFSYEQLPARLKQCYLACALFPKKHLFYKNQLIRIWTALRFVSADGNGGNPVDELASKSFFVNS
ISKREDGQFMLHAVLHELADLLCDGEFFRVEDEAGGQEIKIPQKARHVYVSKADNFVRVSEALAEKEQLR
SLVIDGSVPSDATLRADFMVSLETVLKKCKFLRLLMLPEKFPLESVVAIGRLSRLRCLDFHGIQRKALPQ
YLESLNLLQWPDLKQRPEAWNLTKGGSRIRKQPSAGSEKDISSASGPIRSTSNSSANLPSP


>XP_042445238.1 disease resistance protein RGA2-like [Zingiber officinale]
MDPHIIVLTVIGWIVPAVVTMAINKTLNNPPKDDKAKKLEEEIEKKSRIIAQLDEEITSNQIVKHGLWGV
KNVVGGAKEAIENYRKHDGRCRKVFFWKPDARTNWLEEAHGMLDQTDVDFRAVAVARQNDEEYKFRRTTG
ERKHFTKLRGRDAETRALLNWLENSQRSFSSGSKKFSILSVVGPGGIGKTELAREAYNARASFGIKAWVS
VCKNCDVKKMTIEIMDSADIKLPPGLHSINSPEQIRSIFTKRIKGQRVLVVFDDVWEGFSTSWEELYASL
SHGKQGSRVIVTTQLERVAKLIGSDETINLDPLEHQEYWKLFEECAFGNQNPNNYPELQQLGQAIAAKFE
GSPLAAVEIGRRLASNLTKRHWEKIAGSQFGELQRSRGDILSALEFCYEQLPTRLKQCYLSCALFPKNYC
FDKDQLLRMWVALGFAPSLADEEIRSLAEDLASRSFFVNAERRNNKFMIHPVYHELADMICDGEFFRLEE
ETEETKIPEKARHVYVKADILVKVCKGLGEKENLYSLVIDGSLSSGIPNSKSDFHNSLNKVLDDLKGLRV
LILPELPGNGSLRSIQKLSHLEYLEIPSNENRTLSKSFLARYRRGQVKLNQVSRDLFIKREGMDELAKLY
GVTADWQPEAISTASLGRRRRKRSLPRAARKDQLLWEQ


>XP_042446008.1 putative disease resistance protein RGA3 [Zingiber officinale]
MDVVSPILDRARAKVIDKLIDKVSTYVQDQYYWKANLQEELQNLKRLLPQIQAVVGYAEDKLTMYESHNP
ALIKWLWQFRDDIDEAEEVLDELEYRELEKKYDGDKSRLSTIIDPYFRAAKRFLKSDDDVLERLRTCLEN
LKTSASDVEKFRALVTPTSGIGTGQMQQEQESLTLSNQSRITSCLPELSFKGREEEKGKIIQYLLGEESE
IQTSQNVHCLPLVAMGGMGKTALAQQVFDHFENEKKEHFDIKIWVCDSLPDLNASNLMKKILECLTDQSE
SGPLERIPVKLKEKLHSKRFLLVLDDAWDDKNQREWEKLRAPLLHGQKGSWIILTTRLESVAKMVSKVIK
GGTMKPMTLQGLPKDECRSLLYEHAFVDQDPNEFPLLKKIGEEIVEKLHGVPLLAKSIGGALNNKLEADH
WTSISGSELWKMPQDLNNYEFIPALTLSFKMLSPRLKRCFSYCSIFPQDYKFEKQKLVYMWVAAGLIYLD
GSEEGSDEDIANYCFDILCNKSFFDVHTDNWSAFQEGITPYGLEAIYYTMHDMLNGLSRHVSRYECCRIV
HDTPSYICDYNAIRHISISITSIDAQLGDLANMVCKFKHLRTLRIEKYYDNSQKLDDFIRDACKSPRRIR
VLIIESNQCLESISDFVKLRFLEISSQLPSLSICKFYFLQVLIGYNAILAKDTSKLTNLRHLYRVPYNVL
FSVAKVGKLTSLQELYFNVGTEPGYRIDELMNMNNLCELSISNLSNVHNLEEANNVNLVSKSYLTSLKLN
WKKAYWYESDQDEASSNIGHDQQEVLAALQPPSTIRKLIITKYKGGRPAPWMNPRSLSRLESLELYGCTN
LEELPPLWKLPCLKLIKLIDMKAIRSLGCHSSDPMERQFPVLEELEFRDLPLLEEWNGADDYQWFPPLKR
FKIENCPKLKKIPDLPLSIKNLCMKKLWLESLPRSYKCSNGSITFGGFQQLMSLKSLEMHGYSENVDIGS
IGEEDGNFLPSSLEILKLEILQKHKDLASYLRGLTSLIELSLSCLQGMTSLPLTNELEHLTTLRSLDIWN
CEDLTSPGGLYIIKSLKHLGIKDCPKFLTTDVES


>XP_042446009.1 putative disease resistance protein RGA3 [Zingiber officinale]
MDVVSPILDRARAKVIDKLIDKVSTYVQDQYYWKANLQEELQNLKRLLPQIQAVVGYAEDKLTMYESHNP
ALIKWLWQFRDDIDEAEEVLDELEYRELEKKYDGDKSRLSTIIDPYFRAAKRFLKSDDDVLERLRTCLEN
LKTSASDVEKFRALVTPTSGIGTGQMQQEQESLTLSNQSRITSCLPELSFKGREEEKGKIIQYLLGEESE
IQTSQNVHCLPLVAMGGMGKTALAQQVFDHFENEKKEHFDIKIWVCDSLPDLNASNLMKKILECLTDQSE
SGPLERIPVKLKEKLHSKRFLLVLDDAWDDKNQREWEKLRAPLLHGQKGSWIILTTRLESVAKMVSKVIK
GGTMKPMTLQGLPKDECRSLLYEHAFVDQDPNEFPLLKKIGEEIVEKLHGVPLLAKSIGGALNNKLEADH
WTSISGSELWKMPQDLNNYEFIPALTLSFKMLSPRLKRCFSYCSIFPQDYKFEKQKLVYMWVAAGLIYLD
GSEEGSDEDIANYCFDILCNKSFFDVHTDNWSAFQEGITPYGLEAIYYTMHDMLNGLSRHVSRYECCRIV
HDTPSYICDYNAIRHISISITSIDAQLGDLANMVCKFKHLRTLRIEKYYDNSQKLDDFIRDACKSPRRIR
VLIIESNQCLESISDFVKLRFLEISSQLPSLSICKFYFLQVLIGYNAILAKDTSKLTNLRHLYRVPYNVL
FSVAKVGKLTSLQELYFNVGTEPGYRIDELMNMNNLCELSISNLSNVHNLEEANNVNLVSKSYLTSLKLN
WKKAYWYESDQDEASSNIGHDQQEVLAALQPPSTIRKLIITKYKGGRPAPWMNPRSLSRLESLELYGCTN
LEELPPLWKLPCLKLIKLIDMKAIRSLGCHSSDPMERQFPVLEELEFRDLPLLEEWNGADDYQWFPPLKR
FKIENCPKLKKIPDLPLSIKNLCMKKLWLESLPRSYKCSNGSITFGGFQQLMSLKSLEMHGYSENVDIGS
IGEEDGNFLPSSLEILKLEILQKHKDLASYLRGLTSLIELSLSCLQGMTSLPLTNELEHLTTLRSLDIWN
CEDLTSPGGLYIIKSLKHLGIKDCPKFLTTDVES


>XP_042446010.1 putative disease resistance protein RGA3 [Zingiber officinale]
MDVVSPILDRARAKVIDKLIDKVSTYVQDQYYWKANLQEELQNLKRLLPQIQAVVGYAEDKLTMYESHNP
ALIKWLWQFRDDIDEAEEVLDELEYRELEKKYDGDKSRLSTIIDPYFRAAKRFLKSDDDVLERLRTCLEN
LKTSASDVEKFRALVTPTSGIGTGQMQQEQESLTLSNQSRITSCLPELSFKGREEEKGKIIQYLLGEESE
IQTSQNVHCLPLVAMGGMGKTALAQQVFDHFENEKKEHFDIKIWVCDSLPDLNASNLMKKILECLTDQSE
SGPLERIPVKLKEKLHSKRFLLVLDDAWDDKNQREWEKLRAPLLHGQKGSWIILTTRLESVAKMVSKVIK
GGTMKPMTLQGLPKDECRSLLYEHAFVDQDPNEFPLLKKIGEEIVEKLHGVPLLAKSIGGALNNKLEADH
WTSISGSELWKMPQDLNNYEFIPALTLSFKMLSPRLKRCFSYCSIFPQDYKFEKQKLVYMWVAAGLIYLD
GSEEGSDEDIANYCFDILCNKSFFDVHTDNWSAFQEGITPYGLEAIYYTMHDMLNGLSRHVSRYECCRIV
HDTPSYICDYNAIRHISISITSIDAQLGDLANMVCKFKHLRTLRIEKYYDNSQKLDDFIRDACKSPRRIR
VLIIESNQCLESISDFVKLRFLEISSQLPSLSICKFYFLQVLIGYNAILAKDTSKLTNLRHLYRVPYNVL
FSVAKVGKLTSLQELYFNVGTEPGYRIDELMNMNNLCELSISNLSNVHNLEEANNVNLVSKSYLTSLKLN
WKKAYWYESDQDEASSNIGHDQQEVLAALQPPSTIRKLIITKYKGGRPAPWMNPRSLSRLESLELYGCTN
LEELPPLWKLPCLKLIKLIDMKAIRSLGCHSSDPMERQFPVLEELEFRDLPLLEEWNGADDYQWFPPLKR
FKIENCPKLKKIPDLPLSIKNLCMKKLWLESLPRSYKCSNGSITFGGFQQLMSLKSLEMHGYSENVDIGS
IGEEDGNFLPSSLEILKLEILQKHKDLASYLRGLTSLIELSLSCLQGMTSLPLTNELEHLTTLRSLDIWN
CEDLTSPGGLYIIKSLKHLGIKDCPKFLTTDVES


>XP_042446149.1 disease resistance protein RGA2-like [Zingiber officinale]
MYVCMLHIVTGTGEMLPDFCLAGTPLGRDSIYAGMKEMCQLLQADASDGQYQSDLASATRETSSFLISKV
LGREEEQKRIIELLLRSTDESASASDKGSSFSVIPLVGIGGVGKTTLAQLVYKDKEIQNHFGLKIWICVS
ENFNVQRLTKEIIESVTKTEHSSQMKLDVLQNILKEKIASKMILLVLDDVWNEDEEEWRKLCAPFQDAAA
GSKVIVTTRSKSIADKIGTVEAIVLGDLDKISFWELFKKCAFGPSKPEEYPELEEIGRIIASKLKGLPLA
AKTVGNLLGSNMNPHYWRSIMKSEVWELQQNKNDIIPVLQLSYQYLSAPLKRCFAFCSLFQKDYKFSEIE
LTRMWMAEGFVVAQGNQRMEDVASKYFHELVNMSLFQQETSWLGHYYVMHDLIHDLTQAVSVDEISRTND
GKSNKISTTLRHLALETGFVQTKYLRSRFKKLHSLFFRCLHLKSPPIGFIKKLRSIRVLVLSRCRLRMLP
ISVGELVHLRYLDISYNGIKKLPGSLCELYNLQTLKANCNSLISLPEDISQIINLRHIDVENEVVVKIKM
IGRLTSLQELSEFHVRKEVGFKITELSGLKQLHGKLKITNLENVESKEEAEKAQMKNKEYLDALELGWGF
DPKLDDNKLVVMEEVLEGLQPHESLKRLKIRRYCGATSPSWMKKEELSNLEILELSYCESWKDISCTALL
PHLKVFHIKSMCFSKSCFEVCGSRESKLFPMLEELQLTNMNVLEEFPNLGRFPCLRVVRMTEIKSLKHID
FATFGATENALFPMLEELELMHMHALEELSFLGHFPRLKFLRMKEMRLLKHIGFASVHATENDPFPVLEV
LELMDLPVLEELPDLGSLPCLKSLCLCGMSMLKHIDFSFYGATEKVLLPRVETLVLRDLEALEELPNNLG
RLPCLKVLNILKISAVKQIGHGFFSTEAISKCFLSLERLWIGSMSACEGWCWIDGSELFPSLQRLFITEC
PKLERLPPLPPSLTHLTLEKVGSTELPSLRELETNGSGYNQTTSSLSYLRISECNNLASLEKGLMSQNLS
DIEAIHVEGCNELMRMPLKRFENFTSLKELQIKACPKLSLTQEEEAALLPPSFKVFILNDCGDLNKLWLG
HPYRSTF


>XP_042446150.1 disease resistance protein RGA2-like [Zingiber officinale]
MYVCMLHIVTGTGEMLPDFCLAGTPLGRDSIYAGMKEMCQLLQADASDGQYQSDLASATRETSSFLISKV
LGREEEQKRIIELLLRSTDESASASDKGSSFSVIPLVGIGGVGKTTLAQLVYKDKEIQNHFGLKIWICVS
ENFNVQRLTKEIIESVTKTEHSSQMKLDVLQNILKEKIASKMILLVLDDVWNEDEEEWRKLCAPFQDAAA
GSKVIVTTRSKSIADKIGTVEAIVLGDLDKISFWELFKKCAFGPSKPEEYPELEEIGRIIASKLKGLPLA
AKTVGNLLGSNMNPHYWRSIMKSEVWELQQNKNDIIPVLQLSYQYLSAPLKRCFAFCSLFQKDYKFSEIE
LTRMWMAEGFVVAQGNQRMEDVASKYFHELVNMSLFQQETSWLGHYYVMHDLIHDLTQAVSVDEISRTND
GKSNKISTTLRHLALETGFVQTKYLRSRFKKLHSLFFRCLHLKSPPIGFIKKLRSIRVLVLSRCRLRMLP
ISVGELVHLRYLDISYNGIKKLPGSLCELYNLQTLKANCNSLISLPEDISQIINLRHIDVENEVVVKIKM
IGRLTSLQELSEFHVRKEVGFKITELSGLKQLHGKLKITNLENVESKEEAEKAQMKNKEYLDALELGWGF
DPKLDDNKLVVMEEVLEGLQPHESLKRLKIRRYCGATSPSWMKKEELSNLEILELSYCESWKDISCTALL
PHLKVFHIKSMCFSKSCFEVCGSRESKLFPMLEELQLTNMNVLEEFPNLGRFPCLRVVRMTEIKSLKHID
FATFGATENALFPMLEELELMHMHALEELSFLGHFPRLKFLRMKEMRLLKHIGFASVHATENDPFPVLEV
LELMDLPVLEELPDLGSLPCLKSLCLCGMSMLKHIDFSFYGATEKVLLPRVETLVLRDLEALEELPNNLG
RLPCLKVLNILKISAVKQIGHGFFSTEAISKCFLSLERLWIGSMSACEGWCWIDGSELFPSLQRLFITEC
PKLERLPPLPPSLTHLTLEKVGSTELPSLRELETNGSGYNQTTSSLSYLRISECNNLASLEKGLMSQNLS
DIEAIHVEGCNELMRMPLKRFENFTSLKELQIKACPKLSLTQEEEAALLPPSFKVFILNDCGDLNKLWLG
HPYRSTF


>XP_042446332.1 putative disease resistance protein RGA3 [Zingiber officinale]
MADGWMDKKGRTLINLLVNGTKGNVFVESVNTSGYSYTMDKMFELLYKFVYCIGENNMVHIITDNASRNV
NAGKDCSRVLCTVHQQSGAVREWKALLCSIPTANPEFQHKARLQIEKCSSHLLLISQGKQNSEKLQRIAE
FLIAESSSLKSIKDLSYFESKQYNAFDVTKQIYGRNSDREHIISWLLLGTNSRFSLFEDERSRNKFSAIA
IVGEAGVGKTALAKEVYNDPLICKYFNSRVWLHFTEESDAVSLSKAFFVSITGKSCDGKEPVHLQSVMKE
TLKGKKLLLVLDDPHDLNPRLWEYLQAPLAGVRMAKFIITSLTELDASKLRGIESYPLGCLHIDLSWDLF
QYYAFREDSSHPPELVEIGKYIVQKCRGLPIAVKTLGSLLGYQMDRRIWIDVLESELWKLQETENDISPA
LQLSYYLLPTYLKPCFLYCSLFPRGCKFDKYELVRLWMAQGYIQHEDEDEDDQSLETVGCNYFHELQMLT
IFDRSWDGTFTIHDLLYDVSKYMSNGECSSLSDGKMYTDSGKIRQLYVTSSKKTNELHSSNENLTLQLLY
KSLGGVLPNDILTMALIKSMQGIRALELTHHGDSSIAETIQERALDKLNASSVSNLRFIHLRYLRICDRF
IELLPAAVCQLYNLQTLTLDKCLKLRELPSDICMLVNLRYLELSEANIEMFPESICLLRNLQSLIVDYCR
NLKELPRNIGNLFNLCHLGLCGTSIKRLPESVDRLSKLPTLKLDHCKILMELPSSIGNLVNLQHVTVCKT
KITKLPESLCLLSNLLTLDLAYSNLSELPNDIGNLSNLNYLALSYTNISILPEALCQLTSLRTLKLNGCT
NLSQLPSGIGALKRLSHLVVSGIDIEHMPASVCQLFSLEALEMDGCRRFFSLPDDIGYLTELRQLKLSDT
EIQELPESICQLSKLQNLELNGCQRLSKLPESIGDLSELSNLEVTETKIKALPVSFCRLSNLQVLNLNGN
LDLQELPSGIENLANLSQLELSEVGIEVLPRCIGRLTNLEKLSFEHKQKPFENYQL


>XP_042446333.1 putative disease resistance protein RGA3 [Zingiber officinale]
MANNPFSSFGSKIDDLLPLLAEATIGLSDVAAGSSPEVPLKELKDIKAILKNIKGLLYDSGRQIREDAIK
LLLKELQDLVIEVEDLVDDYEYKMFQREAEFLNKIEQPSGYVSSDRLRGLDGGAMHSPGLDGGAKSCVTG
SSPGLGGGARSPINPSPELSVGASPSSGLDVGASHHSCITDFSSGLGGGARSTIDPSPEFSEGAGHSSGL
DGGASSCITTDPSSGLGGGASHSPGSRGGVSQCTTHLTLALRRVQWIWMELREQLRKSQKFASHLLLVSQ
ENQTFKKLQRVRKFLLAESEDTIRGRKHYNAFDVTKQIYGRNTDREHIISWLLLGTNSRFSLFEDERSRN
KFSAISIVGEAGVGKTALAKEVYNDPLVCKYFNSRVWLHFTEESDAVSLSKAFFVSITGKSCDGKEPVHL
QSVMKEELKGKKLLLVLDDLQDLNPRLWKYLQAPLAGVRMAKFIITSQTELGTSKSRGIESYPLGRLSLD
LSWNVFQHYAFCEDSSCPPELIEIGKHIVQKCWGLPLAVKTLGSLLGYQMDKRIWIDVLDSELWELQESE
THICPALQLSYYLLPTYLKPCFLYCSLFPRGYKFDKYELVRLWMAQGYIQHKYGQSLETVGCNYFHELQM
LTIFDRSWDGTFTIHDLLYDVSKYMSNGECSSLPNVKMYKDSGKIRQLYVTSSKGTNELQSSNAILTLQL
LYRSLGGFLPNDILTMALIESVQGIRALELTCHADSSIAETIQEKALDKLNASSVSSLRFIHLRYLRICD
RFIELLPAAVCELYNLQTLTLDKCLKLRELPSDIGKLVNLRYLGLSEANIEKLPKSVYQLRNLQSLKVDY
CRNLKDLPYNIGSLVNLCHLGLSGTSIKRLPRSVHRLSKLSTLKLDQCKILMELPSSIGNLVNLRHVTAC
KTKITKLPESICSLFNLLTLDLAYSNLSELPNDIGNLSNLNYLALSYTNISILPESFMLLFLASILNSLS
ASVCQLLNLEVLEMDGCRRFFSLPDGIGYLTKLHQLKLSDTEIRELPESIGQLSNLQNLDLNGCQRLSKL
PESIGYLSELSNLEVTETKIKTLPASFCQLSNLKVLNLNGNLDLQELHSGIENLANLSQLELSEVGIEVL
PRCIGRLANLEKLSFEHKQKPFENYQL


>XP_042446810.1 disease resistance protein RGA2-like isoform X1 [Zingiber officinale]
MEGAAALAVGGWLAKPVIRMLVDRVSTSSLRGKLHGLQDDDLQKLQRSLLNIHTIVDKAGMRWSRDARLV
EMTKQLQDAAYDAEDFLDDLTFHDMKQKIEEEASHMASNRISRAIRNAKAKLFSDSVKRLNKIQKKLDDI
YADMEKMCQSLQVDASDVQYQSDLASATRETSSFLISNVLGREEEQKRIIELLLRSTDESASASDKGSSF
SVIPLVGIGGVGKTTLAQLVYKDKEIQNHFALKIWICVSENFNVQRLTKEMIESVTKTELSSQMKLDVLQ
NILKEKIASKMVLLVLDDVWNEEEEEWRKLCAPFMYAAAGSKVIMTTRSKSIADKIGTVEAIVLGDLDEI
SFWELFKQCAFGSSKPEEHPALVEIGRSIASKLKGLPLAAKTVGNLLGSNMNPDHWRSIMKSEVWELQQN
NKNDIIPVLQLSYQYLSAPLKRCFAFCSLFQKDYKFSEIELTRMWMAEGFVVAQGNQRIEDVASKYLHEL
VNMSLFQQETSSSSEHYFVMHDLIHDLTQSVYVDETSRMDNGKSNKISTTLRHLAVETEFVETKELRSRF
KKLHSLFCQHLKSLPLDFIEKLRSIRVLVLYDCGLQMLPTSVGELVHLRYLDIAYNEMEELPESLCELYN
LQTLTASYNSLISLPEDISQLVFLRHLDVENQIVVKIKMIGRLTSLQELSEFQVRKEVGFMITELSGLQQ
LHGKLKITNLENVESKEEAEKAQMKNKEYLNALELEWGFDHKLDDNKLVAMENVLEGLQPHESLKQLKIR
RYCGARSPSWMKKEELSNLERLELSYCESWKDISCTALLPHLKVFHIDQSMWFSKSCFEVCGSRESKLFP
MLEELQLRNMNASEELPNLGRFPCLRVIRMTEIKSLKHIDFAASGAIENSLFPMLEELELRGMPALEEIS
NLGHFPRLKVLHMMRMRLLKHIDFAASCAIENSLFPMLEVLELRDMHALEKLSTLGHFPRLRVLHMIRTW
SLKHIVFAASGAIENSLFPMLEELDLRYMPALEEFSSRGHFPRLRVLGMVAMPLLKHIGFASVHATENDL
FPALEVLELMDLPVLEELPDLGSLPCLKSFHMRRMSMLKHIDFAFYGATKKVILPKVETLVLDDLEALEE
LPSNLGRLPCLKVLKIVKISAVKQIAHGFFSTEVISKCFLSLESLWISDLPACERWCWIGGSELFPSLQK
LTIYECPKLERLPPLPPSLRYLSLREVGLTELPSLQELETNGSGDNQTTSSLSDLRIIECNNLTSFEEGL
LSQNLSNIKDIYVAGCNELMWMPLKRFENFTSLKELQIKACPKLSLTQEEEAALLPPSFKVFILNDCGDL
NKLWLGHPYRSTF


>XP_042446811.1 disease resistance protein RGA2-like isoform X1 [Zingiber officinale]
MEGAAALAVGGWLAKPVIRMLVDRVSTSSLRGKLHGLQDDDLQKLQRSLLNIHTIVDKAGMRWSRDARLV
EMTKQLQDAAYDAEDFLDDLTFHDMKQKIEEEASHMASNRISRAIRNAKAKLFSDSVKRLNKIQKKLDDI
YADMEKMCQSLQVDASDVQYQSDLASATRETSSFLISNVLGREEEQKRIIELLLRSTDESASASDKGSSF
SVIPLVGIGGVGKTTLAQLVYKDKEIQNHFALKIWICVSENFNVQRLTKEMIESVTKTELSSQMKLDVLQ
NILKEKIASKMVLLVLDDVWNEEEEEWRKLCAPFMYAAAGSKVIMTTRSKSIADKIGTVEAIVLGDLDEI
SFWELFKQCAFGSSKPEEHPALVEIGRSIASKLKGLPLAAKTVGNLLGSNMNPDHWRSIMKSEVWELQQN
NKNDIIPVLQLSYQYLSAPLKRCFAFCSLFQKDYKFSEIELTRMWMAEGFVVAQGNQRIEDVASKYLHEL
VNMSLFQQETSSSSEHYFVMHDLIHDLTQSVYVDETSRMDNGKSNKISTTLRHLAVETEFVETKELRSRF
KKLHSLFCQHLKSLPLDFIEKLRSIRVLVLYDCGLQMLPTSVGELVHLRYLDIAYNEMEELPESLCELYN
LQTLTASYNSLISLPEDISQLVFLRHLDVENQIVVKIKMIGRLTSLQELSEFQVRKEVGFMITELSGLQQ
LHGKLKITNLENVESKEEAEKAQMKNKEYLNALELEWGFDHKLDDNKLVAMENVLEGLQPHESLKQLKIR
RYCGARSPSWMKKEELSNLERLELSYCESWKDISCTALLPHLKVFHIDQSMWFSKSCFEVCGSRESKLFP
MLEELQLRNMNASEELPNLGRFPCLRVIRMTEIKSLKHIDFAASGAIENSLFPMLEELELRGMPALEEIS
NLGHFPRLKVLHMMRMRLLKHIDFAASCAIENSLFPMLEVLELRDMHALEKLSTLGHFPRLRVLHMIRTW
SLKHIVFAASGAIENSLFPMLEELDLRYMPALEEFSSRGHFPRLRVLGMVAMPLLKHIGFASVHATENDL
FPALEVLELMDLPVLEELPDLGSLPCLKSFHMRRMSMLKHIDFAFYGATKKVILPKVETLVLDDLEALEE
LPSNLGRLPCLKVLKIVKISAVKQIAHGFFSTEVISKCFLSLESLWISDLPACERWCWIGGSELFPSLQK
LTIYECPKLERLPPLPPSLRYLSLREVGLTELPSLQELETNGSGDNQTTSSLSDLRIIECNNLTSFEEGL
LSQNLSNIKDIYVAGCNELMWMPLKRFENFTSLKELQIKACPKLSLTQEEEAALLPPSFKVFILNDCGDL
NKLWLGHPYRSTF


>XP_042446812.1 disease resistance protein RGA2-like isoform X2 [Zingiber officinale]
MEGAAALAVGGWLAKPVIRMLVDRVSTSSLRGKLHGLQDDDLQKLQRSLLNIHTIVDKAGMRWSRDARLV
EMTKQLQDAAYDAEDFLDDLTFHDMKQKIEEEASHMASNRISRAIRNAKAKLFSDSVKRLNKIQKKLDDI
YADMEKMCQSLQVDASDVQYQSDLASATRETSSFLISNVLGREEEQKRIIELLLRSTDESASASDKGSSF
SVIPLVGIGGVGKTTLAQLVYKDKEIQNHFALKIWICVSENFNVQRLTKEMIESVTKTELSSQMKLDVLQ
NILKEKIASKMVLLVLDDVWNEEEEEWRKLCAPFMYAAAGSKVIMTTRSKSIADKIGTVEAIVLGDLDEI
SFWELFKQCAFGSSKPEEHPALVEIGRSIASKLKGLPLAAKTVGNLLGSNMNPDHWRSIMKSEVWELQQN
NKNDIIPVLQLSYQYLSAPLKRCFAFCSLFQKDYKFSEIELTRMWMAEGFVVAQGNQRIEDVANETSRMD
NGKSNKISTTLRHLAVETEFVETKELRSRFKKLHSLFCQHLKSLPLDFIEKLRSIRVLVLYDCGLQMLPT
SVGELVHLRYLDIAYNEMEELPESLCELYNLQTLTASYNSLISLPEDISQLVFLRHLDVENQIVVKIKMI
GRLTSLQELSEFQVRKEVGFMITELSGLQQLHGKLKITNLENVESKEEAEKAQMKNKEYLNALELEWGFD
HKLDDNKLVAMENVLEGLQPHESLKQLKIRRYCGARSPSWMKKEELSNLERLELSYCESWKDISCTALLP
HLKVFHIDQSMWFSKSCFEVCGSRESKLFPMLEELQLRNMNASEELPNLGRFPCLRVIRMTEIKSLKHID
FAASGAIENSLFPMLEELELRGMPALEEISNLGHFPRLKVLHMMRMRLLKHIDFAASCAIENSLFPMLEV
LELRDMHALEKLSTLGHFPRLRVLHMIRTWSLKHIVFAASGAIENSLFPMLEELDLRYMPALEEFSSRGH
FPRLRVLGMVAMPLLKHIGFASVHATENDLFPALEVLELMDLPVLEELPDLGSLPCLKSFHMRRMSMLKH
IDFAFYGATKKVILPKVETLVLDDLEALEELPSNLGRLPCLKVLKIVKISAVKQIAHGFFSTEVISKCFL
SLESLWISDLPACERWCWIGGSELFPSLQKLTIYECPKLERLPPLPPSLRYLSLREVGLTELPSLQELET
NGSGDNQTTSSLSDLRIIECNNLTSFEEGLLSQNLSNIKDIYVAGCNELMWMPLKRFENFTSLKELQIKA
CPKLSLTQEEEAALLPPSFKVFILNDCGDLNKLWLGHPYRSTF


>XP_042446865.1 putative disease resistance protein RGA3 isoform X1 [Zingiber officinale]
MKKILEYSTGQSESGPSELIPVKLKDKLHSKRFLLVLDDAWDDKNHTEWEKLCIPLLHGQKGSWILLTTR
LESVAKMVSKIIKGGTMKPMTLQGLPKDECRSLLYEHAFVDQDPNEFPLLKKIGEEIVEKLHGVPLLAKS
IGGALNNKLEADHWTSISRSELWKMSQDLNNYEFIPALTLSYKMLPPRLKQCFSYCSIFPQDYTFKKQKL
VCIWVAAGLIYSDGSEEGSDEDIANYCFDMLCNKSFFDVHTNKWSAFQQDIAPYALEVIFYTMHDMLNGL
SRHVSRYECCRIVHDTPSYICDYNAIRHISISITSIDAQLGDLANMVCKFKNLRTLRIEQYYGDSQKLDD
FIRDACKSPRRIRVLTIRPYKYFESISDFVKLRFLEITTLPPSVSISKFYFLQVLTGYRGILAKDTSKLR
NLRHLYRVPENALFSVAEVGKLTCLQELCFTVGIEPGYRIDELMNMDNLRQLSIAKLSNVHSLEEANNVD
LVSKSHLTSLELNWYKPDLDEASSNLGHDQQEVLAALQPPPTIRKLIIREYKGGRPAPWMNTQSLSRLES
LELYNCTNLEELPPLWKLPCLKFIKLSDMKVIRSLGCHSSDMMDRQFSVLEKLEFRDLPLLEEWNGADDY
QWFPCLKRFEIEKCPKLKKIPDLPLSIENLCMKKLGLEALPRFYKCSNGSTTFEGFQQLMSLEFLEMDDY
SEIVDIGSIGEEDGNFLPSELKKLKLKILNKHEDLASYLRGLTSLTELSLSRLQGMTSLPLTNELEHLTT
LRSLYICDCEDLTSPGDVYIIKSLKHLYMYNCPKFLTAEVESQQLLKDKTRKHAASSSSVFDHSTSNKAA
STLPSSLESLTFSTSKISQESLGCCLQGLTSLKSLDISKCNHLVSLPNIEYLHNLTVLWISDCEELCKLE
SLTALISLRQLFISNCPKLIATTMSTVQNPAATTEQSATKIKKGTLPSIETIQIDNIFCLSILPIPEKLK
TLSILNEITCFPSEIEEYRESLNIGTDPSSAIFTHNFGEFFIAQGS


>XP_042446866.1 putative disease resistance protein RGA3 isoform X1 [Zingiber officinale]
MKKILEYSTGQSESGPSELIPVKLKDKLHSKRFLLVLDDAWDDKNHTEWEKLCIPLLHGQKGSWILLTTR
LESVAKMVSKIIKGGTMKPMTLQGLPKDECRSLLYEHAFVDQDPNEFPLLKKIGEEIVEKLHGVPLLAKS
IGGALNNKLEADHWTSISRSELWKMSQDLNNYEFIPALTLSYKMLPPRLKQCFSYCSIFPQDYTFKKQKL
VCIWVAAGLIYSDGSEEGSDEDIANYCFDMLCNKSFFDVHTNKWSAFQQDIAPYALEVIFYTMHDMLNGL
SRHVSRYECCRIVHDTPSYICDYNAIRHISISITSIDAQLGDLANMVCKFKNLRTLRIEQYYGDSQKLDD
FIRDACKSPRRIRVLTIRPYKYFESISDFVKLRFLEITTLPPSVSISKFYFLQVLTGYRGILAKDTSKLR
NLRHLYRVPENALFSVAEVGKLTCLQELCFTVGIEPGYRIDELMNMDNLRQLSIAKLSNVHSLEEANNVD
LVSKSHLTSLELNWYKPDLDEASSNLGHDQQEVLAALQPPPTIRKLIIREYKGGRPAPWMNTQSLSRLES
LELYNCTNLEELPPLWKLPCLKFIKLSDMKVIRSLGCHSSDMMDRQFSVLEKLEFRDLPLLEEWNGADDY
QWFPCLKRFEIEKCPKLKKIPDLPLSIENLCMKKLGLEALPRFYKCSNGSTTFEGFQQLMSLEFLEMDDY
SEIVDIGSIGEEDGNFLPSELKKLKLKILNKHEDLASYLRGLTSLTELSLSRLQGMTSLPLTNELEHLTT
LRSLYICDCEDLTSPGDVYIIKSLKHLYMYNCPKFLTAEVESQQLLKDKTRKHAASSSSVFDHSTSNKAA
STLPSSLESLTFSTSKISQESLGCCLQGLTSLKSLDISKCNHLVSLPNIEYLHNLTVLWISDCEELCKLE
SLTALISLRQLFISNCPKLIATTMSTVQNPAATTEQSATKIKKGTLPSIETIQIDNIFCLSILPIPEKLK
TLSILNEITCFPSEIEEYRESLNIGTDPSSAIFTHNFGEFFIAQGS


>XP_042446867.1 putative disease resistance protein RGA3 isoform X1 [Zingiber officinale]
MKKILEYSTGQSESGPSELIPVKLKDKLHSKRFLLVLDDAWDDKNHTEWEKLCIPLLHGQKGSWILLTTR
LESVAKMVSKIIKGGTMKPMTLQGLPKDECRSLLYEHAFVDQDPNEFPLLKKIGEEIVEKLHGVPLLAKS
IGGALNNKLEADHWTSISRSELWKMSQDLNNYEFIPALTLSYKMLPPRLKQCFSYCSIFPQDYTFKKQKL
VCIWVAAGLIYSDGSEEGSDEDIANYCFDMLCNKSFFDVHTNKWSAFQQDIAPYALEVIFYTMHDMLNGL
SRHVSRYECCRIVHDTPSYICDYNAIRHISISITSIDAQLGDLANMVCKFKNLRTLRIEQYYGDSQKLDD
FIRDACKSPRRIRVLTIRPYKYFESISDFVKLRFLEITTLPPSVSISKFYFLQVLTGYRGILAKDTSKLR
NLRHLYRVPENALFSVAEVGKLTCLQELCFTVGIEPGYRIDELMNMDNLRQLSIAKLSNVHSLEEANNVD
LVSKSHLTSLELNWYKPDLDEASSNLGHDQQEVLAALQPPPTIRKLIIREYKGGRPAPWMNTQSLSRLES
LELYNCTNLEELPPLWKLPCLKFIKLSDMKVIRSLGCHSSDMMDRQFSVLEKLEFRDLPLLEEWNGADDY
QWFPCLKRFEIEKCPKLKKIPDLPLSIENLCMKKLGLEALPRFYKCSNGSTTFEGFQQLMSLEFLEMDDY
SEIVDIGSIGEEDGNFLPSELKKLKLKILNKHEDLASYLRGLTSLTELSLSRLQGMTSLPLTNELEHLTT
LRSLYICDCEDLTSPGDVYIIKSLKHLYMYNCPKFLTAEVESQQLLKDKTRKHAASSSSVFDHSTSNKAA
STLPSSLESLTFSTSKISQESLGCCLQGLTSLKSLDISKCNHLVSLPNIEYLHNLTVLWISDCEELCKLE
SLTALISLRQLFISNCPKLIATTMSTVQNPAATTEQSATKIKKGTLPSIETIQIDNIFCLSILPIPEKLK
TLSILNEITCFPSEIEEYRESLNIGTDPSSAIFTHNFGEFFIAQGS


>XP_042446934.1 putative disease resistance RPP13-like protein 1 [Zingiber officinale]
MEGAAALAVGGWLAKPVIRMLVDRVSTSSLRGKLHGLQDDDLQKLQRSLLNIHTIVDKAGMRWSRDARLV
EMMKQLQDAAYDAEDFLDYLTFHGMKQKIKEEASHMAGNRISRAIRNAKAKLFSDSVKRLNKIQKKLDCI
YADMKEMCQLLQADASDGQYQSDLASATRETSSFLISKVLGREEEQKRIIELLLRSTDESASASDKGSSF
SVIPLVGIGGVGKTTLAQLVYKDKEIQNHFALKIWICVSENFNVQRLTKEIIESVTKTEHSSQMKLDVLQ
NILKEKIASKMILLVLDDVWNEDEEEWRKLCAPFEDAPAGSKVIVTTRSKSIADKIGTVEAIVLGDLDKI
SFWELFKKCAFGPSKPEEYPELEEIGRIIASKLKGLPLAAKTVGNLLGSNMNPHYWRSIMKSEVWELQQN
KNDIIPVLQLSYQYLSAPLKRCFAFCSLFQKDYKFSEIELTRMWMAEGFVVAQGNQRIEDVASKYLHELV
NMSLFQQETSSSSEHYFVMHDLIHDLTLSVSVDETSRMNDGKSNKISTTLRHVALETEFVEIKYLRSRFK
KLHSLFFRCLLLKSPPIDFIKKLRSIRVLVLSRCGLRMLPTSIGELVHLRYLDISYNGIKKLPESLCELY
NLQTLIAKDNSLISLPEDISELYNLETLIDNSLISLPEDISSGLYNLQTPIAKGKPLISLPEDISQLINL
RHIDVENEVAVKIKMIGRLTSLQELSEFQVRKEVGFKITELSGLKQLHGKLKITNLENVETKEEAENAQM
KNKEYLDALELEWESDPKLENKLVATEEVLEGLQPHESLKRLKISRYYGVRSPSWLKKEELSNLERLELS
HCESWKDISCTALLPHLKVFHIESMCFSKSCFEVCGSRESKLFPMLEELQLTNTNVSEEFLNLGRSPCLR
VVRMTKIESLKHIDFAASCAMENSLFPMLEELELKHMAALEELSTLGHFPLLRVLRMIEMRSLKYIDFAA
SGAIENSLFPMLEELELRNLHALEEFSSPGHFPLLRVFRMIEMRSLKHIDFAASGAIENSLFPMLEELEL
RYIPTLEEFSGLGHFPLLRVLRMIEMRSLKHIDFAASDAIENSLFPMLEELHLKGMHTLEEFSNLGHFSR
LRVLRMIEMRLLKHIDFTASGAIKNSLFPMLEELDLRNLHALEEFSGLGHFPRLKVLRVIQMQLLKRIGF
ASVHATENELFPVLEVLELMELPVLDELSDLGSLPCLRSLCMTRMPMVKHIDFAFRGATEKVLLPRMETL
VLHDLEALEELPSNLGRLPCLEVLKIVNIPAVKQIGHGFFSTEAISKCFLSLKNLFINHMPACEGWCWID
GSELFPSLRRLAIYRCPKLERLPPLPPSLTNLVLYAVGLTELPSLRELETNGTGGNQTTSSLSKLQISKC
NNLTSLEEGLLLQNLSNIEVIYVVGCNELMRMPLKRFENFTSLKELQIRACPNLSLTQEEEAALLPPSVK
RLILLD


>XP_042446935.1 putative disease resistance RPP13-like protein 1 [Zingiber officinale]
MEGAAALAVGGWLAKPVIRMLVDRVSTSSLRGKLHGLQDDDLQKLQRSLLNIHTIVDKAGMRWSRDARLV
EMMKQLQDAAYDAEDFLDYLTFHGMKQKIKEEASHMAGNRISRAIRNAKAKLFSDSVKRLNKIQKKLDCI
YADMKEMCQLLQADASDGQYQSDLASATRETSSFLISKVLGREEEQKRIIELLLRSTDESASASDKGSSF
SVIPLVGIGGVGKTTLAQLVYKDKEIQNHFALKIWICVSENFNVQRLTKEIIESVTKTEHSSQMKLDVLQ
NILKEKIASKMILLVLDDVWNEDEEEWRKLCAPFEDAPAGSKVIVTTRSKSIADKIGTVEAIVLGDLDKI
SFWELFKKCAFGPSKPEEYPELEEIGRIIASKLKGLPLAAKTVGNLLGSNMNPHYWRSIMKSEVWELQQN
KNDIIPVLQLSYQYLSAPLKRCFAFCSLFQKDYKFSEIELTRMWMAEGFVVAQGNQRIEDVASKYLHELV
NMSLFQQETSSSSEHYFVMHDLIHDLTLSVSVDETSRMNDGKSNKISTTLRHVALETEFVEIKYLRSRFK
KLHSLFFRCLLLKSPPIDFIKKLRSIRVLVLSRCGLRMLPTSIGELVHLRYLDISYNGIKKLPESLCELY
NLQTLIAKDNSLISLPEDISELYNLETLIDNSLISLPEDISSGLYNLQTPIAKGKPLISLPEDISQLINL
RHIDVENEVAVKIKMIGRLTSLQELSEFQVRKEVGFKITELSGLKQLHGKLKITNLENVETKEEAENAQM
KNKEYLDALELEWESDPKLENKLVATEEVLEGLQPHESLKRLKISRYYGVRSPSWLKKEELSNLERLELS
HCESWKDISCTALLPHLKVFHIESMCFSKSCFEVCGSRESKLFPMLEELQLTNTNVSEEFLNLGRSPCLR
VVRMTKIESLKHIDFAASCAMENSLFPMLEELELKHMAALEELSTLGHFPLLRVLRMIEMRSLKYIDFAA
SGAIENSLFPMLEELELRNLHALEEFSSPGHFPLLRVFRMIEMRSLKHIDFAASGAIENSLFPMLEELEL
RYIPTLEEFSGLGHFPLLRVLRMIEMRSLKHIDFAASDAIENSLFPMLEELHLKGMHTLEEFSNLGHFSR
LRVLRMIEMRLLKHIDFTASGAIKNSLFPMLEELDLRNLHALEEFSGLGHFPRLKVLRVIQMQLLKRIGF
ASVHATENELFPVLEVLELMELPVLDELSDLGSLPCLRSLCMTRMPMVKHIDFAFRGATEKVLLPRMETL
VLHDLEALEELPSNLGRLPCLEVLKIVNIPAVKQIGHGFFSTEAISKCFLSLKNLFINHMPACEGWCWID
GSELFPSLRRLAIYRCPKLERLPPLPPSLTNLVLYAVGLTELPSLRELETNGTGGNQTTSSLSKLQISKC
NNLTSLEEGLLLQNLSNIEVIYVVGCNELMRMPLKRFENFTSLKELQIRACPNLSLTQEEEAALLPPSVK
RLILLD


>XP_042447048.1 putative disease resistance protein RGA1 [Zingiber officinale]
MKNDSFSRFASKIDDLFRLLAAETIELSDVAARSSPEVPQKELKDIKAILKNIKGLLYDSGRQIREDAIK
LRLKEFQDLVIEVEDFVDDYQYKKFQREAEFRSLHGATSDSVDDLPRSRALSGRRLLERNRRNRASSHRK
KPVATEGSLGGVTMRRTTHSPPLYIDGERPCTIDPDPVRQSQIDESFVNQAESFGSAFLPWIYGSSDSSF
VPSLRTDGNFVNQVLVHWTAHLNKPVEIEVPLNIVVRIEVMKRTIDDLLAQRQKAQKCSSHLLLISQEKQ
DPKKLQRVAEFLLAESLKSDQDLSYLPEDSIRGSKQYQAHDVTKEIYGRNSDREHIISWLLLGTNSRFSL
FEDERSRNKFSAISIVGEAGVGKTALAKEVYNDPLVCKYFNSRVWLHFTEESDAVSFSKAFFVSITGKSC
DGKEPVHLQSVMKEELKGKKLLLVLDDLQDLNLRLWEYLQAPLAGVRMAKFIITSRTELEASKLRGIESY
PLGCLPLDLSWDLFQHCAFREDSSHPPELIEIGKHIVQKCWGLPLAVKTLGSLLGYQMDRQIWRGVLESE
LWELQETETDISPALQLSYYLLPTYLKPCFLYCSLFPRGYKFDKYELVRLWMAQGYIQHEDEDYQSLETV
GCNYFHELQMLTIFDRSWDGTFTIHDLLYDVSKYMSNGECSSLPNVKMYKDSGKIHQLYVTSSKGTNELQ
SSNANLTLQSLYKSLGAFPPNDILTMALIESVQGIRALELTCHGDSSIAETTQEEALNEVNASSVSNLRF
IHLRYLRICDRFIEVLPAAVCELYNLQTLNLDKCLKLRELPSDIGKLVNLRYLGLSEANIEKLPKSVYQL
QKLQSLKVDYCRNLKELPYNIGNLVNLCHLGLSGTSIKRLPRSVHRLSKLSTLKLDQCKILMELPSSIGN
LVNLRHVTACRTKITKLPESICSLFNLLTLDLAYSNLSELPNDIGNLSNLNYLALSYTNISILPESLCYL
SRLCTLKLNGCTNLSQLPSGIGALKTLSHLVVSGINIEQLPESVCQLLNLEVLVMDGCRRFFSLPDGIGY
LTKLHQLKLSDTEIQELPESIGQLSNLQNLDLNGCQRLSKLPESIGYLSELSNLEVTETKIKTLPASFCQ
LSNLKVLNLNGNLDLQELPSGIENLANLCQLELSEVGIEVLPRCIVRLTNLEKLTFEHKKKPFENYQL


>XP_042447050.1 putative disease resistance protein RGA1 [Zingiber officinale]
MKNDSFSRFASKIDDLFRLLAAETIELSDVAARSSPEVPQKELKDIKAILKNIKGLLYDSGRQIREDAIK
LRLKEFQDLVIEVEDFVDDYQYKKFQREAEFRSLHGATSDSVDDLPRSRALSGRRLLERNRRNRASSHRK
KPVATEGSLGGVTMRRTTHSPPLYIDGERPCTIDPDPVRQSQIDESFVNQAESFGSAFLPWIYGSSDSSF
VPSLRTDGNFVNQVLVHWTAHLNKPVEIEVPLNIVVRIEVMKRTIDDLLAQRQKAQKCSSHLLLISQEKQ
DPKKLQRVAEFLLAESLKSDQDLSYLPEDSIRGSKQYQAHDVTKEIYGRNSDREHIISWLLLGTNSRFSL
FEDERSRNKFSAISIVGEAGVGKTALAKEVYNDPLVCKYFNSRVWLHFTEESDAVSFSKAFFVSITGKSC
DGKEPVHLQSVMKEELKGKKLLLVLDDLQDLNLRLWEYLQAPLAGVRMAKFIITSRTELEASKLRGIESY
PLGCLPLDLSWDLFQHCAFREDSSHPPELIEIGKHIVQKCWGLPLAVKTLGSLLGYQMDRQIWRGVLESE
LWELQETETDISPALQLSYYLLPTYLKPCFLYCSLFPRGYKFDKYELVRLWMAQGYIQHEDEDYQSLETV
GCNYFHELQMLTIFDRSWDGTFTIHDLLYDVSKYMSNGECSSLPNVKMYKDSGKIHQLYVTSSKGTNELQ
SSNANLTLQSLYKSLGAFPPNDILTMALIESVQGIRALELTCHGDSSIAETTQEEALNEVNASSVSNLRF
IHLRYLRICDRFIEVLPAAVCELYNLQTLNLDKCLKLRELPSDIGKLVNLRYLGLSEANIEKLPKSVYQL
QKLQSLKVDYCRNLKELPYNIGNLVNLCHLGLSGTSIKRLPRSVHRLSKLSTLKLDQCKILMELPSSIGN
LVNLRHVTACRTKITKLPESICSLFNLLTLDLAYSNLSELPNDIGNLSNLNYLALSYTNISILPESLCYL
SRLCTLKLNGCTNLSQLPSGIGALKTLSHLVVSGINIEQLPESVCQLLNLEVLVMDGCRRFFSLPDGIGY
LTKLHQLKLSDTEIQELPESIGQLSNLQNLDLNGCQRLSKLPESIGYLSELSNLEVTETKIKTLPASFCQ
LSNLKVLNLNGNLDLQELPSGIENLANLCQLELSEVGIEVLPRCIVRLTNLEKLTFEHKKKPFENYQL


>XP_042447051.1 putative disease resistance protein RGA1 [Zingiber officinale]
MKNDSFSRFASKIDDLFRLLAAETIELSDVAARSSPEVPQKELKDIKAILKNIKGLLYDSGRQIREDAIK
LRLKEFQDLVIEVEDFVDDYQYKKFQREAEFRSLHGATSDSVDDLPRSRALSGRRLLERNRRNRASSHRK
KPVATEGSLGGVTMRRTTHSPPLYIDGERPCTIDPDPVRQSQIDESFVNQAESFGSAFLPWIYGSSDSSF
VPSLRTDGNFVNQVLVHWTAHLNKPVEIEVPLNIVVRIEVMKRTIDDLLAQRQKAQKCSSHLLLISQEKQ
DPKKLQRVAEFLLAESLKSDQDLSYLPEDSIRGSKQYQAHDVTKEIYGRNSDREHIISWLLLGTNSRFSL
FEDERSRNKFSAISIVGEAGVGKTALAKEVYNDPLVCKYFNSRVWLHFTEESDAVSFSKAFFVSITGKSC
DGKEPVHLQSVMKEELKGKKLLLVLDDLQDLNLRLWEYLQAPLAGVRMAKFIITSRTELEASKLRGIESY
PLGCLPLDLSWDLFQHCAFREDSSHPPELIEIGKHIVQKCWGLPLAVKTLGSLLGYQMDRQIWRGVLESE
LWELQETETDISPALQLSYYLLPTYLKPCFLYCSLFPRGYKFDKYELVRLWMAQGYIQHEDEDYQSLETV
GCNYFHELQMLTIFDRSWDGTFTIHDLLYDVSKYMSNGECSSLPNVKMYKDSGKIHQLYVTSSKGTNELQ
SSNANLTLQSLYKSLGAFPPNDILTMALIESVQGIRALELTCHGDSSIAETTQEEALNEVNASSVSNLRF
IHLRYLRICDRFIEVLPAAVCELYNLQTLNLDKCLKLRELPSDIGKLVNLRYLGLSEANIEKLPKSVYQL
QKLQSLKVDYCRNLKELPYNIGNLVNLCHLGLSGTSIKRLPRSVHRLSKLSTLKLDQCKILMELPSSIGN
LVNLRHVTACRTKITKLPESICSLFNLLTLDLAYSNLSELPNDIGNLSNLNYLALSYTNISILPESLCYL
SRLCTLKLNGCTNLSQLPSGIGALKTLSHLVVSGINIEQLPESVCQLLNLEVLVMDGCRRFFSLPDGIGY
LTKLHQLKLSDTEIQELPESIGQLSNLQNLDLNGCQRLSKLPESIGYLSELSNLEVTETKIKTLPASFCQ
LSNLKVLNLNGNLDLQELPSGIENLANLCQLELSEVGIEVLPRCIVRLTNLEKLTFEHKKKPFENYQL


>XP_042447355.1 putative disease resistance protein RGA3 [Zingiber officinale]
MDVVSPILDRACAKVIDKLIDKVSTYVQDQYYWKANLQEELQNLKRLLPQIQAVVGYAEDKLTMYESHNP
ALIKWLWQFRDDIDEAEEVLDELEYHELEKKSDGDKSRLSTIIDPYFRAAKRFLKSDDDVLERLRTCVEN
LKTSASDVETFRALVMPTSGVGTGQMQQEQESLTLSNQSRITSCLPELSFKGREEEKGKIIQYLLGEESE
IQTSQNVHCLPLVAMGGMGKTALAQQVFDHFENEKKGHFDVKIWVCDSLPDLNASSLMKKILECLTDQSE
SGPLERIPVKLKEKLHSKRFLLVLDDAWDDKNQREWEKLRAPLLHGQKGSWIILTTRLESVAKMVSKVIK
GGTMKPMTLQGLPKDECRSLLYEHAFVDQDPNEFPLLKKIGEEIVEKLHGVPLLAKSIGGALNNKLEADH
WTSISGSELWKMPQDLDNYEFIPALTLSFKMLPPRLKRCFSYCSIFPQDYKFKKQKLVCMWVAAGLIYSD
GSEEGSDEDIANYCFDILCNKSFFDVHIDNWSAFQEGITPYGLEAIYYTMHDMLNGLSRHVSRYECCRIV
HDTPSYICDYNAIRHISISITSIDAQLGDLANMVCKFKHLRTLRIEKYYDNSQKLDDFIRDACKSPRRIR
VLIIESNQCLESISDFVKLRFLEISSQLPSLSICKFYFLQVLIGYNAILAKDTSKLTNLRHLYRVPYNVL
FSVAKVGKLTSLQELYFNVGTEPGYRIDELMNMDNLCELSISNLSNVHNLEEANNVNLVSKSYLTSLKLN
WKKAYWYESDRDEASSNIGHDQQEVLAALQPPSTIRKLIITKYKGGRPAPWMNPRSLSRLESLELYGCTN
LEELPPLWKLPCLKLIKLIDMKAIRSLGCHSSDPMERQFPVLEELEFRDLPLLEEWNGADDYQWFPPLKM
FKIENCPKLKKIPDLPLSIKNLCMKKLWLESLPRSYKCSNGSITFGGFQQLMSLKSLEMHGYSENVDIGS
IGEEDGNFLPSSLEILKLEILQKHKDLASYLRGLTSLIELSLSCLQGMTSLPLTNELEHLTTLRSLDIWN
CEDLTSPGGLYIIKSLKHLGIKDCPKFLTTDVES


>XP_042447356.1 putative disease resistance protein RGA3 [Zingiber officinale]
MDVVSPILDRACAKVIDKLIDKVSTYVQDQYYWKANLQEELQNLKRLLPQIQAVVGYAEDKLTMYESHNP
ALIKWLWQFRDDIDEAEEVLDELEYHELEKKSDGDKSRLSTIIDPYFRAAKRFLKSDDDVLERLRTCVEN
LKTSASDVETFRALVMPTSGVGTGQMQQEQESLTLSNQSRITSCLPELSFKGREEEKGKIIQYLLGEESE
IQTSQNVHCLPLVAMGGMGKTALAQQVFDHFENEKKGHFDVKIWVCDSLPDLNASSLMKKILECLTDQSE
SGPLERIPVKLKEKLHSKRFLLVLDDAWDDKNQREWEKLRAPLLHGQKGSWIILTTRLESVAKMVSKVIK
GGTMKPMTLQGLPKDECRSLLYEHAFVDQDPNEFPLLKKIGEEIVEKLHGVPLLAKSIGGALNNKLEADH
WTSISGSELWKMPQDLDNYEFIPALTLSFKMLPPRLKRCFSYCSIFPQDYKFKKQKLVCMWVAAGLIYSD
GSEEGSDEDIANYCFDILCNKSFFDVHIDNWSAFQEGITPYGLEAIYYTMHDMLNGLSRHVSRYECCRIV
HDTPSYICDYNAIRHISISITSIDAQLGDLANMVCKFKHLRTLRIEKYYDNSQKLDDFIRDACKSPRRIR
VLIIESNQCLESISDFVKLRFLEISSQLPSLSICKFYFLQVLIGYNAILAKDTSKLTNLRHLYRVPYNVL
FSVAKVGKLTSLQELYFNVGTEPGYRIDELMNMDNLCELSISNLSNVHNLEEANNVNLVSKSYLTSLKLN
WKKAYWYESDRDEASSNIGHDQQEVLAALQPPSTIRKLIITKYKGGRPAPWMNPRSLSRLESLELYGCTN
LEELPPLWKLPCLKLIKLIDMKAIRSLGCHSSDPMERQFPVLEELEFRDLPLLEEWNGADDYQWFPPLKM
FKIENCPKLKKIPDLPLSIKNLCMKKLWLESLPRSYKCSNGSITFGGFQQLMSLKSLEMHGYSENVDIGS
IGEEDGNFLPSSLEILKLEILQKHKDLASYLRGLTSLIELSLSCLQGMTSLPLTNELEHLTTLRSLDIWN
CEDLTSPGGLYIIKSLKHLGIKDCPKFLTTDVES


>XP_042447357.1 putative disease resistance protein RGA3 [Zingiber officinale]
MDVVSPILDRACAKVIDKLIDKVSTYVQDQYYWKANLQEELQNLKRLLPQIQAVVGYAEDKLTMYESHNP
ALIKWLWQFRDDIDEAEEVLDELEYHELEKKSDGDKSRLSTIIDPYFRAAKRFLKSDDDVLERLRTCVEN
LKTSASDVETFRALVMPTSGVGTGQMQQEQESLTLSNQSRITSCLPELSFKGREEEKGKIIQYLLGEESE
IQTSQNVHCLPLVAMGGMGKTALAQQVFDHFENEKKGHFDVKIWVCDSLPDLNASSLMKKILECLTDQSE
SGPLERIPVKLKEKLHSKRFLLVLDDAWDDKNQREWEKLRAPLLHGQKGSWIILTTRLESVAKMVSKVIK
GGTMKPMTLQGLPKDECRSLLYEHAFVDQDPNEFPLLKKIGEEIVEKLHGVPLLAKSIGGALNNKLEADH
WTSISGSELWKMPQDLDNYEFIPALTLSFKMLPPRLKRCFSYCSIFPQDYKFKKQKLVCMWVAAGLIYSD
GSEEGSDEDIANYCFDILCNKSFFDVHIDNWSAFQEGITPYGLEAIYYTMHDMLNGLSRHVSRYECCRIV
HDTPSYICDYNAIRHISISITSIDAQLGDLANMVCKFKHLRTLRIEKYYDNSQKLDDFIRDACKSPRRIR
VLIIESNQCLESISDFVKLRFLEISSQLPSLSICKFYFLQVLIGYNAILAKDTSKLTNLRHLYRVPYNVL
FSVAKVGKLTSLQELYFNVGTEPGYRIDELMNMDNLCELSISNLSNVHNLEEANNVNLVSKSYLTSLKLN
WKKAYWYESDRDEASSNIGHDQQEVLAALQPPSTIRKLIITKYKGGRPAPWMNPRSLSRLESLELYGCTN
LEELPPLWKLPCLKLIKLIDMKAIRSLGCHSSDPMERQFPVLEELEFRDLPLLEEWNGADDYQWFPPLKM
FKIENCPKLKKIPDLPLSIKNLCMKKLWLESLPRSYKCSNGSITFGGFQQLMSLKSLEMHGYSENVDIGS
IGEEDGNFLPSSLEILKLEILQKHKDLASYLRGLTSLIELSLSCLQGMTSLPLTNELEHLTTLRSLDIWN
CEDLTSPGGLYIIKSLKHLGIKDCPKFLTTDVES


>XP_042447378.1 disease resistance protein RPM1-like isoform X2 [Zingiber officinale]
MEAAFISLLINKLGEIAVGQAQSRCSLLLLQHTTPPLDQIHARVERITGEFKVMQAFLEGSNWSTAAATN
KPLEAWIEQVREVAFKIEDIIDEYLYLVGRQRERTWKNCLMAPSDLCFNLAKAWRGIDSRLEKLETDLSE
LTSRRDRYGLTISSNDDRAKNSETNNTYHYRAYSPMLTDEDDLVGIEVNKSKLLSWLTNADTCRKMTTIA
VWGMGGHGKTTLVANVYRNDAVKSHFDCQVWITVSQTYGVEELLKSMIQEIFKGKKEPVPNGVTTMQQLE
LFDIIKESLQRKKYIIVLDDVWHVDLWTDISHLFVDTNNGSRLIVTTRMLEVARMANDEHIMKLQQLDEK
DAWILFC


>XP_042447463.1 disease resistance protein RGA2-like [Zingiber officinale]
MEGAAALAVGGWLTQPVIKMLVDSVWTSSLRGKLYGLRDNDLQKLHRSLLNIDTIVDKAGMRWSREARLV
EMMKQLQDAAYDAEDFLDDLTFHGMKQKIKEDASHKVLNQFSRAFSKTKTKLFSNSVKRLNKIQKKLDDI
YADMEKMCQSLQVDASDGQYQSDLASATRETSSFLISKVFGREEEQKRIIGLLRRSTDLSASASDNGNSF
SVIPLVGIGGVGKTTLAQLVYKDEEIQNHFAVKIWICVSENFNVQRLTKEMIESVTETEHDSQMKLDVLQ
NILKREIASKMILLVLDDVWNEDKEEWRKLCAPFMYAAAGSKVIVTTRSKSIADKIGTVEAIVLGDLDGI
SFWELFKQCAFGPSKPEEHPELVEIGRSIASKLKGLPLAAKTVGNLLGSNMNPHYWRSIMKSEVWELQQN
KNDIIPVLQLSYHYLSAPLKRCFAFCSLFQKNHEFSEIELTRMWMAEGFVVAQGNQRMEDVASKYFHELV
NMSLFQPETTFWRHYYVMHDLIHDLTHSVSVDETSRMDNGKSNKISTTLRHLAVETEFVETKELRYRFKK
LHTVFCQHLKSPPLDFIEKLRSIRVLVLSHCSLRMLPTRVGELVHLRYLDISYNGIENLPESLCELYNLQ
TLIAKGNFPNSLPEEITQLINLRHLDVENTEVENIKMIGRLTSLQELSEFLVRKEVGFKITELSGLKQLH
GKLQITNLENVGSKEEAEKAQMKNKEYLDALELEWGFDPKLENKLVAMEEVLEGLQPHESLKQLKIRRYC
GARSPSWIKKEELSNLERLELSNCESWRDIFCTALLPHLKVFHIESSMWFSKSCFEVCGSRESKLFPMLE
ELQLRNMIASEELPNLGRFPCLKVVRMTEIESLKHIDFAASSAIENSLFSMLECLELIYMPALEEFSTLG
YFPRLRVLRMIGMRLLKHIVFAASGAIENSLFPMLEELELRDMPALEEFSCVGHFPRLRVLHMIGMRLLK
HIDFVASGAIENSLFPMLKEFHLKDMHALEGFSNLGHFPRLRVLRMIEMRLLKHIDFAASGAIENSLFPM
LEELELRGMYALEEISNLGHFPRLKVLRMMRMRLLKHIGLASVATENDQFPMLEELELRHLPVLEELPDL
GSLPCLKSLDIIRMRMLKHTDFAFYDVTEKVLLPRVEKLVLHDLEALKELPSNLGRLPCLKVLSIENISA
VKQIGHGFFSTEAISQCFLSLRSLSILNMPSCEGWCWIDGSELFPSLQVLTIHGCPKLERLPPLPPSLTD
LTLTEVGLTELPSLRETGTNGSGCNQTTSSLSNLKISECNNLTSLEEGLLSQNLSNIEVIYVEGCYELMR
MPLKRFENSTSLKELQIKACPNLSLTQEEEAVLLSRGGSRNYMEERFFRITVGGPVLGGYRRFDRLWLDN
CYRWT


>XP_042447464.1 disease resistance protein RGA2-like [Zingiber officinale]
MEGAAALAVGGWLTQPVIKMLVDSVWTSSLRGKLYGLRDNDLQKLHRSLLNIDTIVDKAGMRWSREARLV
EMMKQLQDAAYDAEDFLDDLTFHGMKQKIKEDASHKVLNQFSRAFSKTKTKLFSNSVKRLNKIQKKLDDI
YADMEKMCQSLQVDASDGQYQSDLASATRETSSFLISKVFGREEEQKRIIGLLRRSTDLSASASDNGNSF
SVIPLVGIGGVGKTTLAQLVYKDEEIQNHFAVKIWICVSENFNVQRLTKEMIESVTETEHDSQMKLDVLQ
NILKREIASKMILLVLDDVWNEDKEEWRKLCAPFMYAAAGSKVIVTTRSKSIADKIGTVEAIVLGDLDGI
SFWELFKQCAFGPSKPEEHPELVEIGRSIASKLKGLPLAAKTVGNLLGSNMNPHYWRSIMKSEVWELQQN
KNDIIPVLQLSYHYLSAPLKRCFAFCSLFQKNHEFSEIELTRMWMAEGFVVAQGNQRMEDVASKYFHELV
NMSLFQPETTFWRHYYVMHDLIHDLTHSVSVDETSRMDNGKSNKISTTLRHLAVETEFVETKELRYRFKK
LHTVFCQHLKSPPLDFIEKLRSIRVLVLSHCSLRMLPTRVGELVHLRYLDISYNGIENLPESLCELYNLQ
TLIAKGNFPNSLPEEITQLINLRHLDVENTEVENIKMIGRLTSLQELSEFLVRKEVGFKITELSGLKQLH
GKLQITNLENVGSKEEAEKAQMKNKEYLDALELEWGFDPKLENKLVAMEEVLEGLQPHESLKQLKIRRYC
GARSPSWIKKEELSNLERLELSNCESWRDIFCTALLPHLKVFHIESSMWFSKSCFEVCGSRESKLFPMLE
ELQLRNMIASEELPNLGRFPCLKVVRMTEIESLKHIDFAASSAIENSLFSMLECLELIYMPALEEFSTLG
YFPRLRVLRMIGMRLLKHIVFAASGAIENSLFPMLEELELRDMPALEEFSCVGHFPRLRVLHMIGMRLLK
HIDFVASGAIENSLFPMLKEFHLKDMHALEGFSNLGHFPRLRVLRMIEMRLLKHIDFAASGAIENSLFPM
LEELELRGMYALEEISNLGHFPRLKVLRMMRMRLLKHIGLASVATENDQFPMLEELELRHLPVLEELPDL
GSLPCLKSLDIIRMRMLKHTDFAFYDVTEKVLLPRVEKLVLHDLEALKELPSNLGRLPCLKVLSIENISA
VKQIGHGFFSTEAISQCFLSLRSLSILNMPSCEGWCWIDGSELFPSLQVLTIHGCPKLERLPPLPPSLTD
LTLTEVGLTELPSLRETGTNGSGCNQTTSSLSNLKISECNNLTSLEEGLLSQNLSNIEVIYVEGCYELMR
MPLKRFENSTSLKELQIKACPNLSLTQEEEAVLLSRGGSRNYMEERFFRITVGGPVLGGYRRFDRLWLDN
CYRWT


>XP_042448200.1 disease resistance protein RPM1-like isoform X1 [Zingiber officinale]
MHEVARIANEEHIMKLQQLNEKDAWILFCKKAFRRENNKDCPKELEDYTGRILNKCQGSPLAIVAIGSLL
SFKEKSETEWKKAYDNLQWEFENNPALDKVKNILNLSFNDLPYYLKNCFVYCSIFPEDYLIKRKKLIRLW
VAEGFVEAKSSNRSMEEEAEDYLAELVDRSMLQVVNRNAFGRLQTFKMHDVVREVTQEISRKAKFSMILD
GSQSGLDYQTRRLSIQTTDESLDLDKSLSLSQLRSLVMLSTCNSSSDSLSAILISFKMLRVLELEFQPIS
NLPNEISALFNLHYLGLRGTKVENLPNNIQKLQSLETLDLRCSNIVKLPRGVTQLKQLRHLFMFAREIEF
GGSTVVGCVPTLKGARQWKNLQTLRQVKANKSLVQQLEDMKELRTLAVTEVEYAHCPQLCTSLTKLTKLH
SLCLSARSEEQLNFEILNSPPPPLQKLTLSGRLFEGKMPKFICSCEELTYVQLMSSHLIEDPLPSLGQLH
KLVELTLWEDSYDGQKLHFRTGWFLNLKVLYLETLRNLNNIVIEEGAMPNLLKLIMSSLGELRMIPPGIE
FLTNLQSLELCALPEELVEKLRNDDDNEVLQRIGGTRNVVVDSISN


>XP_042448201.1 disease resistance protein RPM1-like isoform X2 [Zingiber officinale]
MEAAFISLLINKLAQVAFDQAQSRCSQLLLQHTTPPLDQIHAKVRRITDEFIVMKAFLEGSNWSTIAATN
KPLEAWIEQVRKVAFEIEDIIDEYLYLVGRQREMTWKNYLMAPSDLCFNLAKAWRGIDSRLEKMERDLSE
LSSRRDRFGITISGNEDGVKNSERDTHHYRAYSPMFTDEDDLVGIEDNKSKLLSWLTNADTCRKMTAIAV
WGMGGHGKTTLVANVYRNKTVKNHFDCQVWVTVSKTYSALEELLRIMIQEIFKGQKELVPNGVTTMQRLE
LFDIIKESLQQKRYIIVFR


>XP_042448306.1 disease resistance protein RGA2-like isoform X1 [Zingiber officinale]
MEGAAALAVGGWLAKPVIRMLVDRVSTSSLRGKLHGLQDDDLQKLQRSLLNIHTIVDKAGMRWSRDARLV
EMTKQLQDAAYDAEDFLDDLTFHDMKQKIEEEASHMASNRISRAIRNAKAKLFSDSVKRLNKIQKKLDDI
YADMEKMCQSLQVDASDVQYQSDLASATRETSSFLISNVLGREEEQKRIIELLLRSADESASASDKGSSF
SVIPLVGIGGVGKTTLAQLVYKDKEIQNHFALKIWICVSENFNVQRLTKEMIESVTKTELSSQMKLDVLQ
NILKEKIASKMVLLVLDDVWNEEEEEWRKLCAPFMYAASGSKVIMTTRSKSIADKIGTVEAIVLGDLDEI
SFWELFKQCAFRSSKPEEHPALVEIGRSIASKLKGLPLAAKTVGNLLGSNMNPDHWRSIMKSEVWELQQN
NKNDIIPVLQLSYQYLSAPLKRCFAFCSLFQKNHEFSEIELTRMWMAEGFIVAQGNQRMEDVASKYFHEL
VNMSLFQPETTFWRHYYLMHDLIHDLTQSVSVDETNRMDNGKSNKISTTLRHLAVKKEFVETTDLRSRFK
KLHSLFCQHLVSPPLDFIEKLRSIRVLVLCDCGLQMLPTSVGELVHLRYLDISYNGIKKLPEPLCKLYNL
QTLKAICNSQISLPEDISQLVNLRHLDVENQIVVKTKMIGRLTSLQELSEFHVRKKVGFKITELSGLKQL
HGKLKITNLENVESKEEAESAQMKNKEYLDVLELEWKFDPKLENKLVAMQEVLEGLQPHESLKRLKIRRY
CGARSPSWMKKELSNLERLELSFCESWKDISCTALLPRLKVFCIDKSMWFSKSCFNVCGSRESKLFPMLE
ELQLRNMNASEELPNLGRFPCLRVVRLTEIKSLKHIDFAASGTIENSLFPMLEELELIDMDALEEFSNLG
HFQRLRVLRMVRMPLFKHIGLASVHATEKDLFPMLEKLQLMHLPVLEELPDLGSLPCLKFLQMKRMPVLK
HIDFAFDGATDKILLPRVETLELYDLEALEELPSNLGRLPCLTDLIIGNISAVKQISNGFFSIEAISKCF
LSLESLSISGMPACEGWCWLDGSELFPSLQRLTIYGCPKLERLPPLPPSLTDLTIRKVGLTELPNIQELE
TNRSRVNQTTPSLSDLRISECNNLTSLEEGLLSQNLSNIKVIHVEGCNELMRMPLKKFENFTSLKKLQIK
ACPKLSLTQEEEAALLPPSIETLKLDVCCDLDKLLLGNLYNFTD


>XP_042448308.1 putative disease resistance RPP13-like protein 1 [Zingiber officinale]
MEAATLAVGGWLVQPVIKMLVDRLCTLRGELHGLQDDDLQKLHRSLLNIHTIVDKAGMRWSRDARLVEMM
KQLQDAAYDAEDFLDDLTFHGMKQKIKKEASHKASNLFSKAFRKTKTKLFSDSVKRLNKIQKKLDCIYAD
MEKMCQFLQMDALSGGQYQSDSGSVTRETSPFLICKVLGREKEQKRITELLLRSTDESASASDNDSSFSV
IPLVGIGGVGKTTLAQLVYEDDEIQNHFALKLWICVSNNFNVQRLTKEMIESVTETQHSSQMKLAVLQNI
LKKEIESKMILLVLDDVWNEVEEEWRKLCAPFMYAAAGSKVIVTTRIKSIADKIGTVEAIVLGDLDEISF
WELFKQCAFGPSKPEEHPELVEIGRSIASKLKGLPLAARTVGNLLGSNMNPHHWRSIMKSEVWELQQNKN
DIIPVLQLSYQYLSAPLKRCFAVCCLFHKDYKFSEIELTRIWMAEGFIVAQGNQRMEDVASKYLHELVNM
SLFQQETTFGSHYYVMHDLIHDLTQSVSVDETSRMDNGKSNKISTTLRHLAVKKEFVETKDMLRSRIKKL
HSLFCQQLKSPPLDVIEKLRSIRVLVLYDCGLQMLPTSVGELIHLRYLDISYNKIKELPESLCELYNLQT
LKANNSPLICLPEDISQLINLRHLDIENRLVVQIKKIGRLTSLQELSEFQVRKEVGFKITELSGLKQLHG
KLKITNLENVESKEEAENAQMKNKEYLDVLELEWKFDPKLENKLVAMEEVLEGLQPHESLKQLQIKRYCG
ARSPSWMKKELSNLERLELSFCESWKDISCTALLPHLKVFHIYQSMWFSKSCFEVCGSRESKLFPILEEL
QLSYMNASEELPNLGRFPCLRVVRMTGIKSLKHIDFTASGAIENSLFPMLEELDLRYMPALEEFCSRGHF
PRLRVLCMVAMPLLKHIGFASVHATENDLFPALEVLELMDLPALEELPDLCSLPCLKSFHMRRMSMLKHI
DFALYGSTEKVILPRVETLVLDDLEALEELPSNLGRLPCLKVLKIVKISAVKQIGHGFFSTEVITKCFLS
LENLWISDMPACERWCWIGGSELFPSLQKLTIYECPKLERLPPLPPSLIYLSLRAVGLTELPSLQELETN
GSGGNQTTSSLSALRIRKCNNLTSLEEGLLSQNISNIEDIYVEGCNKLMRMPLKRFENFTSLKELQIKAC
PKLSLTQEEEAALLPPSFKVFILNDCGDLNKLRLGHPYRSTF


>XP_042448309.1 putative disease resistance RPP13-like protein 1 [Zingiber officinale]
MEAATLAVGGWLVQPVIKMLVDRLCTLRGELHGLQDDDLQKLHRSLLNIHTIVDKAGMRWSRDARLVEMM
KQLQDAAYDAEDFLDDLTFHGMKQKIKKEASHKASNLFSKAFRKTKTKLFSDSVKRLNKIQKKLDCIYAD
MEKMCQFLQMDALSGGQYQSDSGSVTRETSPFLICKVLGREKEQKRITELLLRSTDESASASDNDSSFSV
IPLVGIGGVGKTTLAQLVYEDDEIQNHFALKLWICVSNNFNVQRLTKEMIESVTETQHSSQMKLAVLQNI
LKKEIESKMILLVLDDVWNEVEEEWRKLCAPFMYAAAGSKVIVTTRIKSIADKIGTVEAIVLGDLDEISF
WELFKQCAFGPSKPEEHPELVEIGRSIASKLKGLPLAARTVGNLLGSNMNPHHWRSIMKSEVWELQQNKN
DIIPVLQLSYQYLSAPLKRCFAVCCLFHKDYKFSEIELTRIWMAEGFIVAQGNQRMEDVASKYLHELVNM
SLFQQETTFGSHYYVMHDLIHDLTQSVSVDETSRMDNGKSNKISTTLRHLAVKKEFVETKDMLRSRIKKL
HSLFCQQLKSPPLDVIEKLRSIRVLVLYDCGLQMLPTSVGELIHLRYLDISYNKIKELPESLCELYNLQT
LKANNSPLICLPEDISQLINLRHLDIENRLVVQIKKIGRLTSLQELSEFQVRKEVGFKITELSGLKQLHG
KLKITNLENVESKEEAENAQMKNKEYLDVLELEWKFDPKLENKLVAMEEVLEGLQPHESLKQLQIKRYCG
ARSPSWMKKELSNLERLELSFCESWKDISCTALLPHLKVFHIYQSMWFSKSCFEVCGSRESKLFPILEEL
QLSYMNASEELPNLGRFPCLRVVRMTGIKSLKHIDFTASGAIENSLFPMLEELDLRYMPALEEFCSRGHF
PRLRVLCMVAMPLLKHIGFASVHATENDLFPALEVLELMDLPALEELPDLCSLPCLKSFHMRRMSMLKHI
DFALYGSTEKVILPRVETLVLDDLEALEELPSNLGRLPCLKVLKIVKISAVKQIGHGFFSTEVITKCFLS
LENLWISDMPACERWCWIGGSELFPSLQKLTIYECPKLERLPPLPPSLIYLSLRAVGLTELPSLQELETN
GSGGNQTTSSLSALRIRKCNNLTSLEEGLLSQNISNIEDIYVEGCNKLMRMPLKRFENFTSLKELQIKAC
PKLSLTQEEEAALLPPSFKVFILNDCGDLNKLRLGHPYRSTF


>XP_042448310.1 putative disease resistance RPP13-like protein 1 [Zingiber officinale]
MEAATLAVGGWLVQPVIKMLVDRLCTLRGELHGLQDDDLQKLHRSLLNIHTIVDKAGMRWSRDARLVEMM
KQLQDAAYDAEDFLDDLTFHGMKQKIKKEASHKASNLFSKAFRKTKTKLFSDSVKRLNKIQKKLDCIYAD
MEKMCQFLQMDALSGGQYQSDSGSVTRETSPFLICKVLGREKEQKRITELLLRSTDESASASDNDSSFSV
IPLVGIGGVGKTTLAQLVYEDDEIQNHFALKLWICVSNNFNVQRLTKEMIESVTETQHSSQMKLAVLQNI
LKKEIESKMILLVLDDVWNEVEEEWRKLCAPFMYAAAGSKVIVTTRIKSIADKIGTVEAIVLGDLDEISF
WELFKQCAFGPSKPEEHPELVEIGRSIASKLKGLPLAARTVGNLLGSNMNPHHWRSIMKSEVWELQQNKN
DIIPVLQLSYQYLSAPLKRCFAVCCLFHKDYKFSEIELTRIWMAEGFIVAQGNQRMEDVASKYLHELVNM
SLFQQETTFGSHYYVMHDLIHDLTQSVSVDETSRMDNGKSNKISTTLRHLAVKKEFVETKDMLRSRIKKL
HSLFCQQLKSPPLDVIEKLRSIRVLVLYDCGLQMLPTSVGELIHLRYLDISYNKIKELPESLCELYNLQT
LKANNSPLICLPEDISQLINLRHLDIENRLVVQIKKIGRLTSLQELSEFQVRKEVGFKITELSGLKQLHG
KLKITNLENVESKEEAENAQMKNKEYLDVLELEWKFDPKLENKLVAMEEVLEGLQPHESLKQLQIKRYCG
ARSPSWMKKELSNLERLELSFCESWKDISCTALLPHLKVFHIYQSMWFSKSCFEVCGSRESKLFPILEEL
QLSYMNASEELPNLGRFPCLRVVRMTGIKSLKHIDFTASGAIENSLFPMLEELDLRYMPALEEFCSRGHF
PRLRVLCMVAMPLLKHIGFASVHATENDLFPALEVLELMDLPALEELPDLCSLPCLKSFHMRRMSMLKHI
DFALYGSTEKVILPRVETLVLDDLEALEELPSNLGRLPCLKVLKIVKISAVKQIGHGFFSTEVITKCFLS
LENLWISDMPACERWCWIGGSELFPSLQKLTIYECPKLERLPPLPPSLIYLSLRAVGLTELPSLQELETN
GSGGNQTTSSLSALRIRKCNNLTSLEEGLLSQNISNIEDIYVEGCNKLMRMPLKRFENFTSLKELQIKAC
PKLSLTQEEEAALLPPSFKVFILNDCGDLNKLRLGHPYRSTF


>XP_042448311.1 putative disease resistance RPP13-like protein 1 [Zingiber officinale]
MEAATLAVGGWLVQPVIKMLVDRLCTLRGELHGLQDDDLQKLHRSLLNIHTIVDKAGMRWSRDARLVEMM
KQLQDAAYDAEDFLDDLTFHGMKQKIKKEASHKASNLFSKAFRKTKTKLFSDSVKRLNKIQKKLDCIYAD
MEKMCQFLQMDALSGGQYQSDSGSVTRETSPFLICKVLGREKEQKRITELLLRSTDESASASDNDSSFSV
IPLVGIGGVGKTTLAQLVYEDDEIQNHFALKLWICVSNNFNVQRLTKEMIESVTETQHSSQMKLAVLQNI
LKKEIESKMILLVLDDVWNEVEEEWRKLCAPFMYAAAGSKVIVTTRIKSIADKIGTVEAIVLGDLDEISF
WELFKQCAFGPSKPEEHPELVEIGRSIASKLKGLPLAARTVGNLLGSNMNPHHWRSIMKSEVWELQQNKN
DIIPVLQLSYQYLSAPLKRCFAVCCLFHKDYKFSEIELTRIWMAEGFIVAQGNQRMEDVASKYLHELVNM
SLFQQETTFGSHYYVMHDLIHDLTQSVSVDETSRMDNGKSNKISTTLRHLAVKKEFVETKDMLRSRIKKL
HSLFCQQLKSPPLDVIEKLRSIRVLVLYDCGLQMLPTSVGELIHLRYLDISYNKIKELPESLCELYNLQT
LKANNSPLICLPEDISQLINLRHLDIENRLVVQIKKIGRLTSLQELSEFQVRKEVGFKITELSGLKQLHG
KLKITNLENVESKEEAENAQMKNKEYLDVLELEWKFDPKLENKLVAMEEVLEGLQPHESLKQLQIKRYCG
ARSPSWMKKELSNLERLELSFCESWKDISCTALLPHLKVFHIYQSMWFSKSCFEVCGSRESKLFPILEEL
QLSYMNASEELPNLGRFPCLRVVRMTGIKSLKHIDFTASGAIENSLFPMLEELDLRYMPALEEFCSRGHF
PRLRVLCMVAMPLLKHIGFASVHATENDLFPALEVLELMDLPALEELPDLCSLPCLKSFHMRRMSMLKHI
DFALYGSTEKVILPRVETLVLDDLEALEELPSNLGRLPCLKVLKIVKISAVKQIGHGFFSTEVITKCFLS
LENLWISDMPACERWCWIGGSELFPSLQKLTIYECPKLERLPPLPPSLIYLSLRAVGLTELPSLQELETN
GSGGNQTTSSLSALRIRKCNNLTSLEEGLLSQNISNIEDIYVEGCNKLMRMPLKRFENFTSLKELQIKAC
PKLSLTQEEEAALLPPSFKVFILNDCGDLNKLRLGHPYRSTF


>XP_042448312.1 putative disease resistance RPP13-like protein 1 [Zingiber officinale]
MEAATLAVGGWLVQPVIKMLVDRLCTLRGELHGLQDDDLQKLHRSLLNIHTIVDKAGMRWSRDARLVEMM
KQLQDAAYDAEDFLDDLTFHGMKQKIKKEASHKASNLFSKAFRKTKTKLFSDSVKRLNKIQKKLDCIYAD
MEKMCQFLQMDALSGGQYQSDSGSVTRETSPFLICKVLGREKEQKRITELLLRSTDESASASDNDSSFSV
IPLVGIGGVGKTTLAQLVYEDDEIQNHFALKLWICVSNNFNVQRLTKEMIESVTETQHSSQMKLAVLQNI
LKKEIESKMILLVLDDVWNEVEEEWRKLCAPFMYAAAGSKVIVTTRIKSIADKIGTVEAIVLGDLDEISF
WELFKQCAFGPSKPEEHPELVEIGRSIASKLKGLPLAARTVGNLLGSNMNPHHWRSIMKSEVWELQQNKN
DIIPVLQLSYQYLSAPLKRCFAVCCLFHKDYKFSEIELTRIWMAEGFIVAQGNQRMEDVASKYLHELVNM
SLFQQETTFGSHYYVMHDLIHDLTQSVSVDETSRMDNGKSNKISTTLRHLAVKKEFVETKDMLRSRIKKL
HSLFCQQLKSPPLDVIEKLRSIRVLVLYDCGLQMLPTSVGELIHLRYLDISYNKIKELPESLCELYNLQT
LKANNSPLICLPEDISQLINLRHLDIENRLVVQIKKIGRLTSLQELSEFQVRKEVGFKITELSGLKQLHG
KLKITNLENVESKEEAENAQMKNKEYLDVLELEWKFDPKLENKLVAMEEVLEGLQPHESLKQLQIKRYCG
ARSPSWMKKELSNLERLELSFCESWKDISCTALLPHLKVFHIYQSMWFSKSCFEVCGSRESKLFPILEEL
QLSYMNASEELPNLGRFPCLRVVRMTGIKSLKHIDFTASGAIENSLFPMLEELDLRYMPALEEFCSRGHF
PRLRVLCMVAMPLLKHIGFASVHATENDLFPALEVLELMDLPALEELPDLCSLPCLKSFHMRRMSMLKHI
DFALYGSTEKVILPRVETLVLDDLEALEELPSNLGRLPCLKVLKIVKISAVKQIGHGFFSTEVITKCFLS
LENLWISDMPACERWCWIGGSELFPSLQKLTIYECPKLERLPPLPPSLIYLSLRAVGLTELPSLQELETN
GSGGNQTTSSLSALRIRKCNNLTSLEEGLLSQNISNIEDIYVEGCNKLMRMPLKRFENFTSLKELQIKAC
PKLSLTQEEEAALLPPSFKVFILNDCGDLNKLRLGHPYRSTF


>XP_042448313.1 putative disease resistance RPP13-like protein 1 [Zingiber officinale]
MEAATLAVGGWLVQPVIKMLVDRLCTLRGELHGLQDDDLQKLHRSLLNIHTIVDKAGMRWSRDARLVEMM
KQLQDAAYDAEDFLDDLTFHGMKQKIKKEASHKASNLFSKAFRKTKTKLFSDSVKRLNKIQKKLDCIYAD
MEKMCQFLQMDALSGGQYQSDSGSVTRETSPFLICKVLGREKEQKRITELLLRSTDESASASDNDSSFSV
IPLVGIGGVGKTTLAQLVYEDDEIQNHFALKLWICVSNNFNVQRLTKEMIESVTETQHSSQMKLAVLQNI
LKKEIESKMILLVLDDVWNEVEEEWRKLCAPFMYAAAGSKVIVTTRIKSIADKIGTVEAIVLGDLDEISF
WELFKQCAFGPSKPEEHPELVEIGRSIASKLKGLPLAARTVGNLLGSNMNPHHWRSIMKSEVWELQQNKN
DIIPVLQLSYQYLSAPLKRCFAVCCLFHKDYKFSEIELTRIWMAEGFIVAQGNQRMEDVASKYLHELVNM
SLFQQETTFGSHYYVMHDLIHDLTQSVSVDETSRMDNGKSNKISTTLRHLAVKKEFVETKDMLRSRIKKL
HSLFCQQLKSPPLDVIEKLRSIRVLVLYDCGLQMLPTSVGELIHLRYLDISYNKIKELPESLCELYNLQT
LKANNSPLICLPEDISQLINLRHLDIENRLVVQIKKIGRLTSLQELSEFQVRKEVGFKITELSGLKQLHG
KLKITNLENVESKEEAENAQMKNKEYLDVLELEWKFDPKLENKLVAMEEVLEGLQPHESLKQLQIKRYCG
ARSPSWMKKELSNLERLELSFCESWKDISCTALLPHLKVFHIYQSMWFSKSCFEVCGSRESKLFPILEEL
QLSYMNASEELPNLGRFPCLRVVRMTGIKSLKHIDFTASGAIENSLFPMLEELDLRYMPALEEFCSRGHF
PRLRVLCMVAMPLLKHIGFASVHATENDLFPALEVLELMDLPALEELPDLCSLPCLKSFHMRRMSMLKHI
DFALYGSTEKVILPRVETLVLDDLEALEELPSNLGRLPCLKVLKIVKISAVKQIGHGFFSTEVITKCFLS
LENLWISDMPACERWCWIGGSELFPSLQKLTIYECPKLERLPPLPPSLIYLSLRAVGLTELPSLQELETN
GSGGNQTTSSLSALRIRKCNNLTSLEEGLLSQNISNIEDIYVEGCNKLMRMPLKRFENFTSLKELQIKAC
PKLSLTQEEEAALLPPSFKVFILNDCGDLNKLRLGHPYRSTF


>XP_042448315.1 disease resistance protein RGA2-like [Zingiber officinale]
MEGAAALAVGGWLAKPVIRMLVDRVSTSSLRGKLHGLQDDDLQKLQRSLLNIHTIVDKAGMRWNRDARLV
EMMKQLQDAAYDAEDFLDDLTFHGMKQKIEEEASHMAGNRISRAIRNAKAKLFSDSVKRLNKIQKKLDCI
YADMKEMCQLLQADASDGQYQSDLASATRETSSFLISKVLGREEEQKRIIELLLRSTDESASASDKGSSF
SVIPLVGIGGVGKTTLAQLVYKDKEIQNHFGLKIWICVSENFNVQRLTKEIIESVTKTEHSSQMKLDVLQ
NILKENVASKMIMLVLDDVWNEDEEEWRKLCAPFEDAAAGSKVIVTTRSKSIADKIGTVEAIVLGDLDKI
SFWELFKKCAFGPSKPEEYPELEEIGRIIASKLKGLPLAAKTVGNLLGSNMNPHYWRSIMKSEVWELQQN
KNDIIPVLQLSYQYLSAPLKRCFAFCSLFQKDYKFSEIELTRMWMAEGFVVAQGNQRMEDVASKYFHELV
NMSLFQQETSWLGHYYVMHDLIHDLTQSVSVDEISRTNDGKSNKISTTLRHLALETGFVQTKYLRSRFKK
LHSLFFRCLHLKSPPIGFIKN


>XP_042448881.1 putative disease resistance protein RGA1 [Zingiber officinale]
MKNDSFSRFASKIDDLFRQLAAEMIELSRRPWREVSQEELKDIKATLKNIKGLLYDSGRQIKEDAIKLRL
KELQDLVVEVEDFVDDYQYKMFLPQAEFHNKIKQLLSYLYSDPSPGLDGGTMHFPGLDGAAKSCITDSSP
GLGGGARSPINPSPELSVEASHSSGHDNLVVRIAGAKHNLLAQLQKSQKFASHLLLVSQENQDSEKLQRV
TEFLLAESSSQKSTKDLNYFPEDTIRGRKHYNAFDVTKQIYGRNSDREHIISWLLLGTNSRFSLFEDERS
RNKFSAISIVGEAGVGKTVLAKEVYNDPLVCKYFNSRVWLHFTEESDAVSLSKAFFVSITGKSCDGKEPL
HLQSVMKETLKGKKLLLVLDDLQDLNPRLWEYLQAPLAGVRMAKFIITSRTELEASKLSGIESYPLGCLP
LDLSWDLFQHCAFREDHSSHPPRLVRIGKYIVQKCRGLPIAVKTLGSLLGYQMNRRIWIDVLESELWKLQ
ETENDISPALQLSYYLLPTYLKPCFLYCSLFPRGYKFDKYELVRLWMAQGYIQHEDEDYQSLETVGCNYF
HELQMLTIFDRSWDGTFTIHDLLYDVSKYMSNGECSSLPNVKMYKDSGKICQLYVTSSKGTNELQSSNAI
LTLQLLYRSLGGFLPNDILTMALIESVQGIRALELTCHGDSSIAVTIQEKSLDKLNASSLRELPSDIGKL
VNLRYLELSEANIEMLPESICLLRNLQSLIVDYCRNLKKLPHNIGNLFSLCHLGLCGTSIKMLPESVDRL
SKLPTLKLDHCKILMELPSSIGKLVNLQHVTVCMTKITKLPESICSLSNLLTLDLAYSNLSELPNDIGNL
SNLNYLALSYTNISILPEPLCQLTSLRTLKLNGCTNLSQLPSGIGALKRLSHLVVSGIDIEQLPASVCQL
FSLEALEMDGCRRFFSLPDDIGYLTELRQLKLSDTEIQELPESICQLSKLQNLELNGCQRLSKLPESIGD
LSELSNLEVTETKIKALPVSFCRLSNLKVLNLNGNLDLQELPGGIENLANLSQLELSEVGIEVLPRCIGR
LTNLEKLSFEHKQKPFENYQL


>XP_042449102.1 putative disease resistance RPP13-like protein 1 [Zingiber officinale]
MHRIKEILEESGSNILTELGSKTILYIATVVYNQASLIRGLEDAVDKLRRSHKRIQCFLNDAESLDIVQE
VVRGWVCEMKTSAFAAENLIDEFQTLAYVIEHAKEAPSRKRKLPVPSFGSVKNLFKRRKIAMDIVEIDNK
RDEIHESWRNLRLRPSDGQRRSDGSNEMDSVPTVATFDKSRIVGRNKEYQSVVDHLKADSVSNLRVVVIY
GLAGIGKTTLAQLIFKHFSEAISYTNFEMMIWVSLTKVYDVLEATKEIIKEITGENCSSQNFSHLQNSLK
ELVKDKKFLLVLDNFCMKESMFSWERLSIPLMEGATGSRVLITAQNSGVPRGMINCHLVQLQGLQKDDSW
KLFSDIAFPQANRDIYQKLKDIGESIVDICQGSPLAIISLGEVLKLEANVDNWQAICNEILRLENNSICP
ILRSFMTSYHQLNYESKQCFAFCSIFQNSYEFDKDELVRMWTAQDWVQRMSEAKGSMLFNNLQSLSFFEC
STESSSSKYTCKYTMPKLIRRLACSLFKNELLVMEDNELNPPSGQFRYASIFHKKDEILFEKLYNQVSLR
VLKLINESGAGVGRIPNDLFNKLKNLWLLDLSNSGIEELPDSVGKLIHLRYLGLARTNVRKLPESIENLY
NLQTLELKFCYNLSSLPQGTSNLVNLKHLILHLDWERIRDLSFMPPGINYMTSLKTLSRFTVTKEDGCNL
RELKDLDLHGELCICKLENITNASDAKKANLRAKGHIDKLMLRWSDDTSSVQQGTNTWKKVVKQMLRWSD
DTSSAQQGTSTWKEVADELRPHEYLRCLWIMNYPGSEFPNWLADTSFSSIEMVRLSCSKECESLPPLGLL
PKLKHLHIEGMKKLRNLENMKGFPSLKTLTIKDMPVLETFCEFVDDEFPNLIEIVIHRCPNLPDTSRLNI
PGWIDVSRIDAPSTDNGNGNDRS


>XP_042449189.1 putative disease resistance protein RGA3 [Zingiber officinale]
MNETKYKFYPLFGLELIFNKTSPFLICKVLGREKEQKRIIELLLRSTDESASASDSGSGFSVLPLVGIGG
VGKTTLAQLVYKHEEIQNHFALKIWICVSDNFNVQRLTKEIIEFVTETQHSSQMKLAVLQNILKKEIASK
RILLVLDDVWNEDEEWRKLCAPFQDAAAGSKVIVTTRSKNIADKIGTVEAIVLGDLDKISFWELFKKCAF
GPSKPEEHPELEEIGRIIASKLRGLPVAAKTVGNLLGSNMNPHYWRRIMKSEVWELQQNKNDIIPVLQLS
YQYLSAPLKWYFVFDLFSLSKESRVF


>XP_042449191.1 putative disease resistance protein RGA3 [Zingiber officinale]
MKLDVLQNILKEKIASKIILLVLDDVWNEDKEEWRKLCAPFMYAAPGSNVIWKPIVLGDLDEISFWELFK
QCAFGPSKPEEHPELVEIGRSIASKLKGLPLAAKTVGNLLGSNMNPHYWRSIMKSEVWILQQNNKNDIIP
VLQLSYQYLSAPLKRCFAFCSLFQKNYMFSEIELTRMWIAEGFVVAQGNQRMEDVASKYLHELVNMSLFQ
TSRGDYYVMHDLIHDLTQSVSVDETSRMDNGKSNKISTTLRHLAVETEFVETKELRCIRVLVLSHCGLQM
LATSVGGLVHLRYLDISYNELEELPESLCELYNLQTLIVKGNFLISLPEDIIQLVNLRHLDVENEIVVKI
KMIGRLISLEELFEFRVRKEVGFMITELSGLQQLHGKLKITNSEIVESKEEAEMAQMKNKEYLDALELGW
GFYTKLENKLVATEEVLEGLQPHESLKGLKIRRYCGARSPSWMKKEELSNLERLELSFCESWKDISCTAL
LPHLMVFHIESTWFSKSCFEVCGSSESKLFPMLEEL


>XP_042449237.1 putative disease resistance protein RGA1 [Zingiber officinale]
MEGVALAVGGWLAQPVINMLVDRVWTLRGKLHGLQDDDLQKLHRSLLNIHTIVDKAGMRWSRDARLVEMM
KQLQDAAYDAEDFLDELTFHGMKQKIKEEASHKVLNQFSRAIRDAKTKLFSDSVKRLNKIQKKLDDIYAD
MERMCQSLQVDASDGQYQSDLASTTRETSSLLISKVLGREEEQQRIIELLLRSTDESASDNGSSFSVIPL
VGIGGVGKTTLAQLVYKDEEIQNHFAHKIWICVSENFNVQRLTKEMIESVTETEHSSHMKLDVLQNILKR
EIASKMILLVLDNVWNEDEEEWRKLCSPFMYAAAGSKVIVTTRSLSIANKIGSVEAIVLGDLGEISFWEL
FKQCAFGPSKPEEHPELVEIGRSIASKLKGLPLAAKTVGNLLRSNMNPHHWRSIMKSEVWELQQNNKNDI
IPVLQLSYQYLSAPLKRCFAFCSLFQKDYKFSKLELTRMWMAEGFVVAQGNQRMEDVASQYFHELVNMSL
FQQETSSSLEHYFVMHDLIHDLTQSVSVDETIRMDNGKSNKISTTLRHLAVETGFIETKELRSRFKKLHS
LFCQHLKSPPLDFIEKIRSIRVLVLSHCRLHMLPTSVGELVHLRYLDISNNEIEKLPESLCKLYNLQTLK
ANYNWLGISFPDIIQLVNLRHLDVDNEVLGMIKMIGRLTSLQELYNFHAQKEVGFKITELSGLKQLHGKL
RITNLENVESKEEAEKAQMKNKEYLDALELRWGFDSKLDDNKLVVMEEVLEGLQPHESLKRLKIRRYCGA
TSPSWMKKEELSNLEILKLSYCKSWKDISCTALLPHLKVFHIESSMWFSKSCFEVCGSRESKLFPMLEEL
QLRKMNASEELPNLGRFPCLKVVRMTEIESLKHIDFAASGATKNALFPMLEELELRDMPALEEISNLGHF
PRLRFFRMIGMPLLKHIGLASIDATENDLFPMLEELQLMDLPVLEELPDLGSLPCLKSLRIIRMSMLKHI
IDFAFSSATEKVLLPRVETLVLDGLKALEELPSNLGRLPCLKFLQILNISVVKQIGHGFFSTEAISKCFL
SLESLFIIGMPACEGWCWIDGSELFPRLQRLFITGCPKLERLPPLPPSLTHLTLGNVGLTELPSLQELET
NGSGGNQTTSFLSKLQISKCNNLTSLEEGLLSQNLSNIEHIYVTGCNELMRIPLKRFENFTSLKKLQIEA
CPKLSLTQEEEAALLPPSFKVFILNDCGDLNKLRLGHPYRSTFDFLPTTDPHRPSSMSHKFSWFRSHNIL
GTFFLA


>XP_042449238.1 putative disease resistance protein RGA1 [Zingiber officinale]
MEGVALAVGGWLAQPVINMLVDRVWTLRGKLHGLQDDDLQKLHRSLLNIHTIVDKAGMRWSRDARLVEMM
KQLQDAAYDAEDFLDELTFHGMKQKIKEEASHKVLNQFSRAIRDAKTKLFSDSVKRLNKIQKKLDDIYAD
MERMCQSLQVDASDGQYQSDLASTTRETSSLLISKVLGREEEQQRIIELLLRSTDESASDNGSSFSVIPL
VGIGGVGKTTLAQLVYKDEEIQNHFAHKIWICVSENFNVQRLTKEMIESVTETEHSSHMKLDVLQNILKR
EIASKMILLVLDNVWNEDEEEWRKLCSPFMYAAAGSKVIVTTRSLSIANKIGSVEAIVLGDLGEISFWEL
FKQCAFGPSKPEEHPELVEIGRSIASKLKGLPLAAKTVGNLLRSNMNPHHWRSIMKSEVWELQQNNKNDI
IPVLQLSYQYLSAPLKRCFAFCSLFQKDYKFSKLELTRMWMAEGFVVAQGNQRMEDVASQYFHELVNMSL
FQQETSSSLEHYFVMHDLIHDLTQSVSVDETIRMDNGKSNKISTTLRHLAVETGFIETKELRSRFKKLHS
LFCQHLKSPPLDFIEKIRSIRVLVLSHCRLHMLPTSVGELVHLRYLDISNNEIEKLPESLCKLYNLQTLK
ANYNWLGISFPDIIQLVNLRHLDVDNEVLGMIKMIGRLTSLQELYNFHAQKEVGFKITELSGLKQLHGKL
RITNLENVESKEEAEKAQMKNKEYLDALELRWGFDSKLDDNKLVVMEEVLEGLQPHESLKRLKIRRYCGA
TSPSWMKKEELSNLEILKLSYCKSWKDISCTALLPHLKVFHIESSMWFSKSCFEVCGSRESKLFPMLEEL
QLRKMNASEELPNLGRFPCLKVVRMTEIESLKHIDFAASGATKNALFPMLEELELRDMPALEEISNLGHF
PRLRFFRMIGMPLLKHIGLASIDATENDLFPMLEELQLMDLPVLEELPDLGSLPCLKSLRIIRMSMLKHI
IDFAFSSATEKVLLPRVETLVLDGLKALEELPSNLGRLPCLKFLQILNISVVKQIGHGFFSTEAISKCFL
SLESLFIIGMPACEGWCWIDGSELFPRLQRLFITGCPKLERLPPLPPSLTHLTLGNVGLTELPSLQELET
NGSGGNQTTSFLSKLQISKCNNLTSLEEGLLSQNLSNIEHIYVTGCNELMRIPLKRFENFTSLKKLQIEA
CPKLSLTQEEEAALLPPSFKVFILNDCGDLNKLRLGHPYRSTFDFLPTTDPHRPSSMSHKFSWFRSHNIL
GTFFLA


>XP_042449239.1 putative disease resistance protein RGA1 [Zingiber officinale]
MEGVALAVGGWLAQPVINMLVDRVWTLRGKLHGLQDDDLQKLHRSLLNIHTIVDKAGMRWSRDARLVEMM
KQLQDAAYDAEDFLDELTFHGMKQKIKEEASHKVLNQFSRAIRDAKTKLFSDSVKRLNKIQKKLDDIYAD
MERMCQSLQVDASDGQYQSDLASTTRETSSLLISKVLGREEEQQRIIELLLRSTDESASDNGSSFSVIPL
VGIGGVGKTTLAQLVYKDEEIQNHFAHKIWICVSENFNVQRLTKEMIESVTETEHSSHMKLDVLQNILKR
EIASKMILLVLDNVWNEDEEEWRKLCSPFMYAAAGSKVIVTTRSLSIANKIGSVEAIVLGDLGEISFWEL
FKQCAFGPSKPEEHPELVEIGRSIASKLKGLPLAAKTVGNLLRSNMNPHHWRSIMKSEVWELQQNNKNDI
IPVLQLSYQYLSAPLKRCFAFCSLFQKDYKFSKLELTRMWMAEGFVVAQGNQRMEDVASQYFHELVNMSL
FQQETSSSLEHYFVMHDLIHDLTQSVSVDETIRMDNGKSNKISTTLRHLAVETGFIETKELRSRFKKLHS
LFCQHLKSPPLDFIEKIRSIRVLVLSHCRLHMLPTSVGELVHLRYLDISNNEIEKLPESLCKLYNLQTLK
ANYNWLGISFPDIIQLVNLRHLDVDNEVLGMIKMIGRLTSLQELYNFHAQKEVGFKITELSGLKQLHGKL
RITNLENVESKEEAEKAQMKNKEYLDALELRWGFDSKLDDNKLVVMEEVLEGLQPHESLKRLKIRRYCGA
TSPSWMKKEELSNLEILKLSYCKSWKDISCTALLPHLKVFHIESSMWFSKSCFEVCGSRESKLFPMLEEL
QLRKMNASEELPNLGRFPCLKVVRMTEIESLKHIDFAASGATKNALFPMLEELELRDMPALEEISNLGHF
PRLRFFRMIGMPLLKHIGLASIDATENDLFPMLEELQLMDLPVLEELPDLGSLPCLKSLRIIRMSMLKHI
IDFAFSSATEKVLLPRVETLVLDGLKALEELPSNLGRLPCLKFLQILNISVVKQIGHGFFSTEAISKCFL
SLESLFIIGMPACEGWCWIDGSELFPRLQRLFITGCPKLERLPPLPPSLTHLTLGNVGLTELPSLQELET
NGSGGNQTTSFLSKLQISKCNNLTSLEEGLLSQNLSNIEHIYVTGCNELMRIPLKRFENFTSLKKLQIEA
CPKLSLTQEEEAALLPPSFKVFILNDCGDLNKLRLGHPYRSTFDFLPTTDPHRPSSMSHKFSWFRSHNIL
GTFFLA


>XP_042449240.1 putative disease resistance protein RGA1 [Zingiber officinale]
MEGVALAVGGWLAQPVINMLVDRVWTLRGKLHGLQDDDLQKLHRSLLNIHTIVDKAGMRWSRDARLVEMM
KQLQDAAYDAEDFLDELTFHGMKQKIKEEASHKVLNQFSRAIRDAKTKLFSDSVKRLNKIQKKLDDIYAD
MERMCQSLQVDASDGQYQSDLASTTRETSSLLISKVLGREEEQQRIIELLLRSTDESASDNGSSFSVIPL
VGIGGVGKTTLAQLVYKDEEIQNHFAHKIWICVSENFNVQRLTKEMIESVTETEHSSHMKLDVLQNILKR
EIASKMILLVLDNVWNEDEEEWRKLCSPFMYAAAGSKVIVTTRSLSIANKIGSVEAIVLGDLGEISFWEL
FKQCAFGPSKPEEHPELVEIGRSIASKLKGLPLAAKTVGNLLRSNMNPHHWRSIMKSEVWELQQNNKNDI
IPVLQLSYQYLSAPLKRCFAFCSLFQKDYKFSKLELTRMWMAEGFVVAQGNQRMEDVASQYFHELVNMSL
FQQETSSSLEHYFVMHDLIHDLTQSVSVDETIRMDNGKSNKISTTLRHLAVETGFIETKELRSRFKKLHS
LFCQHLKSPPLDFIEKIRSIRVLVLSHCRLHMLPTSVGELVHLRYLDISNNEIEKLPESLCKLYNLQTLK
ANYNWLGISFPDIIQLVNLRHLDVDNEVLGMIKMIGRLTSLQELYNFHAQKEVGFKITELSGLKQLHGKL
RITNLENVESKEEAEKAQMKNKEYLDALELRWGFDSKLDDNKLVVMEEVLEGLQPHESLKRLKIRRYCGA
TSPSWMKKEELSNLEILKLSYCKSWKDISCTALLPHLKVFHIESSMWFSKSCFEVCGSRESKLFPMLEEL
QLRKMNASEELPNLGRFPCLKVVRMTEIESLKHIDFAASGATKNALFPMLEELELRDMPALEEISNLGHF
PRLRFFRMIGMPLLKHIGLASIDATENDLFPMLEELQLMDLPVLEELPDLGSLPCLKSLRIIRMSMLKHI
IDFAFSSATEKVLLPRVETLVLDGLKALEELPSNLGRLPCLKFLQILNISVVKQIGHGFFSTEAISKCFL
SLESLFIIGMPACEGWCWIDGSELFPRLQRLFITGCPKLERLPPLPPSLTHLTLGNVGLTELPSLQELET
NGSGGNQTTSFLSKLQISKCNNLTSLEEGLLSQNLSNIEHIYVTGCNELMRIPLKRFENFTSLKKLQIEA
CPKLSLTQEEEAALLPPSFKVFILNDCGDLNKLRLGHPYRSTFDFLPTTDPHRPSSMSHKFSWFRSHNIL
GTFFLA


>XP_042449241.1 putative disease resistance protein RGA1 [Zingiber officinale]
MEGVALAVGGWLAQPVINMLVDRVWTLRGKLHGLQDDDLQKLHRSLLNIHTIVDKAGMRWSRDARLVEMM
KQLQDAAYDAEDFLDELTFHGMKQKIKEEASHKVLNQFSRAIRDAKTKLFSDSVKRLNKIQKKLDDIYAD
MERMCQSLQVDASDGQYQSDLASTTRETSSLLISKVLGREEEQQRIIELLLRSTDESASDNGSSFSVIPL
VGIGGVGKTTLAQLVYKDEEIQNHFAHKIWICVSENFNVQRLTKEMIESVTETEHSSHMKLDVLQNILKR
EIASKMILLVLDNVWNEDEEEWRKLCSPFMYAAAGSKVIVTTRSLSIANKIGSVEAIVLGDLGEISFWEL
FKQCAFGPSKPEEHPELVEIGRSIASKLKGLPLAAKTVGNLLRSNMNPHHWRSIMKSEVWELQQNNKNDI
IPVLQLSYQYLSAPLKRCFAFCSLFQKDYKFSKLELTRMWMAEGFVVAQGNQRMEDVASQYFHELVNMSL
FQQETSSSLEHYFVMHDLIHDLTQSVSVDETIRMDNGKSNKISTTLRHLAVETGFIETKELRSRFKKLHS
LFCQHLKSPPLDFIEKIRSIRVLVLSHCRLHMLPTSVGELVHLRYLDISNNEIEKLPESLCKLYNLQTLK
ANYNWLGISFPDIIQLVNLRHLDVDNEVLGMIKMIGRLTSLQELYNFHAQKEVGFKITELSGLKQLHGKL
RITNLENVESKEEAEKAQMKNKEYLDALELRWGFDSKLDDNKLVVMEEVLEGLQPHESLKRLKIRRYCGA
TSPSWMKKEELSNLEILKLSYCKSWKDISCTALLPHLKVFHIESSMWFSKSCFEVCGSRESKLFPMLEEL
QLRKMNASEELPNLGRFPCLKVVRMTEIESLKHIDFAASGATKNALFPMLEELELRDMPALEEISNLGHF
PRLRFFRMIGMPLLKHIGLASIDATENDLFPMLEELQLMDLPVLEELPDLGSLPCLKSLRIIRMSMLKHI
IDFAFSSATEKVLLPRVETLVLDGLKALEELPSNLGRLPCLKFLQILNISVVKQIGHGFFSTEAISKCFL
SLESLFIIGMPACEGWCWIDGSELFPRLQRLFITGCPKLERLPPLPPSLTHLTLGNVGLTELPSLQELET
NGSGGNQTTSFLSKLQISKCNNLTSLEEGLLSQNLSNIEHIYVTGCNELMRIPLKRFENFTSLKKLQIEA
CPKLSLTQEEEAALLPPSFKVFILNDCGDLNKLRLGHPYRSTFDFLPTTDPHRPSSMSHKFSWFRSHNIL
GTFFLA


>XP_042449242.1 putative disease resistance protein RGA1 [Zingiber officinale]
MEGVALAVGGWLAQPVINMLVDRVWTLRGKLHGLQDDDLQKLHRSLLNIHTIVDKAGMRWSRDARLVEMM
KQLQDAAYDAEDFLDELTFHGMKQKIKEEASHKVLNQFSRAIRDAKTKLFSDSVKRLNKIQKKLDDIYAD
MERMCQSLQVDASDGQYQSDLASTTRETSSLLISKVLGREEEQQRIIELLLRSTDESASDNGSSFSVIPL
VGIGGVGKTTLAQLVYKDEEIQNHFAHKIWICVSENFNVQRLTKEMIESVTETEHSSHMKLDVLQNILKR
EIASKMILLVLDNVWNEDEEEWRKLCSPFMYAAAGSKVIVTTRSLSIANKIGSVEAIVLGDLGEISFWEL
FKQCAFGPSKPEEHPELVEIGRSIASKLKGLPLAAKTVGNLLRSNMNPHHWRSIMKSEVWELQQNNKNDI
IPVLQLSYQYLSAPLKRCFAFCSLFQKDYKFSKLELTRMWMAEGFVVAQGNQRMEDVASQYFHELVNMSL
FQQETSSSLEHYFVMHDLIHDLTQSVSVDETIRMDNGKSNKISTTLRHLAVETGFIETKELRSRFKKLHS
LFCQHLKSPPLDFIEKIRSIRVLVLSHCRLHMLPTSVGELVHLRYLDISNNEIEKLPESLCKLYNLQTLK
ANYNWLGISFPDIIQLVNLRHLDVDNEVLGMIKMIGRLTSLQELYNFHAQKEVGFKITELSGLKQLHGKL
RITNLENVESKEEAEKAQMKNKEYLDALELRWGFDSKLDDNKLVVMEEVLEGLQPHESLKRLKIRRYCGA
TSPSWMKKEELSNLEILKLSYCKSWKDISCTALLPHLKVFHIESSMWFSKSCFEVCGSRESKLFPMLEEL
QLRKMNASEELPNLGRFPCLKVVRMTEIESLKHIDFAASGATKNALFPMLEELELRDMPALEEISNLGHF
PRLRFFRMIGMPLLKHIGLASIDATENDLFPMLEELQLMDLPVLEELPDLGSLPCLKSLRIIRMSMLKHI
IDFAFSSATEKVLLPRVETLVLDGLKALEELPSNLGRLPCLKFLQILNISVVKQIGHGFFSTEAISKCFL
SLESLFIIGMPACEGWCWIDGSELFPRLQRLFITGCPKLERLPPLPPSLTHLTLGNVGLTELPSLQELET
NGSGGNQTTSFLSKLQISKCNNLTSLEEGLLSQNLSNIEHIYVTGCNELMRIPLKRFENFTSLKKLQIEA
CPKLSLTQEEEAALLPPSFKVFILNDCGDLNKLRLGHPYRSTFDFLPTTDPHRPSSMSHKFSWFRSHNIL
GTFFLA


>XP_042449243.1 putative disease resistance protein RGA1 [Zingiber officinale]
MEGVALAVGGWLAQPVINMLVDRVWTLRGKLHGLQDDDLQKLHRSLLNIHTIVDKAGMRWSRDARLVEMM
KQLQDAAYDAEDFLDELTFHGMKQKIKEEASHKVLNQFSRAIRDAKTKLFSDSVKRLNKIQKKLDDIYAD
MERMCQSLQVDASDGQYQSDLASTTRETSSLLISKVLGREEEQQRIIELLLRSTDESASDNGSSFSVIPL
VGIGGVGKTTLAQLVYKDEEIQNHFAHKIWICVSENFNVQRLTKEMIESVTETEHSSHMKLDVLQNILKR
EIASKMILLVLDNVWNEDEEEWRKLCSPFMYAAAGSKVIVTTRSLSIANKIGSVEAIVLGDLGEISFWEL
FKQCAFGPSKPEEHPELVEIGRSIASKLKGLPLAAKTVGNLLRSNMNPHHWRSIMKSEVWELQQNNKNDI
IPVLQLSYQYLSAPLKRCFAFCSLFQKDYKFSKLELTRMWMAEGFVVAQGNQRMEDVASQYFHELVNMSL
FQQETSSSLEHYFVMHDLIHDLTQSVSVDETIRMDNGKSNKISTTLRHLAVETGFIETKELRSRFKKLHS
LFCQHLKSPPLDFIEKIRSIRVLVLSHCRLHMLPTSVGELVHLRYLDISNNEIEKLPESLCKLYNLQTLK
ANYNWLGISFPDIIQLVNLRHLDVDNEVLGMIKMIGRLTSLQELYNFHAQKEVGFKITELSGLKQLHGKL
RITNLENVESKEEAEKAQMKNKEYLDALELRWGFDSKLDDNKLVVMEEVLEGLQPHESLKRLKIRRYCGA
TSPSWMKKEELSNLEILKLSYCKSWKDISCTALLPHLKVFHIESSMWFSKSCFEVCGSRESKLFPMLEEL
QLRKMNASEELPNLGRFPCLKVVRMTEIESLKHIDFAASGATKNALFPMLEELELRDMPALEEISNLGHF
PRLRFFRMIGMPLLKHIGLASIDATENDLFPMLEELQLMDLPVLEELPDLGSLPCLKSLRIIRMSMLKHI
IDFAFSSATEKVLLPRVETLVLDGLKALEELPSNLGRLPCLKFLQILNISVVKQIGHGFFSTEAISKCFL
SLESLFIIGMPACEGWCWIDGSELFPRLQRLFITGCPKLERLPPLPPSLTHLTLGNVGLTELPSLQELET
NGSGGNQTTSFLSKLQISKCNNLTSLEEGLLSQNLSNIEHIYVTGCNELMRIPLKRFENFTSLKKLQIEA
CPKLSLTQEEEAALLPPSFKVFILNDCGDLNKLRLGHPYRSTFDFLPTTDPHRPSSMSHKFSWFRSHNIL
GTFFLA


>XP_042449244.1 putative disease resistance protein RGA1 [Zingiber officinale]
MEGVALAVGGWLAQPVINMLVDRVWTLRGKLHGLQDDDLQKLHRSLLNIHTIVDKAGMRWSRDARLVEMM
KQLQDAAYDAEDFLDELTFHGMKQKIKEEASHKVLNQFSRAIRDAKTKLFSDSVKRLNKIQKKLDDIYAD
MERMCQSLQVDASDGQYQSDLASTTRETSSLLISKVLGREEEQQRIIELLLRSTDESASDNGSSFSVIPL
VGIGGVGKTTLAQLVYKDEEIQNHFAHKIWICVSENFNVQRLTKEMIESVTETEHSSHMKLDVLQNILKR
EIASKMILLVLDNVWNEDEEEWRKLCSPFMYAAAGSKVIVTTRSLSIANKIGSVEAIVLGDLGEISFWEL
FKQCAFGPSKPEEHPELVEIGRSIASKLKGLPLAAKTVGNLLRSNMNPHHWRSIMKSEVWELQQNNKNDI
IPVLQLSYQYLSAPLKRCFAFCSLFQKDYKFSKLELTRMWMAEGFVVAQGNQRMEDVASQYFHELVNMSL
FQQETSSSLEHYFVMHDLIHDLTQSVSVDETIRMDNGKSNKISTTLRHLAVETGFIETKELRSRFKKLHS
LFCQHLKSPPLDFIEKIRSIRVLVLSHCRLHMLPTSVGELVHLRYLDISNNEIEKLPESLCKLYNLQTLK
ANYNWLGISFPDIIQLVNLRHLDVDNEVLGMIKMIGRLTSLQELYNFHAQKEVGFKITELSGLKQLHGKL
RITNLENVESKEEAEKAQMKNKEYLDALELRWGFDSKLDDNKLVVMEEVLEGLQPHESLKRLKIRRYCGA
TSPSWMKKEELSNLEILKLSYCKSWKDISCTALLPHLKVFHIESSMWFSKSCFEVCGSRESKLFPMLEEL
QLRKMNASEELPNLGRFPCLKVVRMTEIESLKHIDFAASGATKNALFPMLEELELRDMPALEEISNLGHF
PRLRFFRMIGMPLLKHIGLASIDATENDLFPMLEELQLMDLPVLEELPDLGSLPCLKSLRIIRMSMLKHI
IDFAFSSATEKVLLPRVETLVLDGLKALEELPSNLGRLPCLKFLQILNISVVKQIGHGFFSTEAISKCFL
SLESLFIIGMPACEGWCWIDGSELFPRLQRLFITGCPKLERLPPLPPSLTHLTLGNVGLTELPSLQELET
NGSGGNQTTSFLSKLQISKCNNLTSLEEGLLSQNLSNIEHIYVTGCNELMRIPLKRFENFTSLKKLQIEA
CPKLSLTQEEEAALLPPSFKVFILNDCGDLNKLRLGHPYRSTFDFLPTTDPHRPSSMSHKFSWFRSHNIL
GTFFLA


>XP_042449245.1 putative disease resistance protein RGA1 [Zingiber officinale]
MEGVALAVGGWLAQPVINMLVDRVWTLRGKLHGLQDDDLQKLHRSLLNIHTIVDKAGMRWSRDARLVEMM
KQLQDAAYDAEDFLDELTFHGMKQKIKEEASHKVLNQFSRAIRDAKTKLFSDSVKRLNKIQKKLDDIYAD
MERMCQSLQVDASDGQYQSDLASTTRETSSLLISKVLGREEEQQRIIELLLRSTDESASDNGSSFSVIPL
VGIGGVGKTTLAQLVYKDEEIQNHFAHKIWICVSENFNVQRLTKEMIESVTETEHSSHMKLDVLQNILKR
EIASKMILLVLDNVWNEDEEEWRKLCSPFMYAAAGSKVIVTTRSLSIANKIGSVEAIVLGDLGEISFWEL
FKQCAFGPSKPEEHPELVEIGRSIASKLKGLPLAAKTVGNLLRSNMNPHHWRSIMKSEVWELQQNNKNDI
IPVLQLSYQYLSAPLKRCFAFCSLFQKDYKFSKLELTRMWMAEGFVVAQGNQRMEDVASQYFHELVNMSL
FQQETSSSLEHYFVMHDLIHDLTQSVSVDETIRMDNGKSNKISTTLRHLAVETGFIETKELRSRFKKLHS
LFCQHLKSPPLDFIEKIRSIRVLVLSHCRLHMLPTSVGELVHLRYLDISNNEIEKLPESLCKLYNLQTLK
ANYNWLGISFPDIIQLVNLRHLDVDNEVLGMIKMIGRLTSLQELYNFHAQKEVGFKITELSGLKQLHGKL
RITNLENVESKEEAEKAQMKNKEYLDALELRWGFDSKLDDNKLVVMEEVLEGLQPHESLKRLKIRRYCGA
TSPSWMKKEELSNLEILKLSYCKSWKDISCTALLPHLKVFHIESSMWFSKSCFEVCGSRESKLFPMLEEL
QLRKMNASEELPNLGRFPCLKVVRMTEIESLKHIDFAASGATKNALFPMLEELELRDMPALEEISNLGHF
PRLRFFRMIGMPLLKHIGLASIDATENDLFPMLEELQLMDLPVLEELPDLGSLPCLKSLRIIRMSMLKHI
IDFAFSSATEKVLLPRVETLVLDGLKALEELPSNLGRLPCLKFLQILNISVVKQIGHGFFSTEAISKCFL
SLESLFIIGMPACEGWCWIDGSELFPRLQRLFITGCPKLERLPPLPPSLTHLTLGNVGLTELPSLQELET
NGSGGNQTTSFLSKLQISKCNNLTSLEEGLLSQNLSNIEHIYVTGCNELMRIPLKRFENFTSLKKLQIEA
CPKLSLTQEEEAALLPPSFKVFILNDCGDLNKLRLGHPYRSTFDFLPTTDPHRPSSMSHKFSWFRSHNIL
GTFFLA


>XP_042449374.1 putative disease resistance protein RGA3 [Zingiber officinale]
MANDSVSRFATKIGNLFRPLAAEMIRVSLSDLAARSMPEVQRYKLEGIKVILKNIKGLLYDSGRQIREDD
IKLWLKELQDLVIEVEDLVDDYQYKMFQREAEFLNKIEQPSGYVSSDPLRGLDGGAMHSPGLDGAAKSCI
IDSCPGLGGGARSSIHPSPELSVGASHSSGLDVGTSHHSGITDFSSGFGGGARSTIDPSPEFSSGLGGGA
RSTIDPSPEFFTIDPSPDFSPELDGRRRIGFFGPHSSLLDQLLDQHKKIDKIISSWKKEEEVISCITTDP
SSGLDGGARHSPGFREVVGPSTIRNEVDASPIKGPFNIVVRIAWVKHNLLAQLQKSQKFASHLLLVSQEN
QDSEKLQRVREFLLAESSSQKSTKDLNYFPADTIRGRKHYNAFDVTKQIYGRNRDKEFIISWLFSTNSRF
SLFEDERSRNKFSAISIVGEAGVGKTTLAKEVYNDPLICKYFNSRVWLHFTEESDAVSFSKAFFVSITGK
SCDGKLPVHLQSVMKEELKGKKLLLVLDDLQDLNPRLWEYLQAPLAGVRMAKFIITSRTELEASKLRGIE
SYPLGCLPLDLSWDLFQHCAFREDSSHPPKLIEIGKRIVQECRGLPIAVKTLGSVLGYQMDKQIWLDVLD
SELWELQETETDISPALQLSYYLLPTYLKPCFLYCSLFPRGYKFDKYELVRLWMAQGYIQHEYGQSLETV
GCNYFHELQMLTIFDRSWDGTFTIHNLLYDVSRYMSNGECSSLPYGKMYKDSGKIRQLYVTSSKGTNELQ
SSNANLTLQLLYKSLGGFLPNDILTMTLIESVQGIRALELTCHGDSSIAETIQEKALDKLNASSVSSLRF
IHLRYLRICDRFIELLPAAVCELYNLQTLTLDKCLKLIELPSDIGKLVNLRYLGLSEANIEKLPKSVYQL
RNLQSLKVDYCRNLKDLPYNIGSLVNLCHLRLSGTSIKRLPRSVHCLSKLSTLKLDQCKILMALPSSIGN
LVNLRHVTACKTKITKLPESICLLFNLLTLDLAYSNLSELPNDIGNLSNLNYLALSYTNISILPESLCYL
YRLRILKLNGCTNLSQLPSGIGALKRLSHLVVSGINIEQLPASVCQLLNLEVLEMDGCRKFFSLPDGIGY
LTKLHQLKLSDTEIQELPESIGQLSNLQNLELNGCQRLCKLPESIGDLSELSNLEVTETKIKALPASFCQ
LSNLKVLNLNGNLDLQELPSGIENLANLCQLELSEVGIEVLPRCIVRLTNLEKLTFEHKQKPFENYQL


>XP_042449396.1 putative disease resistance protein RGA4 isoform X1 [Zingiber officinale]
MDVVSPILDRARAKVIDKLIDKVSTYVQDQYYWKANLQEELQNLKRLLPQIQAVVGYAEDKLTMYESHNP
ALIKWLWQFRDDIDEAEEVLDELEYRELEKKSDGDKSRLSTIIDPYFRAAKRFLKSDDDVLERLRTCVEN
LKTSASYVETFRALVTPTSGIGTGQMQQEQESLTLSNQSRITSSLPGLSFKGREEEKGKIIQYLLGEESE
IQTSQNVHCLPLVAMGGMGKTALAQQVFDHFEKEKKGHFNVKIWVCDSLPNLNASNLMKKILEYSTGQSE
SGPSELMPVKLKDKLHSKRFLLVLDDAWDDKNHTEWEKLCIPLLHGQKGSWILLTTRLESVAKMVSKIIK
GGTMKPMTLQGLPKDECRSLLYEHAFVDQDPNGFPLLKKIGEEIVEKLHGVPLLAKSIGGALNNKLEADH
WTSISRSELWKMPQDLNNYEFIPALTLSYKMLPPRLKQCFSYCSIFPQDYTFKKQKLVCIWVAAGLIYSD
GSEEGSDEDIANYCFDMLCNKSFFDVHTNNWSAFHQDIAPYALEVIFYTMHDMLNGLSRHVSRYECCRIV
HDTPSYICDYNAIRHISISITSIDAQLGDLANMVCKFKNLRTLRIEQYYGDSQKLDDFIRDACKSPRRIR
VLTIRPYKYFESISDFVKLRFLEITALPPSVSISKFYFLQVLTGYRGILAKDTSKLRNLRHLYGVPENAL
FSVAEVGKLTCLQELCFTVGIEPGYRIDELMNMDNLRQLSIAKLSNVHRLEEANNVDLVSKSHLTSLELN
WYKPDLDEASSNLGHDQQEVLAALQPPPTIRKLIIREYKGGRPAPWMNTQSLSRLESLELYNCTNLEELP
PLWKLPCLKFIKLSDMKVIRSLGCHSSDMMDKQFSVLEKLEFRDLPLLEEWNGADDYQWFPRLKRFEIEK
CPKLKKIPDLPLSIENLCMKKLGLEALPRFYKCSNGSRTFEGFQQLMSLEFLEMDDYSEIVDIGSIGEED
GNFLPSELKKLKLKILNKHEDLASYLRGLTLLTELSLSRLQGMTSLPLTNELEHLTTLRSLYICDCEDLT
SPGGVYIIKSLKHLYMYNCPKFLTAEVESQQLLKDKTRKHAASSSSIFDHSTSNKAASTLPSSLESLTFS
TSKISQESLGCCLQGLTSLKSLDISKCNHLVSLPNRDYLHNLTALQTLWIANCKELCKLESLTALISLRE
LYIYNCPKLHTTTLSTVQNPAATTEQSATKIKKGTLLSLEKIQIDNIFYLPILPIPEKLKTLYIKKEITC
FPSEIEEWLLQCQESLENLCLEKMPHLQSLPVILESFSSLKFLSISSAPELKSLPRMPASLEQLTIHGCS
AKLEKRCQKNIGPDWPNIEHIPHIKITAVKEDKAKFLQDVLFS


>XP_042449397.1 putative disease resistance protein RGA4 isoform X1 [Zingiber officinale]
MDVVSPILDRARAKVIDKLIDKVSTYVQDQYYWKANLQEELQNLKRLLPQIQAVVGYAEDKLTMYESHNP
ALIKWLWQFRDDIDEAEEVLDELEYRELEKKSDGDKSRLSTIIDPYFRAAKRFLKSDDDVLERLRTCVEN
LKTSASYVETFRALVTPTSGIGTGQMQQEQESLTLSNQSRITSSLPGLSFKGREEEKGKIIQYLLGEESE
IQTSQNVHCLPLVAMGGMGKTALAQQVFDHFEKEKKGHFNVKIWVCDSLPNLNASNLMKKILEYSTGQSE
SGPSELMPVKLKDKLHSKRFLLVLDDAWDDKNHTEWEKLCIPLLHGQKGSWILLTTRLESVAKMVSKIIK
GGTMKPMTLQGLPKDECRSLLYEHAFVDQDPNGFPLLKKIGEEIVEKLHGVPLLAKSIGGALNNKLEADH
WTSISRSELWKMPQDLNNYEFIPALTLSYKMLPPRLKQCFSYCSIFPQDYTFKKQKLVCIWVAAGLIYSD
GSEEGSDEDIANYCFDMLCNKSFFDVHTNNWSAFHQDIAPYALEVIFYTMHDMLNGLSRHVSRYECCRIV
HDTPSYICDYNAIRHISISITSIDAQLGDLANMVCKFKNLRTLRIEQYYGDSQKLDDFIRDACKSPRRIR
VLTIRPYKYFESISDFVKLRFLEITALPPSVSISKFYFLQVLTGYRGILAKDTSKLRNLRHLYGVPENAL
FSVAEVGKLTCLQELCFTVGIEPGYRIDELMNMDNLRQLSIAKLSNVHRLEEANNVDLVSKSHLTSLELN
WYKPDLDEASSNLGHDQQEVLAALQPPPTIRKLIIREYKGGRPAPWMNTQSLSRLESLELYNCTNLEELP
PLWKLPCLKFIKLSDMKVIRSLGCHSSDMMDKQFSVLEKLEFRDLPLLEEWNGADDYQWFPRLKRFEIEK
CPKLKKIPDLPLSIENLCMKKLGLEALPRFYKCSNGSRTFEGFQQLMSLEFLEMDDYSEIVDIGSIGEED
GNFLPSELKKLKLKILNKHEDLASYLRGLTLLTELSLSRLQGMTSLPLTNELEHLTTLRSLYICDCEDLT
SPGGVYIIKSLKHLYMYNCPKFLTAEVESQQLLKDKTRKHAASSSSIFDHSTSNKAASTLPSSLESLTFS
TSKISQESLGCCLQGLTSLKSLDISKCNHLVSLPNRDYLHNLTALQTLWIANCKELCKLESLTALISLRE
LYIYNCPKLHTTTLSTVQNPAATTEQSATKIKKGTLLSLEKIQIDNIFYLPILPIPEKLKTLYIKKEITC
FPSEIEEWLLQCQESLENLCLEKMPHLQSLPVILESFSSLKFLSISSAPELKSLPRMPASLEQLTIHGCS
AKLEKRCQKNIGPDWPNIEHIPHIKITAVKEDKAKFLQDVLFS


>XP_042449398.1 putative disease resistance protein RGA4 isoform X1 [Zingiber officinale]
MDVVSPILDRARAKVIDKLIDKVSTYVQDQYYWKANLQEELQNLKRLLPQIQAVVGYAEDKLTMYESHNP
ALIKWLWQFRDDIDEAEEVLDELEYRELEKKSDGDKSRLSTIIDPYFRAAKRFLKSDDDVLERLRTCVEN
LKTSASYVETFRALVTPTSGIGTGQMQQEQESLTLSNQSRITSSLPGLSFKGREEEKGKIIQYLLGEESE
IQTSQNVHCLPLVAMGGMGKTALAQQVFDHFEKEKKGHFNVKIWVCDSLPNLNASNLMKKILEYSTGQSE
SGPSELMPVKLKDKLHSKRFLLVLDDAWDDKNHTEWEKLCIPLLHGQKGSWILLTTRLESVAKMVSKIIK
GGTMKPMTLQGLPKDECRSLLYEHAFVDQDPNGFPLLKKIGEEIVEKLHGVPLLAKSIGGALNNKLEADH
WTSISRSELWKMPQDLNNYEFIPALTLSYKMLPPRLKQCFSYCSIFPQDYTFKKQKLVCIWVAAGLIYSD
GSEEGSDEDIANYCFDMLCNKSFFDVHTNNWSAFHQDIAPYALEVIFYTMHDMLNGLSRHVSRYECCRIV
HDTPSYICDYNAIRHISISITSIDAQLGDLANMVCKFKNLRTLRIEQYYGDSQKLDDFIRDACKSPRRIR
VLTIRPYKYFESISDFVKLRFLEITALPPSVSISKFYFLQVLTGYRGILAKDTSKLRNLRHLYGVPENAL
FSVAEVGKLTCLQELCFTVGIEPGYRIDELMNMDNLRQLSIAKLSNVHRLEEANNVDLVSKSHLTSLELN
WYKPDLDEASSNLGHDQQEVLAALQPPPTIRKLIIREYKGGRPAPWMNTQSLSRLESLELYNCTNLEELP
PLWKLPCLKFIKLSDMKVIRSLGCHSSDMMDKQFSVLEKLEFRDLPLLEEWNGADDYQWFPRLKRFEIEK
CPKLKKIPDLPLSIENLCMKKLGLEALPRFYKCSNGSRTFEGFQQLMSLEFLEMDDYSEIVDIGSIGEED
GNFLPSELKKLKLKILNKHEDLASYLRGLTLLTELSLSRLQGMTSLPLTNELEHLTTLRSLYICDCEDLT
SPGGVYIIKSLKHLYMYNCPKFLTAEVESQQLLKDKTRKHAASSSSIFDHSTSNKAASTLPSSLESLTFS
TSKISQESLGCCLQGLTSLKSLDISKCNHLVSLPNRDYLHNLTALQTLWIANCKELCKLESLTALISLRE
LYIYNCPKLHTTTLSTVQNPAATTEQSATKIKKGTLLSLEKIQIDNIFYLPILPIPEKLKTLYIKKEITC
FPSEIEEWLLQCQESLENLCLEKMPHLQSLPVILESFSSLKFLSISSAPELKSLPRMPASLEQLTIHGCS
AKLEKRCQKNIGPDWPNIEHIPHIKITAVKEDKAKFLQDVLFS


>XP_042449399.1 putative disease resistance protein RGA4 isoform X1 [Zingiber officinale]
MDVVSPILDRARAKVIDKLIDKVSTYVQDQYYWKANLQEELQNLKRLLPQIQAVVGYAEDKLTMYESHNP
ALIKWLWQFRDDIDEAEEVLDELEYRELEKKSDGDKSRLSTIIDPYFRAAKRFLKSDDDVLERLRTCVEN
LKTSASYVETFRALVTPTSGIGTGQMQQEQESLTLSNQSRITSSLPGLSFKGREEEKGKIIQYLLGEESE
IQTSQNVHCLPLVAMGGMGKTALAQQVFDHFEKEKKGHFNVKIWVCDSLPNLNASNLMKKILEYSTGQSE
SGPSELMPVKLKDKLHSKRFLLVLDDAWDDKNHTEWEKLCIPLLHGQKGSWILLTTRLESVAKMVSKIIK
GGTMKPMTLQGLPKDECRSLLYEHAFVDQDPNGFPLLKKIGEEIVEKLHGVPLLAKSIGGALNNKLEADH
WTSISRSELWKMPQDLNNYEFIPALTLSYKMLPPRLKQCFSYCSIFPQDYTFKKQKLVCIWVAAGLIYSD
GSEEGSDEDIANYCFDMLCNKSFFDVHTNNWSAFHQDIAPYALEVIFYTMHDMLNGLSRHVSRYECCRIV
HDTPSYICDYNAIRHISISITSIDAQLGDLANMVCKFKNLRTLRIEQYYGDSQKLDDFIRDACKSPRRIR
VLTIRPYKYFESISDFVKLRFLEITALPPSVSISKFYFLQVLTGYRGILAKDTSKLRNLRHLYGVPENAL
FSVAEVGKLTCLQELCFTVGIEPGYRIDELMNMDNLRQLSIAKLSNVHRLEEANNVDLVSKSHLTSLELN
WYKPDLDEASSNLGHDQQEVLAALQPPPTIRKLIIREYKGGRPAPWMNTQSLSRLESLELYNCTNLEELP
PLWKLPCLKFIKLSDMKVIRSLGCHSSDMMDKQFSVLEKLEFRDLPLLEEWNGADDYQWFPRLKRFEIEK
CPKLKKIPDLPLSIENLCMKKLGLEALPRFYKCSNGSRTFEGFQQLMSLEFLEMDDYSEIVDIGSIGEED
GNFLPSELKKLKLKILNKHEDLASYLRGLTLLTELSLSRLQGMTSLPLTNELEHLTTLRSLYICDCEDLT
SPGGVYIIKSLKHLYMYNCPKFLTAEVESQQLLKDKTRKHAASSSSIFDHSTSNKAASTLPSSLESLTFS
TSKISQESLGCCLQGLTSLKSLDISKCNHLVSLPNRDYLHNLTALQTLWIANCKELCKLESLTALISLRE
LYIYNCPKLHTTTLSTVQNPAATTEQSATKIKKGTLLSLEKIQIDNIFYLPILPIPEKLKTLYIKKEITC
FPSEIEEWLLQCQESLENLCLEKMPHLQSLPVILESFSSLKFLSISSAPELKSLPRMPASLEQLTIHGCS
AKLEKRCQKNIGPDWPNIEHIPHIKITAVKEDKAKFLQDVLFS


>XP_042449400.1 putative disease resistance protein RGA4 isoform X1 [Zingiber officinale]
MDVVSPILDRARAKVIDKLIDKVSTYVQDQYYWKANLQEELQNLKRLLPQIQAVVGYAEDKLTMYESHNP
ALIKWLWQFRDDIDEAEEVLDELEYRELEKKSDGDKSRLSTIIDPYFRAAKRFLKSDDDVLERLRTCVEN
LKTSASYVETFRALVTPTSGIGTGQMQQEQESLTLSNQSRITSSLPGLSFKGREEEKGKIIQYLLGEESE
IQTSQNVHCLPLVAMGGMGKTALAQQVFDHFEKEKKGHFNVKIWVCDSLPNLNASNLMKKILEYSTGQSE
SGPSELMPVKLKDKLHSKRFLLVLDDAWDDKNHTEWEKLCIPLLHGQKGSWILLTTRLESVAKMVSKIIK
GGTMKPMTLQGLPKDECRSLLYEHAFVDQDPNGFPLLKKIGEEIVEKLHGVPLLAKSIGGALNNKLEADH
WTSISRSELWKMPQDLNNYEFIPALTLSYKMLPPRLKQCFSYCSIFPQDYTFKKQKLVCIWVAAGLIYSD
GSEEGSDEDIANYCFDMLCNKSFFDVHTNNWSAFHQDIAPYALEVIFYTMHDMLNGLSRHVSRYECCRIV
HDTPSYICDYNAIRHISISITSIDAQLGDLANMVCKFKNLRTLRIEQYYGDSQKLDDFIRDACKSPRRIR
VLTIRPYKYFESISDFVKLRFLEITALPPSVSISKFYFLQVLTGYRGILAKDTSKLRNLRHLYGVPENAL
FSVAEVGKLTCLQELCFTVGIEPGYRIDELMNMDNLRQLSIAKLSNVHRLEEANNVDLVSKSHLTSLELN
WYKPDLDEASSNLGHDQQEVLAALQPPPTIRKLIIREYKGGRPAPWMNTQSLSRLESLELYNCTNLEELP
PLWKLPCLKFIKLSDMKVIRSLGCHSSDMMDKQFSVLEKLEFRDLPLLEEWNGADDYQWFPRLKRFEIEK
CPKLKKIPDLPLSIENLCMKKLGLEALPRFYKCSNGSRTFEGFQQLMSLEFLEMDDYSEIVDIGSIGEED
GNFLPSELKKLKLKILNKHEDLASYLRGLTLLTELSLSRLQGMTSLPLTNELEHLTTLRSLYICDCEDLT
SPGGVYIIKSLKHLYMYNCPKFLTAEVESQQLLKDKTRKHAASSSSIFDHSTSNKAASTLPSSLESLTFS
TSKISQESLGCCLQGLTSLKSLDISKCNHLVSLPNRDYLHNLTALQTLWIANCKELCKLESLTALISLRE
LYIYNCPKLHTTTLSTVQNPAATTEQSATKIKKGTLLSLEKIQIDNIFYLPILPIPEKLKTLYIKKEITC
FPSEIEEWLLQCQESLENLCLEKMPHLQSLPVILESFSSLKFLSISSAPELKSLPRMPASLEQLTIHGCS
AKLEKRCQKNIGPDWPNIEHIPHIKITAVKEDKAKFLQDVLFS


>XP_042449401.1 putative disease resistance protein RGA4 isoform X2 [Zingiber officinale]
MDVVSPILDRARAKVIDKLIDKVSTYVQDQYYWKANLQEELQNLKRLLPQIQAVVGYAEDKLTMYESHNP
ALIKWLWQFRDDIDEAEEVLDELEYRELEKKSDGDKSRLSTIIDPYFRAAKRFLKSDDDVLERLRTCVEN
LKTSASYVETFRALVTPTSGIGTGQMQQEQESLTLSNQSRITSSLPGLSFKGREEEKGKIIQYLLGEESE
IQTSQNVHCLPLVAMGGMGKTALAQQVFDHFEKEKKGHFNVKIWVCDSLPNLNASNLMKKILEYSTGQSE
SGPSELMPVKLKDKLHSKRFLLVLDDAWDDKNHTEWEKLCIPLLHGQKGSWILLTTRLESVAKMVSKIIK
GGTMKPMTLQGLPKDECRSLLYEHAFVDQDPNGFPLLKKIGEEIVEKLHGVPLLAKSIGGALNNKLEADH
WTSISRSELWKMPQDLNNYEFIPALTLSYKMLPPRLKQCFSYCSIFPQDYTFKKQKLVCIWVAAGLIYSD
GSEEGSDEDIANYCFDMLCNKSFFDVHTNNWSAFHQDIAPYALEVIFYTMHDMLNGLSRHVSRYECCRIV
HDTPSYICDYNAIRHISISITSIDAQLGDLANMVCKFKNLRTLRIEQYYGDSQKLDDFIRDACKSPRRIR
VLTIRPYKYFESISDFVKLRFLEITALPPSVSISKFYFLQVLTGYRGILAKDTSKLRNLRHLYGVPENAL
FSVAEVGKLTCLQELCFTVGIEPGYRIDELMNMDNLRQLSIAKLSNVHRLEEANNVDLVSKSHLTSLELN
WYKPDLDEASSNLGHDQQEVLAALQPPPTIRKLIIREYKGGRPAPWMNTQSLSRLESLELYNCTNLEELP
PLWKLPCLKFIKLSDMKVIRSLGCHSSDMMDKQFSVLEKLEFRDLPLLEEWNGADDYQWFPRLKRFEIEK
CPKLKKIPDLPLSIENLCMKKLGLEALPRFYKCSNGSRTFEGFQQLMSLEFLEMDDYSEIVDIGSIGEED
GNFLPSELKKLKLKILNKHEDLASYLRGLTLLTELSLSRLQGMTSLPLTNELEHLTTLRSLYICDCEDLT
SPGGVYIIKSLKHLYMYNCPKFLTAEVESQQLLKDKTRKHAASSSSIFDHSTSNKAASTLPSSLESLTFS
TSKISQESLGCCLQGLTSLKSLDISKCNHLVSLPNRDYLHNLTALQTLWIANCKELCKLESLTALISLRE
LYIYNCPKLHTTTLSTVQNPAATTEQSATKIKKGTLLSLEKIQIDNIFYLPILPIPEKLKTLYIKKEITC
FPSEIEEWLLQCQESLENLCLEKMPHLQSLPVILESFSSLKFLSISSAPELKSLPRMPASLEQLTIHGCS
AKLEKRCQKNIGPDWPNIEHIPHIKITAVKEDKAKDVLFS


>XP_042449620.1 putative disease resistance RPP13-like protein 1 [Zingiber officinale]
MESVALAVGGWLAQPVINMLVDRVWTLRGKLHGLQDDDLKKLHRSLLNIHTIVDKAGMRWSRDARLVEMM
KQLQDAAYDAEDFLDDLTFHGMKQKIKKEASHKASNLFSKAFRKTKTKLFSDSVKRLNKIQKKLDCIYAD
MEKMCQFLQMDALSGGQYQSDSASVTRETSPFLICKVLGREKEQKRIIELLLRSTDESASASDNGSSFSV
IPLVGIGGVGKTTLAQLVYEDDEIQNHFALKLWICVSDNFNVQRLTKEMIESVTETQHSSQMKLAVLQNI
LKKEIESKMILLVLDDVWNEVEEEWRKLCAPFMYAAAGSKVIVTTRIKSIADKIGTVEAIVLGDLDEISF
WELFKQCAFGPSKPEEHPELVEIGRSIASKLKGLPLAARTVGNLLGSNMNPHHWRSIMKSEVWELQQNKN
DIIPVLQLSYQYLSAPLKRCFAVCCLFHKDYKFSEIELTRIWMAEGFIVAQGNQRMEDVASKYLHELVNM
SLFQQETTFGSHYYVMHDLIHDLTQSVSVDETSRKDNGKSNKISTTLRHLAVKKEFVETKDMLRSRIKKL
HSLFCQQLKSPPLDVIEKLRSIRVLVLYDCGLQMLPTSVGELIHLRYLDISYNKIKELPESLCELYNLQT
LKANNSPLICLPEDISQLINLRHLDIENRLVVQIKKIGRLTSLQELSEFQVRKEVGFKITELSGLKQLHG
KLKITNLENVESKEEAENAQMKNKEYLDVLELEWKFDPKLENKLVAMEEVLEGLQPHESLKQLQIKRYCG
ARSPSWMKKELSNLERLELSFCESWKDISCTALLPHLKVFHIYQSMWFSKSCFEVCGSRESKLFPILEEL
QLSYMNASEELPNLGRFPCLRVVRMTGIKSLKHIDFTASGAIENSLFPMLEELDLRYMPALEEFCSRGHF
PRLRVLCMVAMPLLKHIGFASVHATENDLFPALEVLELMDLPALEELPDLCSLPCLKSFHMRRMSMLKHI
DFTLYGSTEKVILPRVETLVLDDLEALEELPSNLGRLPCLKVLKIVKISAVKQIGHGFFSTEVITKCFLS
LENLWISDMPACERWCWIGGSELFPSLQKLTIYECPKLEKLPPLPPSLIYLSLREVGLTELPSLQELETN
ESGGNQTTSSLSALRIRKCNNLTSLEEGLLLQNISNIEDIYVEGCNKLMRMPLKRFENFTSLKELRIKAC
PKLSLTQEEEAALLPPSFKVFILNDCGDLNRLRLGHPYRSTF


>XP_042449621.1 putative disease resistance RPP13-like protein 1 [Zingiber officinale]
MESVALAVGGWLAQPVINMLVDRVWTLRGKLHGLQDDDLKKLHRSLLNIHTIVDKAGMRWSRDARLVEMM
KQLQDAAYDAEDFLDDLTFHGMKQKIKKEASHKASNLFSKAFRKTKTKLFSDSVKRLNKIQKKLDCIYAD
MEKMCQFLQMDALSGGQYQSDSASVTRETSPFLICKVLGREKEQKRIIELLLRSTDESASASDNGSSFSV
IPLVGIGGVGKTTLAQLVYEDDEIQNHFALKLWICVSDNFNVQRLTKEMIESVTETQHSSQMKLAVLQNI
LKKEIESKMILLVLDDVWNEVEEEWRKLCAPFMYAAAGSKVIVTTRIKSIADKIGTVEAIVLGDLDEISF
WELFKQCAFGPSKPEEHPELVEIGRSIASKLKGLPLAARTVGNLLGSNMNPHHWRSIMKSEVWELQQNKN
DIIPVLQLSYQYLSAPLKRCFAVCCLFHKDYKFSEIELTRIWMAEGFIVAQGNQRMEDVASKYLHELVNM
SLFQQETTFGSHYYVMHDLIHDLTQSVSVDETSRKDNGKSNKISTTLRHLAVKKEFVETKDMLRSRIKKL
HSLFCQQLKSPPLDVIEKLRSIRVLVLYDCGLQMLPTSVGELIHLRYLDISYNKIKELPESLCELYNLQT
LKANNSPLICLPEDISQLINLRHLDIENRLVVQIKKIGRLTSLQELSEFQVRKEVGFKITELSGLKQLHG
KLKITNLENVESKEEAENAQMKNKEYLDVLELEWKFDPKLENKLVAMEEVLEGLQPHESLKQLQIKRYCG
ARSPSWMKKELSNLERLELSFCESWKDISCTALLPHLKVFHIYQSMWFSKSCFEVCGSRESKLFPILEEL
QLSYMNASEELPNLGRFPCLRVVRMTGIKSLKHIDFTASGAIENSLFPMLEELDLRYMPALEEFCSRGHF
PRLRVLCMVAMPLLKHIGFASVHATENDLFPALEVLELMDLPALEELPDLCSLPCLKSFHMRRMSMLKHI
DFTLYGSTEKVILPRVETLVLDDLEALEELPSNLGRLPCLKVLKIVKISAVKQIGHGFFSTEVITKCFLS
LENLWISDMPACERWCWIGGSELFPSLQKLTIYECPKLEKLPPLPPSLIYLSLREVGLTELPSLQELETN
ESGGNQTTSSLSALRIRKCNNLTSLEEGLLLQNISNIEDIYVEGCNKLMRMPLKRFENFTSLKELRIKAC
PKLSLTQEEEAALLPPSFKVFILNDCGDLNRLRLGHPYRSTF


>XP_042449622.1 putative disease resistance RPP13-like protein 1 [Zingiber officinale]
MESVALAVGGWLAQPVINMLVDRVWTLRGKLHGLQDDDLKKLHRSLLNIHTIVDKAGMRWSRDARLVEMM
KQLQDAAYDAEDFLDDLTFHGMKQKIKKEASHKASNLFSKAFRKTKTKLFSDSVKRLNKIQKKLDCIYAD
MEKMCQFLQMDALSGGQYQSDSASVTRETSPFLICKVLGREKEQKRIIELLLRSTDESASASDNGSSFSV
IPLVGIGGVGKTTLAQLVYEDDEIQNHFALKLWICVSDNFNVQRLTKEMIESVTETQHSSQMKLAVLQNI
LKKEIESKMILLVLDDVWNEVEEEWRKLCAPFMYAAAGSKVIVTTRIKSIADKIGTVEAIVLGDLDEISF
WELFKQCAFGPSKPEEHPELVEIGRSIASKLKGLPLAARTVGNLLGSNMNPHHWRSIMKSEVWELQQNKN
DIIPVLQLSYQYLSAPLKRCFAVCCLFHKDYKFSEIELTRIWMAEGFIVAQGNQRMEDVASKYLHELVNM
SLFQQETTFGSHYYVMHDLIHDLTQSVSVDETSRKDNGKSNKISTTLRHLAVKKEFVETKDMLRSRIKKL
HSLFCQQLKSPPLDVIEKLRSIRVLVLYDCGLQMLPTSVGELIHLRYLDISYNKIKELPESLCELYNLQT
LKANNSPLICLPEDISQLINLRHLDIENRLVVQIKKIGRLTSLQELSEFQVRKEVGFKITELSGLKQLHG
KLKITNLENVESKEEAENAQMKNKEYLDVLELEWKFDPKLENKLVAMEEVLEGLQPHESLKQLQIKRYCG
ARSPSWMKKELSNLERLELSFCESWKDISCTALLPHLKVFHIYQSMWFSKSCFEVCGSRESKLFPILEEL
QLSYMNASEELPNLGRFPCLRVVRMTGIKSLKHIDFTASGAIENSLFPMLEELDLRYMPALEEFCSRGHF
PRLRVLCMVAMPLLKHIGFASVHATENDLFPALEVLELMDLPALEELPDLCSLPCLKSFHMRRMSMLKHI
DFTLYGSTEKVILPRVETLVLDDLEALEELPSNLGRLPCLKVLKIVKISAVKQIGHGFFSTEVITKCFLS
LENLWISDMPACERWCWIGGSELFPSLQKLTIYECPKLEKLPPLPPSLIYLSLREVGLTELPSLQELETN
ESGGNQTTSSLSALRIRKCNNLTSLEEGLLLQNISNIEDIYVEGCNKLMRMPLKRFENFTSLKELRIKAC
PKLSLTQEEEAALLPPSFKVFILNDCGDLNRLRLGHPYRSTF


>XP_042449623.1 putative disease resistance RPP13-like protein 1 [Zingiber officinale]
MESVALAVGGWLAQPVINMLVDRVWTLRGKLHGLQDDDLKKLHRSLLNIHTIVDKAGMRWSRDARLVEMM
KQLQDAAYDAEDFLDDLTFHGMKQKIKKEASHKASNLFSKAFRKTKTKLFSDSVKRLNKIQKKLDCIYAD
MEKMCQFLQMDALSGGQYQSDSASVTRETSPFLICKVLGREKEQKRIIELLLRSTDESASASDNGSSFSV
IPLVGIGGVGKTTLAQLVYEDDEIQNHFALKLWICVSDNFNVQRLTKEMIESVTETQHSSQMKLAVLQNI
LKKEIESKMILLVLDDVWNEVEEEWRKLCAPFMYAAAGSKVIVTTRIKSIADKIGTVEAIVLGDLDEISF
WELFKQCAFGPSKPEEHPELVEIGRSIASKLKGLPLAARTVGNLLGSNMNPHHWRSIMKSEVWELQQNKN
DIIPVLQLSYQYLSAPLKRCFAVCCLFHKDYKFSEIELTRIWMAEGFIVAQGNQRMEDVASKYLHELVNM
SLFQQETTFGSHYYVMHDLIHDLTQSVSVDETSRKDNGKSNKISTTLRHLAVKKEFVETKDMLRSRIKKL
HSLFCQQLKSPPLDVIEKLRSIRVLVLYDCGLQMLPTSVGELIHLRYLDISYNKIKELPESLCELYNLQT
LKANNSPLICLPEDISQLINLRHLDIENRLVVQIKKIGRLTSLQELSEFQVRKEVGFKITELSGLKQLHG
KLKITNLENVESKEEAENAQMKNKEYLDVLELEWKFDPKLENKLVAMEEVLEGLQPHESLKQLQIKRYCG
ARSPSWMKKELSNLERLELSFCESWKDISCTALLPHLKVFHIYQSMWFSKSCFEVCGSRESKLFPILEEL
QLSYMNASEELPNLGRFPCLRVVRMTGIKSLKHIDFTASGAIENSLFPMLEELDLRYMPALEEFCSRGHF
PRLRVLCMVAMPLLKHIGFASVHATENDLFPALEVLELMDLPALEELPDLCSLPCLKSFHMRRMSMLKHI
DFTLYGSTEKVILPRVETLVLDDLEALEELPSNLGRLPCLKVLKIVKISAVKQIGHGFFSTEVITKCFLS
LENLWISDMPACERWCWIGGSELFPSLQKLTIYECPKLEKLPPLPPSLIYLSLREVGLTELPSLQELETN
ESGGNQTTSSLSALRIRKCNNLTSLEEGLLLQNISNIEDIYVEGCNKLMRMPLKRFENFTSLKELRIKAC
PKLSLTQEEEAALLPPSFKVFILNDCGDLNRLRLGHPYRSTF


>XP_042449714.1 putative disease resistance protein RGA3 [Zingiber officinale]
MQQEQESLTLSNQSRITSSLPGLSFKGREEEKGKIIQYLLGEESEIQTSQNVHCLPLVVMGGMGKTALAQ
QVFDHFENEKKEHFDIKIWVCDSLPDLNASNLMKKILEYLTGLSESEPLELIPVKLKEKLHSKRFLLVLD
DAWDDKNHIEWEKLCIPLLHGQKGSWILLTTRLESVAKMVSKVIKGGTMKPMTLQGLPKDECRSLLYEHA
FVDQDPNEFPLLKKIGEEIVEKLHGVPLLAKSIGGALNNKLEADHWTSISRSELWKMPQDLNNCEFIPAL
TLSYKMLSPRLKQCFSYCSIFPQDYKFNKQKLMCMRIAAGLMYSDGLKEGSNEDIANYCFDMLCNKSFFD
VHTNNWSAFRKGIAPYDLEVIYYTMHDMLNGLSRHVSRYECCRIVHDTPSYICDYNAIRHISISITSIDA
QLGDLANMVCKFKNLRTLRIEQYYGDSQKLDDFIRDACKSPRRIRVLIIQPYKCLKSISDFVKLRFLEIT
ALPLSVSISKFYFLQVLTGYRGILAKDTSKLRNLRHLYEVPENALFSMAEVGKLTCLQELCFTVGTKPGY
RIDELMNMDNLRQLSIAKLSNVHSLEETNNVNLVSKSYLTSLELNWYKPDLDEASSNLGHDQQKVLAALH
PPPTIRKLIIREYKGGRPASWMNTKSLSRLESLELYNCTNLEELPPLWKLSCLKFIKLSDMKAIRSLGCR
SSDPMDRQFSVLEELEFWDLPLLEEWNGADDYQWFPRLKRFEIGNCTKLKKIPDLPLSIENLCMKKLGLE
VLPRFYKCSNGSTTFGGFQQLMSLESLEMDDYSEIVDIGSIGEEDGNFLPPALKKLKLKILNKHEDLASY
LRGLTSLTKLSLSCLQGMTSLPLTNELEHLTTLRSLYICDCEDLTSPGGLYIIKSLEQLHMYNCPKFLTA
EVESQQLLKEKTRSASDKAASILPSSLEFLRFSTSKISQESLGCCLQGLTSLKRLDISNCNHLVSLPNIE
YLHNLTALQTLWISDCEELCKLESLTALISLIQLSIFNCPKLIATTLSTVQNPAATTEQSATKIKKGTLL
SLEEIQIDNIFYLPILPIPEKLKTLYIKKEITCFPSEIEEWLSQCRESLKILILQQMTHLQSLPTILESF
SSLKVLGINSAPELKSLPRMHASLELLVINGCSAKLEKRCQKNIGLDWPNIKHIPDIYITAVKEDKAKKV
L


>XP_042449715.1 putative disease resistance protein RGA3 [Zingiber officinale]
MQQEQESLTLSNQSRITSSLPGLSFKGREEEKGKIIQYLLGEESEIQTSQNVHCLPLVVMGGMGKTALAQ
QVFDHFENEKKEHFDIKIWVCDSLPDLNASNLMKKILEYLTGLSESEPLELIPVKLKEKLHSKRFLLVLD
DAWDDKNHIEWEKLCIPLLHGQKGSWILLTTRLESVAKMVSKVIKGGTMKPMTLQGLPKDECRSLLYEHA
FVDQDPNEFPLLKKIGEEIVEKLHGVPLLAKSIGGALNNKLEADHWTSISRSELWKMPQDLNNCEFIPAL
TLSYKMLSPRLKQCFSYCSIFPQDYKFNKQKLMCMRIAAGLMYSDGLKEGSNEDIANYCFDMLCNKSFFD
VHTNNWSAFRKGIAPYDLEVIYYTMHDMLNGLSRHVSRYECCRIVHDTPSYICDYNAIRHISISITSIDA
QLGDLANMVCKFKNLRTLRIEQYYGDSQKLDDFIRDACKSPRRIRVLIIQPYKCLKSISDFVKLRFLEIT
ALPLSVSISKFYFLQVLTGYRGILAKDTSKLRNLRHLYEVPENALFSMAEVGKLTCLQELCFTVGTKPGY
RIDELMNMDNLRQLSIAKLSNVHSLEETNNVNLVSKSYLTSLELNWYKPDLDEASSNLGHDQQKVLAALH
PPPTIRKLIIREYKGGRPASWMNTKSLSRLESLELYNCTNLEELPPLWKLSCLKFIKLSDMKAIRSLGCR
SSDPMDRQFSVLEELEFWDLPLLEEWNGADDYQWFPRLKRFEIGNCTKLKKIPDLPLSIENLCMKKLGLE
VLPRFYKCSNGSTTFGGFQQLMSLESLEMDDYSEIVDIGSIGEEDGNFLPPALKKLKLKILNKHEDLASY
LRGLTSLTKLSLSCLQGMTSLPLTNELEHLTTLRSLYICDCEDLTSPGGLYIIKSLEQLHMYNCPKFLTA
EVESQQLLKEKTRSASDKAASILPSSLEFLRFSTSKISQESLGCCLQGLTSLKRLDISNCNHLVSLPNIE
YLHNLTALQTLWISDCEELCKLESLTALISLIQLSIFNCPKLIATTLSTVQNPAATTEQSATKIKKGTLL
SLEEIQIDNIFYLPILPIPEKLKTLYIKKEITCFPSEIEEWLSQCRESLKILILQQMTHLQSLPTILESF
SSLKVLGINSAPELKSLPRMHASLELLVINGCSAKLEKRCQKNIGLDWPNIKHIPDIYITAVKEDKAKKV
L


>XP_042449716.1 putative disease resistance protein RGA3 [Zingiber officinale]
MQQEQESLTLSNQSRITSSLPGLSFKGREEEKGKIIQYLLGEESEIQTSQNVHCLPLVVMGGMGKTALAQ
QVFDHFENEKKEHFDIKIWVCDSLPDLNASNLMKKILEYLTGLSESEPLELIPVKLKEKLHSKRFLLVLD
DAWDDKNHIEWEKLCIPLLHGQKGSWILLTTRLESVAKMVSKVIKGGTMKPMTLQGLPKDECRSLLYEHA
FVDQDPNEFPLLKKIGEEIVEKLHGVPLLAKSIGGALNNKLEADHWTSISRSELWKMPQDLNNCEFIPAL
TLSYKMLSPRLKQCFSYCSIFPQDYKFNKQKLMCMRIAAGLMYSDGLKEGSNEDIANYCFDMLCNKSFFD
VHTNNWSAFRKGIAPYDLEVIYYTMHDMLNGLSRHVSRYECCRIVHDTPSYICDYNAIRHISISITSIDA
QLGDLANMVCKFKNLRTLRIEQYYGDSQKLDDFIRDACKSPRRIRVLIIQPYKCLKSISDFVKLRFLEIT
ALPLSVSISKFYFLQVLTGYRGILAKDTSKLRNLRHLYEVPENALFSMAEVGKLTCLQELCFTVGTKPGY
RIDELMNMDNLRQLSIAKLSNVHSLEETNNVNLVSKSYLTSLELNWYKPDLDEASSNLGHDQQKVLAALH
PPPTIRKLIIREYKGGRPASWMNTKSLSRLESLELYNCTNLEELPPLWKLSCLKFIKLSDMKAIRSLGCR
SSDPMDRQFSVLEELEFWDLPLLEEWNGADDYQWFPRLKRFEIGNCTKLKKIPDLPLSIENLCMKKLGLE
VLPRFYKCSNGSTTFGGFQQLMSLESLEMDDYSEIVDIGSIGEEDGNFLPPALKKLKLKILNKHEDLASY
LRGLTSLTKLSLSCLQGMTSLPLTNELEHLTTLRSLYICDCEDLTSPGGLYIIKSLEQLHMYNCPKFLTA
EVESQQLLKEKTRSASDKAASILPSSLEFLRFSTSKISQESLGCCLQGLTSLKRLDISNCNHLVSLPNIE
YLHNLTALQTLWISDCEELCKLESLTALISLIQLSIFNCPKLIATTLSTVQNPAATTEQSATKIKKGTLL
SLEEIQIDNIFYLPILPIPEKLKTLYIKKEITCFPSEIEEWLSQCRESLKILILQQMTHLQSLPTILESF
SSLKVLGINSAPELKSLPRMHASLELLVINGCSAKLEKRCQKNIGLDWPNIKHIPDIYITAVKEDKAKKV
L


>XP_042449717.1 putative disease resistance protein RGA3 [Zingiber officinale]
MQQEQESLTLSNQSRITSSLPGLSFKGREEEKGKIIQYLLGEESEIQTSQNVHCLPLVVMGGMGKTALAQ
QVFDHFENEKKEHFDIKIWVCDSLPDLNASNLMKKILEYLTGLSESEPLELIPVKLKEKLHSKRFLLVLD
DAWDDKNHIEWEKLCIPLLHGQKGSWILLTTRLESVAKMVSKVIKGGTMKPMTLQGLPKDECRSLLYEHA
FVDQDPNEFPLLKKIGEEIVEKLHGVPLLAKSIGGALNNKLEADHWTSISRSELWKMPQDLNNCEFIPAL
TLSYKMLSPRLKQCFSYCSIFPQDYKFNKQKLMCMRIAAGLMYSDGLKEGSNEDIANYCFDMLCNKSFFD
VHTNNWSAFRKGIAPYDLEVIYYTMHDMLNGLSRHVSRYECCRIVHDTPSYICDYNAIRHISISITSIDA
QLGDLANMVCKFKNLRTLRIEQYYGDSQKLDDFIRDACKSPRRIRVLIIQPYKCLKSISDFVKLRFLEIT
ALPLSVSISKFYFLQVLTGYRGILAKDTSKLRNLRHLYEVPENALFSMAEVGKLTCLQELCFTVGTKPGY
RIDELMNMDNLRQLSIAKLSNVHSLEETNNVNLVSKSYLTSLELNWYKPDLDEASSNLGHDQQKVLAALH
PPPTIRKLIIREYKGGRPASWMNTKSLSRLESLELYNCTNLEELPPLWKLSCLKFIKLSDMKAIRSLGCR
SSDPMDRQFSVLEELEFWDLPLLEEWNGADDYQWFPRLKRFEIGNCTKLKKIPDLPLSIENLCMKKLGLE
VLPRFYKCSNGSTTFGGFQQLMSLESLEMDDYSEIVDIGSIGEEDGNFLPPALKKLKLKILNKHEDLASY
LRGLTSLTKLSLSCLQGMTSLPLTNELEHLTTLRSLYICDCEDLTSPGGLYIIKSLEQLHMYNCPKFLTA
EVESQQLLKEKTRSASDKAASILPSSLEFLRFSTSKISQESLGCCLQGLTSLKRLDISNCNHLVSLPNIE
YLHNLTALQTLWISDCEELCKLESLTALISLIQLSIFNCPKLIATTLSTVQNPAATTEQSATKIKKGTLL
SLEEIQIDNIFYLPILPIPEKLKTLYIKKEITCFPSEIEEWLSQCRESLKILILQQMTHLQSLPTILESF
SSLKVLGINSAPELKSLPRMHASLELLVINGCSAKLEKRCQKNIGLDWPNIKHIPDIYITAVKEDKAKKV
L


>XP_042449718.1 putative disease resistance protein RGA3 [Zingiber officinale]
MQQEQESLTLSNQSRITSSLPGLSFKGREEEKGKIIQYLLGEESEIQTSQNVHCLPLVVMGGMGKTALAQ
QVFDHFENEKKEHFDIKIWVCDSLPDLNASNLMKKILEYLTGLSESEPLELIPVKLKEKLHSKRFLLVLD
DAWDDKNHIEWEKLCIPLLHGQKGSWILLTTRLESVAKMVSKVIKGGTMKPMTLQGLPKDECRSLLYEHA
FVDQDPNEFPLLKKIGEEIVEKLHGVPLLAKSIGGALNNKLEADHWTSISRSELWKMPQDLNNCEFIPAL
TLSYKMLSPRLKQCFSYCSIFPQDYKFNKQKLMCMRIAAGLMYSDGLKEGSNEDIANYCFDMLCNKSFFD
VHTNNWSAFRKGIAPYDLEVIYYTMHDMLNGLSRHVSRYECCRIVHDTPSYICDYNAIRHISISITSIDA
QLGDLANMVCKFKNLRTLRIEQYYGDSQKLDDFIRDACKSPRRIRVLIIQPYKCLKSISDFVKLRFLEIT
ALPLSVSISKFYFLQVLTGYRGILAKDTSKLRNLRHLYEVPENALFSMAEVGKLTCLQELCFTVGTKPGY
RIDELMNMDNLRQLSIAKLSNVHSLEETNNVNLVSKSYLTSLELNWYKPDLDEASSNLGHDQQKVLAALH
PPPTIRKLIIREYKGGRPASWMNTKSLSRLESLELYNCTNLEELPPLWKLSCLKFIKLSDMKAIRSLGCR
SSDPMDRQFSVLEELEFWDLPLLEEWNGADDYQWFPRLKRFEIGNCTKLKKIPDLPLSIENLCMKKLGLE
VLPRFYKCSNGSTTFGGFQQLMSLESLEMDDYSEIVDIGSIGEEDGNFLPPALKKLKLKILNKHEDLASY
LRGLTSLTKLSLSCLQGMTSLPLTNELEHLTTLRSLYICDCEDLTSPGGLYIIKSLEQLHMYNCPKFLTA
EVESQQLLKEKTRSASDKAASILPSSLEFLRFSTSKISQESLGCCLQGLTSLKRLDISNCNHLVSLPNIE
YLHNLTALQTLWISDCEELCKLESLTALISLIQLSIFNCPKLIATTLSTVQNPAATTEQSATKIKKGTLL
SLEEIQIDNIFYLPILPIPEKLKTLYIKKEITCFPSEIEEWLSQCRESLKILILQQMTHLQSLPTILESF
SSLKVLGINSAPELKSLPRMHASLELLVINGCSAKLEKRCQKNIGLDWPNIKHIPDIYITAVKEDKAKKV
L


>XP_042449720.1 putative disease resistance protein RGA3 [Zingiber officinale]
MQQEQESLTLSNQSRITSSLPGLSFKGREEEKGKIIQYLLGEESEIQTSQNVHCLPLVVMGGMGKTALAQ
QVFDHFENEKKEHFDIKIWVCDSLPDLNASNLMKKILEYLTGLSESEPLELIPVKLKEKLHSKRFLLVLD
DAWDDKNHIEWEKLCIPLLHGQKGSWILLTTRLESVAKMVSKVIKGGTMKPMTLQGLPKDECRSLLYEHA
FVDQDPNEFPLLKKIGEEIVEKLHGVPLLAKSIGGALNNKLEADHWTSISRSELWKMPQDLNNCEFIPAL
TLSYKMLSPRLKQCFSYCSIFPQDYKFNKQKLMCMRIAAGLMYSDGLKEGSNEDIANYCFDMLCNKSFFD
VHTNNWSAFRKGIAPYDLEVIYYTMHDMLNGLSRHVSRYECCRIVHDTPSYICDYNAIRHISISITSIDA
QLGDLANMVCKFKNLRTLRIEQYYGDSQKLDDFIRDACKSPRRIRVLIIQPYKCLKSISDFVKLRFLEIT
ALPLSVSISKFYFLQVLTGYRGILAKDTSKLRNLRHLYEVPENALFSMAEVGKLTCLQELCFTVGTKPGY
RIDELMNMDNLRQLSIAKLSNVHSLEETNNVNLVSKSYLTSLELNWYKPDLDEASSNLGHDQQKVLAALH
PPPTIRKLIIREYKGGRPASWMNTKSLSRLESLELYNCTNLEELPPLWKLSCLKFIKLSDMKAIRSLGCR
SSDPMDRQFSVLEELEFWDLPLLEEWNGADDYQWFPRLKRFEIGNCTKLKKIPDLPLSIENLCMKKLGLE
VLPRFYKCSNGSTTFGGFQQLMSLESLEMDDYSEIVDIGSIGEEDGNFLPPALKKLKLKILNKHEDLASY
LRGLTSLTKLSLSCLQGMTSLPLTNELEHLTTLRSLYICDCEDLTSPGGLYIIKSLEQLHMYNCPKFLTA
EVESQQLLKEKTRSASDKAASILPSSLEFLRFSTSKISQESLGCCLQGLTSLKRLDISNCNHLVSLPNIE
YLHNLTALQTLWISDCEELCKLESLTALISLIQLSIFNCPKLIATTLSTVQNPAATTEQSATKIKKGTLL
SLEEIQIDNIFYLPILPIPEKLKTLYIKKEITCFPSEIEEWLSQCRESLKILILQQMTHLQSLPTILESF
SSLKVLGINSAPELKSLPRMHASLELLVINGCSAKLEKRCQKNIGLDWPNIKHIPDIYITAVKEDKAKKV
L


>XP_042450499.1 disease resistance protein RPM1-like isoform X2 [Zingiber officinale]
MEAAFISLLINKLAQVAFNQAHSRCSQILLQHTTPPLDQIHARVRRITDEFIVMKAFLEGSNWFTIATNK
PLEAWIEQVRKVAFEIEDIIDEYLYLVGRQRERTWKNCLTAPSDLCFNLAKAWRGIDSRLEKMERDLSEL
SSRRDRFGITISGNEDGVKNSERDTHHYRAYSPMLNDEDDLVGIEVNKSKLLSWLTNADTCRKMTAIAVW
GMGGHGKTTLVADVYRNNTVKSHFDCQAFRRENNKDCPQELEDYTGRILNKCQGSPLAIVAIGSLLSFKE
KSETEWKKVYDNLQWEFENNPVLDKVKNILNLSFNDLPYYLKNCFVFCSIFPEDYLINRKKLIRLWVAEG
FVEAKSSNRSMEEEAEDYLAELVDRSMLQVVNRNAFGRLHTFKMHDVVREVTLAISRKAKFSMILDGSQS
GLDFQTRRLSIQTNDESLDLDRSLSLSQLRSLVMFSTCNSSSDSLRAVLTSFKMLRVLELEGTPISNLPN
EISALFNLHYLCLRDTEVEKLPNNIQKLQSLETLDLSGSNIVKLPRGVTQLKQLRHLFMFPCEIEFGGST
VVGCVPTLKGAWQWKNLQTLRHVKANKNLFQQLEDMKELRTLAVTEVEYAHCPQLCTSLTKLTKLHSLSL
SARSEEQLNFEILNSPPPPLQKLVLCGRLFEGKMPRFICSCEELTDVLLFSSHLIEDPLPSLGQLHKLVE
LTLWGDSYDGQKLHFRTGWFLNLKVLFLDTLTNLNNIVIEEGAMPNLLKLIMRSLGELRMIPPGIEFLAN
LQSLDLCNMPEELVEKLRNDDDNEDRQRIRGIPNVVIGLISSLIMSEICEDEHWL


>XP_042451419.1 putative disease resistance protein RGA3 [Zingiber officinale]
MATETQVFGRCSEINQLIDMLLDTSTSDTDDNISVVSIAGRRGVGKTTVAQSVYCNRKVEKHFDLKAWIC
FKSKPFQLRISMIDMTRSAPMEISDYDNDLLDLLDLDRIEEILCEVLKGNKYLIVLDSVWDERNWKEMRS
YWLVLYAIFDQLGKEGSKILVTTCSHDVANYLNARGAIVLKCLKDQVFWKLFRSCAFGDDANLSENLECI
GQEISNKLVGLPLAAKVVGGLLHSRMEEHYWRDVLDNMSWQQDQETDGILTSLRLSYEFLPQHLKPCFLY
CSLFPEEHRFEKDALVHYWMALDYIGSCAEGGEGEKRTPEDVGRDYFTELQHRSFFQKRKMLETSKTEFY
VTHSLLHDVAKFVAGDVIYRYEYGNFIRPRIPNEVCHLYLGSTDWVNVLRRQISEVKKLQSLVVHPPPYT
DSTVVDLKAIFTALSNVRILIFLDQDVATHVLTECVDSMLQLRYLEVAGGAECYKPWGGNHLCHLQVLKV
TKIKYRLDDISFGSCLTQVFAKLNNLRHLYMDFYSAVSGIGLLTSLQELSRVFKVGEHEGKISQLKHLNQ
LRGSLLIKGLENVRDEREAKEAMLENKEYLEKLDLCWSPADKVNAASIERNENVLRGLQPHSNLKELKII
SYWGPMAPSWISETKLSNIERIELFGCRIMQVFPPLGELPLLRVLRLVNLDFLEYIGNEVYGKADDQAFP
MLEELVLLRLLQLKEWSEPKGGGKITMMPRLRILEIQQCRELKLPIPFALDSPLGEFKVGLYSPKLKGIS
LLTTYIPVNCKLSGLKILSIGPTSKVERFSGDENEWFERLTSLEELRFTDCEDLKSLPATLRSLPSLKRL
HIDKCRQIHFLLEELPAALEELNMIDNCLQQATSAGAKPAE


>XP_042451645.1 putative disease resistance protein RGA3 [Zingiber officinale]
MAMVLDFYVSRVMKVTADMVEAEIFKVLGVDKEIKTLQGRLRTINGYLHQAERKIQGNNEIDIWVRKLKD
IMYDADDIIDLCMIEGGKVLRAQASSGSSTVSIPSSYLFSCFRCLRYRHEVANQIIALNGRLEALKNDSF
IKNNLDQAVKEPVENAHREFGRETSHLQIEGDIIGSQIENATDKLINLILENNPKKTRVFGVVGTGGIGK
STLASKIFEDERIKENFPNRKWLYVSKNYIETDLLKKLIRFEEGNETKGETFEGKSKAELEDKLVTILTK
NTFIVLDDVWNATVWIDILRKPIVKSASSCTILVTSRKEKVVAQMKPSYIHPVEKMDEESGWNLLKHLVF
EGGEEEDEISSLAEIGIKLVKKCDGLPLAIKAIGGVLYQQNKAKWEEVLESDAWKMDQIEEELRPLYLSY
EDLPSTLKQCFLYCSLYHQKDMYYKEIVQFWVAEGLIMDEQEKSRNDLPTEKQKTMEDIGEEIYRELIWR
NLLEADANFDVSKDYFSMHDHFRSLGAHLMREEGILYRHGREFKTDDNIKIRRLSISNMGPKLVLPSQIL
KQGCLRTLILMDSPKTKTIEDSVLQELSCLRVLDLTSTSIEKIPDCIGDLLHLRYLDLDGTNIREIPKTI
GKLVNLQTLNISKCQYLERLPESITMLHNLRCLDMSDTPLLTYVPKGIGKLGNFYNLKGFLVGQNDSTSE
EGCDLEELKNLSKLRGISILRLERAERGASALADKPFLKQLMLGWMQPEEDDTDEEDESEANVGGGDETV
DSESASGGNDDEDARNEKGDGSDDGFKQENENEDAQEAGNETEDRTEEDEEEEEEKGWSEEQISNAERIC
NEMSQPSSSIVDLQFDEYPGRQFPSWIVSSSLAESFPNLAYLNLRGLPCCTELPPLGTLPQLKYLSIEQA
SALITIGSQFLGSRSSAFPKLELIQFEDMPKWEEWTFDGVEELTGHGTPVSVKLFPSLRDCVLIDCPKLR
ALPAVLYRATNFNELYLRQTYELREIIDLPIAYKLEVTNGSGLKKISNISSVRYLEVNNCPNLECVENLS
KLQHLVLICSKEMEQLPLWLSALIEQHNNTSSTHRSFRKFEMQCSLQLLKTCLEGNENWDIIKQIPIVKV
TTYSGKEYVRYTKDPYMYDPHVPSN


>XP_042452850.1 putative disease resistance protein RGA3 [Zingiber officinale]
MGKTALAQEVFDHFKNVKKEHFDIKIWVCDSLPDLNSSNLTKKILEYSTGRSESGPLELIPEKLKEKLHS
KRFLLVLDDAWDDKNQREWEKLCAPLLYGQKGSWVLLTTRSKSVANMVAREIKGTMMPMMLQGLSEDECL
SLLYEHAFAGQDPNGFPLLKEIGREIVKKLKGVPLLAKSIGGALNSKLEADHWTNILRSELWKRSQDSTY
NFIPVLTLSYVMLPPRLKRCFAYCSIFPQDYKFNK


>XP_042452853.1 putative disease resistance protein RGA3 [Zingiber officinale]
MGKTALAQEVFDHFKNVKKEHFDIKIWVCDSLPDLNSSNLTKKILEYSTGRSESGPLELIPEKLKEKLHS
KRFLLVLDDAWDDKNQREWEKLCAPLLYGQKGSWVLLTTRSKSVANMVAREIKGTMMPMMLQGLSEDECL
SLLYEHAFAGQDPNGFPLLKEIGREIVKKLKGVPLLAKSIGGALNSKLEADHWTNILRSELWKRSQDSTY
NFIPVLTLSYVMLPPRLKRCFAYCSIFPQDYKFNK


>XP_042453113.1 disease resistance protein RPM1-like [Zingiber officinale]
MQRLELFDIIKESLQQKRYIIVLDDVWQVDLCNDISCAFVDSNNGSRLIITTRMHEVARIANEEHIMKLQ
QLNEKDAWILFCKKAFRRENNKDCPKELEDYTGRILNKCQGSPLAIVAIGSLLSFKEKSETEWKKAYDNL
QWEFENNPALDKVKNILNLSFNDLPYYLKNCFVYCSIFPEDYLIKRKKLIRLWVAEGFVEAKSSNRSMEE
EAEDYLAELVDRSMLQVVNRNAFGRLQTFKMHDVVREVTQEISRKAKFSMILDGSQSGLDYQTRRLSIQT
TDESLDLDKSLSLSQLRSLVMLSTCNSSSDSLSAILISFKMLRVLELEFQPISNLPNEISALFNLHYLGL
RGTKVENLPNNIQKLQSLETLDLRCSNIVKLPRGVTQLKQLRHLFMFAREIEFGGSTVVGCVPTLKGARQ
WKNLQTLRQVKANKSLVQQLEDMKELRTLAVTEVEYAHCPQLCTSLTKLTKLHSLCLSARSEEQLNFEIL
NSPPPPLQKLTLSGRLFEGKMPKFICSCEELTYVQLMSSHLIEDPLPSLGQLHKLVELTLWEDSYDGQKL
HFRTGWFLNLKVLYLETLRNLNNIVIEEGAMPNLLKLIMSSLGELRMIPPGIEFLTNLQSLELCALPEEL
VEKLRNDDDNEVLQRIGGTRNVVVDSISN


>XP_042454058.1 putative disease resistance protein RGA3 [Zingiber officinale]
MSNFLHVSINNNIQSTHKCRSILLELKETACLLNYLVKRGAAFGLWVETLDSMDPSHDDYATILSEEVIG
REDEDQIIDLLQQQCDEDGNEPFIIAINGSKYSGKTTLARKIYHHPWVRQHFQHRIWLDASSFRDFNSSM
IAIEIARLLTRKPCMNVNCWPLINEHLGGDRYLLIFDDVCISDVLKYKWEELKLNLLHCGAPGSKVILVG
YIFNRDGREFNVKKYILNHLREDAWVRILLRYATFVRPIKGNNNIHREKASPTVTDILIPLAKKFRQDYD
SGDYLGAKCMGLMFRWRDKSQWGELANQLFNIKHLHKYFLSVHQQYRSIEDTRSSLYKLLFEGSKDESYD
EDVLYMLIAEDTLTNTRLKRNLQIMSFKFNLDQCFFRMKVGEDLSIPPQCRHLHLFINSKNILKSKKAIE
VAGVANKLRTLILHRKEKKGHIYQIETKKLEGLFLNLTCLCTLHMRAIMIQDLPSTVSTLHCLRYLNLAE
NKIETLPESLCNLSNLCALILSLCKKLKELPRQIHKLRKLQILKLSCCLRIQKLPDSITRLVNLKELGCW
RLLLAFEVA


>XP_042454428.1 disease resistance protein RPS2-like [Zingiber officinale]
MGSVSPSSLMDIFNLLKACCSPSCNYIMTYEGTFSSLASEVGQLKDKSSDVKRDIEAATRDGQTPRSEVL
GWLSSVQDMEGEAESIERKYNQKIKCLCSFPLNVCSAYRLRNRAEAALATIRELKQSVEFTKLADNLNLT
RSIKMPTTKTIGMDKVFEELLRHAKDDSLSVIGIHGMGGVGKTALLRRFNNDFPSETEADVVIFLELSID
YKLEEVQKSLFDRLSLTWQDEVTHRDRATKLFRVLSTLKFILLLDNLWEPLNYQVVGIPLPAPPSKCKII
FTTRTEDTCSHMGTEKMIKMECLEEEVAWNLFRNSARMDVIDADKNVRIEARDLVKECGGLPAALIVLAQ
AMAPKKTWEEWMHALTIMKDTPHQLPGMTNNVFSILKLSYDRLSSDNLRVCASYGALFIKGSWIGKYNIR
NLWIGEGIIDNVQNPMDADNKTQFLLGILHAASLTVRVHDDYFTMHPMIRAMILWVQRECGKKENKWLVR
DRERVGEAPAAEKWRDAERIALDWNQISDLPEAPQCPNLIFLNLQVNKFLRKIPNGFFLHMPHLKILDLR
DTSIKELPWLIMVDSYSGWREGHTLEGGVSFEELESLKRLKVIGITVSTLAALQNLCDSPRLAPLTHWLH
IEGCPDLTMFNIPSMDFHAETMSRLGQIQLHAMSELEEVVIGNRQPILLPLQELRLSSLPKAKLVWRPTF
PNTLLALKIEVD


>XP_042454429.1 disease resistance protein RPS2-like [Zingiber officinale]
MGYVSPSSLMDIFNLLKACCSPSCNYIMTYDGTFSSLASEVGQLKDKSSDVKRDVEAATRDGMTPRSEVL
GWLSSVQDMEGEAESIERKYNQKIKCLCSFPLNICSAYRLRNRAEAALATIRELKQSAEFTKLSDNLNLT
RSIKMPTTKTIGMDKVFEELQRHAKDDSLSVIGIHGMGGVGKTALLRRFNNDFPSETEADVVIFLELSID
YKLEEVQKSLFDRLSLTWQDEVTHRDRATKLFRVLSTLKFILLLDNLWEPLNYQVVGIPLPAPPSKCKII
FTTRTEDTCSHMGTEKMIKMECLEEEAAWNLFRNSARMDVIDADKNVRIEARDLVKECGGLPAALIVLAQ
AMAPKKTWEEWIHALTIMKDTPHQLPGMTNNVLSILKLSYDRLSSDNLRVCASYGALFEKGSWIYKYNIR
HYWIGEGIIDNADTILDATRKTQFLLGILHAASLTVRVDDVYFTMHPMTRAMILWVQRECGKKENKWLVL
NREQVKEENWRDAERISLGVNQIRELPETPQCPDLIFLNLEFNELLSKIPNGFFLHMPHLKILNLRNTSI
QELPASIGNLVQLHYLDLSRTRITSLPKEMAALVNLKLLSLAFMTSLRIIPDQLFSSLRELQWLDMCDSY
TGWREGQIWEGGVSFEELESLKRLRVIGITVSTLAALQNLCISPRLAAFTCWLYIEGCRDLTLFDIPSKD
FHLENMLEVFCIRLHAMCELEEVVIGNLKPILQSLQQLRLSSLPKAKLVWRATFPSTLFKLEIDGCGAID
RLIKLEGEANGSGETVITIFPDLHTMVLRRLPELKSLSDGERILNFPSLKTIKVEDCPKLTKLTLVADGL
KEIKCQRSWWEQLNWGDERTKSFEHLYNPMNID


>XP_042454430.1 disease resistance protein RPS2-like [Zingiber officinale]
MGYVSPSSLMDIFNLLKACCSPSCNYIMTYDGTFSSLASEVGQLKDKSSDVKRDVEAATRDGMTPRSEVL
GWLSSVQDMEGEAESIERKYNQKIKCLCSFPLNICSAYRLRNRAEAALATIRELKQSAEFTKLSDNLNLT
RSIKMPTTKTIGMDKVFEELQRHAKDDSLSVIGIHGMGGVGKTALLRRFNNDFPSETEADVVIFLELSID
YKLEEVQKSLFDRLSLTWQDEVTHRDRATKLFRVLSTLKFILLLDNLWEPLNYQVVGIPLPAPPSKCKII
FTTRTEDTCSHMGTEKMIKMECLEEEAAWNLFRNSARMDVIDADKNVRIEARDLVKECGGLPAALIVLAQ
AMAPKKTWEEWIHALTIMKDTPHQLPGMTNNVLSILKLSYDRLSSDNLRVCASYGALFEKGSWIYKYNIR
DYWIGEGIIDNADTILDATRKTQFLLGILHAASLTVRVDDVYFTMHPMTRAMILWVQRECGKKENKWLVL
NREQVKEENWRDAERISLGVNQIRELPETPQCPDLIFLNLEFNELLSKIPNGFFLHMPHLKILNLRNTSI
QELPASIGNLVQLHYLDLSRTRITSLPKEMAALVNLKLLSLAFTTSLRIIPDQLFSSLRELQWLDMCDSY
TGWREGQIWEGGVSFEELESLKRLRVIGITVSTLAALQNLCISPRLAAFTCWLYIEGCRDLTLFDIPSKD
FHLENMLEVFCIRLHAMCELEEVVIGNLKPILQSLQQLRLSSLPKAKLVWRATFPSTLFKLEIDGCGAID
RLIKLEGEANGSGETVITIFPDLHTMVLRRLPELKSLSDGERILNFPSLKTIKVEDCPKLTKLTLVADGL
KEIKCQRSWWEQLNWGDERTKSFEHLYNPMNID


>XP_042454436.1 disease resistance protein RPS2-like isoform X1 [Zingiber officinale]
MEGQATAGRRILLQDRISNASLGHTARLLLFVTSRSSSTMGSVSPSSLMDIFNLLKACCSPSCNYIMAYE
GTFSSLASEVGQLKDKSSDVKRDVEAATRDGQTPRSEVLGWLSSVQDMEGEAESIERKYNQKIKCLCSFP
LNVCSAYRLRNRAEAALATIRELKQSAEFTKLADNLNLTRSIKMPTTKTIGMEKVFEELLCHAKDDSLSV
IGIHGMGGVGKTALLRRFNNDFPSETEADVVIFLELSIDYKLEEVQKSLFERLSLTWQDEVTHRDRATKL
FRVLSTLKFILLFDNLWEPLNYQVVGIPLPAPPSKCKIIFTTRTEDTCSHMGTEKMIKMECLEEEAAWNL
FRNSARMDVIDADKNILIKARDLVKECGGLPAALIVLAQAMAPKKTWEEWIHALTIMKDTPHQLPGEGII
DNADNIGDSTRKTQFLLGILHAASLIERVHDNYFRIHPMTRAMILWVQRECGKKENKWLVPDRDRVEEAP
AAEKWRDAERIALVWNQIRDLPEAPQCPNMIFLNLHVNKFLRKIPNGFFLHMPHLKILDLQETSIEELPV
SIGNLMQLHFLELSRTRITSLPKEMAALVNLKYLSLESMKYLRTIPDRLISGLRELQWLNMVDSYSGWRE
GGVSFEELESLKRLKVIGITVSTLAALQNLCDSPRLAAVTHWLHIEGCQDLTMFNIPSTDFHAETMLRLI
RIQLHAMSELEEVVIGNRQPILLPLQEFRLSSLPKAKLVWRATFPNALRELKIEDCGAIDRLIKLEGEAN
GGGETVITIFPDLHTMVLRRLPELKSLSDGERILNFPSLKTIKVEDCPKLMKLTLVADGLKEIECERSWW
EQLNWGDERSKSFEHLYNPMYID


>XP_042454437.1 disease resistance protein RPS2-like isoform X2 [Zingiber officinale]
MEGQATAGRRILLQDRISNASLGHTARLLLFVTSRSSTMGSVSPSSLMDIFNLLKACCSPSCNYIMAYEG
TFSSLASEVGQLKDKSSDVKRDVEAATRDGQTPRSEVLGWLSSVQDMEGEAESIERKYNQKIKCLCSFPL
NVCSAYRLRNRAEAALATIRELKQSAEFTKLADNLNLTRSIKMPTTKTIGMEKVFEELLCHAKDDSLSVI
GIHGMGGVGKTALLRRFNNDFPSETEADVVIFLELSIDYKLEEVQKSLFERLSLTWQDEVTHRDRATKLF
RVLSTLKFILLFDNLWEPLNYQVVGIPLPAPPSKCKIIFTTRTEDTCSHMGTEKMIKMECLEEEAAWNLF
RNSARMDVIDADKNILIKARDLVKECGGLPAALIVLAQAMAPKKTWEEWIHALTIMKDTPHQLPGEGIID
NADNIGDSTRKTQFLLGILHAASLIERVHDNYFRIHPMTRAMILWVQRECGKKENKWLVPDRDRVEEAPA
AEKWRDAERIALVWNQIRDLPEAPQCPNMIFLNLHVNKFLRKIPNGFFLHMPHLKILDLQETSIEELPVS
IGNLMQLHFLELSRTRITSLPKEMAALVNLKYLSLESMKYLRTIPDRLISGLRELQWLNMVDSYSGWREG
GVSFEELESLKRLKVIGITVSTLAALQNLCDSPRLAAVTHWLHIEGCQDLTMFNIPSTDFHAETMLRLIR
IQLHAMSELEEVVIGNRQPILLPLQEFRLSSLPKAKLVWRATFPNALRELKIEDCGAIDRLIKLEGEANG
GGETVITIFPDLHTMVLRRLPELKSLSDGERILNFPSLKTIKVEDCPKLMKLTLVADGLKEIECERSWWE
QLNWGDERSKSFEHLYNPMYID


>XP_042454438.1 disease resistance protein RPS2-like isoform X3 [Zingiber officinale]
MGSVSPSSLMDIFNLLKACCSPSCNYIMAYEGTFSSLASEVGQLKDKSSDVKRDVEAATRDGQTPRSEVL
GWLSSVQDMEGEAESIERKYNQKIKCLCSFPLNVCSAYRLRNRAEAALATIRELKQSAEFTKLADNLNLT
RSIKMPTTKTIGMEKVFEELLCHAKDDSLSVIGIHGMGGVGKTALLRRFNNDFPSETEADVVIFLELSID
YKLEEVQKSLFERLSLTWQDEVTHRDRATKLFRVLSTLKFILLFDNLWEPLNYQVVGIPLPAPPSKCKII
FTTRTEDTCSHMGTEKMIKMECLEEEAAWNLFRNSARMDVIDADKNILIKARDLVKECGGLPAALIVLAQ
AMAPKKTWEEWIHALTIMKDTPHQLPGEGIIDNADNIGDSTRKTQFLLGILHAASLIERVHDNYFRIHPM
TRAMILWVQRECGKKENKWLVPDRDRVEEAPAAEKWRDAERIALVWNQIRDLPEAPQCPNMIFLNLHVNK
FLRKIPNGFFLHMPHLKILDLQETSIEELPVSIGNLMQLHFLELSRTRITSLPKEMAALVNLKYLSLESM
KYLRTIPDRLISGLRELQWLNMVDSYSGWREGGVSFEELESLKRLKVIGITVSTLAALQNLCDSPRLAAV
THWLHIEGCQDLTMFNIPSTDFHAETMLRLIRIQLHAMSELEEVVIGNRQPILLPLQEFRLSSLPKAKLV
WRATFPNALRELKIEDCGAIDRLIKLEGEANGGGETVITIFPDLHTMVLRRLPELKSLSDGERILNFPSL
KTIKVEDCPKLMKLTLVADGLKEIECERSWWEQLNWGDERSKSFEHLYNPMYID


>XP_042454439.1 disease resistance protein RPS2-like isoform X4 [Zingiber officinale]
MEGQATAGRRILLQDRISNASLGHTARLLLFVTSRSSSTMGSVSPSSLMDIFNLLKACCSPSCNYIMAYE
GTFSSLASEVGQLKDKSSDVKRDVEAATRDGQTPRSEVLGWLSSVQDMEGEAESIERKYNQKIKCLCSFP
LNVCSAYRLRNRAEAALATIRELKQSAEFTKLADNLNLTRSIKMPTTKTIGMEKVFEELLCHAKDDSLSV
IGIHGMGGVGKTALLRRFNNDFPSETEADVVIFLELSIDYKLEEVQKSLFERLSLTWQDEVTHRDRATKL
FRVLSTLKFILLFDNLWEPLNYQVVGIPLPAPPSKCKIIFTTRTEDTCSHMGTEKMIKMECLEEEAAWNL
FRNSARMDVIDADKNILIKARDLVKECGGLPAALIVLAQAMAPKKTWEEWIHALTIMKDTPHQLPGEGII
DNADNIGDSTRKTQFLLGILHAASLIERVHDNYFRIHPMTRAMILWVQRECGKKENKWLVPDRDRVEEAP
AAEKWRDAERIALVWNQIRDLPEAPQCPNMIFLNLHVNKFLRKIPNGFFLHMPHLKILDLQETSIEELPW
LNMVDSYSGWREGGVSFEELESLKRLKVIGITVSTLAALQNLCDSPRLAAVTHWLHIEGCQDLTMFNIPS
TDFHAETMLRLIRIQLHAMSELEEVVIGNRQPILLPLQEFRLSSLPKAKLVWRATFPNALRELKIEDCGA
IDRLIKLEGEANGGGETVITIFPDLHTMVLRRLPELKSLSDGERILNFPSLKTIKVEDCPKLMKLTLVAD
GLKEIECERSWWEQLNWGDERSKSFEHLYNPMYID


>XP_042454571.1 probable disease resistance protein At4g33300 [Zingiber officinale]
MDSSFAGEVATELIKELMKVIRGTYLCRPAAEQLKRSVDSLLPIVQEIRHSGVELPQHRQSQLSELADRL
RFALDLARKAAASPRWNVYRSVQLARKMEGIENWISRWIERHMPVHVLADVHHIRVDCAARLDRIERALD
MAASSPVAATASKVPVAFGSAPFSGFPMSDMMDPMAPVKTPFAMGNTLSSGFPTMEGFFPSPAPTKVPVA
MGKPPSSGYPVANIMDGLMMAGEGVKPVGVGIRIGKEKVKEMLMEGSDRSPVVGIFGIGGSGKTTLAREI
CKDPEIRSYFKDRIYFTTLSQSPNLESLKLKLWEQISGNMVLGAYNQIPKWQMELGQIEKGFSLIVLDDV
WSLSELEELIFSLRGCKILVVSRFNFPSIVKNTYEIELLGEEDALSLFCHAAFEQKSVPFSVDKKLVKQV
VDKCKGLPLALKVIGASLRDQPPKFWLRAKNKLTRGEAICESHENKLIERMASSIEFLSAKVRECFLDLG
SFPEDKRIPLDVLINMWMELHDLDEEDAFAILVELSNKNLLTLCKDAQNRAGDIYSSYTELSVTQHDLLR
DLALYVNNQEPSNTRRRLIMARRENELPKEWERNKDHQFEAQIVSINTGEMKETDWFQMHFPKAEVLILS
FCADVYFLPPFLSTMPKLRALILINYGTSCTSLQNCSVFKPLSNLRSLWLEKISVPPLPKSTVRLNNLRK
VSLVLCELNDSLRGSKVDLSSTLPRLSHLTIDHCIDVTELPSCICDINSLECLSISNCHDLSELPCEFGK
LSSLKILRVYACPSLKSLPLSICRMKGLKYLDISQSFNLRELPEELGYMTSLEKIDMRECSQLKTLPRSS
SFLKSLGHVICDEDIALLWKEAERDIPDLRVQVAEESFNLDWLLE


>XP_042455014.1 putative disease resistance protein RGA1 [Zingiber officinale]
MGLEPLQKILHQHIVKKKFLLVLDDVWSDDKSIWEKFCALLKVGAHGSKIIVTTRGMKVSKMVSLAEPIL
LHGLDEDAFWQLFNECSFGTLNPEDYPGLEDIGRKIVRKLNGSPLAAKTIGRVLRSNICQQHWATVMESD
IWKAKQDEDDIMPALQLSYQYLDENLKHCFAFCSLFPIDHKFDKTELVRMWMAEGFINEDKNTKSMEDVG
SDYFLEFVNSSFFQESRYHYEFWDGFGIRIVMHDLIHDLAEMISTEETCRIENSRHTKPASTTRHLRVEK
EKLPLEFSGYNKLRTLVLKLSLPDSSLFEILRSIRVLVVSWCGLLELSERIGKLIHLRYLDISYSKIKIL
PDLLCDLYNLQTLKAEYCYELESIPQELGKLVNLRHFDISNNFKIKILPDSLCDLYNLQTLKVNGCSELE
SIPQELGKLVNLRHIDADKKIWLMIKDVWRLTNLQELPTFSVREDDELKLGQLKDLTQLHGTLCIQNLEN
VVDGKEAQRAKLKSKVHLKELVLEWNLRLDGAKDAKLDEEVIEVLQPHESLKILTIRWYNGGRSPSWLMP
KVLPNLEKLELENCMEWDDVLPFIGQRLHLIELRMTGMPALKRLSHEFEGKCFPKLQVLKLCKFKALREW
SCTEGKDLFPCLRELCVIDCPKLKRLPPFPPSLEMLTIECCPRLILNSKTEDDEEGGRHLPPSLKELKNM
QNFCPTACTTLLDWK


>XP_042455015.1 putative disease resistance protein RGA1 [Zingiber officinale]
MGLEPLQKILHQHIVKKKFLLVLDDVWSDDKSIWEKFCALLKVGAHGSKIIVTTRGMKVSKMVSLAEPIL
LHGLDEDAFWQLFNECSFGTLNPEDYPGLEDIGRKIVRKLNGSPLAAKTIGRVLRSNICQQHWATVMESD
IWKAKQDEDDIMPALQLSYQYLDENLKHCFAFCSLFPIDHKFDKTELVRMWMAEGFINEDKNTKSMEDVG
SDYFLEFVNSSFFQESRYHYEFWDGFGIRIVMHDLIHDLAEMISTEETCRIENSRHTKPASTTRHLRVEK
EKLPLEFSGYNKLRTLVLKLSLPDSSLFEILRSIRVLVVSWCGLLELSERIGKLIHLRYLDISYSKIKIL
PDLLCDLYNLQTLKAEYCYELESIPQELGKLVNLRHFDISNNFKIKILPDSLCDLYNLQTLKVNGCSELE
SIPQELGKLVNLRHIDADKKIWLMIKDVWRLTNLQELPTFSVREDDELKLGQLKDLTQLHGTLCIQNLEN
VVDGKEAQRAKLKSKVHLKELVLEWNLRLDGAKDAKLDEEVIEVLQPHESLKILTIRWYNGGRSPSWLMP
KVLPNLEKLELENCMEWDDVLPFIGQRLHLIELRMTGMPALKRLSHEFEGKCFPKLQVLKLCKFKALREW
SCTEGKDLFPCLRELCVIDCPKLKRLPPFPPSLEMLTIECCPRLILNSKTEDDEEGGRHLPPSLKELKNM
QNFCPTACTTLLDWK


>XP_042455018.1 disease resistance protein RGA2-like [Zingiber officinale]
MEPASGFLNDTLSVLPIVGIGGAGKTTLAQYAHKDSRVQDHFHLKIWICVSDNFTMQGLAKSIIESVTLQ
KQDDNMRLEPLQKILHQHIAKKKFLLVLDDVWSNNKSIWEKFCALLKVGAHGSKIIVTTRDLKVSKMVSL
AEPISLHGLDEDVFWQLFKKCSFGALNLEGYPELEDIGRKKALKLKGSPLAAKTLGSVLQSNLCKQHWAT
IMESDIWKVKQDENDIMPALHLSYQYLNENLKQCFTFCSLFPKDYRFYEDKLIRMWMAEGFINEDKSTKR
MEDVGSDYVLEFLTRSFFQEFEYDGFVMHDLIHDLSERISELSEHIGKLIHLRYLDLSYNSEIKILPESL
CDLYNLQTLKAVGCSELESTPQQLSKLVNLRHIFADEKFWVMIKDIRRLTNLQELPTFRVQEEDGLKLVQ
LKNLTQLRGTLHIQNLENGVDSKEAQTAQYAELKKKVHVQELVLTWNDEKDAKLEEEVIEGLQPHDLLKI
LKIEGYNGGRSPSWLMPKVLSNLEKLELVNCKGWDDVLPFIGQRLYLIELIMYSMPALKQLSHEFKGKCF
PKLEMLDLYELPALEEWSWTEGKDLFPRMRQLRVWKCPKLNRLPPFPHSLEILTIYDCSKLILNSKTEDG
EECGCYLPPSLKVLELDNCGEYSKLLPGCLHSLRLVTRLAIRYCPHITSIPPVQLVELQYLYISNCDELR
RMDCLALLKSLKELKIVGCPKLVQLDVEDEQAGSLSSLCKLCVDNTALLKIFPLRNSLSFITELRIESCS
EEVIFEEAILMQSLTAVTSLTFCNCDKLQSLPTELVRSLTAVTSLNFIDCKKLQSLPTELLQSLPLLKQL
NIYWCPQFQSLPEEELPPLLNHQNAVVFLPSLLYSNAIVAAPRNILLL


>XP_042455019.1 putative disease resistance protein RGA1 [Zingiber officinale]
MSWDKHLIFRHINCSWNNKSSGNLQRYINCRGINYSVVCRLLFCFDLQLPFSNFCFLRVYCSLLKHRRLN
GNNDHLQIHFISRSTLFGDLKEEQRFALFCNQMAVSLTVGGWLAQAFIQTLIDKASDKAIQLFAERRGFA
EDMKKLRTSLLQTQITLDEVQSSRSNNIKWKTLMQELQDASYDAEDLIDEFQYNILRQKIKGEEEDKASG
SSGLLSILPAAKKLFGSSYDMRARVREIQERLETSMKSIVNLPATHDRRKQPEVKFQARESCSSPMADKL
IGREKELNQVVDWLLGSANQVEPASGFVNNTFSVLPIVGIGGAGKTTLAQYAHKDNRIQDHFHLKIWVCV
SDNFTVQGLTKSIIESVTLQKQDENMLEPLQKILHQHIAKKKFLLVLDDVWSDDKSIWEKFCALLKVGAH
GSKIIVTTRDMKVSKMVSLTEPILLHGLDEDAFWQLFMKCSFGTLNPEDYPGLEDIGRKIARKLKGSPLA
AKTIGRVLRSNICQQHWATIMESDIWKVKQDEDDIMPALQLSYQYLDENLKQCFAFCSLFPKDHKFDKAE
LVRMWMAEGFINEDKNTKSMEDVGSDYFLEFVNSSFFQEFRYHYEFGDGFGIRIVMHDLIHDLAEMISAE
ETCRIENSRHTKPPSTTRHLRVEKEKLPLEFSGYNKLRTLVSKLSLPDSSLFEILRSIRVLDVSWCGLLE
LSEHIGKLIHLRYLDISGNSKVKILPDSLCDLYNLQTLKTECCSELESIPQELGKLVNLRHFDISSNFKI
KILPDSLCDLYNLQTLKVNGCSELESIPQELGKLVNLRQIDADGEFWVMLKDVRRLTNLQELPIFSVQED
DAFKLGQLKDLTQLHGTLCIQNLENVVDGKEAQRAKLKSKVHLKELVLDWNLRWYGGKDAKLDEEVIEGL
QPHESLKILTIRRYNGGRSPSWLMPKVLSNLEKLELSNCMEWDDVLPFIGQRLHLIELRMTDMPALKRLS
HEFEGKCFPKLQVLKLCKFQALREWSWTEGKDLFPCLRELCVIDCPKLKRLPPFPPSLEMLTIECCPRLI
LNSKTEDDEEGGRHLPPSLKELKLTDCGEYAKLLSDCLHNLTRLEINDCLYIPSISLVQLVELQCLCISD
CDELRRIECLGLLKSLKELKIVECPKLVQLDVGDEQAGSLSSLRKLCVDNTALLKMFPLRNSLPFITELE
IESCSEEVIFVEPIWVPSLAAVTSLTLRNCKKLQYLPTELLHGLPLLENLIMKNCPQIKSLPDKGLPPRL
QRLQIYGCPHIQLQEIPENLRPIIPCMSLLSFNIF


>XP_042455021.1 putative disease resistance protein RGA3 [Zingiber officinale]
METLCTSLLKTQTMLAKVKSSQSNDTKWMPIMPLMQKLKDAAYDAEDLIDEFQYHVLRQKIKGEEEDKAA
SGSGGLPNILPAAKEKLFGPSHSLEEDAMRTSVVEIQGRLERIANSMEGIMNVLPLNDRGTQLEVKFQSR
ESCSSPATDILFGREKELNQVVEWLLGSANQVEPAPGVVNDTFSVLPITGIGGVGKTTLAQYVYKDTRIQ
HHFDLKIWVCVSHNFSVQGLTKSIIQSVTQQKQHDNMCLESLRKILDEHIANKKFLLFLDDMWSDKESIW
ENFCALLKDGGAHGSKIIVTTRVMKVSKMVNPAESILLHGLDEDVFWQLFNKCSFGILNPEDYPGLEDIG
RKIARKLKGSPLAAKTIGKVMKSNLCWQHWTTIMESDIWEVKQDEDGIMPALQLSYQYLDENMKQCFAFC
SMVPKDYTFDKVELVLMWMAERR


>XP_042456145.1 putative disease resistance protein RGA3 [Zingiber officinale]
MAAADLKRILSQVLPSPSLKAQAGLLRVQNHLEMIEGSLWKINSMYMHGLMTAITKPDVEQWTNDVKEAL
LDVDQLLGRILRCRLPKEAAAKSPSVCGDILLWLKETAAKSPSVRGDILLGLAETAAKSPSVRGDILLGL
TETASKLNHLAFGGASSLGLRAEMMDSIDADHEDFSTVLNNEVQGLEDTTNKIVKELQSQQLYEEIPTIF
YIVGHEGMGKTTLARKVFHHDWVRNYFQHHVWVDSPDSFSFDPMTVARSFVEAVTKKPCGHRGYLQQLWL
DVSKKLNVGRYFLVLDDVPVLMKDRDKWEQLRHVFLRLGSPGSRVVAVTSVHHSDFPEGNPTFKKLPPVL
GLSRDSWTSLLRRRASALIRDDDEGKQIRKSSSAILDRFAGKLHEKSRGSPSLAKVWGSALQCTEVGRWE
DQIEKDLLPKPLQDEQHFGSWSSQYLIPKDAHLYLFSSLFQQDHDEHDYEDLFHMMAAQGFIQDSSNKAL
IISNLKRSLRHFATKDSRQQESLTNDLIRSLPILEATQPSSESEKKVLSYWKTKGFPKSTHQLQCLHLSV
LIHPSTDLTLPVTLPSKLRTLKLTMLVAENEEQKKKMEGQKIETVLKDEFSNLRHLRVLDLRATKMAEMP
DTVDGLVNLRYLNLSWSDIATLPDSFCNLGSLQILKLAHCHKLSELPHRIGKLQNLQVMKLPFCENLTKL
PKSVTNLIDLQELDLECCRQLVEFPDEFGNLKSLRSLSLVGCLSLTKMPSGMRQLTELRQLSGFVALQEC
GSCTVTELGPLKYLEDLHLRGLEGVRSTNDAEAMKLKNKRFIRNLVLHWNGDDGASSDSLLEILECLQPS
TALRTLEINSYSGKDFPKWMKDGQPYHYTLTEIKLVNLRDCASLPPLGQLARLEVVEISGMVKVRKVDDE
FYGLNGAFASLRKLTFSEMPELQKWVKVTRKFQLFPKLTELMIIQCPRLEQLEVELTAVKKLSLWLSNGT
LLTSKSWDWSKFSGLTELEIVGCPGVKHLPKSMKILEQMVDHLTLVGLGTLESLPNWLKKDCCLDITRCG
KVKEQECQNASEAFSSATSIESREWDKK


>XP_042457056.1 disease resistance protein Pik-2-like [Zingiber officinale]
MEIGIATTMAMQLVEFSFQSMTGKLEKMLEEKASLLAGVEDDAQDMVDELRSITSYLTAMSTRRNLDVQQ
QNWVNEVREVAYNAEDSIDEFDYHLRSTPYDERGVKGFFKHFLPRIKSLKARDCIASDIKKLKVKVEDIK
KRHDRYSLPNEATRSGTATGLDMAERYSDPRIIGHFVEEAHLVGINQSRDKIIGWVMDENCLELIVISLV
GFGGLGKTTLAKTIYDDPIRGHFQSRAWIAVSQNYSIKELLKKIIQQISVKKKEIQDVLGCRDAKLNTEK
LLSQMDESQLVQTVRGHLHGKRYLIVFDDVWSTEAWESLSIALPQGKEGSRVIVTSRSEEVANYSCSRNR
QFIFKVSPLSPELSWELFRRKVFEAPDYSCPPELENVGREILQKCNGLPLAIVTIGGLLASKPDKKLEEW
KDLRDHLRLEIQTNDMLSKINQILGLSYNDLPYYLKPCFLFLGTFPEDYEIRRKRLMRRWIAKGIVNGVG
GLPDEKMAERCFNQLVNRSLVQPSEFDDNGTVRSCRVHDMMLDVIISISRKENFAVVLNKHSTQTTIQPR
HQRIRRLSWQGGSSGLVPNTDLSHLRSFAAFGEDVPVNDYRKQRLSRAIDLEGCRNLDDFHPKSFSKLCL
LKYLSLTNTGLSELPDSIGDLQNLEFLDIRETYINKLPNAIVKLQKLVHLLAGGYIKWPCMEDSFFLNVY
LPKGIRKLKKLRTFGLVRAHDVHSLQEIGELVDLQKLGMSFGFRDLKRKALEEISALLSKLNGSLRSLTL
ANSNLKKALDEVVSPPLLLHKLQIHAARGGFPAWFASLKQVVKITLSNTRLQLQDLQVLRNLNTLVKLVL
GFHSFDDNYEDFVFDQVGFANLKFLEIEMHSVSFEEGALQSLEILKMDKIFIGYSVDGIEHLHGLKEVHI
QTENDDTIEMVKNIAANHSNRPKCFAKLLKSA


>XP_042457964.1 uncharacterized protein LOC122042090 [Zingiber officinale]
MDESASHSSEPCTSTLTIRIAGPSSEIGEKSVPISPSISLSPHLNSPSPPSSAFVSALQSPYISPRALEP
PNGTNSYSTTATMPSTTTSNSALHSDDIPSTSYTPPSESSDFVADQIEQKHKFSDAMLPRISFSFPVPRT
SLTRGSVSPPSNLKLHGCDVYIGYNGNNHVLVRFCKWLKTELELQGIASFVADRAKYSDSQSHEIADRII
CSAAFGVIVVTPSSFLNRLSVEEIRFFAQKKNLISVLFDTELSEIVSLSNERLEGKESREALEGFTKCNE
FKIETNGSNWRSCISKVVAVLKSRLGRRSIAEVETETFEELLFPRNGHFVGREKEVAEIEAAFFGCVEAH
EMECPKPSLTRGSSSDGFADEEIDTVRTSKKYISLEMRKSKEPTLEAWIEPVIELASKGRSLQKQRSKHK
KSRCGANKGHGNASVFCVNGSSGIGKTELALEFAYRYAQRYRMVLWIGGETRYLRQNILNLSLKLGLDLS
AEAEKERGRIRSFDEQEFDAFLRVKRELFRDIPYLLVIDNLETEKEWWEGKDLHDLIPRNTGATHVIITT
RLSKVMSFEPMQLPLLSLADSLLLLKGRRKKDYSSEESQVLKKFVERMERLSFGMSVVGSLLSELPISPS
ELLETIDRISVNDGNEDGLWRSSIFLMKTLAFCFAVVDQAAGRSLASRMAQTGAWFASVPVSSTLLAAAS
DNLPTKGSFCQWGKDLTDVFLCGTRCCLAASQARKTEVDSAMLLVNLGLAKRSMRQPGCWIQLHPITQVF
AKRKGGLPPAKAAVHGAMRAGNAAMNLDHLWASAFLVFGFKQEPPLVQLSALDMAFFIRKTALPLAIRSF
MTFSRCNSTLELLKVCTNALEEAEKSFVSQIQDWHRGRLCWTKKLQFNQKVDEYVWQDVTLLKATLLETR
AKLLLRGGHFDEGEELCRTCVSIRTVMLGHNHAQTLAAQETLAKLVRFRRKM


>XP_042459206.1 probable disease resistance protein At1g61300 [Zingiber officinale]
MAFIKLNFNVDVHKCLSGLKATLGLGRPKSSIDKLEREMERLRAKRDDIRNQIVDAERDGKLPTNEVNRW
LDEVEELEGKVTSINQDFRSMSCFSCNCFNQTGGTTNQTRQVGDQVPIRESSNCYSINRRAAEKLNEANE
LMSRTNALDPIAITTIPSRIGSDIQETMARLRAKRDDIKNQINQAEREGKIPTNEVGQWLLEVEKLDGQV
ATINQIPIRESPWKYSIIQRVAKKHNEVNELMIRADVLDPIVTVGPPKPIVTLPILYRSHVGIGSYVEEI
VGYIDGGKDNIIGIHGMGGVGKTTVLKSIQHHYLLKHTIFDPVIWVVASKDCQLKRLQMDIAKSLGLKTL
QESDDEQTCSDKLFSYLKNKKCLLFLDDIWEHLDLQLLGMAHSATDQGQQQQQRKVVVFTTRNQIVCAQM
EAEKKIKIECLNPAQAWQLFVKNFKSDAPFSDAGIHFVAQELVKECAGLPLALITVARAMLGKKSRDVWN
HALHQIRNKHQWTTIGLSEDSNVMYKAFKLSYDSLEDDSTRECLLCCALWPEDHDIHIFEELIPCWIGCG
IIHYDNVFKRYSISDAFQEGCWHLEALINASLLEHSSRRPDYYEAQHVKMHDVIRDMTLLTLKENKRKWI
VKAGIGLRHLPRQEEWQEAERASFMDNEITSLQDYGASTFPKLSMLNLHSNHLSEIHPMLFTNMPLLTYL
NLSLNLGIEELPKEIGCLTELQYLNLSETSITNLPAEFGRLGKLKYLLLRDTKLETVPNGTISNLSTLRW
LDIREIYPSHEWWWDELEHFRGRSKYLSLGITINPDKLKRLETLPNNVSVWSLTVRGLGSSKLPEYNLGT
LQWNNKVRYLVESLEISDVPGHELTMPGDWNRILEFYCLKTLCFRTLEQLENIRFNPVEYEFNNLRDLYI
CGCNKLKDVSCVLDLRYLNLLDIKNCEEIEELISNVGNSNSISRIRMLSLNGMRNLHRFAHQPFQFPALE
YIRVLYCPRLKKLPFEAKMLKKIEGEEEWWNNWNWDEESNDFSTPCFRLKEIEGEKDWWNNLDWDDESIK
DSLTPYFREVFY


>XP_042459940.1 probable disease resistance protein At1g61300 [Zingiber officinale]
MACINININIDVNRCLSELRTSLKLLVRPKSGIQKLEKEMARLRGKRDDIKYQIDLMEREGEIPIDEWIQ
WLREMEELEGQVAAIKQDFQSMSCFSCHCFNRAGGTSSQTQQAESSNFYSIILRMAKKLIEANELMSLTG
APVPIARFRPRRFTTRLPIPHLPPVGIDSYLNDIVGYIDGGEGNTIGIYGMGGVGKTTILMSIQQHYLLE
DTIFDRVIWVVASQNCQLKRLQMDIAMGLGLKTLKESDDEQTCGDKLFSYLKNKACLLLLDDIWEHLDLQ
LLGMTHSATEQSQQQQQQKQPRKVVVFTTRDKAKCEQMNAEKKIKVECLNPDQAWQLFEQNSDGDVLSSD
AGIKFLAEELAKECAGLPLALVTVARAMSGKRSWEAWKEALHQIRDKHVSTPIGLPEESLPMYKSFKSSY
DSLENDLIRECLLCCVLWPKDYDIHKFDELIPCWIGCGIINDFNVINEAFHKGCYYLETLIAASLLEDSR
RQSYYKAEHVKMPNSIRDMVLLMVSELKGNGRKWIVKAGIELSHLPSQEEWQEAERASFMRNNITSLQDY
EASTFSKLCILILHGNHLSEIPPTLLTNMPLLTCLNLSLNFGIEELPKEIGSLTKLQYLNLSSTDIKSLP
LEFGCLKKLEYLLLRNTRIKTIPNEIMSNLSMLKWLDIGGYFPVCDSWLNELKCLREEHHKISLGITINP
ANFEILNMLPNVSVWNLTVSGSESSKFSVHNLGTLKWSHRISDNLECLTILDVPGDELAINAGVDCESSF
GCLKTLYFRRLGKLKNIRWNGVGFNNLHDLYISDCYMLKDVSWVLQLPCLDFLRISNCWEMEELISNVGN
FNSSFGIKMLILFQMNNLHRISHQPLHFPNLKNINVCHCPRLKKLPFGTGILRSGLKEIIGDQTWWDSLD
WDDNSNRDSLTTLFRNQLD


>XP_042459945.1 putative disease resistance protein At3g15700 [Zingiber officinale]
MAFIKLNLNVDVNSCLSGLKATLRLGRPKSGIEKLKKEIKNLRDKRDDIKNRIDQAELEGKIPTNQVSQW
LLDVETLESQVAAIEQDFQSTSCFSCHCFNQTQTQTGGTSQTQQAGDQVPMRESSNCCSIILRVAKKLGE
VKELMDRADRLDPVATVRPSEPTVMIPISHRSPVGIESYEEDIVGYVDGGKGDIIGIYGMGGVGKTTMLT
RIQQHYLLKHTIFDRVIWVVASKDCQLKRLQMDIAKSLGLKTLQESDDERTCGDKLFTFLKSRNCLLLLD
DIWEHLDLQLLGMAHSATTERGQQQQPRKTVVFTTRSEAVCVQMKAEKKIKVKCLDPVQAWRLFEENSEK
DVLNSDAGIKFVAEKLAKECAGLPLALITIARAMSGKKSWEAWDAALRQIRDEHQWKTVCLPEDSVVMYK
AFKMSYDSLENASYAALCGLKIMISINSMI


>XP_042459946.1 probable disease resistance protein At1g61300 [Zingiber officinale]
MAFIKLNLNVDVNSCLSGLKATLRLGRPKSGIEKLKKEMNNLRDKRDDIKNRIDLAELEGRIPTNRVSRW
LRDVETLEGQVAAIEQDFQSTSCFSCCCFNQTQTGGTSQTQQAGDQVPMREPSNCCSIILRVAKKLGEVK
ELMDRADKLDPVKLDPVTTVGPSVPAVMLSISHRPPVGIESDVEGIVSYIDGGEGNIIGIYGMGGVGKTT
MLQRIQQHYHRNHAVFDRVIWVVASKDCQLKRLQMNIAKSLGLNTLQENDDEKTCGDKLFSYLMNKNCLL
LLDDIWEHLDLQLLGMAHSATDRGQQQQPRKTVVFTTRSEAVCVQMKAEKKIKIKCLDPVQAWQLFEENS
EGDVLNSDAGIKFVAEKLVEECAGLPLALITIARAMSGKKTWGDWDAALRQIRDEHQWKTVCLPEDSVVM
YKAFKMSYDSLENDSIRECLLCCALWPEDYDIYKFYDLIPCWIGCGIIREFNVINEAFTKGCSHLEALMA
ASLLEQSSVIEFPYRDTGVKMHDVIRDMALLMVSGLDLEGNKRKWIVKAGIGLSHLPRQEEWPEAERASF
MRNNITSLQEYGAFTFPKLYMLILRENRNLKTIPSSLFASMPRLTYLDLNGCGIRELPREICSLTELQYL
DLSYNLITSLPAEFGCLSKLEYLLLSDTDLKIVPKGTISNLLMLKWLDISKVPLVPEWWWDELKCFKGRY
QLSVGISINATTDNIERLNMLPNVSIWKLTLDGDNISKHQQVMDLGTKQWGCRVSDHLEFLRINYLRIDK
LMLAAGVGHESSFGYLKSLYFEDLELLKEISLNRVRLFNLRKIHIFGCHMLKDASWVLQLPCLNFLEIIS
CEGMKELISEVGNSNSISNPSIQRLFLIDMPNLNRIANQPLHFPNLEYIRVHSCPELKKLPFGAEILNRL
KWIDGEEYWWNNLNWDDKSIKDSLTPYVWFN


>XP_042459947.1 disease resistance protein RPS2-like isoform X1 [Zingiber officinale]
MKAEKKIKVKCLDPVQAWQLFEQNSERDVLNSDAGIKFVAEQLAKECAGLPLALITIARAMSGKKTWEAW
VATLRQIRDEHQWKTVCLPEDSLVMYKAFKLSYDSLENDSIRECLLCCALWPEDYEINTFDQLIPCWIGC
GIIHEFNVINEAFAKGCSHLEALMAASLLEECIPKGRPLHWYGPCVKMHDVIRDMALLMVSGLEGNKRKW
IVKAGIGLSDLHRQEEWQEAERASFMMNKITSLPEYEANFTFPKLSMLILCQNKGLKTIPSSLFASIPRL
TYLDLNGCSIRELPMEICSLNELQYLDLSSNLITSLPAEFGCSVN


>XP_042459948.1 probable disease resistance protein At5g43740 isoform X2 [Zingiber officinale]
MAFIKLNLNVDVNSCLSGLKTTLRLGGPKSGIEKLKKEMKKLRGKRDDIKNRIDQAELEGRIPTNQVSQW
LLDVETLEGQVAAIEQDFQSTSCFSCHCFNQTQTQTGGTSQTQQAGDQAPMRESSNCCSIILRVSKKLGE
VKELMDRADRLDPVATVGPSEPAVMLPISHRSPVGIESYEEDIVGYVDGGKADIIGIYGMGGVGKTTMLK
RILQHYHLNHAIFDRVIWVVASKDCQFKKAPD


>XP_042459949.1 probable disease resistance protein At1g61300 [Zingiber officinale]
MACINLNLDVDVNSCLSGLWASLPVLGRPKSGIQKLEKEMARLRGKRDDIKNQIDQADRQGKIPTNEVSQ
WLREVEILEGKVGVIEQDFQSVSCFSCNCFNQTDGTSSQTQRAGDQVLIRQSSNYCSIIRRVAKELGEAN
ELMSRAGALDPVATVGPLKPTVMLPISHRPPVGIESYVEDIVSYIDGGEDNIIGIYGMGGVGKTTTLNRI
QQHYLLKHTIFDRVIWVVASKDCQLKRLQMDIAKSLGLNTLQENDDEKTCGDKLCSYLMNKNCLMFLDDI
WEHLNLQLLGMAHSTTEQSQQQHQQPRKVTVFTTRSETVCAQMKAEKKIIVRCLDSEQAWQLFEQNSDGD
VLSSDAGIKFLAEELAKECAGLPLALVTVARAMLGKRSWEAWKEALHQIRDKHEWTTIGLSEDSLVMYKA
FKLSYDSLENDSIRECLLCCALWPEDYEINQFSELIPCWIGCGIIREFNVINEAFAQGYSHLEALVAASL
LEQCGDFNFRYSKKRVKMHDVIRDMALLMASRLEGNKRQWIVKARIGMSELPRQEEWQEAERASFMFNNI
TSLQDYEASTFPKLSMLILNYNHLKQIPPSLFASMPHLKYLDLSGCDITELPKEICSLAELQYLNLSDSS
IIRLPFEFGCLGKLEYLLLRATCLEIVPNGTISNLSMLKWLDIREICLVSEWWWDELKCFKGRHQLSVGI
TINVTTDNIQRLNMLPLNVSIWELTLDGENISKHEQVMDLGTLQWGCRVSDHLEILCIQNLRLDRFELAV
GVGRESSFGWLNSLHFTGLKLLEEISLNRVRLYNLRQLYIFGCPMLKDVSWILQLPCLNFLDITMCGKMK
QVISEVGNSNSISSSSIRCLILWHMSNLNLIANRSLHFPYLEYVQVYNCPKLKKLPFGVEILKNRLKVIK
GEDNWWNNMDWNDESIKDSLTPYFRSWHR


>XP_042459950.1 probable disease resistance protein At1g61300 isoform X1 [Zingiber officinale]
MACINLNLDVDVNSCVSGLWASLPVLGRPKSGIQKLEKEMARLRGKRDDIKKQIDQADRQGKIPTNEVSQ
WLREVEELEGQVAAIIQDFQSMSFFSCNCFNQTGSTSSQTQQAGDQVSIGESSNFCSIIRRVAKKLGEAT
ELTNRAGALDPIATVGPPEPTVMLPIAHQPPVGIESYVEDIVGYINGGEGNIIGIFGMGGVGKTTILESI
QQYYLHDHTIFDHVIWVVASKGCQLKKLQIDIAKSLKLDTLEKNDDERTCGDKLFSYLKDKNCLLLLDDI
WERLDLQLLGMAHSATERGQQQQKHPRKVVVLTTRSETVCAQMKAEKKIKVRCLDSEQAWQLFEQNSDGD
VLSSDAGIKFIAEELAKECAGLPLALVTVARAMSGKRSWEVWNDAFNQIRDKHEWTTVCLPEDSLVMYKA
FKLSYDSLENDSIRECLLCCALWPEDYEINQFSELIPCLIGCGIIREFNVINEAFAQGCSHLEALMATSL
LEKCNNINTPYEDTLVKMHDVIRDMALLMVSSLERNKRKWIVKAGIGLLNLPRQEEWQQAERVSFMNNRI
TSLQEYGASTFPKLSMLILRENMDLEAIPSSLLKSMPHLTYLDLSFCSIIELPMEIGSLTELQYLDLSYN
SIAKLPAELGCLCKLEYLLLSYMPLEIVPNGTISNLLMLKWLDISDNYIVPEWWWDELECFKGHHQLSVA
ININATTDSIQRLNMLPNVSIWRLTLDGENVSKLPNYDLGTPQWGCRVSDKLDILNIIDLRVSRLVLAAG
MGRESSFGCLKRLHFECLELLVEISLNRVRLYNLRQIYIYSCDMLKDVSWVLQLPCLNFLRIECCRKMKE
LISEVGNSNSISSSSSIQSLILGYLPNLNCIANRPLHFPYLEYIDVKGCPELKRLPFGIEMLKNRLKWIR
GEEYWWNNLDWDDESIKDSLTPYFRPQISK


>XP_042459951.1 disease resistance protein RFL1-like isoform X2 [Zingiber officinale]
MACINLNLDVDVNSCVSGLWASLPVLGRPKSGIQKLEKEMARLRGKRDDIKKQIDQADRQGKIPTNEVSQ
WLREVEELEGQVAAIIQDFQSMSFFSCNCFNQTGSTSSQTQQAGDQVSIGESSNFCSIIRRVAKKLGEAT
ELTNRAGALDPIATVGPPEPTVMLPIAHQPPVGIESYVEDIVGYINGGEGNIIGIFGMGGVGKTTILESI
QQYYLHDHTIFDHVIWVVASKGCQLKKLQIDIAKSLKLDTLEKNDDERTCGDKLFSYLKDKNCLLLLDDI
WERLDLQLLGMAHSATERGQQQQKHPRKVVVLTTRSETVCAQMKAEKKIKVRCLDSEQAWQLFEQNSDGD
VLSSDAGIKFIAEELAKECAGLPLALVTVARAMSGKRSWEVWNDAFNQIRDKHEWTTVCLPEDSLVMYKA
FKLSYDSLENDSIRECLLCCALWPEDYEINQFSELIPCLIGCGIIREFNVINEAFAQGCSHLEALMATSL
LEKCNNINTPYEDTLVKMHDVIRDMALLMVSSLERNKRKWIVKAGIGLLNLPRQEEWQQAERVSFMNNRI
TSLQEYGASTFPKLSMLILRENMDLEAIPSSLLKSMPHLTYLDLSFCSIIELPMEIGSLTELQYLDLSYN
SIAKLPAELGCLCKLEYLLLSYMPLEIVPNGTISNLLMLKWLDISDNYIVPEWWWDELECFKGHHQLSVA
ININATTDSIQRLNMLPNVSIWRLTLDGENVSKLPNYDLGTPQWGCRAWVGNQVLDV


>XP_042459952.1 probable disease resistance protein At1g61300 isoform X1 [Zingiber officinale]
MACIKLNLNVDVNKGLSGLKATLRLGRPKSGTEKLEKEMTRLRCKRDDIKNQINEAEREGKIPTNEVSQW
LREVEILEGKVADIDQDFQSMIHCCVSLGCFSCNCFNRTGGSSSNPTEAFAANIQEVEENAATDQTQQAG
DDVPIRESSNCCSIIRRAAKKLDEANELMSRAGALDPIATVGPPEPTLMLPISHRSPVGIESYVEDIVGY
VDGGEGNIIGIYGMGGIGKTTMLKRIQQHYLLKHTIFDRVIWVVASKDCQLKRLQMNIAKSLGLQTLQEN
DDEQTCGDKLFSFLKNRNCLLLLDDIWEHVDLQLLGMAHSAIEQGQQQQPRKVVVFTTRSEIVCAQMKAE
KKTKVKCLDSDQAWKLFEQNSDGDVLSSDAGIKFVAEELTKECAGLPLALVTVARAMSGKRSWEAWNDAL
HQIRDKHEWTTIALPEDSLVMYKAFKLSYDSLENDSVRECLLCCALWPEDYEIFKFSKLIPCWIGCGIIH
EFNVINEAFAKGYSHLEALGAASLLEKCDSDYVVKMHDVIRDMALLMVSGLKGNKRKWIVKAGIGLSDLP
RQEEWQEAERASFMINEITCLQEYGASTFPKLSMLILHGNQNLKTIPPSLFASLPRLTYLDLSDCCITEL
PKEICSLTELQYLNLSDNHIIRLPIEFGCLSKLEYLFLRYTGLETVPNGTIANLLMLQWLDIRGIPLASD
WWWDELKCYKGRHQLSVGIHINATTDNIERLNMLPLNVSIWELILDGEHISKLPSYDLGTPQWGCRVSDK
LEFLYVTRVRLDRLVLAAGVGRESSLGCLKRLDFHFLTLLEVISLNRVRLNNLRELIIFGCLMLKDVSWV
LQLPCLNFLQIRYCREMKELISESGNSNSITISSIQTLVLDNMSNLNRIANRPLHFPYLEYIDVKDCPEL
KKLSFGVEMLKNRIKRIRGEDDWWNNLDWDDATNFGMKHGPFGQGGYKAFTI


>XP_042459953.1 probable disease resistance protein At1g61300 isoform X2 [Zingiber officinale]
MACIKLNLNVDVNKGLSGLKATLRLGRPKSGTEKLEKEMTRLRCKRDDIKNQINEAEREGKIPTNEVSQW
LREVEILEGKVADIDQDFQSMIHCCVSLGCFSCNCFNRTGGSSSNPTEAFAANIQEVEENAATDQTQQAG
DDVPIRESSNCCSIIRRAAKKLDEANELMSRAGALDPIATVGPPEPTLMLPISHRSPVGIESYVEDIVGY
VDGGEGNIIGIYGMGGIGKTTMLKRIQQHYLLKHTIFDRVIWVVASKDCQLKRLQMNIAKSLGLQTLQEN
DDEQTCGDKLFSFLKNRNCLLLLDDIWEHVDLQLLGMAHSAIEQGQQQQPRKVVVFTTRSEIVCAQMKAE
KKTKVKCLDSDQAWKLFEQNSDGDVLSSDAGIKFVAEELTKECAGLPLALVTVARAMSGKRSWEAWNDAL
HQIRDKHEWTTIALPEDSLVMYKAFKLSYDSLENDSVRECLLCCALWPEDYEIFKFSKLIPCWIGCGIIH
EFNVINEAFAKGYSHLEALGAASLLEKCDSDYVVKMHDVIRDMALLMVSGLKGNKRKWIVKAGIGLSDLP
RQEEWQEAERASFMINEITCLQEYGASTFPKLSMLILHGNQNLKTIPPSLFASLPRLTYLDLSDCCITEL
PKEICSLTELQYLNLSDNHIIRLPIEFGCLSKLEYLFLRYTGLETVPNGTIANLLMLQWLDIRGIPLASD
WWWDELKCYKGRHQLSVGIHINATTDNIERLNMLPLNVSIWELILDGEHISKLPSYDLGTPQWGCRVSDK
LEFLYVTRVRLDRLVLAAGVGRESSLGCLKRLDFHFLTLLEVISLNRVRLNNLRELIIFGCLMLKDVSWV
LQLPCLNFLQIRYCREMKELISESGNSNSITISSIQTLVLDNMSNLNRIANRPLHFPYLEYIDVKDCPEL
KKLSFGVEMLKNRIKRIRGEDDWWNNLDWDDVSIKDSLTPCFRPPISE


>XP_042459954.1 probable disease resistance protein At1g61300 isoform X3 [Zingiber officinale]
MACIKLNLNVDVNKGLSGLKATLRLGRPKSGTEKLEKEMTRLRCKRDDIKNQINEAEREGKIPTNEVSQW
LREVEILEGKVADIDQDFQSMSCFSCNCFNRTGGSSSNPTEAFAANIQEVEENAATDQTQQAGDDVPIRE
SSNCCSIIRRAAKKLDEANELMSRAGALDPIATVGPPEPTLMLPISHRSPVGIESYVEDIVGYVDGGEGN
IIGIYGMGGIGKTTMLKRIQQHYLLKHTIFDRVIWVVASKDCQLKRLQMNIAKSLGLQTLQENDDEQTCG
DKLFSFLKNRNCLLLLDDIWEHVDLQLLGMAHSAIEQGQQQQPRKVVVFTTRSEIVCAQMKAEKKTKVKC
LDSDQAWKLFEQNSDGDVLSSDAGIKFVAEELTKECAGLPLALVTVARAMSGKRSWEAWNDALHQIRDKH
EWTTIALPEDSLVMYKAFKLSYDSLENDSVRECLLCCALWPEDYEIFKFSKLIPCWIGCGIIHEFNVINE
AFAKGYSHLEALGAASLLEKCDSDYVVKMHDVIRDMALLMVSGLKGNKRKWIVKAGIGLSDLPRQEEWQE
AERASFMINEITCLQEYGASTFPKLSMLILHGNQNLKTIPPSLFASLPRLTYLDLSDCCITELPKEICSL
TELQYLNLSDNHIIRLPIEFGCLSKLEYLFLRYTGLETVPNGTIANLLMLQWLDIRGIPLASDWWWDELK
CYKGRHQLSVGIHINATTDNIERLNMLPLNVSIWELILDGEHISKLPSYDLGTPQWGCRVSDKLEFLYVT
RVRLDRLVLAAGVGRESSLGCLKRLDFHFLTLLEVISLNRVRLNNLRELIIFGCLMLKDVSWVLQLPCLN
FLQIRYCREMKELISESGNSNSITISSIQTLVLDNMSNLNRIANRPLHFPYLEYIDVKDCPELKKLSFGV
EMLKNRIKRIRGEDDWWNNLDWDDATNFGMKHGPFGQGGYKAFTI


>XP_042459956.1 probable disease resistance protein At1g61300 [Zingiber officinale]
MACINLNLDVDVNSCLSGLWASLPVLGRPKSGIQKLDKEMARLRVKRDDIKNQIDQADRQGKIPTNEVSQ
WLREVEELERQLAAIKQDFQSMSCFSCNCFNQTSGTSSQTQEVGDQVLIRESSNYCSIIRRVAKKLGEAT
ELTSRAGALDPIATVGPPEPTMMLPISHRPPVGIESYVEDIVSYIDGGEGNIIGIYGMGGVGKTTMLKRI
QQHYHLNHAIFDRVIWVVASKDCQLKRLQMDIAKSLGLETLQESESEQTCGDKLFSYLKNKNCLMFLDDI
WEHLNLQLLGMAHSATEQSQQQHQQQHQQPRKVMVFTTRSETVCAQMKAEKKIKVRCLDSEQAWQLFEQN
SDGDVLSSDAGIKFLAEELAKECAGLPLALVTVARAMSGKRSWEAWKEALHQIRDKHEWTTIGLSEDSLV
MYKAFKLSYDSLENDSIRECLLYCALWPEDYEIDKFYELIPCWIGCGIIHEFNVINEAFAKGYSHLEALG
AASLLEKCDSDKVVKMHDVIRDMALLMVSGLKGNKRKWMVKAGIALSDLPRQEEWQEAERASFMCNKITS
LREYRASTFSKLSMLILLGNRDLETIPPSLFASMPNLTYLDLSYCHITELPREMCSLTELRYLNLSNCHI
TRLPIEFGCLVKLEYLLLVNTGLEIVPNGTISNLSMLKWLDISHIYPATEWWWDELKCFKGRHQLSVEID
INATTDDIERLNMLSPNVSIWKLTLDGENISKLPNYDLGTPQWGCRVSDNLEFLCIHNLRLDRLELAVGV
DRESSLGCLKSLRFIGLKLLEEILLNRVRLYNLREIFIFDCPMLKDVSWVLQLPCLKSLEINMCRTMKEV
ISEVGNSNSISSSSIQRLILWYMSDLNLIANRSLYFPYLEYVQVYDCPKLKKLPFGSEILKNRLKVIKGE
EDDESIKDSLTPYFRPRPY


>XP_042459957.1 disease resistance protein RFL1-like [Zingiber officinale]
MACIKLNLNVDVNDCLRGLKATLRLGRPKSGIEKLEKEMTRLRSKRDDIKNQINEAERQGKIPTNEVSQW
LREVEILEGEVADIEQDFQSMSCFSCNCFNRTGGTSSNPTEAFAANQEDEENAATQTQQAGDGVPIRESS
NCCSIIQRAAKKLDEANELMSRAGALDPIATVGPPEPTVMLPISHRSPVGIESDVEDIVGYVDGGKVDII
GIYGMGGVGKTTTLKSIQQHYSLLKHSTFDCVIWVVASKDCQLKRLQMDIAKSLGLKTLQESDDERTCGD
KLFSFLKKRNCLLLLDDIWEHVDLQLLGMAHSVIEQGQQQQPRKVVVFTTRNETVCAEMKAEKKIKVRCL
DSEQAWQLFEQNSDGDVLSSDAGIKFVAEELAKECAGLPLALVTVARAMSGKRSWEAWKEALSQIRDKHE
WTTVCLPEDSVMYKTFKLSYDSLENDFIRKCLLCCALWLEDHMIRKLELIPCWIGCGIISEFNVINEALV
KGCSYLEALIATSLLEKCTDIDSSYGDTLVKMHDVIRDMALLMVSDLESNKRKWIVKAGIGLSDLPRQEE
WQEAERASFMRNRITSLQGYGAFAFPKLSMLILLGNLDLEAIPSSLFASMPHLTYLDLGCCGITELPMEI
GSLTELQYLDFSFNPIAKLPAELGCLCKLEYLFLNSTCLKIVPNGTISNLLMLKWLDISNNPLVPEWWWD
ELKSFKGRHQLSVGININATTDNIQRLNM


>XP_042459958.1 probable disease resistance protein At1g61300 isoform X1 [Zingiber officinale]
MACINLNLDVDVNSCLSGLWASLPVLGRPKSGIQKLEKEMARLRGKRDDIKNQIDQADRQGKIPTNEVSQ
WLREVEILEGKVGVIEQDFQSVSCFSCNCFNQTDGTSSQTQRAGDQVLVRQSSNYCSIIRRVAKELGEAN
ELMSRAGALDPVATVGPLKSTVMLPISHRPPVGIESYVEDIVGYIDGGEDNIIGIYGMGGFGKTTTLNRI
QQHYLLKHTIFDRVIWVVASKGCQLKRLQMDIAKSLGLNTLQENDGENTCGDKLCSYLMNKNCLMFLDDI
WEHLNLQLLGMAHSATEQGQQQHQQPRKVVVFTTRSETVCAQMKAEKKIKVRCLDSEQAWQLFEQNIDGD
VLSSDAGIKFLAEELAKECAGLPLALVTVARAMSGKRSWEAWKEALHQTRDKHEWTTIGLSEDSLVMYKA
FKLSYDSLENDSIRECLLYCALWPEDYEINKFEELIPCWIGCGIFDEFNMINEAFAKGYSHLEALGAASL
LEKCDSDKVVKMHDVIRDMALLMVSGLQGNKRKWIVKAEIGLSDLPRQEEWQEAERASFMRNEITSLQEY
EASTFPKLSMLILHGNINLKTIPPSLFTSMPRLTYLDLSDCCITELPKEICSLAELQYLNLSDNHIIRLQ
FEFGCLSKLENLFLRGTGLEIVPNGTISNLSMLQWLDIRNIPLVTDWWWDELKCFKGRHQLSVGITINAT
TDNIQRLNMLPPTVSIWHLTLDGENISKLPNYDLGTLQWGCRVSDNLEFLCIQNLRLDRLELAVGVGRES
SLGCLKRLDFRFLNLLEEISLNRVRLNNLRELSICGCPMLNDVSWILQLPCLNFLEIIYCEGMKEVISEV
GNSNPISSSSIQCLILWHMSDLNLIANRPFHFPYLEYVQVYDCPKLKKLPFGAEILKNRLKVIKGEDNWW
NNLDWDDESIKDSLTPYFRSWPR


>XP_042459959.1 probable disease resistance protein At1g61300 isoform X2 [Zingiber officinale]
MSRAGALDPVATVGPLKSTVMLPISHRPPVGIESYVEDIVGYIDGGEDNIIGIYGMGGFGKTTTLNRIQQ
HYLLKHTIFDRVIWVVASKGCQLKRLQMDIAKSLGLNTLQENDGENTCGDKLCSYLMNKNCLMFLDDIWE
HLNLQLLGMAHSATEQGQQQHQQPRKVVVFTTRSETVCAQMKAEKKIKVRCLDSEQAWQLFEQNIDGDVL
SSDAGIKFLAEELAKECAGLPLALVTVARAMSGKRSWEAWKEALHQTRDKHEWTTIGLSEDSLVMYKAFK
LSYDSLENDSIRECLLYCALWPEDYEINKFEELIPCWIGCGIFDEFNMINEAFAKGYSHLEALGAASLLE
KCDSDKVVKMHDVIRDMALLMVSGLQGNKRKWIVKAEIGLSDLPRQEEWQEAERASFMRNEITSLQEYEA
STFPKLSMLILHGNINLKTIPPSLFTSMPRLTYLDLSDCCITELPKEICSLAELQYLNLSDNHIIRLQFE
FGCLSKLENLFLRGTGLEIVPNGTISNLSMLQWLDIRNIPLVTDWWWDELKCFKGRHQLSVGITINATTD
NIQRLNMLPPTVSIWHLTLDGENISKLPNYDLGTLQWGCRVSDNLEFLCIQNLRLDRLELAVGVGRESSL
GCLKRLDFRFLNLLEEISLNRVRLNNLRELSICGCPMLNDVSWILQLPCLNFLEIIYCEGMKEVISEVGN
SNPISSSSIQCLILWHMSDLNLIANRPFHFPYLEYVQVYDCPKLKKLPFGAEILKNRLKVIKGEDNWWNN
LDWDDESIKDSLTPYFRSWPR


>XP_042459960.1 disease resistance protein SUMM2-like isoform X1 [Zingiber officinale]
MDIAKSLGLKTLQESDDERTCGDKLFSFLKKRNCLLLLDDIWEHVDLQLLGMAHSVIEQGQQQQPRKVVV
FTTRSETVCAQMKAEKKIKVRCLDSEQAWQLFEQNSDGDVLSSDAGIKFIAEELAKECAGLPLALLTVAR
AMSGKRSWEAWNDALNQIRDRHEWTTVCLPEDSVMYKAFKLSYDSLENDFIRKCLLCCALWPEDHMISKL
ELIPCWIGCGIISEFNVINEALAKGCSYLEALIATSLLEKCTDIDSSYGDTLVKMHDVIRDMALLMVSGL
ESNKRKWIVKAGIGLSDLPRQEEWQEAERASFMRNKITSLQGYEASAFPKLSMLILLGNLDLEAIPSSLF
ASMPHLTYLDLGCCGITELPMEIGSLTELQYLDFSFNPIAKLPAELGCLCKLEYLFLNSTRLKIVPNGTI
SNLLMLKWLDISNNPLVPEWWWDELKSFKGRHQLSVGININATTDNIQRLNMLPNVSIWGLTLDGENISK
HEQVMDLGTPQWGCRVSDKLDILNIVCLGLRRFVLAAGISRESSFGCLKRLHFQFLKLLVEISLKRVRFY
NLREIYISNCPMLKDVSWVLQLPCLKFLEIHSCGKMKELISEVGNSNSITISSIQTLTLDKMSNLNRIAN
RPLHFPYLEFIDVQDCPELKKLSFRAEMLKNKLKEICGEYYWWNNLDWDDESIKDSLTPYFRPPIWT


>XP_042459961.1 probable disease resistance protein At1g12290 isoform X2 [Zingiber officinale]
MDIAKSLGLKTLQESDDERTCGDKLFSFLKKRNCLLLLDDIWEHVDLQLLGMAHSVIEQGQQQQPRKVVV
FTTRSETVCAQMKAEKKIKVRCLDSEQAWQLFEQNSDGDVLSSDAGIKFIAEELAKECAGLPLALLTVAR
AMSGKRSWEAWNDALNQIRDRHEWTTVCLPEDSVMYKAFKLSYDSLENDFIRKCLLCCALWPEDHMISKL
ELIPCWIGCGIISEFNVINEALAKGCSYLEALIATSLLEKCTDIDSSYGDTLVKMHDVIRDMALLMVSGL
ESNKRKWIVKAGIGLSDLPRQEEWQEAERASFMRNKITSLQGYEASAFPKLSMLILLGNLDLEAIPSSLF
ASMPHLTYLDLGCCGITELPMEIGSLTELQYLDFSFNPIAKLPAELGCLCKLEYLFLNSTRLKIVPNGTI
SNLLMLKWLDISNNPLVPEWWWDELKSFKGRHQLSVGININATTDNIQRLNMLPNVSIWGLTLDGENISK
HEQVMDLGTPQWGCRA


>XP_042459962.1 probable disease resistance protein At1g61300 [Zingiber officinale]
MACINLNLDVDVNSCLSGLWASLPLLGRPKSGIQKLEKEMARLRGKRDDIKNQIDQADRQGKIPTNEVSQ
WLREVEILEGKVGVIEQDFQSVSCFSCNCFNQTDGTSSQTQRAGDQVLIRQSSNYCSIIRRVAKELGEAN
ELMSRAGALDPVATVGPLKSTVMLPISHRPPVGIESYVEDIVGYIDGGEDNIIGIYGMGGVGKTTTLNRI
QQHYLLKHTIFDRVIWVVASKGCQLKRLQMDIAKSLGLNTLQENDGENTCGDKLCSYLMNKNCLMFLDDI
WEHLNLQLLGMAHSATEQGQQQHQQPRKVVVFTTRSETVCAQMKAEKKIKVRCLDSEQAWQLFEQNIDGD
VLSSDAGIKFLAEELAKECAGLPLVLVTIARAMSGKRSWEAWKEALHQTRDKHEWTTIGLSEDSLVMYKA
FKLSYDSLENDSIRECLLYCALWPEDYEINKFEELIPCWIGCGIFDEFNMINEAFAKGYSHLEALGAASL
LEKCDSDKVVKMHDVIRDMALLMVSGLQGNKRKWIVKAEIGLSDLPRQEEWQEAERASSMRNEITSLQEY
EASTFPKLSMLILHGNINLKTIPPSLFTSMPRLTYLDLSDCCITELPKEICSLAELQYLNLSDNHIIRLQ
FEFGCLSKLENLFLRGTGLEIVPNGTISNLSMLQWLDIRNIPLVTDWWWDELKCFKGRHQLSVGITINAT
TDNIQRLNMLPPTVSIWHLTLDGENISKLPNYDLGTLQWGCRVSDNLEFLCIQNLRLDRLELAVGVGRES
SLGCLKRLDFRFLNLLEEISLNRVRLNNLRELSICGCPMLNDVSWILQLPCLNFLEIIYCEGMKEVISEV
GNSNPISSSSIQCLILWHMSDLNLIANRPFHFPYLEYVQVYDCPKLKKLPFGAEILKNRLKVIKGEDNWW
NNLDWDDESIKDSLTPYFRSWPR


>XP_042459963.1 probable disease resistance protein At1g61300 [Zingiber officinale]
MACTCINLNLNLDCNSCLSVLWASLRLCRPKSGIQKLEKEITILRAKRDDIKNQIDQAEREGRIPTNQVS
QWLLEVEMLEGQVADIEQDFQSISYFSCNCFNPTRGASTTSQTQQAGDQVPIRESSNCCSIIRRVAKKLG
EANELMSRAGALDPIATVGPPEPTVMLPISHQPPVGIESYVEDIVGYINGGEGNIIGIYGMGGVGKTTML
KSIQQHYLPKHTIFDRVIWVVASKDWQLKRLQIDIAKSLELMTLKESDNERTCGDKLFSYLKNKNCLLLL
DDIWELVDLQLLGMAHSATEQGQHQQQPRKVVVFTTRSETVCTQMKAEKKIKAKCLDPDQAWQLFEQNSD
KKFLSSDGGINFVAQELAKECAGLPLALVTVTRAMSGKKSWEAWKDALHQIRDKHEWTTIDLSEDSVVMY
KAFQLSYDSLENDSIRECLLCCALWPEDYKIHKFKELIPCWIGCGIIHEFNVINEAFTNGCPHLEALMAA
SLLEQCNDQKDIRYLDTFVKMHDVIRDMALLMVSGLKGNGRKWIVKAGIGLSHLPIQEAWQEEWQEAERA
SFMDNEIASLPDYGASTFSKLSMLFLHGNDSLTTIPPSLFPSMPLLTYLDLSKCHITELPMEICRLTELQ
YLNLSKNPITRLPTEFGCLCKLEYLLLRKTEIKSVTRGTISKLSMLRWLDIRRAFPIRGCLKNGRKIIGM
RPISEWWWDELKCFRGRHKLSVAIDINVTTANIKRVNMLPNVSIWNLTMEGGNFLQLQTLHLGTLQWSCS
VSDNLESLSFKNVAVDKLMLTAGVGRESSFGCLKTLHFYNLRKLEKISLNGVGLYNLRELCIHSCSMLKD
VSWVLQLPCLNLLLISRCFEMKEVISNVGNTNSSSSIQRLSLSLLPNLNCIAHQPLYFPYLEYVHVYKCP
IFKKLSFGAEILKSRLKEIRGIQTWWDNMEWDDESNKNLLTPLFIPFTESFD


>XP_042459967.1 probable disease resistance protein At1g61300 [Zingiber officinale]
MAFATINLNVDVNSCLGGLWASLRLGRPKSGIQKLEKEMTRLRGKRDDIKNQIEEAEREGKIPTNEASQW
LLDVEELEGQLAVIKQDFQSMSCFSCNCFNQTGGTSSQTQEAGDQLSIRESSNCCSIIRRVAKMLSEANE
LMSRAGALDPIVTVRPPRPTVMLSISHRPPVGIESDVEGIVSYIDGGEGNIIGIYGMGGVGKTTMLKRIQ
RHYHLNHAIFDCVIWVVASKDCQLKRLQMDIAKSLGLNTLQENDDEKTCGDKLFSYLMNKSCLMFLDDIW
EHLNLQLLGMAHSATEQGQQQHQQPRKVMVFTTRSETVCAQMKAEKKIKVRCLDSEQAWQLFEQNSDGDV
LSSDAGIKFVAEELAKECAGLPLALVTVARAMSGKRSWEAWKEALHQIRDKHEWTTISLSEDSLVMYKAF
KLSYDSLENDSIRECLLCCALWPEDYEINKFEELIPCWIGCGIFDEFNVINEAFAKGYSHLEALGAASLL
EKCDSDYVVKMHDVIRDMALLMVSGLKGNKRKWIVKAGIGLSDLPRQEEWQEAERASFMRNKITSLQEYG
ASIFPKLYMLILHGNRGLKRIPLSLFASMPHLTYLDLSNCGITNLPKEICSLTELQYLNLSSNPITRLSA
KFGCLIKLEYLLLRYTNLEIVPNGTISNLSMLKWLDIPHAYPANEWWWDELKYFKGRHQLSVGITINATT
NDIERLNMLPLNVSIWELTLDGENISKLPNYDLGSSQWGCRVSDKLEFLYIQNLRLDRLELAVGVGRESS
FGCLKRLWFIDLELLEEISLNRIRLYNLREIYISECPMLKDVSWVLQLPCLNSLCIVNCEKMEELISEVG
NSNSISSSSIQNLALDNMPNLNRIANRPLHFPYLEYIDVNDCPELKKLPFGAEILKNRLKVIKGEEYWWN
NLDWDDESLKDSLAPYFRSRHFNFWPISKWSIDLLVKEAIEFDRRKRKGSK


>XP_042460049.1 probable disease resistance protein At5g43740 [Zingiber officinale]
MACCIKLNLNVDVNSCLSGMWATLQSGRPKSGIKKLEKGMTRLRGKRDDIKNKITEAEREGKIPTSQVSQ
WLREVEILEAKVGDIDQDFQSISCFSCNCFNRTDGTSSNPTEAFAAHLEDAENAVTQTQQAGDDVPIRES
SNCCSIIPRVAKRLDEANELMSRAGGLDPIATVGPPEPTLMLPISHRSPVGIESDVEDIVGYVDGREGNI
IGIYGMGGIGKTTMLKSIQRHYYNQRIFDCVIWVVASKDCQLGRLQMDIAKSLGLSTLQESDDERTCGDK
LFRFLEDRNCLLLLDDIWEHVDLQLLGMAHSATERGQQQKPRKIVVFTTRSETVCAQMKAEKKIKVKCLD
SDQAWQLFEQNSDGDVLCSDAGIKFVAEKLTKECGGLPLALVTVARAMSGKRSWEAWKEALHQIRDKHEW
TTIGLSEDSLVMYKAFKLSYDSLENDSIRKCLLCCVLWPEDYEINKLSDLIPCWIGCGIIHEFNVINESF
DKGYSCLEALMAASLLEQCSSMDYYRDTAVKMHDVIRDMALLMVSGSEGNRRKWMVKAGIGLRDLPRQEE
WQEAERASFMRNKITSLQDYIASPFPKLSMLILNENRFLKMIPPSLFANMPCLTYLDLSGCGITELPKEI
CSLTELRYLNLWANPITRLPAEFGCLGKLEYLLLRGTHLKIVPTGTISNLSMLKWLDMANIFPTTDWWYD
ELKCFKGHHQLCVGIKINATTDNIE


>XP_042460056.1 putative disease resistance protein RGA1 [Zingiber officinale]
MAGVGMSVVEWFATYVMDKLVDFASSRLADPHRDVFSVVDEKLKEMEGRLPRIHAAIHAAEGRPIRDPAL
ASWMRQLKDAAFEADDLLDELDYRQLEARVQDRSKVSAFASSSLRFLKNLFVSDDELRRLKNILGDLDKI
SLEINQRKAELEEYNHARQQNRETSSFSTQEVVFGRDKERDLILEILLSAGDGPDYDDTKRAGSSRHLAN
LDVLPILGIGGVGKTTLAQLVYSDQRVAQHFELRKWVYVSDNFDVKRIAMELETNVTSDSHPFRDASLDA
QLCKLRDATANKRFLFVLDDVWDEIESSWTKLRSALTFGSKGSTILITTQSPLVAEIMGTVKPIKLELLE
EDDYWRLFEHCSLGDKEIDLDLRRKLELLGQQIAKKMHGLPLAAKTVGSMLRCRLEEQYWKAIQESEWWE
HDFVVDNILPSLGLSYQHLSSNYKQCFAYTSIFPKGHMFNKERLVQMWIAQGFIQEKTLRGRMTLEDIGS
QIFDELTSRYFFMRTVNDRYVMHDLIRELAVCVSIDECLVLHDEHVKIPATVCHLTLRVVKMNALPELRK
LQKLRTLIFYPEYDSEFLLLPRDGSKEFFKFLEGLLEDMKSLRVIDLSQDRSGINKLPDAICDLPHLRYL
DVSWTKIKQLPKGFPKLYHLQVLNLKRRGTFSILPQGMNRLIKLRHLYADANTVSLIHGIGKLTELQELE
EFHVSNKRGRQIEELKDLRYLRRRLTIQDIQNVESKEEAVGANLDDKENLHELILNRKPDIRSQGDKEKE
ILDGLQPHHNLKSLEIHHYGGMKSPSWLENNQITNLEFVYLNKCARWDTLPPLGKLPFLKNLVFKMMPSI
QRIGREFFGDGDTVFPSLEKLIFDQLNEWEEWSGTDKKSVFPRLFEINIINCVKLRQIPLLPLRSMSVLK
IWNCGDIGTTLPQYLLHLTSLVDLSLENYPHRVSVCLSNLTALKNLELQNCPELILLGGFQSLGNLKLLK
VTKCPKLNESSQPLEEPYVEEGLRSLSYIITDESIINHVWVIVGRAQAVKSLILANCEHLKHFKPELEEW
FQQLTSLQELQFVSCPDLQRLPANLETVFSIRRLIITHCPSIDSLPENGLPISLKELKIYGCRKLKDRCQ
KDDGPDWPKIAMIPHIVIEGEVISGAEEAA


>XP_042460057.1 putative disease resistance protein RGA1 [Zingiber officinale]
MAGVGMSVVEWFATYVMDKLVDFASSRLADPHRDVFSVVDEKLKEMEGRLPRIHAAIHAAEGRPIRDPAL
ASWMRQLKDAAFEADDLLDELDYRQLEARVQDRSKVSAFASSSLRFLKNLFVSDDELRRLKNILGDLDKI
SLEINQRKAELEEYNHARQQNRETSSFSTQEVVFGRDKERDLILEILLSAGDGPDYDDTKRAGSSRHLAN
LDVLPILGIGGVGKTTLAQLVYSDQRVAQHFELRKWVYVSDNFDVKRIAMELETNVTSDSHPFRDASLDA
QLCKLRDATANKRFLFVLDDVWDEIESSWTKLRSALTFGSKGSTILITTQSPLVAEIMGTVKPIKLELLE
EDDYWRLFEHCSLGDKEIDLDLRRKLELLGQQIAKKMHGLPLAAKTVGSMLRCRLEEQYWKAIQESEWWE
HDFVVDNILPSLGLSYQHLSSNYKQCFAYTSIFPKGHMFNKERLVQMWIAQGFIQEKTLRGRMTLEDIGS
QIFDELTSRYFFMRTVNDRYVMHDLIRELAVCVSIDECLVLHDEHVKIPATVCHLTLRVVKMNALPELRK
LQKLRTLIFYPEYDSEFLLLPRDGSKEFFKFLEGLLEDMKSLRVIDLSQDRSGINKLPDAICDLPHLRYL
DVSWTKIKQLPKGFPKLYHLQVLNLKRRGTFSILPQGMNRLIKLRHLYADANTVSLIHGIGKLTELQELE
EFHVSNKRGRQIEELKDLRYLRRRLTIQDIQNVESKEEAVGANLDDKENLHELILNRKPDIRSQGDKEKE
ILDGLQPHHNLKSLEIHHYGGMKSPSWLENNQITNLEFVYLNKCARWDTLPPLGKLPFLKNLVFKMMPSI
QRIGREFFGDGDTVFPSLEKLIFDQLNEWEEWSGTDKKSVFPRLFEINIINCVKLRQIPLLPLRSMSVLK
IWNCGDIGTTLPQYLLHLTSLVDLSLENYPHRVSVCLSNLTALKNLELQNCPELILLGGFQSLGNLKLLK
VTKCPKLNESSQPLEEPYVEEGLRSLSYIITDESIINHVWVIVGRAQAVKSLILANCEHLKHFKPELEEW
FQQLTSLQELQFVSCPDLQRLPANLETVFSIRRLIITHCPSIDSLPENGLPISLKELKIYGCRKLKDRCQ
KDDGPDWPKIAMIPHIVIEGEVISGAEEAA


>XP_042460059.1 putative disease resistance protein RGA1 [Zingiber officinale]
MAGVGMSVVEWFATYVMDKLVDFASSRLADPHRDVFSVVDEKLKEMEGRLPRIHAAIHAAEGRPIRDPAL
ASWMRQLKDAAFEADDLLDELDYRQLEARVQDRSKVSAFASSSLRFLKNLFVSDDELRRLKNILGDLDKI
SLEINQRKAELEEYNHARQQNRETSSFSTQEVVFGRDKERDLILEILLSAGDGPDYDDTKRAGSSRHLAN
LDVLPILGIGGVGKTTLAQLVYSDQRVAQHFELRKWVYVSDNFDVKRIAMELETNVTSDSHPFRDASLDA
QLCKLRDATANKRFLFVLDDVWDEIESSWTKLRSALTFGSKGSTILITTQSPLVAEIMGTVKPIKLELLE
EDDYWRLFEHCSLGDKEIDLDLRRKLELLGQQIAKKMHGLPLAAKTVGSMLRCRLEEQYWKAIQESEWWE
HDFVVDNILPSLGLSYQHLSSNYKQCFAYTSIFPKGHMFNKERLVQMWIAQGFIQEKTLRGRMTLEDIGS
QIFDELTSRYFFMRTVNDRYVMHDLIRELAVCVSIDECLVLHDEHVKIPATVCHLTLRVVKMNALPELRK
LQKLRTLIFYPEYDSEFLLLPRDGSKEFFKFLEGLLEDMKSLRVIDLSQDRSGINKLPDAICDLPHLRYL
DVSWTKIKQLPKGFPKLYHLQVLNLKRRGTFSILPQGMNRLIKLRHLYADANTVSLIHGIGKLTELQELE
EFHVSNKRGRQIEELKDLRYLRRRLTIQDIQNVESKEEAVGANLDDKENLHELILNRKPDIRSQGDKEKE
ILDGLQPHHNLKSLEIHHYGGMKSPSWLENNQITNLEFVYLNKCARWDTLPPLGKLPFLKNLVFKMMPSI
QRIGREFFGDGDTVFPSLEKLIFDQLNEWEEWSGTDKKSVFPRLFEINIINCVKLRQIPLLPLRSMSVLK
IWNCGDIGTTLPQYLLHLTSLVDLSLENYPHRVSVCLSNLTALKNLELQNCPELILLGGFQSLGNLKLLK
VTKCPKLNESSQPLEEPYVEEGLRSLSYIITDESIINHVWVIVGRAQAVKSLILANCEHLKHFKPELEEW
FQQLTSLQELQFVSCPDLQRLPANLETVFSIRRLIITHCPSIDSLPENGLPISLKELKIYGCRKLKDRCQ
KDDGPDWPKIAMIPHIVIEGEVISGAEEAA


>XP_042460060.1 putative disease resistance protein RGA1 [Zingiber officinale]
MAGVGMSVVEWFATYVMDKLVDFASSRLADPHRDVFSVVDEKLKEMEGRLPRIHAAIHAAEGRPIRDPAL
ASWMRQLKDAAFEADDLLDELDYRQLEARVQDRSKVSAFASSSLRFLKNLFVSDDELRRLKNILGDLDKI
SLEINQRKAELEEYNHARQQNRETSSFSTQEVVFGRDKERDLILEILLSAGDGPDYDDTKRAGSSRHLAN
LDVLPILGIGGVGKTTLAQLVYSDQRVAQHFELRKWVYVSDNFDVKRIAMELETNVTSDSHPFRDASLDA
QLCKLRDATANKRFLFVLDDVWDEIESSWTKLRSALTFGSKGSTILITTQSPLVAEIMGTVKPIKLELLE
EDDYWRLFEHCSLGDKEIDLDLRRKLELLGQQIAKKMHGLPLAAKTVGSMLRCRLEEQYWKAIQESEWWE
HDFVVDNILPSLGLSYQHLSSNYKQCFAYTSIFPKGHMFNKERLVQMWIAQGFIQEKTLRGRMTLEDIGS
QIFDELTSRYFFMRTVNDRYVMHDLIRELAVCVSIDECLVLHDEHVKIPATVCHLTLRVVKMNALPELRK
LQKLRTLIFYPEYDSEFLLLPRDGSKEFFKFLEGLLEDMKSLRVIDLSQDRSGINKLPDAICDLPHLRYL
DVSWTKIKQLPKGFPKLYHLQVLNLKRRGTFSILPQGMNRLIKLRHLYADANTVSLIHGIGKLTELQELE
EFHVSNKRGRQIEELKDLRYLRRRLTIQDIQNVESKEEAVGANLDDKENLHELILNRKPDIRSQGDKEKE
ILDGLQPHHNLKSLEIHHYGGMKSPSWLENNQITNLEFVYLNKCARWDTLPPLGKLPFLKNLVFKMMPSI
QRIGREFFGDGDTVFPSLEKLIFDQLNEWEEWSGTDKKSVFPRLFEINIINCVKLRQIPLLPLRSMSVLK
IWNCGDIGTTLPQYLLHLTSLVDLSLENYPHRVSVCLSNLTALKNLELQNCPELILLGGFQSLGNLKLLK
VTKCPKLNESSQPLEEPYVEEGLRSLSYIITDESIINHVWVIVGRAQAVKSLILANCEHLKHFKPELEEW
FQQLTSLQELQFVSCPDLQRLPANLETVFSIRRLIITHCPSIDSLPENGLPISLKELKIYGCRKLKDRCQ
KDDGPDWPKIAMIPHIVIEGEVISGAEEAA


>XP_042460061.1 putative disease resistance protein RGA1 [Zingiber officinale]
MAGVGMSVVEWFATYVMDKLVDFASSRLADPHRDVFSVVDEKLKEMEGRLPRIHAAIHAAEGRPIRDPAL
ASWMRQLKDAAFEADDLLDELDYRQLEARVQDRSKVSAFASSSLRFLKNLFVSDDELRRLKNILGDLDKI
SLEINQRKAELEEYNHARQQNRETSSFSTQEVVFGRDKERDLILEILLSAGDGPDYDDTKRAGSSRHLAN
LDVLPILGIGGVGKTTLAQLVYSDQRVAQHFELRKWVYVSDNFDVKRIAMELETNVTSDSHPFRDASLDA
QLCKLRDATANKRFLFVLDDVWDEIESSWTKLRSALTFGSKGSTILITTQSPLVAEIMGTVKPIKLELLE
EDDYWRLFEHCSLGDKEIDLDLRRKLELLGQQIAKKMHGLPLAAKTVGSMLRCRLEEQYWKAIQESEWWE
HDFVVDNILPSLGLSYQHLSSNYKQCFAYTSIFPKGHMFNKERLVQMWIAQGFIQEKTLRGRMTLEDIGS
QIFDELTSRYFFMRTVNDRYVMHDLIRELAVCVSIDECLVLHDEHVKIPATVCHLTLRVVKMNALPELRK
LQKLRTLIFYPEYDSEFLLLPRDGSKEFFKFLEGLLEDMKSLRVIDLSQDRSGINKLPDAICDLPHLRYL
DVSWTKIKQLPKGFPKLYHLQVLNLKRRGTFSILPQGMNRLIKLRHLYADANTVSLIHGIGKLTELQELE
EFHVSNKRGRQIEELKDLRYLRRRLTIQDIQNVESKEEAVGANLDDKENLHELILNRKPDIRSQGDKEKE
ILDGLQPHHNLKSLEIHHYGGMKSPSWLENNQITNLEFVYLNKCARWDTLPPLGKLPFLKNLVFKMMPSI
QRIGREFFGDGDTVFPSLEKLIFDQLNEWEEWSGTDKKSVFPRLFEINIINCVKLRQIPLLPLRSMSVLK
IWNCGDIGTTLPQYLLHLTSLVDLSLENYPHRVSVCLSNLTALKNLELQNCPELILLGGFQSLGNLKLLK
VTKCPKLNESSQPLEEPYVEEGLRSLSYIITDESIINHVWVIVGRAQAVKSLILANCEHLKHFKPELEEW
FQQLTSLQELQFVSCPDLQRLPANLETVFSIRRLIITHCPSIDSLPENGLPISLKELKIYGCRKLKDRCQ
KDDGPDWPKIAMIPHIVIEGEVISGAEEAA


>XP_042460062.1 putative disease resistance protein RGA1 [Zingiber officinale]
MAGVGMSVVEWFATYVMDKLVDFASSRLADPHRDVFSVVDEKLKEMEGRLPRIHAAIHAAEGRPIRDPAL
ASWMRQLKDAAFEADDLLDELDYRQLEARVQDRSKVSAFASSSLRFLKNLFVSDDELRRLKNILGDLDKI
SLEINQRKAELEEYNHARQQNRETSSFSTQEVVFGRDKERDLILEILLSAGDGPDYDDTKRAGSSRHLAN
LDVLPILGIGGVGKTTLAQLVYSDQRVAQHFELRKWVYVSDNFDVKRIAMELETNVTSDSHPFRDASLDA
QLCKLRDATANKRFLFVLDDVWDEIESSWTKLRSALTFGSKGSTILITTQSPLVAEIMGTVKPIKLELLE
EDDYWRLFEHCSLGDKEIDLDLRRKLELLGQQIAKKMHGLPLAAKTVGSMLRCRLEEQYWKAIQESEWWE
HDFVVDNILPSLGLSYQHLSSNYKQCFAYTSIFPKGHMFNKERLVQMWIAQGFIQEKTLRGRMTLEDIGS
QIFDELTSRYFFMRTVNDRYVMHDLIRELAVCVSIDECLVLHDEHVKIPATVCHLTLRVVKMNALPELRK
LQKLRTLIFYPEYDSEFLLLPRDGSKEFFKFLEGLLEDMKSLRVIDLSQDRSGINKLPDAICDLPHLRYL
DVSWTKIKQLPKGFPKLYHLQVLNLKRRGTFSILPQGMNRLIKLRHLYADANTVSLIHGIGKLTELQELE
EFHVSNKRGRQIEELKDLRYLRRRLTIQDIQNVESKEEAVGANLDDKENLHELILNRKPDIRSQGDKEKE
ILDGLQPHHNLKSLEIHHYGGMKSPSWLENNQITNLEFVYLNKCARWDTLPPLGKLPFLKNLVFKMMPSI
QRIGREFFGDGDTVFPSLEKLIFDQLNEWEEWSGTDKKSVFPRLFEINIINCVKLRQIPLLPLRSMSVLK
IWNCGDIGTTLPQYLLHLTSLVDLSLENYPHRVSVCLSNLTALKNLELQNCPELILLGGFQSLGNLKLLK
VTKCPKLNESSQPLEEPYVEEGLRSLSYIITDESIINHVWVIVGRAQAVKSLILANCEHLKHFKPELEEW
FQQLTSLQELQFVSCPDLQRLPANLETVFSIRRLIITHCPSIDSLPENGLPISLKELKIYGCRKLKDRCQ
KDDGPDWPKIAMIPHIVIEGEVISGAEEAA


>XP_042460363.1 putative disease resistance protein RGA3 [Zingiber officinale]
MEAAAQLRHILMKILPAPEMVAQRKAFRISNHLEMIRDSLWVINSFVMDGSLRALEQPDVAEWMKEVGAA
VEDVHNLLERILDYWKPSNEDAAERKRKMINNFFQSTSSRRSILLELQEIVCTLNYLANRGATFGLWAEM
MDSMDPSHDDYAAIMSEEVMGSHEETVIKLLQEQHHWSQRDMIAIRGDEYFGKTTLARKVYHHPWVRQHF
QRRIWLDASSFNDFNSNMISKEIARLLTRRPYMDLNCWKIVDEHLYRVRYLFIMDNLYSYGASGHKLDEL
VRKLFHWAAPGSKFIFTVYPPYEYETHFFCDTYDDLSPLPDGAWVRLLLKYATFVHPIEGNNNQKVKVSP
AATNMLIQFAKKYSSQNYVQNFLIPKGMGLMFRQRDVSQWQELANELLIRHYPSTSRHFSLMHLHYWSFG
RIRRFLYELLFGGSSVPGYDEDVFHILVAEGTLTYYWHKRNIDFTPLEYGVDLCFFRMEVSGASRIPRQC
RHLYLPINSKNISKFKKAIEVARVARKLRTLVLHREEINEHICQIETKILESMFSSLTSLCTLDMRAIMI
QGLPRAVVTLRCLRYLNLAENKIETLPESICNLYNLCVLNLSNCEKLKELPRRIHELRKLQILKLCYCLR
IQKLPESIICLVNLNELDIRGCCRLSELPDDLSGMKNLMQLNMAGCAALTRMPSGIRRWINLQSLRGIDA
VDGHGNVTLSELHDLRNLESLHIQHLERLELDELKSATLPTYLLKDQDLYELVLHWERWNDMATKGTSNP
MVQLLEGFLRSLRELKVLRIISYMSKRLPTWLMLEPRLIVLKKLKRVELVNLRRCATLPPLGVLPQLEEV
TISGFDSVRVIDDEFYGEDRKPFVFPELRKLTFSEMPRLEMWLGMKSMNRLEKDLGLKSMPRLEKWLGMK
SIRRHGLFAKLEELTLIQCPKLMVFLAQFPTSSQLKLKLWLSNEMLMPTSKFNSWSNLGGINMVQIFGCQ
ELRSLPNDTREIHNLKTLTIMNCNKLEALPIWLEQSCLESLCMYGCRALSFIPEELKVKGRLKNLIVEAC
PKLQSQKYLSHKWNPFS


>XP_042460563.1 disease resistance protein RPS2-like [Zingiber officinale]
MESVSTSCLMDIFNLLKACCSRPCNYIMTYEGTFSSLANEVGQLKDKSVDVKREVEAAERDGLTPRREVL
GWLNSVQNMEDEAKSIEGIYDQKIKCLCSLPFNICSTYRLRNRAEAALETIRELKQSAEFTKLADNLNLT
RSIKIPTTKTIGMDKVFEELQRHAKDDSLSVIGIHGMGGVGKTALLRRFNNDFPSEKEADVVIFLELSID
YKLEEVQKSLFDRLSLTWQDEVTHRDRATKLFRVLSMLKFILLLDNLWEPLNYQVVGIPFPAPPSKCKII
FTTRTEDTWPHGNVVFTFNCDHINNSVEHFLTNEMMLKFNMFCPRVEDRIRQAAWNLFRNSARMDVIDAD
KNIRIEARNLVKECGGLPAALIVLAQAMAPKKTWEEWIHALTIMKDTPHQLPTSLTVRVDDVYFTMHPMT
RAMILWVQRECGKKENKWLVRDRERVEEAPVAKKWRDAERIALVWNQIIDLPETPQCPDLIFLNLQVNKF
LRKIPNGFFLHMPLLKILDLQETSIEELPVSIGNLVQLHYLNLCGTRITSLPKEMTALVNLKYLSLASMK
YLRLIPDQLISSLRELQWLIMMDSYTGWKEVQSCEGGVSFKELESSKRLKAIGITVSTLAALQNLCDSPR
LTAFTHWLHIKGCPNLTSIPSLDFHAETMPRVISIQLHAMSELEEVVIGNRQPILLPLQELRLSSLPKAK
LVWRARFPNTLLALKIEDCRAIDRLIKLEGEANGSGETNYPSLKTIEVKDCPNLKKLTLVANGLKEIKCQ
KSWWEQLNWGDERTKSFEHLYNPMNID


>XP_042460580.1 disease resistance protein RPS2-like [Zingiber officinale]
MESVSTSSVMDILNLLKACCSQSCNYIMTYGGTFSSLASEVGQLKDKSSDVKRDVEAATRDGQTPRSEVL
GWLSSVQDMEGEAESIERKYNQKIKCLCSFPLNVCSAYRLRNRAEAALATIRELKQSAEFTKLADNLNLT
RSIKMPTTKTIGMDKVFEELQRHAKDDSLSVIGIHGMGGVGKTALLRRFNNDFPSETEADVVIFLELSID
YKLEEVQKSLFDRLSLTWQDEVTHRDRATKLFRVLSTLKFILLLDNLWEPLNYQVVGIPLPAPPSKCKII
FTTRTEDTCSHMGTEKMIKMECLEEEAAWNLFRNSARMDVIDADKNVRIEARDLVKECGGLPAALIVLAQ
AMAPKKTWEEWMHALTIMKDTPHQLPGMTNNVFSILKLSYDRLSSDNMRVCASYGALFIKGSWIGKFNIR
NSWIGEGIIDNVQNVMDADHKTQFLLGILHAASLTVRVHDDYFTMHPMTRAMILWVQRECGKKENKWLVR
DRERVEEAPAAEKWRDAERIALVWNQISDLPEAPQCPNLIFLNLQFNKFLRKIPNGFFLHMPPLRILDLQ
QTSIEELPVSIGNLVQLHFLELSRTRITSLPKEMAALVNLKYLSLAFMKYLRIIPDQLISSLRELQWLIM
MDSYSGWKEGQSC


>XP_042460738.1 disease resistance protein RFL1-like [Zingiber officinale]
MACCIKLNLNVDVNRCLSGLWATLQLGRPKFAVKKLEKEMPRLQGKRDDIKNQINEAELEGKIPTNEVKQ
WLREVEILERKAAAIEQDFQSMSCFSCNCFNRTGGTSSKPKEAFAANIQEEETQRAGDDVPITESSNCCS
ISWRAVKTLDEANELMSRAGQLDPIATVGPPEPAVMLPISHRPLVGIESYVEDIVRYVNGGESNIIGIYG
MGGVGKTTMLKRIQQHYLLKHTIFDRVIWVAASKDCQLKRLQMDIAESLGLKTLQESDDERTRGDKLFSY
LKNRNCLLLLDDIWKQVDLQLLGMAHSAAEPGQQKQPRKVVVFTTRSKTVCAQMKPEKTIKVKCSDTGRK
YEDLFFRRNLK


>XP_042460763.1 putative disease resistance protein RGA1 [Zingiber officinale]
MAGVGMSVGDWFATYVMEKLVDFASSRLADAHRDVFSVVDEKLKEMEGRLPRIHAAIHAAEGRPIRDPAL
ASWMRQLKDAAFEADDLLDELDYRQLEARVQDRSKVSAFASSSLRFLKNLFVSDDELRRLKNILGDLDKI
SLEINQRKAELEEYNHARHQSRETSSFSTQEHKESGSSRHLANLDVLPILGIGGVGKTTLAQLVYSDQRV
AQHFELRKWVYVSDNFDVKRIAMELETNVTSDSHPFRDASLDAQLSKLRDATANKRFLFVLDDVWDETES
SWTKLRSALTFGSKGSTILITTQSPLVAEIMGTVKHIKLELLEEDDYWRLFEHCSLGDKEIDLDLRRKLE
LLGQQIAKKMHGLPLAAKTVGSMLRCRLEEQYWKAIQESEWWEHDFVVDNILPSLGLSYQHLSSNYKQCF
AYTSIFPKGHMFNKERLVQMWIAQGFIQEKTLRGRMTLEDIGSQIFDELTSRYFFMRTVNDRYVMHDLIR
ELAVCVSIDECLVLHDEHVKIPATVCHLTLRVVKMNALPELRKLQKMRTLIFYPEYDSEFLLLPRDGSKE
FFKFLEGLLEDMKILRVIDLSQDRSGINKLPDAICDLPHLRYLDVSWTKIKQLPKGFPKLYHLQVLNLKR
RGTFSILPQGMNRLIKLRHLYADANTISLIHGIGKLTELQELEEFHVSNKRGRQIEELKDLRYLRRRLTI
QDIQNVESKEEAVGANLDDKENLHELMLNRKPDIRSQGDKEKEILDGLQPHHNLKSLEIHHYGGMKSPSW
LENNQITNLEFVYLNKCARWDILPPLGKLPFLKNLVFNMMPSIRRIGSEFYGDTDTVFPSLEKLTFNQLN
EWEEWSGTDKKSVFPRLSEIKIQDCVKLRQIPLLPLGSMGNLRIQNCGDISSTLPRYLLHLTSLVDLLLE
NYPHRVSVCLSNLTTLKNLELCNCLELMLLGGFQSLVNLKYLRVSKCPKLNESSQPLEEPYVEEGLRSLS
HLDTDESIINHVWVTVGRTQTVKSLIFTNCEHLKNFEPEQEEWFQQLTSLQELHFVSCPNLQRLPANLET
VFSIRKLTITHCPSIDSLPENGLPILLKELKIYGCRKLKDRCQKDDGPDWPKIALIPYIVIDSEVIQML


>XP_042460881.1 putative disease resistance RPP13-like protein 3, partial [Zingiber officinale]
MSKNYFQCKAWVSVSQKYAVKELLCSIVKQVFDFNDEQVKGMEELEMKEKLSEHLSNRRYLVVMDDIWEV
AAWNAIKAAFPKESTGSRVLLTTRKMNVANVADVPPHELKFWNVEESWNLFCRKAFRTACCPPEFERFKE
DIFKKTKGLPLAIVVLGGVLRGTSQASNWRKKMEHISREFREGEDQILRILALSYHDLPNHLKPCFLYFA
AFPEDYSIWAERIIHLWIAEGFIQTNDKVDQTMEDLAEAYLKDLTDRSMLQIERGRMYYSHQVRIHDLLL
DLARHEARELNFFRTIDDIGDDPRSLRRLSVTENVNDHILLNCSTTKLRSLVTCRNEGFKRMLAVAIPGA
KFLRVLDLQELPIEHLPKEIGDLILLRYLNLERSKLKELPSSIGNLIHLQTFNIFGTKIQHLPDAFWKIR
TLRHVFLTEENTSMPKAAYYCSEDIRTLENISIGPWVCDGVLEKLRNLRALYLKSISSSDEDALANAVQN
LFRLEKLGLVGESLPMSVLTSSSYHHIQFLYLWGPLVRPARIHIEAENSMIFSNLISLFISETRLEKDED
IAMLASLANLEILRLRFGAFVGRVLVFPKGGFPSLQEIELFDLSTLEQWEVGEGAMSFLRELRLLN


>XP_042462483.1 disease resistance protein RGA2-like [Zingiber officinale]
MYTTGVAMMVGDWFAGYTINKLANFVASHVSDHWDVLTDVEEKLKEIQDRLPRIQAVIHEAEGRPIRDPA
LVNWLRQIKEAAYEADDLLDEIEYRQLEDQVQDKGKVSALAASALRFVKNLFVSDDELKRLKNLLGDVDK
IYSEIDRKNVELKEDNAKHTASIRETSSFTQEVVFGRDKERERILEMLLSSGNDANFLNKGAGSSSHASL
GVLPIVGIGGVGKTTLAQIIYNDPRVADHFELRKWVYVSNDFNVKRIARDLEGEMASDSRPGHISLDTQL
SNLSHATAGKRFLFVLDDVWDEAGKNWKELRSALTYGNRGSTILITTQSPLVAEFMGTMDQIELQLLKES
DYWRLFEHCAFGSRVVDSYLRRKLQLIGQQIAKKLHGLPLAGKVLGSLLHTRLEEQYWKMIQESEWWAND
FVLENILPSLGLSYQHLSSNVKQCFAFTAMFPKSHIFDKEQLVQMWIAQGFITPETQHGRMTLEDIGNQI
FDELTCRYFFLHTINERYVIHDLIRELALYISRDECFVIDDEPSKIPSTARHVTVIKTAKLDTLAELTKL
HKVRTLVFYRDYHPEDLFSLGENGSIKFYESLEGILRNLKNLRILDLSYMRIEIKKLPDAICDLSHLRYL
DISGTKIRQLPESFSKIYHLQVLKLKLCWIKKLPAGMNRLIKMRHLHADADTISLVDGIGRLTDLQELDE
FRITRKRGHQIGELKELRDIRRRLVIQNLECVETQEEALEAKLKDKEHLDHLVLNFKEGTRSQGDIQKDI
MEGLEPHYNIKRLTIQHYRGLNSPCWLEKNHLTNLVSISLERCARWEDLPPLGHLPFLMAIYIFKLPVRK
IGAKFYGDARQVFPSLQELTFNTLNEWEELSESDSRTIFPCLRIMRIETCPNLRRIPVLPLISMTHFQIW
NSGDIGNALPDYLLTLTSLICLELRNCAQRASVSLYNLRFLEYLRLLECPELTLIGGLQSLANLKDIIIE
KCPKLIEPAQMPAQAYGEQELRSLSTVWIDDSVLKHVWEILGRIPCIQMLRIQHCNDLSHFNTEQEEWFQ
QLTALNLLEFQHCQKLQKLPSSLGTASSIKILSILDCPNIESLPDNGLPFLLQKLEMYGCTKLKDRCRKD
DGLDWPLISNIPNINIDGELIQMQEQQHQRDWSWFRMDSNREQNSYHEGRPQ


>XP_042462506.1 putative disease resistance RPP13-like protein 1 [Zingiber officinale]
MALATFARVLRLIDSSEASIPPSRTRPAFLSDLSKHMAALKQNLTRIQVAIRGAEERQASDPSAKLWLTE
ITSLAYDAEDVLLDFDDLLPRPQIRSALNHSDSGLLLNSFSSLASISQRIKELGERLVELHGKSEALQLG
EQGGAEGSADARRLRPTGSLMDGESPIFGREKDKENILELLRPSGDEGSIPNKLLVLPIVGMGGLGKTTL
AQQVYADDQIKYFFDLRIWIHVSQDFNLFNLTKAMVESVTGNPCFLSELHSLQSELGKILEGKRFFLVLD
DVWDESSSHWESLQVPLLSANLDSKVLLTTRSHGVARSIGTMPSFNLDPLKDDDAWLLFSENAFHGREPG
ERLVTIGKKIVKECNGVPLTLKALGLHLCNEEREDKWSAILESNIWHLSGSQETILPILMLSYLQLPAPV
KQCFAYCSLFGKGHLFLRHKIVRHWIAQGFVETDGERKAEDVGSEYFYILLARSFFQQCARNKYFIMHDL
IHDLAEYVSGAECFKIDVLQDEDGSRMNVERAYNFPEGVRHTSLTFHSTSTETDLQPLLEANSLRTLMVN
CTSWPPMPHPHANVLNDLFVKLRYLRVLLLDYTFAPAPRLPDSISNLKYLHYLRIGRLSFQGQGFPESVC
SLRNLQTLEWYSDESIELPRGISNLINLRHLHSETYYASFPEGIGRLTKLQELPDFHTSKEHGRARIAEL
KDLVNLQGELKLLNLENVIDVEDSRTADLKGKPGLTALELDWGKHNRSPQNAPLVLQYLQPHTNIQELRI
ANYKHGQLSEWICHPSYSKLVTIKIQYCFLSTVPAFGQLLSLEHLSLVSIKGLEYIGPVFFHGGFPSLKK
LRLSAIYKMVEWSGAEHGHFPHLNELTVTSCPSLRCLPIDNFTSLKRLHISHCSNLQTLYSENSPLVGIQ
QHCSLKNLEVIQCPKLKFLPEYQVPESLQLLDITKSTLLINWYRRIAGKLTHVKNLLGVDLKEVKLDDIF
SVEEARNACLTKQRIYMLHLEWETSSLRSVDDTNCEADEVLEYLQPNVSLNKLVIRGYRGLKLAEWLCSP
LYSNLISIKLDLCPNCKFLPALGQLPYLMELHLERLNGITSIDLSFYGNGSQKGFQSLRRLQLMSMAGLE
EWKGASDGGFPILRQLIVQDCMKLRGLPCLSPSVQEIKVEDCPALTLELPSSLAALLSLHVSNVAAMDEL
CNLSYLSVLAVENCSGCRLIELPSLRSLMINGWSERMLLDSLPGLTALTTLKISCLENLEALPLHNFRIL
EELVVSDCPKLVSIECSSTSTYEPYYVEGLQSLSALKCMVLSGCPELHFSASEQLPASLQSLTISRCPTL
RIWYERYSSKFRTSVVQFAD


>XP_042462812.1 disease resistance protein RGA2-like [Zingiber officinale]
MIGFALTALGWLVENFISALVGKAADRAVQQFGEQHGVEHDLQKLHDSVTHARFTISTIESLRIKDEGLQ
QRLKELLIHLKDAAYDADDLLDEFQYRILKQQIEQQADEAGNRASSSSYSTPPSSKKIKTSFSSYTSGLF
GKGDDDDDDVLRVRKIKGRVDDISVAFEKIYSLLDAEDDRGKKQLMSPASRHTSSFSTEPQLFGRDEELQ
ELKDLLLESEVAFGQSGFSVLTIDGIGGIGKTTLAQEVFNDCSIEEYFKLRIWICVSENFCTDRLTREII
EYTTKEKCNVPNFPALQVVLKEKITPERFLLVLDDVWNEDKHKWESLCAPLRSGKPGSKILVTTRSRKIA
DMVGDVDAIHLEGLDEESFWEFFKKCAFGSSNSGVHQPHLEAMAKKMICKLKGLPLAAKTLGGLLSMKLD
EQYWKSILDSEIWQLPQEENGIMPVLQLSYQYLPSHLKQCFAFCSLFPKDYRFSESELIRIWIAEGFIMP
QGSIRMEELGRNYFHELVNRSFIQKSKDREFIMHDLIHDLAELIYVGESYRIEEGKSHEIPSTIRHLSMH
VEKEGMQARCLSEFSHYNKLRTLMLSVSYICKSFILDCGVLEKLKKIRVLILRNCALEELPDNIGKLIHL
RYLKLSYNYNIRRLPEALCNLYNLQSLILQNCALEELPNSIGKLIHLRYLDLTYNRNIQRLPESLCDLYN
LQTLILWNCALKELPNSIGKLIHLRFLKLYYNYNIRRLPESLCDLYNLQSLILQNCALEELPNSIGKLIH
LRYLDLSGNNNIRRLPQSLCDLYNLQTLVLYSCDNLESLPHDMMKLTNLRKLAGADKFIPGITKVGNLTS
LQNLSLFKVLKDNGHKLAELNGLKQLQGGLCITNLENVENKDEANIANLKSIEHLDSLVLEWTSLQEFDL
DINLHISEQVLEGLQPHHNLQWLTIRGYNGARPPNWLQKQVYSRLETLELQNCKNWNDLSVIGQLSQLKY
LYLGRIPVHTQNLHRLFDPKDCKFFSQLEDLVLEGITMLEDLPNLGQLPCLKSLGIRSLPAVKIIGDRFF
AGAEEDSCFPRLHTLRFDDMPAWEEFFCSNDRNLFLYLDFLDISNCQKLRMLPPLPPSITRLKLNNVGLV
DFPRFWKAIDECSSITNSAFVTELPIQECPNLTSLEQGLLPHHLQQIHIQKCEQLLWVPVKRLKELTSLW
SLSIKECPKLMSMTQDQDIDFQLPPSITQLCLSDCGNLSKSLPGCLHNLTSLRDLEISNCPNLVSLPVEQ
LLNLDSVTIKNCTELRLERLQIKSLQKLKIAGCPKLLLSQGEAQTEKLSLQRLDIDDTAFMKQSLIKNSL
SSVTHLRISSSCEVTMFDREDQESLQSLTSLYSLYFSDCKNLQSLPTKLYTLTSLQFLRIHNCSQIQSLP
EKGLPPALTDLKFEGCHLALEQQLESHLAEIKKSGPYCKIFCQ


>XP_042462829.1 disease resistance protein RGA2-like [Zingiber officinale]
MIGFALTALGWLAESFMVALAGKAVDRAVQQFGEQHGVEDDLKKLKDSLANAMLQISTIENLWLKDEVLQ
QRLKELLIDLKDAAYDADDLFDEFQYRILKQQIEQQGDEAGNRASSSSYSTPPPGKKIKTSLSSYASGLF
GKGDDDDNNNNDVQRMREIKGRLDDNSVALEKIYSSLGTEDDRGKKQLVSSESRQTSSFSIEPQLFGRDK
ELQQLKDLLLKSEVASKFGQSGVSVLSIDGIGGIGKTTLAQEVFNDSSVEEYFKLRIWVCVSENFSTERL
TREITEYTTKEKCNVPNFAALQVVLKEKITQERFLLVLDDVWNEERHKWESLCAPLRFGKPGSKILVTTR
SRSIAGMVGDVDPIHLDRMDEKSFWEFFKKCAFGFSNSGVHDPHLEAMAKKMTCKLKGLPLAAKTLGGLL
SKKLDEQHWKSILDSEIWQLPQEENGIMPALQLSYQYLPPHLKQCFAFCSLFPKDYKFSESELIGIWIAE
GFIVHQGSIRMEELGSNYFHELVNRSFFQKSTTRLRKQGSRSNYFHELVYRRSFFQKLGTKTDRRGRFFI
ESSTDGKFVMHDLIHDLAELISMSESYRVEKGKSHAIPSTIRHLSLHKEEKGTQTRCLTEFSHYNKLRTL
NLSFGYTRESFIFDCGVLEKFKKIRVLDLSHCALRELPDNIGMLIHLRYLDLSWNQKIRRLPESLCNLYN
LQTLILRECINLESLPHGMMKLINLRKLDAMEHVVDKFIHNITEIGKLTSLQNLSTFKVLKDNGHKLAEL
NGLKRLRGKLCITNLENVENKDEASIASLNSKEHLNRLELQWTSLQESDSDDKLHISEQVLEGLQPHHNL
QWLTIRGYNGARPPNWLHEQVYSRLEALQLQNCKNWNDLLVIGQLSQLKHLSLVRIPVQIQNLHNLFNPK
HCKFFSQLEELVLEGITMLEDLPNLGQLPSLKSLDIRSLTGVKMIGDKFFAAIEGGSCFPKLHTLRFNNM
SAWEEFYCSDDRNLFPCLDLLNISNCQKLLMLPRLPPSITCLQLNDVGLEDCPRFWKAIDEGSSITNSAS
VTELSIQECPNLKILEEGLLAHHLQQIYIHKCEQLSSVPVKRLKELTSLWSLSITECPKLTSMTQDECID
FQLPPLITELCLSDCGNISISLPGCLHNLSSLTVLIIGKCSDLVSLPIQPLFNLNRLIIENCNELRSVGG
LLIKSLMDLEITGCPMLQLSQREAQTEKLLLRKLVIDDTAFMQQSPIKNSLSSVEILSISSSCEAVMFEG
EDQESLQSLTSLYQLSFSDCKNLQFLPTKLYTLTSLQVLRILNCPQIQSLPEKGLPPALINLVFRDCHLA
LEQQLLVHLEEIKKSGRCRGITYG


>XP_042462901.1 disease resistance protein RGA2-like [Zingiber officinale]
MIGFALTALGWLAESFMIALVGKAVDRAVQQFGEQHGVEEDLKKLKDSLANAMLQISTIENLWLKDDVLQ
QRLKELLIGLKDAAYDADDLLDEFQYRILKQQSEQQGDEAGNRASSSSYSTPPPGKKIKTSLSSYASGLF
GKGDDDDNNNDVQRMREIKGRLDDNSVALEKIYSSLGTEDDRGKKQLVSSESRQTSSFSIEPQLFGRDKE
LQQLKDLLLKSEVASKFGQSGVSVLSITGIGGIGKTTLAQEVFNDNTVEEYFKLRIWVCVSENFSTERLT
REIIEYTTKEKCNVPNFAALQVVLKEKITQERFLLVLDDVWNEERHKWESLCAPLRFGKPGSKILVTTRS
RSIAGMVGDVDPIHLDRMDEKSFWEFFKKCAFGSSNSGIHHPHLEAMAKKMTYKLKGLPLAAKTLGGLMS
MKLDEQHWKSILDSKIWQLPQEENGVMPALQLSYQYLPSHLKQCFAFCSLFPKDYEFSESKLISIWIAEG
FIVPQGSIKMEELGSNYFHELVNRSFFQKSTTRMVERGSNYFHELVYKWSRFQKLRTTTNSRGRVCFPSS
TDEKFVMHDLIHDLAELISMGESYRVEKGKFHAIPSTIRHLSMYKEEEGMLTRGLTELSHYNKLRTLMLS
SRYTHESFIFDCGVLEKFKKIRVLGLRDCAIRELPNSIGTLIHLRYLDLSYNHKIRRLPESLCDLYNLQT
LILWKCFNLESLPHGMMKLINLRKLDASKYVVDKFIHNITEVGKLTSLQNLSTFKVLKDNGHKLAELNRL
KQLRGKLCITNLENVENKDEANIASLNSKEHLNRLELEWTFSRESGSEVTLQISEQVLEGLQPHHNLQWL
TIRGYNGARPPNWLHEQVYSRLDTLQLQNCKNWNDLLVIGQLSQLKHLCLVRIQVQTQNLHNLFNPKHCK
FFSQLEELVLEGITMLEDLPNLGQLPSLKSLDIRSLTGVKMIGDKFFAAMEEGSCFPKLHTLRFNSMSAW
EEFYCSDDRNLFPCLDLLNISNCQKLLMLPSLPPSITCLQLKNVGLEDCPRFWKAIDGGSSITNSASVIE
LSIQECPNLKILEEGLLAHHLQQIYIHKCEQLSSVPVKRLKELTSLWSLSITECPKLTSMTRDECIDFQL
PPLITELCLYDCGNLSISLPGCLHNLSSLTVLIIGKCSDLVSLPIQPLFNLNRLIIENCNELRSVGVLKK
SLKNLEITGCPMLQLSQREAQTEKLLLRKLVIDDTAFMQQFPIKNSLSSVELLSISSSCEAVMFDGEDQE
SLQSLTSLQQLSFSDCKNLQFLPTKLYTLTSLQVLQIHNCPQIQSLPEKGLPPALINIDFRGCHLALGQQ
LVIHLEEIKKSGRYDGITYV


>XP_042462913.1 disease resistance protein RGA2-like isoform X1 [Zingiber officinale]
MIGFALTALGWLAESFMVALAGKAVDRAVQQFGEQHGVEDDLKKLRDSLANGRLKISTIENLWLKDEVLQ
QRLNELLIGLKDAAYDADDLFDEFQYRILKQQIEQQGDEAGNRASSSSYSTPPPGKKIKTSLSSYASGLF
GKGDDDDNNNDVQRMREIKGRLDDNSVALEKIYSSLGTEDDRGKKQLVSSESRQTSSFSIEPQLFGRDKE
LQQLKDLLLKSEVASKFGQSGVSVLSITGIGGIGKTTLAQEVFHDNTVEEYFKLRIWVCVSENFSTERLT
REIIEYTTKEKCNVPNFAALQVVLKEKITQERFLLVLDDVWNEERHKWESLCAPLRFGKPGSKILVTTRS
RSIAGMVGDADPIHLDRMEEKSFWEFFKKCAFGSSNSDIHYPHLEAMAKKMTYKLKGLPLAAKTLGGLMS
TKLDEQHWKSILDSKIWQLPQEENGIMPALQLSYQYLPPHLKQCFASCSLFPKDYEFSESELISLWIAEG
FIVPQGSIRMEELGSNYFHELVNRSFFQKSTTRLWKQGSQSNYFHELVYRRSFFQKLGTTTDSRGRVFIQ
SSTDEKFVMHDLIHDLAELISMSESYRVEKGKSHAIPSTIRHLSMYKKEEGMQTRGLTEFSHYNKLRTLI
LSSRYTRESFIFDCGVWEKFKKIRVLGLRDCALRELPDSIGTLIHLRYLDLSCNRKIRRLPESLCDLYNL
QTLILQGCFNLESLPRGMMKLINLRKLDGVNHFILNIIEVGKLTSLQNLPTFKVLKDNGYKLVELNGLKQ
LRGELCITNLENVKNKDEASIASLNRKEHLNQLKLEWTFSQESGSEVNLQISEQVLEGLQPHHNLQWLTI
RGYNGARPPNWLHEQVYSRLDTLQLQNCKNWNDLLVIGQLSQLKHLCLVRIPVHTQNLHNLFNPKHCKFF
SQLEELVLEGITMLEDLPNLGQLPSLKSLDIRSLTGVKMIDDKFFAATKEGSCFPKLHTLRFNNMSAWEE
FYCSDDRNLFPCLDLLNISNCQKLLMLPRLPPSITCLQLNNVGLEDCPRFWKAIDEDSSITNSASVTELF
IQECPKLEILEQGLLAHHLQQIYIHKCEQLLWMPVKRLKELTSLWSLSITECPKLMSMTQDECIDFQLPP
LITELCLYDCGNLSISLPGCLHNLTSLSVLIIGKCPALISLPIKPLLNLNYLRIENCNELRSVEVLLIKS
LRDLDVTGCPMLQLSQREAQTEKLLLRKLVIDDTAFMQQSPIKNSLSVEILSISSSCEAVMFEGEDQESL
QSLTSLYQLSFSNCKNLQFLPTKLYTLTSLQVLQIHNCPQIQSLPEKGLPPALINLVFHGCHLALEQQLV
IHLEEIKKSGRYDGITYG


>XP_042462923.1 disease resistance protein RGA2-like isoform X1 [Zingiber officinale]
MIGFALTALGWLAESFMVALAGKAVDRAVQQFGEQHGVEDDLKKLRDSLANGRLKISTIENLWLKDEVLQ
QRLNELLIGLKDAAYDADDLFDEFQYRILKQQIEQQGDEAGNRASSSSYSTPPPGKKIKTSLSSYASGLF
GKGDDDDNNNDVQRMREIKGRLDDNSVALEKIYSSLGTEDDRGKKQLVSSESRQTSSFSIEPQLFGRDKE
LQQLKDLLLKSEVASKFGQSGVSVLSITGIGGIGKTTLAQEVFHDNTVEEYFKLRIWVCVSENFSTERLT
REIIEYTTKEKCNVPNFAALQVVLKEKITQERFLLVLDDVWNEERHKWESLCAPLRFGKPGSKILVTTRS
RSIAGMVGDADPIHLDRMEEKSFWEFFKKCAFGSSNSDIHYPHLEAMAKKMTYKLKGLPLAAKTLGGLMS
TKLDEQHWKSILDSKIWQLPQEENGIMPALQLSYQYLPPHLKQCFASCSLFPKDYEFSESELISLWIAEG
FIVPQGSIRMEELGSNYFHELVNRSFFQKSTTRLWKQGSQSNYFHELVYRRSFFQKLGTTTDSRGRVFIQ
SSTDEKFVMHDLIHDLAELISMSESYRVEKGKSHAIPSTIRHLSMYKKEEGMQTRGLTEFSHYNKLRTLI
LSSRYTRESFIFDCGVWEKFKKIRVLGLRDCALRELPDSIGTLIHLRYLDLSCNRKIRRLPESLCDLYNL
QTLILQGCFNLESLPRGMMKLINLRKLDGVNHFILNIIEVGKLTSLQNLPTFKVLKDNGYKLVELNGLKQ
LRGELCITNLENVKNKDEASIASLNRKEHLNQLKLEWTFSQESGSEVNLQISEQVLEGLQPHHNLQWLTI
RGYNGARPPNWLHEQVYSRLDTLQLQNCKNWNDLLVIGQLSQLKHLCLVRIPVHTQNLHNLFNPKHCKFF
SQLEELVLEGITMLEDLPNLGQLPSLKSLDIRSLTGVKMIDDKFFAATKEGSCFPKLHTLRFNNMSAWEE
FYCSDDRNLFPCLDLLNISNCQKLLMLPRLPPSITCLQLNNVGLEDCPRFWKAIDEDSSITNSASVTELF
IQECPKLEILEQGLLAHHLQQIYIHKCEQLLWMPVKRLKELTSLWSLSITECPKLMSMTQDECIDFQLPP
LITELCLYDCGNLSISLPGCLHNLTSLSVLIIGKCPALISLPIKPLLNLNYLRIENCNELRSVEVLLIKS
LRDLDVTGCPMLQLSQREAQTEKLLLRKLVIDDTAFMQQSPIKNSLSVEILSISSSCEAVMFEGEDQESL
QSLTSLYQLSFSNCKNLQFLPTKLYTLTSLQVLQIHNCPQIQSLPEKGLPPALINLVFHGCHLALEQQLV
IHLEEIKKSGRYDGITYG


>XP_042462931.1 disease resistance protein RGA2-like isoform X1 [Zingiber officinale]
MIGFALTALGWLAESFMVALAGKAVDRAVQQFGEQHGVEDDLKKLRDSLANGRLKISTIENLWLKDEVLQ
QRLNELLIGLKDAAYDADDLFDEFQYRILKQQIEQQGDEAGNRASSSSYSTPPPGKKIKTSLSSYASGLF
GKGDDDDNNNDVQRMREIKGRLDDNSVALEKIYSSLGTEDDRGKKQLVSSESRQTSSFSIEPQLFGRDKE
LQQLKDLLLKSEVASKFGQSGVSVLSITGIGGIGKTTLAQEVFHDNTVEEYFKLRIWVCVSENFSTERLT
REIIEYTTKEKCNVPNFAALQVVLKEKITQERFLLVLDDVWNEERHKWESLCAPLRFGKPGSKILVTTRS
RSIAGMVGDADPIHLDRMEEKSFWEFFKKCAFGSSNSDIHYPHLEAMAKKMTYKLKGLPLAAKTLGGLMS
TKLDEQHWKSILDSKIWQLPQEENGIMPALQLSYQYLPPHLKQCFASCSLFPKDYEFSESELISLWIAEG
FIVPQGSIRMEELGSNYFHELVNRSFFQKSTTRLWKQGSQSNYFHELVYRRSFFQKLGTTTDSRGRVFIQ
SSTDEKFVMHDLIHDLAELISMSESYRVEKGKSHAIPSTIRHLSMYKKEEGMQTRGLTEFSHYNKLRTLI
LSSRYTRESFIFDCGVWEKFKKIRVLGLRDCALRELPDSIGTLIHLRYLDLSCNRKIRRLPESLCDLYNL
QTLILQGCFNLESLPRGMMKLINLRKLDGVNHFILNIIEVGKLTSLQNLPTFKVLKDNGYKLVELNGLKQ
LRGELCITNLENVKNKDEASIASLNRKEHLNQLKLEWTFSQESGSEVNLQISEQVLEGLQPHHNLQWLTI
RGYNGARPPNWLHEQVYSRLDTLQLQNCKNWNDLLVIGQLSQLKHLCLVRIPVHTQNLHNLFNPKHCKFF
SQLEELVLEGITMLEDLPNLGQLPSLKSLDIRSLTGVKMIDDKFFAATKEGSCFPKLHTLRFNNMSAWEE
FYCSDDRNLFPCLDLLNISNCQKLLMLPRLPPSITCLQLNNVGLEDCPRFWKAIDEDSSITNSASVTELF
IQECPKLEILEQGLLAHHLQQIYIHKCEQLLWMPVKRLKELTSLWSLSITECPKLMSMTQDECIDFQLPP
LITELCLYDCGNLSISLPGCLHNLTSLSVLIIGKCPALISLPIKPLLNLNYLRIENCNELRSVEVLLIKS
LRDLDVTGCPMLQLSQREAQTEKLLLRKLVIDDTAFMQQSPIKNSLSVEILSISSSCEAVMFEGEDQESL
QSLTSLYQLSFSNCKNLQFLPTKLYTLTSLQVLQIHNCPQIQSLPEKGLPPALINLVFHGCHLALEQQLV
IHLEEIKKSGRYDGITYG


>XP_042462938.1 disease resistance protein RGA2-like isoform X2 [Zingiber officinale]
MIGFALTALGWLAESFMVALAGKAVDRAVQQFGEQHGVEDDLKKLRDSLANGRLKISTIENLWLKDEVLQ
QRLNELLIGLKDAAYDADDLFDEFQYRILKQQIEQQGDEAGNRASSSSYSTPPPGKKIKTSLSSYASGLF
GKGDDDDNNNDVQRMREIKGRLDDNSVALEKIYSSLGTEDDRGKKQLVSSESRQTSSFSIEPQLFGRDKE
LQQLKDLLLKSEVASKFGQSGVSVLSITGIGGIGKTTLAQEVFHDNTVEEYFKLRIWVCVSENFSTERLT
REIIEYTTKEKCNVPNFAALQVVLKEKITQERFLLVLDDVWNEERHKWESLCAPLRFGKPGSKILVTTRS
RSIAGMVGDADPIHLDRMEEKSFWEFFKKCAFGSSNSDIHYPHLEAMAKKMTYKLKGLPLAAKTLGGLMS
TKLDEQHWKSILDSKIWQLPQEENGIMPALQLSYQYLPPHLKQCFASCSLFPKDYEFSESELISLWIAEG
FIVPQGSIRMEELGSNYFHELVNRSFFQKSTTRLWKQGSQSNYFHELVYRRSFFQKLGTTTDSRGRVFIQ
SSTDEKFVMHDLIHDLAELISMSESYRVEKGKSHAIPSTIRHLSMYKKEEGMQTRGLTEFSHYNKLRTLI
LSSRYTRESFIFDCGVWEKFKKIRVLGLRDCALRELPDSIGMF


>XP_042463327.1 uncharacterized protein LOC122046615 [Zingiber officinale]
MDKSASHSSEPCTSTLTIRIAGPSSEIGEKSVPISPSISLSPHLNSPSPPSSAFVSALQSPYISPRALEP
PNGNNSYSTTATMPSTTTSNSALHSDDIPSTSYTPPSESSDFVADQIEQKHKFSDAMLPRISFSFPVPRT
SLTRGSVSPPSNLKLHGCDVYIGYNGNNHVLVRFCKWLKTELELQGIASFVADRAKYSDSQSHEIADRII
CSASFGVIVVTPSSFLNRLSVEEIRFFAQKKNLISVLFDTELSEIVSLSNERLEGKESREALEGFTKCNE
FKIETNGSNWRSCISKVVAILKSRLGRRSIAEVETETFEELPFPRNGHFVGREKEVAEIEAAFFGCVEAH
EMECPKPSLTRGSSSDGFADEEIDTVRTSKKYISLEMRKSKEPTLEAWIEPVIELPSKGRSLQKQRSKHK
KSRCGANKGHGNASVFCVNGSWGIGKTELALEFAYRYAQRYRMVLWIGGETKYLRQNILNLSLKLGLDLS
AEAEKERGRIRSFDEQEFDAFLRVKRELFRDIPYLLVIDNLETEKEWWEGKDLHDLIPRNTGATHVIITT
RLSKVMSFEPMQLPLLSLADSLLLLKGRRKKDYTSEDSQVLKKIVERMERLSFGMSVVGSLLSELPISPS
ELLETIDRISVNDGNEDGLWRSSSFLMKTLAFCFAVVDQAAGRSLASRMAQTGAWFASVPVSSTLLAAAS
NNLPTKGSFCQWGKDLTDVFLCGTRCCLATSQARKTEVDSAMLLVNLGLAKRSLRQPGCWIQLHPITQVF
AKRKGGLPPAKAAVHGAMRAGNAAMNLDHLWASAFLVFGFKQEPPLVQLSALDMAFFIRKTALPLAIRSF
MTFSRCNSTLELLKVCTNALEEAEKSFVSQIQDWHRGRLCWTKKLQFNQKVDEYVWQDVTLLKATLLETR
AKLLLRGGHFDEGEELCRTCVSIRTVMLGHNHAQTLAAQETLAKLVRFRRKM


>XP_042464445.1 putative disease resistance protein RGA1 [Zingiber officinale]
MAVSLTVVGGWVAQAFIQTLIDKASDTAIQLFAERRGFAADMKKLRTSLLETRIILDKVQSSGSNSTKWK
TLMRDLKDAAYDAEDLIDEFQYHLLRQKIKGEEEDKASGSSGLSNIFSAAKKRLFASSYSLGEDDIRARV
REIQERLEGIAISVKDIMKVLPPNDQPEVKFQARESCSSPVTDILFGRDKELNQVVDWLLGSASQVKPAS
GFVNDTFSVLPIVGIGGVGKTTLAQYVHKDNRVQDHFHLKIWVCVSDNFSVQRLTKSIIESVTLKKEYDN
IELEPLQKILHQHIAKKKFLLFLDDVWSDDKSIWEKFCALLKVGEHGSKIIVTTRDMKVSKMVSPAEPIL
LHDLDEDAFWKLFKKCSFGTLNPEDYPELEDIGRKIARKLKGSPLAAKTLGSVLQLDLRKQHWATIMKSD
IWKVKQDEDSIMPALHLSYQYLNENLKQCFAFCSVFTKDTSYHKAHLVPMWMAEGFIEDNNTKRMEDVGN
DYFLEFVNRSFFQEFKHGFYPYMMHDLIHDLAEMIAEEETCKIQSNEQTKKLPSTVRHLLVEKRKVPLEL
SGYDKLRTLLLKNSPPDSLFEKLRSIRVLDLSFCGLLELSGHIGKLIHLRFLDLSYNTEIKFLPDSLCDL
YHLQTLRARNCFSMESIPQELHKLVNLRHIDADEKIWLMIKDVWRLTNLQELLTFSVREGDALKLGQLKD
MTQFHGTLHIQNLENVVDSKEAQHAELKNKVHLQELVLKWNDEKDAKLEEEVIEGLQPHESLEILKINGY
NGGRSPSWLMPKVLSILKKLELVNCKRWDDDLPFIGQRLHLIELLMDNMPALKRLSHEFEGKCFPKLEML
KLFNLPAFEEWFWTDGKDLFPCMRELVVINCPKLKRLPPFPPSLETLIIRGCPELILNNETADDEECDRL
LPPSLKVLELSDSGEYAKLLPDCLHNLCLVTRLTISHCPHITSIPLVQLVELRWLFINYCDELTRMESLG
LLKSLELLQIIGCPKLVQLNVEDEQAGSLSSLRKLCVDNTAVLKMFPLRNSLSFIIELEIAACSGEVIFE
EAMQSLTAVTSLIFYNCKKLQSLPTELLHSLPYLEELTVANCPQIHSLPDIGLLPSLRMLTIDNCPQIHS
LPEKGLPTLLECLNICDCPQIHEMPDQEGFPKSLYVFRCIGDVHPTLKEQSQKFYTDRNMRERALKLE


>XP_042464484.1 disease resistance protein RGA2-like isoform X1 [Zingiber officinale]
MAFLLTAGGWFAPFFIQNLVDKASNKAIQLFAEGQGFEEDMDKLCTSLLKTQIILDEVQSSGSNSTKWKT
LMQELKDAAYDAEDLIDEFQYHVFKKKIKDEEKYEASGSIGLPNILSRAKKKLFGSSYYMRERVRRIQGK
LERIANSMESIKNVLPRNDKGMQPEVKFQARESCSSPVTDILFGRDKELNQVVDWLLGSASQVELESGFA
NDTFSVLPIVGIGGAGKTTLAQYVHRDDRVQDHFHLKIWICVPDNFTVQGLTKSIIESVTLQKQYDSMRL
EPLQKILQQHIAKKKFLLFLDDMWSDEKSIWENFCALLKVGAHGSKIIVTTRDMKVSKMVSLVEPILLHG
LDEDAFWQLFNKCSFGTLNPKDYPELENIGRKIAHRLKGSPLAAKTLGRVLQSNLCQQHWATVMESDIWK
VKQDEDSIMPALHLSYQYLNENLKQCFAFCSLFPKDYEFNKDKLIQMWMAEGFIEDKNTNRMEDVGSDYF
LEFVNRSFFEEFGNYGLYHFVMHDLIHDLAEMIAAEETCRIKSNERRKMLATVRHLRVEERILPLEFSGF
DKLRTLVLRNSPPNSLFGKLRSIRVLDVSRCHFRELSKHIDKLIHLRYLDLSYNSEIKILPNSLGDLYNL
QTLKVKGCSKLESIPQELGKLVNLRHIDANCKFWVLMKDVRRLTNLQELPTFRVQEDDAHKLGQLKDMTQ
LHGTLNIQNLENVVDSKEAHHAELKNKVHLKELELEWNDEKDAKLEEEVIEGLQPHESLKKLRIRGYNGA
KSPSWLMPKVLSNLEKLDLVDCKGWDDVLPFIGQRLHLIKLYMINMPALKQLSHEFEGKCFPKLEVLYLF
DLPALEEWSWTEGRDLFPCMRKLCVQICPKLKRLPPFPPSLEKLTIVRCPKLILNSKTEVDEEGGRHFPP
SLKVLELINCGEYAKLLPDCLHNLCLVTRLEIGHCPHITSIPLVQLVELQYLNISNCDELRRMECLGLLI
SLKKLKIVGCPKLVQLDVEDERAQSLSSLLKLCVDNTDLLKMFPLRNSLSFITKLQIESCSEEVIFIEPI
LVRSLTAVTSLRFIDCDKLQSLPTELLHCLPFLEKLVMYHCPQLQSLPEKGILPSLRILKIDDCPRIQSL
SEKGLPPLLEELNIFDCPQIRAMPEDGLPMSLIFFHCFGDVHPTLKEQSEKFYADRKRRVSTLDASYFHV


>XP_042464494.1 disease resistance protein RGA2-like isoform X2 [Zingiber officinale]
MAFLLTAGGWFAPFFIQNLVDKASNKAIQLFAEGQGFEEDMDKLCTSLLKTQIILDEVQSSGSNSTKWKT
LMQELKDAAYDAEDLIDEFQYHVFKKKIKDEEKYEASGSIGLPNILSRAKKKLFGSSYYMRERVRRIQGK
LERIANSMESIKNVLPRNDKGMQPEVKFQARESCSSPVTDILFGRDKELNQVVDWLLGSASQVELESGFA
NDTFSVLPIVGIGGAGKTTLAQYVHRDDRVQDHFHLKIWICVPDNFTVQGLTKSIIESVTLQKQYDSMRL
EPLQKILQQHIAKKKFLLFLDDMWSDEKSIWENFCALLKVGAHGSKIIVTTRDMKVSKMVSLVEPILLHG
LDEDAFWQLFNKCSFGTLNPKDYPELENIGRKIAHRLKGSPLAAKTLGRVLQSNLCQQHWATVMESDIWK
VKQDEDSIMPALHLSYQYLNENLKQCFAFCSLFPKDYEFNKDKLIQMWMAEGFIEDKNTNRMEDVGSDYF
LEFVNRSFFEEFGNYGLYHFVMHDLIHDLAEMIAAEETCRIKSNERRKMLATVRHLRVEERILPLEFSGF
DKLRTLVLRNSPPNSLFGKLRSIRVLDVSRCHFRELSKHIDKLIHLRYLDLSYNSEIKILPNSLGDLYNL
QTLKVKGCSKLESIPQELGKLVNLRHIDANCKFWVLMKDVRRLTNLQELPTFRVQEDDAHKLGQLKDMTQ
LHGTLNIQNLENVVDSKEAHHAELKNKVHLKELELEWNDEKDAKLEEEVIEGLQPHESLKKLRIRGYNGA
KSPSWLMPKVLSNLEKLDLVDCKGWDDVLPFIGQRLHLIKLYMINMPALKQLSHEFEGKCFPKLEVLYLF
DLPALEEWSWTEGRDLFPCMRKLCVQICPKLKRLPPFPPSLEKLTIVRCPKLILNSKTEVDEEGGRHFPP
SLKVLELINCGEYAKLLPDCLHNLCLVTRLEIGHCPHITSIPLVQLVELQYLNISNCDELRRMECLGLLI
SLKKLKIVGCPKLVQLDVEDERAQSLSSLLKLCVDNTDLLKMFPLRNSLSFITKLQIESCSEEVIFIEPI
LVRSLTAVTSLRFIDCDKLQSLPTELLHCLPFLEKLVMYHCPQLQSLPEKGILPSLRILKIDDCPRIQSL
SEKGLPPLLEELNIFDCPQIRAMPEDGLPMSLIFFHCFGDVHPTLKEQSEKFYADRKRRLTTARLELE


>XP_042464508.1 putative disease resistance protein RGA1 [Zingiber officinale]
MALSLTVGGWLAQAFIQTLIDKASDKAIQLFAERRGFAEDMKKLRTSLLQTQITLDEVQSSRSNNIKWKT
LMQELKDASYDAEDLIDEFQYNILRQKIKGEEEDKASGSSGLLSILPAAKKLFGSSYDMRARVREIQERL
ETSMKSIVNLPATHDRRKQPEVKFQARESCSSPMADKLIGREKELNQVVDWLLGSANQVEPASGFVNDTF
SVLPIVGIGGAGKTTLAQYAHKDNRIQDHFHLKIWVCVSDNFTVQGLTKSIIESVTLQKQDENMGLEPLQ
KILHQHIAKKKFLLVLDDVWSDDKSIWEKFCALLKVGSHGSKIIVTTRDMKVSKMVSLTEPILLHGLDAD
AFWQLFMKCSFGTLNPEDYPGLEDIGRKIARKLKGSPLAAKTIGRVLRSNVCQQHWATIMESDIWKVKQD
EDDIMPALQLSYQYLDENLKQCFAFCSLFPKDHKFDKVELIRMWMAEGFINEDKNTKSMEDVGSDYFLEF
VNSSFFQEFRYHYEFGDGFGIRIVMHDLIHDLAEMISAEETCRIENSRHTKPPSTTRHLRVEKEKLPLEF
SGYNKLRTLVSKLSLPDSSLFEILRSIRVLDVSWCGLLELSEHIGKLIHLRYLDISGNSKVKILPDSLCD
LYNLQTLKAECCSELESIPQELGKLVNLRHFDISSNFKIKILPDSLCDLYNLQTLKVNSCSELESIPQEL
GKLVNLRQIDADGEFWVMLKDVRRLTNLQELPIFSVQEDDAFKLGQLKDLTQLHGTLCIQNLENVVDGKE
AQRAKLKSKVHLKELVLDWNLRWYGGKDAKLDEEVIEGLQPHESLKILTIRRYNGGRSPSWLMPKVLSNL
EKLELENCMEWDDVLPFIGQRLHLIELRMTDMPALKRLSHEFEGKCFPKLQVLKLCKFKALREWSCTEGK
DLFPCLRELCVIDCPKLKRLPPFPPSLEMLTIECCPRLILNSKTEDDEEGGRHLPPSLKELKLTDCGEYA
KLLSDCLHNLTRLEINDCLYIPSISLVQLVELQCLCISDCDELRRIECLGLLKSLKELKIVECPKLVQLD
VGDEQAGSLSSLRKLCVDNTALLKMFPLRNSLPFITELEIESCSEEVIFVEPIWVPSLAAVTSLTLRNCK
KLQYLPTELLHGLPLLENLIMKNCPQIKSLPDKGLPPRLQRLQIYGCPHIQLQAIPENLLPIIPFM


>XP_042464516.1 putative disease resistance protein RGA1 [Zingiber officinale]
MALSLTVGGWLAQAFIQTLIDKASDKAIQLFAERRGFAEDMKKLRTSLLQTQITLDEVQSSRSNNIKWKT
LMQELKDASYDAEDLIDEFQYNILRQKIKGEEEDKASGSSGLLSILPAAKKLFGSSYDMRARVREIQERL
ETSMKSIVNLPATHDRRKQPEVKFQARESCSSPMADKLIGREKELNQVVDWLLGSANQVEPASGFVNDTF
SVLPIVGIGGAGKTTLAQYAHKDNRIQDHFHLKIWVCVSDNFTVQGLTKSIIESVTLQKQDENMGLEPLQ
KILHQHIAKKKFLLVLDDVWSDDKSIWEKFCALLKVGSHGSKIIVTTRDMKVSKMVSLTEPILLHGLDAD
AFWQLFMKCSFGTLNPEDYPGLEDIGRKIARKLKGSPLAAKTIGRVLRSNVCQQHWATIMESDIWKVKQD
EDDIMPALQLSYQYLDENLKQCFAFCSLFPKDHKFDKVELIRMWMAEGFINEDKNTKSMEDVGSDYFLEF
VNSSFFQEFRYHYEFGDGFGIRIVMHDLIHDLAEMISAEETCRIENSRHTKPPSTTRHLRVEKEKLPLEF
SGYNKLRTLVSKLSLPDSSLFEILRSIRVLDVSWCGLLELSEHIGKLIHLRYLDISGNSKVKILPDSLCD
LYNLQTLKAECCSELESIPQELGKLVNLRHFDISSNFKIKILPDSLCDLYNLQTLKVNSCSELESIPQEL
GKLVNLRQIDADGEFWVMLKDVRRLTNLQELPIFSVQEDDAFKLGQLKDLTQLHGTLCIQNLENVVDGKE
AQRAKLKSKVHLKELVLDWNLRWYGGKDAKLDEEVIEGLQPHESLKILTIRRYNGGRSPSWLMPKVLSNL
EKLELENCMEWDDVLPFIGQRLHLIELRMTDMPALKRLSHEFEGKCFPKLQVLKLCKFKALREWSCTEGK
DLFPCLRELCVIDCPKLKRLPPFPPSLEMLTIECCPRLILNSKTEDDEEGGRHLPPSLKELKLTDCGEYA
KLLSDCLHNLTRLEINDCLYIPSISLVQLVELQCLCISDCDELRRIECLGLLKSLKELKIVECPKLVQLD
VGDEQAGSLSSLRKLCVDNTALLKMFPLRNSLPFITELEIESCSEEVIFVEPIWVPSLAAVTSLTLRNCK
KLQYLPTELLHGLPLLENLIMKNCPQIKSLPDKGLPPRLQRLQIYGCPHIQLQAIPENLLPIIPFM


>XP_042464619.1 probable disease resistance protein At1g61300 [Zingiber officinale]
MAFIKLNFNVDVHKCLSGLKATLGLGRPKSSIDKLEKEMERLRAKRDDIRNQIVEAVLEGKVPTNEVNRW
LDEVEELEGKVTAINQDFQSMSCFSCNCFNQTGGATNQTRQVGDQVPIRESSNCYSINRRAAEKLNEANE
LMSRTNALDPIAITTIPSRIGSDIQETMARLRAKRDDIENQIKQAEREGKIPTNEVSQWLLEVEKLDGQV
ATINQVPIRESSSHHSIRAKKCNEINELMIRADVLDPIATVGPPKPIVTLPIVYRSHVGIGSYVEEIVGY
IDGGKDNIIGIHGMGGVGKTTVLKSIQHHYLLKHTIFDPVIWVVASKDCQLKRLQMDIAKSLGLKTLQES
DDEQTCSDKLFSYLKNKKCLLFLDDIWEHVDLQLLGMAHSATDQGQQQQRKVVVFTTRNLIVCAQMEAEK
KIKIECLNPAQAWQLFVKNFKSDAPFSDAGIYSVAQELVKECAGLPLALITVARAMLGNKSRDVWNHALH
QIRNKHQWTTIGLSEDSTVMYKAFKLSYDSLKNDSIRECLLCCALWPEDHDIHKFEELIPCWIGCGIIHN
DIVFPPYSINDAFQQGCLHLEALINASLLEHSSRRPDYYEAQHVKMHDVIRDMTLLTLKGNKRKWIVKAG
IGLRHLPRQEEWQEIERASFMDNEITSLQDYGASTFPKLSMLNLHSNHLSEIHPMLFTNMPRLTYLNLSL
NLGIEELPKEIGCLTELQYLNLSETSITNLPAEFGRLGKLKYLFLRDTKLETVPNGTISNLSMLKFLDIR
EIYPSHEWWWDELEHFRRRPKYLSLGITIDPDKLKRLDTLPYNVFVRSLTVRGLGSSKLPEYNLGTLQWN
HKASGWVESLEISDVPGDELTMTEDWNRMLEFNCLKTLCFRTLEQLENVRFNQVEVGYKFKNLRDLYICG
CNKLKDVSWVLHLPYLNLLDIKNCEEIEELISNLGNSNSISPIRMLSLNGMRNLHRFAHQPFQFPALEYI
RVLYCPRLKKLPFEAKMLEKMEGEKEWWNNCNWDEESNDFPTCFRLKEIEGEKDWWNNLDWDDESIKDSL
TPYFREVFY


>XP_042464694.1 disease resistance protein RGA2-like [Zingiber officinale]
MSKVSNLDKTKTNTLPTVTNCSYPIYLLTDACRVDRVGLAISKQAKRLVPLGDRYRHDPGTRPTTDLKEE
QRFALFCNQVAVSLTVGGWLAQAFIQTLIDKASDKAIQLFAERRGFAEDMKKLHTSLLQTQITLDEVQSS
RSNNIKWKTLMQELKDASYDAEDLIDEFQYNILRQKIKGEEEDKASGSSGLLSILPAAKKLFGSSYDERA
RVREIQGRLETSMKSIVNLPATHDRGKQPEVKFQARESCSSPVADKLIGREKELNQVVEWLLGSANQVEP
AYGFVNDTFSILPIVGIGGAGKTTLVQYAHKDNRVQDHFHLKIWVCVSDNFTVQGLTKSIIESVTLQKQD
ENMGLEPLQKILHQHIVKKKFLLVLDDVWSDDKSIWEKFCALLKVGAHGSKIIVTTRGMKVSKMVSLAEP
ILLHGLDEDAFWQLFNECSFGTLNPEDYPGLEDIGRKIARKLKGSPLAAKTIGRVLRSNICQQQWATVME
SDIWKVKQDEDDIMPALQLSYQYLDENLKHCFAFCSLFPKDHKFDKTELVRMWMAEGFINEDKNTKSMED
VGSDYFLEFVNNSFFQESDIIMNFGMDLGLEL


>XP_042464828.1 putative disease resistance protein RGA1 [Zingiber officinale]
MAVSLTVVGGWFAQAFIQTLIDKASDKAIQLFAERRGFAADMETLCTSLLETQIILDKVQSSQSNDTKWK
TLMQKLKDAAYDAEDLIDEFQYHVLRQKINGEEEDKAVSGSGGLPNIFSAAKEKLFGSSHSLEEEAMRAS
VVEIQGRLERIANSMKSIMNVLPPNDRGKQPDQMKFQSRESCSSPVTDILFGRDKELNQVVDWLLGSANQ
VEPASGFLNDALSVLPIVGIGGAGKTTLAQYAHKDNRVQEHFQLKIWVCVSDNFTVQRLTKSMIESVTLK
KEYDNMELESLQKILHQHIAQKKFLLVLDDLWSDNKRIWEKFCALLKVGAYGSKIIVTTRDMKISKMVSM
VEPILLHGLDEDTFWQLFKKCSFGTLNPEEYPELEDIGRKIVRKLKGSPLAAKTLGGVLQSNLCQQHWAT
VMESDIWKVKQDEDDIMPALHLSYQYLNENMKQCFAFCSVFPKDYRFGKAELVRMWMAEGFIKDKNTKRM
EDVGSDYFLEFVNKSFFQEYEFGAFVMHDLEYEFGAFVMHDLIHDLAEMISAEETCRIKNNRQTKMLSTI
RHLRVEEEEKLPLEFSGYDKLHTLLLRTNSPPDNLFEKLRSIRILDVSWCDLEELSEHIGKLIHLRYLDI
SWNSKIKILPDSLCDLYNLQTLKVNGCSKLESIPQELGKLVNLRHIDAGYEFWNMIKLDVHRLTNLQELP
TFSVREDDELKLGRLKDLTQLHGTLRIQNLENVVDSKEAQRAGLKSKVHLKKLVLEWNYWKLHGGKDAIL
DEEVIEGLQPHESLKMLKIRGYNGGRSPSWLMPKVLSNLEKLELVNCKGWDDVLPFIGQRLHLIELRMED
MPALKQLSHEFSGKCFPKLKVLNLLNLPALEEWSWTEGKDLFPCMRELRVRDCPKLNRLPSFPPSLEKLK
ISWCPSLIFNSKMKDDEEGGCYLPPAVKVLELDNCGEYSKLLLECLSNLHLVTRLTIRHCPHITSIPPVQ
LVELQYLYISKCDELRRMECLGLLKSLERLKIVGCPKLVQLDVEDEQAARLLSSLRYLCVDNTALLKMFP
LRNSLSFITELEIESCPEEMIFEEPILVRSLTAVTSLSFNCCDKLQSLPTELLHCLPFLKKLMVSNCPQL
QSLPEIGLSPFLKTLEICNCPQIQPMPEDGLPMSLDVFHCSGNAHPTLMKHYKKFHADRCR


>XP_042464837.1 putative disease resistance protein RGA1 [Zingiber officinale]
MAVSLTVVGGWFAQAFIQTLIDKASDKGMQLFAERRGFTADMDKLRISLLETQIILDEVQISRSNNTKWK
RLMQELKDAAYDAEDLIDEFQYHFLRKKVKGEEDDKESGSSGLPDIFSAAKEKLFGSSHSLEEDAMRASV
VEIQGRLERIANSMKSIMNVLPPNDRGKQPDQVKFQTRESCSSPVTDILFGRDKELNQVVDWLLESANQV
EPASGFLNDALSVLPIVGIGGAGKTTLAQYAHKDNRVQNHFHLKIWVCVSNNFTVQGLAKSIIESVTLQK
QYDNMGLESLQKILHQHIAQKKFLLVLDDVWSDNKRIWEIFCALLKVGAYGSKIIVTTRDMKVSKMVSLA
EPILLDGLDKDAFWQLFKKCSFGTLNPEDYPELEDIGRKISHKLKGSPLAAKTLGSVLQSDLCQQHWAII
MESDIWKVKQDEDDIMPALHLSYQYLNENLKQCFAFCSLFPKDYRFYKAELIQMWMAEGFIEDKNTKKME
DVGSDYFLEFVNRSFFQEFRYDYEFEDEFVMHDLIHDLAEMISTEEIYRIENNRQTKPPSTTRHLRVEEE
KLPLEFSGYNKLRTLMLRKNLPTDSLFEKLRSIRVLDVSWCDLQELSEHIGKLIHLRYVDISYNFKIKIL
PGSLCDLYNLQTLKVICCPELQFIPQELGKLVNLRHIVADDEFWVMIKDVRKLTNLQELQRFSVEEDDRL
KLGQLKDLTQLHGTLCIQNLENVVDSKEAQHAELKNKVHLKQLELDWNDEKDAKLEEEVIEALQPHESVK
ILKVEGYNGGRSPSWLMPKVLPNLEKLELVNCNGWDDVLPFIGQRLHLIELIMYSMPALKQLSHEFEGKC
FPKLKVLNLWNLPALEEWSWTEGKDLFPCMRKLLVSNCPKLKRLPPFPPSLEILEIKKCPNLILNSKTED
EEEVDRHALPSLKVLELANSGEYAKLLTDFLHNLRLVTRLNIRDCPYITSIPQAQLLELQYLSISNCVEL
RRMECLGLLKSLKELRIVGCPKLVQLDVGDEQAGRLSSLRKLYVDNTALLKMFPLRNSLSFITELKIESC
SEEVIFEELILARSLTAVTSLSFSYCKKLQSLPTKLLHSFPLLENLMVYCCPQLQSLPEIGLSPLLKKLE
ICHCPQIQAMPEDGLPMSLDVFKCSGYVHPTLMEQSEKFNAKREMRRASTLDARYFHDIEVV


>XP_042464849.1 putative disease resistance protein RGA1 [Zingiber officinale]
MAVSLTVVGGWFAQAFIQTLIDKASDKSIQLFAERRGFAADMDKLRISLLETQIILDEVQISRSNNTKWK
RLMQELKDAAYDAEDLIDEFQYHVLRQKVKGEEENKASGSSGLPNIFSVAKEKLFGSSHSLEEDAMRASV
VEIQGRLERIANSMKSIMNVLPSNDRGKQPDQVKFQARESCSSPVTDILFGRDKELNQVVDWLLGSANQV
EPASEFVTDTFSVLPIVGIGGAGKTTLAQYAHKHNRVQVHFHLKIWVCVSDNFTVQGLAKSVIQSVTPQK
QYDSMGLEPLQKLLHEHIANKKFLLVLDDVWSDNKSIWHKFCALLKVGAHGSKIIVTTRDMKVSKMVSLV
EPILLHGLDEDAFWQLFKKCSFGTLDPTDYPELEDIGRKIARKLKGSPLAAKTLGSVLKSDLCQQHWDTI
MKSDIWKVKQDEDDIMPALHLSYQYLNENLKQCFSFCSVFPKDYVFEEAELVRMWMAEGFIEDKNTKRME
DVGSDYFLEFVNRSFFQEFKFGGFVMHDLIHDLAEMISAEDTCSIEIKRQTNTLSIVRHLRVEGKLPLEF
FGYDKLHTLLLRTKSPPDSIFEKLRSIRVLDVSWCDLQELSEHISKLIHLRYLDISWNSEIKILPNSLCD
LYNLQTLKIQGCDELKSVPQELSKLANLRHIYADPKFWKMIKDVRKLTNLQELSIFRVQEDDGLKLGQLK
DMTQLHGTLGICNLENVVDSTEAQQAELKNKVRLNKLVLEWNDKKDAKLEEEVIEGLQPHESLKILKIEG
YNGGRSPSWLMPKVLSNLEELELANCKGWDDVLPFIGQRLHLIELRMTNMPALKRLSHEFEGKCFPKLKV
LELSYFPALREWSWTEGKDLFPCMRELRVCLCPKLKRLPPFPPSLEILRIEDCPKLILNSRTEDDGEGGC
YLPPSLKVLELDNCGEYSKLLPECLPNLRLVTRLTIRHCPHKTSIPLVQLDVEDEQAASFLSSLRYLCVD
NTALLKMFPLRNSLPFITELEINSCSEEVIFEEEILVRSLPAVTSLSFCFCDALQSLPTELLHSFPFLEE
LKIHNCPQLQSLPDIGLSPFLKTLRICYCPQIPAIPEAGLPQSLEIFDCFGNVHPTLKEQSQKFYADRYD
IGEQGWN


>XP_042464861.1 putative disease resistance protein RGA1 [Zingiber officinale]
MAVALTVGGWFAQAFIQTLIDKASDKSIQLFAQRRGFAEDMENLHPSLLEIQIILDEVQISRSNNTKWKT
LMQELKDAAYDAEDLIDEFQYHVLRQKIKGEEEDKVAGGSSGLSNMFYAAKKKLLGSSHSLEEDDTRARV
RKMQGRLEKIANRMKSIMNVLPPHDRRKQPEVKFQARESCSSPATDIMFGRDKELNQVVDWLLESANQVE
PASAFVNDTFSVLPIVGIGGAGKTTLAQYAHKHNRVQVHFHLKIWVCVSDNFTVQGLAKSIIQSVAPQKQ
YDNMGLEPLQKLLHEHIADKKFLLVLDDVWSDNKSIWHKLCALLKVGAHGSKIIVTTRDVKVSKMVSLVE
PILLHGLDEDAFWQLFKKCSFGTLNPGDYPELEDIGRKIARKLKGSPLAAKTLGSVLQSDLRQQHWDTIM
KSDIWKVKQDEEDIMHVLHLSYEYLNENMKQCFAFCSVFPKDYKFDKAVLVQMWIAEGFIEDKNTKRMED
VGSDYFLEFVNRSFFQEFGYGLFVMHDLIHDLAEMISAEETCRIENNRQTKMLSTIRHLRVEEEGKLPLE
FSGYDKLHTLMLRKNSPPNSLFEKLRSIRVLDVSWCGLQELSEHIGKLIHLRYLDISWNSEIKILPDSLF
DLYNLQTLKVEGCSKLEYIPQELSKLVNLRCIDADDMFLVMVKDVRRLTNLQELPTFSVQEDDGLKLEQL
KDMTQLHGTLHIQNLENVVDSTEAQQAELKNKVRLNKLVLEWNDEKDAKLEEEVIEGLQPHKSLKILKIK
GYNGGRSPSWLMPKVLSNLEKLYLVNCKGWDDVLPFIGQRLHLIELHMDGMPALKQLSHEFEGKCFPKLE
VLYLYELPALEEWSWTEGKDLFPCMRELRVSYCHKLKRLPPFPPSLEMLTIECCPRLKLNSRTEDDEEGG
CHLPPSLKGLKISQWPHITSISLVQSVELQYLYISKCDELRWMECLGVLKSLKQLNIVGCPKLVQLDVED
EQSASLLPSLRYLCVDNTALLKMFPLRNSLPFITELVFVSCSEEVIFEEPILVRSLTAVTSLSFIGCEKL
QSLPAKLLHCLPFLKTLMVYNCPQLQSLPEIGLSPFLKTLDICDCPQIQAMPEDGLPMSLDDFQCSGDVH
PNLKEQSDKFFVDTYNKRKARLELE


>XP_042464870.1 putative disease resistance protein RGA1 [Zingiber officinale]
MAVALTVGGWFAQAFIQTLIDKASDKSIQLFAQRRGFAEDMENLHPSLLEIQIILDEVQISRSNNTKWKT
LMQELKDAAYDAEDLIDEFQYHVLRQKIKGEEEDKVAGGSSGLSNMFYAAKKKLLGSSHSLEEDDTRARV
RKMQGRLEKIANRMKSIMNVLPPHDRRKQPEVKFQARESCSSPATDIMFGRDKELNQVVDWLLESANQVE
PASAFVNDTFSVLPIVGIGGAGKTTLAQYAHKHNRVQVHFHLKIWVCVSDNFTVQGLAKSIIQSVAPQKQ
YDNMGLEPLQKLLHEHIADKKFLLVLDDVWSDNKSIWHKLCALLKVGAHGSKIIVTTRDVKVSKMVSLVE
PILLHGLDEDAFWQLFKKCSFGTLNPGDYPELEDIGRKIARKLKGSPLAAKTLGSVLQSDLRQQHWDTIM
KSDIWKVKQDEEDIMHVLHLSYEYLNENMKQCFAFCSVFPKDYKFDKAVLVQMWIAEGFIEDKNTKRMED
VGSDYFLEFVNRSFFQEFGYGLFVMHDLIHDLAEMISAEETCRIENNRQTKMLSTIRHLRVEEEGKLPLE
FSGYDKLHTLMLRKNSPPNSLFEKLRSIRVLDVSWCGLQELSEHIGKLIHLRYLDISWNSEIKILPDSLF
DLYNLQTLKVEGCSKLEYIPQELSKLVNLRCIDADDMFLVMVKDVRRLTNLQELPTFSVQEDDGLKLEQL
KDMTQLHGTLHIQNLENVVDSTEAQQAELKNKVRLNKLVLEWNDEKDAKLEEEVIEGLQPHKSLKILKIK
GYNGGRSPSWLMPKVLSNLEKLYLVNCKGWDDVLPFIGQRLHLIELHMDGMPALKQLSHEFEGKCFPKLE
VLYLYELPALEEWSWTEGKDLFPCMRELRVSYCHKLKRLPPFPPSLEMLTIECCPRLKLNSRTEDDEEGG
CHLPPSLKGLKISQWPHITSISLVQSVELQYLYISKCDELRWMECLGVLKSLKQLNIVGCPKLVQLDVED
EQSASLLPSLRYLCVDNTALLKMFPLRNSLPFITELVFVSCSEEVIFEEPILVRSLTAVTSLSFIGCEKL
QSLPAKLLHCLPFLKTLMVYNCPQLQSLPEIGLSPFLKTLDICDCPQIQAMPEDGLPMSLDDFQCSGDVH
PNLKEQSDKFFVDTYNKRKARLELE


>XP_042464878.1 putative disease resistance protein RGA1 [Zingiber officinale]
MAVALTVGGWFAQAFIQTLIDKASDKSIQLFAQRRGFAEDMENLHPSLLEIQIILDEVQISRSNNTKWKT
LMQELKDAAYDAEDLIDEFQYHVLRQKIKGEEEDKVAGGSSGLSNMFYAAKKKLLGSSHSLEEDDTRARV
RKMQGRLEKIANRMKSIMNVLPPHDRRKQPEVKFQARESCSSPATDIMFGRDKELNQVVDWLLESANQVE
PASAFVNDTFSVLPIVGIGGAGKTTLAQYAHKHNRVQVHFHLKIWVCVSDNFTVQGLAKSIIQSVAPQKQ
YDNMGLEPLQKLLHEHIADKKFLLVLDDVWSDNKSIWHKLCALLKVGAHGSKIIVTTRDVKVSKMVSLVE
PILLHGLDEDAFWQLFKKCSFGTLNPGDYPELEDIGRKIARKLKGSPLAAKTLGSVLQSDLRQQHWDTIM
KSDIWKVKQDEEDIMHVLHLSYEYLNENMKQCFAFCSVFPKDYKFDKAVLVQMWIAEGFIEDKNTKRMED
VGSDYFLEFVNRSFFQEFGYGLFVMHDLIHDLAEMISAEETCRIENNRQTKMLSTIRHLRVEEEGKLPLE
FSGYDKLHTLMLRKNSPPNSLFEKLRSIRVLDVSWCGLQELSEHIGKLIHLRYLDISWNSEIKILPDSLF
DLYNLQTLKVEGCSKLEYIPQELSKLVNLRCIDADDMFLVMVKDVRRLTNLQELPTFSVQEDDGLKLEQL
KDMTQLHGTLHIQNLENVVDSTEAQQAELKNKVRLNKLVLEWNDEKDAKLEEEVIEGLQPHKSLKILKIK
GYNGGRSPSWLMPKVLSNLEKLYLVNCKGWDDVLPFIGQRLHLIELHMDGMPALKQLSHEFEGKCFPKLE
VLYLYELPALEEWSWTEGKDLFPCMRELRVSYCHKLKRLPPFPPSLEMLTIECCPRLKLNSRTEDDEEGG
CHLPPSLKGLKISQWPHITSISLVQSVELQYLYISKCDELRWMECLGVLKSLKQLNIVGCPKLVQLDVED
EQSASLLPSLRYLCVDNTALLKMFPLRNSLPFITELVFVSCSEEVIFEEPILVRSLTAVTSLSFIGCEKL
QSLPAKLLHCLPFLKTLMVYNCPQLQSLPEIGLSPFLKTLDICDCPQIQAMPEDGLPMSLDDFQCSGDVH
PNLKEQSDKFFVDTYNKRKARLELE


>XP_042464916.1 putative disease resistance protein At3g14460 [Zingiber officinale]
MAVALTVGGWFAQAFIQTLIDKASDKSIQLFAQRRGFAEDMENLHPSLLEIQIILDEVQSSGCNDTKWKT
LIQELKDAAYDAEDLIDEFQYHVLRQKIKGEEEDKVATGSSGLSNMFYAAKKRLLGSSHSLEEDDTRARV
RKMQGRLEKIANRMKSIMNVLPPNDRRKQPEVKFQARESCSSPATDKMFGRDKELNQVVDWLLGSANQVE
LASGFVNNTFSVLPIVGIGGAGKTTLAQYAHKDNRVQEHFHLKIWVCVSNNFTVQRLTKSMIESVTLKKE
YDNMELECLQKILHQHIAQKKFLLFLDDVWSDNKNIWHKFCALLKVGAHGSKIIVTTRDMKVSKMVSLVE
PILLHGLDEVAFRQLFNKCSFGTLDPEDYPELQDSGRNIADKLKGSPLAAKTLGSVLQSDLCQQHWDTIM
KSDIWKVKQDEDDIMPALHLSYQYLNENLKQCFSFCSVFPKDYVFEEAELVRMWMAEGFIEDKNTKRMED
VGSDYFLEFVNRSFFQKFKFGGFVMHDLIHDLAEMISAEDTCSIEKKRQTKTLSTVRHLRVEGKLPLEFF
GYDKLRTWMLRKTSPPNSLFEKLRSIRVLNVSQCGMQELSEHIGKLIHLRYLDISFNYEIKILPDSLCDL
YNLQTLKAQQCIAMESVPQELCKLVNLRCIDADDMFLVMIKDVRRLTNLQELPTFSVQEDEGLKLVQLKD
LTQLHGSLHIQNLENVVDSKEAQDAELKNKVHLKELVLEWNDEKDAKLEEEVIEGLQPHESVKILKIEGY
NGGRSPSWLMPKVLPNLEKLELVNCMGWDDVLPFIGQRLHLIELSMEDMPALKQLSHQFEGKCFPKLEVL
YLFDLPALEEWSWTEGKDLFPCMRVLRVIDCPKLKRLPPFPPSLEILAIEHCPSLILNSKTEDDEEADGH
LPPSLKELELRDCGKYEKLLLDCLHNLRLVTRLEINDFPHITSISLVHLVELQYLCITNCEELRWMECLG
LLKSLKKLKIVGCPKLVQLDVEDEQSASLLSSLHTLCVDNIALLKMFPLRNSLSFITELLFVSCSEEVIF
EEAILVRSLTAVTSLSFLRCDKLRSLPAELLHCLPFLKTLMVSNCPQLQSLPEMGLSPFLERLEIYNCPQ
IQAMPEDGLPMSLDVFICSGDVYPKLTEKSEKFFVDRYNRRVKLELVWNKNLDGSINYNKKDLVL


>XP_042464937.1 putative disease resistance protein RGA1 [Zingiber officinale]
MAVPLTVVGGWFAQAFIQTLIDKASDKAIQLFAESRGFAEDMENLHPSLLEIQIILDEVQSRGCNDTKWK
TLIQELKDAAYDAEDLIDEFQYHALRQKIKGEEEDKAASGSSGLSNMFYAAKIKLLGSSHSLEEDDMRAR
VRKMQGRLERIANRMKSIINVLPRNDRRKQPNQMKFQTRESCSSPVTDVLFGRDKELNQVVDWLLGLANQ
VELASGFFSNTFSVLPIVGIGGVGKTTLAQYAYKDIRVQDHFHLKIWVCVSDDFTVQGLTKSIIQSVTPQ
KQYDNMGLEPLQKLLHEHIENKKFLLVLDDVWSDNKSIWETFCALLKVGAHGSKIIVTTRDMQVSKMVSL
AEPILLHGLDEDAFWQLFKKCSFGTLSPEDYPGLEDIGRKIARKLKGSPLAAKTIGRVLQSNICQQHWAT
IMESDIWKVKQNEDDIMPALQLSYQYLDENLKQCFAFCSFFPKDYKFDKAELIQMWMAEGFIEDTKRMEE
VESDYFLEFVNRSFFQESEYDQFVMHDLIHDLAEMISAEEICRIKSNEQTKMLSTIRHLRVEEGKLPLEF
SGYNKLRTLSLVNSPPDSLFEKLRSIRVLDVSWCDLLELSEHIGKLIHLRYLDLSYNFKVKNLPDSLCDL
YNLQTLKVNGCSKLESLPQELGKLVNLRHIVAEYWVMTKDAWKLANLQDLPTFSVQEGDGFNLVQLKDLT
QLHGSLHIRNLENVVDSKEAQHAELKNKVHLKELVLEWNHRKDAKLEEEVIEDLQPHESLKILKIEGYHG
GRSPSWLMPKVLSKLEKLELVNCKGWDDVLPFIGPRLHLIELRIYHMFALKQLSHEFEGKCFPKLKVLDL
WNLRALEEWSWTEGKDLFPCMRELRVRDCPKLKRLPPFPPSLEILTIQHCPELKLNSKTENDEEGGCHLP
PSLKGLELSYCGEYSKLLPDCLHNLCLITSLEISHCPHITSISLVQLVELQYLDISDCVELRLMECLGHL
KSLKELKIVGCPELRWMECLGLLNSLEELRIVGCPKLVQLDVEDEQAGGLSSLRKLCVDNTALLKMFPLR
NSLSFITELEIESSSEEVIFEEAILMRSLTAVTSLKFFNCEKLQSLPTELLHNFPFLERLEMCDCPQLQS
LPEIGLSPFLKELHIYDCPQIQAMPELGLPKSLDDFYCFGNVHPTLKEQSQKFNI


>XP_042464948.1 putative disease resistance protein RGA1 [Zingiber officinale]
MAVALTVGGWFAQAFIQTLIDKASDKSIQLFAQRRGFAEDMENLHPSLLEIQIILDEVQSSGCNDTKWKT
LIQELKDAAYDAEDLIDEFQYHVLRQKIKGEEEDKVATGSSGLSNMFYAAKKRLLGSSHSLEEDDTRARV
RKMQGRLEKIANRMKSIMNVLPPNDRRKQPEVKFQARESCSSPATDKMFGRDKELNQVVDWLLGSANQVE
LASGFVNNTFSVLPIVGIGGAGKTTLAQYAHKDNRVQEHFHLKIWVCVSNNFTVQRLSKSMIESVTLKKE
YDNMELECLQKILHQHIAQKKFLLFLDDVWSDNKNIWHKFCALIKVGAHGSKIIVTTRDMKVSKMVSLVE
PILLHGLDEVAFRQLFNKCSFGTLDPEDYPELQDSGRNIADKLKGSPLAAKTLGSVLQSDLCQQHWDTIM
KSDIWKVKQDEDDIMPALHLSYQYLNENLKQCFSFCSVFPKDYVFEEAELVRMWMAEGFIEDKNTKRMED
VGSDYFLEFVNRSFFQKFKFGGFVMHDLIHDLAEMISAEDTCSIEKKRQTKMLSTIRHLRVKEGKLPLEF
SGYDKLRTLMLRKNSPPNSLFEKLRSIRVLDVSRCDLQELSEHIGKLIHLRYLDLSSNYEIKILPDSFCH
LHNLQTLEILGCHKLESIPQELGKKMVNLRHINADNKFWVMIKDVRRLTNLQELPTFSVQEDDGLKLVQL
KDLTQLHGTLHIQNLENVVDSKEAQDAELKNKVHLKGLGLEWNDEKDAKLEEEVIEALLPHESLKRLKIE
GYNGGRSPSWLMPKVLSNLEKLYLANCKGWDDVLPFIGQRLHLIELCMERMPSLKQLSHEFEGKCFPKLK
VLYLWSLPALEEWSWTEGKNLFPCLRELRVNDCPKLKR


>XP_042465415.1 probable disease resistance protein At1g61300 [Zingiber officinale]
MACINININIDVNRCLSELRTLLKLLLRPKSGIQKLEKEMAILRGKRDDIMNQIDLAEREGQIPTHEWIL
WLHKMEELEGQVAAIEQDFQSMSCFSCHCFNRAGGTSSQTQQAKSSNFYSIIRRMANTLDEANELMSLTG
ALVPIAGFWPWRFTTRLPIPHLPPVGIESYLDDIVGYINGGEGSTIGIYGMGGVGKTTILMSIQQHYYLL
EDTIFDRVIWVVASHCQLKRLQMDIAMSLGLKTLKESDDEQTCGDKLFSYLKNKSCLLLLDDIWEHLDLQ
LSGMTHLATEQSQQQQQQQKQPRKVVVFTTRSETMCAQMNAEKKIKVECLNPDQAWQLFEQNSDGDVLSS
DAQIKLAAKELVKECGGLPLALITTAKAMSGKKSWEVWYDTLYMIRDKHESIPIGLPKESLPMYKSFKLR
YDSLENDLIRECLLCCVLWPKDYDIHKFDELIPCWIGCGIINKFNVINEAFHEGCCHLETLIAASLLEDS
RRQNYYKAEHVKMPNTIRDMALLMVSELKGNGRKWIVKAGIELSHLPRQEERQEAERASFMRNNITSLQD
YEASTLSKLCILILHGNHLSKIPPTLLTNMPLLTYLSLSRNFGIEELPKEIGSLTKLQYLNLSSTDIKSL
PLEFGRLKKLEYLLLRNTRIKTIPNEIMSNLSMLKWLDIGGYFPVCDSWLNELKCLREEHHKISLGITIN
PAIFEILNMLPNVSVWNLTVSGSESSKFSVHNLGTLKWSHRISDNLECLTILDVPGDELAINAGVDYESS
FGCLKTLYFRRLGKLKNIRWNGVGFNNLHDLYISDCYMLKDVSWVLQLPCLDFLRISNCWEMEELISNVG
NFNSSFGIKMLILFQMNNLHRISHQPLHFPNLKNINVCHCPRLKKLPFGTGILRSGLKEIIGDQTWWDSL
VWDDNSNRDSLTTLFRNQLD


>XP_042465420.1 probable disease resistance protein At1g61300 isoform X1 [Zingiber officinale]
MACIKLNLNVDVNSCLSGLKATLRLGRPKSGIEKLKKEMKNLRDKRDDIKNRIDQAELEGKIPTYQVSQW
LLDVETLEGQVAAIEQDFQSTSCFSCHCFNQTQTQTQTGGTSQTQQAGDQVPIRESSNCCSIILRVAKKL
GEVKELMDRADRLDPVATVRPSEPTVMIPISHRSPVGIESYEEDIVGYVDGGKGDIIGIYGMGGVGKTTI
LKRIQQHYHLNHAIFDRVIWVVASKDCQLKRLQMDIAKSLGLKTLQESDDERTCGDKLFTFLKSRNCLLL
LDDIWEHLDLQLLGMAHSATTERGQQQQPRKTVVFTTRSEAVCVQMKAEKKIKVKCLDPVQAWRLFEENS
EKDVLNSDAGIKFVAEKLAKECAGLPLALVTVARAMSGKKSWEAWNGALRQIRDEHQWKTVCLPEDSVVM
YKAFKLSYDSLENDSIRECLLCCALWPEDWQINQFYNLIPCWIGCGLICEFNVINEAFDKGYSYLEALMA
ASLLEECIPMRRSVHWDPCVKMHDVIRDMALLMVSGLEGNKRKWIVKAGIGLSDLPRQEEWQEAERASFM
RNNITSFQEYGTSTFPKLSMLILCHNKGPKTIPSSLLSSMPRLTYLGLNGCGIRELPMEICSLTELQYLD
LSYNPITSLPAKFGCLSKLEYLLLSDTDLKIVPKGTISNLLILRWLDITEIPLVPECWWDELKYFKGRHQ
LSLGINIDATTDNIKQLNMLPNVSIWKLTLDGSNISKHEQVTDLGTQQWGCRVSDHLEFLCFYFLKLDKL
VLATGVGRESNFGCLKSLYFEDLEQLEEISLNGVRLYNLRKIYIDTCRMLKDVSWVLELPCLNFLEIIYC
EEMKELISEVGNSNSISSSSIQRLILSRMPNLNRIANQPLHFPYFEYIQVHRCPKLKKLPFMAEILKSRL
KCIEGEEDWWNNLVWDDENIKDSLTPYFRFN


>XP_042465421.1 probable disease resistance protein At4g14610 isoform X2 [Zingiber officinale]
MACIKLNLNVDVNSCLSGLKATLRLGRPKSGIEKLKKEMKNLRDKRDDIKNRIDQAELEGKIPTYQVSQW
LLDVETLEGQVAAIEQDFQSTSCFSCHCFNQTQTQTQTGGTSQTQQAGDQVPIRESSNCCSIILRVAKKL
GEVKELMDRADRLDPVATVRPSEPTVMIPISHRSPVGIESYEEDIVGYVDGGKGDIIGIYGMGGVGKTTI
LKRIQQHYHLNHAIFDRVIWVVASKDCQLKRLQMDIAKSLGLKTLQESDDERTCGDKLFTFLKSRNCLLL
LDDIWEHLDLQLLGMAHSATTERGQQQQPRKTVVFTTRSEAVCVQMKAEKKIKVKCLDPVQAWRLFEENS
EKDVLNSDAGIKFVAEKLAKECAGLPLALVTVARAMSGKKSWEAWNGALRQIRDEHQWKTVCLPEDSVVM
YKAFKLSYDSLENDSIRECLLCCALWPEDWQINQFYNLIPCWIGCGLICEFNVINEAFDKGYSYLEALMA
ASLLEECIPMRRSVHWDPCVKMHDVIRDMALLMVSGLEGNKRKWIVKAGIGLSDLPRQEEWQEAERASFM
RNNITSFQEYGTSTFPKLSMLILCHNKGPKTIPSSLLSSMPRLTYLGLNGCGIRELPMEICSLTELQYLD
LSYNPITSLPAKFGCLSKLEYLLLSDTDLKIVPKGTISNLLILRWLDITEIPLVPECWWDELKYFKGRHQ
LSLGINIDATTDNIKQLNMLPNVSIWKLTLDGSNISKHEQVTDLGTQQWGCRAWVANQILDV


>XP_042465422.1 probable disease resistance protein At1g61300 isoform X1 [Zingiber officinale]
MACINLNLDVDVNNCLSGLRASLPVLGRPKSGIQKLEKEMARLRGERDDIKNQIDQADRQGKIPTNKVSQ
WLREVEELEAQVAAINQDFQSMSCFSCNCFNQTGGTSGQTQQAGDQVPIRESSNCCSINRRAKEKLGKAN
ELMSQTDALDPITTVGPPEPTMMLSISHRSPVGIESYVEGIVSYIDGGEGNIISIYGMGGVGKTTMLKRI
QRHYHHNHAIFDRVIWVVASKDCQLKKLQIDIARSLNLYTLEENDDEQICGVKLCSFLKNKNCLLLLDDI
WERLDLQLLGMAHSGTEQGQQQHQQPRKVVVFTTRSETVCAQMKAEKKFKVRCLDSEQAWQLFVQNSDGD
VLGSDPGIMFVAKELVQECAGLPLALVTVARAMSGRRSWEAWNDALHQIRDKHEWTTIALPEDSVMYKAF
KLSYDNLENDSVRECLLCCTLWPEDYEIDKLSELIPCWIGCGIIHEYNVINEAFAKGYSHLEALGAASLL
EKCDSDKVVKMHDVIRDMALLLISGLEGNKRKWIVKAGIRLSDLPRQEEWQEAERASFIWNQITSLQEYE
ASTFPKLSMLILHGNKNLKTIPSSLFASMPRLTYLDLSDCYITELPMMIGTLTELQYLNLSKNPITRLPL
EFGCLGKLEYLLLRATCLKIVPNGTISNLSMLKWLDIRQTPLVPEWWWDELKCFKGRHQLSVGININATT
GSIDRLNMLSPNVSIWELTLDGNYISELSNDDMGTPQWGCRVSDNLEYLNIMHLVLDRLILAAGVGRESS
FGCLKRLQFCFLKLLKEISLNRVRLYNLREVVFRECHELKDVSWVLQLPCLKFLEINYCEKMKELISEVG
NSNSISSSSSSSSIQRLILCGMLNLNRIANIPLHFPYLEYIAVYECPRFQKLPFGAEILNNKLKMIKGEK
NWWNNLKWDDESIKDSLTPCFRSYDDDF


>XP_042465423.1 probable disease resistance protein At4g14610 isoform X2 [Zingiber officinale]
MACINLNLDVDVNNCLSGLRASLPVLGRPKSGIQKLEKEMARLRGERDDIKNQIDQADRQGKIPTNKVSQ
WLREVEELEAQVAAINQDFQSMSCFSCNCFNQTGGTSGQTQQAGDQVPIRESSNCCSINRRAKEKLGKAN
ELMSQTDALDPITTVGPPEPTMMLSISHRSPVGIESYVEGIVSYIDGGEGNIISIYGMGGVGKTTMLKRI
QRHYHHNHAIFDRVIWVVASKDCQLKKLQIDIARSLNLYTLEENDDEQICGVKLCSFLKNKNCLLLLDDI
WERLDLQLLGMAHSGTEQGQQQHQQPRKVVVFTTRSETVCAQMKAEKKFKVRCLDSEQAWQLFVQNSDGD
VLGSDPGIMFVAKELVQECAGLPLALVTVARAMSGRRSWEAWNDALHQIRDKHEWTTIALPEDSVMYKAF
KLSYDNLENDSVRECLLCCTLWPEDYEIDKLSELIPCWIGCGIIHEYNVINEAFAKGYSHLEALGAASLL
EKCDSDKVVKMHDVIRDMALLLISGLEGNKRKWIVKAGIRLSDLPRQEEWQEAERASFIWNQITSLQEYE
ASTFPKLSMLILHGNKNLKTIPSSLFASMPRLTYLDLSDCYITELPMMIGTLTELQYLNLSKNPITRLPL
EFGCLGKLEYLLLRATCLKIVPNGTISNLSMLKWLDIRQTPLVPEWWWDELKCFKGRHQLSVGININATT
GSIDRLNMLSPNVSIWELTLDGNYISELSNDDMGTPQWGCRVL


>XP_042465424.1 probable disease resistance protein At1g61300 [Zingiber officinale]
MACIKLNLNVDVNSCLSGLWASLPVLGRPKSGIQKLEKEMARLRGKRDDIKNQIEEADRQGKIPTNQVSQ
WLREVEELEAQVAAIKQDFQSMSCFSCNCFNQTGGTSSQTQQAGDQVSIGESSNFCSIIRRVAKKLCEAT
ELMSRAGALDPIATVGPPEPTVMLPIAHQPPVGIESYVEDIVGYINGGEGNIIGIFGMGGVGKTTMLKRI
QQHYHLNHSIFDRVIWVVASKDCQLKRLQIDIAKSLNLHTLEENDDEQTCGVKLCSFLKNKNCLLLLDDI
WERLYLQLLGMAHSGTEQGQQQHQQPRKVVVFTTRSETMCAQMKAEKKMKVNCLDSDQAWQLFVQNSDGD
VLGSDAGIKFVAEKLAKECAGLPLALVTVARSMSGKRSWEAWNDALHQIRDKHEWTTIALPEDSLVMYKA
FKLSYDSLENDSVRECLLCCALWPEDYEIFKSSELIPCWIGSGIIREFNVINEAFAKGYSHLEALGAASL
LEKCDSDKVVKMHDVIRDMALLMVSGLKGNKRKWMVKAGIGLSDLPRQEEWQEAERASFMMNNITSLQEY
EASTFPKLSMLILHHNHSPITIPPSLFASMPHLTYLDLDGCGITELPREICSLTKLQYLNLSFNPITRLP
AEFGCLVKLECLLLMDAGLEIVPNGTISNLSMLKWLNIASTYPVTEWWCDELKCFKGRHQLSVGITINAT
TDNIERLNMLPPNVSIWQLILDGENISKLPNYDLGIPQWSCRVSDKLEILCISNLRLDRLVLAAGVGGES
SLGCLKRLGFHFLILLEEISLNRVRLNNLRELSICGCPMLNDVSWVLQLPCINFLYISMCRKMKEVISEV
GNSNSISSSTIRRLILWSMPNLNHIANRSLHFPYLEYIRVDECPELKKLPFGAEILKNRLKVIKGEEDWW
NNLDWDDENIKDSLTPYFRPLI


>XP_042465425.1 probable disease resistance protein At1g61300 isoform X1 [Zingiber officinale]
MACINLNLDVDVNSCLSGLWASLPVLGRPKSGIQKLEKEMARLRGKRDDIKNQIDQADRQGKIPTNEVSQ
WLREVEELEGQVAAIKQDFQSMSQYAPLYTFCFSFSCQFNCPALCFNAYTTTTYVLYCFVFSLGCFSCNC
FNQTGGTSSQTQQAGDQVSIGESSNFCSIIRRVAKKLGEATELTSRAGALDPIATVGPPEPTVMLPIAHQ
PTVGIESYVEDIVGYINGGEGNIIGIFGMGGVGKTTILESIQQYYLHDHTIFDHVIWVVASKGCQLKKLQ
NDIAKSLKLDTLEKNDDERTCGDKLFSYLKDKNCLLLLDDIWERLDLQLLGMAHSATERGQQQQKHPRKV
VVLTTRSETVCAQMKAEKKIKVRCLDSEQAWQLFEQNSDGDVLSSDAGIKFIAEELAKECAGLPLALVTV
ARAMSGKRSWEVWNDAFNQIRDKHEWTTVCLPEDSLVMYKAFKLSYDSLENDSIRECLLCCALWPEDYEI
NQFSELIPCLIGCGIIREFNVINEAFAQGCSHLEALMATSLLEKCNNINPPYEDTLVKMHDVIRDMALLM
VSSLERNKRKWIVKAGIGLHDLPRQEEWQQAERVSFMSNQITSLQEYGASTFLKLSMLILHDNMGLETIP
SSLLKSMPHLTYLDLSFCGITELPMEIGSLTELQYLDLSYSSIAKLPAELGCLCKLEYLLLSSMYLKIVP
NGTISNLLMLKWLDISDNYLVPEWWWDELECFKGRHQLSVAISINATTDNIQRLNMLPNVSIWRLTLDGE
NVSKLPNYDLGTPQWGYRVSDKLDILNIMYLKVSRLVLAAGMGRESSFGCLKRLHFECLQLLVEISLNRV
RLYNLRQIFIHDCPMLKDVSWVLELPCLNFLQIEYCRKMKELISEVGNSNSISSSSSVQSLILGYMPNLN
CIANRPLHFPYLEYIDVKDCPELKRLPFGTEMLKNRLKRIRGEEYWWNNLDWDDESIKDSLTPYFRPQIS
K


>XP_042465426.1 probable disease resistance protein At1g61300 isoform X2 [Zingiber officinale]
MACINLNLDVDVNSCLSGLWASLPVLGRPKSGIQKLEKEMARLRGKRDDIKNQIDQADRQGKIPTNEVSQ
WLREVEELEGQVAAIKQDFQSMSCFSCNCFNQTGGTSSQTQQAGDQVSIGESSNFCSIIRRVAKKLGEAT
ELTSRAGALDPIATVGPPEPTVMLPIAHQPTVGIESYVEDIVGYINGGEGNIIGIFGMGGVGKTTILESI
QQYYLHDHTIFDHVIWVVASKGCQLKKLQNDIAKSLKLDTLEKNDDERTCGDKLFSYLKDKNCLLLLDDI
WERLDLQLLGMAHSATERGQQQQKHPRKVVVLTTRSETVCAQMKAEKKIKVRCLDSEQAWQLFEQNSDGD
VLSSDAGIKFIAEELAKECAGLPLALVTVARAMSGKRSWEVWNDAFNQIRDKHEWTTVCLPEDSLVMYKA
FKLSYDSLENDSIRECLLCCALWPEDYEINQFSELIPCLIGCGIIREFNVINEAFAQGCSHLEALMATSL
LEKCNNINPPYEDTLVKMHDVIRDMALLMVSSLERNKRKWIVKAGIGLHDLPRQEEWQQAERVSFMSNQI
TSLQEYGASTFLKLSMLILHDNMGLETIPSSLLKSMPHLTYLDLSFCGITELPMEIGSLTELQYLDLSYS
SIAKLPAELGCLCKLEYLLLSSMYLKIVPNGTISNLLMLKWLDISDNYLVPEWWWDELECFKGRHQLSVA
ISINATTDNIQRLNMLPNVSIWRLTLDGENVSKLPNYDLGTPQWGYRVSDKLDILNIMYLKVSRLVLAAG
MGRESSFGCLKRLHFECLQLLVEISLNRVRLYNLRQIFIHDCPMLKDVSWVLELPCLNFLQIEYCRKMKE
LISEVGNSNSISSSSSVQSLILGYMPNLNCIANRPLHFPYLEYIDVKDCPELKRLPFGTEMLKNRLKRIR
GEEYWWNNLDWDDESIKDSLTPYFRPQISK


>XP_042465427.1 probable disease resistance protein At1g61300 isoform X3 [Zingiber officinale]
MACINLNLDVDVNSCLSGLWASLPVLGRPKSGIQKLEKEMARLRGKRDDIKNQIDQADRQGKIPTNEVSQ
WLREVEELEGQVAAIKQDFQSMSQYAPLYTFCFSFSCQFNCPALCFNAYTTTTYVLYCFVFSLGCFSCNC
FNQTGGTSSQTQQAGDQVSIGESSNFCSIIRRVAKKLGEATELTSRAGALDPIATVGPPEPTVMLPIAHQ
PTVGIESYVEDIVGYINGGEGNIIGIFGMGGVGKTTILESIQQYYLHDHTIFDHVIWVVASKGCQLKKLQ
NDIAKSLKLDTLEKNDDERTCGDKLFSYLKDKNCLLLLDDIWERLDLQLLGMAHSATERGQQQQKHPRKV
VVLTTRSETVCAQMKAEKKIKVRCLDSEQAWQLFEQNSDGDVLSSDAGIKFIAEELAKECAGLPLALVTV
ARAMSGKRSWEVWNDAFNQIRDKHEWTTVCLPEDSLVMYKAFKLSYDSLENDSIRECLLCCALWPEDYEI
NQFSELIPCLIGCGIIREFNVINEAFAQGCSHLEALMATSLLEKCNNINPPYEDTLVKMHDVIRDMALLM
VSSLERNKRKWIVKAGIGLHDLPRQEEWQQAERVSFMSNQITSLQEYGASTFLKLSMLILHDNMGLETIP
SSLLKSMPHLTYLDLSFCGITELPMEIGSLTELQYLDLSYSSIAKLPAELGCLCKLEYLLLSSMYLKIVP
NGTISNLLMLKWLDISDNYLVPEWWWDELECFKGRHQLSVAISINATTDNIQRLNMLPNVSIWRLTLDGE
NVSKLPNYDLGTPQWGYRATNFEMKHRPFGQGGYRTFNVLIVVNGQIVGFFGWSDMYLNLIDDS


>XP_042465428.1 probable disease resistance protein At1g61300 isoform X4 [Zingiber officinale]
MACINLNLDVDVNSCLSGLWASLPVLGRPKSGIQKLEKEMARLRGKRDDIKNQIDQADRQGKIPTNEVSQ
WLREVEELEGQVAAIKQDFQSMSQYAPLYTFCFSFSCQFNCPALCFNAYTTTTYVLYCFVFSLGCFSCNC
FNQTGGTSSQTQQAGDQVSIGESSNFCSIIRRVAKKLGEATELTSRAGALDPIATVGPPEPTVMLPIAHQ
PTVGIESYVEDIVGYINGGEGNIIGIFGMGGVGKTTILESIQQYYLHDHTIFDHVIWVVASKGCQLKKLQ
NDIAKSLKLDTLEKNDDERTCGDKLFSYLKDKNCLLLLDDIWERLDLQLLGMAHSATERGQQQQKHPRKV
VVLTTRSETVCAQMKAEKKIKVRCLDSEQAWQLFEQNSDGDVLSSDAGIKFIAEELAKECAGLPLALVTV
ARAMSGKRSWEVWNDAFNQIRDKHEWTTVCLPEDSLVMYKAFKLSYDSLENDSIRECLLCCALWPEDYEI
NQFSELIPCLIGCGIIREFNVINEAFAQGCSHLEALMATSLLEKCNNINPPYEDTLVKMHDVIRDMALLM
VSSLERNKRKWIVKAGIGLHDLPRQEEWQQAERVSFMSNQITSLQEYGASTFLKLSMLILHDNMGLETIP
SSLLKSMPHLTYLDLSFCGITELPMEIGSLTELQYLDLSYSSIAKLPAELGCLCKLEYLLLSSMYLKIVP
NGTISNLLMLKWLDISDNYLVPEWWWDELECFKGRHQLSVAISINATTDNIQRLNMLPNVSIWRLTLDGE
NVSKLPNYDLGTPQWGYRAWVGNQVLDV


>XP_042465429.1 probable disease resistance protein At1g61300 isoform X5 [Zingiber officinale]
MLPIAHQPTVGIESYVEDIVGYINGGEGNIIGIFGMGGVGKTTILESIQQYYLHDHTIFDHVIWVVASKG
CQLKKLQNDIAKSLKLDTLEKNDDERTCGDKLFSYLKDKNCLLLLDDIWERLDLQLLGMAHSATERGQQQ
QKHPRKVVVLTTRSETVCAQMKAEKKIKVRCLDSEQAWQLFEQNSDGDVLSSDAGIKFIAEELAKECAGL
PLALVTVARAMSGKRSWEVWNDAFNQIRDKHEWTTVCLPEDSLVMYKAFKLSYDSLENDSIRECLLCCAL
WPEDYEINQFSELIPCLIGCGIIREFNVINEAFAQGCSHLEALMATSLLEKCNNINPPYEDTLVKMHDVI
RDMALLMVSSLERNKRKWIVKAGIGLHDLPRQEEWQQAERVSFMSNQITSLQEYGASTFLKLSMLILHDN
MGLETIPSSLLKSMPHLTYLDLSFCGITELPMEIGSLTELQYLDLSYSSIAKLPAELGCLCKLEYLLLSS
MYLKIVPNGTISNLLMLKWLDISDNYLVPEWWWDELECFKGRHQLSVAISINATTDNIQRLNMLPNVSIW
RLTLDGENVSKLPNYDLGTPQWGYRVSDKLDILNIMYLKVSRLVLAAGMGRESSFGCLKRLHFECLQLLV
EISLNRVRLYNLRQIFIHDCPMLKDVSWVLELPCLNFLQIEYCRKMKELISEVGNSNSISSSSSVQSLIL
GYMPNLNCIANRPLHFPYLEYIDVKDCPELKRLPFGTEMLKNRLKRIRGEEYWWNNLDWDDESIKDSLTP
YFRPQISK


>XP_042465430.1 putative disease resistance protein At5g05400 [Zingiber officinale]
MIHCCVSLGCFSCNCFNRTGGTSSNPTQQAGDDVPIIESSNCCSIIRRAAKKLDEANELMSRAGALDPIA
TVGPPEPTLMLPISHQSPVGIESYVEDIVGYVDGGEGNIIGIYGMGGIGKTTVLKRIQQHYLLKHTIFDR
VIWVVASKDCQLKRLQMNIAKSLGLQTLQENDDEQTCGDKLFSFLKNRNCLLLLDDIWEHVDLQLLYWGW
HTQLLSEASSSSRVKLWCSRPAVR


>XP_042465431.1 disease resistance protein SUMM2-like [Zingiber officinale]
MACINLNLDADINKCLSGLWASLPVLGRPKSGIQKLEKEMARLRVKRDDIKNQIDQADRQGKIPTNEVSQ
WLREVEELEAQVAAIKQDFQSMSCFSCNCFNQTGGTSTQTQQAGDQVSIGESSNCCSIIRRVAKKLGEAT
ELTNRAGALDPIATVGPPEPTMMLPISHRPPVGIESYVEGIVSYIDGGEGNIIGIYGMGGVGKTTMLKRI
QQHYHLNHAIFDRVIWVVASKDCQLKRLQIDIARSLNLHTLEENDDEQTCGVKLCSFLKNKNCLLLLDDI
WERLDLQLLGMAHSGTEQGQQQHQQPRKVVVFTTRSEIMCAQMNAEKKVKVNCLDSDQAWQLFVQNSDGD
VLGSDAGIKFVAEKLAKECAGLPLALVTVARAMSGKRSWEAWNDALHQIRDKHEWATIALPEDSLVMYKA
FKLSYDSLENDSVRECLLCYALWPEDYQFDKFFELIQCWIGCGIIHEFNVINEAFAQGYSHLETLVAASL
LEQCGDLNFPYGNKSVKMHDVIRDMALLMVSRLEGNKRQWIVKAGIGMSELPRQEEWQEAERASFMRNEI
TSLQEYEASTFPKLSMLILHYNHHLKQIPPSLFASMPRLKYLDLSGCRITELPKEICSLAELQYLNLSDN
RIIRLPFEFGCLSKLQYLFLSSTRLKIVPNGAISNLLMLKWLDISNNPLVPEWWWDELKCFKGRHQLSVT
IDINATTDNIERLNMLPPNVSLWVLTLDGENISKLPNYDLDTLQWGCRVSDNLVFLCIQNLRLDRLELAV
GVGRESSFGCLKSLRFIDLTLLEEISLNRVRFYNLREIYIHDCPMLKDASWVLQLPCLNCLDISMCGKMK
EVISEVGNSNSICSSSIQYLILWNMSDLNLIANRPLHFPYLEYIRVRECPKLIKLPFGTEILKNRLKVIK
GEEDWWNNLDWDDESIKDSLTPYFRSWHR


>XP_042465433.1 probable disease resistance protein At1g61300 [Zingiber officinale]
MACTCINLNLNLDGNSCLSVLWASLRLCRPKSGIQKLEKEITILRAKRDDIKNQIDQAEREGRIPTNQVS
QWLLEVEMLEGQVADIEQDFQSISYFSCNCFNPTGGASTTSQTQQAGDQVPIRESSNCCSIIRRVAKKLG
EANELMSRAGALDPIATVGPPEPTVMLPISHQPPVGIESYVEDIVGYINGGEGNIIGIYGMGGVGKTTML
KSIQQHYLPKHTIFDRVIWVVASKDWQLKKLQMDIAKSLELMTLKESDNERTCGDKLFSYLKNKNCLLLL
DDIWELMDLQLLGMAHSATEQGQHQQQPRKVVVFTTRSETVCTQMKADKKIKAKCLDPDQAWRLFEQNSD
KKFLSSDGGINFVAQELAKECAGLPLALVTVARAMSGKKSWEAWKDALHQIRDKHEWTTIDLSEDSVVMY
KAFQLSYDSLENDSIRECLLCCALWPEDYKIHKFKELIPCWIGCGIIHEFNVINEAFTKGCPHLEALVAA
SLLEQCNDQKDIRYLDTFVKMHDVIRDMALLMVSGLKGNGRKWIVKAGIGLSHLPIQEAWQEEWQEAERA
SFMDNEIASLPDYGASTFSKLSMLFLHGNDSLTTIPPSLFPSMPLLTYLDLSKCHITKLPMEICRLTELQ
YLNLSKNPITRLPAKFGCLCKLEYLLLRKTEIKSVPSGTISKLSMLRWLDIRRAFPIRGCLKNGRKIIGM
RPISEWWWDELKCFRGRHKLSVAIVINVTTANIKRLNMLPNVSIWNLTMEGGNFLQLQTLHLGTLQWSCN
VSDNLESLSFKNVAVDKLMLTAGVGRESSFGCLKTLHFYNLRKLENISLNGVGLCNLRELCIHSCSMLKD
VSWVLQLPCLNLLKISRCFEMKEVISNVGNTNSSSSIQRLSLSLVPNLNCIAHQPLYFPYLEYVHVYKCP
IFKKLPFEVEILKSRLKEIRGVQTWWDNLEWDDESNKNLLTPLFIPFIESFD


>XP_042465434.1 probable disease resistance protein At1g61300 [Zingiber officinale]
MGGIGKTTMLKRIQQHYLLKHTIFDRVIWVVASKGCQLKRLQIDIAKSLKLHTLEENDDEQTCGDKLFSF
LKSRNCLLLLDDIWEHVDVQLLGMAHSATERGQQQQPRKVVVFTTRSEIVCAQMKAEKKTKVKCLDSDQA
WKLFEQNSDGDVLSSDAGIKFVAEKLAKECAGLPLALVTIARALSGKKSWEVWNDALNQIRDKHEWTTVC
LPEDSFVMYKAFKLSYDSLENDSIRECLLCCALWPEDHKINKFELIPCWIGCGIISEFNVINEALAKGCS
YLEALMATSLLEKCSDMDSSYGDTLVKMHDVIRDMALLMVFGLESNKRKWIVKAGVGLSDLPRQEE


>XP_042465435.1 probable disease resistance protein At1g61300 [Zingiber officinale]
MGGIGKTTMLKRIQQHYLLKHTIFDRVIWVVASKGCQLKRLQIDIAKSLKLHTLEENDDEQTCGDKLFSF
LKSRNCLLLLDDIWEHVDVQLLGMAHSATERGQQQQPRKVVVFTTRSEIVCAQMKAEKKTKVKCLDSDQA
WKLFEQNSDGDVLSSDAGIKFVAEKLAKECAGLPLALVTIARALSGKKSWEVWNDALNQIRDKHEWTTVC
LPEDSFVMYKAFKLSYDSLENDSIRECLLCCALWPEDHKINKFELIPCWIGCGIISEFNVINEALAKGCS
YLEALMATSLLEKCSDMDSSYGDTLVKMHDVIRDMALLMVFGLESNKRKWIVKAGVGLSDLPRQEE


>XP_042465436.1 probable disease resistance protein At1g61300 [Zingiber officinale]
MACINLNLDVDVNSCLSGLWASLPVLGRPKSGIQKLEKEMARLRVKRDDIKNQIDQADRQGKNPTNEVSQ
WLREVEELEGQLAAINQDFQSMSCFSCNCFNQTSGTSSQTQEVGDQVLIRESSNYCSIIRRVAKKLGEAT
ELTSRAGALDPIATVGPPEPTMMLPISHRPPVGIESYVEDIVSYIDGGEGNIIGIYGMGGVGKTTMLKRI
QQHYHLNHAIFDRVIWVVASKDCQLKRLQMDMAKSLGLETLQESESEQTCGDKLFSYLKNKNCLMFLDDI
WEHLNLQLLGMAHSATEQGQQQHQQPRKVMVFTTRSETVCAQMKAEKKIKVRCLDSEQAWQLFEQNSDGD
VLSSDAGIKFIAEELAKECAGLPLALVTVARAMSGKRSWEAWKEALHQIRDKHEWTAISLSEDSLVMYKA
FKLSYDSLENDSIRECLLCCALWPEDYEINKFEELIPCWIGCGIFDEFNVINEAFAKGYSHLEALGAASL
LEKCDSDYVVKMHDVIRDMTLLMVSGLKGNKRKWIVKAGIGLSDLPRQEEWQEAERASFMVNNITSLQEY
GASTFSKLSMLILRRNRGLETIPPSLFASMPNLTYLDLSYCHITELPREMCSLTELRYLNLTNCYITRLP
IEFGCLVKLEYLLLVNTGLEIVPNGMISNLSMLKWLNISHIYPATEWWWDELKCFKGHHQLSVEIGINAT
TDDIERLNMLSPNVSIWKLTLDGENISKLPNYDLGTPQWGCRVSDNLEILYIQDLRLDRLELAIGVGRES
SFGCLNILRFINLKLLEEISLNRVRLYNLREVLIFDCPMLKDVSWVLQLPCLKSLDIRLCRTMKQVISEV
GNSNSISSSSIQHLKLWHMSDLNLFANRPFHFPYLEYVQVYGCPKLKKLPFGVEILKNRLKVIKGEEYWW
NNLDWDDESIKDSLTPYFRSRPY


>XP_042465437.1 probable disease resistance protein At1g61190 [Zingiber officinale]
MACINLNLDVDVNRCLSGLWASLPVLGRPKSGIKKLEKQMARLRSKRDDIKNQITEAEREGKIPTNEVSQ
WLREVEELEGQLAAIKQDFQSISCFSCNCFNRGTSSNPTEAFAANPEDEENAATQTQQARDDVPIRESSN
CCSIILRMAEKLRETDELMSRAGALDLIATVCPPESNVMLSISHRPPVGIESYVEDIVGYVDGGKDNIIG
IYGMGGVGKTTMLKRIQRHYYNHRIFDSVIWVVASNDCQLKRLQMDIAKSLELKTLKESDDEQTCGDKLF
SFLKNRNCLLLLDDIWGHVDLQLLGMAHSATKRGQQQPRKVVVFTTRSETVCAQMKAEKKVKVKCLDSDQ
AWQLFEQNSDGDVFSSDAGIKFVAEELAKECAGLPLALITVARVMSGKKSWEVWNDALNQIRDKHEWTTV
CLPEDSVMYKAFKLSYDSLENDSIRECLLCCALWPEDHKINKFSELIPCWIGCGIIHEFNVINEAFTKGC
SHLEALVDASLLEQCSDLDFPDRSTVVKMHDVIRDMALLMVSGLEGNKRKWIVKARIGLSDLLRQEEWQE
AERASFMMNEITSLQEYGTSIFPKLSMLILCHNRGLKTIPPSLFTSMPRLTYLDLCKCRITELPEDIGSL
TELQYLDLSFNPITTLPVKFGCLGKLEYLLLCYTGLKIVPNGSISNLSMLKWLDISQIPLIPEWWWDELK
CFKGRQLSVGININATTYNIERLNMLPPNVSIWHLVLDEHNISKLPNYDLSTPQWGCRVSDKLEFLWIRR
LRLDRLVLAADMGRESSFGCLKSLHFQGLRLLRDFIE


>XP_042465438.1 disease resistance protein RFL1-like [Zingiber officinale]
MACIKLNLNVDVNDCLRGLKATLRLGRPKSAIEKLGKEMTRLRGKRDDIKNQINEAEREGKIPTNEVSQW
LREVEILEGKVADIDQDFQSMSCFSCNCFNRTGGTSSNPTEAFAANTQEDEENAATQTQQAGDGVPIRES
SNCCSITQRAAKKLDEANELISRAGALDPIATVGPPEPTVMLPISHRSPVGIESDVEDIVGYVDGGKGDI
IGIYGMGGVGKTTTLKSIQQHYSLLKHSTFDCVIWVVASKDCQLKRLQMDIAKSLGVKTLQESDDEPTCG
DKLFSFLKKRNCLLLLDDIWEHVDLQLLGMAHSVNEQGQQQQPRKVVVFTTRSETVCAQMKAEKRIKVRC
LDSERAWQLFEQNSDGDVLSSDAGIKFVAEELAKECAGLPLALVTVARAMSGKRSWEAWKEARSQIRDKH
EWTTVCLPEDSVMYKAFKLSYDSLENDFIRKCLLCCALWPEDHMVSKLELIPCWIGCGIISEFNVINEAL
DKGCSYLEALIATSLLEKCTDIDSSYRDTLVKMHDVIRDMAMLMVSGLESNKRKWIVKAGIGLSDLPREE
EWQEAERASFMRNKITSLQGYGASAFPKLSMLILLGNLDLEAIPSSLFASMPHLAYLDLGCCGITELPME
FGSLTELQYLDLSFNPIAKLPTELGCLCKLEYLFLNSTRLKIVPDFQFINAQVAGYK


>XP_042465439.1 disease resistance protein RFL1-like [Zingiber officinale]
MACIKLNLNVDVNDCLRGLKATLRLGRPKSAIEKLGKEMTRLRGKRDDIKNQINEAEREGKIPTNEVSQW
LREVEILEGKVADIDQDFQSMSCFSCNCFNRTGGTSSNPTEAFAANTQEDEENAATQTQQAGDGVPIRES
SNCCSITQRAAKKLDEANELISRAGALDPIATVGPPEPTVMLPISHRSPVGIESDVEDIVGYVDGGKGDI
IGIYGMGGVGKTTTLKSIQQHYSLLKHSTFDCVIWVVASKDCQLKRLQMDIAKSLGVKTLQESDDEPTCG
DKLFSFLKKRNCLLLLDDIWEHVDLQLLGMAHSVNEQGQQQQPRKVVVFTTRSETVCAQMKAEKRIKVRC
LDSERAWQLFEQNSDGDVLSSDAGIKFVAEELAKECAGLPLALVTVARAMSGKRSWEAWKEARSQIRDKH
EWTTVCLPEDSVMYKAFKLSYDSLENDFIRKCLLCCALWPEDHMVSKLELIPCWIGCGIISEFNVINEAL
DKGCSYLEALIATSLLEKCTDIDSSYRDTLVKMHDVIRDMAMLMVSGLESNKRKWIVKAGIGLSDLPREE
EWQEAERASFMRNKITSLQGYGASAFPKLSMLILLGNLDLEAIPSSLFASMPHLAYLDLGCCGITELPME
FGSLTELQYLDLSFNPIAKLPTELGCLCKLEYLFLNSTRLKIVPDFQFINAQVAGYK


>XP_042465440.1 probable disease resistance protein At1g61300 [Zingiber officinale]
MAFATINLNVDVNSCLGGLWASLRLGRPKSGIQKLEKEMTRLRGKRDDIKNQIEEAEREGKIPTNEASQW
LRDVEELEGQLAVIKQDFQNISCFSCNCFNQTGGTSSQTQEAGDQLSIRESSNCCSIIRRVAKMLSEANE
LMSRAGALDPIVTVRPPRPTVMLSISHRPPVGIESDVEGIVSYIDGGEGNIIGIYGMGGVGKTTMLKRIQ
RHYHLNHAIFDCVIWVVASKDCQLKRLQMDIAKSLGLNTLQENDDEKTCGDKLFSYLMNKSCLMFLDDIW
EHLNLQLLGMAHSATEQGQQQHQQPRKVTVFTTRSETVCAQMKAEKKIKVRCLDSEQAWQLFEQNSDGDV
LSSDAGIKFIAEELAKECAGLPLALVTVARAMSGKRSWEAWKEALHQIRDKHEWTTISLSEDSLVMYKAF
KLSYDSLENDSIRECLLCCALWPEDYEINKFEELIPCWIGCGIFDEFNVINEAFAKGYSHLEALGAASLL
EKCDSDYVVKMHDVIRDMALLMVSGLKGNKRKWIVKAGIGLSDLPRQEEWQQAERASFMHNKMTSLQEYG
ASTFPKLYMLILHGNRGLKRIPLSLFASMPHLTYLDLSNCGITNLPKEICSLTELQYLNLSSNPITRLSA
KFGCLIKLEYLLLRYTNLEIVPNGTISNLSMLKWLDIPHAYPANEWWWDELKCFKGRHQLSVGITINAIT
DDIERLNMLPLNVSIWELTLDGENISKLPNYDLGTPQWGCRVSDKLEFLYIQNLRLDRLELAVGVDRESS
FGCLKRLWFIDLELLEEISLNRIRLYNLREIYISECPMLKDVSWVLQLPCLNSLCIVNCEKMEELISEVG
NSNSISSSSIQNLALDNMPNLNRIANRPLHFPYLEYIDVNDCPELKKLPFGAEILKNRLKMIKGEEYWWN
DLDWDDESLKDSLTPYFRSRHFNFWPISKWSIDLLVKEAIEFDRRKRKGSK


>XP_042465442.1 putative disease resistance protein At3g15700 [Zingiber officinale]
MAFATINLNVDVNSCLGGLWASLRLGRPKSGIQKLEKEMTRLRGKRDDIKNQIEEAEREGKIPTNEASQW
LRDVEELEGQLAVIKQDFQSMSCFSCNCFNQTGGTSSQTQEEAGDQLSIRESSNCCSIIRRVAKKLSEAN
ELMSRAGALDPIITVRPPGPTAMLSISHRPPVGIESYVGDIVGYIDGGEGNIIGIYGMGGVGKTTILNRI
QQHYLPKHTIFDRVIWAVASKDCQLKRLQMNIAKSLGLQTLQENDDEQTCGDKLFSYLKNRSCLLLLDDI
WEHMKSVQLLGMAHSATEPGQQQPRKVMVFTTRSETVCAQMKAGKKIKVRCLDSEQAWQLFEQNSDEDVL
SSDAGIKFVAEELAKECAGLPLALVTVARAMSGKRSWEAWSDALHQIRDEHQWKTVCLPEDSLVMYKAFK
LSYDSLENDSIRECLLCCALWPEDYEINTFDQLIPCWIGCGIIHEFNLINEAFAKGYSHLETLVAASLLE
QHSPMFFSSMDIDVKMHDVIRDMALLMVSGSEGNKRKWIVRAGIGFSDLPRQEEWQEAERASFMCNKITS


>XP_042465569.1 putative disease resistance protein RGA1 [Zingiber officinale]
MAGVGMSVVEWFATYVMEKLVDFASSRLADPHRDVFSVVDEKLKEMEGRLPRIHAAIHAAEGRPIRDPAL
ASWMRQLKDAAFEADDLLDELDYRQLEARVQDRSKVSAFASSSLRFLKNLFVSDDELRRLKNILGDLDKI
SLEINQRKAELEEYNHARQQNRETSSFSTQEVVFGRDKERDLILEILLSAGDGPDYDDTKRAGSSRHLAN
LDVLPILGIGGVGKTTLAQLVYSDQRVAQHFELRKWVYVSDNFDVKRIAMELETNVTSDAHPFRDSSLDA
QLSKLRDATANKRYLFVLDDVWDEIESSWAKLRSALTFGSKGSTILITTQSPLVAEIMGTVKPIKLELLE
EDDYWRLFEHCSLGDKEIDLDLRRKLELLGQQIAKKMHGLPLAAKTVGSMLRCRLEEQYWKAIQESEWWE
HDFVVDNILPSLGLSYQHLSSNYKQCFAYTSIFPKGHMFNKERLVQMWIAQGFIQEKTLRGRMTLEDIGS
QIFDELTSRYFFMRTVNDRYVMHDLIRELAVCVSIDECLVLHDEHVKIPATVCHLTLRVVKMNALPELRK
LQKLRTLIFYPEYDSEFLLLPRDGSKEFFKFLEGLLEDMKSLRVIDLSQDRSGINKLPDAICDLPHLRFL
DVSWTKIKQLPKGFPKLYHLQVLNLKRRGTFSILPQGMNRLIKLRHLYADANTISLIHGIGKLTELQELE
EFHVSNKRGRQIEELKDLRYLRRRLTIQDIQNVESKEEAVGANLDDKENLHELMLNRKPDIRSQGDKEKE
ILDGLQPHHNLKSLEIHHYGGMKSPSWLENNQITNLEFVYLNKCARWDTLPPLGKLPFLKNLVFKMMPSI
RRIGREFFGDGDTVFPSLEKLIFDQLNEWEEWSGTDKKSVFPRLFEINIINCVKLRQIPLLPLRSMSVLK
IWNCGDIGTTLPQYLLHLTSLVDLSLENYPHRVSVCLSNLTALKNLELQNCPELILLGGFQSLGNLKLLK
VTKCPKLNESSQPLEEPYVEEGLRSLSYIITDESIINHVWVIVGRAQAVKSLILANCEHLKHFKPELEEW
FQQLTSLQELQFVSCPDLQRLPANLETVFSIRRLIITHCPSIDSLPENGLPISLKELKIYGCRKLKDRCQ
KDDGPDWPKIAMIPHIVIEGEVISGAEEAA


>XP_042465619.1 disease resistance protein PIK6-NP-like [Zingiber officinale]
MATMMAMKVVDFSFLSIAGKLEKMLEEEAALLAGVEDDVCDIVAELRSVTSFLTAMSTRRNLDDQLQNWV
QEVREVAYDATSLEMAGRYSDPRIIGHFVEEAQLVGINQRRDKIIGWVMDENRLELTVISIVGLGGLGKT
TLAKTVYDNSIIAGSHFQPRAWIVVSQNYSIRELLKKIILQISVDEQQIRDVLGCPDASLNTEQLLNMME
ESQLVQTVRGHLHGKRYMLIFYDVWRTDTWESLRNTGLSELPDSIGDLQNLEFLDMRGTRIKELPNTMVK
LQKLVYLLAGPQGFKFLKGIGKLKRLVAFGMAYADKMQSLQEIGELVDLQKLAISFGEHDLSLRMLEEIR
ALLSKLNGTLRSLTIFPPVNISLKNALDEVASPPLLLCKLQIGCRLGQLPPWFASLKHVVKISLVGTLLQ
LEDLQVLRNLPALVNLKLGFKSFVNNDEDLVFDRGGFAQLKFLQIKCQHVSFRVGAVRSLEILEIFFPPE
SVNGIEHLHGLREIYILTFNEHISEMVKNIAANHSNRPKCFVNQL


>XP_042466334.1 probable disease resistance protein At5g43730 [Zingiber officinale]
MACIKLNLNVDVNSCLSGLKATLRLGRPKSGIKKLKKEMKILKVKRDDIKNRIDQAELEGRIPTNQVSHW
LWTWRRWKAKKIERKKKSLFRSSGCFSCHCFNQTQTQTGGTSQTQQAGDQVPIRESSNCCSIILRVAKKL
GEVKELMDRADRLDPVATVGPSEPAVMLPISHRSPVGIESYEEDIVGYVDGGKGDIIGIYGMGGVGKTTM
LTRIQQHYLLKHTIFDRVIWVVASKDCQLKRLQMDIAKSLGLKTLQESDDERTCGDKLFTFLKSRNCLLL
LDDIWEHLDLQLLGMAHSATTERGQQQQPRKTVVFTTRSEGVCVQMEAEKKIKVKCLDPVQAWQLFEENS
EGDVLNSDAGIKFVAEKLAKECAGLPLALVTVARAMSGKKSWEVWDAALRQIRDEHQWKTVCLPEDSVVM
YKAFKLSYDSLENDSIRECLLCCALWPEDFKIDQFSRLIPCWIGCGIICEFNVINEAFAKGCSHLEALKT
ASVEIGKYFGRALEEKNVWTIFARTILGTPSLLERKTDENFAYQPLICNIFTMRFHYIDQIKDSASLLEH
SADFIKMHDVIRDMALLMVSGSDGNKRKWIVKAGIGMSDLPRQEEWQEAERASFMNNRITSLPDYGASTF
PKLSMLIIHHNKGLKTIPPSLFASMPRLVYLDLSDCRITKLPKEICSLTELQYLNLSDNHITGLPAEFGC
LGKLEYLFLMNTDLQIVPNGAISNLSMLKWLDIKENPLALEWWWDELKCFKGRHQLSVAISINATIDNIE
RLNMLPPNVSIWHLTLAGENISKLPNNYDLGTTQWGCRVSDKLESLYIVNLGLDRLVLAAGEGRESSFGC
LKLLYFTELKLLEDISLNRVRLHNLRKIYIFDCPMLKDVSWVLQLPCLNSLSIVNCGKMEELISDVGNSN
SISSSSIQHLFLGNIPNLNRIANRSLHFPYLEFIDVIDCPKLKKLPFGIEILKNKLKRIDGEDDWWNNLD
WDDETIKDSLTPYFR


>XP_042466335.1 disease resistance protein RFL1-like [Zingiber officinale]
MACCIKLNLNVDVNSCLSGLWATLQLGRPKYAVKKLEKEMPRLRGKRDDIKNQINEAELEGKIPTNEVKQ
WLREVEILERKAAAIERDFQSMSCFSCNCFNRTGGTSSKPKEAFAANIQEEETQRAGDDVPIRESSNCCS
IIWRAVKTLDEANELTSRAGQLDPIAKVGPPEPVVMLPISHRPLVGIESYVEDIVRYVNGGESEIIGIYG
MGGVGKTTMLKRIQQHYLLKHAIFDRVIWVAASKDCQLKRLQMDIAESLGLKTLQESDDKRTRGDKLFSY
LKNRNCLLLLDDIGKQVDLQLLGMAHSATEPGQQKQPRKVVMFTTRSETVCAQMKPEKTIKVKCSDTGRK
YEDIFFRRNLK


>XP_042466338.1 disease resistance protein RFL1-like [Zingiber officinale]
MKAEKKTKVKCLDSDQAWKLFEQNSDGDVLSSDAGIKFVAEELAKECAGLPLALVTVARAMSGKRSWEAW
NDALHQIRDKHEWTTIALQEDSLVMYKAFKLSYDSLENDSVRECLLCCALWPEDYEIFKFSKLIPCWIGC
GIIHEFNVINEAFAKGYSHLEALGAASLLEKCDSDKVVKMHDVIRDMTLLMVSGLKGNKRKWIVKAGIGL
SDLPRQEEWQEAERASFMINEITYLQEYGAPTFPKLSMLILHGNENLKTIPPSLFASLPRLTYLDLSDCC
ITELPKEICSLTELQYLNLSDNRIIRLLIEFGCLSKLEYLFLRYTGLETVSNGTIANLLMLQWLDIRGIP
LASDWWWDELKCYKGRHQLSVGIHINATTDNIERLNMLPLNVSVWELILDGEHISKLPSYDLGTPQWGCR
ATNFEMKHGPFGQGGYRAFTILIVDNGHIVGFFGWLDMYLNLLDDS


>XP_042466343.1 probable disease resistance protein At4g14610 [Zingiber officinale]
MNLLNHSPEYGKHGESIACNSLECNCFDQTDGTSSQRVAKKLSEANELGPPEPTVMLPISHQPPVGIELY
VEDIVGYINGGEGNIIGIYGMGGVRKITMLKSIQQHYLPKHTIFDRVIWVMASKDWQLKRLQMDIAKSLE
LMALKESDKERTCGDKLFSYLKNKNCLLLLDDIWEHVDLQLLGMAHSATERGQQQPRKVMVFMTRSETVC
AQMKAEKKIKVRCLDSEQAWQLFEQNSDGDVLSSDARIKFLAEELAKECAGLPLALVTVARAMSGKRSWE
AWNDALHQIRDKHEWTTIALLEDSLVMYKAFKLNYDSCGIIHKFNVINEAFAKGCFYLEALVTAFLLEKC
SDPDFPFGDTNVKMHDVIRDMILLMVSGLEGNKRKWIVKQGIGLSDLPTQQQWQEAERASFMMNDDTMEV
KVKMVNTQMSKSRAEDKDNGR


>XP_042466551.1 disease resistance protein Pik-2-like [Zingiber officinale]
MAGILETMIAANVVGFSFQFIVGKLEKMLEEEAALLAGVEDDVRYIVAELRSITSFLTALSTRRNLQDDQ
LQNWMQEVREVAYDAEDSIDEFVCRLGWTPCDERGVKGFIKHFLHRIKSLKARHCIASDLKKLKVHVEEV
RKRHDRYSHPNEATGTATSLEMAGTYSDPRIIGHFVEEAQLVGIKESKGTLIEWVLDKNRLELTVISLFG
FGGLGKTTLVRTVYDDPTIVGGHFESRAWITVSQNYSIKGLLKKIIRQISVNEQQIRDVLGCQDDRLNTE
QLLNMMDETQLVKTVRDHLQGKRYLLVFDDVWRTQAWEGLSIALPPGKEGSRVIVTTRIEDVANISCSRN
HRFIFKVDPLSPELSWELLCKRVFEAPYYSCPPELENVGREILQKCNGLPLAIVTIGGLLASKPDKKLEE
WKDLSNHLRLEIATNDMLLKIHQILVLSYNDLPYHLKPCFLFLGIFPEDFEIHRKRLMRRWIAEGIVSGI
GGLPAEKVGERYFNQLVNRSLVQPSQFDDSGTVKSCRVHDMMLDVILWISSKENFAVILDEQTTTPPQRQ
KIRRLSWHGGNSGLVPDPDLSRLRSFTAFGVDVPPPKDYRKLRQLRAIDLEGCRALHYLLPTSFSKLYIL
KYLSLRNTGLSELSDSIGDLHNLEFLDIRGNHISKLPNTIVKLQKLVYLLASNYLKVPKRIEKLKRLVAF
GMAYVENVQSLQEIGELVDLQKLGIGFHDDLSLRMQEISALFSKLIGSLRSLKISSWPNSGLKTALDEVA
SPPLLLCKLQIWCKLGELPPWFASLNHVVKISLIWTLLQLENLQVLKNLRALVNLKLGFRSFVHHDLVFD
QGGFTQLKFLEISGYNVSFKVGAVRSLEILKIFFVTGGRRVNGIEHLHGLREVHIKTRDEEIIEMVKNIS
ANHSNRLKCFATQL


>XP_042466619.1 putative disease resistance protein RGA3 [Zingiber officinale]
MEAAAQLRHILMKILPAPEMVAQRKAFRISNHLEMIRDSLWVINSFVMDGSLRALEQPDVAEWMKEVGAA
VEDVHNLLERILDYWKPSNEDEAERKWKMINNFFQSTSSRRSILLELREIVCTLNYLANRGAAFGLWVEM
MDSMDPSHDDYAAIMSEEVMGSHEETVIKLLQEQHHWSQRDMIAIRGDEYFGKTTLARKVYHHPWVRQHF
QRRIWLDASSFNDFNSNMIAKEIARLLTGRPCTDLNCWKIVDEHLYRVRYLFILDNLYSYGASGHKLDEL
VRKLFHWAAPGSKFIFTVYPPYEYETHFFCDTYDDLSPLPDGAWVRLLLKYATFVHPIEGNNNHKVKVSP
AATNMLIQFAKKYSSQNYVQNFLIPKGMGLMFRQRDVSQWQELANELLIRHYPSTSRHFSLMHLHYWPFG
RIRRFLYELLFGGSSVPGYDEDVFHILVAEGTLTYYWYKRNIEFTPLEYGVDLCFFRMEVSGPSRIPPQC
RHLYLPINSKNISKFKKAIEVARVARKLRTLVLHREEINEHICQIETKILESMFSSLTSLCTLDMRAIMI
QGLPRAVVTLRCLRYLNLAENKIETLPESICNLYNLCVLNLSNCEKLKELPRRIHELRKLQILKLSYCLR
IQKLPESIICLVNLNELDIGGCCRLSELPDDLSGMKNLMQLNMAGCAALTRMPSGIRRWINLQSLRGIDA
VDGHGNVTLSELQDLRNLESLHIQHLERLELDELKSATLPTYLLKDQDLYELVLHWERWNDMATKGTSNP
MVQLLEGFLRSLRELKVLRIISYMSKRLPTWLMLEPRLIVLKKLKRVELVNLRRCATLPPLGVLPQLEEV
TISGFDSVRVIDDEFYGEDRKPFVFPQLRKLTFSEMPRLEMWLGMKSKNRLEKWLGMKSIRRHGLFAKLE
ELTLIQCPKLMVFLVQFPTSSQLKLKLWLSNEMLMPTSKFNSWSNLGGINMLQIFGCQELRSLPNDTREI
HNLKTLTIMNCNKLEALPIWLEQSCLESLCIYGCRALSFIPE


>XP_042467161.1 putative disease resistance protein RGA3 [Zingiber officinale]
MAVVLSFFVKRYIDKLSEFIEGEISKVLGVKEEIKRLHRKLSRISIYIQDAEKKRQKDPVIDNWVKELKD
IMYDAEDILDLCLIEGGRLLEAHPSSSGVCSPVSLLSSCFQCSKFRRNICHQIKRVDERLDEIKEDNRVI
PRLLEHRYEGLQETPVKKSISPTSPIHVAADIVGTQIVDAAEGLISEIEHSKKRCSVLGISGMGGIGKTI
LAQKIFNDEMVKKQFPNRVWLHVSKDYSHIELLKQVLRGVRGNDDGVQSRAEVEGRIVSLLSESLLLVLD
DIWSASVWRDLLRNPILNGSCRTAILFTTRHEDVATDMRADFVHHVEKMDQDNGWELIRKIVFGDGEDQI
ISELKEVGMEIVRKCDGLPLAIKVIAGVLFRKERTKREWKNVIESDLWFMKENENEVSKALYLSYENLPC
HLKQCFLSCAFYCAISIRSDIIRLWVAEGFVIERSNSLMEDIAEDYYKELIASNLLQMDNIFLTGTRFVM
HDILRSFGENLMEEEGIIINNALYTNINSLTKIRRLSISSQGDLLLLPNAIIEQKCLRALHLVNCPQIKR
IENHAFENLKRLRVLDLCDTSIDSLPDSLTKLLHLKYLGLDRTKIRRLPESIKCLANLQTLNLSGCESLH
ELPKGITRLINLRCLRIEDKLERATSTGSRNFVLANKAFLRRLNLGWTMNINEYSEEQITEAERIFNQLS
PPPTLQGLRITVNFPGRQFPEWMVSTSGLDSLADLTFFNLVNFPSCTVLPPLGQLPNLKILHIEGGEAIK
SIGPEFLGCRTPAFPKLMYVAFKNMTNWETWVLSETQDVVEPNEDVHARNLNSFPNLKECKIIHCPKLKN
SILPSNRYLQINNCPNLEYVEKIGMFQYFRVVFPSEIQQLPQWASCLVNVTLHKFSMECNSLLLDSCSKG
KQNWHIIQRIPKVTIDSIDRERRLLLNKDSYKYEIKDEFGSVEETCQTLRSYWIKLNPIKYLFGAKGGHF
LGYIVTERGIEVNPGKVKALQDMSPPRNLKEVQRLTGKITALSRFISKSSDRSLPFFKILRRATKFQWDD
GCDQAFKELKQYLSSLPILAKPIVGEPFWIYLSSIEYAIGSALVRQEGGIQ


>XP_042467164.1 putative disease resistance RPP13-like protein 1 [Zingiber officinale]
MSAGGCEELAIAKQEKVKRFKGQKTYWLNYRRNTDAEKCGRWGRTNAGRESKWRWERKLTRKRSPKEQEG
GTPPEHRRRVAEEFEDEMCSMWLRTALTWRRLQVLRGVGGNDVGVETKAEVEGRLDPLLSGSLLLVLDDI
WSANVWRELLRNPILKGSCRSVILFTTRHEVVAREMRADYVHPAEKIDEGSGWELIRKIVFGDGEDAIIS
ELEEVGMEIVRKCDGLPLAIKVMAGVLFHKERTKTEWKKVVESDLWFRKEIKLSNALYLSYEDLPNHLKQ
CFLSCAFYHGISHRSDIIRLWVAEGFVIEELDSLMEVTAKDYYKELIARNLLQIDQRFEDGRLFVMHGVL
RSFGEKLMEEEGIIISGDPYRNSLPDSLVKLSHLKYLNLDGTKIRKLPESIKDLANLQTLCLSGCKSLHE
LPDGITRLSNLRCLRILSTPLTHFPKGFGKLKNLNNLAGFFVGHRDSMSMMEGGCDLDELQYLCNLNDLV
ISKLERARTTNFVLENKTFLRILTLGWTMNNNENNDEQSSEAERICKQLSPPATLEGLSIDNFPGRQFPD
WMVSTSLADLTFLALDKFPSCRENK


>XP_042467165.1 putative disease resistance protein RGA3 [Zingiber officinale]
MVGVGAVPKRGREEEGHRGVGLAVCSGEERWWWLTLAKKQLIHQPQEMAVVLSFFVKRYIDKLSEFIEGE
ISKVLGVKEEIKRLHRKLSRISIYIQDAEKKRQKDPVIDNWVKELKDIMYDAEDILDLCLIEGGRLLEAH
PSSSGVCSPVSLLSSCFQCSKFRRNICHQIKRVDERLDEIKEDNRVIPRLLEHRYEGLQENPVKKSISPT
SPIHVAADIVGTQIVDAAEGLISEIEHSKKRCSVLGISGMGGIGKTILAQKIFNDEMVKKQFPNRVWLHV
SKDYSHIELLKQVLRGVRGNDDGVQSRAEVEGRIVSLLSESLLLVLDDIWSASVWRDLLRNPILNGSCRT
AILFTTRHEDVATDMRADFVHHVEKMDQDNGWELIRKIVFGDGEDQIISELKEVGMEIVRKCDGLPLAIK
VIAGVLFRKERTKREWKKVIESDLWFMKENENEVSKALYLSYENLPCHLKQCFLSCAFYCAISIRSDIIR
LWVAEGFVIERSNSLMEDIAEDYYKELIASNLLQMDNIFLTGTRFVMHDILRSFGENLMEEEGIIINNAL
YTNINSLTKIRRLSISSQGDLLLLPNAIIEQKCLRALHLVNCPQIKRIENHAFENLKRLRVLDLCDTSID
SLPDSLTKLLHLKYLGLDRTKIRRLPESIKCLANLQTLNLSGCESLHELPKGITRLINLRCLRIEGTPLT
HVPKGVGKLKNLNHLSGFLVGHCDSTSEMDGGCDMDELQHLCNLRFLRIDKLERATSTGSRNFVLANKAF
LRRLNLGWTMNINEYNEEQITEAERIFNQLSPPPTLQGLRITVNFPGRQFPEWMVSTSGLDSLADLTFFN
LVNFPSCTVLPPLGQLPNLKILHIEGGEAIRSIGPEFLGSRTPAFPKLMYVAFKNMTNWETWVLSETQDV
VEPNEDLHARNLNSFPNLKECKIIHCPKLKNSILPSNRYLQINNCPNLEYVEKIGMFQYFRVVFPSEIQL
LPQWASCLVNVTLHTFSMECNSLLLDSCSKGKQNWHIIQRIPKVTIDSIDRERRLLLNKDSYKYEIKDEF
GSFITLDQSILSVSEEIGQDQASFHG


>XP_042467167.1 putative disease resistance RPP13-like protein 1 [Zingiber officinale]
MRADYVHPAEKIDEGSGWELIRKIVFGDGEDAIISELEEVGMEIVRKCDGLPLAIKVMAGVLFHKERTKT
EWKKVVESDLWFRKEIKLSNALYLSYEDLPNHLKQCFLSCAFYHGISHRSDIIRLWVAEGFVIEELDSLM
EVTAKDYYKELIARNLLQIDQRFEDGRLFVMHDVLRSFGEKLMEEEGIIISGENHCMNFQMASQGHRDSM
SMMEGGCDLDDLQYLCNLNDLVISKLERARTTNFVLESKTFLRILTLGWTMHNNENNDEQSGEAERICKQ
LSPPATLEVLSINNFPGRQFPDWMVSTSLADLTFLALDKFPSCTALPPLGQLPNLKILHIEGGEAIKSIG
PEFLGRRTPAFPKLEYLAFDSMRNWEEWVLRVAPIEDVHASNLNFFPNLEKCYFYDCPKLKNSIHPPTRL
LQINGCPNLESMEKVGMLQLRKFEVVLPSEIKQLPKWISSLINMTLQSLQLFNMQCNSLVLDSCRKGKQN
WHIIQHIPKVIIHSIGLETRLLRSKDGYQYQIKDELGSSFITPGKSFDHQSSGPLGWI


>XP_042467168.1 putative disease resistance RPP13-like protein 1 [Zingiber officinale]
MGGIGKTTLAQKIFNDEMVKKQFSNRVWLHVSKDYSHIELLKQVLRGVRGNDDGVQSRAEVEGRIVSLLS
ESLLLVLDDIWSASAWRDLLRNPILNGSCRTAILFTTRHEDVATDMRADFVHHVEKMDEDNGWELIRKIV
FEDGEDQIISELKEVGMEIVRKCDGLPLAIKVIAGVLFRKERTKREWKKVIESDLWFMKENENEVSKALY
LSYENLPCHLKQCFLSCAFYCAISIRSDIIRLWVAEGFVIERSNSLMEDIAEDYYKELIASNFLQMDHIF
LTGTRFVMHDILRSFGENLMVDEGIIINDGQCTNTNSLTKIRHLSISNQGDLLLLPNVIIEQKCLRALHL
VNCPQIKKIEDHAFKSLKRLRVLDLRDTCIDNLSDSLMKLLHLKYLGLDRTKIRKLPESIECLANLHTLN
LSGCESLHELPKNITRLSNLRCLRIEDTPLTHVPKGVGKLKNLNYLSGFLVGHCDSMNKMDGGCDLDELQ
YLCNLRYLRMDKLERATSTVNRNFVLANKTFLRRLTLGWTMNDNENNEEQITEAERIFNQLCPPPTLQGL
RIIDSFPGRHFPEWMVSTSVLDSLADLTFLCFVNFPSCTVLPPLGQLPNLKILEIEVGEAIKNIGPEFFG
YRTPAFPKLEYLEFKNMPNWEAWVLREAQDGVDPNEDVHASNLNLFPSLKQCFFRYCPKLKNSILPSNRL
LQINLCPKLEYVEKVGMLQQLEVIFPSEINQLPQWVSRLINGILHSLQTFYMECNSVLLDSCSKGKQNWH
IIQQIPKVTIDSIDRERRLLLNKDSYKYEIKDEFGSFITLVSPLFS


>XP_042467180.1 putative disease resistance RPP13-like protein 1 [Zingiber officinale]
MLARNVYNDSRIHDFFPRKTWLYVSKRFSGDELLKEQIRSFGGDHGKARSKAELELKLSHLLPKKFFIVL
DDLWNANVWEDLLKPPFKYSSGGILITARDERVARQMGASIHCVEKMDKVTSWMLLSTLVSRDGEDEELC
KLKATGGEIVKKYDGLPLAIKTVAGVLRSKERCEKEWNKVLERLLLGIWVAEGFVKPQGYRLLEDLAEGY
YEELLGRNLLQLHPFYLDNSRCSMHGLLRSLAVYLVEEESVSISNGERLERPNSLTKIRHLSVSDMGEEV
AVPEEVVTQNCLRTLLVWNSLKTKRIRADLHEKLGQLRVLCFSNTEIDRIPDSLGNLIQLRFLLYLPDAI
TKLQNLRCLRVGGTPLNHLPKGIGNLTKINHLNGFLIGHERDTQGQVEDCALDDLQSLNDLRFLYVAALK
RARRGSLADLTLCGNQIAEDFAESLSELFPPSSLECFTEEENQRNVRLFSELSLPSSLEGLSICHFLGQE
LPKCMDRCMPMSFPNLQILGLHCFLLCAQLPVLGQLPQLKVLSIARADAIVTVGPELLYGQSPLTTLVAF
PKLEYLEFMIMPNWEQWSFGETETAKAQELQLLPSLKRLCVVDCPKLKALPDGLHHATNLEELRIYGAHE
LGEVKNLPSLTTELFLRDNKKLEKVSNLPMLKSLIVGSCPLLKQVDSLSALEKLELQQNSSRRLPESLGT
QEDPLPVWLPELLEQHMKGYAASGVLLVYCSFSLLCSCCKDGPYWHTIQQSPGVTMKSLEGRAYMTYTKN
PFKYESNASFHCYHFSSL


>XP_042467181.1 putative disease resistance protein RGA3 [Zingiber officinale]
MAEILSDFAGRCLSKLLSFVEGEATKILGVKDDLKKLQRRLLRVRGVLEDAEKKRHGSAEINAWVREMKD
IMYDVEDLLDLCKTKAENLWVNHSPLPSASDFSCLPLSRQIANKVREVNDRLDEISEDRHVMSRLHEIDP
SIHDSGINTRNTSPLLIQSDIVGTQIKEVSESLVKSLITERDEGWKIFGIVGMGGIGKTTLARNVYNDSR
IPGYFPRKTWLCVSKEFSGNELLKELIRSVGGDHGEARSKSELELILSHLLPKKFFIVLDDLWNANVWED
LLRAPFKCSSGGILITTRDERVARQIGASSIHCVEKMDKLTSWMLLSTMVSRDGEDEDLCQLEAIGGEIV
KKCDGLPLAIKTVAGVLRSKERCEKEWNKVLESEIWSMNQLQEELPRALYLSYEDLPSHLKQCFLFCSLY
PENISMHYKDLTRSWVAEGFVKPQGYRLLEDLAEGYYEELLGRNLLQLHPLYLDNSVCTMHGLLRSLAVY
LVEEESVSISNGERLESTNTLTKIRHLSVSNMGEEVAVPVELVSQNCLRTLLVWNSFKTKRIGADLFEKL
GQLRVLCIAATEIERIPDSLGNLIQLRYLDLDRTNVHSLPESIGCLKNLEILNLQSCRSLHYLPDDITKL
QNLRCLRVRGTPLNHLPKGIGNLTKINHLEGFLIGHERDTQGEVEDCALDDLQSLNDLRFLHVAALKRAR
RGSLVLANKTFLKHLDLRWLPPCVKADLTRCGNQAAEDIAKSYSDLFPPSSLECLTEAESQRNVRLFSEL
SLPSSLEFLSIYHFLGQELPKCMERCTPMSFPNLQFLDLNCFISCTHLPVLGQLPQLKILSIARADAIVT
VGPELLYGQSPLTTLVAFPKLEYLEFMIMPNWEQWSFGEIETAKAQELKLLPSLKRLCVVDCPKLKALPD
GLHHATNLQELRIYGAHELGEVKNLPSLTNELFLRDNKKLEKVSNLPMLKSLIVGSCPLLKQVDSLSALE
MLELRHNSSQRLPSDASLQHLSLDTQEDPLPVWLPELLEQNMKGYAGSGVLLVECSLSLLRRCCKDGPYW
HTIQQFAGVLMQSEEGSAYMTYTKNPFNLLSTAARHWSLTFVADRCRLPPAPPPPVARRRRPSPPVAGHR
PPPSPLPAGRRPPAVAHRRRLAMTVACCGDRRWRRQLVADGCRKLRQRCGDHR


>XP_042467204.1 putative disease resistance protein RGA4 [Zingiber officinale]
MEKLKELSTIIDMVIQDVEACPVMDAAVKNLLRKLKHLAYEVEDVVDYYDTKALRKQRSRAYSRPVRDFF
SSNNNQLVFKSKISGMIKAVTENLDSILLEKSILKNLSQGSNPSAYGEIHAHNSLAVIGRETEKAMIVNM
LTDDEGSSSGTLKVIAIVGMGGLGKTTLARHVFNDKRVKDHFNTYWKVVGKNFKPTEIMKSILELAVDAK
VDISEPELVRGRLETVLSLSGKRFLLVLDDVWNEDALLWRELKAALSCGARGSTVLVTTRSQKVSSIMGK
FNTHQIQQLSRDDCLSLFRKFAFGDAEPNENLMKIGEKIVEKCAGVPLAAVSLGSALHSIRDETYWSSVL
NSEVGQLRDEDQKFLAVLKLSYDALPPWSKKCFAFVSLFPKNYAMKKDDLIQMWAANGFVSSEGNFDAET
VGNSIFDDLVLRSCFLPSKKCDDGRHVTESTMHDLMHDLARSISKDQYYNKGYSEPTIYA


>XP_042467405.1 putative disease resistance protein RGA3 [Zingiber officinale]
MYLLDALVNNLVDHVSQELQKVHGVADELVTLQNIVSSIQAVLKDAQESEETRNSVKQQLNELREVAYRA
NDILDDVATEQQRQQLIKYAAVRNSLGAVNPKRFFFKQDVYDRIQSIKTELDEIVKKCPLSALTSHNGSQ
RTHISETTSVSPPCVLGRERDKQKIKELLVPLNGQSDSTASVISIFGMPGVGKTTLAQQLFDDETVKKHF
ELRLWVYVSNDFDLMRIMRCMIESIDRFKCDLASLNNLQQEIRKKVSGRRYLLVLDDVGQESQEWERLKN
CLYSADEGSKILVTTKNEQVAAFMAANSPPVLYRLEGLSMEDCWSLICQPALSRNPSASFTLDFYRSHAV
NRCGGLPMAAKALGQRLAREADRNKWGAILTSQSWEFSGAGSTSITEPLGLSYKYLPNYLKPCFAYLSII
PKRCELERDFIIQLWMRKASSGREGRNRWKTSAATTSTPSGAARSCSIHISITRAVGKEECSVIEPGTEL
HLSASVRHLSVNYEEFVRRVTPDEVYKCKGLQSLLLIGNSTSRPIMVLPGDLAQKLSSLRTLMLTNSRLT
QLPESIGDLRHLRCLQLQNTSIKRLPDSVSRLYNLQTLGLRNCYDLEELPKDMSRLRNLRHLDLHLDDNS
QGTLRCMPPEIGLLTHLRTLNRFVVSKRHECGLSQLENLNDLRSELLIERLDLVSSREDATNANLSSKGH
IHRLELTWNYSSVTDASARSAGYNSRENILEYLKPHPRLKEIGVVGYGGTLLPKWMGDSSLFNLETVRIS
KTYSWLNLLPPLGQLPNLKYLFLEEMHGLKHLDCSFCGRNEIRFPKLEKLHLENMSGLQEWLGDHRCALP
SLSELTIKNCPALQQLTHELPSLTKLVIEASPYFAGLPDFPKLQSLEVKTNDDWIWRSCRAAISSLPSLT
LSGLTRADLPFYIGSRHASIRRLEIGYCSQLKFIPDGWLPECLSRFVIRHCPMLQNVPAGLTRLTMLEDL
EIENCEQLEHLPVGLRNMNSLAHLEISDCPALAWLPSDGLPRKLQFLSISNCPELIQKLQHQDLFTRRQD
LQLWINGERVVT


>XP_042467407.1 putative disease resistance protein RGA3 [Zingiber officinale]
MEFVSMFLLDALVNTLADTLQDHVFQELQKVHRVGDELVKLEKSVSSIQAILSDAQEIEETRNIVKQLLN
ELREVAYRANDILDDVATEQQRQQLIKFAAVRNSLGAVNPMRFFFKQDVYHKIQSIDEELDKIVKRCPLI
ALSPRNRSQRTHSSESTPAIPPCVLGRERDKQKIKELLMPFSGRTDSAASVISIFGMPGVGKTTLAQELF
DDETVKKHFELRLWVYVSHDFDLMRIMRFMIESIDGFKCDLTSLNNLQQEVRKKVSRRRYLLVLDNVWQE
SQEWEKLKSFLYSADEGSKILVTTKSEQVARFMAANSPPYHLEGLSMDDCWSLICQQVLSGNPSATLTHD
FSQSHALRRCMGLPMAAKALGQRLAREADRSKWEAILTGQSWEFSGADRSITETLSLSYQHLPHYLKPCF
EYLSVIPKGFKLERDFIIQLWMAQSFIRPKGTEHMEDVGSDYLDSLRSSSFLQYSHFDHKSRRQRYVMHD
VFHEFARHVAAEGCSVMEPSTELHLSLSAGVRHLSVNYEELVRRVPRGGDMYEQVYKCKGLQSLLLIGNS
TSRPTMVVPDDLAQRLRSLRTLMLTNSCLTQLPESIGDLSHLRCLQLQNTGIKRLPDSVSRLYNLQTLGL
RNCYDLEELPKDMSKLRNLRHLDLHLNGNSQGSNAGGKLRLMPPEIGLLTHLRTLSRFVVSKRHECGLSQ
LENLNDLRSELLIERLDLVSSGEDAKNANLSSKEHIHRLELTWNYSDVTEASASSAGYNSRENILKYLRP
HNKLKEIGVVGYGGTLLPTWMGDSSLENLETVWISKTYSCQNLPPLGQLPKLKYLFLEEMHGLKHIECSF
CGRNEIRFPKLEKLHLENMSGLQEWLGDHRCALPSLRELTIKNCPALQQLTHELPSLTKLVIEASPYFAG
LPDFPKLQSLEVKTNDDWIWRSCATISSLPSLTLSGLRRANLPSEIGSCHSFIRRLEISYCSQLIFIPDG
WLPAFLSHFVIRHCPKLQNLPAELTRLTRLEDLEIEKCEKLEQLPFGLRNMNLLAHLEISDCPGLSWLHG
LPRKLQFLSISNCPELSQKLQDQGWFTRRKDLQVWINGKHVLT


>XP_042467552.1 disease resistance protein RGA2-like [Zingiber officinale]
MSDLTKVLQTEIAIHLTELLWKRTHHVIKSLRMHRKSKVLIANSGLEELLAFLRYNWFSMTDYLYNKISN
KFLQDWLWRFDDFFYMTEDVLDDFEFMLFPSDKPQGRDDFSAFDEAMQKLPEVIDTAADLFLEITDFRVA
RKEFPRLSYEEVMEMRTILKRPAAFEQVQSRVEKPLATSSGLPTLPYEVRELKGRVVEKNKILEALFHRA
EGESKKLPISISISGPVGIGKTDLARAVYNSAQVEAEFDVRAWIYMGNHHLDKWLTLQRSESDSVDQPSK
LHRSSILDILNILETEMTAKKVLIVLDNLEGMGDEVDVNNIIYQCRRKGARIIVTTQSEDVGRLSAVWLN
VELNGLEEEDYLELFKECALGDRNRNKYPELENIVGEIAKRFGGNPLAAVMIGRHLKWHQSEDRWRIISR
SNLGMIDPTESNILSVLRHSYEKLPGDQKQCYLACALFPKNYPFKQNQLFKIWKAIGCCSHISNQSSWTW
KNIEPFFVSSARKDGEFILHAIFHELADYICDGEFFRLEDEIKEEDDVVQIPDKARHVYVTADYSVKVYR
VLQEKTHLRSLVIGGVLSSEEHKSSFMGWLEEVLRNLKGLRLLLIYVLPSGKLPDAIGGLRHLQYLELPI
DTITKESIQELPAWLSDNRFVGLRRLLNLKALREAILKKGSIQEHPTW


>XP_042468718.1 putative disease resistance RPP13-like protein 1 [Zingiber officinale]
MAVVLNFFVIRYLGKLSDVIEGEIVKVLGVKEEIKRLHRKLLRISPYIQDAEKRIHRDPAINNWVKELKD
IMYDAEDILDLCLIEGGRLLEAHPSSPLEVCSPVSLLSSCFQCCKFRRNIWNKIKRVNDRLDEIKDDSNV
IPRLVAHRNEGLQDNTVKMSSPTSSTHVATDIVGTQIVDAAQMLISEIERNKNKCSVLGISGMGGIGKTT
LAQKIFNDEMVKKQFPKRVWLHVSKDYSQIELLKQILRGVGGHDDGVQSRAEVEGRIVPLLSESLLLVLD
DIWSASAWGDLIRNPILNGSCRATVLFTTRHEDVVAEMRADFVHHVEKMHEDSGWELIRKIVFGEGENEI
ISELKEVGMEIVRKCDGLPLAIKVMAGVLFHKERTKREWIKVVESDLWFMTENRNEVSNALYLSYEDLPS
HLKQCFLSCAFYRGISFRSDLIRLSMAEGFVIEQSDRLMEDTAEKYYEELIARNLLQNYTKNLNSVGVVM
HDVLRSFGEKLMEEEGIIINNGQCTSTNSLSKIRRLSISNQGDDVLSLPNVITEQKCLRVLRLINCPRIN
RIENHAFESLKRLRVLDLCDTSIDSLPDCLTKLLHLKYLDLDRTKIRRLPESIGCLANLQTLNLSECESL
HELPMGITKLSNLRCLRIEKTPLTHVPKGVGKLKNLSTLFGFFVGHCDSMSKMDGGCDLDELQYLCNLRH
LRIDKLERATRTRNGNFMLANKKFLRRLILEWTKNNNENNEEQITEAEMICNQFSPPPTLQSLAIKNFPG
RQFPEWMVSTSALDSLANLTLLSLANFPSYTVLPPLGQLPNLKVLDIEGGEAIRSIGPEFLGRRTPAFPK
LEYIAFDNMRNWEAWILREALDVQATNLNLFPNLKSCNIINCPKLKNSILPSNRYLQINLCPNLECVEKV
GMLQQLVVIFPAEIKQLPQWLSSLINATLHSLQLFYMHCDSLLLDSCSKGKQNCHIIQQIPKVTIYSIDR
KTRLLFNKDSYKYEIKDEFGSFISLDQPSFHG


>XP_042468719.1 putative disease resistance RPP13-like protein 1 [Zingiber officinale]
MAVVLNFFVIRYLGKLSDVIEGEIVKVLGVKEEIKRLHRKLLRISPYIQDAEKRIHRDPAINNWVKELKD
IMYDAEDILDLCLIEGGRLLEAHPSSPLEVCSPVSLLSSCFQCCKFRRNIWNKIKRVNDRLDEIKDDSNV
IPRLVAHRNEGLQDNTVKMSSPTSSTHVATDIVGTQIVDAAQMLISEIERNKNKCSVLGISGMGGIGKTT
LAQKIFNDEMVKKQFPKRVWLHVSKDYSQIELLKQILRGVGGHDDGVQSRAEVEGRIVPLLSESLLLVLD
DIWSASAWGDLIRNPILNGSCRATVLFTTRHEDVVAEMRADFVHHVEKMHEDSGWELIRKIVFGEGENEI
ISELKEVGMEIVRKCDGLPLAIKVMAGVLFHKERTKREWIKVVESDLWFMTENRNEVSNALYLSYEDLPS
HLKQCFLSCAFYRGISFRSDLIRLSMAEGFVIEQSDRLMEDTAEKYYEELIARNLLQNYTKNLNSVGVVM
HDVLRSFGEKLMEEEGIIINNGQCTSTNSLSKIRRLSISNQGDDVLSLPNVITEQKCLRVLRLINCPRIN
RIENHAFESLKRLRVLDLCDTSIDSLPDCLTKLLHLKYLDLDRTKIRRLPESIGCLANLQTLNLSECESL
HELPMGITKLSNLRCLRIEKTPLTHVPKGVGKLKNLSTLFGFFVGHCDSMSKMDGGCDLDELQYLCNLRH
LRIDKLERATRTRNGNFMLANKKFLRRLILEWTKNNNENNEEQITEAEMICNQFSPPPTLQSLAIKNFPG
RQFPEWMVSTSALDSLANLTLLSLANFPSYTVLPPLGQLPNLKVLDIEGGEAIRSIGPEFLGRRTPAFPK
LEYIAFDNMRNWEAWILREALDVQATNLNLFPNLKSCNIINCPKLKNSILPSNRYLQINLCPNLECVEKV
GMLQQLVVIFPAEIKQLPQWLSSLINATLHSLQLFYMHCDSLLLDSCSKGKQNCHIIQQIPKVTIYSIDR
KTRLLFNKDSYKYEIKDEFGSFISLDQPSFHG


>XP_042468785.1 putative disease resistance RPP13-like protein 1 isoform X1 [Zingiber officinale]
MAVVLDFFVKRYLGRLSDFLDGEIGKVLEVKEEIKKLHRKLSRISPYIQDAEKRRHRDPVINNWVKELKD
IMYDAEDILDLCMVEGGRFLEAQPFAPSGVCSSVSLLSSCFQCYKFRTNIWNQIKRVNDRLDEIKRVIPR
LVEHRNEGLQDNIVKMSSSTSPTHVAEDIVSKQIIDAAQNLISEIEHNKKKCSVFGISGMGGIGKTTLAQ
KIFNDEMMKKQFPNRVWLHVSKDYSQIELLKQILRGVGGHDDGVQSRAEVEGRIIPLLSESLLLVLDDIW
SASAWGDLIRNPILNGSCRTAIIFTTRHEDVAREMRADFVHHVKKMHDDSGWEFIRKIVFGDGEDIMISE
LKEIGMEIVKKCDGLPLAIKVMAGVLFHKERTKREWKKIVESDSWFMKETEDKLLKALYLSYEDLPSHLK
QCFLSCAFYRSISYRWDIIRLWVAEGFVIEQSNSLMEDIAENYYEELIARNLLQIDSRFLDGRVFVMHDV
LRSFGEKLMEEEGIIINDTQCTSTTSLTKVRRLSISNQGDVLLLPNVIIEQKCLRALHLLNCSQIKRIED
HVFESLKRLRVLDLHDTSIVSLPDSLLKLLHLKYLNLCGTKIRKLPESIECLANLQTLNLSECESLHELP
KGITRMSNLRCLQIVSTPLTHVPKGVGKLKNLNTFDGFFVGHCDSMSKMDGSCDLDELQYLCNLRYLSIY
KLERARTIGSRHTVLANKPFLRGLKLVWTMNIENNEEQITEGERICNQLSPPETLKDLWIDNFPGQQFPA
WMVSTHDSFADLTTLWLCNFPSCMVLPPLGQLPNLKHLHIEGGEAIRSIGPEFLGCTTPAFPKLEHLKFT
SMPNWESWVLREAQDDEKPNEDVHARNLNLFPNLKQCYFLHCPKLKSSLLPPTRFLKIKICPNLEYVEKV
GILQLRKLEVIFPSEIQQLPPWVSGLINATLHSLQTLYMRCNLVLLDSCRTGKQNWHTIEEIPKVIIHSI
DPEARLLLSKDGYKYQIKDEFGSFVDLDQ


>XP_042468786.1 putative disease resistance RPP13-like protein 1 isoform X2 [Zingiber officinale]
MYDAEDILDLCMVEGGRFLEAQPFAPSGVCSSVSLLSSCFQCYKFRTNIWNQIKRVNDRLDEIKRVIPRL
VEHRNEGLQDNIVKMSSSTSPTHVAEDIVSKQIIDAAQNLISEIEHNKKKCSVFGISGMGGIGKTTLAQK
IFNDEMMKKQFPNRVWLHVSKDYSQIELLKQILRGVGGHDDGVQSRAEVEGRIIPLLSESLLLVLDDIWS
ASAWGDLIRNPILNGSCRTAIIFTTRHEDVAREMRADFVHHVKKMHDDSGWEFIRKIVFGDGEDIMISEL
KEIGMEIVKKCDGLPLAIKVMAGVLFHKERTKREWKKIVESDSWFMKETEDKLLKALYLSYEDLPSHLKQ
CFLSCAFYRSISYRWDIIRLWVAEGFVIEQSNSLMEDIAENYYEELIARNLLQIDSRFLDGRVFVMHDVL
RSFGEKLMEEEGIIINDTQCTSTTSLTKVRRLSISNQGDVLLLPNVIIEQKCLRALHLLNCSQIKRIEDH
VFESLKRLRVLDLHDTSIVSLPDSLLKLLHLKYLNLCGTKIRKLPESIECLANLQTLNLSECESLHELPK
GITRMSNLRCLQIVSTPLTHVPKGVGKLKNLNTFDGFFVGHCDSMSKMDGSCDLDELQYLCNLRYLSIYK
LERARTIGSRHTVLANKPFLRGLKLVWTMNIENNEEQITEGERICNQLSPPETLKDLWIDNFPGQQFPAW
MVSTHDSFADLTTLWLCNFPSCMVLPPLGQLPNLKHLHIEGGEAIRSIGPEFLGCTTPAFPKLEHLKFTS
MPNWESWVLREAQDDEKPNEDVHARNLNLFPNLKQCYFLHCPKLKSSLLPPTRFLKIKICPNLEYVEKVG
ILQLRKLEVIFPSEIQQLPPWVSGLINATLHSLQTLYMRCNLVLLDSCRTGKQNWHTIEEIPKVIIHSID
PEARLLLSKDGYKYQIKDEFGSFVDLDQ


>XP_042468787.1 putative disease resistance RPP13-like protein 1 isoform X1 [Zingiber officinale]
MLHTQSSISELIHLSQEMAMVLEFFVSRYLKKLSDFIEGEICKMLGVKEEIERLHRKLSRIRIYIQDAER
RRHRDSVINNWVKELKDIMYDVEDILDLCMIEGGRLLEAQPSTSSWVCSRISLLSSYIHRSTFNTNIWNQ
IKRVNARLDEIKEDSSVIPRLFEHITEAFQDNLVKKSSPSSFKHVATDIVGKQIADDAQNLISKIDQSKK
SCYVLGISGMGGIGKTTLAQKIFNDEMVKKQFPKRVWLHVSKDCSHINLLKELLREVGGNDNGVQSRAEI
EGRIIPLLSESMLLVLDDIWSASVWMDLLGNFILNDSRRTTILFTTRHENVAKEMTYDFVHHVKKMDEGS
GWKLIRKIVFGDGNDQIISELKEVGMEIVKKCYGLPLAFKVIAGVLRNKEKTKREWEKVASDLWSMKEKV
DELSNALYLSYEDLPSHLKQCFLSCAFYRGVSLRSDIIRLWVDEGFVIEQSDNLMENIAEDYYKELIARN
LLQIDFRLLDGVRFVMHDGLRSLGEKLMEDQAIFINDAQYTSTNSLTKVRCLSISNQADVLWLPNAIIEQ
KCLRALHFANCPQIERIENHAFESLKYLRVLNLNDTSIGSFPDSLMKLFHLKYLDLDRTKITKLPESIEC
LANLQTLSLSGCESLHELPKGITRLSNLRCLRIVDTPLTHVPKGVAKLKNMNQLEGFLVGHCDSMSRMDG
GCDLDELQDLCNLIYLFIDKLERATTRGNRNFVLANKLFLRRLTLGWRVNNENNEEQITEAERICNQLRP
PPTLEVLCFSNFVGRQFPEWMVSTSILDSLVDLTYLNLNIFPSCTMLPPLGQLPNLKLLNIEQGEAIKSI
GPEFLGCRTPAFPKLEYLAFDNMPNWEEWVLRMAQDVVDPIEDVHARNLNLFPNLNSCGIIRCPKLKNSI
LPLTRLLKIKLCPNLEYVEKVGMLQQLFVIFPPEIQQLPQWVSNLINATLHSLQTFDMECNSLLLDSCSK
GKQNWHIIQKIPKVTINSIDREARLLLHKGSYKYEIKNEFGSFITLDQSSNKRRSACLQHPRQPTRKLTR
RR


>XP_042468788.1 putative disease resistance RPP13-like protein 1 isoform X2 [Zingiber officinale]
MYDVEDILDLCMIEGGRLLEAQPSTSSWVCSRISLLSSYIHRSTFNTNIWNQIKRVNARLDEIKEDSSVI
PRLFEHITEAFQDNLVKKSSPSSFKHVATDIVGKQIADDAQNLISKIDQSKKSCYVLGISGMGGIGKTTL
AQKIFNDEMVKKQFPKRVWLHVSKDCSHINLLKELLREVGGNDNGVQSRAEIEGRIIPLLSESMLLVLDD
IWSASVWMDLLGNFILNDSRRTTILFTTRHENVAKEMTYDFVHHVKKMDEGSGWKLIRKIVFGDGNDQII
SELKEVGMEIVKKCYGLPLAFKVIAGVLRNKEKTKREWEKVASDLWSMKEKVDELSNALYLSYEDLPSHL
KQCFLSCAFYRGVSLRSDIIRLWVDEGFVIEQSDNLMENIAEDYYKELIARNLLQIDFRLLDGVRFVMHD
GLRSLGEKLMEDQAIFINDAQYTSTNSLTKVRCLSISNQADVLWLPNAIIEQKCLRALHFANCPQIERIE
NHAFESLKYLRVLNLNDTSIGSFPDSLMKLFHLKYLDLDRTKITKLPESIECLANLQTLSLSGCESLHEL
PKGITRLSNLRCLRIVDTPLTHVPKGVAKLKNMNQLEGFLVGHCDSMSRMDGGCDLDELQDLCNLIYLFI
DKLERATTRGNRNFVLANKLFLRRLTLGWRVNNENNEEQITEAERICNQLRPPPTLEVLCFSNFVGRQFP
EWMVSTSILDSLVDLTYLNLNIFPSCTMLPPLGQLPNLKLLNIEQGEAIKSIGPEFLGCRTPAFPKLEYL
AFDNMPNWEEWVLRMAQDVVDPIEDVHARNLNLFPNLNSCGIIRCPKLKNSILPLTRLLKIKLCPNLEYV
EKVGMLQQLFVIFPPEIQQLPQWVSNLINATLHSLQTFDMECNSLLLDSCSKGKQNWHIIQKIPKVTINS
IDREARLLLHKGSYKYEIKNEFGSFITLDQSSNKRRSACLQHPRQPTRKLTRRR


>XP_042468789.1 putative disease resistance protein RGA3 [Zingiber officinale]
MAVVLEFFVKIFLSKLSVFIQGEIGKVLGVKKEIERLHRKLSRIRFYIQDAERRRHRDSAINNWVKELKD
VMYDAEDIFDRCLIESGRLLEAQPSASSGVHSWFRTLNFRRNICDEIRRVNNRLNEINDDNNVVRRLVED
KHEGRLVQRSSSTSPTHVSTDIVGTQIVDATQNLISKIEESKNKCTVLGISGTGGIGKTTLAQKIFNDEM
VKKQFPNRVWLHVFKDYSEIEILKQVLRGVGGNDVGVETKAEVEGRLDPLLSGSLLLVLDDIWSANVWRE
LLRNPILKGSCRSVILFTTRHEVVAREMRADYVHPAEKIDEGSGWELIRKIVFGDGEDAIISELEEVGME
IVRKCDGLPLAIKVMAGVLFHKERTKTEWKKVVESDLWFRKEIKLSNALYLSYEDLPNHLKQCFLSCAFY
HGISHRSDIIRLWVAEGFVIEELDSLMEVTAKDYYKELIARNLLQIDQRFEDGRLFVMHDVLRSFGEKLM
EEEGIIISGENHCMNFQMASQG


>XP_042468790.1 putative disease resistance RPP13-like protein 1 [Zingiber officinale]
MAMVLEFFVSRYLKKLSDFIEGEICKMLGVKEEIERLHRKLSTIRIYIQDAERRRHRDSVINNWVKKLKD
IIYDVEDILDLCMVEGGRLLEAQPSTSSWVCSRISLLSSYIHRYTFNRNIWNQIKRVNARLDEIKEDSSV
IPRLFEHITEAFQDNLVKKSSPSSFKHVATDIVGKQIADDAQNLISKIDQSKKSCYVLGISGMGGIGKTT
LAQKIFNDEMVKKQFPKRVWLHVSKDCSHINLLKELLREVGGNDNGVQSRAEIEGRIIPLRPKSMLLVLD
DIWSASVWMNLLRNFIWDDSCRTTILFTTRHENVAREMRADFVHHVKKMKDDNGWELIRKIVFGDEEDII
ISELEEVGMEIVKKCDGLPLAVKVIAGVLFHKEKTKREWENVAKSDLWFMKENEDQLSNVLYLSYEDLPS
HLKQCFLSCAFYRGVSLRSDIIRLWVDEGFVIEQSDNFMENIAEDYYKELIARNLLQIDFRFLDGIRFVM
HDGLRSIGEKLMEDEAIFINDAPCTSTNSLTKVRRLSISNQADVLLLPNTIIEQKCLRALHFTNCPQIER
IENHAFESLKYLRVLNLNDASIGSFPDSLMKLFHLKYLDLDRTKITKLPESIECLANLQTLSLSGCESLH
ELPKGITRLSNLRCLRIVDTPLTHVPKGVAKLKNMNHLEGFLVGHCDSMSRMDGGCDLDELQDLCNLIYL
FIDKLERATTRGNRNFVLANKLFLRRLTLGWRVNNENNEEQITEAERICNQLSPPPTLEVLRIGNFIGRQ
FPEWMVSTSILDSLVDLTYLSLVIFPSCTALPPLGQLPNLKLLNIEQGEAIKSIGPEFLGCRTPVFPKLE
YLAFDNMRNWEEWVLRVAQDVVDPIEDVHASNLNLFPNLEKCYFIDCPKLKNSILPSTRLLQIKLCPNLE
YVEKVGMLQQLFVIFPPEIQQLPQWVSNLINATLHSLQTFDMECNSLLLDSCSNGKQNWHIIQQIPKVTI
NSIDRETRLLLHKGSYKYKIKNEFGSFITLD


>XP_042468791.1 putative disease resistance RPP13-like protein 1 [Zingiber officinale]
MAMVLEFFVSRYLKKLSDFIEGEICKMLGVKEEIERLHRKLSTIRIYIQDAERRRHRDSVINNWVKKLKD
IIYDVEDILDLCMVEGGRLLEAQPSTSSWVCSRISLLSSYIHRYTFNRNIWNQIKRVNARLDEIKEDSSV
IPRLFEHITEAFQDNLVKKSSPSSFKHVATDIVGKQIADDAQNLISKIDQSKKSCYVLGISGMGGIGKTT
LAQKIFNDEMVKKQFPKRVWLHVSKDCSHINLLKELLREVGGNDNGVQSRAEIEGRIIPLRPKSMLLVLD
DIWSASVWMNLLRNFIWDDSCRTTILFTTRHENVAREMRADFVHHVKKMKDDNGWELIRKIVFGDEEDII
ISELEEVGMEIVKKCDGLPLAVKVIAGVLFHKEKTKREWENVAKSDLWFMKENEDQLSNVLYLSYEDLPS
HLKQCFLSCAFYRGVSLRSDIIRLWVDEGFVIEQSDNFMENIAEDYYKELIARNLLQIDFRFLDGIRFVM
HDGLRSIGEKLMEDEAIFINDAPCTSTNSLTKVRRLSISNQADVLLLPNTIIEQKCLRALHFTNCPQIER
IENHAFESLKYLRVLNLNDASIGSFPDSLMKLFHLKYLDLDRTKITKLPESIECLANLQTLSLSGCESLH
ELPKGITRLSNLRCLRIVDTPLTHVPKGVAKLKNMNHLEGFLVGHCDSMSRMDGGCDLDELQDLCNLIYL
FIDKLERATTRGNRNFVLANKLFLRRLTLGWRVNNENNEEQITEAERICNQLSPPPTLEVLRIGNFIGRQ
FPEWMVSTSILDSLVDLTYLSLVIFPSCTALPPLGQLPNLKLLNIEQGEAIKSIGPEFLGCRTPVFPKLE
YLAFDNMRNWEEWVLRVAQDVVDPIEDVHASNLNLFPNLEKCYFIDCPKLKNSILPSTRLLQIKLCPNLE
YVEKVGMLQQLFVIFPPEIQQLPQWVSNLINATLHSLQTFDMECNSLLLDSCSNGKQNWHIIQQIPKVTI
NSIDRETRLLLHKGSYKYKIKNEFGSFITLD


>XP_042468793.1 putative disease resistance RPP13-like protein 1 [Zingiber officinale]
MAMVLEFFVSRYLKKLSDFIEGEICKMLGVKEEIERLHRKLLRIRIYIQDAERRRHRDSVINNWVKELKD
IMYDVEDILDLCMVEGGRLLEAQPSTSSWVRSRVSKLLSYLMSSPNENASKFSRNIWNQIKRVNDRLDEI
KEDSSVVPRLLEHITEDLQDNPGKKSSPTSPTHVATDVVGTQIVDAAQNLISKIEQSKKKCSVLGISGMG
GIGKTTLTQKIFNDEMVKKQFPKRVWLHVSKDCSYINILKELLREVGGNDNGLQSRAEIERRIVPLLSES
LLLVLDDIWTATVWMDWLRNLILNSSCRTAILFTTRNENVVKEMRPDFVHHVKKMKDDSGWELIRKIIFG
DEEDIIISELEEVGMEIVRKCYGLPLAIKVIAGVLFHKKRTKREWKKVVESDLWSMKEKVDELSNALYLS
YEDLPSHLKQCFLSCAFYRGVSLRSDIIRLWVDEGFVIEQSDNLMENIAEDYYTELIARNLLQIDFRFLY
GVKFVMHDVLRSLGEKLIEEEGILINDAQCTSKNSLTKVRRLSISNQADVLLLPKAIIEQKCLRALHVTN
CPQIERIENHAFESLKYLRVFHLNDTSIDSFPDSLMKLFHLKYLDLDRTKITKLPESIECLANLQTLSLS
GCESLHELPKGITRLSNLRCLRIEGTQITHVPKGVGKLKNLTHLAGFVVGHCDSMSRMDGGCDLDELQYL
CSLINLFIYKLERATTIGNRNFVLANKLFLRRLILAWTVNNENNEEQITEAERICNQLSPPPTLEVLCFS
NFIGRQFPEWMVSTSILDSLVDLTYLNLNIFPSCTMLPPLGQLPNLQILNIEQGEAIKSIGPEFLGCRTP
AFPKLEYLAFNNMCNWEEWVLRMAQDVVDPIEDVHARNLNLFPNLNSCNIIHCPKLKNSILPLTRHLQIK
LCPNLEYVEKVGMLQQLFVIFPPEIQQLPQWVSNLINATLHSLQTFDMECNSLLLDSCSKGKQNWHIIQK
IPKVTINSIDREARLLLHKGSYKYEIKNEFGSFITLDQSSNKRRSACLQHPRQPTRKLTRRR


>XP_042468953.1 disease resistance protein RGA2-like [Zingiber officinale]
MEPLAISAAGFLGQRLVSLLQLDKKLKDLVDIERKMEKLKELPTIIDTVIQYVEACSVRDAAVKKLLRNL
KHLAYDLEDVVDYYDTKALRKQRSRAYSRPVRDFFSFNNNQLVFKSRISGMIKAVTENLDSILLDKAILE
NLPQGTNRISQSAYREFHSHNSLAVIGRETEKEMIINMLTDEEGSSNSTTMKVIAIVGMGGLGKTTLARH
VFNDERVKAHFGKLNTYWKVVGAEFDPTKIMKSILELATGAPVSISEPELVKRELEKALSEKRFLLVLDD
VWNEDKSQWTALEAVLTCGARGSKVLVTTRSPKVSSIMGSFNTHQIQQLPRDDCLSLFQQFAFGDEEPNE
NLMEIGGKIVEKCGGVPLAAKSLGSLLHSTRDETYWSSVLNSEVWQLGDEGEKFLAVLKLSYDALPLRSK
KCFAFGSLFPKNYVMKKDELIQLWTANSFVCSEGNFNAETDGNRIFDDLVLRSFFLLAPSEKCDDDGRHV
TECTMHDLMHDLARSISEDEFYNDVDDGKKDIQKRTYHIWLKYEEISNTSLFKMPLYLRTLSLRSCLSFK
KAHLLQFVFSKLKLLRVLDLSNNYIKEVPTSIGNLILLRYLTLSGNRIKFLPDAITLLQNLRYLSLIENP
LQQLPKKLRNMQSLEYLHCDCRDLTHMPLGLSRLTSLRSLSCYVSDDNRNGSCSITELEDLKLHGNMRIK
FSKNSSNYSCGGRKILKNKIFNELSLSFNCSETNDMSMLDDLCPNMNLKKLQILDYGSRQFPTWLMESQL
LNLVEIILRDCNFCEHIPHFGNLQFLRKLVLDDIDGVKHLGAEFHGHGPIRGFPSLQELQLEWMRNLEEW
SESDDADKSFPLLKTLKIRHCPKLKAVPRFPTIEFLNLDNCSESLVSCVRRMTSLSHLILVGMKGMTSLP
SGCLRNLTSLMRLEILSCNELQFLPMDEMQLLTMVHSLSIKKCNNLTSFPLEMGRLGALRYLCLKNPDNN
TLAPNNGSLIVQILNSVHEFDIQICGKNVNLLGQLQHLHTLQQLRISGSHDTSYGPAILGCIRASLSICC
CDELESLMTTAPSTSVLEILDIYDIPNLTILPEWLQYLGSLRMLWICNCPQLGSLPRGLQDLRSLNFLRI
DGCCLQLKRRCKRETGEDWPNISHVPRIGISTRDEAQRCGPFDKFFKINPTRWREI


>XP_042468954.1 putative disease resistance protein RGA4 isoform X1 [Zingiber officinale]
MIASPFLSILCLCFCYCFSFPLLPSSSNVSCSHIHSKQTTRPSFQLAGIAMEPLAISAAGFLGQRLVSLL
QLDKKLKDLVDIERKMEKLKELPTIIDTVIQYVEACSVRDAAVKKLLRNLKHLAYDLEDVVDYYDTKALR
KQRSRAYSRPVRDFFSFNNNQLVFKSRISGMIKAVTENLDSILLDKAILENLPQGTNRISQSAYREFHSH
NSLAVIGRETEKEMIINMLTDEEGSSNSTTMKVIAIVGMGGLGKTTLARHVFNDERVKAHFGKLNTYWKV
VGAEFDPTKIMKSILELATGAPVSISEPELVKRELEKALSEKRFLLVLDDVWNEDKSQWTALEAVLTCGA
RGSKVLVTTRSPKVSSIMGSFNTHQIQQLPRDDCLSLFQQFAFGDEEPNENLMEIGGKIVEKCGGVPLAA
KSLGSLLHSTRDETYWSSVLNSEVWQLGDEGEKFLAVLKLSYDALPLRSKKCFAFGSLFPKNYVMKKDEL
IQLWTANSFVCSEGNFNAETDGNRIFDDLVLRSFFLLAPSEKCDDDGRHVTECTMHDLMHDLARSISEDE
FYNDVDDGKKDIQKRTYHIWLKYEEISNTSLFKMPLYLRTLSLRSCLSFKKAHLFQFVFSKLKLLRVLDL
SNNDIKEVPTSIGNLIHLRYLNLFMNEIKVLPDAITLLQNLRYLNLIENPLQQLPKKLRNMQSLGYLHCD
CFDLTHMPLGLSRLTSLRSLSCFVSDDNRTGSCSITELEDLKLHGNMRIQFSKNSSNYSCGGRKILKNKN
FNELSLSFNFSETNDMSMLDDLCPNMNLKKLEICNYGSRQFPTWLMELQFPNLVEVILNYSYNCEHVPPF
GNLQSLRKLAINSMGEVKRMGAEFHGHGPIRGFPSLQELQLEWMLNLEEWSESDDAEKLFPLLKTLKILN
CPKLKTMPRFPTIEFLNLDNCSESLVSCVRRMTSLSHLILEGMKGMTSLPSGCLRNLTSLMRLEILSCNE
LQFLPREEMQLLTMLHSLSIEKCNNLTSFPLEMGRLGALRYLCFKNPDNNTLAPNNGSLIVQILNSVHEF
DIQICGKNVNLLGQLQHLHTLRELRISGSHDSTDEGVILEYIRASLRICCCDELESLMTTAPSTSVLEVL
YIYDTPNLTILPEWLQYLRSLVRYRSTTASN


>XP_042468955.1 putative disease resistance protein RGA4 isoform X2 [Zingiber officinale]
MEPLAISAAGFLGQRLVSLLQLDKKLKDLVDIERKMEKLKELPTIIDTVIQYVEACSVRDAAVKKLLRNL
KHLAYDLEDVVDYYDTKALRKQRSRAYSRPVRDFFSFNNNQLVFKSRISGMIKAVTENLDSILLDKAILE
NLPQGTNRISQSAYREFHSHNSLAVIGRETEKEMIINMLTDEEGSSNSTTMKVIAIVGMGGLGKTTLARH
VFNDERVKAHFGKLNTYWKVVGAEFDPTKIMKSILELATGAPVSISEPELVKRELEKALSEKRFLLVLDD
VWNEDKSQWTALEAVLTCGARGSKVLVTTRSPKVSSIMGSFNTHQIQQLPRDDCLSLFQQFAFGDEEPNE
NLMEIGGKIVEKCGGVPLAAKSLGSLLHSTRDETYWSSVLNSEVWQLGDEGEKFLAVLKLSYDALPLRSK
KCFAFGSLFPKNYVMKKDELIQLWTANSFVCSEGNFNAETDGNRIFDDLVLRSFFLLAPSEKCDDDGRHV
TECTMHDLMHDLARSISEDEFYNDVDDGKKDIQKRTYHIWLKYEEISNTSLFKMPLYLRTLSLRSCLSFK
KAHLFQFVFSKLKLLRVLDLSNNDIKEVPTSIGNLIHLRYLNLFMNEIKVLPDAITLLQNLRYLNLIENP
LQQLPKKLRNMQSLGYLHCDCFDLTHMPLGLSRLTSLRSLSCFVSDDNRTGSCSITELEDLKLHGNMRIQ
FSKNSSNYSCGGRKILKNKNFNELSLSFNFSETNDMSMLDDLCPNMNLKKLEICNYGSRQFPTWLMELQF
PNLVEVILNYSYNCEHVPPFGNLQSLRKLAINSMGEVKRMGAEFHGHGPIRGFPSLQELQLEWMLNLEEW
SESDDAEKLFPLLKTLKILNCPKLKTMPRFPTIEFLNLDNCSESLVSCVRRMTSLSHLILEGMKGMTSLP
SGCLRNLTSLMRLEILSCNELQFLPREEMQLLTMLHSLSIEKCNNLTSFPLEMGRLGALRYLCFKNPDNN
TLAPNNGSLIVQILNSVHEFDIQICGKNVNLLGQLQHLHTLRELRISGSHDSTDEGVILEYIRASLRICC
CDELESLMTTAPSTSVLEVLYIYDTPNLTILPEWLQYLRSLVRYRSTTASN


>XP_042470163.1 disease resistance protein RGA2-like [Zingiber officinale]
MSTETPQTEIARYLAQSLHNRSLKAIQRSWEHQEPEVYKAKAGLGKLIRDILEFIQDLHIYDQHKQISND
CLDDWLWRFKEFFYATEDVLDDLDFIEFRSGKWQGDGASAFEEMRFMKAIGKLPEVIKTAAGLFSENKHF
KNELQKSKPVFSSLDQQIITGSGLRTLPYKVRELKGRAMEKAKILEAIFHKAEGESKKSPVMISITGPVG
IGKTDLARAVYNSAQVAAEFDVRAWIYMGNHHLGEWWLTLQRSVSASVYKQSKIHRTSGSSLGDSILETM
KTEIKGRKVLIVLDNLTEGFCDDLLKYGAKVGSRIIVTSQFRHVGNSDDLLFDVELDGLEEEEYLKLFKE
CALGDRNRNKNPELEDIVEEIAKRFGGNPLAAVRIGRLLKSQADKDHWRIISRSNLGVIDPTESNILSVL
RRSYEQLPWLSKQCYLAYALFPKNYPFEKGQLLRIWNATGFGSCDSFGVFSERSFFVSSAKENDKLVLQA
TLHELADCICDGEFFRLETEIKEKDVIEIPHKAQHVYVTADNFVKVCKVLQKQTHLRSLVIGGTLSSEEH
KTNFMELLEEVLRNWKGLRLLMISVLPSGKLPGAIGGLRHLRYLELPTETITKDSVQELPAWLSDKQFVG
LRQLQNLKELRQAIRKLQTGESSDEFETIEELSPREPRDSSVSPPLEFSKDDPRVLEEKKTTESWSKSKR
ESDDTEYVDVDEKRWVLGGFSGRFKDEELQKKILYYQEMIGSVILNFNVFI


>XP_042470164.1 putative disease resistance protein At3g14460 [Zingiber officinale]
MDPILIIITIVGWMATPLMTKLINSAHLLRNQRMSDQLNRLKQRLYAIGKMAENAQIGNWQADVPYFRDW
LRRFKDVIYDAEDVIYSHKLDERQIDKILEKFQRLTNEIEDFLQGLNKREEIPTWRKTTYLMSRSIRGRT
TQINELENWLLSDQSTNSSKNFSLQSIVGPGGIGKTVLSQLVFNNPEVQQKFEVTAWVLLCNPTTPDIKI
KPSPRSLYQKIISLFQTNDSTNTPEILDEFESKFESRMKGKTFFMVLDDMRELPTNWDNFYWPLFNCGKQ
GSKIIVTTQFERTANMIDSDLPINLDVLEQDQYWELFKECAFGHNSTPSHHSVLEDVGRNISNKFGCSPL
AAVEVGRELKCSLNKTRWNSISHNKFCIVDRRDGDIISILGLCYEQLPERLKQCYLSCALFPRNYPFEEE
ELNLIWIGLGFLHFESKTTNYVDDFSKRSFLVNATRTNGRYVFHHVLHELAEYISDGEFLRLEEEIRGCE
DTEIPSHTRHLYINANNFVEATKALGKNSKLRSLVIVGGLSIPDHKRTFLKYLEKVLEKLEFLRFLVLPL
PPTNLSETVGTLKYLRYLQFPKNQQELPKLSNSILGKYKLKLWNGCNYLLVSNDINKLIQRHCSLENIED
LSDLVP


>XP_042470165.1 putative disease resistance protein At3g14460 [Zingiber officinale]
MDPILIIITIVGWMATPLMTKLINSAHLLRNQRMSDQLNRLKQRLYAIGKMAENAQIGNWQADVPYFRDW
LRRFKDVIYDAEDVIYSHKLDERQIDKILEKFQRLTNEIEDFLQGLNKREEIPTWRKTTYLMSRSIRGRT
TQINELENWLLSDQSTNSSKNFSLQSIVGPGGIGKTVLSQLVFNNPEVQQKFEVTAWVLLCNPTTPDIKI
KPSPRSLYQKIISLFQTNDSTNTPEILDEFESKFESRMKGKTFFMVLDDMRELPTNWDNFYWPLFNCGKQ
GSKIIVTTQFERTANMIDSDLPINLDVLEQDQYWELFKECAFGHNSTPSHHSVLEDVGRNISNKFGCSPL
AAVEVGRELKCSLNKTRWNSISHNKFCIVDRRDGDIISILGLCYEQLPERLKQCYLSCALFPRNYPFEEE
ELNLIWIGLGFLHFESKTTNYVDDFSKRSFLVNATRTNGRYVFHHVLHELAEYISDGEFLRLEEEIRGCE
DTEIPSHTRHLYINANNFVEATKALGKNSKLRSLVIVGGLSIPDHKRTFLKYLEKVLEKLEFLRFLVLPL
PPTNLSETVGTLKYLRYLQFPKNQQELPKLSNSILGKYKLKLWNGCNYLLVSNDINKLIQRHCSLENIED
LSDLVP


>XP_042470166.1 putative disease resistance protein At3g14460 [Zingiber officinale]
MDPILIIITIVGWMATPLMTKLINSAHLLRNQRMSDQLNRLKQRLYAIGKMAENAQIGNWQADVPYFRDW
LRRFKDVIYDAEDVIYSHKLDERQIDKILEKFQRLTNEIEDFLQGLNKREEIPTWRKTTYLMSRSIRGRT
TQINELENWLLSDQSTNSSKNFSLQSIVGPGGIGKTVLSQLVFNNPEVQQKFEVTAWVLLCNPTTPDIKI
KPSPRSLYQKIISLFQTNDSTNTPEILDEFESKFESRMKGKTFFMVLDDMRELPTNWDNFYWPLFNCGKQ
GSKIIVTTQFERTANMIDSDLPINLDVLEQDQYWELFKECAFGHNSTPSHHSVLEDVGRNISNKFGCSPL
AAVEVGRELKCSLNKTRWNSISHNKFCIVDRRDGDIISILGLCYEQLPERLKQCYLSCALFPRNYPFEEE
ELNLIWIGLGFLHFESKTTNYVDDFSKRSFLVNATRTNGRYVFHHVLHELAEYISDGEFLRLEEEIRGCE
DTEIPSHTRHLYINANNFVEATKALGKNSKLRSLVIVGGLSIPDHKRTFLKYLEKVLEKLEFLRFLVLPL
PPTNLSETVGTLKYLRYLQFPKNQQELPKLSNSILGKYKLKLWNGCNYLLVSNDINKLIQRHCSLENIED
LSDLVP


>XP_042471863.1 putative disease resistance protein At3g14460 [Zingiber officinale]
MEFIPIGLTAVGWVASPWATVWINSFRSRRKQSRTGKQKLNLLKQFVDLGREDKVPHSQGDLLYSKNWLR
RFKDAISDAEDAIYSHEFAKDDNQINNILEIFEDLAGEKKAFSQKLMQQEISTWRRTNYLMCREIKGRTD
ETEKLKNWLLSDQSSTNSNTNVSALSIIGTGGIRKTILSQLAFNNQEVQQNFEVRAWVFLYEPTRPGPTV
YIKANESNSASSDQTSTSFEDFHNKFVSNTKNKRFFMVLDDLWNEFADEWDKYLSLFKCGKHGSKIIVTA
RLKGVANVINLDPDSQIDLDVLRQDEYLKLFKECVFGNSELLSEEFAFGNKSSREDYSALENVLFRIAMR
FGGSPLAAVEVGRELKLSLDQERWNSILPNKFCIADPREKDIISILGLCYRKLPGRLEQCYLSCALFPRD
YQFEEHQLNLIWIGMGFVHSGSTAGNYIKDFSIRSFFIDTARTDNKYVFHHVLHELAEYISDGEFFRLEK
KIMESESIEIPEEARHVYILADNFAKASEALRRNEKLRSLVIDGPLSNSNDEKSFMKSLGKVLNNLKSLR
FLVLSVLPQNLPTTVGKLKYLRYLEFPINQEKLPKLSNSFQRNYTLKRWDSKYLLVAKDIDKLIEHRCSS
AKIVNEDMIYYCC


>XP_042472123.1 putative disease resistance RPP13-like protein 1 [Zingiber officinale]
MGGIGKTTLAQKIFDDEMMKKQFSKKVWLHIFKDYSEIEILKQVLRGVGGNDVGVKTKAEVEGRLDPLLS
GSLLLVLDDIWSANVWRELLRNPILKGSCRSVILFITRHEVVAREMRANYVHLAEEIDEGSGWELIRKIV
FGDGEDAIISELEEVGMEIVRNVMVFLRQSK


>XP_042472124.1 putative disease resistance RPP13-like protein 1 [Zingiber officinale]
MYDAEDIFDRCLIEGGRLLEAQPSASSGGHSWLRTLNFRRNICDEIRRVNDRLNEINDDNNVVLRGVGGN
DVGVETKAEVEGRLDPLLSGSLLLVLDDIWSANVWRELLRNPILKGSCRSVILFTTRHEVVARKMRADYV
HPAEKIDEGSGWELIRKIVFGDGEDAIISELEEVGMEIVRKCDGLPLAIKVMAGVLFHKERTKTEWKKVV
ESDLWFRKEIKLSNALYLSYEDLPNHLKQCFLSCAFYHGISHRSDIIRLWVAEGFVIEELDSLMEVTAKD
YYKELIARNLLQIDQRFEDGRLFVMHDVLRTFGEKLMEEEGSIISGDPYRSTNSLTTINSSTKIRRLSIS
NQVNVLSLPNMIIEQKCLRTLHLVNCPQIKLIEDHVFKRLKRLRVVNLCDTSIDSLPDSLVKLSHLKYLN
LDGTKIRKLPESIKDLANLQTLCLSGCKSLHELPDGITRLSNLRCLRILNTPLTHVPKGVGKLKNLNNLA
GCFVGHRDSMSMMEGGCDLDELQYLCNLNDLVISKLERARTTNFVLENKTFLRILTLGWTMHNNENNDEQ
SSEAERICKQLSPPATLEGLSIDNFPGRQFPDWMVSTSLADLTFLALDKFPSCTALPPLGQLPNLKILHT
EGGEAIKSIGPEFLGRRTPAFPKLEYLAFDSMRNWEEWVLRVAQDVVAPIEDVHASNLNLFPNLEKCYFI
DCPKLKNSILPPTRLLQINGCPNLEYMEKVGMLQLRKFEVVLPSEIKQLSQWISSLINMTLQSLQLFNMQ
CNSLVLDSCRKGKQNWHIIQHIPKVIIHSIGLETRLLRSEDGYQYQIKDELGSSFITPCKSFDH


>XP_042472127.1 putative disease resistance RPP13-like protein 1 [Zingiber officinale]
MGGIGKTTLAQELFNDEMVKKQFSNRVWLHVSKDYSQIELLKQVLRGVRGNDDGVQSRAEVEGRIVSLLS
ESLLLVLDDIWSASVWRDLLRNSILNGSCRTAILFTTRHEDVATDMRADFVHHVEKMDEDNGWELIRKIV
FGNGEDQIISELKEVGMQIVRKCDGLPLAIKVIAGVLFRKEKTKREWKKVVESDLWFMKENENEVSKTLY
LSYEDLPGHLKQCFLSCVFYRAITNQSDIIRLWVAEGFVIERSDILMEDIAEDYYKELIASNFLQMDHIF
LTGTRFVMHDILRSFGENLMVDEGIIINDGQCANANSLRKIRHLSISNQGDLLLLPKVIIEQKCLRALHL
VNCPQIKKIEDHAFKSLKRLRVLDLRDTCIDNLSDSLMKLLHLKYLGLDRTKIRKLPESIERLANLQTLN
LSGCESLHELPKNITRLSNLRCLRIEDTPLTHVPKGVGKLKNLNYLSGFLVGHCDSMNKMDGGCDLDELQ
YLCNLRYLRMDKLERATSTVNRNFVLANKAFLRRLTLGWTMNDNETNEEQITEAERIFNQLCPPPTLQGL
RIIDMLPPLGQLPNLKILEIEVGEAIKNIGPEFFGYRNPAFPKLEYLEFKNMPNWEAWVLREAHDVVDPN
EDVHASNLNLFPSLKQCFFRYCPKLKNSILPSNRLLQINLCPKLEYVEKVGMLQQLEVIFPSEINQLPQW
VSRLINAILHSLQTFYMECNSLLLDSCSKGKQNWHIIQQIPKVTIDSIDRERRLLLNKDSYKYEIKDEFG
SFITLVSPLFS


>XP_042472136.1 putative late blight resistance protein homolog R1A-3 [Zingiber officinale]
MDNSKQKVKQDVPAMDNSKSTLARNVYNDSRIHDFFPRKTWLCVSKRFLGNELLKELIRSFGGDHGEARS
KAELELKLSHLLPKKFFIVLDDLWNANVWEDLLRAPFKCSSGGILITTRDERVARQMGASIHCVEKMDKV
TSWMLLSTLVSRDGEDEEVCKLKAIGGEIVNKCDGLPLAIKTVAGVLRSKERCEKEWNKVLERLLLGIWV
AEGFVKPQGYRLLEDLAEGYYEELLGRNLLQLHPFYLDNS


>XP_042472137.1 putative disease resistance protein RGA3 [Zingiber officinale]
MAEILSDFAGRCMSKLLSFVEGEATKILGVKDDLKKLQRRLLRVRGVLEDAEKKRHGSAEINAWVREMKD
IMYDVEDLLDLCKTKAENLWVSHSPLPSASDFSCLPLSRQIANKVREVNDRLDEISEDRHVMSRLHEIDP
SIHDSGINTRNTSPLLIQSDIVGTQIKEVSESLVKSLITKRDEGWKIFGIVGMGGIGKTTLARNVYNDSR
IPGYFPRKTWLCVSKEFSGNELLKELIRSVGGDHGEARSKAELELILSHLLPKKFFIVLDDLWNANVWED
LLRAPFKCSSGGILITTRDERVARQMGASIHCVEKMDKVTSWMLLSTLVSRDGEDEEVCKLKAIGGEIVK
KCDGLPLAIKTVAGVLRSKERCEKEWNKVLESEIWSMNQLQEELPRALYLSYEDLPSHLKQCFLFCSLYP
ENISMHYKDLTRSWVAEGFVKPQGYRLLEDLAEGYYEELLGRNLLQLHPLYLDNSVCTMHGLLRSLAVYL
VEEESVSISNGERLESTNTLTKIRHLSVSNMGEEVAVPVELVSQNCLRTLLVWNSFKTKRIGADLFEKLG
QLRVLCIAATEIERIPDSLGNLIQLRYLDLDRTHVQSLPESIGCLKNLEILNLQSCRSLQYLPDAITKLQ
NLRCLRVRGTPLNHLPKGIGNLTKINHLEGFLIGHERDTQGEVEDCALDDLQSLNDLRFLHVAALKRARR
GSLVLANKTFLKHLDLRWLPPCVKADLTRCGNQAAEDIAKSYSDLFPPSSLECLTEAESQRNVRLFSDLS
LPSSLEFLSIYHFLGQELPKCMERCTPMSFPNLQFLDLNCFISCTQFPVLGQLPQLKILSIARADAIVTV
GPELLYGQSPLTTLVAFPKLEYLEFMIMPNWEQWSFGETETAKAQELQLLPSLKRLCVVDCPKLKALPDG
LHHATNLQELRIYGAHELGEVKNLPSLTNELFLRDNKKLEKVSNLPMLKSLIVGSCPLLKQVDSLSALEM
LELRHNSSQRLPSDASLQHLNLDTQEDPLPVWLPELLEQNMKGYAGSGVLLVECSLSLLRRCCKDGPYWH
TIQQFAGVLMQSEEGSAYMTYTKNPFKYESNAFSHQKFIEQRI


>XP_042472138.1 putative disease resistance RPP13-like protein 1 [Zingiber officinale]
MAEILSDFAGRCLSKLLSFVEGEATKILGVKHDLKKLQWRLLRVRGVLEDAEKKRHGSAEINAWVREMKD
IMYDVEDLLDLCKTKAENLWVSHYSPLPSASDFSCLPLARQIANKVREVNDRLDDISEDRHVMSRLHEIE
PSIQESGINTRDTSPLLIQSDIVGTQIKEVSESLVKSLITERDEGWKIFGIVGMGGIGKTTLARNVYNDS
RIHDFFPMKTWLCVSKRFSGNELLKELIRSFGGDHGEARSKAELELKLSHLLPKKFLIVLDDLWNANVWE
DLLRAPFKCSSGGILMTTRDERVARQMGASIHCVEKMDKVTSWMLLSTLVSRDGEDEEVCKLKAIGGEIV
KKCDGLPLAIKTVAGVLRSKERCEKEWNKVVESEIWSMNQLQEELPRALYLSYEDLPSHLKQCFLFCSLY
PENHIMHYQDLTRFWIAEGFVKPQGDRLLEDLAEGYYEELLGTTLLKHLFLNWLPPCVEADLTRCGNQVA
EALAKGFSGLFPPSSLECFPEEEYHRNVRLFNELSLPSSLELLSIYHFLGQELPKCMDRCMPMSFPNLQF
LFLHCFISCTQLPVLGQLPQLKFLSIARAEAIVAIGPELLCGQSPSTTLAAFPKLEYLVFSIMPNWEQWS
FGETKTAIAHELKLLPSLKRLLLIDCPKLKALPDGLHHATNLQELWINGAHELGAVKNLPSLTTELFLED
NKKLEKVSNLPMLKSLIVGSCPLLKQVDSLSALEMLELRHNSSWRLPESWWNPSLRHLSLDSQEGPLPVW
LPELLEQRMKGYAASGVLLVKCSLSLLRRCCKDGPYWHTIQQLPGVMMKSKESSAYMTYTKNPFKYESNA
SFRC


>XP_042472309.1 putative disease resistance protein RGA1 [Zingiber officinale]
MREIERFTIEVIEYTTKEKCNVPNFAALQVVLKEKITQERFLLVLDDVWNEERHKWESLCAPLRFGKPGS
KILVTTRSRSIAGMVGDVDPIHLDRMDEKSFWEFFKKCAFGSSNSGIHHPHLEAMAKKMTYKLKGLPVAA
KTLGGLISMPLDEHHWKGVSDSEIWTNFPKKKWD


>XP_042472352.1 putative disease resistance protein RGA3 [Zingiber officinale]
MEFVSMDLLNALVHTLDHVSKELQKVYGVRDELVKLRNIVSSIQGVLKDAQESEETRNSVKQQLNELREV
AYLANDILDDVTTEQQRQQLIKFAAVRNFLDDVNPKRFFFKQDVYDRIQWIKTELDEIVKKCPLSTLTSH
NGSQRTHISETTSLSPPCVLGREREKQEIKELLVPLSGQSDSTASVISICGMPGVGKTTLAQQLFDDETV
KKHFELRLWVYVSNDFDLMRIMRCMIESIDRFKCDLASLNNLQQEIRKKVSGRRYLLVLDDVGQESREWE
RLKNCLYSADEGSKILVTTKNEQVAAFMAANSPPVLYRLEGLAMEDCWSLICQPALSRNPSASFTLDFYR
SHAVNRCGGLPMAAKALGQRLAREADRNKWGAILTSQSWEFSGADSTRCELERDFIIQLWMAQGFIRPRG
TEQMEDVGSDYIDSLRRSSFLQYSHFDHKSRRQRYVMQNVFHEFARYAAAEECSVIEPGMELHLSASVRH
LSVNYEEFVRRVTPDEVYKCKGLQSLLLIGNSTSRPIMALPGDLAQKLSSLRTLMLTNSRLTQLPESIGD
LRHLRCLQLQNTSIKRLPDSVSRLYNLQTLGLRNCYDLEELPKDMSKLRNLRHLDLHLDGNSQGTLRCMP
PEIGLLTHLRTLNRFVVSKRHECGLSQLENLNDLRSDLLIERLDLVSSREDATNANLSSKEHIHRLELTW
NYSCVTDASARSAGYNSRENILEYLKPHPRLKEIGVVGYGGTLLPKWMGDSSLFNLETVRISKTYSCLNL
LPPLGQLPNLKYLFLEEMHGLKHLDCSFCGRNEIRFPKLEKLHLENMSGLQEWLGDHRCALPSLSELTIK
NCPALQQLTHELPSLTKLVIEASPYFAGLPDFPKLQSLEVKTNDDWIWRSWAAISLLPSPTLSGLTRADL
PFHIGSRHASIRRLEISYCSQLKFIPDGWLPECLSHFVIRHCPILQNVPVGLTRLTMLEDLEIENCEQLE
HLPVGLRNMNSLAHLEISDCPALSWLPSDGLPRKLQFLSISNCPELIQKLQRQDLFTRRQDLQVWINGEH
VVT


>XP_042472353.1 putative disease resistance protein RGA3 [Zingiber officinale]
MPGVGKTTLAQELFNDVTVMEHFELRLWVYVPHDFDLMKILRCMIESIDGFKCDLASLDTLQQEVRKKVS
GRRYLLVLDDVWEESEEWERLKSFLYSADGGSKILVTTKREQVARFMAANSTPYHLEGLSMDDCWSLICQ
QVLSRNPSASFTHDFSQSDALRRCMGLPMAAKALGQRLAREADRSKWEAILTSQPWEFSGSGPSSNTMKP
LSLSYQYLPHHLKPCSAYLSIIPKGWELETDLIIQLWMAQSFIRPRGTEEMEDVGSDYIDSLRRSSFLQY
SHFDHKSRRQRYVMHDVFHEFVRHVAAEECSVMEPGTGLYLAHSERVRHLSVNYEELIRRVPSGGDMYEQ
VYKCKGLQSLLLIGNSTSRPTMVVRDDLAERLSSLRTLMLTNSCLTQLPESIGDLRHLRCLQLQNTDIKR
LPDSVSRLYNLQTLGLRNCYHLKELPKDMSYLRNLRHLDLHLDGNSQGTNAGGKLRRMPPEIGLLTHLRT
LSRFVVSKRRNCGLSQLKNLNDLCSELLIERLDLVSSREDAKNANLSSKEHIHRLELTWNYTIVTDASAR
KNILEYLKPHHGLKEIGVIGYGGTLLPTWMGDSSFNNLEKVWISKTYSCLNLPPLGQLPNLKYLLLKEMH
GLTHLDCSFCGTNEIRFPKLEKLHLENMPELQEWLGADNCALPSLRELTIKDCLALQRLRHELPSLTKLV
IEASPSFARLPYFPKLQSLEVKTNDDWIWRSWAALSSLTSLTLSGLTRADLPFEINSCHASIRRLEISYC
SQLKFIPDGWLPPCLSSFVIRHCPMLQNLPAAGLTKLTMLEDLEIEECEQLEHLPVGLRNINSLAHLEIS
DCPGLSWLPSNGFPSKLQFLSISNCPELIQKLRDQGWLAADREYPQVWINGVHLVT


>XP_042472472.1 putative disease resistance protein At3g14460 [Zingiber officinale]
MSLFAETPQFEIATYLSKLLEERTYHVIESLRQHQDLEVYNAIAILERLREILPKILRKPWKLRTDNFHT
TISNKFLEDWLCRFKGFFYMTEDVFDDLDIIVLPSDKRQGDYLSAFGKRMLICKKAIAKLPEVIDAATGL
LGENKNLMEGMREFEQILYRRWKEQQVTSSELPTLPYKVRELKGRAGEEKKILEALLHKEEGESKKSTRL
IRIAGPVGIGKTELARAVYNSAQVEAEFDVRAWIYMGNHHRDDNWLTLQRSEPASVDKSSKLQRLNGLAI
FNIFDTLERELQSKKVLIVLDNLADKAEHSSYLGTFRSFRATEDCRIIVTTQFEYVGRVNASLNVELDGL
EEEEYLELFKECAALGDKNHDKYPAELENTCKEIAKRFGGNPLAAVMIGRHLKWHQSEDRWRVISRSNLG
MIDPTESNIISVLKHSYEELTGNQKQCYLACALFPKNYPFKQNQLFEIWKAIGCCSHTSNQWSWAWTDIE
PFFVSSARKDGEFILHAIFHELADYICDGDFFRLEDEIKEEDGIEIPDKARHVYVTADNFVKIYKVLQEK
THLRSLVICGVLSSKEHKSSFMGLLEEVLQNLEGLRLLMISVLPTGKLPDAIGSLRHLRYLELPIDKHTL
TKESFLELPTWISDDGFAGLRKLQNLEELRGAIQKLKTGESSHSFKSIGPELSYRESSDPSDQLFRP


>XP_042473836.1 putative disease resistance RPP13-like protein 1 [Zingiber officinale]
MADVLNFFVIRYLDKLSDVIKGEIGKVLGVKEETKRLHRKLSRIRPYIQDAEKRRRRDPAINNWVKELKD
IMYDVEDTLDLCLIEGGRLLEALPSSPLEVCSPVSLLSFCFQCYKFRRNIWNQIKRVNDRLDEIKDDSNV
IPRLVAHINEGLQDNTVKMSSPTSSTHVATDIVGTQIVDAAQMLISEIERNKKKCSVLGISGMGGIGKTT
LAQKIFNDEMVKKQFPKRVWLHVSKDYSQIELLKQILRGVGGHDDGVQSRAEVEGRIVPLLSESLLLVLD
DIWSASAWGDLIRNPILNGSCRATVLYTTRHEDVVAEMRADFVHHVEKMHEDSGWELIRKIVFGEGENEI
ISELKEVGMEIVRKCDGLPLAIKVMAGVLFHKDRTKREWIKVVESDLWFMTENRNEVSNALYLSYEDLPS
HLKQCFLSCAFYRGISFRSDLIRLLMAEGFVIEESNRLMEDTAENYYEELIARNLLQNHTKNLNSVGVVM
HDVLRSFAEKLMEEEGIIINNGQCTSTNSLTKIRRLSISNQGDDVLSLPNVITEQKCLRVLRLINCPRIN
RIENHAFESLQRLRVLDLCDTSIESLPDCLTKLLHLKYLDLDRTKIRRIPESIECLANLQTLNLSGCESL
HELPMGITKLSNLRCLRIEKTPLTHVPKGVGKLKNLNTFLGFFVGHCDSMSKMDGGCDLDELQYLCNLRH
LRIDKLERATRTRNGNFMLANKKFLRRLILEWTKNNNENNEEQITEAEMICNQFSPPSNLQSLAIKNFPG
RQFPEWMVSTSALDSLANLTLLSLANFPSYTVLPPLGQLPNLKVLDIEGGEAIRSIGPEFLGCRTPAFPK
LEYIAFDNMRNWEAWILREALDVQATNLNLFPNLKSCNIINCPKLKNSILPSNRYLQINLCPSLEYVEKV
GTLQQLVVIFPAEIKQLPQWLSSLINATLHSLQLFYMHCDSLLLDSCSKGKQNCHIIQQIPKVTIYSVDR
KTRLLLNKGSYKYEIKDEFGSFISLDQPSFHG


>XP_042473837.1 putative disease resistance RPP13-like protein 1 [Zingiber officinale]
MADVLNFFVIRYLDKLSDVIKGEIGKVLGVKEETKRLHRKLSRIRPYIQDAEKRRRRDPAINNWVKELKD
IMYDVEDTLDLCLIEGGRLLEALPSSPLEVCSPVSLLSFCFQCYKFRRNIWNQIKRVNDRLDEIKDDSNV
IPRLVAHINEGLQDNTVKMSSPTSSTHVATDIVGTQIVDAAQMLISEIERNKKKCSVLGISGMGGIGKTT
LAQKIFNDEMVKKQFPKRVWLHVSKDYSQIELLKQILRGVGGHDDGVQSRAEVEGRIVPLLSESLLLVLD
DIWSASAWGDLIRNPILNGSCRATVLYTTRHEDVVAEMRADFVHHVEKMHEDSGWELIRKIVFGEGENEI
ISELKEVGMEIVRKCDGLPLAIKVMAGVLFHKDRTKREWIKVVESDLWFMTENRNEVSNALYLSYEDLPS
HLKQCFLSCAFYRGISFRSDLIRLLMAEGFVIEESNRLMEDTAENYYEELIARNLLQNHTKNLNSVGVVM
HDVLRSFAEKLMEEEGIIINNGQCTSTNSLTKIRRLSISNQGDDVLSLPNVITEQKCLRVLRLINCPRIN
RIENHAFESLQRLRVLDLCDTSIESLPDCLTKLLHLKYLDLDRTKIRRIPESIECLANLQTLNLSGCESL
HELPMGITKLSNLRCLRIEKTPLTHVPKGVGKLKNLNTFLGFFVGHCDSMSKMDGGCDLDELQYLCNLRH
LRIDKLERATRTRNGNFMLANKKFLRRLILEWTKNNNENNEEQITEAEMICNQFSPPSNLQSLAIKNFPG
RQFPEWMVSTSALDSLANLTLLSLANFPSYTVLPPLGQLPNLKVLDIEGGEAIRSIGPEFLGCRTPAFPK
LEYIAFDNMRNWEAWILREALDVQATNLNLFPNLKSCNIINCPKLKNSILPSNRYLQINLCPSLEYVEKV
GTLQQLVVIFPAEIKQLPQWLSSLINATLHSLQLFYMHCDSLLLDSCSKGKQNCHIIQQIPKVTIYSVDR
KTRLLLNKGSYKYEIKDEFGSFISLDQPSFHG


>XP_042473838.1 putative disease resistance RPP13-like protein 1 [Zingiber officinale]
MADVLNFFVIRYLDKLSDVIKGEIGKVLGVKEETKRLHRKLSRIRPYIQDAEKRRRRDPAINNWVKELKD
IMYDVEDTLDLCLIEGGRLLEALPSSPLEVCSPVSLLSFCFQCYKFRRNIWNQIKRVNDRLDEIKDDSNV
IPRLVAHINEGLQDNTVKMSSPTSSTHVATDIVGTQIVDAAQMLISEIERNKKKCSVLGISGMGGIGKTT
LAQKIFNDEMVKKQFPKRVWLHVSKDYSQIELLKQILRGVGGHDDGVQSRAEVEGRIVPLLSESLLLVLD
DIWSASAWGDLIRNPILNGSCRATVLYTTRHEDVVAEMRADFVHHVEKMHEDSGWELIRKIVFGEGENEI
ISELKEVGMEIVRKCDGLPLAIKVMAGVLFHKDRTKREWIKVVESDLWFMTENRNEVSNALYLSYEDLPS
HLKQCFLSCAFYRGISFRSDLIRLLMAEGFVIEESNRLMEDTAENYYEELIARNLLQNHTKNLNSVGVVM
HDVLRSFAEKLMEEEGIIINNGQCTSTNSLTKIRRLSISNQGDDVLSLPNVITEQKCLRVLRLINCPRIN
RIENHAFESLQRLRVLDLCDTSIESLPDCLTKLLHLKYLDLDRTKIRRIPESIECLANLQTLNLSGCESL
HELPMGITKLSNLRCLRIEKTPLTHVPKGVGKLKNLNTFLGFFVGHCDSMSKMDGGCDLDELQYLCNLRH
LRIDKLERATRTRNGNFMLANKKFLRRLILEWTKNNNENNEEQITEAEMICNQFSPPSNLQSLAIKNFPG
RQFPEWMVSTSALDSLANLTLLSLANFPSYTVLPPLGQLPNLKVLDIEGGEAIRSIGPEFLGCRTPAFPK
LEYIAFDNMRNWEAWILREALDVQATNLNLFPNLKSCNIINCPKLKNSILPSNRYLQINLCPSLEYVEKV
GTLQQLVVIFPAEIKQLPQWLSSLINATLHSLQLFYMHCDSLLLDSCSKGKQNCHIIQQIPKVTIYSVDR
KTRLLLNKGSYKYEIKDEFGSFISLDQPSFHG


>XP_042473932.1 putative disease resistance RPP13-like protein 1 isoform X1 [Zingiber officinale]
MAVVLDFFVKRYLGRLSDFLDGEIGKVLEVKEEIKKLHRKLSRISPYIQDAEKRRHRDPVINNWVKELKD
IMYDAEDILDLCMVEGGRFLEAQPFAPSGVCSSVSLLSSCFQCYKFRTNIWNQIKRVNDRLDEIKRVIPR
LVEHRNEGLQDNIVKMSSSTSPTHVAEDIVSKQIIDAAQNLISEIEHNKKKCSVFGISGMGGIGKTTLAQ
KIFNDEMMKKQFPNRVWLHVSKDYSQIELLKQILRGVGGHDDGVQSRAEVEGRIIPLLSESLLLVLDDIW
SASAWGDLIRNPILNGSCRTAIIFTTRHEDVAREMRADFVHHVKKMHDDSGWEFIRKIVFGDGEDIMISE
LKEIGMEIVKKCDGLPLAIKVMAGVLFHKERTKREWKKIVESDSWFMKETEDKLLKALYLSYEDLPCHLK
QCFLSCAFYRSISYRWDIIRLWVAEGFVIEQSNSLMEDTAENYYEELIARNLLQIDSRFLDGRVFVMHDV
LRSFGEKLMEEEGIIINDTQFTSTTSLTKVRRLSISNQGDVLLLPNVIIEQKCLRALHLLNCSQIKRIED
HVFESLKRLRVLDLHDTSIDSLPDSLLKLLHLKYLNLCGTKIRKLPESIECLANLQTLNLSECESLHELP
KGITRMSNLRCLQIVSTPLTHVPKGVGKLKNLNTLDGFFVGHCDSMSKMDGGCDLDELQYLCNLRYLSIY
KLERARTIGSRHTVLANKPFLRGLKLVWTINIENNEEQITEGERICNQLSPPETLKDLWIDNFPGRQFPA
WMVSTHDSFADLTTLWLCNFPSCMVLPPLGQLPNLKHLHIEGGEAIRSIGPEFLGCTTPAFPKLEHLKFT
SMPNWESWVLREAQDVHARNLNLFPNLKQCYFLHCPKLKSSLLPPTRFLKIKICPNLEYVEKVGMLQLRK
LEVIFPSEIQQLPPWVSSLINATLHSLQTLYMRCNLVLLDSCRTGKQNWHTIEEIPKVIIHSIDREARLL
LSKDGYKYQIKDEFGSFVALDQRGFNG


>XP_042473933.1 putative disease resistance RPP13-like protein 1 isoform X2 [Zingiber officinale]
MYDAEDILDLCMVEGGRFLEAQPFAPSGVCSSVSLLSSCFQCYKFRTNIWNQIKRVNDRLDEIKRVIPRL
VEHRNEGLQDNIVKMSSSTSPTHVAEDIVSKQIIDAAQNLISEIEHNKKKCSVFGISGMGGIGKTTLAQK
IFNDEMMKKQFPNRVWLHVSKDYSQIELLKQILRGVGGHDDGVQSRAEVEGRIIPLLSESLLLVLDDIWS
ASAWGDLIRNPILNGSCRTAIIFTTRHEDVAREMRADFVHHVKKMHDDSGWEFIRKIVFGDGEDIMISEL
KEIGMEIVKKCDGLPLAIKVMAGVLFHKERTKREWKKIVESDSWFMKETEDKLLKALYLSYEDLPCHLKQ
CFLSCAFYRSISYRWDIIRLWVAEGFVIEQSNSLMEDTAENYYEELIARNLLQIDSRFLDGRVFVMHDVL
RSFGEKLMEEEGIIINDTQFTSTTSLTKVRRLSISNQGDVLLLPNVIIEQKCLRALHLLNCSQIKRIEDH
VFESLKRLRVLDLHDTSIDSLPDSLLKLLHLKYLNLCGTKIRKLPESIECLANLQTLNLSECESLHELPK
GITRMSNLRCLQIVSTPLTHVPKGVGKLKNLNTLDGFFVGHCDSMSKMDGGCDLDELQYLCNLRYLSIYK
LERARTIGSRHTVLANKPFLRGLKLVWTINIENNEEQITEGERICNQLSPPETLKDLWIDNFPGRQFPAW
MVSTHDSFADLTTLWLCNFPSCMVLPPLGQLPNLKHLHIEGGEAIRSIGPEFLGCTTPAFPKLEHLKFTS
MPNWESWVLREAQDVHARNLNLFPNLKQCYFLHCPKLKSSLLPPTRFLKIKICPNLEYVEKVGMLQLRKL
EVIFPSEIQQLPPWVSSLINATLHSLQTLYMRCNLVLLDSCRTGKQNWHTIEEIPKVIIHSIDREARLLL
SKDGYKYQIKDEFGSFVALDQRGFNG


>XP_042473934.1 putative disease resistance RPP13-like protein 1 [Zingiber officinale]
MAVVLDYFVSRYLGKLSDFIEGEICKVLGVREEIERLHRKLSRIKIYIQDAEKRRHRDSAINNWVKELKD
IMYDAEDILDLCMVEGGRFLEAQPSASSWVRSRLSKLSSYLMSSPNENASKFSRNIWNQIKRVNDRLDEI
KEDSSVVPRLLEHITEDLQDNPGKKSSPTSPTHVATDVVGTQIVDAAQNLISKIEQSKKMCSVLGISGMG
GIGKTTLTQKIFNDEMVKKQFPKRVWLHVSKDCSHINILKELLREVGGNDNGLQSRAEIERRIVPLLSES
LLLVLDDIWTATVWMDWLRNLILNSSCRTAILFTTRNENVVKEMRPDFVHHVKKMKDDSGWELIRKIIFG
DEEDIIISELEEVGMEIVRKCYGLPLAIKVIAGVLFHKKRTKREWKKVVESDLWFMKEIDDELSNALYLS
YEDLPSHLKQCFLSCAFYRGVSLRSDIIRLWVDEGFVIEQSDNLMENIAEDYYKELIARNLLQIDFRFLF
GVRFVMHDVLRSLGEKLMEDEAIFINDAQCRSTNSLTKVRCLSISNQADVLLLPDAIIEQKCLRALHFTN
CPQIERIDQNHAFESLKYLRVFHLNDTSIGSFPDSLMKLFHLKYLDLDRTKITKLPESIECLANLQTLSL
SGCESLHELPKGITRLSNLRCLRIENTPLTHVPKGVGKLKNLNHLDGFLVGHCDSMIRMDGGCDLDELQD
LCNLMDLFIDKLERATTRGNRNFVLANKLFLRILTLVWRVNNEKNEEQITEAERICNQLSPPPTLEVLRI
GNFVGRQFPEWMVSTSILDSLVDLTFLTLIIFPSCTALPPLGQLPNLKILNIEVGEAIKSIGPEFLGCRT
PAFPKLEYLAFDSMPNWEEWVLRVAQDVVDPIEDVHARNVNSFPNLKECNIIHCPKLKNSILPLTRHLQI
KLCPNLEYVENLGMLQQLFVIFPPELQQLPQWVSNLINATLHSLQTFDMECNSLLLDSCSKGKQNWHIIQ
KIPKVTINSIDREARLLFHKGSYKYEKKNEFGSFITLD


>XP_042473935.1 putative disease resistance RPP13-like protein 1 [Zingiber officinale]
MAVVLDYFVSRYLGKLSDFIEGEICKVLGVREEIERLHRKLSRIKIYIQDAEKRRHRDSAINNWVKELKD
IMYDAEDILDLCMVEGGRFLEAQPSASSWVRSRLSKLSSYLMSSPNENASKFSRNIWNQIKRVNDRLDEI
KEDSSVVPRLLEHITEDLQDNPGKKSSPTSPTHVATDVVGTQIVDAAQNLISKIEQSKKMCSVLGISGMG
GIGKTTLTQKIFNDEMVKKQFPKRVWLHVSKDCSHINILKELLREVGGNDNGLQSRAEIERRIVPLLSES
LLLVLDDIWTATVWMDWLRNLILNSSCRTAILFTTRNENVVKEMRPDFVHHVKKMKDDSGWELIRKIIFG
DEEDIIISELEEVGMEIVRKCYGLPLAIKVIAGVLFHKKRTKREWKKVVESDLWFMKEIDDELSNALYLS
YEDLPSHLKQCFLSCAFYRGVSLRSDIIRLWVDEGFVIEQSDNLMENIAEDYYKELIARNLLQIDFRFLF
GVRFVMHDVLRSLGEKLMEDEAIFINDAQCRSTNSLTKVRCLSISNQADVLLLPDAIIEQKCLRALHFTN
CPQIERIDQNHAFESLKYLRVFHLNDTSIGSFPDSLMKLFHLKYLDLDRTKITKLPESIECLANLQTLSL
SGCESLHELPKGITRLSNLRCLRIENTPLTHVPKGVGKLKNLNHLDGFLVGHCDSMIRMDGGCDLDELQD
LCNLMDLFIDKLERATTRGNRNFVLANKLFLRILTLVWRVNNEKNEEQITEAERICNQLSPPPTLEVLRI
GNFVGRQFPEWMVSTSILDSLVDLTFLTLIIFPSCTALPPLGQLPNLKILNIEVGEAIKSIGPEFLGCRT
PAFPKLEYLAFDSMPNWEEWVLRVAQDVVDPIEDVHARNVNSFPNLKECNIIHCPKLKNSILPLTRHLQI
KLCPNLEYVENLGMLQQLFVIFPPELQQLPQWVSNLINATLHSLQTFDMECNSLLLDSCSKGKQNWHIIQ
KIPKVTINSIDREARLLFHKGSYKYEKKNEFGSFITLD


>XP_042473936.1 putative disease resistance RPP13-like protein 1 [Zingiber officinale]
MLHTQSSISELIHLSQEMAMVLEFFVSRYLKKLSDFIEGEICKMLGVKEEIERFHRKLSTIRIYIQDAER
RRHRDSVINNWVKKLKDIIYDVEDILDLCMVEGGRLLEAQPSTSSWVCSRISLLSSYIHRYTFNRNIWNQ
IKRVNARLDEIKEDSSVIPRLFEHITEAFQDNLVKMSSPSSFKHVATDIVGKQIADDAQNLISKIDQGKK
SCYVLGISGMGGIGKTTLAQKIFNDEMVKKQFPKRVWLHVSKDCSHINLLKELLREVGGNDNGVQSRAEI
EGRIIPLRPKSMLLVLDDIWSASVWMDLLRKFIWDDSCRTTILFTTRNENVVKEMRPDFVHHVKKMKDDS
GWELIRKIVFGDEEDIIISELEEVGMEIVKKCDGLPLAVKVIAGVLFHKEKTKREWKKVAKSDLWFMKEN
EDELSNVLYLSYEDLPSHLKQCFLSCAFYRGVSLRSDIIRLWVDEGFVIEQSDNLMENIAEDYYKELIAR
NLLQINFRFLEGARFVMHDVLRSLGEKLMEDEAIFINDAQCTSTNSLTKVRRLSISNQADVLLLPNAIIK
QKCLRALHFTNCPQIERIENHAFESLKYLRVFHLNDTSIGSFPDSLMKLFHLKYLDLDRTKITKLPESIE
CLANLQTLSLSGCESLHELPKGITRLSNLRCLRIENTPLTHVPKGVGKLKNLNHLDGFLVGHCDSMIRMD
GGCDLDELQDLCNLIDLFIDKLERATTRGNRNFVLEKKLFLRRLKLVWTVNNENNEEQITEAERICNQLR
PPPTLEVLRIGNFIGRQFPEWMVSTSILDSLVDLTYLSLIIFPSCTVLPPLGQLPNLKLLNIEQGEAIKS
IGPEFLGRRTPAFPKLEYLAFDNMRNWEEWVPIEDVHASNLNLFPNLEKCYFIDCPKLKNSILPSTRLLQ
IKLCPNLEYVEKVGMLQQLFVFFPPEIQQLPQWVSNLINANLNSLQTFDMVCNSHLLDSCSNGKQNWLII
QQIPKVTIHSIDPEKRLLLHKGSYKYEEKKNKFGNFITLDQSSNKRRSACLQHPCQPIRKLTRRR


>XP_042474101.1 putative disease resistance protein RGA4 [Zingiber officinale]
MAMEVALATSAVRFLGQRVADLLQLDKKLKELVGIEGRMEKLKELSTIIDAVIQDVEVCSVRDATAKDLL
RKLKYLAYDLEDVVDYYDTETLRKQRSKAYSRPVRDFFSSNNNQLVFKSRISGMIKAVRKNLDSILKQKS
ILENLPQGTNRISPSAYREIHSHNSLVVVGRETEKKMIVNMLTDDEGSSSGTLKVIAIVGMGGLGKTTLA
RHVFNDERVKAYFRKLRMWKVVGAEFDLTKIMKSILELATDAPVKISEAESVRRKLEKALSEKRFLLVLD
DVWNEDALQWMALEAALSCGARGSKVLLTTRSREVSSIMGSFNTHQMQQLSRDDCLSLFQQFAFGDEEPN
KKLMEIAGKIVEKCGGVC


>XP_042474103.1 putative disease resistance protein RGA4 [Zingiber officinale]
MEPALLTAVSLFMGPWVADLNKKLKEVVGIEGRMAKLRELSTIIDAVIQDVEACSVRDATAKDLLRKLKY
LAYDLEDVVDYYDTETLRKQRSKAYSRPVRDFFSSNNNQLVFKSKISGMIKAVTENLDSILLQRSILLNL
PQGTVRMSPIAYREIHSHNSLAVIGRDTEKEMIIKMLTDEEGSSNGTMKVIAIVGMGGLGKTTLARHVFK
DERVKTHFGELNMYWKVVGEEFDPTKIMKSIFELATGAPVNISEPELVKRELEKALLEKRFLLVLDDVWN
EDKSQWTALEAALTCGARGSKVLVTTRSREVSSIMGSFNTHQIQQLSRDDCLSLFRRFAFGDEEPNKNLM
KIGEKIVEKCGGVPLAAVSLGSTLHSIRDETYWSSVLNSEIWQLGDEGEKFLAVLKLSYDALPPRSKKCF
AFASLFPKNRMMSKDELIQLWTANGFASSEGNFDAETVGNRIFDDLVLRAFFLLAPSKECDECTMHDLMH
ELGRSVAEDEYHNRNDYKKKENIKITDHLFKKPLYLRTLLLRNCFPFGKFQLLQLVFSKLKFLRALDLSK
NGFTEVPTSVGNLIHLRYLNLSDNCIKFLPDAITLLQNLQYLNFTKNPLEELPKKLRNMQSLRYLDFDLY
KLTHMPLGLSRLTSLRSLSCFVSDDNITGSCSITELEDLKLHGKMKIKFSGNFSNYSCGGRKILKNKDFN
ELSLSFNYSVTNDMSMLDDLCPNTSLKKLQISKYGSQQFPTWFMKSQLPNLVEVILEDCKICEHIPHFGN
LQFLRKLVLDDIGGVKHLGAEFHGHGGFPSLQKLELLSMFDLEEWSESDSVDELFPLLNKLQIDDCPKLE
TVPRLPRIKQLALFNCSKSLMSGVGRMTSLSHLILEGMKDMTYLPSGCLRNLTSLMTLEIRGCNELQFLP
WDEMQLLPKLHSLSIKKCDNLCLKNHDSDTLQLDMLVQILNSVHEFDIQIRGKNVNSSFFSQNNVQSHQG
IIKYLLL


>XP_042474104.1 putative disease resistance protein RGA4 [Zingiber officinale]
MEPALLTAVSLFMGPWVADLNKKLKEVVGIEGRMAKLRELSTIIDAVIQDVEACSVRDATAKDLLRKLKY
LAYDLEDVVDYYDTETLRKQRSKAYSRPVRDFFSSNNNQLVFKSKISGMIKAVTENLDSILLQRSILLNL
PQGTVRMSPIAYREIHSHNSLAVIGRDTEKEMIIKMLTDEEGSSNGTMKVIAIVGMGGLGKTTLARHVFK
DERVKTHFGELNMYWKVVGEEFDPTKIMKSIFELATGAPVNISEPELVKRELEKALLEKRFLLVLDDVWN
EDKSQWTALEAALTCGARGSKVLVTTRSREVSSIMGSFNTHQIQQLSRDDCLSLFRRFAFGDEEPNKNLM
KIGEKIVEKCGGVPLAAVSLGSTLHSIRDETYWSSVLNSEIWQLGDEGEKFLAVLKLSYDALPPRSKKCF
AFASLFPKNRMMSKDELIQLWTANGFASSEGNFDAETVGNRIFDDLVLRAFFLLAPSKECDECTMHDLMH
ELGRSVAEDEYHNRNDYKKKENIKITDHLFKKPLYLRTLLLRNCFPFGKFQLLQLVFSKLKFLRALDLSK
NGFTEVPTSVGNLIHLRYLNLSDNCIKFLPDAITLLQNLQYLNFTKNPLEELPKKLRNMQSLRYLDFDLY
KLTHMPLGLSRLTSLRSLSCFVSDDNITGSCSITELEDLKLHGKMKIKFSGNFSNYSCGGRKILKNKDFN
ELSLSFNYSVTNDMSMLDDLCPNTSLKKLQISKYGSQQFPTWFMKSQLPNLVEVILEDCKICEHIPHFGN
LQFLRKLVLDDIGGVKHLGAEFHGHGGFPSLQKLELLSMFDLEEWSESDSVDELFPLLNKLQIDDCPKLE
TVPRLPRIKQLALFNCSKSLMSGVGRMTSLSHLILEGMKDMTYLPSGCLRNLTSLMTLEIRGCNELQFLP
WDEMQLLPKLHSLSIKKCDNLCLKNHDSDTLQLDMLVQILNSVHEFDIQIRGKNVNSSFFSQNNVQSHQG
IIKYLLL


>XP_042474105.1 putative disease resistance protein At3g14460 [Zingiber officinale]
MELESLQKILHQHIAQKKFLLFLDDVWSDNKNIWHKFCALLKVGAHGSKIIVTTRDMKVSKMVSLVEPIL
LHGLDEVAFRQLFNKCSFGTLDPEDYPELQDIGRNIADKLKGSPLAAKTLGSVLQSDLCQQHWDTIMKSD
IWKVKQDEDDIMPALHLSYKYLNENLKQCFAFCPLFPKDYKFDKAELVRMWMAEGFIEDTNTKRMEDVGS
DYFLEFVNRAFFQKYKFGGFVMHDLIHDLAEMISAEETCSIENNRQTKMFSTIRHLRVEGKLPLEVSGYD
KLHTLMLRKNSPSDSLFEKLRSIRILNVSQCGLQELSEHIGKLIHLRYLDISWNSEIKILPDSLCHLHNL
QTLEILGCHKLESIPQELSKKMVNVRHINANNKFWGMIKDVQRLTNLQELPTFSVQEDDGLRLVQLKDLA
QLHGTLHIENLENVVDSKEVQHAELKNKVHLTELVLEWNHQKDAKLEEEVIEGLQPHESLKILTISGYKG
AKSPSWLMPKVLSNLEKLELVNCMGWDDVLPFIGQRLHLIELHMDGMPALKQLSHEFEGKCFPKLKVLNL
WNLPALEEWSWTEGKDLFPCMRELRVWKCPKLKRLPPFPPSLEILTIEDCPELKLNSKTEDDEEGGCYLP
PSLKVLELDNCGEYSKLLPECLPNLRLVTRLTIRHCPHITSIPPVQLVELQFLYISNCDELRRMECLGLL
KSLERLQIAGCPMLVQLDVEDEQAASLLSSLRKLCVDNTALLKMSPLRHSLPFITELVIESCSEEVIFEE
AILVRSLTAVTSLRFLRCDKLRSLPAELLHCLPFLKTLMVSNCPQLQSLPEMGLSPFLERLEIYNCPQIQ
AMPEDGLPMSLDVFICSGDVHPKLREQSEKFFVDRYNRRVSTLDARYFHA


>XP_042474107.1 putative disease resistance protein RGA4 [Zingiber officinale]
MEPALLTAVSLFMGPWVADLNKKLKEVVGIEGRMAKLRELSTIIDAVIQDVEACSVRDATAKDLLRKLKY
LAYDLEDVVDYYDTETLRKQRSKAYSRPVRDFFSSNNNQLVFKSKISGMIKAVTENLDSILLQRSILLNL
PQGTVRMSPIAYREIHSHNSLAVIGRDTEKEMIIKMLTDEEGSSNGTMKVIAIVGMGGLGKTTLARHVFK
DERVKTHFGELNMYWKVVGEEFDPTKIMKSIFELATGAPVNISEPELVKRELEKALLEKRFLLVLDDVWN
EDKSQWTALEAALTCGARGSKVLVTTRSREVSSIMGSFNTHQIQQLSRDDCLSLFRRFAFGDEEPNKNLM
KIGEKIVEKCGGVPLAAVSLGSTLHSIRDETYWSSVLNSEIWQLGDEGEKFLAVLKLSYDALPPRSKKCF
AFASLFPKNRMMSKDELIQLWTANGFASSEGNFDAETVGNRIFDDLVLRAFFLLAPSKECDECTMHDLMH
ELGRSVAEDEYHNRNDYKKKENIKITDHLFKKPLYLRTLLLRNCFPFGKFQLLQLVFSKLKFLRALDLSK
NGFTEVPTSVGNLIHLRYLNLSDNCIKFLPDAITLLQNLQYLNFTKNPLEELPKKLRNMQSLRYLDFDLY
KLTHMPLGLSRLTSLRSLSCFVSDDNITGSCSITELEDLKLHGKMKIKFSGNFSNYSCGGRKILKNKDFN
ELSLSFNYSVTNDMSMLDDLCPNTSLKKLQISKYGSQQFPTWFMKSQLPNLVEVILEDCKICEHIPHFGN
LQFLRKLVLDDIGGVKHLGAEFHGHGGFPSLQKLELLSMFDLEEWSESDSVDELFPLLNKLQIDDCPKLE
TVPRLPRIKQLALFNCSKSLMSGVGRMTSLSHLILEGMKDMTYLPSGCLRNLTSLMTLEIRGCNELQFLP
WDEMQLLPKLHSLSIKKCDNLCLKNHDSDTLQLDMLVQILNSVHEFDIQIRGKNVNSSFFSQNNVQSHQG
IIKYLLL


>XP_042474108.1 putative disease resistance protein RGA4 [Zingiber officinale]
MEPALLTAVSLFMGPWVADLNKKLKEVVGIEGRMAKLRELSTIIDAVIQDVEACSVRDATAKDLLRKLKY
LAYDLEDVVDYYDTETLRKQRSKAYSRPVRDFFSSNNNQLVFKSKISGMIKAVTENLDSILLQRSILLNL
PQGTVRMSPIAYREIHSHNSLAVIGRDTEKEMIIKMLTDEEGSSNGTMKVIAIVGMGGLGKTTLARHVFK
DERVKTHFGELNMYWKVVGEEFDPTKIMKSIFELATGAPVNISEPELVKRELEKALLEKRFLLVLDDVWN
EDKSQWTALEAALTCGARGSKVLVTTRSREVSSIMGSFNTHQIQQLSRDDCLSLFRRFAFGDEEPNKNLM
KIGEKIVEKCGGVPLAAVSLGSTLHSIRDETYWSSVLNSEIWQLGDEGEKFLAVLKLSYDALPPRSKKCF
AFASLFPKNRMMSKDELIQLWTANGFASSEGNFDAETVGNRIFDDLVLRAFFLLAPSKECDECTMHDLMH
ELGRSVAEDEYHNRNDYKKKENIKITDHLFKKPLYLRTLLLRNCFPFGKFQLLQLVFSKLKFLRALDLSK
NGFTEVPTSVGNLIHLRYLNLSDNCIKFLPDAITLLQNLQYLNFTKNPLEELPKKLRNMQSLRYLDFDLY
KLTHMPLGLSRLTSLRSLSCFVSDDNITGSCSITELEDLKLHGKMKIKFSGNFSNYSCGGRKILKNKDFN
ELSLSFNYSVTNDMSMLDDLCPNTSLKKLQISKYGSQQFPTWFMKSQLPNLVEVILEDCKICEHIPHFGN
LQFLRKLVLDDIGGVKHLGAEFHGHGGFPSLQKLELLSMFDLEEWSESDSVDELFPLLNKLQIDDCPKLE
TVPRLPRIKQLALFNCSKSLMSGVGRMTSLSHLILEGMKDMTYLPSGCLRNLTSLMTLEIRGCNELQFLP
WDEMQLLPKLHSLSIKKCDNLCLKNHDSDTLQLDMLVQILNSVHEFDIQIRGKNVNSSFFSQNNVQSHQG
IIKYLLL


>XP_042474109.1 putative disease resistance protein RGA4 [Zingiber officinale]
MIASPFLSIFCFCFCFSFPLLSSSSNVSCSHIHSKQTTRPSFQLAGIAMEPLAISAAGFLGQRLVSLLQL
DKKLKDLVDIERKMEKLKELPTIIDTVIQYVEACSVRDAAVKKLLRNLKHLAYDLEDVVDYYDTKALRKQ
RSRSYSRPVRDFFSFNNNQLVFKSRISGMIKAVTENLDSILLDKAILENLPQGTNRISQSAYREFHSHNS
LAVIGRETEKEMIINMLTDEEGSSNSTTTKVIAIVGMGGLGKTTLARHVFNDERVKAHFGKLNTYWKVVG
AEFDPTKIMKSILELATGAPVNISEPELVKRELEKALSEKRFLLVLDDVWNEDKSQWTALEAVLTCGARG
SKVLVTTRSPKVSSIMGSFNTHQIQQLPRDDCLSLFQQFAFGDEEPNENLMEIGGKIVEKCGGVPLAAKS
LGSMLHSTRDETYWSSVLNSEVWQLGDEGEKFLAVLKLSYDALPLRSKKCFAFGSLFPKNYVMKKDELIQ
LWTANGFVCSEGNFNAETDGNRIFDDLVLRSFFLLAPPKKCDDDGRHVTECTMHDLMHDLARSISEDEYY
NDVDDEEKDIQKRTYHIWLKYEEISHTSLFKMPLYLRTLSLRSCLSFKKAHLLQFVFSKLKLLRVLDLSE
NGIEEVPTSIGNLIHLRYLTLSGNRIKFLPDAITLLQNLRYLSLIDNPLQQLPKKLRNMQSLGYLHCDCY
YLTHMPLGLSRLTSLRSLSCYVSDDNRTGSCSITELEDLKLHGNMRIKFSKNSSNYSCGGRKILKNKNFN
ELSLSFNCSETNDMSMLDDLCPNMNLKKLKISYYGSRQFPTWLMEPQLPNLVEVILNYSYTCEHVPPFGN
LQSLRKLAMIRMDNVKRMGAEFHGHGPIRGFPSLQELQLEWMRNLEEWSESDGADELFPLLKTLKILNCP
KLKTMPRFPTIEFLNLDNCSESLVSCVRRMTSLSHLILEGMKGMTSLPSGCLRNLTSLMRLEILSCNELQ
FLPRDEMQLLTMVHSLSIEKCNNLTSFPLEMGRLGALRYLCLKNPDNNTLAPNNGSPIVQILNSVHEFDI
QICGKNVNLLGQLQHLHTLRELTISGSHDTTYGPAIMGYIIRASLSICCCDELESLMTTAPSTSVLEILG
IFDIPNLTILPEWLRHLGSLDMLWIRNCPQLGSLPRGLQELRSLNILRIDGCCLQLKRRCKRETGEDWPN
ISHVSLIRISPRDEAQRCRPFDRFFKINPTRWREI


>XP_042474790.1 putative disease resistance protein RGA3 isoform X1 [Zingiber officinale]
MEFLTAVVPLLASNLAHMRQELQTVYGLHVELGRLQNSVSMIQAVLSEAQENEQSRNAVKHLLPELSQAA
YEANDALDDVATEWQRCQLIKYASVRNFLAPVNPKREKFKREMGIRLREIENRLSYIASRCPLHNLHSGS
PRLYGYQTTSLSPPRLLGREFDKQKLKELLIPLNEVTGSGVSVIPIFGMPGVGKTTLAQLVCNDESVKDH
FELRLWVNVSRDFDLVRIMSTIIEFIDGFQCDLVTLSDLQNEITKKLSGKRCLLVLDDVWQESQEWERLK
SFLYSADEGSKILVTTKSEQVAAFMATNSPPYHLEGLSRDDCWSLICQYAFARDPTATFALEGYRILAVS
KCKGFPLAAIALGQRLFREADRSKWGAILRSNSSPLPLSSGLSGADGSIMDAFSLSYQNFPQYLKSCLAY
FSMIPKGSEFEKDFIIQLWMAQSFIQTRGDEQVEDIANDYFDSLVQSSFLQYSRFDHKSHQHRYMVQDVF
HECARCIAAEECSNMEPGLDLHVAASLRHLSVNYEQFAASFPWFQGHSYLYEEVYKCKGLQSLLLIGNST
NGPTMVVPDDLAKKLSSLRTLMLTNLCLNQLPESIGDLKHLRCLQLQNTSIKRLPESVSYLYNLQTLGLR
NCYRLKELPKDTRNLLNLRHLDLHLDQNSRVSLAPEDTNTSGELRCMPPEIGSLTHLRTLPRFIVSTRPE
CGLSQLRYLNNLRGELAIERLDLVFGVGEAVEANLSSKEHIHRLELTWKYNNLTEAVAQSVGNDSRETIL
KYLRPHSNLREIGIVGYGGAMFPTWMGDSSFYNLETVQISQTYNCLNLPPLGQLPKLKYLFLKEMHGLKC
MDCSLCGKNKTRFPALETLHLENMSGLQEWWGDDDCTLLSLRELRIKNCMALDQLRHKLPSLERLVIEAS
RNFVGLQDFPELKSLEVKTNDDWIWSSWPVMSLLPSLTLSGLQRRTLPFYVEGRHALIRRLEISSCSQLL
SLPDAWLPAGLSDFAVRHCSELQHLPKGLTELRELEHLEIENCKRLKYLPVGLRNMNSLTYLEVSDCPGL
LCLPTDGFPANLRFLGISNCPELRQQCQGMGDQGWFDLQHGLRVWIDGRLVSFSGHRHPHAPEAPTTFRT
VIV


>XP_042474791.1 putative disease resistance protein RGA3 isoform X2 [Zingiber officinale]
MEFLTAVVPLLASNLAHMRQELQTVYGLHVELGRLQNSVSMIQAVLSEAQENEQSRNAVKHLLPELSQAA
YEANDALDDVATEWQRCQLIKYASVRNFLAPVNPKREKFKREMGIRLREIENRLSYIASRCPLHNLHSGS
PRLYGYQTTSLSPPRLLGREFDKQKLKELLIPLNEVTGSGVSVIPIFGMPGVGKTTLAQLVCNDESVKDH
FELRLWVNVSRDFDLVRIMSTIIEFIDGFQCDLVTLSDLQNEITKKLSGKRCLLVLDDVWQESQEWERLK
SFLYSADEGSKILVTTKSEQVAAFMATNSPPYHLEGLSRDDCWSLICQYAFARDPTATFALEGYRILAVS
KCKGFPLAAIALGQRLFREADRSKWGAILRSNSSPLPLSSGLSGADGSIMDAFSLSYQNFPQYLKSCLAY
FSMIPKGSEFEKDFIIQLWMAQSFIQTRGDEQVEDIANDYFDSLVQSSFLQYSRFDHKSHQHRYMVQDVF
HECARCIAAEECSNMEPGLDLHVAASLRHLSVNYEQFAASFPWFQGHSYLYEEVYKCKGLQSLLLIGNST
NGPTMVVPDDLAKKLSSLRTLMLTNLCLNQLPESIGDLKHLRCLQLQNTSIKRLPESVSYLYNLQTLGLR
NCYRLKELPKDTRNLLNLRHLDLHLDQNSRVSLAPEDTNTSGELRCMPPEIGSLTHLRTLPRFIVSTRPE
CGLSQLRYLNNLRGELAIERLDLVFGVGEAVEANLSSKEHIHRLELTWKYNNLTEAVAQSVGNDSRETIL
KYLRPHSNLREIGIVGYGGAMFPTWMGDSSFYNLETVQISQTYNCLNLPPLGQLPKLKYLFLKEMHGLKC
MDCSLCGKNKTRFPALETLHLENMSGLQEWWGDDDCTLLSLRELRIKNCMALDQLRHKLPSLERLVIEAS
RNFVGLQDFPELKSLEVKTNDDWIWSSWPVMSLLPSLTLSGLQRRTLPFYVEGRHALIRRLEISSCSQLL
SLPDAWLPAGLSDFAVRHCSELQHLPKGLTELRELEHLEIENCKRLKYLPVGLRNMNSLTYLEVSDCPGL
LCLPTDGFPANLRFLGISNCPELRQQCQGMGDQGWFDLQHGLRVWIDGRLVSFSGHRHPHAPEAPTTFS


>XP_042474792.1 putative disease resistance protein RGA3 [Zingiber officinale]
MEFVSMFLLDALVNTLADTLQDHVFQELQKVHRVGDELVKLQKSVSSIQAVLSDAQESEETRNIVKQLLN
ELRDVAYRANDILDDVATEQQRQQLINYAPVRNFFGPVNLMRLLFQRDVYHKIQSIDEELDKIVKRCPLI
ALSPRNRSQRTHSSESTPAIPPCVLGRERDKQKIKELLVPFSGRTDSAASVISIFGMPGVGKTTLAQQLF
DDETVKKHFELRLWVYVSHDFDLMRIMRCMIESIDGFKCDLTSLNNLQQEVRKKVSRRRYLLVLDNVWQE
SQEWEKLKSFLYSADEGSKILVTTKSEQVARFMAANSPPYHLEGLSMDDCWSLICQQVLSRNPSATFTHD
FSQSHALRRCMGLPMAAKALGERLAREADRSKWEAILTSQSWEFSGAGISITETLSLSYQHLPHYLKPCF
EYLSIIPKGFKLERDFIIQLWMAQSFIRPKGTEHMEDVGSDYLDSLRSSSFLQYSHFDHKSRRQRYVMHD
VFHEFARHVAAEECSVMEPSTEPSTDLHLSLSARVRHLSVNYEELVRRVPRGGDMYEQVYKCKGLQSLLL
IGNSTSRPTMVVPDNLAQRLRSLRTLMLTNSCLTQLPESIGDLSHLRCLQLQNTGIKRLPDSVSRLYNLQ
TLGLRNCYDLEELPKDMSKLRNLRHLDLHLDGNSQGSNAGGKLRLMPPEIGLLTHLRTLSRFVVSKRHEC
GLSQLENLNDLRSDLLIERLDLVSSGEDAKNANLWSKEHIHRLELTWNYSDVTEASASSAGYNSRENILK
YLRPHNKLKEIGVVGYGGTLLPTWMGDSSLENLETVWISKTYSCQNLPPLGQLPKLKYLFLEEMHGLKHI
DCSFCGRNEIRFPKLEKLHLENMSGLQEWLGDHRCALPSLRELTINNCPALQQLTHELPSLTKLVIEASP
YFAGLPDFPKLQSLEVKTNDDWIWRSCATISSLPSLTLSGLRRANLPSEISSCHSFIRRLEISYCSQLIF
IPDGWLPAFLSHFVIRHCPKLQNLPAELTRLTRLEDLEIEKCEKLEQLPFGLRNMNLLAHLEISDCPGLS
WLHGLPRNLQFLSISNCPELSQKLQDQGWFTRRKDLQVWINGHRLDFMKISH


